Citrus Sinensis ID: 007055
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 620 | 2.2.26 [Sep-21-2011] | |||||||
| Q944Q0 | 563 | Serine/threonine-protein | yes | no | 0.843 | 0.928 | 0.546 | 1e-169 | |
| Q6EU49 | 612 | Probable serine/threonine | yes | no | 0.929 | 0.941 | 0.519 | 1e-161 | |
| Q8RXE5 | 524 | Probable serine/threonine | no | no | 0.812 | 0.961 | 0.514 | 1e-152 | |
| Q8S8Y8 | 567 | Probable serine/threonine | no | no | 0.645 | 0.705 | 0.627 | 1e-150 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.643 | 0.716 | 0.629 | 1e-148 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.687 | 0.605 | 0.550 | 1e-133 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.687 | 0.605 | 0.550 | 1e-133 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.654 | 0.58 | 0.526 | 1e-131 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.638 | 0.637 | 0.551 | 1e-129 | |
| Q8S8Y9 | 568 | Serine/threonine-protein | no | no | 0.737 | 0.804 | 0.485 | 1e-127 |
| >sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 594 bits (1531), Expect = e-169, Method: Compositional matrix adjust.
Identities = 336/615 (54%), Positives = 410/615 (66%), Gaps = 92/615 (14%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++YD++LG+GAFKTVYK FDEVDGIEVAWN V+IEDVMQ P QLERLYSEVHLLK+LKH
Sbjct: 28 YIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSEVHLLKALKH 87
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
ENIIK + SWVD+ N+TINMITELFTSGSLR YRKKH+ VD KAIKNWARQIL+GL+YLH
Sbjct: 88 ENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLH 147
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
S NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA V+QQPTARSVIGTPEFMAPELYEEEY
Sbjct: 148 SQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEY 207
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMC+LEMVTCEYPYNEC+N AQIYKKVTS IKP SL KV DPQV+QFIEKC
Sbjct: 208 NELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKC 267
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDP--------LRLPNLVPEVMNLAHSEPHPM 306
++PAS R ALEL KDPFL D KD +R P L E PM
Sbjct: 268 LLPASSRPTALELSKDPFLARDGGKDSALLASSSTSSKYVRPPQL----------EHLPM 317
Query: 307 DIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSG 366
D+D N K S + + W T+ELQR+ EN EF LRGE++DD T S+ LRI D SG
Sbjct: 318 DVDHNENK----SVSSNEDYPWSQTIELQRIAENKEFRLRGERSDDVTASMVLRIADPSG 373
Query: 367 HVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTA 426
+HF FYL +DTA +IAEEMVE+L L+ ++VV IA++ID+ IM+L+ T+
Sbjct: 374 KCRIVHFAFYLESDTATAIAEEMVEELHLTSQEVVVIADMIDDFIMQLLSD------RTS 427
Query: 427 SQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLS--ELASGKYQYNQESSD 484
S N P + EA +QQ V S E A+G +S
Sbjct: 428 SHHN------------------QNSPRLTHEDHEAANQQTVNSKDEEAAG------QSMK 463
Query: 485 SDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNS 544
SDISA++ P + DG +A A D ES+
Sbjct: 464 SDISADYYFPYSAN---------DGNAAMEAGRD-------------AESM--------- 492
Query: 545 ETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEM 604
+S++DSCS M S+I +LS++D ++ + LK EL+ I S++ Q FQ+LL+ +ED +
Sbjct: 493 -SSYLDSCSMM------STIYNLSISDNDYPEDLKTELNLIESQFNQSFQDLLKLKEDAI 545
Query: 605 ENARKRWLAGSNVSV 619
ENA+++W+ +V
Sbjct: 546 ENAKRKWITKKQKAV 560
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 568 bits (1465), Expect = e-161, Method: Compositional matrix adjust.
Identities = 316/608 (51%), Positives = 410/608 (67%), Gaps = 32/608 (5%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++Y+E+LG+GA KTVYK FDEV+GIEVAW+QV I++VMQSPD LERLYSEVHLLKSLKH
Sbjct: 24 YIRYNEVLGRGAMKTVYKAFDEVEGIEVAWSQVEIDEVMQSPDNLERLYSEVHLLKSLKH 83
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
EN++KFYN WVDD +TIN+ITELFTSGSLRQYR+KH VD+KAIKNWARQ+LRGL YLH
Sbjct: 84 ENVMKFYNYWVDDQKKTINVITELFTSGSLRQYRQKHPRVDLKAIKNWARQVLRGLDYLH 143
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
+H PPIIHRDLKCDNIFVNGN+GEVKIGDLGLA VM P A+SVIGTPEFMAPELY+E Y
Sbjct: 144 THQPPIIHRDLKCDNIFVNGNHGEVKIGDLGLATVMLTPRAKSVIGTPEFMAPELYDENY 203
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
+ELVDIYSFGMC+LEM T EYPY+EC N AQI+KKV+ G+KPA+L+K+T+ Q KQFI+KC
Sbjct: 204 DELVDIYSFGMCMLEMFTLEYPYSECTNAAQIFKKVSKGVKPAALAKITNIQAKQFIDKC 263
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKK 314
+VPAS RL A ELL+DPFL +DN LV + P+ +P+ ++++ H MD+D N
Sbjct: 264 LVPASERLSAKELLQDPFLCSDNSSVLV--GTKFPSSLPKSVDVSLEALH-MDVDTNESM 320
Query: 315 VSADSCAKSNTGTWFLT-LELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHF 373
++ +C +++ G + LE R +N E L GEK DD++VSL LRI D GH NIHF
Sbjct: 321 CTS-TCKRNDLGGPHRSVLEFTRTNKNTELKLTGEKLDDNSVSLVLRIADLCGHARNIHF 379
Query: 374 VFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPS---WNPSLGSTASQQN 430
+FYL++DTA+S+A EMVEQL+L+ DV IA+ ID LI+ LVP N ++ ST+S+
Sbjct: 380 LFYLDSDTAMSVAAEMVEQLELADCDVTFIADFIDLLIVNLVPGQQLMNDAVMSTSSESK 439
Query: 431 -GLLKGSPVSQGNSISLK---CPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSD 486
G + SQ + L E ++ A A + S L + S SD
Sbjct: 440 MGESEHVITSQQHPSELTHDYVLVEGMMHSKEANASPSDYIDSLLNATNLGGPNSSEGSD 499
Query: 487 ISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVS--LGESILFNESTQNS 544
IS + D KSL + Y V ++ E A + + LG + + N
Sbjct: 500 ISVQLDGS-------SKSL------SEYGVDEYRTLECGAYKGTDKLGCRHPLSNGSSNF 546
Query: 545 ETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEM 604
+D S S+ + +S+S E+ D L EL I ++Y+Q F+EL R RE+ +
Sbjct: 547 AIFQMDQASHHSELVIGASVSI-----TENRDVLNGELGLIEAQYEQWFRELTRMREEAL 601
Query: 605 ENARKRWL 612
E ARK+WL
Sbjct: 602 EGARKKWL 609
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXE5|WNK10_ARATH Probable serine/threonine-protein kinase WNK10 OS=Arabidopsis thaliana GN=WNK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 537 bits (1384), Expect = e-152, Method: Compositional matrix adjust.
Identities = 309/601 (51%), Positives = 376/601 (62%), Gaps = 97/601 (16%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++Y+++LG+GAFKTVYK FDEV+GIEVAWN ++IEDV+Q P QL+RLYSEVHLL SLKH
Sbjct: 15 YIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSEVHLLNSLKH 74
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
+NIIK + SWVDD N++INMITELFTSGSL YRKKH+ VD KAI NWARQIL+GLHYLH
Sbjct: 75 DNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLH 134
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
S PP+IHRDLKCDNIFVNGN G+VKIGDLGLA VMQQPTARSVIGTPEFMAPELYEEEY
Sbjct: 135 SQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEY 194
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMC+LEMVTCEYPY EC+N AQIYKKVTSGIKP SLSKV DPQVKQFIEKC
Sbjct: 195 NELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKC 254
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDL-NHK 313
++PA R ALELLKD L D KD P + E PMD++ +
Sbjct: 255 LLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMP--PQCEYRPMDVEYKKNT 312
Query: 314 KVSADSCAKSNTGTWFL-TLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIH 372
VS S AKS+ L T+E+QR+ E+ EF L GE+ DD S+ LRI SG +
Sbjct: 313 SVSICSSAKSSQECALLQTMEVQRVAESTEFKLSGERRDDVAASMALRIAGSSGQARKVD 372
Query: 373 FVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGL 432
F F L DTA ++ EMVE+LDLS +V IAE+ID LIMKL N SL
Sbjct: 373 FDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKL--KANRSL---------- 420
Query: 433 LKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFD 492
P +N+ + + G ES S+ISA++
Sbjct: 421 -------------------PNANSVYQSKDEEAG--------------ESMKSEISADY- 446
Query: 493 VPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVS-LGESILFNESTQNSETSFIDS 551
H V ++E S LG E+ ++ +SF+DS
Sbjct: 447 ----------------------------YHRVSSNEGSRLG---CCCEAVESLLSSFLDS 475
Query: 552 CSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRW 611
CS +S + S+ LK EL+ I S+Y Q Q LLR +E+ +E A+++W
Sbjct: 476 CSMVS---------------NKQSEDLKTELNVIESQYNQSCQRLLRMKEEAIEKAKRKW 520
Query: 612 L 612
+
Sbjct: 521 M 521
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 531 bits (1367), Expect = e-150, Method: Compositional matrix adjust.
Identities = 261/416 (62%), Positives = 322/416 (77%), Gaps = 16/416 (3%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++Y E++GKGAFKTVYK FDEVDGIEVAWNQV I+DV+QSP+ LERLYSEV LLKSLKH
Sbjct: 27 YIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKH 86
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
NII+FYNSW+DD N+T+N+ITELFTSGSLR YRKKH+ V+MKA+KNWARQIL GL YLH
Sbjct: 87 NNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLH 146
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
PPIIHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVIGTPEFMAPELY+E Y
Sbjct: 147 GQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENY 206
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NEL DIYSFGMC+LEMVT +YPY ECKN AQIYKKV+SGIKPASLS+V DP+VKQFIEKC
Sbjct: 207 NELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKC 266
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV-PE--------VMNLAHSEPHP 305
++PAS RL A ELL DPFL + + +PL LP++V P+ +M+ P
Sbjct: 267 LLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIVMPKEGAFGDRCLMSEGPPTTRP 324
Query: 306 ---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIG 362
+ IDL+ N+G+ +E++R N F L+GE+ND+ +VSL LRI
Sbjct: 325 SKTLSIDLDEDSNLPIVTFSDNSGSR--CIEVRRAKRGNFFVLKGEENDEQSVSLILRIV 382
Query: 363 DKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSW 418
D++G V NIHF+FY DTA ++ EMVEQL+L+ ++V IAELID L++ ++P+W
Sbjct: 383 DENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTW 438
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 525 bits (1353), Expect = e-148, Method: Compositional matrix adjust.
Identities = 262/416 (62%), Positives = 328/416 (78%), Gaps = 17/416 (4%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++Y E++GKGA KTV+KGFDEVDGIEVAWNQV I+D++QSPD LERLYSEV LLKSLKH
Sbjct: 27 YIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKSLKH 86
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
+NII+FYNSW+DD N+T+N+ITELFTSGSLRQYRKKH+ V+MKA+K WARQIL GL YLH
Sbjct: 87 KNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLH 146
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
S +PPIIHRD+KCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVIGTPEFMAPELY+E Y
Sbjct: 147 SQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENY 206
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NEL DIYSFGMC+LEMVT EYPY EC+N AQIYKKV+SGIKPASLSKV DP+V +FIEKC
Sbjct: 207 NELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKC 266
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVC-DPLRLPNLV-PEVMNLAH----SEPHP--- 305
++PAS RL A ELL D FL N LV +PL LP++V P+ + SE P
Sbjct: 267 LLPASERLSAEELLLDSFL---NVNGLVMNNPLPLPDIVMPKEGSFGERCLMSEGPPNAR 323
Query: 306 ---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIG 362
M ++L+ + +N+GT +E++R N F L+GE+ND+++VSL LRI
Sbjct: 324 NRTMSMNLDEDNNLPIVISSNNSGTN--CIEVRRAKRGNFFVLKGEENDENSVSLILRIV 381
Query: 363 DKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSW 418
D++G V NIHF+F+ DTA +++ EMVEQL+L+ ++V IAELID L++ L+P+W
Sbjct: 382 DENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNW 437
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 477 bits (1227), Expect = e-133, Method: Compositional matrix adjust.
Identities = 246/447 (55%), Positives = 305/447 (68%), Gaps = 21/447 (4%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+ +Y+++LGKGA KTVY+ FDE G+EVAWNQV + D +QSP+ LERLY E+HLLK+LKH
Sbjct: 26 YGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCEIHLLKTLKH 85
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
NI+KFY SWVD + R IN ITE+FTSG+LRQYR+KH V++ A+K+W RQIL GL YLH
Sbjct: 86 RNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLH 145
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
SH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA ++++ A +GTPEFMAPE+YEEEY
Sbjct: 146 SHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEY 205
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMC+LEMVT EYPY+EC +P QIYKKV SG KP +L KV DP V+QF+EKC
Sbjct: 206 NELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKC 265
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDP----------LRLPNLVPEVMNLAH---- 300
+ AS RL A ELLKDPFL D DLV P LR P L N++
Sbjct: 266 LATASRRLSARELLKDPFLQVD---DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNG 322
Query: 301 -SEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTL 359
SE D + D K++ F E + L N + T++G K++D ++ L L
Sbjct: 323 LSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLG-NVDITIKGRKSEDGSIFLRL 381
Query: 360 RIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWN 419
RI D GHV NI+F F + ADTA+S+A EMV +LD++ +V IAE+ID + LVP W
Sbjct: 382 RIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWR 441
Query: 420 PSLGSTASQQNGLLK--GSPVSQGNSI 444
P G SQ GS VS S+
Sbjct: 442 PGPGIEESQDTTYCHNCGSNVSSCGSL 468
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 477 bits (1227), Expect = e-133, Method: Compositional matrix adjust.
Identities = 246/447 (55%), Positives = 305/447 (68%), Gaps = 21/447 (4%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+ +Y+++LGKGA KTVY+ FDE G+EVAWNQV + D +QSP+ LERLY E+HLLK+LKH
Sbjct: 26 YGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCEIHLLKTLKH 85
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
NI+KFY SWVD + R IN ITE+FTSG+LRQYR+KH V++ A+K+W RQIL GL YLH
Sbjct: 86 RNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLH 145
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
SH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA ++++ A +GTPEFMAPE+YEEEY
Sbjct: 146 SHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEY 205
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMC+LEMVT EYPY+EC +P QIYKKV SG KP +L KV DP V+QF+EKC
Sbjct: 206 NELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKC 265
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDP----------LRLPNLVPEVMNLAH---- 300
+ AS RL A ELLKDPFL D DLV P LR P L N++
Sbjct: 266 LATASRRLSARELLKDPFLQVD---DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNG 322
Query: 301 -SEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTL 359
SE D + D K++ F E + L N + T++G K++D ++ L L
Sbjct: 323 LSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLG-NVDITIKGRKSEDGSIFLRL 381
Query: 360 RIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWN 419
RI D GHV NI+F F + ADTA+S+A EMV +LD++ +V IAE+ID + LVP W
Sbjct: 382 RIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWR 441
Query: 420 PSLGSTASQQNGLLK--GSPVSQGNSI 444
P G SQ GS VS S+
Sbjct: 442 PGPGIEESQDTTYCHNCGSNVSSCGSL 468
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1203), Expect = e-131, Method: Compositional matrix adjust.
Identities = 235/446 (52%), Positives = 298/446 (66%), Gaps = 40/446 (8%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+ +Y+E+LGKGA KTVY+ FDE +GIEVAWNQV + D +QSP+ LERLY E+HLLK+LKH
Sbjct: 23 YGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
+NI+KFY SWVD NR IN +TELFTSG+LRQYR +HK V+++A+K+W RQILRGLHYLH
Sbjct: 83 KNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLH 142
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
SH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++++ A +GTPEFMAPE+YEE Y
Sbjct: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAY 202
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMCILEMVT +YPY+EC +PAQIYKKV SG KP +L KV DP+VK FIEKC
Sbjct: 203 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKC 262
Query: 255 IVPASLRLPALELLKDPFLVTDNP---------KDLVCDPLRLPNLVPEVMNLAHSEP-- 303
+ SLR+ A ELL DPFL D+ +D V R P+ +P+ N +
Sbjct: 263 LATVSLRVSARELLDDPFLRIDDGEFDLRSVDMEDSVGPLYRQPHHLPDYYNYPSNSSSL 322
Query: 304 --------HPMD-IDLNHKKVSADSCAKSNTGTWFLT--------------------LEL 334
+P + LN + + + W E
Sbjct: 323 NRQYSNGNYPSNSSSLNRQYSNGYNSHHEYQNGWAYNPAETEETHGIELFESRNNDDQEE 382
Query: 335 QRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLD 394
++ + N + T++G++ DD + L LRI DK G V NI+F F + DTA+S+A EMV +LD
Sbjct: 383 EKKSGNVDITIKGKRRDDGGLFLRLRIADKEGRVRNIYFPFDIETDTALSVATEMVAELD 442
Query: 395 LSHEDVVSIAELIDNLIMKLVPSWNP 420
+ V IA +ID I LVPSW P
Sbjct: 443 MDDHGVTKIANMIDGEISSLVPSWRP 468
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1186), Expect = e-129, Method: Compositional matrix adjust.
Identities = 229/415 (55%), Positives = 296/415 (71%), Gaps = 19/415 (4%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+ +Y E+LGKGAFKTVYK FD+++G+EVAWNQ+ + D++++ D LERL SEV LLK+LKH
Sbjct: 27 YGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLERLRSEVRLLKTLKH 86
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
+NIIKFYNSW+D N IN ITE+FTSG+LRQYR KHK VD++A+K W+RQIL GL YLH
Sbjct: 87 KNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALKKWSRQILSGLVYLH 146
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE 193
SH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++ +A S+IGTPEFMAPELY+EE
Sbjct: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSIIGTPEFMAPELYDEE 206
Query: 194 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253
YNELVDIY+FGMC+LE+VT EYPY EC N AQIYKKV+ G KP+SL+K+ DP+V+ FIEK
Sbjct: 207 YNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSLAKIEDPEVRFFIEK 266
Query: 254 CIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHK 313
CI AS RL A ELL DPFL D K + PL+ + ++S + +
Sbjct: 267 CIAKASQRLSAQELLMDPFLRDDGEK--IFYPLQSNTKASDGAGSSNSS-----MGYKYD 319
Query: 314 KVSADSCAKSNTGTW----------FLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGD 363
+ ++ + +TG++ T++ Q T+ + D +T+ L LRI D
Sbjct: 320 RDASSMAIREHTGSFAEEHPSDRYIHSTMDPQ-AAAGRIITVESQMKDLNTIFLKLRIAD 378
Query: 364 KSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSW 418
+GH NIHF F + ADT+IS+A EMV QLDL+ +DV +IAE+ID I +P W
Sbjct: 379 STGHAQNIHFPFDIEADTSISVATEMVVQLDLTDQDVTAIAEMIDAEIRAHIPDW 433
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1173), Expect = e-127, Method: Compositional matrix adjust.
Identities = 232/478 (48%), Positives = 314/478 (65%), Gaps = 21/478 (4%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+ +YDEILGKGA KTVY+ FDE +GIEVAWNQV + + ++P++LE+ + E+HLLK+L H
Sbjct: 23 YGRYDEILGKGASKTVYRAFDEYEGIEVAWNQVKLRNFTRNPEELEKFFREIHLLKTLNH 82
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
+NI+KFY SWVD N +IN +TELFTSG+LRQYR +H+ V+++A+K W +QIL+GL YLH
Sbjct: 83 QNIMKFYTSWVDTNNLSINFVTELFTSGTLRQYRLRHRRVNIRAVKQWCKQILKGLLYLH 142
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
S +PPIIHRDLKCDNIF+NGN GEVKIGDLGLA ++++ A +GTPEFMAPE+Y+EEY
Sbjct: 143 SRSPPIIHRDLKCDNIFINGNQGEVKIGDLGLAAILRKSHAVRCVGTPEFMAPEVYDEEY 202
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVD+Y+FGMC+LEMVT +YPY+EC +PAQIYKKVTSG KP + V DP+V++F+EKC
Sbjct: 203 NELVDVYAFGMCVLEMVTFDYPYSECTHPAQIYKKVTSGKKPEAFYLVKDPEVREFVEKC 262
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPM-DIDLNHK 313
+ + RL ALELL+DPFL DN V P+ N E HP+ D L H
Sbjct: 263 LANVTCRLTALELLQDPFLQDDNMDGFVMRPIDYYNGYDETGVFLR---HPLIDDPLYHD 319
Query: 314 KVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHF 373
+ + + + L ++ + +++G++N DD + L LRI D G + NI+F
Sbjct: 320 QFESSQICE-------IDLFANDDEDHVDISIKGKRNGDDGIFLRLRISDAEGRIRNIYF 372
Query: 374 VFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLL 433
F DTA S+A EMV +LD++++DV IAE+ID I LVP W T S QN
Sbjct: 373 PFETAIDTAWSVAVEMVSELDITNQDVAKIAEMIDAEIAALVPDWK---NDTESSQNVNN 429
Query: 434 KGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEF 491
+ + G GE SN E VS G S ++ +++ S S + F
Sbjct: 430 NKNNNTAGFC------GECASNGYIQETVS-SGEKSHHNHHEFDSSEDKSCSSVHGRF 480
|
Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 620 | ||||||
| 224072272 | 596 | predicted protein [Populus trichocarpa] | 0.914 | 0.951 | 0.656 | 0.0 | |
| 255555709 | 585 | kinase, putative [Ricinus communis] gi|2 | 0.906 | 0.960 | 0.636 | 0.0 | |
| 359474135 | 645 | PREDICTED: serine/threonine-protein kina | 0.967 | 0.930 | 0.636 | 0.0 | |
| 224058021 | 571 | predicted protein [Populus trichocarpa] | 0.874 | 0.949 | 0.643 | 0.0 | |
| 357462359 | 614 | Serine/threonine protein kinase WNK8 [Me | 0.958 | 0.967 | 0.613 | 0.0 | |
| 449452398 | 679 | PREDICTED: serine/threonine-protein kina | 0.948 | 0.865 | 0.590 | 0.0 | |
| 351724041 | 618 | with no lysine kinase 8 [Glycine max] gi | 0.946 | 0.949 | 0.591 | 0.0 | |
| 356547519 | 618 | PREDICTED: serine/threonine-protein kina | 0.977 | 0.980 | 0.582 | 0.0 | |
| 225470964 | 625 | PREDICTED: probable serine/threonine-pro | 0.95 | 0.942 | 0.564 | 1e-175 | |
| 255564615 | 693 | kinase, putative [Ricinus communis] gi|2 | 0.969 | 0.867 | 0.540 | 1e-175 |
| >gi|224072272|ref|XP_002303683.1| predicted protein [Populus trichocarpa] gi|222841115|gb|EEE78662.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1884), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/600 (65%), Positives = 455/600 (75%), Gaps = 33/600 (5%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++ DE LGKGAFKTVYK FDEVDGIEVAWNQVNIEDV+QS QLERLYSEVHLLKSLKH
Sbjct: 23 YIRNDEFLGKGAFKTVYKAFDEVDGIEVAWNQVNIEDVLQSSQQLERLYSEVHLLKSLKH 82
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
ENIIKFY+SWVDD N+TIN+ITELFTSGS+RQYRKKHK VDMKAIKNWARQILRGLHYLH
Sbjct: 83 ENIIKFYSSWVDDKNKTINIITELFTSGSMRQYRKKHKTVDMKAIKNWARQILRGLHYLH 142
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
+H+PPIIHRDLKCDNIFVNGN GEVKIGDLGLAIVMQQP ARSVIGTPEFMAPELYEEEY
Sbjct: 143 THSPPIIHRDLKCDNIFVNGNTGEVKIGDLGLAIVMQQPIARSVIGTPEFMAPELYEEEY 202
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMC+LEMVTCEYPY+ECKNPAQIYKKV+SGIKPASL KV+D QVK FIEKC
Sbjct: 203 NELVDIYSFGMCMLEMVTCEYPYSECKNPAQIYKKVSSGIKPASLGKVSDHQVKVFIEKC 262
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKK 314
+VPAS RLPA+ELLKDPFL T+N K+LV L+LPNL+ ++L SE H MDID KK
Sbjct: 263 LVPASTRLPAIELLKDPFLATENSKELVSSSLQLPNLISRQVHLLQSESHLMDIDC--KK 320
Query: 315 VSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHF 373
+S SC KS N F TLEL R TENNEF LRG KN+D+TVSLTLRI D G NIHF
Sbjct: 321 LSVGSCTKSINESPQFSTLELSRFTENNEFRLRGAKNNDNTVSLTLRIADPCGRARNIHF 380
Query: 374 VFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLL 433
FYL++DTA+ IAEEMVEQLDL EDV IAELIDNLI KLVPSWN
Sbjct: 381 TFYLDSDTAVLIAEEMVEQLDLLTEDVAVIAELIDNLIAKLVPSWNT------------- 427
Query: 434 KGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDV 493
SP + S L+ N++ +EAV + L L + ++S +SDISAE+++
Sbjct: 428 --SPSVRNGSSELE-------NHSTSEAVKKPDFLP-LTNMTDLETKQSVNSDISAEYNM 477
Query: 494 PVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDSCS 553
+ D+ +KSL +YD E E + + N+ST+NS S+I S S
Sbjct: 478 AIASDSGTNKSLGSSDCCLQSNMYD---LEFGMLEDGISK---HNKSTRNSNDSYIGSFS 531
Query: 554 GMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLA 613
GMS+N S SSI SLSLADK+ S+ LK ELD+I+S Y QC QEL++ RE+ +ENA+KR +
Sbjct: 532 GMSRNASMSSICSLSLADKDGSE-LKQELDSIDSHYNQCLQELMKMREEAIENAKKRGIT 590
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555709|ref|XP_002518890.1| kinase, putative [Ricinus communis] gi|223541877|gb|EEF43423.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1862), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/608 (63%), Positives = 450/608 (74%), Gaps = 46/608 (7%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++YDE+LGKGAFKTVYK FDE++GIEVAWNQV++EDV+QSPDQLERLYSEVHLLKSLKH
Sbjct: 22 YVRYDEVLGKGAFKTVYKAFDEINGIEVAWNQVSVEDVLQSPDQLERLYSEVHLLKSLKH 81
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
ENI+KFYNSWVDD N+TINMITELFTSGSLR+YRKKHKNVD+KAIKNWARQILRGLHYLH
Sbjct: 82 ENIMKFYNSWVDDNNKTINMITELFTSGSLRKYRKKHKNVDIKAIKNWARQILRGLHYLH 141
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
SHNPPIIHRDLKCDN+FVNGNNGEVKIGDLGLA VMQQPTARSVIGTPEFMAPELYEEEY
Sbjct: 142 SHNPPIIHRDLKCDNVFVNGNNGEVKIGDLGLATVMQQPTARSVIGTPEFMAPELYEEEY 201
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMCILEMVTCEYPY+ECKNPAQIYKKVTSGIKPASL KV DP VK+FIEKC
Sbjct: 202 NELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTSGIKPASLCKVNDPLVKRFIEKC 261
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKK 314
IVPAS+RLPALELLKDPFL T+NPK+LV L LP+L+ + ++ SE +PMDID NHKK
Sbjct: 262 IVPASMRLPALELLKDPFLATENPKELVFASLHLPDLMLKQVSRGQSESYPMDIDSNHKK 321
Query: 315 VSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHF 373
+S SC KS + F T E QRLT NEF LRGEKNDD+T+SLTLRI D+ G V NIHF
Sbjct: 322 LSVGSCTKSMDESLHFSTSEFQRLTVKNEFRLRGEKNDDNTISLTLRIVDRCGGVKNIHF 381
Query: 374 VFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLL 433
FYL++DT +SIAEEMVEQLDLS+EDV IAELID LI+KLVP + S GST+S NG
Sbjct: 382 TFYLDSDTTLSIAEEMVEQLDLSNEDVAIIAELIDALILKLVPHLSQS-GSTSSMPNGF- 439
Query: 434 KGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDV 493
N+A + S+ L LA K Q Q+S S++S E +
Sbjct: 440 -----------------SELHNDATFKVASKHDFLP-LADLKGQETQDSLLSELSTELPL 481
Query: 494 PVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESIL-FNESTQNSETSFIDSC 552
V DA +K L Y+ + Y+ G +D + G+ + + T++SE
Sbjct: 482 TVASDASTNKPLGSSDYTIDFNTYEFG-----SDFMMHGDGTFKYGKYTKHSE------- 529
Query: 553 SGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWL 612
L A E D LKLELDAI+ +Y QCF+EL RE+ +ENA+K+W+
Sbjct: 530 ------------KHLPSAKGEVQDDLKLELDAIDMQYNQCFRELSMMREEAIENAKKKWI 577
Query: 613 AGSNVSVI 620
V I
Sbjct: 578 TRKKVPAI 585
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474135|ref|XP_002273005.2| PREDICTED: serine/threonine-protein kinase WNK8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1851), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/619 (63%), Positives = 468/619 (75%), Gaps = 19/619 (3%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++Y+E LGKGAFKTVYK FDEVDGIEVAW QV IED++QSP QLERLYSEVHLLKSLKH
Sbjct: 22 YVRYNEFLGKGAFKTVYKAFDEVDGIEVAWGQVEIEDLLQSPQQLERLYSEVHLLKSLKH 81
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
+NIIKFYNSWVDDTN+TIN+ITELFTSGSLRQYRKKHKNVD+KAIKNWA+QILRGLHYLH
Sbjct: 82 DNIIKFYNSWVDDTNKTINLITELFTSGSLRQYRKKHKNVDLKAIKNWAKQILRGLHYLH 141
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY
Sbjct: 142 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 201
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMCILE+VTCEYPYNECKNPAQIYKKV+SGIKPASL KV+DPQVKQFIEKC
Sbjct: 202 NELVDIYSFGMCILELVTCEYPYNECKNPAQIYKKVSSGIKPASLGKVSDPQVKQFIEKC 261
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVC------DPLRLPNLVPEVMNLAHSEPHPMDI 308
+VPASLRL A ELLKD F T+N K+ V D L+ N +P +MNL E PMD+
Sbjct: 262 LVPASLRLSAQELLKDAFFATENSKEPVYNHMHVDDSLQSSNFMPNLMNLPKPELQPMDM 321
Query: 309 DLNHKKVSADSCAKSNTGT-WFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGH 367
D N+KK+S + KS +GT F L+ +R +NN F LRGEK DD+++S+TL I D G
Sbjct: 322 DPNYKKLSVSTHMKSISGTPHFRALQFERFNKNNLFKLRGEKIDDNSISMTLHIADPCGR 381
Query: 368 VSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTAS 427
NIHF FYL++DTA+SIA EMVEQLDL +EDV IAELID +I +LVP+W P+ S
Sbjct: 382 AKNIHFAFYLDSDTALSIAGEMVEQLDLYNEDVAVIAELIDVMISELVPTWKPAFESMLC 441
Query: 428 QQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDI 487
N + S V SL+ P + GS ++AV++ ++S A+G+ Q ES+ S +
Sbjct: 442 GANSSCEDSLVLHNGGTSLRHPSDSGSAKGTSDAVTEH-LISLSANGEEQSTVESALSGM 500
Query: 488 SAEFDVPVILDAHIDKSL-VPDG----------YSAHYAVYDHGGHEVKADEVSLGESIL 536
S + D V DA+ KSL PD ++ V DH H+ ++GE +
Sbjct: 501 STKDDATVASDANDIKSLECPDDECYEASDRCCFNGDRQVLDHERHKEGRYNGNIGEPVA 560
Query: 537 FNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQEL 596
N T++ E S I+SCSGMS +LS SSI SLSLADK+ SD LKLE+D I+++Y QCFQEL
Sbjct: 561 MNGFTKDWEISCIESCSGMSNSLSLSSICSLSLADKDPSDELKLEVDTIDTQYHQCFQEL 620
Query: 597 LRQREDEMENARKRWLAGS 615
LR RE+ +E A+ RW+ S
Sbjct: 621 LRMREEAIEKAKNRWITKS 639
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224058021|ref|XP_002299436.1| predicted protein [Populus trichocarpa] gi|222846694|gb|EEE84241.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1848), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/601 (64%), Positives = 446/601 (74%), Gaps = 59/601 (9%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++YDEILGKGAFKTVYK FDEVDGIEVAWNQV+IEDV+QS QLERLYSEVHLLKSLKH
Sbjct: 23 YVRYDEILGKGAFKTVYKAFDEVDGIEVAWNQVDIEDVLQSSQQLERLYSEVHLLKSLKH 82
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
ENIIKFYNSWVDD N+TINMITEL TSG+LRQYRKKHK VDMKAIKNWARQILRGL YLH
Sbjct: 83 ENIIKFYNSWVDDKNKTINMITELLTSGNLRQYRKKHKTVDMKAIKNWARQILRGLQYLH 142
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
+ +P IIHRDLKCDNI VNGNNGEVKIGDLGLAIVMQQP ARSVIGTPEFMAPELYEEEY
Sbjct: 143 TRSPRIIHRDLKCDNILVNGNNGEVKIGDLGLAIVMQQPIARSVIGTPEFMAPELYEEEY 202
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMC+LEMVTCEYPY+ECKNPAQIYKKVTSGIKPASL KV D QVK+FIEKC
Sbjct: 203 NELVDIYSFGMCMLEMVTCEYPYSECKNPAQIYKKVTSGIKPASLVKVNDLQVKEFIEKC 262
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKK 314
+VPAS+RL A++LLKDPFL T+N K++V +LPN++ + ++L SE H MDID K
Sbjct: 263 LVPASVRLSAIDLLKDPFLATENSKEVVSSLSQLPNVICKQVHLPQSESHHMDIDC--KM 320
Query: 315 VSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHF 373
+S SC KS N FLTLEL+R TENNEF LR EKNDD+TVSLTLRI D G NIHF
Sbjct: 321 LSLGSCPKSINESPQFLTLELRRFTENNEFRLRAEKNDDNTVSLTLRIADPCGRARNIHF 380
Query: 374 VFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLL 433
FYLN+DTA+SIAEEMVEQLDLS EDV IAELID+LI+KLVP WN S +S +NG
Sbjct: 381 TFYLNSDTAVSIAEEMVEQLDLSSEDVAVIAELIDSLIVKLVPCWNTS----SSVRNG-- 434
Query: 434 KGSPVSQGNSISLKCPG-EPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFD 492
+ S + K P P +N EA+ +S +SDISAE++
Sbjct: 435 SSELENHATSETGKTPDFSPLTNITDHEAL------------------QSVNSDISAEYN 476
Query: 493 VPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDSC 552
+ + DA +KSL S V+ IDSC
Sbjct: 477 MAIASDASTNKSLGSSSCSLQSNVF------------------------------HIDSC 506
Query: 553 SGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWL 612
SGMS+N S S I SL LADK+ S+ LKLELD+I+S Y QCFQEL++ RE+ +ENA++RW+
Sbjct: 507 SGMSRNASLSIICSLFLADKDGSE-LKLELDSIDSHYNQCFQELMKTREEAIENAKRRWI 565
Query: 613 A 613
+
Sbjct: 566 S 566
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357462359|ref|XP_003601461.1| Serine/threonine protein kinase WNK8 [Medicago truncatula] gi|355490509|gb|AES71712.1| Serine/threonine protein kinase WNK8 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 691 bits (1784), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/608 (61%), Positives = 448/608 (73%), Gaps = 14/608 (2%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+ +YDE+LGKGAFKTVYK FDEVDGIEVAWNQ++IEDVMQSP LE+LYSEVHLLKSLKH
Sbjct: 19 YARYDEMLGKGAFKTVYKAFDEVDGIEVAWNQISIEDVMQSPQNLEKLYSEVHLLKSLKH 78
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
ENIIK Y+SWVD+ + INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL +LH
Sbjct: 79 ENIIKMYSSWVDEKSSNINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLCFLH 138
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
SHNPP+IHRDLKCDNIFVNGNNG+VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY
Sbjct: 139 SHNPPVIHRDLKCDNIFVNGNNGQVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 198
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVD+YSFGMCILEM+TCEYPY+ECKNPAQIYKKVTSGIKPASL++V DP+VKQFIEKC
Sbjct: 199 NELVDVYSFGMCILEMITCEYPYSECKNPAQIYKKVTSGIKPASLARVNDPEVKQFIEKC 258
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKK 314
+VPAS+RLPA ELLKDPFL T N K++ D L LPN + +N EPHPM+ID N K
Sbjct: 259 LVPASMRLPASELLKDPFLATGNTKEIYHDNLLLPNPPSKSLNPPTCEPHPMEIDSNVKH 318
Query: 315 VSADSCAKSNTGTWFLTL--ELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIH 372
S S + + T ++ ++ R TENNEF LRGEKN D T+SLTLRI D +G NIH
Sbjct: 319 TSPASTVERDKETSQVSSNHDILRKTENNEFRLRGEKNADRTISLTLRIADANGGARNIH 378
Query: 373 FVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGL 432
F FY+++DT ISIAEEMVE L+L EDV IAELI N+I KLVP W P L +S + L
Sbjct: 379 FPFYIDSDTTISIAEEMVEHLELKDEDVAVIAELIHNMIFKLVPDWKP-LCENSSGTDNL 437
Query: 433 LKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFD 492
+ P+ N L C GSNN +++ + S+L G+ Q QES SDISAE+
Sbjct: 438 YR--PLEPQNE-QLNCHWTLGSNNFDMKSMYEDLGHSQL-DGEDQDKQESVSSDISAEYG 493
Query: 493 VPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDSC 552
+ DA K + + + H G D G+ + ++ SE S + SC
Sbjct: 494 TVIATDA---KGVEQNCFILHECCKGSNGLNTNPDVRICGQE---DGNSNQSENSVV-SC 546
Query: 553 SGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWL 612
S+NL S SL+ D++H D L+LE++AI +YQQ F+EL++ RE+ +EN +KRW
Sbjct: 547 CSPSENLDRLSKCSLTALDQDHLDELQLEIEAIEIQYQQSFRELMKMREEAIENVKKRWT 606
Query: 613 AGSNVSVI 620
+ N+SV+
Sbjct: 607 SKKNISVM 614
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452398|ref|XP_004143946.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus] gi|449529646|ref|XP_004171809.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1731), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/623 (59%), Positives = 444/623 (71%), Gaps = 35/623 (5%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++YDEILGKGAFKTVYK FDEV GIEVAW+QV+IEDV+QSP+QL+RLYSEVHLLKSLKH
Sbjct: 75 YIRYDEILGKGAFKTVYKAFDEVGGIEVAWSQVDIEDVLQSPEQLQRLYSEVHLLKSLKH 134
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
ENIIKFY+ WVDD ++TINMITELFTSGSLRQYRKKH+ VD+KA KNWARQILRGL YLH
Sbjct: 135 ENIIKFYSYWVDDKHKTINMITELFTSGSLRQYRKKHRKVDLKAFKNWARQILRGLTYLH 194
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
HNPPIIHRDLKCDNIFVNGN GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY+E+Y
Sbjct: 195 GHNPPIIHRDLKCDNIFVNGNTGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYDEDY 254
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMC+LE+VTCEYPYNECKN AQI+KKVTSGIKPASL KV DPQVKQFIEKC
Sbjct: 255 NELVDIYSFGMCMLEIVTCEYPYNECKNSAQIFKKVTSGIKPASLEKVLDPQVKQFIEKC 314
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKK 314
+VPAS RLPA ELLKDPFL ++PKD + R N + +N HPM+ D N K
Sbjct: 315 LVPASTRLPASELLKDPFLAAESPKDNSSELSRSLNEHFKSVNPPLLGSHPMETDHNCTK 374
Query: 315 VSAD--SCAKSNTG-TWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNI 371
+S S KSN G + F T ELQRLTENNE TL+G+ D +T+S LRI + G NI
Sbjct: 375 LSGSVASSVKSNNGISHFSTQELQRLTENNELTLKGDMTDHNTMSFHLRIAELYGKSRNI 434
Query: 372 HFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNG 431
HF FYL++DT+++IA EMVEQL+LS+ED IA+LID LI K VPSW P QQ
Sbjct: 435 HFAFYLDSDTSLAIALEMVEQLELSNEDATIIAKLIDELIAKFVPSWKPCPNYCEEQQQN 494
Query: 432 LLKGSPVSQGNSISLKCPGEPGSNNAFAEAV-------SQQGVLSELASGKYQYNQESSD 484
SP +Q + + + F+E V + + L+ LA + Q NQ+S
Sbjct: 495 -TPHSPEAQEDKTFI--------SPFFSELVLSSPMVAAARNNLTGLAKVEDQENQQSII 545
Query: 485 SDISAEFDVPVILDAHIDKSLV------PDGYSAHYAVYDHGGHEVKADEV-SLGESILF 537
S S E+ + D I K PD A+ + G ++ A+ V SL +I F
Sbjct: 546 SCASVEYIYSTVSDYSIGKGSECGEFGHPDCEKAYIS---SGTIDLDAEAVGSLSTTIDF 602
Query: 538 NESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELL 597
++ S I SCS MSK LS SS S+LS+ +++H D LK+E+DAI+ +Y QC EL
Sbjct: 603 ------AKPSLISSCSEMSKELSLSSFSTLSMEERDHQDELKMEIDAIDLQYHQCLCELS 656
Query: 598 RQREDEMENARKRWLAGSNVSVI 620
R RE+ +E+A+KRW++ + I
Sbjct: 657 RMREEAIESAKKRWMSKKKATGI 679
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351724041|ref|NP_001236020.1| with no lysine kinase 8 [Glycine max] gi|225348645|gb|ACN87284.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/600 (59%), Positives = 442/600 (73%), Gaps = 13/600 (2%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+ +YDE+LGKGAFKTVYK FDEVDGIEVAWN++ +EDV+Q+P QL +LYSEVHLLKSLKH
Sbjct: 15 YARYDELLGKGAFKTVYKAFDEVDGIEVAWNRIGVEDVVQTPQQLGKLYSEVHLLKSLKH 74
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
+N+IK YNSWVDDT TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL +LH
Sbjct: 75 DNVIKLYNSWVDDTAGTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLCFLH 134
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
S +PPI+HRDLKCDNIFVNGN+G VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY
Sbjct: 135 SQSPPIVHRDLKCDNIFVNGNSGLVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMCILEMVTCEYPY+ECKNPAQIYKKVTSGIKPA+L+KV DP+VKQFIEKC
Sbjct: 195 NELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTSGIKPAALAKVNDPEVKQFIEKC 254
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKK 314
+VPAS+RL A ELLKDPFL T+N K++ D L+LPN +++NL EPHPM+ID ++
Sbjct: 255 LVPASMRLSASELLKDPFLATENTKEINHDTLQLPNPHIKLVNLPKCEPHPMEIDSYSRR 314
Query: 315 VS-ADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHF 373
S S + + +L R+T+NN+ LRGEKN + T+SLTLRI D G NIHF
Sbjct: 315 TSPGSSMGRIEETSQVSFFDLVRMTDNNKLMLRGEKNAESTISLTLRIPDACGGARNIHF 374
Query: 374 VFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLL 433
FY+++DTAISIAEEMVE L+L++EDV IAELI+++I KLVP+ P +S+ N L
Sbjct: 375 PFYMDSDTAISIAEEMVEHLELTNEDVSVIAELINDMIAKLVPNSKPLCEKLSSETNLLY 434
Query: 434 KGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDV 493
+ S Q N C S++ +A+ + V S G Q QES SDISA +
Sbjct: 435 RPSSEVQ-NGEQFNCHWPLQSSDYDMKAMYKDLVHSRPVDGDDQEKQESVMSDISAACGI 493
Query: 494 PVILDAHIDKSLVPDGYSAHYAVYD---HGGHEVKADEVSLGESILFNESTQNSETSFID 550
+ D+ K + PD + ++D G +D G+ ++NS S I+
Sbjct: 494 TIASDS---KVVEPDIF-----IFDEFWEGFFNSTSDIRFCGQEDGHKNQSENSVGSLIN 545
Query: 551 SCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKR 610
SC KN SSI SL+LADK+ S+GL+L+++AI++ + + F EL R++ +++A++R
Sbjct: 546 SCCCPFKNFDMSSICSLTLADKDPSEGLRLDIEAIDTYFDRRFLELEMMRQEAIKSAKRR 605
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547519|ref|XP_003542159.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 653 bits (1685), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/611 (58%), Positives = 436/611 (71%), Gaps = 5/611 (0%)
Query: 1 MLLLDLVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE 60
M +V L + +YDE+LGKGAFKTVYK FDEVDGIEVAWN +++EDV+Q+P QLE
Sbjct: 1 MTTFHVVEKDLTSRYARYDELLGKGAFKTVYKAFDEVDGIEVAWNMISVEDVVQTPQQLE 60
Query: 61 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK 120
+LYSE+HLLKSLKH+N+IK YNSWVDDT TINMITELFTSGSLRQYR KHKNVDMKAIK
Sbjct: 61 KLYSEIHLLKSLKHDNVIKLYNSWVDDTTGTINMITELFTSGSLRQYRNKHKNVDMKAIK 120
Query: 121 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 180
NWARQILRGL +LH H+PPI+HRDLKCDNIFVNGN+G VKIGDLGLAIVMQQPTARSVIG
Sbjct: 121 NWARQILRGLCFLHCHSPPIVHRDLKCDNIFVNGNSGLVKIGDLGLAIVMQQPTARSVIG 180
Query: 181 TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 240
TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY+EC NPAQIYKKVTSGIKPA+L+
Sbjct: 181 TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYSECNNPAQIYKKVTSGIKPAALA 240
Query: 241 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAH 300
KV DP+VKQFIEKC+VPAS+RL A ELLKDPFL T+N K++ D L LPN +++N
Sbjct: 241 KVNDPEVKQFIEKCLVPASMRLSASELLKDPFLATENTKEINHDILELPNPHTKLVNPPT 300
Query: 301 SEPHPMDIDLNHKKVS-ADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTL 359
EPHPM+ID ++ S S + + +L R+TENN+F LRGEKN + T+SLTL
Sbjct: 301 CEPHPMEIDSKSRRTSPGSSMGRIEETSQVSFFDLVRMTENNKFMLRGEKNAESTISLTL 360
Query: 360 RIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWN 419
RI + G NIHF FY+N+DTAISIAEEMVE L+L++EDV IAELI+++I KLVP+
Sbjct: 361 RIANACGGARNIHFPFYINSDTAISIAEEMVEHLELTNEDVSVIAELINDMIAKLVPNLK 420
Query: 420 PSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYN 479
P +S + L + S Q N C S++ + V + V S G
Sbjct: 421 PLSEKLSSGTDQLYRPSSEVQ-NGEQFNCHWPLQSSDYDMKPVFKDLVHSWPVDGDDLEK 479
Query: 480 QESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNE 539
QES SDIS E + V D+ K + PD + +D G+
Sbjct: 480 QESVMSDISVECGITVASDS---KVVEPDIFIFDEFWEGFDAFNSTSDVRFCGQEDGHKN 536
Query: 540 STQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQ 599
++NS S I+SC KN SSI SL+LADK+ S+GL+LE++AI++ ++Q F+EL
Sbjct: 537 QSENSSGSLINSCCCPFKNFDISSICSLTLADKDPSEGLRLEIEAIDTYFEQRFRELEMM 596
Query: 600 REDEMENARKR 610
R +E+ ++R
Sbjct: 597 RVAAIESLKRR 607
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470964|ref|XP_002266888.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 622 bits (1603), Expect = e-175, Method: Compositional matrix adjust.
Identities = 350/620 (56%), Positives = 430/620 (69%), Gaps = 31/620 (5%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
++++ EILGKGAFKTVYK FDEVDGIE+AWNQV I+DV++SP+ LE+LYSEVHLLKSLKH
Sbjct: 21 YVRFKEILGKGAFKTVYKAFDEVDGIEIAWNQVKIDDVLRSPEDLEKLYSEVHLLKSLKH 80
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
ENIIKFYNSWVDD +T+NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ+LRGL YLH
Sbjct: 81 ENIIKFYNSWVDDKKKTVNMITELFTSGSLRQYRKKHKNVDMKAIKNWARQVLRGLVYLH 140
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
SHNPPIIHRDLKCDNIFVNGN+GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY
Sbjct: 141 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 200
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMC+LEMVT EYPYNECKNPAQIYKKVTSGIKPASL KVTD Q+K+FI KC
Sbjct: 201 NELVDIYSFGMCMLEMVTFEYPYNECKNPAQIYKKVTSGIKPASLCKVTDLQIKEFIVKC 260
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKK 314
+ PAS RLPA ELLKDPF ++NPK+ + PL+LP+ P+ + L+ S P MDID +H +
Sbjct: 261 LAPASERLPAKELLKDPFFQSENPKEPIRVPLQLPSRSPKSIILSKSGPFSMDIDPDHPQ 320
Query: 315 VSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFV 374
+S+ + ++N F LE QR+ +++EF LR +K +D+++SLTLR D G V NIHF
Sbjct: 321 LSSSTSTENNGSPDFPVLEFQRMYKSSEFRLRAKKINDNSISLTLRTVDSYGPVKNIHFP 380
Query: 375 FYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNP----SLGSTASQQN 430
F L+ DT S+ EMVEQL+L+ +V IA+ ID +IM+L+P W P LG S
Sbjct: 381 FSLDTDTVHSVVGEMVEQLELAEHEVAFIADFIDYVIMRLLPGWKPPRDDPLGGARSPN- 439
Query: 431 GLLKGSPVSQGNSISLKCP---GEPGSNNAFAEAVSQQGV-------LSELASGKYQYNQ 480
P GN + C G+ S+ A A Q + L+ AS K
Sbjct: 440 ----AEPPVLGNGNNHDCTISHGDGNSSPNLANAEDQDSLASAGLVTLTVDASKKNDKTV 495
Query: 481 ESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNES 540
D +I + H + D Y H ++++ + S+ E N+
Sbjct: 496 GFGDYNIGGNYKGSN--GGHASEQESRDPY--------HEDYKLQRNNSSIEEFTPMNKF 545
Query: 541 TQNSETSFIDSCSGMSK-NLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQ 599
+++ SF D SG+S S SSLSLAD + GLK ELDAI+ +YQ FQEL R
Sbjct: 546 QKSTVLSF-DDLSGLSNVRSLTCSCSSLSLADIDQDPGLKQELDAIDLQYQHWFQELSRM 604
Query: 600 REDEMENARKRWLAGSNVSV 619
R + +E +KRW+ ++V
Sbjct: 605 RVEALEATKKRWMTKKKLAV 624
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255564615|ref|XP_002523302.1| kinase, putative [Ricinus communis] gi|223537390|gb|EEF39018.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1600), Expect = e-175, Method: Compositional matrix adjust.
Identities = 352/651 (54%), Positives = 441/651 (67%), Gaps = 50/651 (7%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++YDE+LGKGAFKTVYKGFDEVDGIEVAWNQV I DV++SP LE+L+SEVHLL+SLKH
Sbjct: 40 YVRYDEVLGKGAFKTVYKGFDEVDGIEVAWNQVRIADVLRSPKDLEKLHSEVHLLRSLKH 99
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
ENI++ NSWVDD +TINMITELFTSG+LRQYRKKHKNVDMKAIKNWARQIL+GL YLH
Sbjct: 100 ENIMELCNSWVDDKKKTINMITELFTSGNLRQYRKKHKNVDMKAIKNWARQILQGLVYLH 159
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
HNPPIIHRDLKCDNIFVNG+NG VKIGDLGLAI+MQQPTA SVIGTPEFMA ELYEEEY
Sbjct: 160 GHNPPIIHRDLKCDNIFVNGHNGVVKIGDLGLAIIMQQPTATSVIGTPEFMATELYEEEY 219
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NEL+DIYSFGMC+LEMVT EYPY+EC+NPAQIYKKVTSGIKPASL V+DPQVK+FI KC
Sbjct: 220 NELIDIYSFGMCMLEMVTFEYPYSECRNPAQIYKKVTSGIKPASLGNVSDPQVKEFILKC 279
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKK 314
+VPAS RL A ELLKDPFL N + V DPL LPN P+ + S P MDID ++K+
Sbjct: 280 LVPASERLSAKELLKDPFLQPQNLVEPVRDPLLLPNQYPKSSSATKSGPLSMDIDADYKQ 339
Query: 315 VSADSCAKSNT-GTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHF 373
+S+ +C SN GT F E QR +N F L+G+++DD++VSLTLRI D SG V NIHF
Sbjct: 340 ISSSTCTGSNNEGTRFPVPEYQREHKNKVFKLKGKESDDNSVSLTLRIADSSGRVWNIHF 399
Query: 374 VFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLL 433
+FYL++DTA+S+A EMV+QL+L+ DV IAE ID+LIMKL P W S + ++
Sbjct: 400 LFYLDSDTALSVASEMVDQLELADHDVAFIAEFIDHLIMKLSPGWKLSSNYSLNELTSFY 459
Query: 434 KGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLS---------ELASGKYQYN----- 479
S + S+ CP + ++ +Q LS L + + YN
Sbjct: 460 TASAALEN---SVACPWDSVLTTVLSQPAVEQEALSGMTTTPPEGSLQADDFNYNDNRDG 516
Query: 480 ---------------QESSDSDISAEFDVPVILDAHIDKSL--VPD-----------GYS 511
E DS S ++ V + D + +PD GY+
Sbjct: 517 AVFHINYHSSPSFGYMEDQDSQTSGVSEILVEDVSSKDDRISELPDYNTDGNCKYLNGYT 576
Query: 512 AHYAVYD-HGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKN--LSFSSISSLS 568
+ + D + +++ ++ +GE I NE+ + SET F SG + ++ SS SSL
Sbjct: 577 SEPELRDSYSLRKLERNDSGVGECIPMNENAKVSETPF-PKLSGAPNDMSMTSSSSSSLY 635
Query: 569 LADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSV 619
L K LKLELDAI ++YQ F++L R+RE+ +E+ +KRW A + V
Sbjct: 636 LVGKSMDTELKLELDAIEAQYQNWFRDLSRRREEALESTKKRWTAKKKLPV 686
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 620 | ||||||
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.637 | 0.701 | 0.693 | 1.4e-160 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.645 | 0.705 | 0.627 | 1.5e-140 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.761 | 0.900 | 0.584 | 8.3e-138 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.643 | 0.716 | 0.629 | 1.2e-134 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.427 | 0.378 | 0.703 | 5.7e-125 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.414 | 0.498 | 0.713 | 4.1e-119 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.654 | 0.825 | 0.528 | 1e-114 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.451 | 0.510 | 0.638 | 2.1e-111 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.419 | 0.455 | 0.632 | 2e-102 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.425 | 0.840 | 0.593 | 4.9e-85 |
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1435 (510.2 bits), Expect = 1.4e-160, Sum P(3) = 1.4e-160
Identities = 278/401 (69%), Positives = 322/401 (80%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++YD++LG+GAFKTVYK FDEVDGIEVAWN V+IEDVMQ P QLERLYSEVHLLK+LKH
Sbjct: 28 YIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSEVHLLKALKH 87
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
ENIIK + SWVD+ N+TINMITELFTSGSLR YRKKH+ VD KAIKNWARQIL+GL+YLH
Sbjct: 88 ENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLH 147
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
S NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA V+QQPTARSVIGTPEFMAPELYEEEY
Sbjct: 148 SQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEY 207
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMC+LEMVTCEYPYNEC+N AQIYKKVTS IKP SL KV DPQV+QFIEKC
Sbjct: 208 NELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKC 267
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKK 314
++PAS R ALEL KDPFL D KD L + + + E PMD+D N K
Sbjct: 268 LLPASSRPTALELSKDPFLARDGGKDSAL--LASSSTSSKYVRPPQLEHLPMDVDHNENK 325
Query: 315 VSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFV 374
S + + W T+ELQR+ EN EF LRGE++DD T S+ LRI D SG +HF
Sbjct: 326 ----SVSSNEDYPWSQTIELQRIAENKEFRLRGERSDDVTASMVLRIADPSGKCRIVHFA 381
Query: 375 FYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLV 415
FYL +DTA +IAEEMVE+L L+ ++VV IA++ID+ IM+L+
Sbjct: 382 FYLESDTATAIAEEMVEELHLTSQEVVVIADMIDDFIMQLL 422
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1330 (473.2 bits), Expect = 1.5e-140, Sum P(2) = 1.5e-140
Identities = 261/416 (62%), Positives = 322/416 (77%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++Y E++GKGAFKTVYK FDEVDGIEVAWNQV I+DV+QSP+ LERLYSEV LLKSLKH
Sbjct: 27 YIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKH 86
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
NII+FYNSW+DD N+T+N+ITELFTSGSLR YRKKH+ V+MKA+KNWARQIL GL YLH
Sbjct: 87 NNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLH 146
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
PPIIHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVIGTPEFMAPELY+E Y
Sbjct: 147 GQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENY 206
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NEL DIYSFGMC+LEMVT +YPY ECKN AQIYKKV+SGIKPASLS+V DP+VKQFIEKC
Sbjct: 207 NELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKC 266
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV-PE--------VMNLAHSEPHP 305
++PAS RL A ELL DPFL + + +PL LP++V P+ +M+ P
Sbjct: 267 LLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIVMPKEGAFGDRCLMSEGPPTTRP 324
Query: 306 ---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIG 362
+ IDL+ N+G+ +E++R N F L+GE+ND+ +VSL LRI
Sbjct: 325 SKTLSIDLDEDSNLPIVTFSDNSGS--RCIEVRRAKRGNFFVLKGEENDEQSVSLILRIV 382
Query: 363 DKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSW 418
D++G V NIHF+FY DTA ++ EMVEQL+L+ ++V IAELID L++ ++P+W
Sbjct: 383 DENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTW 438
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1349 (479.9 bits), Expect = 8.3e-138, P = 8.3e-138
Identities = 284/486 (58%), Positives = 337/486 (69%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++Y+++LG+GAFKTVYK FDEV+GIEVAWN ++IEDV+Q P QL+RLYSEVHLL SLKH
Sbjct: 15 YIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSEVHLLNSLKH 74
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
+NIIK + SWVDD N++INMITELFTSGSL YRKKH+ VD KAI NWARQIL+GLHYLH
Sbjct: 75 DNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLH 134
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
S PP+IHRDLKCDNIFVNGN G+VKIGDLGLA VMQQPTARSVIGTPEFMAPELYEEEY
Sbjct: 135 SQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEY 194
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NELVDIYSFGMC+LEMVTCEYPY EC+N AQIYKKVTSGIKP SLSKV DPQVKQFIEKC
Sbjct: 195 NELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKC 254
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLN-HK 313
++PA R ALELLKD L D KD P + E PMD++ +
Sbjct: 255 LLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMP--PQCEYRPMDVEYKKNT 312
Query: 314 KVSADSCAKSNTGTWFL-TLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIH 372
VS S AKS+ L T+E+QR+ E+ EF L GE+ DD S+ LRI SG +
Sbjct: 313 SVSICSSAKSSQECALLQTMEVQRVAESTEFKLSGERRDDVAASMALRIAGSSGQARKVD 372
Query: 373 FVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGL 432
F F L DTA ++ EMVE+LDLS +V IAE+ID LIMKL N SL + S
Sbjct: 373 FDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKLKA--NRSLPNANSVYQSK 430
Query: 433 LKGSPVSQGNSISL----KCPGEPGSN-NAFAEAVSQQGVLSELASGKYQYNQESSDSDI 487
+ + S + IS + GS EAV + +LS + + S+ D+
Sbjct: 431 DEEAGESMKSEISADYYHRVSSNEGSRLGCCCEAV--ESLLSSFLDSCSMVSNKQSE-DL 487
Query: 488 SAEFDV 493
E +V
Sbjct: 488 KTELNV 493
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1319 (469.4 bits), Expect = 1.2e-134, P = 1.2e-134
Identities = 262/416 (62%), Positives = 328/416 (78%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+++Y E++GKGA KTV+KGFDEVDGIEVAWNQV I+D++QSPD LERLYSEV LLKSLKH
Sbjct: 27 YIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKSLKH 86
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
+NII+FYNSW+DD N+T+N+ITELFTSGSLRQYRKKH+ V+MKA+K WARQIL GL YLH
Sbjct: 87 KNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLH 146
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 194
S +PPIIHRD+KCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVIGTPEFMAPELY+E Y
Sbjct: 147 SQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENY 206
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NEL DIYSFGMC+LEMVT EYPY EC+N AQIYKKV+SGIKPASLSKV DP+V +FIEKC
Sbjct: 207 NELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKC 266
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCD-PLRLPNLV-PEVMNLAH----SEPHP--- 305
++PAS RL A ELL D FL N LV + PL LP++V P+ + SE P
Sbjct: 267 LLPASERLSAEELLLDSFL---NVNGLVMNNPLPLPDIVMPKEGSFGERCLMSEGPPNAR 323
Query: 306 ---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIG 362
M ++L+ + +N+GT +E++R N F L+GE+ND+++VSL LRI
Sbjct: 324 NRTMSMNLDEDNNLPIVISSNNSGT--NCIEVRRAKRGNFFVLKGEENDENSVSLILRIV 381
Query: 363 DKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSW 418
D++G V NIHF+F+ DTA +++ EMVEQL+L+ ++V IAELID L++ L+P+W
Sbjct: 382 DENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNW 437
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1022 (364.8 bits), Expect = 5.7e-125, Sum P(3) = 5.7e-125
Identities = 187/266 (70%), Positives = 223/266 (83%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+Y+E+LGKGA KTVY+ FDE +GIEVAWNQV + D +QSP+ LERLY E+HLLK+LKH+N
Sbjct: 25 RYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
I+KFY SWVD NR IN +TELFTSG+LRQYR +HK V+++A+K+W RQILRGLHYLHSH
Sbjct: 85 IMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSH 144
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNE 196
+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++++ A +GTPEFMAPE+YEE YNE
Sbjct: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNE 204
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256
LVDIYSFGMCILEMVT +YPY+EC +PAQIYKKV SG KP +L KV DP+VK FIEKC+
Sbjct: 205 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLA 264
Query: 257 PASLRLPALELLKDPFL-VTDNPKDL 281
SLR+ A ELL DPFL + D DL
Sbjct: 265 TVSLRVSARELLDDPFLRIDDGEFDL 290
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1005 (358.8 bits), Expect = 4.1e-119, Sum P(2) = 4.1e-119
Identities = 184/258 (71%), Positives = 221/258 (85%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+Y E+LGKGAFK VY+ FD+++GIEVAWNQV ++D S + L+RLYSEVHLLK+LKH++
Sbjct: 23 RYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYSEVHLLKTLKHKS 82
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
IIKFY SW+D + TIN+ITE+FTSG+LRQYRKKHK VD++A+K W+RQIL GL YLHSH
Sbjct: 83 IIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSH 142
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYN 195
+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ + +A SVIGTPEFMAPELYEE+YN
Sbjct: 143 DPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYN 202
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
LVDIY+FGMC+LE+VT EYPY+EC N AQIY+KVTSGIKPA+L VTDPQV+ FIEKCI
Sbjct: 203 VLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCI 262
Query: 256 VPASLRLPALELLKDPFL 273
S RL A ELL DPFL
Sbjct: 263 AKVSQRLSAKELLDDPFL 280
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1131 (403.2 bits), Expect = 1.0e-114, P = 1.0e-114
Identities = 230/435 (52%), Positives = 299/435 (68%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+Y+E+LGKG+ KTVY+GFDE GIEVAWNQV + D +QSP +LERLY E+HLLK+LKH++
Sbjct: 26 RYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQELERLYCEIHLLKTLKHKS 85
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
I+KFY SWVD NR IN +TE+FTSG+LRQYR KHK V+++A+KNW RQILRGL+YLH+H
Sbjct: 86 IMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTH 145
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNE 196
+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA +Q A +GTPEFMAPE+Y+EEYN+
Sbjct: 146 DPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHCVGTPEFMAPEVYKEEYNQ 205
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256
LVDIYSFGMC+LEMVT +YPY+EC +PAQIYK+V SG KP L KV DP+V+ FIEKC+
Sbjct: 206 LVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLA 265
Query: 257 PASLRLPALELLKDPFLVTD--------NPKDLVCD---PLRLPNLVPEVMNLAHSEPHP 305
SLRL A ELL D FL D + K L+ + PLR +P N +S +
Sbjct: 266 TVSLRLSACELLDDHFLCIDESDMRRVESEKGLIDEAGTPLRHSYHIPHYSNGYYSLYNQ 325
Query: 306 MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNE---------FTLRGEKNDD-DTV 355
D N D +S+ LE Q + E +++G++ D+ D +
Sbjct: 326 NQWDYN-----GDETVESHE---IDLLEFQNDDDEEEEDKRFGSVDISIKGKRRDNGDGL 377
Query: 356 SLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLV 415
L L+ +K G V NI+F F + DTAIS+A EMVE+L++ DV IA +ID I LV
Sbjct: 378 FLRLKTVNKEGCVRNIYFPFDIETDTAISVAREMVEELEMDDRDVTKIANMIDGEIASLV 437
Query: 416 PSWNPSLGSTASQQN 430
P+W+ S +++ +
Sbjct: 438 PNWSIFCSSESNRSS 452
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 962 (343.7 bits), Expect = 2.1e-111, Sum P(2) = 2.1e-111
Identities = 182/285 (63%), Positives = 226/285 (79%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
++ E+LGKGA KTVYK FD+V G+EVAWNQV + +V +SP+ L+RLYSEVHLLK+L HE+
Sbjct: 26 RFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRSPEPLQRLYSEVHLLKNLNHES 85
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
II++ SW+D RT N ITELFTSG+LR+YR+K++ VD++AIK+WARQIL GL YLH H
Sbjct: 86 IIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGH 145
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELYEEEYN 195
+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA +++ A SVIGTPEFMAPELYEE+YN
Sbjct: 146 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYN 205
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
ELVDIYSFGMC+LEM+T EYPY+EC NPAQIYKKVTSG P S + + ++F+ KC+
Sbjct: 206 ELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCL 265
Query: 256 VPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLA 299
S RLPA ELL DPFL + +DL PL RLP + + NLA
Sbjct: 266 ETVSRRLPAKELLADPFLAATDERDLA--PLFRLPQQLA-IQNLA 307
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 904 (323.3 bits), Expect = 2.0e-102, Sum P(2) = 2.0e-102
Identities = 165/261 (63%), Positives = 212/261 (81%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
++ EILG+GA KTVYK DE GIEVAW+QV +++V++S L+RLYSEVHLL +L H++
Sbjct: 20 RFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYSEVHLLSTLNHKS 79
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
II+FY SW+D N T+N ITELFTSG+LRQY+ K+ +D++AIK+WARQIL GL YLH H
Sbjct: 80 IIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLVYLHEH 139
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYN 195
+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA +++ +A S+IGTPEFMAPELYEE YN
Sbjct: 140 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELYEENYN 199
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
EL+D+YSFGMC LEM+T E+PY+EC +PAQIYKKV G P + +V D + ++FI KC+
Sbjct: 200 ELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRFIGKCL 259
Query: 256 VPASLRLPALELLKDPFLVTD 276
V AS R+ A ELL+DPFL +D
Sbjct: 260 VSASKRVSAKELLQDPFLASD 280
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 851 (304.6 bits), Expect = 4.9e-85, P = 4.9e-85
Identities = 159/268 (59%), Positives = 203/268 (75%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+Y E+LG GA K VY+ FD+ +GIEVAWNQV + P ERLYSEV LLK+LK+ N
Sbjct: 32 RYGELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRCFSDDPAMTERLYSEVRLLKNLKNSN 91
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
II Y W D+ N T+N ITE+ TSG+LR+YRKKH++V M+A+K W++QIL+GL YLH+H
Sbjct: 92 IITLYKVWRDERNNTLNFITEICTSGNLREYRKKHRHVSMRALKKWSKQILKGLDYLHTH 151
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELYEEEYN 195
+P IIHRDL C NIFVNGN G+VKIGDLGLA IV + A S++GTPEFMAPELYEE Y
Sbjct: 152 DPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGKNHLAHSILGTPEFMAPELYEENYT 211
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
E+VDIYS+GMC+LE+V+ E PY+EC + A+IYK+V+ G+KP +L+KV DP+ K FIEKCI
Sbjct: 212 EMVDIYSYGMCVLELVSLEIPYSECDSVAKIYKRVSKGLKPEALNKVNDPEAKAFIEKCI 271
Query: 256 VPASLRLPALELLKDPF---LVTDNPKD 280
R A ELL DPF ++ D+ +D
Sbjct: 272 AQPRARPSAAELLCDPFFDGILDDDDED 299
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6EU49 | WNK4_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5197 | 0.9290 | 0.9411 | yes | no |
| Q944Q0 | WNK8_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5463 | 0.8435 | 0.9289 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00031177 | hypothetical protein (596 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 620 | |||
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-71 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-69 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-62 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-56 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-53 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-52 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-51 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-46 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-42 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-42 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-42 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-39 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-39 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-39 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-38 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-38 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-37 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-37 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-36 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-36 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-35 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-35 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-34 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-32 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-32 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-32 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-32 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-30 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-30 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-29 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-28 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-28 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-27 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-27 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-26 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-26 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-25 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-24 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-23 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-23 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-21 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-17 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.002 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 4e-71
Identities = 96/260 (36%), Positives = 141/260 (54%), Gaps = 11/260 (4%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E+LG+G+F +VY D+ G +A V + S ++LE L E+ +L SL+H NI++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSG--DSEEELEALEREIRILSSLQHPNIVR 63
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+Y S D+ T+N+ E + GSL KK + I+ + RQIL GL YLHS+
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEY 194
I+HRD+K NI V ++G VK+ D G A + SV GTP +MAPE+ EEY
Sbjct: 122 IVHRDIKGANILV-DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
DI+S G ++EM T + P++E NP K+ S +P + + + K F+ KC
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240
Query: 255 IVP-ASLRLPALELLKDPFL 273
+ R A ELL+ PFL
Sbjct: 241 LRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 2e-69
Identities = 87/259 (33%), Positives = 132/259 (50%), Gaps = 14/259 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E LG+G+F VY D+ G VA + + + ER+ E+ +LK LKH NI++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI---KKDRERILREIKILKKLKHPNIVR 61
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
Y+ + D+ + ++ E G L KK + + + RQIL L YLHS
Sbjct: 62 LYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG-- 117
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPE-LYEEEYNEL 197
I+HRDLK +NI ++ +G VK+ D GLA + + +GTPE+MAPE L + Y +
Sbjct: 118 IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 198 VDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCI 255
VDI+S G IL E++T + P+ +++KK+ P + P+ K I K +
Sbjct: 177 VDIWSLG-VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235
Query: 256 VP-ASLRLPALELLKDPFL 273
V RL A E L+ PF
Sbjct: 236 VKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 5e-62
Identities = 80/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
LG G+F TVYK + G VA + + + + E+ +L+ L H NI++
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVR 62
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+++ D + + ++ E G L Y + + K A QILRGL YLHS+
Sbjct: 63 LIDAFEDKDH--LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE--LYEEEYN 195
IIHRDLK +NI ++ NG VKI D GLA + + + +GTP +MAPE L Y
Sbjct: 119 IIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASLSKVTD--PQVKQFI 251
VD++S G+ + E++T + P++ Q+ ++ K + + K I
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 252 EKCIVP-ASLRLPALELLKDPFL 273
+KC+ S R A E+L+ P+
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 3e-56
Identities = 79/256 (30%), Positives = 122/256 (47%), Gaps = 47/256 (18%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG+G F TVY D+ G +VA + ED S LE L E+ +LK L H NI+K Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED---SSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 82 NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
+ D+ + + ++ E GSL+ ++ + I QIL GL YLHS+ I
Sbjct: 58 GVFEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--I 113
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNE 196
IHRDLK +NI ++ +NG+VK+ D GL+ ++ ++++GTP +MAPE+ Y+E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256
DI+S G+ + E+ P++K I K +
Sbjct: 174 KSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199
Query: 257 P-ASLRLPALELLKDP 271
R A E+L+
Sbjct: 200 KDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 183 bits (465), Expect = 2e-53
Identities = 94/262 (35%), Positives = 147/262 (56%), Gaps = 17/262 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLKHENII 78
E+LG G+F +VY+G + DG A +V++ D Q+ + +++L E+ LL L+H NI+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
++ + ++ N + + EL GSL + KK+ + I+ + RQIL GL YLH N
Sbjct: 66 QYLGTEREEDN--LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN- 122
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY--EEEYN 195
+HRD+K NI V+ NG VK+ D G+A V++ A+S G+P +MAPE+ + Y
Sbjct: 123 -TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIE 252
DI+S G +LEM T + P+++ + A ++K S P LS + K FI
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS----DEAKDFIL 236
Query: 253 KCI-VPASLRLPALELLKDPFL 273
KC+ SLR A ELL+ PF+
Sbjct: 237 KCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 3e-52
Identities = 90/269 (33%), Positives = 141/269 (52%), Gaps = 23/269 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +G+GA VYK D G EVA ++ + E + +E+ ++K KH NI+
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-----QNKELIINEILIMKDCKHPNIVD 79
Query: 80 FYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+Y+S++ + ++ E GSL Q + + + R++L+GL YLHS
Sbjct: 80 YYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV---CREVLQGLEYLHS 134
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE-E 192
N +IHRD+K DNI ++ +G VK+ D G A + ++ SV+GTP +MAPE+ + +
Sbjct: 135 QN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQFI 251
+Y VDI+S G+ +EM E PY + P + ++ T GI P + P+ K F+
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250
Query: 252 EKCIVP-ASLRLPALELLKDPFLVTDNPK 279
KC+V R A ELL+ PFL PK
Sbjct: 251 NKCLVKDPEKRPSAEELLQHPFLKKACPK 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 4e-51
Identities = 80/267 (29%), Positives = 139/267 (52%), Gaps = 19/267 (7%)
Query: 17 QYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+Y+ I +GKG+F VY + DG ++++ + S + E +EV +LK L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNH 58
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGL 130
NIIK+Y S+ + + ++ E G L Q KK K + I +W Q+ L
Sbjct: 59 PNIIKYYESFEEKGK--LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE 188
YLHS I+HRD+K NIF+ +NG VK+GD G++ V+ A++V+GTP +++PE
Sbjct: 117 KYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173
Query: 189 LYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247
L + + YN DI+S G + E+ T ++P+ E +N ++ K+ G + + ++
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKG-QYPPIPSQYSSEL 231
Query: 248 KQFIEKCIVP-ASLRLPALELLKDPFL 273
+ + + R ++L+ PF+
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 7e-51
Identities = 88/258 (34%), Positives = 143/258 (55%), Gaps = 15/258 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +GKG F VYK + G EVA + +E S ++ E++ +E+ +LK KH NI+K
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKIINEIQILKKCKHPNIVK 61
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
+Y S++ I M E + GSL+ + ++ + I +++L+GL YLHS+
Sbjct: 62 YYGSYLKKDELWIVM--EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG- 118
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE-LYEEEYNE 196
IIHRD+K NI + ++GEVK+ D GL+ + AR +++GTP +MAPE + + Y+
Sbjct: 119 -IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCI 255
DI+S G+ +E+ + PY+E ++K T+G + K +D K F++KC+
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDE-FKDFLKKCL 235
Query: 256 VPA-SLRLPALELLKDPF 272
R A +LLK PF
Sbjct: 236 QKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-46
Identities = 88/258 (34%), Positives = 142/258 (55%), Gaps = 13/258 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+++G+GAF VYKG + G VA Q+++E + + L+ + E+ LLK+LKH NI+K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ S +T+ ++ +I E +GSLRQ KK + + Q+L+GL YLH
Sbjct: 64 YIGSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG-- 119
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYEEE-YNE 196
+IHRD+K NI +G VK+ D G+A + SV+GTP +MAPE+ E +
Sbjct: 120 VIHRDIKAANILTTK-DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256
DI+S G ++E++T PY + A +++ V P L + P++K F+ +C
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQ 236
Query: 257 P-ASLRLPALELLKDPFL 273
+LR A +LLK P++
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 1e-42
Identities = 89/261 (34%), Positives = 139/261 (53%), Gaps = 14/261 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHENII 78
++LG+GAF VY +D G E+A QV + D ++ ++ L E+ LLK+L+HE I+
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
++Y DD +I M E GS++ K + + + + RQIL G+ YLHS+
Sbjct: 68 QYYGCLRDDETLSIFM--EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM- 124
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELYE-E 192
I+HRD+K NI + + G VK+GD G + I +SV GTP +M+PE+ E
Sbjct: 125 -IVHRDIKGANI-LRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252
Y D++S G ++EM+T + P+ E + A I+K T P S V P + F+
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARNFLR 241
Query: 253 KCIVPASLRLP-ALELLKDPF 272
+ V + + P A ELL+ F
Sbjct: 242 RTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 82/265 (30%), Positives = 146/265 (55%), Gaps = 16/265 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +GKG+F TV K + DG + W +++ + M ++ ++L SEV++L+ LKH NI++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEK-QQLVSEVNILRELKHPNIVR 63
Query: 80 FYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+Y+ +D +N+T+ ++ E G L ++ +K+ K ++ + I Q+L L+ H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 136 HNPP---IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-L 189
+ P ++HRDLK NIF++ NN VK+GD GLA ++ + A++ +GTP +M+PE L
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 190 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249
Y+E DI+S G I E+ P+ +N Q+ K+ G + ++ +
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASKIKEGKFR-RIPYRYSSELNE 240
Query: 250 FIEKCI-VPASLRLPALELLKDPFL 273
I+ + V R ELL+ P +
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 3e-42
Identities = 90/267 (33%), Positives = 141/267 (52%), Gaps = 25/267 (9%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G G F VY + G +A ++ I+D P ++ + E+ +L+ LKH N++K+Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQD--NDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
V I M E + G+L + + + +D I+ + Q+L GL YLHSH I+
Sbjct: 66 GVEVHREKVYIFM--EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGTPEFMAPELY----E 191
HRD+K NIF+ +NG +K+GD G A+ ++ T S+ GTP +MAPE+
Sbjct: 122 HRDIKPANIFL-DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 192 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVK 248
+ + DI+S G +LEM T + P++E N QI V +G KP SL P+ K
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL--SPEGK 238
Query: 249 QFIEKCIV--PASLRLPALELLKDPFL 273
F+++C+ P R A ELL+ PF+
Sbjct: 239 DFLDRCLESDP-KKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 9e-42
Identities = 74/259 (28%), Positives = 133/259 (51%), Gaps = 15/259 (5%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG+G+ VYK + G A +++++ + ++L E+ L+S + ++K Y
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDG---DEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPI 140
++ I+++ E GSL KK + + ARQIL+GL YLH+ + I
Sbjct: 66 GAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-LYEEEYNEL 197
IHRD+K N+ +N + GEVKI D G++ V++ + +GT +M+PE + E Y+
Sbjct: 122 IHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 198 VDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
DI+S G+ +LE ++P+ + ++ + + G P+ ++ P+ + FI C+
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240
Query: 256 VP-ASLRLPALELLKDPFL 273
R A ELL+ PF+
Sbjct: 241 QKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 89/261 (34%), Positives = 142/261 (54%), Gaps = 11/261 (4%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHENII 78
++LG+GAF VY +D G E+A QV + + ++ ++ L E+ LLK+L HE I+
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
++Y D RT+++ E GS++ K + + + + RQIL G+ YLHS+
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM- 126
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELYE-E 192
I+HRD+K NI + + G VK+GD G + I + +SV GTP +M+PE+ E
Sbjct: 127 -IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252
Y DI+S G ++EM+T + P+ E + A I+K T P V+D + F++
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRDFLK 243
Query: 253 KCIVPASLRLPALELLKDPFL 273
+ V A LR A ELL+ F+
Sbjct: 244 RIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 2e-39
Identities = 88/260 (33%), Positives = 140/260 (53%), Gaps = 11/260 (4%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHENII 78
++LG+GAF VY +D G E+A QV + + ++ ++ L E+ LLK+L+HE I+
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
++Y D +T+ + E GS++ K + + + + RQIL G+ YLHS+
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM- 126
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELYE-E 192
I+HRD+K NI + + G VK+GD G + I M RSV GTP +M+PE+ E
Sbjct: 127 -IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252
Y D++S G ++EM+T + P+ E + A I+K T P S +++ + F+
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARDFLG 243
Query: 253 KCIVPASLRLPALELLKDPF 272
V A R A ELL+ PF
Sbjct: 244 CIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +GKG+F VYK D+ VA +++E+ + D++E + E+ L + I K
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITK 63
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+Y S++ + I M E GS K K +D I R++L GL YLH
Sbjct: 64 YYGSFLKGSKLWIIM--EYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEGK- 119
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY-EEEYNE 196
IHRD+K NI ++ G+VK+ D G++ + ++ + +GTP +MAPE+ + Y+E
Sbjct: 120 -IHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASL--SKVTDPQVKQFI 251
DI+S G+ +E+ E P ++ +P +V I P SL +K + P K F+
Sbjct: 178 KADIWSLGITAIELAKGEPPLSD-LHPM----RVLFLIPKNNPPSLEGNKFSKP-FKDFV 231
Query: 252 EKCIV--PASLRLPALELLKDPFL----VTDNPKDLV 282
C+ P R A ELLK F+ T L+
Sbjct: 232 SLCLNKDPKE-RPSAKELLKHKFIKKAKKTSYLTLLI 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 78/244 (31%), Positives = 128/244 (52%), Gaps = 14/244 (5%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+GKG F VYK +DG VA +V I ++M + E+ LLK L H N+IK+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 82 NSWVDDTNRTINMITELFTSGSLRQ----YRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
S+++ N +N++ EL +G L + ++K+ + + + I + Q+ L ++HS
Sbjct: 69 ASFIE--NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEY 194
I+HRD+K N+F+ G VK+GDLGL T A S++GTP +M+PE ++E Y
Sbjct: 127 --IMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 195 NELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253
N DI+S G + EM + P Y + N + KK+ P + +++ + +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243
Query: 254 CIVP 257
CI P
Sbjct: 244 CINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 22/230 (9%)
Query: 16 LQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
L+ + LG+GAF VYKG E +VA + S ++ E E ++K
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA---SEEEREEFLEEASIMKK 57
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGL 130
L H NI++ + ++TE G L + +KH + +K + A QI +G+
Sbjct: 58 LSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF-----M 185
YL S N +HRDL N V N VKI D GL+ + M
Sbjct: 116 EYLESKN--FVHRDLAARNCLV-TENLVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWM 171
Query: 186 APELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233
APE ++ ++ D++SFG+ + E+ T E PY N ++ + + G
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 85/260 (32%), Positives = 140/260 (53%), Gaps = 11/260 (4%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHENII 78
++LG+GAF VY +D G E+A QV + D ++ ++ L E+ LLK+L+H+ I+
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
++Y D + +++ E GS++ K + + + + RQIL+G+ YLHS+
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM- 126
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELYE-E 192
I+HRD+K NI + + G VK+GD G + I M +SV GTP +M+PE+ E
Sbjct: 127 -IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252
Y D++S ++EM+T + P+ E + A I+K T KP V+D + F++
Sbjct: 185 GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRDFLK 243
Query: 253 KCIVPASLRLPALELLKDPF 272
+ V R A LL+ PF
Sbjct: 244 QIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 86/265 (32%), Positives = 137/265 (51%), Gaps = 26/265 (9%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
E LG+G++ +VYK + G VA V +E+ +Q + E+ +LK I+
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE------IIKEISILKQCDSPYIV 61
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHN 137
K+Y S+ +T+ I M E +GS+ K +K + + I Q L+GL YLHS+
Sbjct: 62 KYYGSYFKNTDLWIVM--EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE-Y 194
IHRD+K NI +N G+ K+ D G++ + A+ +VIGTP +MAPE+ +E Y
Sbjct: 120 --KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASLSKVTD--PQVKQ 249
N DI+S G+ +EM + PY++ I+ I P +LS P+
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKPPPTLSDPEKWSPEFND 231
Query: 250 FIEKCIV-PASLRLPALELLKDPFL 273
F++KC+V R A++LL+ PF+
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 79/260 (30%), Positives = 143/260 (55%), Gaps = 15/260 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+GKG+F V+K + D A Q+++ M ++ E + E +L L II+
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAI-DEARVLAKLDSSYIIR 63
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR--QILRGLHYLHSHN 137
+Y S++D +N++ E +G L + K + + + W QIL GL +LHS
Sbjct: 64 YYESFLDK--GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-Y 194
I+HRD+K N+F++ + VKIGDLG+A ++ T A +++GTP +++PEL E++ Y
Sbjct: 122 --ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
NE D+++ G+ + E T ++P+ + N + K+ G+ P +S++ Q+ Q I++C
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQC 236
Query: 255 IVPASLRLP-ALELLKDPFL 273
+ + P +LL++P L
Sbjct: 237 LTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 70/246 (28%), Positives = 109/246 (44%), Gaps = 20/246 (8%)
Query: 19 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+ LG+GAF VYKG +EVA V S Q+E E +++ L H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVA---VKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYL 133
N++K ++ + ++ E G L Y RK + + + ++A QI RG+ YL
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE---FMAPE-L 189
S N IHRDL N V G N VKI D GL+ + G +MAPE L
Sbjct: 119 ESKN--FIHRDLAARNCLV-GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 190 YEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248
E ++ D++SFG+ + E+ T E PY N ++ + + +G + +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYRLPQPPNCPPE-LY 233
Query: 249 QFIEKC 254
+ +C
Sbjct: 234 DLMLQC 239
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-37
Identities = 73/250 (29%), Positives = 114/250 (45%), Gaps = 21/250 (8%)
Query: 16 LQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
L + LG+GAF VYKG + +EVA V S Q+E E +++
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVA---VKTLKEDASEQQIEEFLREARIMRK 57
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRG 129
L H NI+K ++ + ++ E G L Y +K++ ++ ++A QI RG
Sbjct: 58 LDHPNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE---FMA 186
+ YL S N IHRDL N V G N VKI D GL+ + V G +MA
Sbjct: 116 MEYLESKN--FIHRDLAARNCLV-GENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMA 172
Query: 187 PE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244
PE L E ++ D++SFG+ + E+ T E PY N A++ + + G +
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLKKGYRLPKPPNCPP 231
Query: 245 PQVKQFIEKC 254
+ + + +C
Sbjct: 232 E-LYKLMLQC 240
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-36
Identities = 84/260 (32%), Positives = 131/260 (50%), Gaps = 19/260 (7%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--EVHLLKSLKHENIIK 79
LGKG++ +VYK D A +V++ S Q ER + E+ +L S+ H NII
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDL----GSMSQKEREDAVNEIRILASVNHPNIIS 63
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKN-VDMKAIKNWARQILRGLHYLHS 135
+ +++D I M E G L + RKK + + + I Q+LRGL LH
Sbjct: 64 YKEAFLDGNKLCIVM--EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-Y 194
I+HRDLK NI + N VKIGDLG++ V+++ A++ IGTP +MAPE+++ Y
Sbjct: 122 QK--ILHRDLKSANILLV-ANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
+ DI+S G + EM T P+ E ++ + KV G P + + ++ FI
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPP-IPPIYSQDLQNFIRSM 236
Query: 255 IVP-ASLRLPALELLKDPFL 273
+ LR ++L P +
Sbjct: 237 LQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 9e-36
Identities = 78/264 (29%), Positives = 126/264 (47%), Gaps = 16/264 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLKHENI 77
+ LG GAF + Y+ D G +A QV + + +E L E+ L+ L H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
I+ + +D++ N+ E GS+ K+ I N+ Q+LRGL YLH +
Sbjct: 66 IRMLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS------VIGTPEFMAPE-LY 190
IIHRD+K N+ ++ ++I D G A + + ++GT FMAPE L
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 191 EEEYNELVDIYSFGMCILEMVTCEYPYN--ECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248
E+Y D++S G I+EM T + P+N + N + K+ S S+ + P ++
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241
Query: 249 QFIEKCI-VPASLRLPALELLKDP 271
+C+ + R P+ ELLK P
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 88/268 (32%), Positives = 142/268 (52%), Gaps = 22/268 (8%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-----LERLYSEVHLLKSLKHE 75
++G G+F +VY G + G +A QV + V S L+ L E+ LLK L+HE
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
NI+++ S +D + +N+ E GS+ + + ++N+ RQIL+GL+YLH+
Sbjct: 67 NIVQYLGSSLDADH--LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTAR-SVIGTPEFMAP 187
IIHRD+K NI V+ N G +KI D G++ + + AR S+ G+ +MAP
Sbjct: 125 RG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 188 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246
E+ ++ Y DI+S G ++EM+T ++P+ +C I+ K+ P S ++ +
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASPEIPSNISS-E 239
Query: 247 VKQFIEKCIVP-ASLRLPALELLKDPFL 273
F+EK + R A ELLK PFL
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 91/269 (33%), Positives = 131/269 (48%), Gaps = 31/269 (11%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 80
+LGKG + VY D + +A ++ D + L+ E+ L LKH NI+++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV----QPLHEEIALHSYLKHRNIVQY 70
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMK--AIKNWARQILRGLHYLHSHN 137
S D N + E GSL R K + I + +QIL GL YLH +
Sbjct: 71 LGS--DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLG----LAIVMQQPTARSVIGTPEFMAPELYEE- 192
I+HRD+K DN+ VN +G VKI D G LA + P + GT ++MAPE+ ++
Sbjct: 129 --IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDKG 184
Query: 193 --EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYK----KVTSGIKPASLSKVTDP 245
Y DI+S G I+EM T + P+ E P A ++K K+ I P SLS
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI-PESLSA---- 239
Query: 246 QVKQFIEKCIVPASLRLP-ALELLKDPFL 273
+ K FI +C P + A +LL+DPFL
Sbjct: 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 86/265 (32%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLKH---E 75
E++G+GA+ VY+G G VA +N++ +P D + + EV LL L+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQSQPP 62
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
NI K+Y S++ I M E GS+R K + K I R++L L Y+H
Sbjct: 63 NITKYYGSYLKGPRLWIIM--EYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALKYIHK 119
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEE- 192
+IHRD+K NI V N G VK+ D G+A ++ Q +++ + +GTP +MAPE+ E
Sbjct: 120 V--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 193 -EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-KVTDPQVKQF 250
Y+ DI+S G+ I EM T PY A + KP L +++F
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY--SDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF 234
Query: 251 IEKCI--VPASLRLPALELLKDPFL 273
+ C+ P RL A ELLK ++
Sbjct: 235 VAACLDEEPKE-RLSAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 79/271 (29%), Positives = 129/271 (47%), Gaps = 29/271 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E++G GA VY + +VA ++++E + ++ L EV + H N++K
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLE---KCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 80 FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+Y S+V + M + GSL + +D I +++L+GL YLHS+
Sbjct: 64 YYTSFVVGDELWLVM--PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS------VIGTPEFMAPELY 190
IHRD+K NI + G +G VKI D G++ + R+ +GTP +MAPE+
Sbjct: 122 G--QIHRDIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 191 EEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV- 247
E+ Y+ DI+SFG+ +E+ T PY++ P ++ P SL D +
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQN-DPPSLETGADYKKY 236
Query: 248 ----KQFIEKCIV--PASLRLPALELLKDPF 272
++ I C+ P+ R A ELLK F
Sbjct: 237 SKSFRKMISLCLQKDPSK-RPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 94/298 (31%), Positives = 135/298 (45%), Gaps = 58/298 (19%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSL 72
+ E LG+G + VYK D+ G VA ++ +++ + E + S E+ LLK L
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN------EEEGIPSTALREISLLKEL 55
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLH 131
KH NI+K + V T R + ++ E + L++Y K+ + IK+ Q+LRGL
Sbjct: 56 KHPNIVKLLD--VIHTERKLYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAP 187
Y HSH I+HRDLK NI +N +G +K+ D GLA I ++ T V T + AP
Sbjct: 113 YCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAP 167
Query: 188 ELY--EEEYNELVDIYSFGMCILEMVT--------CE------------YPYNE-----C 220
E+ + Y+ VDI+S G EM+T E P E
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227
Query: 221 KNPAQIYKKVTSGIKPASLSKVT---DPQVKQFIEK--CIVPASLRLPALELLKDPFL 273
K P YK P L KV DP+ + K PA R+ A E LK P+
Sbjct: 228 KLPD--YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK-RISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 75/267 (28%), Positives = 126/267 (47%), Gaps = 45/267 (16%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ----LERLYSEVHLLKSLKHE 75
+I+G+G+F TV ++ E A ++ +++ +E+ EV L + H
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK---EV-LTRLNGHP 62
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
IIK Y ++ D+ N + + E +G L QY +K+ ++D K + +A +IL L YLHS
Sbjct: 63 GIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----------------------QQP 173
IIHRDLK +NI ++ + +KI D G A V+ +
Sbjct: 121 KG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 174 TARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVT 231
S +GT E+++PEL E+ + D+++ G CI+ +M+T + P+ N ++K
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFR-GSNEYLTFQK-- 233
Query: 232 SGIKPASLS--KVTDPQVKQFIEKCIV 256
I S P K IEK +V
Sbjct: 234 --ILKLEYSFPPNFPPDAKDLIEKLLV 258
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---SPDQLERLYSEVHLLKSLKHEN 76
+ LG+GAF VYKG ++ G + +V ++ ++ S ++ + E ++K L H N
Sbjct: 1 KKLGEGAFGEVYKG--KLKGKDGKTTEVAVK-TLKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN---------WARQIL 127
+++ V + ++ E G L Y +K + V K+ +A QI
Sbjct: 58 VVRLLG--VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 128 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPE--- 183
+G+ YL S +HRDL N V G + VKI D GL+ + R G
Sbjct: 116 KGMEYLASKK--FVHRDLAARNCLV-GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 184 FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241
+MAPE L + + D++SFG+ + E+ T PY N ++ + + G +
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKGYRLPKPEY 231
Query: 242 VTDPQVKQFIEKC 254
D ++ + + C
Sbjct: 232 CPD-ELYELMLSC 243
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 80/269 (29%), Positives = 127/269 (47%), Gaps = 23/269 (8%)
Query: 17 QYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
Y+ I +G G + VYK D G VA + +E D E + E+ +LK +H
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRH 59
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYL 133
NI+ ++ S++ I M E GSL+ Y+ + I R+ L+GL YL
Sbjct: 60 PNIVAYFGSYLRRDKLWIVM--EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYE 191
H IHRD+K NI + +G+VK+ D G++ + A+ S IGTP +MAPE+
Sbjct: 118 HETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 192 EE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVT--D 244
E Y+ DI++ G+ +E+ + P + +P + ++ S P L
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKEKWS 233
Query: 245 PQVKQFIEKCIVPASLRLP-ALELLKDPF 272
P FI+KC+ + P A +LL+ PF
Sbjct: 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 62/238 (26%), Positives = 118/238 (49%), Gaps = 12/238 (5%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LGKG+F V + G A + + +++ ++E +E ++L + H I+K +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
++ + + ++ E G L + K + + +A +I+ L YLHS II
Sbjct: 60 YAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--II 115
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 198
+RDLK +NI ++ +G +K+ D GLA + + + GTPE++APE L + Y + V
Sbjct: 116 YRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 199 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256
D +S G+ + EM+T + P+ ++ +IY+K+ P + P+ + I +
Sbjct: 175 DWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQ 229
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-32
Identities = 83/372 (22%), Positives = 136/372 (36%), Gaps = 38/372 (10%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE- 75
+ LG+G+F VY D VA + + ++ER E+ +L SL H
Sbjct: 3 RILRKLGEGSFGEVYLARDR---KLVALKVLAK-KLESKSKEVERFLREIQILASLNHPP 58
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHY 132
NI+K Y+ + D+ + + M E GSL KK + QIL L Y
Sbjct: 59 NIVKLYDFFQDEGSLYLVM--EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--------QQPTARSVIGTPEF 184
LHS IIHRD+K +NI ++ + VK+ D GLA ++ + +GTP +
Sbjct: 117 LHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 185 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPA 237
MAPE+ + DI+S G+ + E++T P+ +Q K + P+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 238 SLSKV-------TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 289
S + ++K + RL + L L L L
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL---AHLKLKESDLSDL 291
Query: 290 NLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEK 349
+ L S P ++ ++ A S + + EL ++
Sbjct: 292 LKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSL 351
Query: 350 NDDDTVSLTLRI 361
S +
Sbjct: 352 LLSTASSKRSSL 363
|
Length = 384 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 81/257 (31%), Positives = 138/257 (53%), Gaps = 14/257 (5%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G+G F VY+ +DG+ VA +V I D+M + + + + E+ LLK L H N+IK+Y
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPNVIKYY 68
Query: 82 NSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
S+++D +N++ EL +G L + ++K+ + + K + + Q+ L ++HS
Sbjct: 69 ASFIEDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEY 194
++HRD+K N+F+ G VK+GDLGL T A S++GTP +M+PE ++E Y
Sbjct: 127 --VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 195 NELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253
N DI+S G + EM + P Y + N + KK+ P S +++Q +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243
Query: 254 CIVPASLRLPALELLKD 270
CI P + P + + D
Sbjct: 244 CINPDPEKRPDITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-32
Identities = 85/267 (31%), Positives = 131/267 (49%), Gaps = 20/267 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKHENI 77
E+LGKGA+ TVY G G +A QV ++ +V+ + + E+L EV LLKSLKH NI
Sbjct: 6 EVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
+++ + +DD TI++ E GS+ + + + +QIL G+ YLH++
Sbjct: 65 VQYLGTCLDDN--TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--------VMQQPTARSVIGTPEFMAPEL 189
++HRD+K +N+ + NG +K+ D G A +S+ GTP +MAPE+
Sbjct: 123 --VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 190 YEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQV 247
E Y DI+S G + EM T + P A + Y G+ P L
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSFSAAA 238
Query: 248 KQFIEKCIVPASLRLP-ALELLKDPFL 273
F+ C+ P AL+LL+ FL
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 79/256 (30%), Positives = 138/256 (53%), Gaps = 13/256 (5%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 80
++G+GAF V+ + D V Q+ +E + + D+ +E +LK L H NII++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEY 64
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNP 138
Y ++++D I M E G+L +Y +K N +D I ++ QIL LH++H+
Sbjct: 65 YENFLEDKALMIVM--EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELYE-EEYNE 196
I+HRDLK NI ++ + VKIGD G++ I+ + A +V+GTP +++PEL E + YN+
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI- 255
DI++ G + E+ + + + PA + K+ SG A +S P ++Q I +
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSG-TFAPISDRYSPDLRQLILSMLN 238
Query: 256 VPASLRLPALELLKDP 271
+ S R +++ P
Sbjct: 239 LDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 76/234 (32%), Positives = 127/234 (54%), Gaps = 20/234 (8%)
Query: 60 ERLYSEVHLLKSLKHENIIKFYNSW-VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA 118
E L++EV +++ +H NI++ Y+S+ V D + ++ E G+L H ++ +
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSSYLVGDE---LWVVMEFLEGGALTDI-VTHTRMNEEQ 116
Query: 119 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 176
I +L+ L +LH+ +IHRD+K D+I + ++G VK+ D G + + P +
Sbjct: 117 IATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRK 173
Query: 177 SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGI 234
S++GTP +MAPE+ Y VDI+S G+ ++EMV E PY NE P Q K++ +
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE--PPLQAMKRIRDNL 231
Query: 235 KPAS--LSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 284
P L KV+ P+++ F+++ +V PA R A ELL PFL P +
Sbjct: 232 PPKLKNLHKVS-PRLRSFLDRMLVRDPAQ-RATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 86/279 (30%), Positives = 138/279 (49%), Gaps = 27/279 (9%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG GAF VYK + G+ A + IE ++LE E+ +L KH NI+ Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES----EEELEDFMVEIDILSECKHPNIVGLY 68
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
++ + ++ E G+L + + + I+ RQ+L L++LHSH +
Sbjct: 69 EAYFYENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--V 124
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----- 193
IHRDLK NI + +G+VK+ D G++ + + + IGTP +MAPE+ E
Sbjct: 125 IHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 194 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQF 250
Y+ DI+S G+ ++E+ E P++E NP ++ K+ P SK + F
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSS-SFNDF 241
Query: 251 IEKCIVP-ASLRLPALELLKDPFL--VTDNP--KDLVCD 284
++ C+V R A ELLK PF+ +DN KDL+ +
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLLAE 280
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 88/265 (33%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +G+GA TVY D G EVA Q+N++ Q P + E + +E+ +++ KH NI+
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKK-ELIINEILVMRENKHPNIVN 80
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ +S++ + ++ E GSL + +D I R+ L+ L +LHS+
Sbjct: 81 YLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ-- 135
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY-EEEYNE 196
+IHRD+K DNI + G +G VK+ D G I +Q +++GTP +MAPE+ + Y
Sbjct: 136 VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 197 LVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
VDI+S G+ +EMV E PY NE NP + +Y T+G + + F+ +C
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252
Query: 255 I-VPASLRLPALELLKDPFLVTDNP 278
+ + R A ELL+ PFL P
Sbjct: 253 LEMDVEKRGSAKELLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+ + +G GA+ V D+ G +VA I +V +R+ E+ LL+ L+HEN
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 77 IIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
II + + + ++TEL + L + K + + I+ + QILRGL YL
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-------- 185
HS N +IHRDLK NI VN N ++KI D GLA + F+
Sbjct: 120 HSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDED-----EKGFLTEYVVTRW 171
Query: 186 --APE--LYEEEYNELVDIYSFGMCIL-EMVT 212
APE L Y + +DI+S G CI E++T
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 63/235 (26%), Positives = 107/235 (45%), Gaps = 9/235 (3%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G F V + A V + + Q E ++SE +L+ H I+K Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVK-KRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
++ D + I M+ E G L + D + + ++ YLH+ II
Sbjct: 60 RTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--II 115
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE-YNELVD 199
+RDLK +N+ ++ +NG VK+ D G A ++ + GTPE++APE+ + Y+ VD
Sbjct: 116 YRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVD 174
Query: 200 IYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253
+S G+ + E++T P+ E +P +IY + G D K I++
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-29
Identities = 74/256 (28%), Positives = 136/256 (53%), Gaps = 14/256 (5%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
Q ++ +G+G F VY+ +D VA +V I ++M + + + E+ LLK L H
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHP 62
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQ----YRKKHKNVDMKAIKNWARQILRGLH 131
N+IK+ +S+++D +N++ EL +G L Q ++K+ + + + + + Q+ +
Sbjct: 63 NVIKYLDSFIEDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE- 188
++HS ++HRD+K N+F+ G VK+GDLGL T A S++GTP +M+PE
Sbjct: 121 HMHSRR--VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 189 LYEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247
++E YN DI+S G + EM + P Y + N + +K+ P ++ ++
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 248 KQFIEKCIVPASLRLP 263
++ + CI P + P
Sbjct: 238 RELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 76/261 (29%), Positives = 133/261 (50%), Gaps = 19/261 (7%)
Query: 21 ILGKGAF--KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
+LGKGAF T+Y+ + D V W +VN+ + S + +E+ +L L+H NII
Sbjct: 7 VLGKGAFGEATLYRRTE--DDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNII 62
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+YN ++DD I M E G+L R+K + + + + + QI+ + Y+H
Sbjct: 63 AYYNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EE 193
I+HRD+K NIF+ G +K+GD G++ ++ A +V+GTP +M+PEL + +
Sbjct: 121 G--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 194 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253
YN DI++ G + E++T + + + NP + K+ G +S + ++ +
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVVSVYSS-ELISLVHS 235
Query: 254 CI-VPASLRLPALELLKDPFL 273
+ R A E+L P L
Sbjct: 236 LLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 67/260 (25%), Positives = 124/260 (47%), Gaps = 14/260 (5%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G V K G +A + +E + +++ E+ +L I+ FY
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE---INEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
++ ++ + I++ E GSL + K+ + + + A +L+GL YLH I
Sbjct: 66 GAFYNNGD--ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKI 122
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVD 199
IHRD+K NI VN + G++K+ D G++ + A++ +GT +MAPE + +Y+ D
Sbjct: 123 IHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 200 IYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
I+S G+ ++E+ T +PY ++ + + + P S P + F+ C+
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCL 241
Query: 256 VPASLRLPAL-ELLKDPFLV 274
+ P+ ELL+ PF+
Sbjct: 242 IKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIED-VMQSPDQLERLYSEVHLLKSLKHENII 78
+G+G + VYK ++ G VA ++ +E+ P R E+ LL+ L+H NI+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR---EIKLLQKLRHPNIV 61
Query: 79 KFYNSWVDDTNRTINMITELFT---SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+ +I M+ E +G L K IK + +Q+L GL YLHS
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLEGLQYLHS 118
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS----VIGTPEFMAPELY- 190
+ I+HRD+K NI +N N+G +K+ D GLA + + VI T + PEL
Sbjct: 119 NG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLL 174
Query: 191 -EEEYNELVDIYSFGMCIL-EMVT 212
Y VD++S G CIL E+
Sbjct: 175 GATRYGPEVDMWSVG-CILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 66/194 (34%), Positives = 100/194 (51%), Gaps = 15/194 (7%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHENIIKF 80
LG+G + VYK D+ G VA ++ + + ++ D + E+ LL+ LKH NII
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA-IKNWARQILRGLHYLHSHNPP 139
+ + +N IN++ E F L + K V A IK++ LRGL YLHS+
Sbjct: 68 LDVFGHKSN--INLVFE-FMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW-- 122
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELY--EEEY 194
I+HRDLK +N+ + ++G +K+ D GLA P + V+ T + APEL Y
Sbjct: 123 ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGARHY 180
Query: 195 NELVDIYSFGMCIL 208
VD++S G CI
Sbjct: 181 GVGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 4e-28
Identities = 88/270 (32%), Positives = 143/270 (52%), Gaps = 19/270 (7%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+ +Y++I G+GA TV+ D G EVA Q+N +Q + E + +E+ ++K LK+
Sbjct: 21 YTRYEKI-GQGASGTVFTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVMKELKN 75
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
NI+ F +S++ + ++ E GSL + +D I R+ L+ L +LH
Sbjct: 76 PNIVNFLDSFL--VGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLH 132
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEE 192
++ +IHRD+K DN+ + G +G VK+ D G I +Q +++GTP +MAPE+
Sbjct: 133 ANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 193 E-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQ 249
+ Y VDI+S G+ +EMV E PY NE NP + +Y T+G + P +
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLSPIFRD 247
Query: 250 FIEKCI-VPASLRLPALELLKDPFLVTDNP 278
F+ +C+ + R A ELL+ PFL P
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLLKSLK 73
E++GKG + VY + G +A QV + + D ++ L SE+ LK L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
H NI+++ + T +++ E GS+ + + + + ++ + Q+L GL YL
Sbjct: 67 HLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----AIVMQQPTARSVIGTPEFMAPE- 188
HS I+HRDLK DN+ V+ +G KI D G+ + S+ G+ +MAPE
Sbjct: 125 HSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 189 --LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK----KVTSGIKPASLSKV 242
Y + Y+ VDI+S G +LEM P+++ + A ++K + I P +
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 243 TDPQVKQFIEKCIVPASLRLP-ALELLKDPF 272
+ P F+ C P A ELL+ PF
Sbjct: 242 S-PVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 78/236 (33%), Positives = 128/236 (54%), Gaps = 18/236 (7%)
Query: 60 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 119
E L++EV +++ +HEN+++ YNS++ + ++ E G+L H ++ + I
Sbjct: 62 ELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 118
Query: 120 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS 177
+L+ L LH+ +IHRD+K D+I + ++G VK+ D G + + P +S
Sbjct: 119 AAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKS 175
Query: 178 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 235
++GTP +MAPEL Y VDI+S G+ ++EMV E PY NE P + K + +
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLP 233
Query: 236 P--ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 287
P +L KV+ P +K F+++ +V PA R A ELLK PFL P + +R
Sbjct: 234 PKLKNLHKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPSCIVPLMR 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 91/269 (33%), Positives = 142/269 (52%), Gaps = 26/269 (9%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +G+GA TVY D G EVA Q+N++ Q P + E + +E+ +++ K+ NI+
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQ---QQPKK-ELIINEILVMRENKNPNIVN 80
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ +S++ + ++ E GSL + +D I R+ L+ L +LHS+
Sbjct: 81 YLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ-- 135
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY-EEEYNE 196
+IHRD+K DNI + G +G VK+ D G I +Q +++GTP +MAPE+ + Y
Sbjct: 136 VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 197 LVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPASLSKVTDPQVKQF 250
VDI+S G+ +EMV E PY NE NP + +Y T+G P LS V + F
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPERLSAV----FRDF 248
Query: 251 IEKCI-VPASLRLPALELLKDPFLVTDNP 278
+ +C+ + R A ELL+ PFL P
Sbjct: 249 LNRCLEMDVDRRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 69/238 (28%), Positives = 121/238 (50%), Gaps = 15/238 (6%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G G F V+ D + A + I +V+ Q + +++E +LK + H II+ +
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
+ D + M+ E G L Y + +A +I+ L YLHS I+
Sbjct: 68 WTEHDQRF--LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IV 123
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 200
+RDLK +NI ++ G +K+ D G A ++ T ++ GTPE++APE+ + + +N+ VD
Sbjct: 124 YRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTW-TLCGTPEYLAPEVIQSKGHNKAVDW 181
Query: 201 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIEKCIV 256
++ G+ I EM+ P+ + NP IY+K+ +G ++ P L D K I+K +V
Sbjct: 182 WALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLEFPRHL----DLYAKDLIKKLLV 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 87/270 (32%), Positives = 140/270 (51%), Gaps = 16/270 (5%)
Query: 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 73
LF + ++I GKG+F V+KG D VA + I D+ ++ D++E + E+ +L
Sbjct: 5 LFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
+ K+Y S++ DT I I E GS + +D I R+IL+GL YL
Sbjct: 61 SPYVTKYYGSYLKDTKLWI--IMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYL 117
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE 191
HS IHRD+K N+ ++ +GEVK+ D G+A + Q + +GTP +MAPE+ +
Sbjct: 118 HSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 174
Query: 192 EE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250
+ Y+ DI+S G+ +E+ E P++E +P ++ + P + P +K+F
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNNPPTLEGNYSKP-LKEF 232
Query: 251 IEKCI-VPASLRLPALELLKDPFLVTDNPK 279
+E C+ S R A ELLK F+V K
Sbjct: 233 VEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 66/267 (24%), Positives = 124/267 (46%), Gaps = 22/267 (8%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+ KGA+ V+ + G A + + M +Q++++ +E +L + ++K Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIK-KADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
S+ N + ++ E G L + ++D + + +I+ L YLHS+ II
Sbjct: 60 YSFQGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--II 115
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGL--------AIVMQQPTARS--VIGTPEFMAPE-LY 190
HRDLK DNI ++ +NG +K+ D GL I + ++GTP+++APE +
Sbjct: 116 HRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 191 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250
+ +++ VD +S G + E + P++ + P +I++ + +G +
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233
Query: 251 IEKCIVPASL-RLPAL---ELLKDPFL 273
I K +VP RL A E+ PF
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 73/270 (27%), Positives = 133/270 (49%), Gaps = 21/270 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
LG+GA +V K + G+ A + +PD +++ E+ + KS K I+K
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTIT---TDPNPDLQKQILRELEINKSCKSPYIVK 63
Query: 80 FYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+Y +++D+++ +I + E GSL ++ +K+ + K + A +L+GL YLHS
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEY 194
IIHRD+K NI + G+VK+ D G++ + A + GT +MAPE + + Y
Sbjct: 124 RK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPY 180
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD-PQV------ 247
+ D++S G+ +LE+ +P+ P ++ S I ++ D P
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240
Query: 248 --KQFIEKCIVPASLRLPA-LELLKDPFLV 274
K FI++C+ R P ++L+ P++
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 77/281 (27%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHE 75
+ E++G+G + VYK + G VA + I D++ D+ E + E ++L+ H
Sbjct: 9 ELVEVIGEGTYGKVYKARHKKTGQLVA---IKIMDII--EDEEEEIKEEYNILRKYSNHP 63
Query: 76 NIIKFYNSWV--DDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNW----ARQIL 127
NI FY +++ + + ++ EL GS+ K + + + W R+ L
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123
Query: 128 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFM 185
RGL YLH + +IHRD+K NI + N EVK+ D G++ + R + IGTP +M
Sbjct: 124 RGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 186 APEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA-----QIYKKVTSGI 234
APE+ + Y+ D++S G+ +E+ + P C +I + +
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--CDMHPMRALFKIPRNPPPTL 238
Query: 235 K-PASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 273
K P + SK + FI +C++ + P ELL+ PF+
Sbjct: 239 KSPENWSK----KFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 74/209 (35%), Positives = 108/209 (51%), Gaps = 26/209 (12%)
Query: 18 YDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNI---EDVMQSPDQLERLYSEVHLLKSL 72
Y+E+ +G+GA+ TVYK D G VA +V + E+ + P R E+ LLK L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI--PLSTLR---EIALLKQL 55
Query: 73 K---HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWAR 124
+ H NI++ + D + ++ E L Y K + + IK+ R
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKDLMR 114
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPE 183
Q+LRG+ +LHSH I+HRDLK NI V ++G+VKI D GLA + A SV+ T
Sbjct: 115 QLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLW 171
Query: 184 FMAPE-LYEEEYNELVDIYSFGMCIL-EM 210
+ APE L + Y VD++S G CI E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVG-CIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 79/265 (29%), Positives = 134/265 (50%), Gaps = 25/265 (9%)
Query: 22 LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 77
LGKG+F TVY K + ++V ++ + ++ +P++ + E LL L H I
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVL-KEIPVGEL--NPNETVQANQEAQLLSKLDHPAI 64
Query: 78 IKFYNSWVDDTNRTINMITELFTSG-----SLRQYRKKHKNVDMKAIKNWARQILRGLHY 132
+KF+ S+++ I ITE + G L + + K + + W Q+L G+HY
Sbjct: 65 VKFHASFLERDAFCI--ITE-YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-L 189
+H I+HRDLK NIF+ N +KIGD G++ ++ A + GTP +M+PE L
Sbjct: 122 MHQRR--ILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 190 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249
+ Y+ DI+S G + EM + + E +N + ++ G P SL + Q+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP-SLPETYSRQLNS 235
Query: 250 FIEKCIVP-ASLRLPALELLKDPFL 273
++ + SLR A E+L++PF+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 78/273 (28%), Positives = 141/273 (51%), Gaps = 20/273 (7%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G+G+ V ++ G +VA +++ ++ + E L++EV +++ HEN++ Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD----LRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
NS++ + ++ E G+L H ++ + I +LR L YLH+ +I
Sbjct: 86 NSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQG--VI 140
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEE-EYNELV 198
HRD+K D+I + ++G +K+ D G + + P +S++GTP +MAPE+ Y V
Sbjct: 141 HRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 199 DIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCI 255
DI+S G+ ++EM+ E PY NE P Q +++ + P KV+ ++ F++ +
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNE--PPLQAMRRIRDNLPPRVKDSHKVSS-VLRGFLDLML 256
Query: 256 V-PASLRLPALELLKDPFLVTDNPKDLVCDPLR 287
V S R A ELL+ PFL P + +R
Sbjct: 257 VREPSQRATAQELLQHPFLKLAGPPSCIVPLMR 289
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 88/269 (32%), Positives = 141/269 (52%), Gaps = 26/269 (9%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +G+GA TVY D G EVA Q+N++ Q P + E + +E+ +++ K+ NI+
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVMRENKNPNIVN 81
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ +S++ + ++ E GSL + +D I R+ L+ L +LHS+
Sbjct: 82 YLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY-EEEYNE 196
+IHRD+K DNI + G +G VK+ D G I +Q +++GTP +MAPE+ + Y
Sbjct: 137 VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 197 LVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPASLSKVTDPQVKQF 250
VDI+S G+ +EM+ E PY NE NP + +Y T+G P LS + + F
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLSAI----FRDF 249
Query: 251 IEKCI-VPASLRLPALELLKDPFLVTDNP 278
+ +C+ + R A ELL+ FL P
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 72/260 (27%), Positives = 126/260 (48%), Gaps = 14/260 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ +G+G+F +Y + D ++++ + + + EV LL +KH NI+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMKHPNIVT 63
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLHYLHSHN 137
F+ S+ ++ I M E G L + + + V I +W QI GL H H+
Sbjct: 64 FFASFQENGRLFIVM--EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK--HIHD 119
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-Y 194
I+HRD+K NIF++ N K+GD G+A + A + +GTP +++PE+ + Y
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
N DI+S G + E+ T ++P+ E N Q+ K+ G A +S ++ I +
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQG-YFAPISPNFSRDLRSLISQL 237
Query: 255 IVPASLRLPAL-ELLKDPFL 273
+ P++ +LK PFL
Sbjct: 238 FKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 82/265 (30%), Positives = 133/265 (50%), Gaps = 16/265 (6%)
Query: 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 73
LF + + I GKG+F VYKG D VA + I D+ ++ D++E + E+ +L
Sbjct: 5 LFTKLERI-GKGSFGEVYKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
I ++Y S++ T I I E GS K ++ I R+IL+GL YL
Sbjct: 61 SPYITRYYGSYLKGTKLWI--IMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYL 117
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE 191
HS IHRD+K N+ ++ G+VK+ D G+A + Q + +GTP +MAPE+ +
Sbjct: 118 HSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 174
Query: 192 EE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250
+ Y+ DI+S G+ +E+ E P ++ +P ++ + P + + P K+F
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNSPPTLEGQYSKP-FKEF 232
Query: 251 IEKCI-VPASLRLPALELLKDPFLV 274
+E C+ R A ELLK F+
Sbjct: 233 VEACLNKDPRFRPTAKELLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 85/293 (29%), Positives = 141/293 (48%), Gaps = 20/293 (6%)
Query: 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 73
LF EI G G+F VY D VA +++ QS ++ + + EV L+ L+
Sbjct: 16 LFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQQLR 73
Query: 74 HENIIKFYNSWVDDTNRTINMITELFT-SGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 132
H N I++ ++ + + M L + S L ++K + V++ AI L+GL Y
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI---CHGALQGLAY 130
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-- 190
LHSH IHRD+K NI + G VK+ D G A ++ A S +GTP +MAPE+
Sbjct: 131 LHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVS--PANSFVGTPYWMAPEVILA 185
Query: 191 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ-V 247
E +Y+ VD++S G+ +E+ + P + +Y + +LS
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTLSSNDWSDYF 243
Query: 248 KQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNL 298
+ F++ C+ R + ELLK F++ + P ++ D + R + V E+ NL
Sbjct: 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELDNL 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 74/256 (28%), Positives = 131/256 (51%), Gaps = 34/256 (13%)
Query: 20 EILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
+ LG G+F V +KG + A ++ +++ Q+E + +E +L+S++H
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKY----YALKILSKAKIVKL-KQVEHVLNEKRILQSIRHP 61
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
++ Y S+ DD+N + ++ E G L + +K + +A Q++ L YLHS
Sbjct: 62 FLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-Y 194
+ I++RDLK +N+ + ++G +KI D G A ++ T ++ GTPE++APE+ + Y
Sbjct: 120 LD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRT-YTLCGTPEYLAPEIILSKGY 175
Query: 195 NELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGIKPASLSKVT-----DPQV 247
+ VD ++ G+ I EM+ YP +++ NP QIY+K+ G KV P
Sbjct: 176 GKAVDWWALGILIYEML-AGYPPFFDD--NPIQIYEKILEG-------KVRFPSFFSPDA 225
Query: 248 KQFIEK-CIVPASLRL 262
K I V + RL
Sbjct: 226 KDLIRNLLQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 72/262 (27%), Positives = 133/262 (50%), Gaps = 14/262 (5%)
Query: 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 77
+ ++GKG++ V DG + ++N+ + S + + E LL LKH NI
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNI 61
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHS 135
+ + SW + + + ++ G L K+ K + + W QI L YLH
Sbjct: 62 VAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELYEEE 193
+ I+HRDLK N+F+ N +K+GDLG+A V+ Q A ++IGTP +M+PEL+ +
Sbjct: 121 KH--ILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 194 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252
YN D+++ G C+ EM T ++ +N + +Y+ + + P + K P++ + I
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--MPKDYSPELGELIA 235
Query: 253 KCIVPASLRLPALE-LLKDPFL 273
+ + P+++ +L+ P++
Sbjct: 236 TMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 83/270 (30%), Positives = 134/270 (49%), Gaps = 16/270 (5%)
Query: 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 73
LF + + I GKG+F V+KG D VA + I D+ ++ D++E + E+ +L
Sbjct: 5 LFTKLERI-GKGSFGEVFKGIDNRTQQVVA---IKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
+ K+Y S++ T I I E GS + D I ++IL+GL YL
Sbjct: 61 SPYVTKYYGSYLKGTKLWI--IMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYL 117
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE 191
HS IHRD+K N+ ++ G+VK+ D G+A + Q + +GTP +MAPE+ +
Sbjct: 118 HSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 192 EE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250
+ Y+ DI+S G+ +E+ E P N +P ++ + P + + K+F
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE-PPNSDMHPMRVLFLIPKNNPPTLTGEFSK-PFKEF 232
Query: 251 IEKCI-VPASLRLPALELLKDPFLVTDNPK 279
I+ C+ S R A ELLK F+V + K
Sbjct: 233 IDACLNKDPSFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 78/272 (28%), Positives = 139/272 (51%), Gaps = 23/272 (8%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG GAF VYK ++ G+ A ++ +S ++LE E+ +L S H NI+K
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID----TKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
+++ + N I + E G++ + + + I+ +Q L L+YLH + I
Sbjct: 69 DAFYYENNLWI--LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--I 124
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY------EE 192
IHRDLK NI +G++K+ D G++ + R S IGTP +MAPE+ +
Sbjct: 125 IHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQF 250
Y+ D++S G+ ++EM E P++E NP ++ K+ +P +L++ + + K F
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKS-EPPTLAQPSRWSSEFKDF 241
Query: 251 IEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 281
++KC+ R +LL+ PF+ ++ K +
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 82/270 (30%), Positives = 134/270 (49%), Gaps = 20/270 (7%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
+QY EILG G TVYK + + +A V + + + + +++ SE+ +L
Sbjct: 3 IQYQEILGHGNGGTVYKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
II FY ++ + NR I++ TE GSL YRK ++V + A +++GL YL S
Sbjct: 60 YIIGFYGAFFVE-NR-ISICTEFMDGGSLDVYRKIPEHV----LGRIAVAVVKGLTYLWS 113
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEY 194
I+HRD+K N+ VN G+VK+ D G++ + A++ +GT +MAPE + E+Y
Sbjct: 114 LK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQY 170
Query: 195 NELVDIYSFGMCILEMVTCEYPY-----NECK-NPAQIYKKVTSGIKPASLSKVTDPQVK 248
D++S G+ +E+ +PY N+ P Q+ + + P +
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230
Query: 249 QFIEKCIVPASLRLPALELLKD-PFLVTDN 277
FI +C+ PA E L D PF+V N
Sbjct: 231 HFITQCMRKQPKERPAPENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 8/200 (4%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 80
++GKGAF V A +N + + + + +E +L+ L H ++
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNL 65
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
+ S+ D+ N + ++ +L G LR + + + +K W +I+ L YLHS I
Sbjct: 66 WYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--I 121
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY-EEEYNELV 198
IHRD+K DNI ++ G V I D +A V S GTP +MAPE+ + Y+ V
Sbjct: 122 IHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAV 180
Query: 199 DIYSFGMCILEMVTCEYPYN 218
D +S G+ E + + PY
Sbjct: 181 DWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 79/267 (29%), Positives = 138/267 (51%), Gaps = 17/267 (6%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G+G+ V ++ G +VA V + D ++ + E L++EV +++ +H+N+++ Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVA---VKMMD-LRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
S++ + ++ E G+L + + ++ + I +L+ L YLHS +I
Sbjct: 85 KSYL--VGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHSQG--VI 139
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEEE-YNELV 198
HRD+K D+I + +G VK+ D G I P +S++GTP +MAPE+ Y V
Sbjct: 140 HRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 199 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIVP 257
DI+S G+ ++EMV E PY +P Q K++ P + P ++ F+E+ +
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257
Query: 258 ASL-RLPALELLKDPFLV-TDNPKDLV 282
R A ELL PFL+ T P+ LV
Sbjct: 258 EPQERATAQELLDHPFLLQTGLPECLV 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 65/201 (32%), Positives = 110/201 (54%), Gaps = 18/201 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E LG+G + TVYKG + G VA +++++ +P R E+ L+K LKHENI++
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVR 62
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSH 136
++ V T + ++ E + L++Y H +D +K++ Q+L+G+ + H +
Sbjct: 63 LHD--VIHTENKLMLVFE-YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEE 192
++HRDLK N+ +N GE+K+ D GLA P T + + T + AP+ L
Sbjct: 120 R--VLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 193 EYNELVDIYSFGMCIL-EMVT 212
Y+ +DI+S G CI+ EM+T
Sbjct: 177 TYSTSIDIWSVG-CIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 82/272 (30%), Positives = 135/272 (49%), Gaps = 29/272 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NII 78
E++G G + VYKG G A + + DV + D+ E + E+++LK H NI
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTE--DEEEEIKLEINMLKKYSHHRNIA 76
Query: 79 KFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW----ARQILRGL 130
+Y +++ + + + ++ E +GS+ K K +K ++W R+ILRGL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK--EDWIAYICREILRGL 134
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE 188
+LH+H +IHRD+K N+ + N EVK+ D G++ + + R + IGTP +MAPE
Sbjct: 135 AHLHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191
Query: 189 LY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 242
+ + Y+ DI+S G+ +EM P + +P + + P SK
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLKSKK 250
Query: 243 TDPQVKQFIEKCIVPASLRLPALE-LLKDPFL 273
+ FIE C+V L P+ E LLK PF+
Sbjct: 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G+G + VYK D++ G VA ++ + +S + E+ LLK L H NIIK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
+ V + ++ E + + + + + + IK++ Q+L+GL + HSH I+
Sbjct: 65 D--VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--IL 120
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELY--EEEYNEL 197
HRDLK +N+ +N G +K+ D GLA + T + APEL ++ Y+
Sbjct: 121 HRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 198 VDIYSFGMCIL-EMVT 212
VDI+S G CI E+++
Sbjct: 180 VDIWSVG-CIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 15 FLQYDEILGKGAFKTVYKG-FDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
L++ + LG+G F V +D + G +VA +N Q ER E+ +L+
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEILR 61
Query: 71 SLKHENIIKFYNSWVDDTN-RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILR 128
+L HENI+K Y + R++ +I E SGSLR Y ++H+ +++K + ++ QI +
Sbjct: 62 TLDHENIVK-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICK 120
Query: 129 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF 184
G+ YL S IHRDL NI V + VKI D GLA V+ + + +P F
Sbjct: 121 GMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 185 -MAPE-LYEEEYNELVDIYSFGMCILEMVT 212
APE L +++ D++SFG+ + E+ T
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 18 YDEI--LGKGAFKTVYKGFDEVDGIEVAWNQV-----NIEDVMQSPDQLERLYSEVHLLK 70
Y I LG G F +VY ++ G VA ++ + E+ M EV L+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR--------EVKSLR 52
Query: 71 SLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKNWARQIL 127
L H NI+K + + N + + E + G+L Q K K I++ QIL
Sbjct: 53 KLNEHPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 128 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEFMA 186
+GL ++H H HRDLK +N+ V+G VKI D GLA + +P + T + A
Sbjct: 110 QGLAHIHKHG--FFHRDLKPENLLVSG-PEVVKIADFGLAREIRSRPPYTDYVSTRWYRA 166
Query: 187 PE--LYEEEYNELVDIYSFGMCIL-EMVTCE 214
PE L Y+ VDI++ G CI+ E+ T
Sbjct: 167 PEILLRSTSYSSPVDIWALG-CIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 79/270 (29%), Positives = 131/270 (48%), Gaps = 25/270 (9%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENII 78
E++G G + VYKG G A + + DV + D+ E + E+++LK H NI
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAA---IKVMDV--TGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 79 KFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHY 132
+Y +++ + + ++ E +GS+ K K +K I R+ILRGL +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY 190
LH H +IHRD+K N+ + N EVK+ D G++ + + R + IGTP +MAPE+
Sbjct: 127 LHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 191 ------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244
+ Y+ D++S G+ +EM P + +P + + P SK
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWS 242
Query: 245 PQVKQFIEKCIVPASLRLPALE-LLKDPFL 273
+ + FIE C+V + P E L+K PF+
Sbjct: 243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 74/204 (36%), Positives = 104/204 (50%), Gaps = 28/204 (13%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM---QSPDQLERLYSEVHLLKSLKHENII 78
+G GA+ V FD G +VA I+ + QS +R Y E+ LLK + HEN+I
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVA-----IKKLSRPFQSAIHAKRTYRELRLLKHMDHENVI 77
Query: 79 KFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
+ + ++ + + ++T L + L K K D I+ QILRGL Y+H
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDH-IQFLVYQILRGLKYIH 135
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAPE--L 189
S IIHRDLK NI VN + E+KI D GLA + T + G T + APE L
Sbjct: 136 SAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA----RHTDDEMTGYVATRWYRAPEIML 188
Query: 190 YEEEYNELVDIYSFGMCIL-EMVT 212
YN+ VDI+S G CI+ E++T
Sbjct: 189 NWMHYNQTVDIWSVG-CIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 15 FLQYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
FL+ LG+G F V Y + G +VA + E + + L E+ +L+
Sbjct: 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILR 61
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRG 129
+L HENI+K+ +D I +I E SGSL++Y ++KN +++K +A QI +G
Sbjct: 62 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKG 121
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF- 184
+ YL S +HRDL N+ V + +VKIGD GL ++ T + + +P F
Sbjct: 122 MDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178
Query: 185 MAPE-LYEEEYNELVDIYSFGMCILEMVT 212
APE L + ++ D++SFG+ + E++T
Sbjct: 179 YAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 9e-23
Identities = 69/195 (35%), Positives = 104/195 (53%), Gaps = 17/195 (8%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---SPDQLERLYSEVHLLKSLKHENII 78
+G GAF V D++ G VA I+ +M+ +P +R Y E+ LLK L+HENII
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVA-----IKKIMKPFSTPVLAKRTYRELKLLKHLRHENII 72
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
+ ++ I +TEL + R + ++ + I+ + QILRGL Y+HS
Sbjct: 73 SLSDIFISPLE-DIYFVTELLGTDLHRLL--TSRPLEKQFIQYFLYQILRGLKYVHSAG- 128
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYNE 196
++HRDLK NI +N N ++KI D GLA + Q P + T + APE L ++Y+
Sbjct: 129 -VVHRDLKPSNILIN-ENCDLKICDFGLARI-QDPQMTGYVSTRYYRAPEIMLTWQKYDV 185
Query: 197 LVDIYSFGMCILEMV 211
VDI+S G EM+
Sbjct: 186 EVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 16 LQYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
L++ + LGKG F +V Y + G VA ++ + + L E+ +LKS
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ----HSTAEHLRDFEREIEILKS 61
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGL 130
L+H+NI+K+ R + ++ E GSLR Y +KH+ +D + + +A QI +G+
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FM 185
YL S +HRDL NI V N VKIGD GL V+ Q + P +
Sbjct: 122 EYLGSKR--YVHRDLATRNILVESEN-RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178
Query: 186 APE-LYEEEYNELVDIYSFGMCILEMVT 212
APE L E +++ D++SFG+ + E+ T
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-22
Identities = 86/294 (29%), Positives = 144/294 (48%), Gaps = 18/294 (6%)
Query: 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 73
+F+ EI G G+F VY + VA +++ Q+ ++ + + EV L+ LK
Sbjct: 22 IFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMSYSG-KQTNEKWQDIIKEVKFLQQLK 79
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHY 132
H N I++ ++ + + M L ++ L + KK + V++ AI + A L+GL Y
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA---LQGLAY 136
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-- 190
LHSHN +IHRD+K NI + G+VK+ D G A A S +GTP +MAPE+
Sbjct: 137 LHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSS--PANSFVGTPYWMAPEVILA 191
Query: 191 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248
E +Y+ VD++S G+ +E+ + P + +Y + P S +
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQSNEWTDSFR 250
Query: 249 QFIEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLAH 300
F++ C+ PA ELL+ F+ D P ++ D + R + V E+ NL +
Sbjct: 251 GFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDNLQY 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 68/222 (30%), Positives = 110/222 (49%), Gaps = 33/222 (14%)
Query: 17 QYDEI--LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERL----YSEVHL 68
+Y+ +G+G + VYK + DG E A I+ +Q + E+ L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYA-----IKKFKGDKEQYTGISQSACREIAL 55
Query: 69 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-----YRKKHKNVDMKAIKNWA 123
L+ LKHEN++ +++ ++++ ++ + + L Q + K ++ +K+
Sbjct: 56 LRELKHENVVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMVKSLL 114
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP-----TA 175
QIL G+HYLHS+ ++HRDLK NI V G G VKIGDLGLA + P
Sbjct: 115 WQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 176 RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE 214
V+ T + APEL Y + +DI++ G CI E++T E
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 23/264 (8%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG GAF VYK ++ G A + +S ++LE E+ +L + H I+K
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIE----TKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
++ D I MI E G++ + + + I+ RQ+L L YLHS I
Sbjct: 76 GAFYWDGKLWI-MI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--I 131
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE------LYEE 192
IHRDLK N+ + +G++K+ D G++ + R S IGTP +MAPE + +
Sbjct: 132 IHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQF 250
Y+ DI+S G+ ++EM E P++E NP ++ K+ +P +LS+ + + + F
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKS-EPPTLSQPSKWSMEFRDF 248
Query: 251 IEKCIVP-ASLRLPALELLKDPFL 273
++ + R A +LL+ PF+
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFV 272
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-21
Identities = 88/295 (29%), Positives = 148/295 (50%), Gaps = 20/295 (6%)
Query: 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 73
LF EI G G+F VY D VA +++ QS ++ + + EV L+ +K
Sbjct: 26 LFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVKFLQRIK 83
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHY 132
H N I++ ++ + + M L ++ L + KK + V++ AI + A L+GL Y
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA---LQGLAY 140
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-- 190
LHSHN +IHRD+K NI + G+VK+ D G A + A S +GTP +MAPE+
Sbjct: 141 LHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIAS--PANSFVGTPYWMAPEVILA 195
Query: 191 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248
E +Y+ VD++S G+ +E+ + P + +Y + P S +
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPTLQSNEWSDYFR 254
Query: 249 QFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLAH 300
F++ C+ +P R + ELLK F++ + P+ ++ D + R + V E+ NL +
Sbjct: 255 NFVDSCLQKIPQD-RPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELDNLQY 308
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 88/294 (29%), Positives = 147/294 (50%), Gaps = 18/294 (6%)
Query: 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 73
LF EI G G+F VY D + VA +++ QS ++ + + EV L+ L+
Sbjct: 16 LFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLR 73
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHY 132
H N I++ ++ + + M L ++ L + KK + V++ A+ + A L+GL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA---LQGLAY 130
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-- 190
LHSHN +IHRD+K NI ++ G VK+GD G A +M A +GTP +MAPE+
Sbjct: 131 LHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA--PANXFVGTPYWMAPEVILA 185
Query: 191 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248
E +Y+ VD++S G+ +E+ + P + +Y + PA S +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFR 244
Query: 249 QFIEKCIVPASLRLPALE-LLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLAH 300
F++ C+ P E LLK F++ + P ++ D + R + V E+ NL +
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQY 298
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 72/253 (28%), Positives = 127/253 (50%), Gaps = 21/253 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQSPDQLER------LYSEVHLLK-S 71
E LG GAF VYK + +G +A ++N+ + D+ ER + SEV ++K
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQIL 127
L+H NI+++Y ++++ N + ++ +L L ++ ++K + + I N Q++
Sbjct: 66 LRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 128 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFM 185
L YLH I+HRDL +NI + G + +V I D GLA +QP ++ SV+GT +
Sbjct: 124 LALRYLHKEKR-IVHRDLTPNNIML-GEDDKVTITDFGLA-KQKQPESKLTSVVGTILYS 180
Query: 186 APELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244
PE+ + E Y E D+++FG + +M T + P+ N + K+ + +
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYS 239
Query: 245 PQVKQFIEKCIVP 257
V I C+ P
Sbjct: 240 EDVTDVITSCLTP 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 5e-21
Identities = 77/286 (26%), Positives = 131/286 (45%), Gaps = 38/286 (13%)
Query: 19 DEI-----LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 73
DEI LGKG + +VYK G+ +A ++ +E + ++ E+ +L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAV 57
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGL 130
I+ FY ++ + + M E +GSL + + + ++ +++GL
Sbjct: 58 SPYIVDFYGAFFIEG--AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 131 HYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL 189
+L HN IIHRD+K N+ VNGN G+VK+ D G++ + A++ IG +MAPE
Sbjct: 116 KFLKEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPER 172
Query: 190 YEEE-------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------P 236
+ Y D++S G+ ILEM YPY P + Y + + + P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFAQLSAIVDGDP 227
Query: 237 ASLSKVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKD 280
+L + F+ KC+ +P + R +LL+ P+LV D
Sbjct: 228 PTLPSGYSDDAQDFVAKCLNKIP-NRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 13/220 (5%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G+G+F + DG + ++NI + SP + E EV +L ++KH NI+++
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLHYLHSHNPP 139
S+ ++ N I M + G L + + V I +W QI L H H+
Sbjct: 66 ESFEENGNLYIVM--DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--HVHDRK 121
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-YNE 196
I+HRD+K NIF+ +G +K+GD G+A V+ AR+ IGTP +++PE+ E YN
Sbjct: 122 ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236
DI++ G + EM T ++ + E N + K+ G P
Sbjct: 181 KSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 17 QYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 73
+Y + +G+GA V+K D G VA +V + + P+Q R E+ L++ +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR---EIKALQACQ 57
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
H ++K + + + ++ E S R + + + +K++ R +L+G+ Y+
Sbjct: 58 HPYVVKLLDVFPHGSG--FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV---IGTPEFMAPELY 190
H++ I+HRDLK N+ + +G +KI D GLA + + R + T + APEL
Sbjct: 116 HANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 191 --EEEYNELVDIYSFGMCIL-EMVTC 213
+Y+ VD+++ G CI E++
Sbjct: 173 YGARKYDPGVDLWAVG-CIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
L+ ++LG GAF TVYKG +G I VA + E SP + + E +++ S
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE---TSPKANKEILDEAYVMAS 65
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGL 130
+ H ++++ + + + +IT+L G L Y + HK N+ + + NW QI +G+
Sbjct: 66 VDHPHVVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT----P-EFM 185
YL ++HRDL N+ V VKI D GLA + + P ++M
Sbjct: 123 SYLEEKR--LVHRDLAARNVLVKTPQ-HVKITDFGLA-KLLDVDEKEYHAEGGKVPIKWM 178
Query: 186 APE-LYEEEYNELVDIYSFGMCILEMVT 212
A E + Y D++S+G+ + E++T
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 63/205 (30%), Positives = 117/205 (57%), Gaps = 23/205 (11%)
Query: 17 QYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 73
+Y+++ +G+G + TV+K + VA +V ++D + P R E+ LLK LK
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELK 57
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHY 132
H+NI++ Y+ V +++ + ++ E + L++Y + ++D + +K++ Q+L+GL +
Sbjct: 58 HKNIVRLYD--VLHSDKKLTLVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPE 188
HSHN ++HRDLK N+ +N NGE+K+ D GLA I ++ +A V T + P+
Sbjct: 115 CHSHN--VLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPD 169
Query: 189 --LYEEEYNELVDIYSFGMCIL-EM 210
+ Y+ +D++S G CI E+
Sbjct: 170 VLFGAKLYSTSIDMWSAG-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ LG+G++ TVYKG ++ G VA ++ +E +P R E LLK LKH NI+
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVT 67
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNP 138
++ + T +T+ ++ E + L+QY + M ++ + Q+LRGL Y H
Sbjct: 68 LHD--IIHTKKTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR- 123
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEY 194
++HRDLK N+ ++ GE+K+ D GLA P T + + T + P+ L EY
Sbjct: 124 -VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 195 NELVDIYSFGMCILEMVT 212
+ +D++ G EM T
Sbjct: 182 STSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 66/196 (33%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG+G + TV+KG ++ VA ++ +E +P R EV LLK+LKH NI+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVTLH 69
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPI 140
+ + T R + ++ E S L+QY N+ M +K + Q+LRGL Y H I
Sbjct: 70 D--IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--I 124
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEYNE 196
+HRDLK N+ +N GE+K+ D GLA PT + + T + P+ L EY+
Sbjct: 125 LHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 197 LVDIYSFGMCILEMVT 212
+D++ G + EM T
Sbjct: 184 PIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 76/271 (28%), Positives = 133/271 (49%), Gaps = 20/271 (7%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKH 74
L+ E LG+GA+ V K G +A + I + S +Q +RL ++ + ++S+
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKR--IRATVNSQEQ-KRLLMDLDISMRSVDC 59
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK----AIKNWARQILRGL 130
+ FY + + + I M E+ + SL ++ KK + + + A I++ L
Sbjct: 60 PYTVTFYGALFREGDVWICM--EVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPEL 189
YLHS +IHRD+K N+ +N NG+VK+ D G++ + A+++ G +MAPE
Sbjct: 117 EYLHS-KLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPER 174
Query: 190 YEEE-----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244
E Y+ D++S G+ ++E+ T +PY+ K P Q K+V P ++
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234
Query: 245 PQVKQFIEKCIVPASLRLPAL-ELLKDPFLV 274
P+ + F+ KC+ P ELL+ PF
Sbjct: 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-20
Identities = 67/238 (28%), Positives = 104/238 (43%), Gaps = 52/238 (21%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYS----EVHLL 69
+ LG G+F V +G W+ V+ D+L + E ++
Sbjct: 1 KKLGDGSFGVVRRG---------EWSTSG-GKVIPVAVKCLKSDKLSDIMDDFLKEAAIM 50
Query: 70 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQIL 127
SL HEN+I+ Y + + M+TEL GSL +K + + ++A QI
Sbjct: 51 HSLDHENLIRLYGVVLTH---PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA 107
Query: 128 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------IVMQQ----PT 174
G+ YL S IHRDL NI + ++ +VKIGD GL VM++ P
Sbjct: 108 NGMRYLESKR--FIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
Query: 175 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 230
A + APE L ++ D++ FG+ + EM T E P+ + +QI KK+
Sbjct: 165 A--------WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 72/261 (27%), Positives = 122/261 (46%), Gaps = 20/261 (7%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G G + VYK + G A + +E + + E+ ++K KH NI+ ++
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLE----PGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
S++ I M E GSL+ + I +R+ L+GL+YLHS +
Sbjct: 73 GSYLRRDKLWICM--EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--M 128
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----YN 195
HRD+K NI + +NG VK+ D G++ + A+ S IGTP +MAPE+ E YN
Sbjct: 129 HRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS---KVTDPQVKQFIE 252
+L DI++ G+ +E+ + P + ++ S +P L K ++ F++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN-SFHHFVK 246
Query: 253 KCIVPASLRLPALE-LLKDPF 272
+ + P E LL+ PF
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 63/196 (32%), Positives = 103/196 (52%), Gaps = 14/196 (7%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG+G + TVYKG ++ VA ++ +E +P R EV LLK LKH NI+ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLH 70
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPI 140
+ + T +++ ++ E + L+QY N ++M +K + Q+LRGL+Y H +
Sbjct: 71 D--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--V 125
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEYNE 196
+HRDLK N+ +N GE+K+ D GLA PT + + T + P+ L +Y+
Sbjct: 126 LHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
Query: 197 LVDIYSFGMCILEMVT 212
+D++ G EM T
Sbjct: 185 QIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 17/255 (6%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G G + VYK + G A + +E D + E+ ++K KH NI+ ++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE----PGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
S++ I M E GSL+ + I R+ L+GL YLHS +
Sbjct: 73 GSYLSREKLWICM--EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--M 128
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----YN 195
HRD+K NI + +NG+VK+ D G+A + A+ S IGTP +MAPE+ E YN
Sbjct: 129 HRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQFIEK 253
+L DI++ G+ +E+ + P + ++ S +P L T F++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKI 247
Query: 254 CIVPASLRLPALELL 268
+ + P E L
Sbjct: 248 SLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 21 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHE 75
+LGKG+F V KG +E I+ V +ED D +E E +L + +H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-----DDVECTMVERRVLALAWEHP 56
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+ + ++ T + + E G L + + D + +A +I+ GL +LH
Sbjct: 57 FLTHLFCTF--QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-E 192
II+RDLK DN+ ++ +G +KI D G+ + + A + GTP+++APE+ + +
Sbjct: 115 KG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNEC 220
+YNE VD +SFG+ + EM+ + P++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 78
E +G+G + VYK +++ G VA ++ ++ + P R E+ LLK L H NI+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 62
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSH 136
K + V T + ++ E F L+++ + + IK++ Q+L+GL + HSH
Sbjct: 63 KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEE 192
++HRDLK N+ +N G +K+ D GLA P T + T + APE L +
Sbjct: 120 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 193 EYNELVDIYSFGMCILEMVT 212
Y+ VDI+S G EMVT
Sbjct: 177 YYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 32/269 (11%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQV--NIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
+G GA TVYK G A + N ED ++ Q+ R E+ +L+ + H N++
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR--QICR---EIEILRDVNHPNVV 135
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
K ++ + D N I ++ E GSL + + + + ARQIL G+ YLH +
Sbjct: 136 KCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADE----QFLADVARQILSGIAYLHRRH- 188
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---PTARSVIGTPEFMAPELYEEEYN 195
I+HRD+K N+ +N VKI D G++ ++ Q P SV GT +M+PE + N
Sbjct: 189 -IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLN 245
Query: 196 ELV------DIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSGIKPASLSKVTDPQV 247
DI+S G+ ILE +P+ + A + + P + + + +
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS-REF 304
Query: 248 KQFIEKCIV--PASLRLPALELLKDPFLV 274
+ FI C+ PA R A++LL+ PF++
Sbjct: 305 RHFISCCLQREPAK-RWSAMQLLQHPFIL 332
|
Length = 353 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 15 FLQYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
+L+ +LG+G F V Y ++ G VA + E E+++LK
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILK 61
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 130
+L HENI+K+ + + + +I E GSLR Y KH +++ + +A+QI G+
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGM 120
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPEF 184
YLHS + IHRDL N+ ++ N+ VKIGD GLA + P R +P F
Sbjct: 121 AYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPVF 175
Query: 185 -MAPE-LYEEEYNELVDIYSFGMCILEMVT 212
A E L E +++ D++SFG+ + E++T
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 78
E +G+G + VYK D++ G VA ++ +E + P R E+ LLK L H NI+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIV 61
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+ + + + ++ E F L++Y +D IK++ Q+L+G+ Y HSH
Sbjct: 62 RLLDVVHSENK--LYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPE--LY 190
++HRDLK N+ ++ G +K+ D GLA + ++ T V T + APE L
Sbjct: 119 R--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 173
Query: 191 EEEYNELVDIYSFGMCIL-EMVT 212
+Y+ VDI+S G CI EMV
Sbjct: 174 SRQYSTPVDIWSIG-CIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 64/255 (25%), Positives = 125/255 (49%), Gaps = 18/255 (7%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G F V++G + + + VA + +D+++ + EV LK L+H+++I +
Sbjct: 14 LGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLK----QQDFQKEVQALKRLRHKHLISLF 68
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
V + +ITEL GSL + + + + + + ++ + A Q+ G+ YL N
Sbjct: 69 A--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN-- 124
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNE 196
IHRDL NI V G + K+ D GLA ++++ + ++ APE ++
Sbjct: 125 SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 197 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
D++SFG+ + EM T + PY N ++Y ++T+G + +K ++ + + +C
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYRMPCPAKCP-QEIYKIMLECW 241
Query: 256 VPASLRLPALELLKD 270
P+ + L++
Sbjct: 242 AAEPEDRPSFKALRE 256
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 24/275 (8%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G +V K G +A V+I Q+ R E+ ++ + I+ FY
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR---ELQIMHECRSPYIVSFY 69
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPI 140
+++++ N I M E GSL + KK + ++ + A ++ GL YL++ H I
Sbjct: 70 GAFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVD 199
+HRD+K NI VN G++K+ D G++ + A + +GT +M+PE + +Y D
Sbjct: 126 MHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 200 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------KPASLSKVTDPQV-K 248
++S G+ I+E+ ++P+ N + GI P L P+ +
Sbjct: 185 VWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243
Query: 249 QFIEKCIV--PASLRLPALELLKDPFLVTDNPKDL 281
F++ C++ P P PF+ ++
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-19
Identities = 59/177 (33%), Positives = 86/177 (48%), Gaps = 10/177 (5%)
Query: 65 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNW 122
E LL +KH NI+ F S+ D + I M E G L Q K + I W
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVM--EYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 123 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IG 180
Q+ G+ H H ++HRD+K NIF+ NG+VK+GD G A ++ P A + +G
Sbjct: 106 FVQMCLGVQ--HIHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVG 162
Query: 181 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236
TP ++ PE++E YN DI+S G + E+ T ++P+ I K KP
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 36/263 (13%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQ---VNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
LG G F V++G WN V ++ + + +E ++K L+H +I
Sbjct: 14 LGAGQFGEVWEGL---------WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLI 64
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+ Y V I ++TEL GSL +Y + + + + + A Q+ G+ YL +
Sbjct: 65 QLYA--VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPELYEEE 193
N IHRDL N+ V G N K+ D GLA V+++ AR P ++ APE
Sbjct: 123 N--YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE--AAL 177
Query: 194 YNELV---DIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PASLSKVTDPQ 246
YN D++SFG+ + E+VT PY N A++ ++V G + P +
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQGYRMPCPPG----CPKE 232
Query: 247 VKQFIEKCIVPASLRLPALELLK 269
+ + C P E L+
Sbjct: 233 LYDIMLDCWKEDPDDRPTFETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E LG+G + TV+KG ++ VA ++ +E +P R EV LLK LKH NI+
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNP 138
++ + T++++ ++ E + L+QY N+ M +K + QILRGL Y H
Sbjct: 69 LHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEY 194
++HRDLK N+ +N GE+K+ D GLA PT + + T + P+ L EY
Sbjct: 125 -VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 195 NELVDIYSFGMCILEMVT 212
+ +D++ G EM +
Sbjct: 183 STQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 73/242 (30%), Positives = 118/242 (48%), Gaps = 22/242 (9%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G GA+ +V FD G+ VA +++ QS +R Y E+ LLK +KHEN+I
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 82 NSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
+ + + + ++T L L K K D ++ QILRGL Y+HS +
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGLKYIHSAD 140
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAPELYEE-- 192
IIHRDLK N+ VN + E+KI D GLA + T + G T + APE+
Sbjct: 141 --IIHRDLKPSNLAVN-EDCELKILDFGLA----RHTDDEMTGYVATRWYRAPEIMLNWM 193
Query: 193 EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250
YN+ VDI+S G + E++T +P + + ++ ++ L K++ + +
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253
Query: 251 IE 252
I+
Sbjct: 254 IQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 14/197 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E LG+G++ TVYKG +V+G VA + +++ +P R E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLKGLKHANIVL 67
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNP 138
++ + T T+ ++ E + L QY KH + + +K + Q+LRGL Y+H
Sbjct: 68 LHD--IIHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY- 123
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEY 194
I+HRDLK N+ ++ + GE+K+ D GLA P T + + T + P+ L EY
Sbjct: 124 -ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 195 NELVDIYSFGMCILEMV 211
+ +D++ G +EM+
Sbjct: 182 STCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
++G+GA+ V K ++ G VA + + D + EV +L+ L+HENI+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVN 64
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
++ + ++ E L + A++++ Q+L+ + Y HSHN
Sbjct: 65 LKEAFRRK--GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN-- 120
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELY--EEEY 194
IIHRD+K +NI V+ +G +K+ D G A ++ A + T + APEL + Y
Sbjct: 121 IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 195 NELVDIYSFGMCIL-EMVT 212
+ VD+++ G CI+ E++
Sbjct: 180 GKPVDVWAIG-CIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 32/219 (14%)
Query: 12 FVLFLQY--DEILGKGAFKTVYKGFDEVDGIEVAWNQV-NIEDVMQSPDQLERLYSEVHL 68
F + +Y E +G GA+ V D G +VA ++ + DV +R E+ +
Sbjct: 1 FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA---KRTLRELKI 57
Query: 69 LKSLKHENIIKFYNSWVDDTNRT-------INMITELFTSGSLRQYRKKHKNVDMKAIKN 121
L+ KH+NII + D R + ++ +L S L + + + I+
Sbjct: 58 LRHFKHDNIIA-----IRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRY 111
Query: 122 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSV-- 178
+ Q+LRGL Y+HS N +IHRDLK N+ VN + E++IGD G+A + PT
Sbjct: 112 FLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNE-DCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 179 ---IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMV 211
+ T + APEL EY +D++S G CI EM+
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVG-CIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 83/284 (29%), Positives = 140/284 (49%), Gaps = 32/284 (11%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E++GKG++ V D G +VA ++N DV + R+ E+ LL+ L+H +I++
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDIVE 63
Query: 80 FYNSWVDDTNRT---INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+ + + R I ++ EL S L Q K + ++ + + + Q+LR L Y+H+
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA 122
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-----IGTPEFMAPEL-- 189
N + HRDLK NI N + ++KI D GLA V T ++ + T + APEL
Sbjct: 123 N--VFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 190 -YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDP 245
+ +Y +DI+S G CI V P KN +T + P ++S+V +
Sbjct: 180 SFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238
Query: 246 QVKQFI----EKCIVPASLRLP-----ALELLKDPFLVTDNPKD 280
+ ++++ +K VP S + P AL LL+ L+ +PKD
Sbjct: 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLER--LLAFDPKD 280
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQL--ERLYSEVHLLKSLKHE 75
+G+GA+ V + G++VA ++ SP Q +R E+ +L+ KHE
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFEHQTFCQRTLREIKILRRFKHE 63
Query: 76 NIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 132
NII + + + N ++ EL + + + +H + D I+ + QILRGL Y
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH--IQYFLYQILRGLKY 121
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAP 187
+HS N ++HRDLK N+ +N N ++KI D GLA + + + T + AP
Sbjct: 122 IHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178
Query: 188 E--LYEEEYNELVDIYSFGMCIL-EMVTCE 214
E L + Y + +DI+S G CIL EM++
Sbjct: 179 EIMLNSKGYTKAIDIWSVG-CILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 50/141 (35%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
I+ FY ++ D +I M E GSL Q KK + + + +LRGL YL
Sbjct: 61 IVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE- 117
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYN 195
I+HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y
Sbjct: 118 KHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYT 176
Query: 196 ELVDIYSFGMCILEMVTCEYP 216
DI+S G+ ++EM YP
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKF 80
+G+G F V K G A + +S +Q+ L E+ L+ L H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK--KHFKSLEQVNNL-REIQALRRLSPHPNILRL 63
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPP 139
D + ++ EL +L + K K + K +K++ Q+L+ L ++H +
Sbjct: 64 IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE--LYEEEYN 195
I HRD+K +NI + + +K+ D G I + P I T + APE L + Y
Sbjct: 121 IFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYT-EYISTRWYRAPECLLTDGYYG 177
Query: 196 ELVDIYSFGMCILEMVT 212
+DI++ G E+++
Sbjct: 178 PKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 41/99 (41%), Positives = 63/99 (63%), Gaps = 6/99 (6%)
Query: 122 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 179
+ QI+ GL +LH II+RDLK +N+ ++ N+G V+I DLGLA+ ++ Q +
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 180 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPY 217
GTP FMAPEL + EEY+ VD ++ G+ + EM+ P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 7e-18
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 16 LQYDEI---LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 72
L+ EI LGKGA+ V+K D VA + I D ++ +R + E+ L+ L
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKK--IFDAFRNATDAQRTFREIMFLQEL 63
Query: 73 K-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRG 129
H NI+K N + ++ I ++ E + L + + ++V + I Q+L+
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYI---MYQLLKA 119
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTARSVIGTP 182
L Y+HS N +IHRDLK NI +N ++ VK+ D GLA + P + T
Sbjct: 120 LKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 183 EFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTC 213
+ APE L Y + VD++S G CIL EM+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVG-CILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+ D +G GAF V+ D DG VA + + +V Q+ +R++ E+ +L KH+N
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKK--MPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 77 IIKFYNSWVD-------DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 129
++ S +D D I ++TEL S L + + + +K + QILRG
Sbjct: 61 VL----SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV---IGTPEFMA 186
L YLHS I+HRD+K N+ VN +N +KI D GLA V + ++ + + T + A
Sbjct: 116 LKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 187 PELY--EEEYNELVDIYSFGMCI 207
PE+ Y VDI+S G CI
Sbjct: 173 PEILMGSRHYTSAVDIWSVG-CI 194
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 58/262 (22%), Positives = 110/262 (41%), Gaps = 17/262 (6%)
Query: 24 KGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYN 82
KGAF +VY G A + D M + +Q+ + +E ++ + K Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSD-MIAKNQVTNVKAERAIMMIQGESPYVAKLY- 63
Query: 83 SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 142
+ + + ++ E G K + K + +++ G+ LH IIH
Sbjct: 64 -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIH 120
Query: 143 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIY 201
RD+K +N+ ++ G +K+ D GL+ + + +GTP+++APE +++ D +
Sbjct: 121 RDIKPENLLID-QTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETILGVGDDKMSDWW 177
Query: 202 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVP-A 258
S G I E + YP + P ++ + S P + + P+ I + +
Sbjct: 178 SLGCVIFEFLF-GYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 259 SLRLPA---LELLKDPFLVTDN 277
+ RL A E+ PF + N
Sbjct: 237 AKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 40/219 (18%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
LG+G F VYK G VA ++ N +D P R E+ +LK LKH N++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITALR---EIKILKKLKHPNVV 70
Query: 79 KFYNSWVDDTNRTINMITELFT---------SGSLRQYRKKHKNVDMKAIKNWARQILRG 129
+ V+ +++ ++ SG L K + IK + Q+L G
Sbjct: 71 PLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKCYMLQLLEG 127
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFM 185
++YLH ++ I+HRD+K NI ++ N G +KI D GLA P GT ++
Sbjct: 128 INYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 186 ---------APELY--EEEYNELVDIYSFGMCIL-EMVT 212
PEL E Y VDI+ G C+ EM T
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 21 ILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK---SLK 73
+LG+G F V YK E+ I+ + D++ + D++E L E + + S +
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKA----LKKGDII-ARDEVESLMCEKRIFETANSER 60
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHY 132
H ++ + + T + + E G L H +V +A ++ GL Y
Sbjct: 61 HPFLVNLFACF--QTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQY 116
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPE-L 189
LH + I++RDLK DN+ ++ G VKI D GL R+ GTPEF+APE L
Sbjct: 117 LHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL 173
Query: 190 YEEEYNELVDIYSFGMCILEMVTCEYPY 217
E Y VD + G+ I EM+ E P+
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 40/216 (18%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIK 79
+G+G + VYK D+ G VA +V +++ + P R E+ +L+ L H NI+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIVN 70
Query: 80 FYNSWVDDTN--------RTINMITE--------LFTSGSLRQYRKKHKNVDMKAIKNWA 123
D + ++ E L SG L + + H IK++
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDH-------IKSFM 122
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVI 179
+Q+L GL+Y H N +HRD+KC NI +N N G++K+ D GLA + +P VI
Sbjct: 123 KQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 180 GTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 212
T + PEL EE Y +D++S G CIL E+ T
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 78/276 (28%), Positives = 130/276 (47%), Gaps = 35/276 (12%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENII 78
E +GKG + VYK ++ DG A V I D + D E + +E ++L+SL H N++
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAA---VKILDPISDVD--EEIEAEYNILQSLPNHPNVV 82
Query: 79 KFYNSWVDDTNRT---INMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLH 131
KFY + + ++ EL GS+ + K + +D I L GL
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 189
+LH N IIHRD+K +NI + G VK+ D G++ + R + +GTP +MAPE+
Sbjct: 143 HLH--NNRIIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199
Query: 190 ------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243
Y+ Y+ D++S G+ +E+ + P + +P + K+ P L
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKIPRNPPPTLL---- 254
Query: 244 DPQ-----VKQFIEKCIVPASLRLPAL-ELLKDPFL 273
P+ FI +C++ P++ LL+ PF+
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 17 QYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 73
QY+ E +G+G + VYK D V +A ++ +E + P R E+ LLK ++
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR---EISLLKEMQ 59
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV------DMKAIKNWARQIL 127
H NI++ + V + + + ++ E L KKH + + + IK + QIL
Sbjct: 60 HGNIVRLQD--VVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 128 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFM 185
RG+ Y HSH ++HRDLK N+ ++ +K+ D GLA P T + T +
Sbjct: 113 RGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 186 APE--LYEEEYNELVDIYSFGMCILEMVT 212
APE L Y+ VDI+S G EMV
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 74/332 (22%), Positives = 138/332 (41%), Gaps = 56/332 (16%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G+ V+ D VA ++ V+ P ++ E+ +++ L H+NI+K Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI----VLTDPQSVKHALREIKIIRRLDHDNIVKVY 68
Query: 82 NSWVD---DTNRTINMITELFTSGSLRQYRK-------KHKNVDMKAIKNWARQILRGLH 131
D + +TEL + +++Y + + + + + + Q+LRGL
Sbjct: 69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLK 128
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMA 186
Y+HS N ++HRDLK N+F+N + +KIGD GLA ++ + + T + +
Sbjct: 129 YIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 187 PE--LYEEEYNELVDIYSFGMCIL-EMVTC------------------------EYPYNE 219
P L Y + +D+++ G CI EM+T E NE
Sbjct: 187 PRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNE 245
Query: 220 CKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIVPASL-RLPALELLKDPFL-V 274
N + + G L + +P+ F+E+ + + RL A E L P++
Sbjct: 246 LLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305
Query: 275 TDNPKD--LVCDPLRLPNLVPEVMNLAHSEPH 304
P D + P + + + +++ +
Sbjct: 306 YSCPFDEPVSLHPFHIEDELDDILLMTEIHSI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 19 DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
+G+G F VY+G E + I VA SP E+ E ++++ H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHP 67
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 134
+I+K ++ + ++ EL G LR Y + +K +D+ ++ ++ Q+ L YL
Sbjct: 68 HIVKLIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTP-EFMAPE-LY 190
S +HRD+ N+ V+ + VK+GD GL+ ++ + S P ++MAPE +
Sbjct: 125 SKR--FVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 191 EEEYNELVDIYSFGMCILEM 210
+ D++ FG+C+ E+
Sbjct: 182 FRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS---------- 64
++Q LG+G + V K +D + G VA +V I ++ + +L
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 65 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 124
E+ ++ +KHENI+ + +V+ IN++ ++ + L++ + + +K
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGD--FINLVMDIM-ASDLKKVVDRKIRLTESQVKCILL 126
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----------IVMQQP 173
QIL GL+ LH +HRDL NIF+N + G KI D GLA + +
Sbjct: 127 QILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 174 TARSVIGTPE-----FMAPELY--EEEYNELVDIYSFGMCI 207
R T + + APEL E+Y+ VD++S G CI
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 21 ILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHE 75
+LGKG+F V KG DE+ ++V V ++D D +E +E +L + KH
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD-----DDVECTMTEKRVLALAGKHP 56
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+ + ++ + T + + E G L + ++ D + +A +I+ GL +LH
Sbjct: 57 FLTQLHSCF--QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEE 192
II+RDLK DN+ ++ G +KI D G+ ++ T + GTP+++APE L +
Sbjct: 115 RG--IIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 193 EYNELVDIYSFGMCILEMVTCEYPY 217
Y VD ++ G+ + EM+ + P+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 6e-17
Identities = 58/202 (28%), Positives = 108/202 (53%), Gaps = 29/202 (14%)
Query: 61 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RQYRKKHK---NVDM 116
+L EV++++ LKH+NI+++ + +++ N+ + ++ E +G L R +K +K ++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 117 KAIKNWARQILRGLHYLHS-----HNPPIIHRDLKCDNIFV--------------NGNNG 157
AI + RQ+L L Y H+ + ++HRDLK NIF+ N NG
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 158 E--VKIGDLGLAI-VMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMV 211
KIGD GL+ + + A S +GTP + +PEL E Y++ D+++ G I E+
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 212 TCEYPYNECKNPAQIYKKVTSG 233
+ + P+++ N +Q+ ++ G
Sbjct: 238 SGKTPFHKANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 14/197 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E LG+G++ TVYKG ++G VA ++++ P R E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVL 67
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNP 138
++ + T T+ + E + L QY +H + ++ + Q+LRGL Y+H +
Sbjct: 68 LHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH- 123
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEY 194
I+HRDLK N+ ++ GE+K+ D GLA P T S + T + P+ L +Y
Sbjct: 124 -ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181
Query: 195 NELVDIYSFGMCILEMV 211
+ +DI+ G +EM+
Sbjct: 182 SSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 68/244 (27%), Positives = 118/244 (48%), Gaps = 21/244 (8%)
Query: 20 EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKH 74
++LGKG+F V KG DEV I+V V ++D D ++ +E +L + KH
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD-----DDVDCTMTEKRILALAAKH 55
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
+ + + T + + E G L ++ + D + +A ++ L +LH
Sbjct: 56 PFLTALHCCF--QTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYE 191
H +I+RDLK DNI ++ G K+ D G+ ++ T + GTP+++APE L E
Sbjct: 114 RHG--VIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 192 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQ 249
EY VD ++ G+ + EM+ + P+ E N +++ + + P LSK +K
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKA 229
Query: 250 FIEK 253
F+ K
Sbjct: 230 FMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSL 72
L+ + LG G F V+ G WN +V ++ + E E ++K L
Sbjct: 8 LKLERKLGAGQFGEVWMGT---------WNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL 58
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGL 130
+H+ +++ Y V I ++TE + GSL + K K + + + + A QI G+
Sbjct: 59 RHDKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAP 187
YL S N IHRDL NI V G N KI D GLA +++ TAR P ++ AP
Sbjct: 117 AYLESRN--YIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAP 173
Query: 188 E--LYEEEYNELVDIYSFGMCILEMVT---CEYP 216
E Y + D++SFG+ + E+VT YP
Sbjct: 174 EAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 21/203 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 78
E +G+G + VYKG ++ G VA ++ +E + P R E+ LLK L+H NI+
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---EISLLKELQHPNIV 62
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYR---KKHKNVDMKAIKNWARQILRGLHYLHS 135
+ + + +R + +I E F S L++Y K + +D + +K++ QIL+G+ + HS
Sbjct: 63 CLQDVLMQE-SR-LYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPE--L 189
++HRDLK N+ ++ N G +K+ D GLA P T V T + APE L
Sbjct: 120 RR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLL 174
Query: 190 YEEEYNELVDIYSFGMCILEMVT 212
Y+ VDI+S G EM T
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 77/328 (23%), Positives = 138/328 (42%), Gaps = 49/328 (14%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G+GA+ V + +VA + I + + +R E+ LL+ L HEN+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKK--IANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 82 NSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
+ N ++ EL + L Q + + + + + Q+LRGL Y+HS N
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN- 128
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----------APE 188
++HRDLK N+ +N N ++KI D GL AR+ +FM APE
Sbjct: 129 -VLHRDLKPSNLLLNANC-DLKICDFGL--------ARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 189 LY--EEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVT 243
L EY +D++S G CI E++ + +P + + ++ ++ L +
Sbjct: 179 LLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237
Query: 244 DPQVKQFIEKCIVPASLRLP-----------ALELLKDPFLVTDNPKDL-VCDPLRLPNL 291
+ + +++I +P + R A++LL + LV D K + V + L P L
Sbjct: 238 NEKARRYIRS--LPYTPRQSFARLFPHANPLAIDLL-EKMLVFDPSKRITVEEALAHPYL 294
Query: 292 VP-EVMNLAHSEPHPMDIDLNHKKVSAD 318
+ P D ++ +
Sbjct: 295 ASLHDPSDEPVCQTPFSFDFEEDALTEE 322
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 71/276 (25%), Positives = 130/276 (47%), Gaps = 35/276 (12%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 78
E +GKG + V+K ++ +G + A V I D + D E + +E ++LK+L H N++
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAA---VKILDPIHDID--EEIEAEYNILKALSDHPNVV 78
Query: 79 KFYNSWVDDTNRT---INMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLH 131
KFY + + + ++ EL GS+ + + K+ + ++ I + L GL
Sbjct: 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 189
+LH IHRD+K +NI + G VK+ D G++ + R + +GTP +MAPE+
Sbjct: 139 HLH--VNKTIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 190 ------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243
+ Y+ D++S G+ +E+ + P + +P + K+ P +
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRNPPP----TLH 250
Query: 244 DPQV-----KQFIEKCIVPA-SLRLPALELLKDPFL 273
P++ FI KC+ R +LL+ F+
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 66/256 (25%), Positives = 116/256 (45%), Gaps = 25/256 (9%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G F V+ G I+VA + E M D +E E ++ L H N+++ Y
Sbjct: 12 LGSGQFGVVHLGKWR-GKIDVAIKMIR-EGAMSEDDFIE----EAKVMMKLSHPNLVQLY 65
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPI 140
V R I ++TE +G L Y ++ K + + + + + YL S+
Sbjct: 66 G--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--F 121
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP-EFMAPELYE-EEYNE 196
IHRDL N V G + VK+ D GLA ++ Q T+ P ++ PE+++ ++
Sbjct: 122 IHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 197 LVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIE 252
D++SFG+ + E+ + + PY N +++ + V++G +P K+ +V +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAGYRLYRP----KLAPTEVYTIMY 235
Query: 253 KCIVPASLRLPALELL 268
C PA + L
Sbjct: 236 SCWHEKPEDRPAFKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 65/197 (32%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G GA+ TV D G +VA + + QS +R Y E+ LLK +KHEN+I
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 82 NSWVDDTNRTINMITELFT----SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
+ + D + ++ + + G+ KH+ + I+ Q+L+GL Y+H+
Sbjct: 81 DVFTPDLS--LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG 138
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYN 195
IIHRDLK N+ VN + E+KI D GLA V+ T + APE L Y
Sbjct: 139 --IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEMTGYVV-TRWYRAPEVILNWMHYT 194
Query: 196 ELVDIYSFGMCILEMVT 212
+ VDI+S G + EM+T
Sbjct: 195 QTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 39/207 (18%)
Query: 25 GAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNS 83
G + VY+ D+ G VA ++ +E + P R E+++L L+H NI+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR---EINILLKLQHPNIVTVKEV 72
Query: 84 WVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA-------------IKNWARQILRGL 130
V I M+ E +H D+K+ +K Q+L G+
Sbjct: 73 VVGSNLDKIYMVMEYV----------EH---DLKSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE 188
+LH + I+HRDLK N+ +N N G +KI D GLA P ++ T + APE
Sbjct: 120 AHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPE 176
Query: 189 LY--EEEYNELVDIYSFGMCIL-EMVT 212
L +EY+ +D++S G CI E++T
Sbjct: 177 LLLGAKEYSTAIDMWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 34/204 (16%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--EVHLLKSLKHENII 78
+G+G + VY+ D G VA +V ++ D + + S E+ LL +L+H NI+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMD---NERDGIP-ISSLREITLLLNLRHPNIV 69
Query: 79 KFYNSWVDDTNRTINMITELFTS--GSLRQYRKKHKNVDMKA------IKNWARQILRGL 130
+ V +I ++ E SL +M +K Q+LRGL
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLD--------NMPTPFSESQVKCLMLQLLRGL 121
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMA 186
YLH + IIHRDLK N+ + G +KI D GLA P T + V T + A
Sbjct: 122 QYLHENF--IIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRA 176
Query: 187 PELY--EEEYNELVDIYSFGMCIL 208
PEL Y +D+++ G CIL
Sbjct: 177 PELLLGCTTYTTAIDMWAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 76/208 (36%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 17 QYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 73
QY+ + +G GA+ TVYK D G VA V ++ P R EV LLK L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR---EVALLKRLE 57
Query: 74 ---HENIIKFYNSWVDDTNRTIN--MITELF--TSGSLRQYRKK--HKNVDMKAIKNWAR 124
H NI++ + V T+RT +T +F LR Y K + + IK+ R
Sbjct: 58 AFDHPNIVRLMD--VCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMR 115
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPE 183
Q LRGL +LH++ I+HRDLK +NI V + G+VK+ D GLA I Q V+ T
Sbjct: 116 QFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLW 172
Query: 184 FMAPE-LYEEEYNELVDIYSFGMCILEM 210
+ APE L + Y VD++S G EM
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHEN-I 77
E +G+G + VYK D+ G VA + +E D P R E+ LL+ L I
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR---EISLLQMLSESIYI 63
Query: 78 IKFYN-SWVDDTNRTINM-ITELFTSGSLRQY-----RKKHKNVDMKAIKNWARQILRGL 130
++ + V++ N ++ + + L+++ R + + K IK++ Q+L+G+
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IGTPEFMAPE 188
+ H H ++HRDLK N+ V+ G +KI DLGL P I T + APE
Sbjct: 124 AHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181
Query: 189 --LYEEEYNELVDIYSFGMCILEMVT 212
L Y+ VDI+S G EM
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 70/272 (25%), Positives = 121/272 (44%), Gaps = 23/272 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ +G+GAF TV K + G +A ++ + +L + +V +++S
Sbjct: 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRL-LMDLDV-VMRSSDCP 63
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSL-----RQYRKKHKNVDMKAIKNWARQILRGL 130
I+KFY + + + I M EL SL Y + + + A ++ L
Sbjct: 64 YIVKFYGALFREGDCWICM--ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 131 HYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPE 188
+YL IIHRD+K NI ++ NG +K+ D G++ + A++ G +MAPE
Sbjct: 121 NYLKEELK--IIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 177
Query: 189 LYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSK 241
+ Y+ D++S G+ + E+ T ++PY + + +V G I S +
Sbjct: 178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237
Query: 242 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPF 272
P FI C++ S R ELL+ PF
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 55/205 (26%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 17 QYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD--QLERL-YSEVHLLKS 71
+Y+++ +G+G++ V+K + G VA I+ ++S D ++++ E+ +LK
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVA-----IKKFVESEDDPVIKKIALREIRMLKQ 56
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 131
LKH N++ V R ++++ E L + K + V IK Q L+ ++
Sbjct: 57 LKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 189
+ H HN IHRD+K +NI + G++K+ D G A ++ P + T + APEL
Sbjct: 115 FCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL 171
Query: 190 Y--EEEYNELVDIYSFGMCILEMVT 212
+ +Y VD+++ G E++T
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER---LYSEVHLLKSLKHEN 76
++G+G++ V K + G VA I+ ++S D E+ +LK L+HEN
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVA-----IKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
++ V + + ++ E L K +D ++ + QILRG+ + HSH
Sbjct: 62 LVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY--EE 192
N IIHRD+K +NI V+ +G VK+ D G A + P + T + APEL +
Sbjct: 120 N--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 193 EYNELVDIYSFGMCILEMVTCE 214
+Y VDI++ G + EM+T E
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G V K + G+ +A +++E P ++ E+ +L I+ FY
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
++ D +I M E GSL Q K+ K + + + + +LRGL YL + I+
Sbjct: 70 GAFYSDGEISICM--EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ-IM 126
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 200
HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y+ DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 201 YSFGMCILEMVTCEYP 216
+S G+ ++E+ YP
Sbjct: 186 WSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G V+K + G+ +A +++E P ++ E+ +L I+ FY
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
++ D +I M E GSL Q KK + + + + +++GL YL + I+
Sbjct: 70 GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 126
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 200
HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y+ DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 201 YSFGMCILEMVTCEYP 216
+S G+ ++EM YP
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 22 LGKGAFKTVYKG-FDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
LG G F +V KG + G +EVA + E + + R E ++ L H I+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPCIV 59
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
+ + + ++ EL G L +Y KK + + + +K A Q+ G+ YL S +
Sbjct: 60 RLIGVCKGEP---LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH- 115
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTP-EFMAPE-LYEE 192
+HRDL N+ + N + KI D G++ + A + P ++ APE +
Sbjct: 116 -FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 193 EYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+++ D++S+G+ + E + PY E K ++ + SG
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 15/205 (7%)
Query: 17 QYDEI--LGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQS-PDQLERLYSEVHLLKSL 72
QY+ + +G+GA+ V+K D +G VA +V ++ + P R + + L++
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 73 KHENIIKFYN-SWVDDTNRTINMITELF--TSGSLRQYRKK--HKNVDMKAIKNWARQIL 127
+H N+++ ++ V T+R + T +F L Y K V + IK+ Q+L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 128 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMA 186
RGL +LHSH ++HRDLK NI V ++G++K+ D GLA I Q SV+ T + A
Sbjct: 121 RGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 177
Query: 187 PE-LYEEEYNELVDIYSFGMCILEM 210
PE L + Y VD++S G EM
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 7e-16
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 16 LQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
L+ ++LG GAF TVYKG E I VA + I + P E ++ S
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMAS 65
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGL 130
+ H ++++ + + TI ++T+L G L Y +HK N+ + + NW QI +G+
Sbjct: 66 MDHPHLVRLLGVCL---SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM 122
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMA 186
YL ++HRDL N+ V N VKI D GLA +++ + A ++MA
Sbjct: 123 MYLEERR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 187 PE-LYEEEYNELVDIYSFGMCILEMVT 212
E ++ ++ D++S+G+ I E++T
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 33/219 (15%)
Query: 22 LGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
LG+G+F VY+G VA VN M+ +++E +E ++K +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIE-FLNEASVMKEFNCHH 70
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA----------IKNWARQI 126
+++ V T+ ++ EL G L+ Y + + A +I
Sbjct: 71 VVRLLGV-VSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 127 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ---QPTARSVIGT 181
G+ YL + +HRDL N V + VKIGD G+ I + + ++
Sbjct: 129 ADGMAYLAAKK--FVHRDLAARNCMVAE-DLTVKIGDFGMTRDIYETDYYRKGGKGLL-- 183
Query: 182 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPY 217
P +MAPE L + + D++SFG+ + EM T E PY
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 9/154 (5%)
Query: 65 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 124
E LL+++ H ++I+ ++ V + M+ ++S K+ + + + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPE 183
QIL GL YLH+ IIHRD+K +NIF+N + +V IGDLG A + P + GT E
Sbjct: 165 QILEGLRYLHAQR--IIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 184 FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 216
APE L ++YN DI+S G+ + EM+ YP
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLA--YP 253
|
Length = 357 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 68/245 (27%), Positives = 116/245 (47%), Gaps = 35/245 (14%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSL 72
LQ + LG G F V+ G WN +V ++ + E E ++K L
Sbjct: 8 LQLIKKLGNGQFGEVWMG---------TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL 58
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGL 130
+H+ +++ Y + I ++TE + GSL + K + + + + + + A Q+ G+
Sbjct: 59 RHDKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 115
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAP 187
Y+ N IHRDL+ NI V G+ KI D GLA +++ + TAR P ++ AP
Sbjct: 116 AYIERMN--YIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 188 E--LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK-------PA 237
E LY + D++SFG+ + E+VT PY N ++ ++V G + P
Sbjct: 173 EAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPI 230
Query: 238 SLSKV 242
SL ++
Sbjct: 231 SLHEL 235
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 71/239 (29%), Positives = 116/239 (48%), Gaps = 16/239 (6%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G GA+ +V +D +VA +++ QS R Y E+ LLK +KHEN+I
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLS--RPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 82 NSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
+ + T+ + ++T L L K K D + ++ Q+LRGL Y+HS
Sbjct: 81 DVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSD-EHVQFLIYQLLRGLKYIHSAG 138
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYN 195
IIHRDLK N+ VN + E++I D GLA + T + APE L YN
Sbjct: 139 --IIHRDLKPSNVAVN-EDCELRILDFGLARQADDEMT-GYVATRWYRAPEIMLNWMHYN 194
Query: 196 ELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252
+ VDI+S G + E++ + +P N+ + + +V P L K++ +++I+
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 126 ILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPE 183
I++ LHYL H +IHRD+K NI ++ +G VK+ D G++ + A++ G
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 184 FMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA- 237
+MAPE + +Y+ D++S G+ ++E+ T ++PY CK ++ K+ P+
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 238 SLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKD 280
++ P F++ C+ + P ELL+ PF+ +
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 38/103 (36%), Positives = 61/103 (59%), Gaps = 7/103 (6%)
Query: 122 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVI 179
+A QI+ GL +LH I++RDLK +N+ ++ ++G V+I DLGLA+ + +
Sbjct: 100 YAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRA- 155
Query: 180 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 221
GTP +MAPE L E Y+ VD ++ G + EM+ P+ + K
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 19 DEILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKH 74
++LG GAF TVYKG E + +++ V I+++ + SP + + E +++ S+ +
Sbjct: 12 IKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 133
++ + + T+ +IT+L G L Y ++HK N+ + + NW QI +G++YL
Sbjct: 69 PHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE- 188
++HRDL N+ V VKI D GLA ++ ++ A ++MA E
Sbjct: 126 EERR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 189 LYEEEYNELVDIYSFGMCILEMVT 212
+ Y D++S+G+ + E++T
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ + LG G F V+ G+ +V I+ + Q E +E +L+K L+H
Sbjct: 8 LKLVKKLGAGQFGEVWMGYYNGH------TKVAIKSLKQGSMSPEAFLAEANLMKQLQHP 61
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYL 133
+++ Y T I +ITE +GSL + K + + + K + A QI G+ ++
Sbjct: 62 RLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP-EFMAPE-L 189
N IHRDL+ NI V+ KI D GLA I + TAR P ++ APE +
Sbjct: 119 ERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 190 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 226
+ D++SFG+ + E+VT PY NP I
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 50/291 (17%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 80
++G+GAF V+ D+ G A + D+++ Q+ + +E +L I+K
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN-QIAHVRAERDILADADSPWIVKL 66
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
Y S+ D+ + + ++ E G L + + + + +++ L +H
Sbjct: 67 YYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--F 122
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----------------------------Q 171
IHRD+K DNI + +G +K+ D GL M +
Sbjct: 123 IHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 172 QPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQI 226
Q A S +GTP+++APE L Y D +S G+ + EM+ +P Y++ +
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY-GFPPFYSD--TLQET 238
Query: 227 YKKVTSGIKPASLSKVTDPQV----KQFIEKCIVPASLRL-PALELLKDPF 272
Y K+ + + SL DP V I + + RL E+ PF
Sbjct: 239 YNKIINWKE--SLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 49/177 (27%), Positives = 92/177 (51%), Gaps = 8/177 (4%)
Query: 58 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 117
Q++ + E +L L H I+ S+ D+ + + E G L + +K
Sbjct: 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPND 118
Query: 118 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 177
K + +++ YLHS + II+RDLK +N+ ++ N G VK+ D G A + T +
Sbjct: 119 VAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTF-T 174
Query: 178 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 233
+ GTPE++APE+ + + + + VD ++ G+ + E + P+ + P +IY+K+ +G
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG 230
|
Length = 329 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 6e-15
Identities = 92/326 (28%), Positives = 143/326 (43%), Gaps = 50/326 (15%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G GA+ +V D+ G +VA +++ QS +R Y E+ LLK ++HEN+I
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLS--RPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 82 NSWV-----DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+ + D+ ++ + T L++ + D ++ Q+L GL Y+HS
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSED--KVQYLVYQMLCGLKYIHSA 136
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEY 194
IIHRDLK N+ VN + E+KI D GLA V+ T + APE L Y
Sbjct: 137 G--IIHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGYVV-TRWYRAPEVILNWMHY 192
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASLSKVTDPQVKQFIE 252
N+ VDI+S G + EM+T + + Q+ + KVT P + K+ D K +I+
Sbjct: 193 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIK 252
Query: 253 KCIVPA------SLRLP-----ALELLKDPFLVTDNPKDLVC---------DPLRLPNLV 292
+P S P A++LL + L D K L D R +
Sbjct: 253 S--LPKYPRKDFSTLFPKASPQAVDLL-EKMLELDVDKRLTATEALEHPYFDSFRDADEE 309
Query: 293 PEVMNLAHSEPHPMDIDLNHKKVSAD 318
E P D L ++K+S D
Sbjct: 310 T--------EQQPYDDSLENEKLSVD 327
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 20 EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKH 74
++LGKG+F V+ KG ++ I+ +DV+ D +E E +L + +H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKAL-----KKDVVLMDDDVECTMVEKRVLSLAWEH 55
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
+ Y ++ T + + E G L + + D+ +A +I+ GL +LH
Sbjct: 56 PFLTHLYCTF--QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYE 191
S I++RDLK DNI ++ +G +KI D G+ ++ + GTP+++APE L
Sbjct: 114 SKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 192 EEYNELVDIYSFGMCILEMVTCEYPYN 218
++YN VD +SFG+ + EM+ + P++
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-15
Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 42/226 (18%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
+LG GA TV DG A V++E + S R +EV L + +I+
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIV 94
Query: 79 KFYNSWV--DDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR-------- 124
K + + D N I ++ + +G LRQ IK+ A+
Sbjct: 95 KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQ-----------EIKSRAKTNRTFREH 143
Query: 125 -------QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----AIVMQQP 173
Q+L +H++HS + +IHRD+K NI + +NG VK+GD G A +
Sbjct: 144 EAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILL-CSNGLVKLGDFGFSKMYAATVSDD 200
Query: 174 TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN 218
R+ GTP ++APE++ + Y++ D++S G+ + E++T + P++
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 50/201 (24%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
++LGKG F V ++ G A + E V+ + D++ +E +L++ +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ T+ + + E G L + + + + + + +I+ L YLHS +
Sbjct: 60 L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 115
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 196
+++RD+K +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E+ +Y
Sbjct: 116 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 197 LVDIYSFGMCILEMVTCEYPY 217
VD + G+ + EM+ P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 42 VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 101
VA ++N++ S + L+ L E+ + L+H NI+ + S++ D+ + +++ L
Sbjct: 28 VAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAY 83
Query: 102 GSLRQYRKKHKNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 159
GS K H + AI + +L L Y+HS IHR +K +I ++G +G+V
Sbjct: 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSG-DGKV 140
Query: 160 KIGDLGLAIVM--QQPTARSVIGTPEF-------MAPELYEEE---YNELVDIYSFGMCI 207
+ L ++ M R V P+ ++PE+ ++ YNE DIYS G+
Sbjct: 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITA 200
Query: 208 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247
E+ P+ + Q+ + G P L K T P
Sbjct: 201 CELANGHVPFKDMP-ATQMLLEKVRGTVPCLLDKSTYPLY 239
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 55/204 (26%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
++LGKG F V ++ G A ++ ++V+ + D++ +E +LK+ +H +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAM-KILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
S+ T + + E G L + + + + + +I+ L YLHS
Sbjct: 60 LKYSF--QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 196
I++RDLK +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E+ +Y
Sbjct: 116 IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 197 LVDIYSFGMCILEMVTCEYP-YNE 219
VD + G+ + EM+ P YN+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 38/229 (16%)
Query: 16 LQYDEILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSL 72
L + LG+G F V K + G + V ++ + + S +L L SE +LLK +
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGR-AGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD----------------- 115
H ++IK Y + D + +I E GSLR + ++ + V
Sbjct: 61 NHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 116 -------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168
M + ++A QI RG+ YL ++HRDL N+ V ++KI D GL+
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLV-AEGRKMKISDFGLSR 175
Query: 169 VMQQPTA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 212
+ + + RS P ++MA E L++ Y D++SFG+ + E+VT
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 22 LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G+G + VYK D D E A Q+ + S + E+ LL+ LKH N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR------EIALLRELKHPNVIA 62
Query: 80 FYNSWVDDTNRTINMITE--------LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 131
++ ++R + ++ + + + KK + +K+ QIL G+H
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-----RSVIGTPE 183
YLH++ ++HRDLK NI V G G VKI D+G A + P V+ T
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 184 FMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 221
+ APEL Y + +DI++ G E++T E P C+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 58/214 (27%), Positives = 110/214 (51%), Gaps = 9/214 (4%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+++GKG+F V ++DG A + + V+ +Q + LLK++KH ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ S+ T + + + G L + ++ ++ + +A +I L YLHS N
Sbjct: 61 LHYSF--QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN-- 116
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNE 196
I++RDLK +NI ++ + G V + D GL + Q T + GTPE++APE + ++ Y+
Sbjct: 117 IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 230
VD + G + EM+ P+ C++ A++Y +
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF-YCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSE 65
W + L+ + LG+G F V+ G WN +V I+ + E E
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQE 51
Query: 66 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWA 123
++K L+HE +++ Y ++ I ++TE + GSL + K K + + + + A
Sbjct: 52 AQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMA 108
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT 181
QI G+ Y+ N +HRDL+ NI V G N K+ D GLA +++ + TAR
Sbjct: 109 AQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKF 165
Query: 182 P-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 212
P ++ APE LY + D++SFG+ + E+ T
Sbjct: 166 PIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 22/175 (12%)
Query: 50 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT---SGSLRQ 106
E V+ Q +E H+L+++ H +II+ ++ T N T L L
Sbjct: 118 EHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTF------TYNKFTCLILPRYKTDLYC 171
Query: 107 YRKKHKNV---DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163
Y +N+ D+ AI+ R +LR + YLH IIHRD+K +NIF+N + G+V +GD
Sbjct: 172 YLAAKRNIAICDILAIE---RSVLRAIQYLH--ENRIIHRDIKAENIFIN-HPGDVCLGD 225
Query: 164 LGLA---IVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCE 214
G A + + GT APEL + Y VDI+S G+ + EM TC
Sbjct: 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 58 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 117
Q++ ++SE +L + H + Y S+ D++ + ++ E G + +++K
Sbjct: 74 QVDHVFSERKILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRNKRFPND 131
Query: 118 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 177
+A QI+ YL S N I++RDLK +N+ ++ +G +K+ D G A V+ T +
Sbjct: 132 VGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDTRT-YT 187
Query: 178 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236
+ GTPE++APE L + + D ++ G+ I E++ P+ P IY+K+ GI
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF-YANEPLLIYQKILEGI-- 244
Query: 237 ASLSKVTDPQVKQFIEKCI 255
K D K ++K +
Sbjct: 245 IYFPKFLDNNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 69/244 (28%), Positives = 119/244 (48%), Gaps = 23/244 (9%)
Query: 21 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+LGKG+F V KG DE+ I++ V I+D D +E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD-----DDVECTMVEKRVLALPGKPP 61
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLR-QYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+ +S +R + + E G L ++ K + A+ +A +I GL +LHS
Sbjct: 62 FLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGKFKEPHAV-FYAAEIAIGLFFLHS 119
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE--LYE 191
II+RDLK DN+ ++ G +KI D G+ + T R+ GTP+++APE Y
Sbjct: 120 KG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY- 175
Query: 192 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SGIKPASLSKVTDPQVKQ 249
+ Y + VD ++FG+ + EM+ + P+ + ++ ++++ + + P SLSK K
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234
Query: 250 FIEK 253
+ K
Sbjct: 235 LLTK 238
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSE 65
W + L+ D LG+G F V+ G WN +V I+ + E E
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMG---------TWNGTTKVAIKTLKPGTMMPEAFLQE 51
Query: 66 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWA 123
++K L+H+ ++ Y ++ I ++TE GSL + K+ K + + + + A
Sbjct: 52 AQIMKKLRHDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA 108
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT 181
QI G+ Y+ N IHRDL+ NI V G+N KI D GLA +++ + TAR
Sbjct: 109 AQIADGMAYIERMN--YIHRDLRAANILV-GDNLVCKIADFGLARLIEDNEYTARQGAKF 165
Query: 182 P-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 212
P ++ APE LY + D++SFG+ + E+VT
Sbjct: 166 PIKWTAPEAALY-GRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 20 EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
++LGKG+F V KG E ++ +DV+ D +E E +L +L E
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKAL-----KKDVVLIDDDVECTMVEKRVL-ALAWE 54
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
N + T + + E G L + + D+ +A +I+ GL +LHS
Sbjct: 55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS 114
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-E 192
II+RDLK DN+ ++ +G +KI D G+ V A + GTP+++APE+ +
Sbjct: 115 KG--IIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYN 218
+Y VD +SFG+ + EM+ + P++
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 9/216 (4%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+++GKG+F V + DG A + + +++ +Q + LLK+LKH ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ S+ T + + + G L + ++ + + +A ++ + YLHS N
Sbjct: 61 LHYSF--QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN-- 116
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNE 196
II+RDLK +NI ++ + G V + D GL +P T + GTPE++APE L +E Y+
Sbjct: 117 IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 232
VD + G + EM+ P+ ++ +Q+Y +
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 57/236 (24%), Positives = 114/236 (48%), Gaps = 11/236 (4%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+++GKG+F V + + A + + +++ ++ + LLK++KH ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ S+ T + + + G L + ++ + + +A +I L YLHS N
Sbjct: 61 LHFSF--QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN-- 116
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNE 196
I++RDLK +NI ++ + G + + D GL + T + GTPE++APE L+++ Y+
Sbjct: 117 IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252
VD + G + EM+ P+ +N A++Y + + KP L + +E
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILN--KPLQLKPNITNSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 22 LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G+G + VYK D D + A Q+ + S + E+ LL+ LKH N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 62
Query: 80 FYNSWVDDTNRTINMITE--------LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 131
++ +R + ++ + + + KK + +K+ QIL G+H
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-----RSVIGTPE 183
YLH++ ++HRDLK NI V G G VKI D+G A + P V+ T
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 184 FMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 221
+ APEL Y + +DI++ G E++T E P C+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +GKG F VYKG + EVA PD + E +LK H NI+K
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVK 56
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
V + I ++ EL GSL + RKK + +K + + G+ YL S N
Sbjct: 57 LIGVCVQ--KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN- 113
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEEE 193
IHRDL N V G N +KI D G++ + G + + APE L
Sbjct: 114 -CIHRDLAARNCLV-GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 194 YNELVDIYSFGMCILEMVT---CEYP 216
Y D++S+G+ + E + YP
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYP 197
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER----LYSEVHLLKS 71
L + LG+GAF V K E G++ + M D E+ L SE+ ++K
Sbjct: 14 LTLGKPLGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 72 L-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM-------------- 116
+ KH+NII V + ++ E G+LR + + +
Sbjct: 72 IGKHKNIINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 117 --KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IV 169
K + ++A Q+ RG+ +L S IHRDL N+ V ++ +KI D GLA I
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDH-VMKIADFGLARDIHHID 186
Query: 170 MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 212
+ T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 187 YYRKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 23/209 (11%)
Query: 16 LQYDEILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV--HLLK- 70
L+ ++LG G F TV+KG E D I++ I+D +S Q + E+ H+L
Sbjct: 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQT---FQEITDHMLAM 63
Query: 71 -SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILR 128
SL H I++ ++ ++T+L GSL + ++H+ ++D + + NW QI +
Sbjct: 64 GSLDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 129 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTP-EF 184
G++YL H ++HR+L NI + ++ V+I D G+A ++ + S TP ++
Sbjct: 121 GMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 185 MAPE-LYEEEYNELVDIYSFGMCILEMVT 212
MA E + Y D++S+G+ + EM++
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 30/214 (14%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKHENIIK 79
LGKG GF EV + QV M + +L+ RL + +L + I++
Sbjct: 1 LGKG-------GFGEVCAV-----QVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILE 48
Query: 80 FYNS-------WVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGL 130
NS + ++ + ++ L G L+ Y + ++M+ + +++ QI G+
Sbjct: 49 KVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI 108
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE 188
LH H+ I++RD+K +N+ ++ + G ++ DLGLA+ ++ + + GT +MAPE
Sbjct: 109 --LHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPE 164
Query: 189 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 221
L EE Y+ VD ++ G I EMV P+ + K
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 67/254 (26%), Positives = 121/254 (47%), Gaps = 16/254 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENII 78
+LGKG+F V + G + +V +DV+ D +E +E +L + H +
Sbjct: 1 RVLGKGSFGKVMLARLKESG-RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
+ Y + T + + E G L + +K + D + +A +I L +LH
Sbjct: 60 QLYCCF--QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYN 195
II+RDLK DN+ ++ + G K+ D G+ + T + GTP+++APE L E Y
Sbjct: 117 -IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEK 253
VD ++ G+ + EM+ P+ E +N +++ + + + P LS+ +K F+ K
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233
Query: 254 CIVPASLRLPALEL 267
++RL +L L
Sbjct: 234 ---NPTMRLGSLTL 244
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 79/284 (27%), Positives = 126/284 (44%), Gaps = 27/284 (9%)
Query: 10 SLFVLFLQYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 67
S F + +Y ++ +G GA V FD V GI VA +++ Q+ +R Y E+
Sbjct: 15 STFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS--RPFQNQTHAKRAYRELV 72
Query: 68 LLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 123
LLK + H+NII N + + + + ++ EL + + H +D + +
Sbjct: 73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLL 129
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV-----MQQPTARSV 178
Q+L G+ +LHS IIHRDLK NI V ++ +KI D GLA M P
Sbjct: 130 YQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTACTNFMMTP----Y 182
Query: 179 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP 236
+ T + APE + Y E VDI+S G + E+V + + Q K + G
Sbjct: 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242
Query: 237 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD 280
A P V+ ++E P + EL D +++ +D
Sbjct: 243 AEFMNRLQPTVRNYVEN--RPQYPGISFEELFPDWIFPSESERD 284
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 10 SLFVLFLQYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 67
S F + +Y + +G GA V +D V G VA + + Q+ +R Y E+
Sbjct: 10 STFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKK--LSRPFQNVTHAKRAYRELV 67
Query: 68 LLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 123
L+K + H+NII N + + + + ++ EL + +L Q ++D + +
Sbjct: 68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQV--IQMDLDHERMSYLL 124
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 183
Q+L G+ +LHS IIHRDLK NI V ++ +KI D GLA + S + TP
Sbjct: 125 YQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPY 177
Query: 184 -----FMAPE-LYEEEYNELVDIYSFGMCIL-EMV 211
+ APE + Y E VDI+S G CI+ EM+
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 73/245 (29%), Positives = 111/245 (45%), Gaps = 25/245 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE-RLYSEVHLLKSLKHENII 78
E+LGKG F V+KG + D VA ED+ P +L+ + SE +LK H NI+
Sbjct: 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCK-EDL---PQELKIKFLSEARILKQYDHPNIV 55
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
K V + I ++ EL G + RKK + K + +A G+ YL S N
Sbjct: 56 KLIG--VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEE 192
IHRDL N V G N +KI D G++ + S G + + APE L
Sbjct: 114 --CIHRDLAARNCLV-GENNVLKISDFGMS-RQEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 193 EYNELVDIYSFGMCILEMVT---CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249
Y+ D++S+G+ + E + C YP Q ++V G + + K D V +
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYP---GMTNQQAREQVEKGYRMSCPQKCPD-DVYK 225
Query: 250 FIEKC 254
+++C
Sbjct: 226 VMQRC 230
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 47/182 (25%), Positives = 88/182 (48%), Gaps = 12/182 (6%)
Query: 60 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKA 118
+ E ++ L HE +++ Y V R I ++TE ++G L Y ++H K
Sbjct: 44 DEFIEEAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ 101
Query: 119 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 178
+ + + G+ YL S IHRDL N V+ + G VK+ D GL+ + S
Sbjct: 102 LLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSS 158
Query: 179 IGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+G+ + PE L +++ D+++FG+ + E+ + + PY N ++ +KV+ G
Sbjct: 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQG 217
Query: 234 IK 235
++
Sbjct: 218 LR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 25/233 (10%)
Query: 21 ILGKGAFKTVYKG-FDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 77
LG GAF VY+G ++ G +V ++ + + E+ E HL+ + H NI
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-------VDMKAIKNWARQILRGL 130
+K + N +I EL G L Y + + + +K + + + +G
Sbjct: 62 VKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVMQQPTARSVIGTP---- 182
YL + IHRDL N V+ + VKIGD GLA + + G
Sbjct: 120 VYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 183 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+MAPE L + ++ D++SFG+ + E++T + PY N ++ + VT+G
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
++LGKG F V ++ G A + E V+ + D++ +E +L++ +H +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKE-VIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
S+ T+ + + E G L + + + + + +I+ L YLHS
Sbjct: 60 LKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN- 116
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 196
+++RDLK +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E+ +Y
Sbjct: 117 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 197 LVDIYSFGMCILEMVTCEYP-YNE 219
VD + G+ + EM+ P YN+
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 78/294 (26%), Positives = 138/294 (46%), Gaps = 20/294 (6%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 80
++GKG+F V + DG A + + +++ +Q + LLK++KH ++
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
+ S+ T + + + G L + ++ ++ + +A +I L YLHS N I
Sbjct: 62 HYSF--QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--I 117
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNEL 197
I+RDLK +NI ++ + G V + D GL + T + GTPE++APE L ++ Y+
Sbjct: 118 IYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 198 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 257
VD + G + EM+ P+ ++ A++Y + + KP L + +E +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF-YSRDTAEMYDNILN--KPLRLKPNISVSARHLLEGLLQK 233
Query: 258 -ASLRLPA----LELLKDPFLVTDNPKDLVCDPLRLPNLVPEV---MNLAHSEP 303
+ RL A LE+ F + N DLV + P P V M+L H +P
Sbjct: 234 DRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPP-FNPNVSGPMDLKHFDP 286
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSL 72
F Y +LGKG F EV QV M + +LE R+ +L
Sbjct: 2 FRHY-RVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 48
Query: 73 KHENIIKFYNS-------WVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWA 123
+ I++ NS + +T + ++ L G L+ Y + D + +A
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA 108
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTP 182
+I GL LH I++RDLK +NI ++ + G ++I DLGLA+ + + T R +GT
Sbjct: 109 AEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTV 165
Query: 183 EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK 221
+MAPE+ + E Y D + G I EM+ + P+ + K
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 21 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+LGKG+F V KG DE+ I++ V I+D D +E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALQDKPP 61
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+ +S +R + + E G L + ++ +A +I GL +LH
Sbjct: 62 FLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EE 193
II+RDLK DN+ ++ + G +KI D G+ ++ T R+ GTP+++APE+ +
Sbjct: 121 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 194 YNELVDIYSFGMCILEMVTCEYPYN 218
Y + VD +++G+ + EM+ + P++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-13
Identities = 88/340 (25%), Positives = 146/340 (42%), Gaps = 61/340 (17%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-- 78
I+G G+F VY+ +D E +V I+ V+Q P R E+ ++K+L H NII
Sbjct: 73 IIGNGSFGVVYEAIC-IDTSE----KVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFL 124
Query: 79 --KFYNSWV--DDTNRTINMITELF---TSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 131
+Y ++ N +N++ E ++ Y + + + + +K ++ Q+ R L
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEFMAPELY 190
Y+HS I HRDLK N+ ++ N +K+ D G A ++ + S I + + APEL
Sbjct: 185 YIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELM 242
Query: 191 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKN--------------PAQIYKKVTS-- 232
Y +D++S G I EM+ YP ++ P + K +
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN 301
Query: 233 -------GIKPASLSKV----TDPQVKQFIEKCIVPASL-RLPALELLKDPFLVTDNPKD 280
+KP L KV T FI + + L RL +E L DPF D
Sbjct: 302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF------D 355
Query: 281 LVCDP-LRLPNLV---PEVMNLAHSEPHPMDIDLNHKKVS 316
+ DP ++LP + P++ N +E M K +
Sbjct: 356 DLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIP 395
|
Length = 440 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 75/298 (25%), Positives = 122/298 (40%), Gaps = 76/298 (25%)
Query: 17 QYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 73
+Y+++ +G+G F V+K + VA +V +E+ + P R E+ +L+ LK
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR---EIKILQLLK 69
Query: 74 HENIIKFY---NSWVDDTNR---TINMITELFT---SGSLRQYRKKHKNVDMK--AIKNW 122
HEN++ + NR + ++ E +G L KNV IK
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN-----KNVKFTLSEIKKV 124
Query: 123 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--------T 174
+ +L GL+Y+H + I+HRD+K NI + +G +K+ D GLA T
Sbjct: 125 MKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 175 ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT------------------- 212
R V T + PEL E +Y +D++ G CI+ EM T
Sbjct: 182 NRVV--TLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWTRSPIMQGNTEQHQLTLISQ 238
Query: 213 -C------------EYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256
C + + + + P +KV +KP V DP I+K +V
Sbjct: 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKDPHALDLIDKLLV 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 9e-13
Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 23/197 (11%)
Query: 66 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 125
VH L + N IK Y S T + +I + G L KK + +K RQ
Sbjct: 61 VHQLMK-DNPNFIKLYYSV--TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ 117
Query: 126 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 185
++ L+ LH HN IIH D+K +N+ + + + D GL ++ P+ GT ++
Sbjct: 118 LVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--GTLDYF 173
Query: 186 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPY----NECKNPAQ----IYKKVTSGIKP 236
+PE + Y+ D ++ G+ E++T ++P+ +E + KK+
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP----- 228
Query: 237 ASLSKVTDPQVKQFIEK 253
K F++
Sbjct: 229 --FIKNVSKNANDFVQS 243
|
Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 22/223 (9%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G + VY+G + + VA + ED M+ +E E ++K +KH N+++
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 68
Query: 82 NSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
V +ITE T G+L Y + V+ + A QI + YL N
Sbjct: 69 G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 195
IHRDL N V G N VK+ D GL+ +M T + G ++ APE L +++
Sbjct: 125 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 196 ELVDIYSFGMCILEMVT---CEYPYNECKNPAQIYKKVTSGIK 235
D+++FG+ + E+ T YP + +Q+Y+ + G +
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGYR 223
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 62/235 (26%), Positives = 111/235 (47%), Gaps = 18/235 (7%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSL- 72
L + + LG GAF V + A +V ++ + + ER L SE+ ++ L
Sbjct: 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGL 130
HENI+ + I +ITE G L + RK+ + ++ + +++ Q+ +G+
Sbjct: 97 NHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEV-KIGDLGLAIVMQQPTARSVIGTP----EFM 185
+L S N IHRDL N+ + +G++ KI D GLA + + V G ++M
Sbjct: 155 AFLASKN--CIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 186 APE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 238
APE ++ Y D++S+G+ + E+ + PY ++ YK + G + A
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 63/230 (27%), Positives = 112/230 (48%), Gaps = 19/230 (8%)
Query: 21 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+LGKG+F V KG DE+ I++ V I+D D +E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALSGKPP 61
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+ +S +R + + E G L ++ +A +I GL +LHS
Sbjct: 62 FLTQLHSCFQTMDR-LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EE 193
II+RDLK DN+ ++ + G +KI D G+ + T ++ GTP+++APE+ +
Sbjct: 121 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 194 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSK 241
Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P S+SK
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 56/181 (30%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 64 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAI 119
SE+H L + H I+K ++ + D + +I E + G L +Q K+H +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 120 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----A 175
QI+ L +HS ++HRDLK NIF+ G +K+GD G + A
Sbjct: 172 GLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 176 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ--IYKKVTS 232
S GTP ++APEL+E + Y++ D++S G+ + E++T P+ K P+Q I ++V
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLY 285
Query: 233 G 233
G
Sbjct: 286 G 286
|
Length = 478 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 73/270 (27%), Positives = 121/270 (44%), Gaps = 40/270 (14%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSL 72
F QY +LGKG F EV QV M + +LE R+ +L
Sbjct: 2 FRQY-RVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGESMAL 48
Query: 73 KHENIIKFYNS-------WVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWA 123
+ I++ NS + +T + ++ L G L+ Y + +A
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYA 108
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTP 182
+I GL LH I++RDLK +NI ++ ++G ++I DLGLA+ V + T + +GT
Sbjct: 109 AEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTV 165
Query: 183 EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 241
+MAPE+ + E Y D ++ G + EM+ + P+ + K KK IK + +
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK------KK----IKREEVER 215
Query: 242 VTDPQVKQFIEKCIVPASLRLPALELLKDP 271
+ +++ EK P + L + L KDP
Sbjct: 216 LVKEVQEEYSEK-FSPDARSLCKMLLCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-12
Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 80
++GKG VY +D V VA ++ ED+ ++P +R E + L H I+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 81 YN--SWVDDTNRTINMITELFTSGS-LRQYRKK-------HKNVDMKAIKNWARQILRGL 130
Y+ S D T+ I E +T S L+ +K + + A + +I +
Sbjct: 68 YSICSDGDPVYYTMPYI-EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----------PTARS--- 177
Y+HS ++HRDLK DNI + G GEV I D G AI +
Sbjct: 127 EYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 178 -------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 217
++GTP++MAPE L +E DIY+ G+ + +M+T +PY
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 37/210 (17%)
Query: 22 LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 77
+G+G + V+ K E+ VA ++ + ++ +++ + +E +L + K E +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEI----VALKRMK-KSLLFKLNEVRHVLTERDILTTTKSEWL 63
Query: 78 IKFYNSWVDDTNRTINM--------ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 129
+K ++ DD + M T L G L + + +M +
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD-------A 116
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 187
LH L IHRDLK +N F+ +G +K+ D GL+ IV A SV+G+P++MAP
Sbjct: 117 LHELG-----YIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTY---ANSVVGSPDYMAP 167
Query: 188 E-LYEEEYNELVDIYSFGMCILEMVTCEYP 216
E L + Y+ VD +S G C+L C +P
Sbjct: 168 EVLRGKGYDFTVDYWSLG-CMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G F V+ G+ +V ++ + ++ E +L+K+L+H+ +++ Y
Sbjct: 14 LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 67
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPP 139
V I +ITE GSL + K + V + + +++ QI G+ Y+ N
Sbjct: 68 A--VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 123
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPELYE-EEYN 195
IHRDL+ N+ V+ + KI D GLA V++ + TAR P ++ APE +
Sbjct: 124 YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 196 ELVDIYSFGMCILEMVT 212
D++SFG+ + E+VT
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 51/201 (25%), Positives = 103/201 (51%), Gaps = 9/201 (4%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
++LGKG F V ++ G A ++ ++V+ + D++ +E +L++ +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAM-KILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
S+ T+ + + E G L + + + + + +I+ L YLHS +
Sbjct: 60 LKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 196
+++RDLK +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E+ +Y
Sbjct: 116 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 197 LVDIYSFGMCILEMVTCEYPY 217
VD + G+ + EM+ P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 39/129 (30%), Positives = 69/129 (53%), Gaps = 5/129 (3%)
Query: 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 154
I +L G L + +H K ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 155 NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 212
+G V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191
Query: 213 CEYPYNECK 221
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 65/277 (23%), Positives = 130/277 (46%), Gaps = 38/277 (13%)
Query: 21 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHE 75
++G+G++ V K + + ++V ++ +D + ++ + +E H+ ++ H
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHP 56
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
++ ++ + T + + E G L + ++ + + + + ++ +I L+YLH
Sbjct: 57 FLVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-E 192
II+RDLK DN+ ++ + G +K+ D G+ +P T + GTP ++APE+ E
Sbjct: 115 RG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249
+Y VD ++ G+ + EM+ P++ NP Q D +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDYLFQV 216
Query: 250 FIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 285
+EK I +P SL + A +LK FL D + L C P
Sbjct: 217 ILEKQIRIPRSLSVKAASVLKS-FLNKDPKERLGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 40/210 (19%)
Query: 22 LGKGAFKTV--YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 78
LG+GA+ V + + + VA + I +V +R E+ LL+ + H+NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKK--ITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI------------KNWARQI 126
Y D EL+ L + D+ I +++ QI
Sbjct: 66 CLY----DMDIVFPGNFNELYLYEELMEA-------DLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 127 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA------IVMQQPTARSVIG 180
L GL Y+HS N ++HRDLK N+ VN + E+KI D GLA +
Sbjct: 115 LCGLKYIHSAN--VLHRDLKPGNLLVNA-DCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 181 TPEFMAPE--LYEEEYNELVDIYSFGMCIL 208
T + APE L + Y + +D++S G CIL
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 58/231 (25%), Positives = 107/231 (46%), Gaps = 17/231 (7%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
+++G G F V++G ++ G + + + Q + SE ++ H NII
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSH 136
+ V + +ITE +G+L +Y + H + + + R I G+ YL
Sbjct: 70 RLEG--VVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFMAPE-LY 190
N +HRDL NI VN +N E K+ D GL+ V++ + + + APE +
Sbjct: 127 N--YVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 191 EEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK-PASL 239
++ D++SFG+ + E+++ E PY + N ++ K + G + PA +
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 62/270 (22%), Positives = 122/270 (45%), Gaps = 27/270 (10%)
Query: 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 68
W+L + L+ + +GKG F V G + G +VA + + Q+ +E +
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA------FLAEASV 52
Query: 69 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV-DMKAIKNWARQI 126
+ L+H N+++ V++ + ++TE GSL Y R + ++V + ++ +
Sbjct: 53 MTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 127 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF 184
+ YL ++N +HRDL N+ V+ +N K+ D GL Q T + + ++
Sbjct: 112 CEAMEYLEANN--FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPV---KW 165
Query: 185 MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243
APE L E++++ D++SFG+ + E+ Y + P K V ++
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEI----YSFGRVPYPRIPLKDVVPRVEKGYKMDAP 221
Query: 244 D---PQVKQFIEKCIVPASLRLPALELLKD 270
D P V +++C + P+ L++
Sbjct: 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 21 ILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+LG GAF TVYKG DG I VA + + SP + + E +++ +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVA---IKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHS 135
+ + + T+ ++T+L G L Y +++K+ + + + NW QI +G+ YL
Sbjct: 71 VCRLLGICL---TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIG--TP-EFMAPE-LY 190
++HRDL N+ V N VKI D GLA ++ T G P ++MA E +
Sbjct: 128 VR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 191 EEEYNELVDIYSFGMCILEMVT 212
+ D++S+G+ + E++T
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 22 LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 76
LG+G F V G D+ E V + + L L SE+ ++K + KH+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR------------ 124
II + D + +I E + G+LR+Y + + M+ + AR
Sbjct: 83 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 125 ----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 175
Q+ RG+ YL S IHRDL N+ V NN +KI D GLA I + T
Sbjct: 141 SCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTT 197
Query: 176 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 212
+ ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 198 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 66/241 (27%), Positives = 98/241 (40%), Gaps = 36/241 (14%)
Query: 20 EILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
LG+GAF V+ G E D VA V S D + E LL + +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVA---VKTLKETASNDARKDFEREAELLTNFQH 67
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN------------- 121
ENI+KFY + M+ E G L ++ + H
Sbjct: 68 ENIVKFYGVCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 122 -WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 180
A QI G+ YL S + +HRDL N V G + VKIGD G++ + V G
Sbjct: 126 QIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDVYTTDYYRVGG 182
Query: 181 TP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+M PE +Y + E D++SFG+ + E+ T + P+ N ++ + +T G
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECITQG 240
Query: 234 I 234
Sbjct: 241 R 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 38/129 (29%), Positives = 68/129 (52%), Gaps = 5/129 (3%)
Query: 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 154
I +L G L + +H ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 155 NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 212
+G V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 213 CEYPYNECK 221
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 51/180 (28%), Positives = 93/180 (51%), Gaps = 17/180 (9%)
Query: 62 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT-----ELFTSGSLRQYRKKHKNVDM 116
L +E+ L L HENI+K + N MIT +L++ + K + + +
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTY--MITQKYDFDLYSFMYDEAFDWKDRPL-L 266
Query: 117 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TA 175
K + +Q+L + Y+H +IHRD+K +NIF+N +G++ +GD G A+ ++ A
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC-DGKIVLGDFGTAMPFEKEREA 323
Query: 176 RSV--IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY-PYNE-CKNPAQIYKKV 230
+GT +PE L + Y E+ DI+S G+ +L+M++ ++ P + P + K+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383
|
Length = 501 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSL 72
F QY +LGKG F EV QV M + +LE R+ +L
Sbjct: 2 FRQY-RVLGKGGFG------------EVCACQVRATGKMYACKRLEKKRIKKRKGESMAL 48
Query: 73 KHENIIKFYNS-------WVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWA 123
+ I++ NS + +T + ++ + G L+ Y + + + +A
Sbjct: 49 NEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYA 108
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTP 182
+IL GL LH N ++RDLK +NI ++ + G ++I DLGLA+ + + + R +GT
Sbjct: 109 AEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTV 165
Query: 183 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 217
+MAPE L + Y D + G I EM+ + P+
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 65 EVHLLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 122
E+ L+ + NI+K Y +D D +++I E T G LR+ K K++ K +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 123 ARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 181
A +GL+ L+ N P +++L + V N ++KI GL ++ P ++V
Sbjct: 128 AIDCCKGLYNLYKYTNKP--YKNLTSVSFLVT-ENYKLKIICHGLEKILSSPPFKNV--- 181
Query: 182 PEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 235
FM Y+ EY DIYS G+ + E+ T + P+ +IY + +
Sbjct: 182 -NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNN 239
Query: 236 PASLSKVTDPQVKQFIEKCIVPASLRLPAL 265
L ++K +E C S++ P +
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
|
Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 63/228 (27%), Positives = 112/228 (49%), Gaps = 25/228 (10%)
Query: 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQ---VNIEDVMQSPDQLERLYSE 65
W + L+ ++ LG G F V+ +N+ V ++ + +E +E
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMA---------TYNKHTKVAVKTMKPGSMSVEAFLAE 51
Query: 66 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWA 123
+++K+L+H+ ++K ++ V T I +ITE GSL + K + + + +++
Sbjct: 52 ANVMKTLQHDKLVKL-HAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 108
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT 181
QI G+ ++ N IHRDL+ NI V+ + KI D GLA V++ + TAR
Sbjct: 109 AQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKF 165
Query: 182 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 226
P ++ APE + + D++SFG+ ++E+VT PY NP I
Sbjct: 166 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 22 LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 76
LG+G F V G D+ V V + + L L SE+ ++K + KH+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIK 120
II + D + +I E + G+LR+Y + + + K +
Sbjct: 86 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 121 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 175
+ A Q+ RG+ YL S IHRDL N+ V +N +KI D GLA I + T
Sbjct: 144 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 200
Query: 176 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 212
+ ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 201 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 66/274 (24%), Positives = 126/274 (45%), Gaps = 34/274 (12%)
Query: 21 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
++G+G++ V K D++ ++V ++ +D + ++ + +E H+ +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD-----EDIDWVQTEKHVFEQASSNP 56
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+ +S T+R ++ E G L + ++ + + + + +A +I L++LH
Sbjct: 57 FLVGLHSCFQTTSRLF-LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE 193
II+RDLK DN+ ++ +G +K+ D G+ P T + GTP ++APE+ EE
Sbjct: 116 G--IIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 194 YNELVDIYSFGMCILEMVTCEYPYN-ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252
Y VD ++ G+ + EM+ P++ NP D + +E
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM---------------NTEDYLFQVILE 217
Query: 253 KCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 285
K I +P L + A +LK FL D + L C P
Sbjct: 218 KPIRIPRFLSVKASHVLKG-FLNKDPKERLGCQP 250
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 20/196 (10%)
Query: 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 153
+ E + G L + ++ + + + + ++ +I L++LH II+RDLK DN+ ++
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD 130
Query: 154 GNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 210
G +K+ D G+ +P T + GTP ++APE L E+Y VD ++ G+ + EM
Sbjct: 131 A-EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 211 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLK 269
+ P++ G+ D + +EK I +P SL + A +LK
Sbjct: 190 MAGRSPFD------------IVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 270 DPFLVTDNPKDLVCDP 285
FL D + L C P
Sbjct: 238 G-FLNKDPKERLGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 88 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 147
T+ + ++T+ + G L + +K K + +++ L +LH ++ I++RDLK
Sbjct: 67 TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKP 124
Query: 148 DNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSF 203
+NI ++ G + + D GL A + T + GT E++APE+ +E Y + VD +S
Sbjct: 125 ENILLDA-TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183
Query: 204 GMCILEMVTCEYPYNECKNPAQIYKKVTSG 233
G+ + EM P+ ++ Q+Y+ + G
Sbjct: 184 GVLVFEMCCGWSPF-YAEDTQQMYRNIAFG 212
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 37/220 (16%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQ------VNIEDVMQSPDQLERLYSEVHLLKSL-KH 74
LG+G F V + E GI+ + V + + L L SE+ L+K + KH
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY----------------RKKHKNVDMKA 118
+NII + + +I E G+LR++ + + + K
Sbjct: 78 KNIINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 119 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQP 173
+ + A Q+ RG+ YL S IHRDL N+ V +N +KI D GLA I +
Sbjct: 136 LVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYYKK 192
Query: 174 TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 212
T+ + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 193 TSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 15/220 (6%)
Query: 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 72
V ++ +E++G G F V +G ++ G + + + Q SE ++
Sbjct: 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLH 131
H NII V +R + +ITE +G+L + R+ + + R I G+
Sbjct: 63 DHPNIIHLEG--VVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTP---EF 184
YL N +HRDL NI VN +N K+ D GL+ ++ PT S +G +
Sbjct: 121 YLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 185 MAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 222
APE + ++ D++S+G+ + E M E PY + N
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 97 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 156
ELFT R++ + ++ + +I+ L +LH II+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTES------EVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDS-E 141
Query: 157 GEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 210
G V + D GL+ A S GT E+MAPE+ +++ VD +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 211 VTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253
+T P+ E + ++I +++ P K + + FI+K
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQK 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 123 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSV 178
ARQ+L + Y+H IIHRD+K +N+ VNG ++ +GD G A + P +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGI 322
Query: 179 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 209
GT + APE L + Y VDI+S G+ I E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 38/132 (28%), Positives = 72/132 (54%), Gaps = 7/132 (5%)
Query: 102 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 161
G L + ++ D+ + + ++L L LH N +I+RDLK +NI ++ G + +
Sbjct: 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134
Query: 162 GDLGLAIVMQQPTARS--VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 218
D GL + + ++ GTPE++APEL Y + VD ++ G+ + EM+T P+
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
Query: 219 ECKNPAQIYKKV 230
+ +N ++Y+K+
Sbjct: 195 D-ENVNEMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G G F V+ G+ +V I+ + + E E ++ L H +++ Y
Sbjct: 12 IGSGQFGLVWLGYWLEK------RKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 82 NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
V I ++ E G L Y R + + + + G+ YL S N +
Sbjct: 66 G--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--V 121
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPELYE-EEYNE 196
IHRDL N V G N VK+ D G+ + S GT ++ +PE++ +Y+
Sbjct: 122 IHRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNP 223
D++SFG+ + E+ ++E K P
Sbjct: 181 KSDVWSFGVLMWEV------FSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 68
W++ L+ +GKG F V G + G +VA ++D + +E +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLG--DYRGQKVAVK--CLKDDSTAAQAF---LAEASV 53
Query: 69 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKA-IKNWARQI 126
+ +L+H N+++ + + ++TE GSL Y R + + V A +A +
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111
Query: 127 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF 184
G+ YL N +HRDL N+ V+ + K+ D GLA Q + + + ++
Sbjct: 112 CEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQDSGKLPV---KW 165
Query: 185 MAPE-LYEEEYNELVDIYSFGMCILEM 210
APE L E++++ D++SFG+ + E+
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 56/218 (25%), Positives = 107/218 (49%), Gaps = 18/218 (8%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G F V+ G I+VA +N E M D +E E ++ L H +++ Y
Sbjct: 12 LGSGQFGVVHLG-KWRAQIKVAIKAIN-EGAMSEEDFIE----EAKVMMKLSHPKLVQLY 65
Query: 82 NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
V + + ++TE +G L Y R++ + + + + + G+ YL ++
Sbjct: 66 G--VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--F 121
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP-EFMAPELYE-EEYNE 196
IHRDL N V+ + G VK+ D G+ ++ + T+ S P ++ PE++ +Y+
Sbjct: 122 IHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 197 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233
D++SFG+ + E+ T + P+ E K+ ++ + ++ G
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 74/270 (27%), Positives = 121/270 (44%), Gaps = 27/270 (10%)
Query: 10 SLFVLFLQYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 67
S F + +Y + +G GA V +D V VA +++ Q+ +R Y E+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELV 68
Query: 68 LLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 123
L+K + H+NII N + + + + ++ EL + + + + +D + +
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLL 125
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP- 182
Q+L G+ +LHS IIHRDLK NI V ++ +KI D GLA + S + TP
Sbjct: 126 YQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPY 178
Query: 183 ----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIK 235
+ APE + Y E VDI+S G + EMV + + ++ + KV G
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTP 237
Query: 236 PASLSKVTDPQVKQFIEKCIVPASLRLPAL 265
K P V+ ++E A L P L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 29/177 (16%)
Query: 59 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM- 116
L L SE+ ++K + KH+NII + D + ++ E + G+LR+Y + + M
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 117 ---------------KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 161
K + + A Q+ RG+ YL S IHRDL N+ V +N +KI
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDN-VMKI 175
Query: 162 GDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 212
D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 67/291 (23%), Positives = 133/291 (45%), Gaps = 30/291 (10%)
Query: 20 EILGKGAFKTVY-----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
++LG GA+ V+ G D G A + ++Q E +E +L+ ++
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDS--GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63
Query: 75 EN-IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
++ + ++ DT +++I + G L + + + + ++ ++ +I+ L +L
Sbjct: 64 SPFLVTLHYAFQTDTK--LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELY 190
H II+RD+K +NI ++ +NG V + D GL+ + A S GT E+MAP++
Sbjct: 122 HKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 191 ---EEEYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTD 244
+ +++ VD +S G+ + E++T P+ E + A+I +++ P +
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMS 236
Query: 245 PQVKQFIEKCIVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 289
K I++ ++ RL A E+ K PF N DL + P
Sbjct: 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAP 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 22 LGKGAFKTV-----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHE 75
LG+GAF V Y E D I VA ++ + + D + + E LL +L+HE
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVA-----VKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------------KNVDMKAIKNW 122
+I+KFY V+ + M+ E G L ++ + H + + +
Sbjct: 68 HIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 123 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 182
A+QI G+ YL S + +HRDL N V G N VKIGD G++ + V G
Sbjct: 126 AQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 183 ----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+M PE + ++ D++S G+ + E+ T + P+ + N ++ + +T G
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 10 SLFVLFLQYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 67
S F + +Y + +G GA V +D + VA +++ Q+ +R Y E+
Sbjct: 18 STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELV 75
Query: 68 LLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 123
L+K + H+NII N + + + + ++ EL + + + + +D + +
Sbjct: 76 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLL 132
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 183
Q+L G+ +LHS IIHRDLK NI V ++ +KI D GLA + S + TP
Sbjct: 133 YQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPY 185
Query: 184 -----FMAPE-LYEEEYNELVDIYSFGMCILEMV 211
+ APE + Y E VDI+S G + EM+
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-------QSPDQLER--LYSEVHLLKSL 72
LG+GAF V+ + +N +D M + P R E LL +L
Sbjct: 13 LGEGAFGKVF--------LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 64
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDM 116
+HE+I+KFY D + M+ E G L ++ + H + +
Sbjct: 65 QHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 117 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 176
+ + A QI G+ YL S + +HRDL N V G N VKIGD G++ +
Sbjct: 123 SQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSRDVYSTDYY 179
Query: 177 SVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 212
V G +M PE + ++ D++SFG+ + E+ T
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 57/249 (22%), Positives = 110/249 (44%), Gaps = 45/249 (18%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+++G+GAF V + G A + D+++ +Q+ + +E +L ++K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-EQVGHIRAERDILVEADSLWVVK 65
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ S+ D N + +I E G + K + + + + + + + +H
Sbjct: 66 MFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG-- 121
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------------PT----------- 174
IHRD+K DN+ ++ + G VK+ D GL +++ P+
Sbjct: 122 FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 175 ------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 221
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP +
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPFCSE 239
Query: 222 NPAQIYKKV 230
P + YKKV
Sbjct: 240 TPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSL 72
F Y +LGKG F EV QV M + +LE R+ +L
Sbjct: 2 FRHY-RVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 48
Query: 73 KHENIIKFYNS-------WVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWA 123
+ I++ NS + +T + ++ + G L+ Y + D + +A
Sbjct: 49 NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYA 108
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTP 182
++ GL L I++RDLK +NI ++ + G ++I DLGLA+ + + T R +GT
Sbjct: 109 AELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTV 165
Query: 183 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 221
+MAPE + E+Y D + G I EM+ + P+ + K
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 57/249 (22%), Positives = 110/249 (44%), Gaps = 45/249 (18%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+++G+GAF V + G A + D+++ +Q+ + +E +L ++K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-EQVAHIRAERDILVEADGAWVVK 65
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ S+ D R + +I E G + K + +A + + + + + +H
Sbjct: 66 MFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG-- 121
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------------PT----------- 174
IHRD+K DN+ ++ G VK+ D GL +++ P+
Sbjct: 122 FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 175 ------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 221
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP +
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPFCSE 239
Query: 222 NPAQIYKKV 230
P + Y+KV
Sbjct: 240 TPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 4/87 (4%)
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE 191
H H+ II+RDLK +NI ++ G +K+ D GL+ + + A S GT E+MAPE+
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 192 EE-YNELVDIYSFGMCILEMVTCEYPY 217
+ + D +SFG+ + EM+T P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 64 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 123
E+ +LK++ H II +++ T+ M+ + L Y + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAY--RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQ 191
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVI 179
R++L L YLH IIHRD+K +NIF++ +GD G A + P
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 180 GTPEFMAPELYE-EEYNELVDIYSFGMCILEM 210
GT E +PEL + Y DI+S G+ + EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 60/239 (25%), Positives = 105/239 (43%), Gaps = 42/239 (17%)
Query: 22 LGKGAFKTVYKG-FDEVDGIEVAWNQVNIEDVMQSP---DQLERLYSEVHLLKSLKHENI 77
LG GAF VY+G + DG V QV ++ + +S D+ + L E ++ H+NI
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVEL-QVAVKTLPESCSEQDESDFL-MEALIMSKFNHQNI 71
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-------VDMKAIKNWARQILRGL 130
++ + R I + EL G L+ + ++++ + MK + AR + +G
Sbjct: 72 VRLIGVSFERLPRFI--LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 131 HYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP------ 182
YL ++ IHRD+ N + G KI D G+ AR +
Sbjct: 130 KYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGM--------ARDIYRASYYRKGG 179
Query: 183 ------EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSG 233
++M PE + + + D++SFG+ + E+ + Y PY N ++ + VT G
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 51/223 (22%), Positives = 95/223 (42%), Gaps = 21/223 (9%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLYSEVHLLKSLK 73
LQ LG+G F V+ + E V ++ + ++ D+ E+ + + L
Sbjct: 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS 66
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---------RKKHKNVDMKAIKNWAR 124
H+N+++ + MI E G L+Q+ + K + K
Sbjct: 67 HKNVVRLLGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQP--TARSVIGT 181
QI G+ +L + +HRDL N V+ EVK+ L L+ V R+ +
Sbjct: 125 QIALGMDHLSNAR--FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 182 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKN 222
++APE + E++++ D++SFG+ + E+ T E P+ +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 19/225 (8%)
Query: 19 DEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
++++G G F V +G ++ G I+VA ++ +L+ L +E ++ H
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKAGSSDKQRLDFL-TEASIMGQFDHP 65
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
NII+ V +R + +ITE +GSL ++ R+ + + R I G+ YL
Sbjct: 66 NIIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPE-L 189
N +HRDL NI VN +N K+ D GL+ ++ T + + APE +
Sbjct: 124 EMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 190 YEEEYNELVDIYSFGMCILE-MVTCEYPYNECKNPAQIYKKVTSG 233
++ D++SFG+ + E M E PY + N + K V G
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 55/230 (23%), Positives = 106/230 (46%), Gaps = 22/230 (9%)
Query: 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 68
W L + L EI+G+G F V +G E G +VA + + Q+ E +
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQA------FLEETAV 52
Query: 69 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQI 126
+ L H+N+++ + + + ++ EL + G+L + + V + + ++ +
Sbjct: 53 MTKLHHKNLVRLLGVIL---HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV 109
Query: 127 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMA 186
G+ YL S ++HRDL NI V+ +G K+ D GLA V S + ++ A
Sbjct: 110 AEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPV-KWTA 165
Query: 187 PE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 235
PE L ++++ D++S+G+ + E+ + Y P K+V ++
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEV----FSYGRAPYPKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 20 EILGKGAFKTVYKG-FDEVDGIEV--AWNQVN-IEDVMQSPDQLERLYSEVHLLKSLKHE 75
++GKG F VY G + DG ++ A +N I D+ +++E+ E ++K H
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL----EEVEQFLKEGIIMKDFSHP 56
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
N++ + + ++ G LR + R + N +K + + Q+ +G+ YL
Sbjct: 57 NVLSLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA 115
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------IVMQQPTARSVIGTPEFM 185
S +HRDL N ++ + VK+ D GLA V A+ + ++M
Sbjct: 116 SKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWM 169
Query: 186 APE-LYEEEYNELVDIYSFGMCILEMVT 212
A E L +++ D++SFG+ + E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 36/224 (16%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKSLK 73
+++ E LG+ AF +YKG + G++ A V I+ + + +P Q E L+ L
Sbjct: 7 VRFMEELGECAFGKIYKGHLYLPGMDHA-QLVAIKTLKDINNPQQWGEFQQEASLMAELH 65
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNV--------------DM 116
H NI+ + + + M+ E G L ++ R H +V D
Sbjct: 66 HPNIVCLLGVVTQE--QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 117 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----- 171
+ A QI G+ YL SH +H+DL NI + G VKI DLGL+ +
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHVKISDLGLSREIYSADYY 180
Query: 172 --QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 212
QP + I +M PE + +++ DI+SFG+ + E+ +
Sbjct: 181 RVQPKSLLPI---RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 52/232 (22%)
Query: 20 EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
++LGKG V+ KG ++ ++V + M ++++R+ +E +L +L H
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVL-----DKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSG----SLRQYRKKHKNVDMKAIKNWARQILRGLH 131
+ Y T + ++ + + G L Q R+ K + + + +A ++L L
Sbjct: 62 FLPTLY--ASFQTETYLCLVMD-YCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLLALE 117
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA------------------------ 167
YLH I++RDLK +NI ++ +G + + D L+
Sbjct: 118 YLH--LLGIVYRDLKPENILLHE-SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 168 -----IVMQQPTAR--SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMV 211
++P+ R S +GT E++APE+ + + VD ++ G+ + EM+
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 61/219 (27%), Positives = 91/219 (41%), Gaps = 30/219 (13%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLK 73
+++ E LG+GAF VYKG ++ V I+ + + P + E L+ L+
Sbjct: 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNV-------------DMK 117
H NI+ V + M+ E G L ++ H +V D
Sbjct: 67 HPNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 118 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 177
+ A QI G+ YL SH+ +HRDL N V G VKI D GL+ +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYYR 181
Query: 178 VIGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEM 210
V +M PE LY + E DI+SFG+ + E+
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 38/218 (17%)
Query: 22 LGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLKHE 75
LG+GAF V+ E D + VA +++ +S Q +R E LL L+H+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQR---EAELLTVLQHQ 67
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------KNVDMKAIK 120
+I++FY + R + M+ E G L ++ + H + + +
Sbjct: 68 HIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 121 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 180
A QI G+ YL S + +HRDL N V G VKIGD G++ + V G
Sbjct: 126 AIASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 181 TP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 212
+M PE LY + E DI+SFG+ + E+ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 49/192 (25%), Positives = 74/192 (38%), Gaps = 16/192 (8%)
Query: 50 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 109
D + Q R E L L H NI+ +S + E +LR+
Sbjct: 13 TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLF-AVFEYVPGRTLREVLA 71
Query: 110 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGL- 166
+ Q+L L +HN I+HRDLK NI V+ K+ D G+
Sbjct: 72 ADGALPAGETGRLMLQVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129
Query: 167 --------AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 217
A V V+GTP + APE L E D+Y++G+ LE +T +
Sbjct: 130 TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RV 188
Query: 218 NECKNPAQIYKK 229
+ + A+I +
Sbjct: 189 VQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 60/231 (25%), Positives = 93/231 (40%), Gaps = 36/231 (15%)
Query: 20 EILGKGAFKTVY-------KGFDEVDGIEVAWNQVNIEDVMQSP------DQLERLYSEV 66
E LG+G F V+ + F E E + ++ + E EV
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 67 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-----------KNVD 115
+L L NI + D + MI E +G L Q+ +KH K++
Sbjct: 71 KILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 116 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 175
+ A QI G+ YL S N +HRDL N V G N +KI D G++ +
Sbjct: 129 FSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLYSSDY 185
Query: 176 RSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 219
V G +MA E + ++ D+++FG+ + E++T C E PY
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 41/146 (28%), Positives = 77/146 (52%), Gaps = 21/146 (14%)
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 186
+H LH +HRD+K DNI ++ NG +++ D G + +M+ T +S +GTP++++
Sbjct: 118 VHQLH-----YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 187 PELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----P 236
PE+ + +Y D +S G+C+ EM+ E P+ ++ + Y K+ + + P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFP 230
Query: 237 ASLSKVTDPQVKQFIEKCIVPASLRL 262
A ++ V++ K I + I RL
Sbjct: 231 AQVTDVSE-DAKDLIRRLICSREHRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL--YSEVHLLKSLKHENIIK 79
LG+G+F VY+G + + +V I+ V ++ ER+ +E ++K ++++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKN------VDMKAIKNWARQILRG 129
V + +I EL T G L+ Y R + +N +K + A +I G
Sbjct: 74 LLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP----EFM 185
+ YL+++ +HRDL N V + VKIGD G+ + + G +M
Sbjct: 132 MAYLNANK--FVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 186 APE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233
+PE L + + D++SFG+ + E+ T E PY N Q+ + V G
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 45/196 (22%), Positives = 96/196 (48%), Gaps = 26/196 (13%)
Query: 57 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 116
+Q+++++ E +L ++ ++ + S+ +T R + M+ E G K + +
Sbjct: 43 NQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLCMVMEYVEGGDCATLLKNIGALPV 100
Query: 117 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV------- 169
+ + + + L YLH++ I+HRDLK DN+ + + G +K+ D GL+ +
Sbjct: 101 DMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTT 157
Query: 170 ----------MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPY 217
++ + V GTPE++APE + + Y + VD ++ G+ + E +V C +
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217
Query: 218 NECKNPAQIYKKVTSG 233
+ P +++ +V S
Sbjct: 218 GD--TPEELFGQVISD 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 39/235 (16%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLER---------L 62
L+ E LG+G F V+ E +G+ + + + V+ + L
Sbjct: 7 LRLKEKLGEGQFGEVH--LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 63 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---------N 113
E+ ++ LK+ NII+ V D + MITE +G L Q+ + + N
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 114 VDMKAIKN---WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170
+ +I N A QI G+ YL S N +HRDL N V GN+ +KI D G++ +
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV-GNHYTIKIADFGMSRNL 179
Query: 171 QQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYN 218
+ G +MA E + ++ D+++FG+ + EM T C E PY+
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 35/135 (25%), Positives = 72/135 (53%), Gaps = 8/135 (5%)
Query: 88 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 147
T +++I + + G + + + N ++ ++ +I+ L +LH I++RD+K
Sbjct: 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKL 133
Query: 148 DNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYS 202
+NI ++ + G V + D GL+ + ++ S GT E+MAPE+ + + + VD +S
Sbjct: 134 ENILLD-SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWS 192
Query: 203 FGMCILEMVTCEYPY 217
G+ I E++T P+
Sbjct: 193 LGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 40/144 (27%), Positives = 78/144 (54%), Gaps = 17/144 (11%)
Query: 133 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS--VIGTPEFMAPE 188
+HS H +HRD+K DN+ ++ NG +++ D G + M Q T +S +GTP++++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 189 LYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----PAS 238
+ + +Y D +S G+C+ EM+ E P+ ++ + Y K+ + + P+
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHEERFQFPSH 232
Query: 239 LSKVTDPQVKQFIEKCIVPASLRL 262
++ V++ + K I++ I RL
Sbjct: 233 ITDVSE-EAKDLIQRLICSRERRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 59/235 (25%), Positives = 104/235 (44%), Gaps = 36/235 (15%)
Query: 16 LQYDEILGKGAFKTVY--------KGFDEVDGIEVAWNQ---VNIEDVMQSPDQLER--L 62
L + E LG+G F V+ K D+ ++V+ NQ V ++ + + ++ R
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 63 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---------- 112
E+ ++ LK NII+ + + MITE +G L Q+ +H+
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 113 -NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171
+ + A QI G+ YL S N +HRDL N V G N +KI D G++ +
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLY 181
Query: 172 QP-----TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 219
R+V+ + ++ D+++FG+ + E++T C E PY++
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 47/219 (21%)
Query: 53 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 112
M +Q+ + +E +L + ++K Y S+ D+ + +I E G + K
Sbjct: 39 MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY--LYLIMEYLPGGDMMTLLMKKD 96
Query: 113 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL------ 166
+ + + + + + +H IHRD+K DN+ ++ G +K+ D GL
Sbjct: 97 TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKK 153
Query: 167 ------------------AIVMQQPT----------------ARSVIGTPEFMAPELYEE 192
+ +P A S +GTP+++APE++ +
Sbjct: 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ 213
Query: 193 E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 230
YN+ D +S G+ + EM+ YP NP + Y+K+
Sbjct: 214 TGYNKECDWWSLGVIMYEMLV-GYPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 36/149 (24%), Positives = 77/149 (51%), Gaps = 14/149 (9%)
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+++ + ++ DD + + M+ E G L + +V K K + +++ L +HS
Sbjct: 105 VVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM 161
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEEE 193
+IHRD+K DN+ ++ +G +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 162 G--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 194 -----YNELVDIYSFGMCILEMVTCEYPY 217
Y D +S G+ + EM+ + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 16/223 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +G+G F V+ G D VA + + + PD + E +LK H NI++
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK--SCRETL-PPDLKAKFLQEARILKQYSHPNIVR 57
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
V + I ++ EL G + R + + +K + G+ YL S +
Sbjct: 58 LIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH- 114
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEEE 193
IHRDL N V N +KI D G++ + S G + + APE L
Sbjct: 115 -CIHRDLAARNCLVTEKNV-LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 194 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 235
Y+ D++SFG+ + E + PY N Q + + G++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSN-QQTREAIEQGVR 214
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL---AIVMQQPTARSVIGT 181
+I L +LH II+RDLK +NI ++ G VK+ D GL +I T + GT
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVT-HTFCGT 163
Query: 182 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPAS 238
E+MAPE L + + VD +S G + +M+T P+ +N + K+ G P
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPY 222
Query: 239 LSKVTDPQVKQFIEK 253
L+ P+ + ++K
Sbjct: 223 LT----PEARDLLKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 29/220 (13%)
Query: 20 EILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHE 75
++L +G F ++ G DE G E +V ++ V S Q+ L E LL L H+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKE---EEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 76 NIIKFYNSWVDDTNRTINMITELFTS-GSLRQYRKKHKNVDM---KAIK-----NWARQI 126
NI+ + ++D + + + G+L+ + ++ + + +A+ + A QI
Sbjct: 69 NILPILHVCIEDGEPP--FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 127 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE--- 183
G+ YLH +IH+D+ N ++ +VKI D L+ + P +G E
Sbjct: 127 ACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNALSRDLF-PMDYHCLGDNENRP 182
Query: 184 --FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNE 219
+MA E L +EY+ D++SFG+ + E++T + PY E
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 22 LGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G+G +VY G V ++E+ + + L+ L +EV L +H NI+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMT 63
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHYLHSHN 137
+ V T + +I+ GS K + M I N LRGL+YLH +
Sbjct: 64 SWT--VFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLG--LAIVMQQPTARSVIGTPEF-------MAPE 188
IHR++K +I ++G+ G V + L ++V A+ V P+F ++PE
Sbjct: 122 --YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 189 LYEEE---YNELVDIYSFGMCILEMVTCEYPYNE 219
L ++ YN DIYS G+ E+ T P+ +
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 64/273 (23%), Positives = 94/273 (34%), Gaps = 79/273 (28%)
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------------------------- 170
H IHRD+K DNI ++ +G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 171 --------------------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 209
Q+ A S++GTP ++APE+ Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 210 MVTCEYPYNECKNPAQIYKKV-----TSGIKP-ASLSKVTDPQVKQFIEKCIVPASLRL- 262
M+ + P+ PA+ KV T I A LS + I + A RL
Sbjct: 237 MLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLS----REASDLILRLCCGAEDRLG 291
Query: 263 --PALELLKDPFLVTDNPKDLVCDPLRLP-NLVPEVMNLAHSEPHPMDIDLNHKKVSADS 319
A E+ PF D R +P++ HP D N V +
Sbjct: 292 KNGADEIKAHPFFKG---IDFASLIRRQKAPYIPKIT-------HPTDTS-NFDPVDPEK 340
Query: 320 CAKSNTG---TWFLTLELQR-LTENN--EFTLR 346
++G R TE+ EFT R
Sbjct: 341 LRSDDSGESSPDRNVKPNNRKRTEHAFYEFTFR 373
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 13/215 (6%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
++ ++++G G F V G ++ G + + Q SE ++ H
Sbjct: 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLH 134
NII V ++ + ++TE +GSL + +KH + + R I G+ YL
Sbjct: 66 NIIHLEG--VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE- 188
+HRDL NI VN +N K+ D GL+ V++ T R + APE
Sbjct: 124 DMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 189 LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 222
+ ++ D++S+G+ + E M E PY E N
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 36/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+++ + ++ DD R + M+ E G L + +V K + + +++ L +HS
Sbjct: 105 VVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM 161
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEEE 193
IHRD+K DN+ ++ +G +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 162 G--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 194 -----YNELVDIYSFGMCILEMVTCEYPY 217
Y D +S G+ + EM+ + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 33/182 (18%)
Query: 65 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD--------- 115
EV +L LK NII+ VD+ + MITE +G L Q+ H D
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 116 ----------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165
++ + A QI G+ YL S N +HRDL N V G N +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLV-GENLTIKIADFG 183
Query: 166 LAIVM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE--MVTCEYPY 217
++ + + R+V+ +MA E + ++ D+++FG+ + E M+ E PY
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPI-RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 218 NE 219
E
Sbjct: 243 GE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 28/232 (12%)
Query: 22 LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERL--YSEVHLLKSLKHENI 77
LG+G+F VY+G D + G A +V ++ V +S ER+ +E ++K ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKG--EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKN------VDMKAIKNWARQIL 127
++ V + ++ EL G L+ Y R + +N ++ + A +I
Sbjct: 72 VRLLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 128 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP----E 183
G+ YL++ +HRDL N V + VKIGD G+ + + G
Sbjct: 130 DGMAYLNAKK--FVHRDLAARNCMVAHDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 184 FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233
+MAPE L + + D++SFG+ + E+ + E PY N Q+ K V G
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFVMDG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 15/108 (13%)
Query: 122 WAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ---QPT 174
WAR +++ L +HS IHRD+K DN+ ++ +G +K+ D G + M
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVR 199
Query: 175 ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPY 217
+ +GTP++++PE+ + Y D +S G+ + EM+ + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 19/155 (12%)
Query: 133 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTPEFMAPE 188
+HS H +HRD+K +N+ ++ G +K+ D G A + + ++ +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 189 LYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 241
+ Y D +S G+ EM+ P++E A+ Y + + L
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMN--FQRFLKF 230
Query: 242 VTDPQV----KQFIEKCIVPASLRLPALELLKDPF 272
DP+V I+ + RL L PF
Sbjct: 231 PEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 45/192 (23%), Positives = 98/192 (51%), Gaps = 12/192 (6%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 80
++G+GA+ V K + VA + +D ++ + E E+ +L++LK ENI++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKK--FKDSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
++ + ++ E L + V + ++++ Q+++ +H+ H ++ I
Sbjct: 66 KEAF--RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--I 121
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGTPEFMAPE-LYEEEYNE 196
+HRD+K +N+ ++ N+ +K+ D G A + + + + + T + +PE L Y +
Sbjct: 122 VHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 197 LVDIYSFGMCIL 208
VD++S G CIL
Sbjct: 181 AVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 43/136 (31%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGT-- 181
Q+ G+ +L S N +HRDL N+ + VKI D GLA +M+ S T
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 182 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 238
P ++MAPE ++ Y L D++SFG+ + E+ T PY E Q Y + G + A
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK 363
Query: 239 LSKVTDPQVKQFIEKC 254
+ +D ++ + ++KC
Sbjct: 364 PAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 63/261 (24%), Positives = 117/261 (44%), Gaps = 32/261 (12%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KH 74
+++++++G+G F V + + DG+++ +++ D + E+ +L L H
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-FAGELEVLCKLGHH 62
Query: 75 ENIIKFYNSWVDDTNRTINMIT-ELFTSGSLRQYRKKHKNVDM---------KAIKNWAR 124
NII + NR I E G+L + +K + ++ A ++
Sbjct: 63 PNIINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 125 QILR-------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 177
Q+L+ G+ YL IHRDL N+ V G N KI D GL+ + ++
Sbjct: 120 QLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVKKT 176
Query: 178 VIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSG 233
+ P +MA E L Y D++SFG+ + E+V+ PY C A++Y+K+ G
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY--CGMTCAELYEKLPQG 234
Query: 234 IKPASLSKVTDPQVKQFIEKC 254
+ + D +V + + +C
Sbjct: 235 YR-MEKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 26/201 (12%)
Query: 22 LGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
LG G F TV KG ++ E VA + ++ P + L E ++++ L + I++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVR 60
Query: 80 FY-----NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
SW+ ++ EL G L ++ +K+K+V K I Q+ G+ YL
Sbjct: 61 MIGICEAESWM--------LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE- 188
N +HRDL N+ + + KI D GL+ + A++ P ++ APE
Sbjct: 113 ETN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 189 LYEEEYNELVDIYSFGMCILE 209
+ +++ D++SFG+ + E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 66/263 (25%), Positives = 115/263 (43%), Gaps = 36/263 (13%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KH 74
+++ +++G+G F V K + DG+ + +++ S D E+ +L L H
Sbjct: 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHH 67
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK---AIKN---------- 121
NII + + + + E G+L + +K + ++ AI N
Sbjct: 68 PNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 122 ---WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 178
+A + RG+ YL IHRDL NI V G N KI D GL+ + +++
Sbjct: 126 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTM 182
Query: 179 IGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGI 234
P +MA E L Y D++S+G+ + E+V+ PY C A++Y+K+ G
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGY 240
Query: 235 ---KPASLSKVTDPQVKQFIEKC 254
KP + D +V + +C
Sbjct: 241 RLEKPLN----CDDEVYDLMRQC 259
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 21/146 (14%)
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 186
+H L +HRD+K DN+ ++ NG +++ D G + ++ T +S +GTP++++
Sbjct: 118 VHQLG-----YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 187 PELYEE------EYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASL 239
PE+ + Y D +S G+C+ EM+ E P Y E + + Y K+ + +
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQF 229
Query: 240 -SKVTD--PQVKQFIEKCIVPASLRL 262
VTD + K I + I RL
Sbjct: 230 PPDVTDVSEEAKDLIRRLICSPETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 31/230 (13%)
Query: 22 LGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENII 78
+G G F V G E G+ A +V ++++ S PD+ EV + L H N++
Sbjct: 3 IGNGWFGKVLLG--EAHRGMSKA--RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKA----IKNWARQILRGLHYL 133
+ ++ ++ E G L+ Y R V A ++ A ++ GL +L
Sbjct: 59 QCLGQCIESI--PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPEL 189
H + IH DL N + + VKIGD GLA+ T ++APEL
Sbjct: 117 HQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 190 YEEEYNELV--------DIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 230
E +L+ +I+S G+ + E+ T + PY + + Q+ K+V
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 184
Q+ RG+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 229
Query: 185 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 212
MAPE ++++ Y D++SFG+ + E+ +
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 21 ILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 77
+LGKG F +V + ++ +VA + D+ S D +E E +K H N+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSD-IEEFLREAACMKEFDHPNV 63
Query: 78 IKFYNSWVDDTNRT-----INMITELFTS-GSLRQYRKKHK------NVDMKAIKNWARQ 125
IK V +R I M+ F G L + + + ++ + +
Sbjct: 64 IKLIG--VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121
Query: 126 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------QQPTARSVI 179
I G+ YL S N IHRDL N +N N V + D GL+ + +Q A +
Sbjct: 122 IASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGDYYRQGCASKL- 177
Query: 180 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK-- 235
+++A E L + Y D+++FG+ + E++T + PY +N ++IY + G +
Sbjct: 178 -PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKGNRLK 235
Query: 236 --PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 270
P L V + + +C P P+ + L+D
Sbjct: 236 QPPDCLEDVYE-----LMCQCWSPEPKCRPSFQHLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 182
Q+ RG+ +L S N +HRDL N+ + VKI D GLA + + G+
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 183 --EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 238
++MAPE +++ Y L D++S+G+ + E+ + PY + Y K+ SG + A
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK 361
Query: 239 LSKVTDPQVKQFIEKCIVPASLRLPALELLKD 270
T +V + KC + P+ L D
Sbjct: 362 PDHATQ-EVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 184
Q+ RG+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 230
Query: 185 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 212
MAPE ++++ Y D++SFG+ + E+ +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 39/173 (22%), Positives = 62/173 (35%), Gaps = 22/173 (12%)
Query: 122 WA--RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 179
WA Q L L LH L + + +G V + +S
Sbjct: 20 WAVCLQCLGALRELHRQAKS--GNILLTWDGLLK-LDGSV----------AFKTPEQS-R 65
Query: 180 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 238
P FMAPE+ + Y E DIYS G+ + E + E PYNE + + I + + +G +
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG--MPA 123
Query: 239 LSKVTDPQVKQFIEKCIVPASLRLPALELLK---DPFLVTDNPKDLVCDPLRL 288
++ +RL A L + + + L + L L
Sbjct: 124 DDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 22 LGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLY--SEVHLLKSLKHENII 78
+G G F V G EV+ G A QV ++++ S E++ E +SL+H N++
Sbjct: 3 IGNGWFGKVILG--EVNSGYTPA--QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-----DMKAIKNWARQILRGLHYL 133
+ + T + M E G L+ Y + + D ++ A +I GL +L
Sbjct: 59 QCLGQCTEVTPYLLVM--EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPEL 189
H +N IH DL N + + VKIGD GL+ + T + ++APEL
Sbjct: 117 HKNN--FIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 190 YEEEYNELV--------DIYSFGMCILEM 210
+E + L+ +++S G+ I E+
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 26/144 (18%)
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 184
Q+ +G+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 235
Query: 185 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 230
MAPE +++ Y D++SFG+ + E+ + PY K + +++
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295
Query: 231 TSGIKPASLSKVTDPQVKQFIEKC 254
G + + T P++ Q + C
Sbjct: 296 KEGTRMRA-PDYTTPEMYQTMLDC 318
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 115 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170
D+ IK RQ+L GL LH I+HRD+K +N+ V +G+VKI D G A+ M
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 85/388 (21%), Positives = 146/388 (37%), Gaps = 81/388 (20%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG GAF V A + +DV+ +Q+ + +E +L +E ++K Y
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR-NQVAHVKAERDILAEADNEWVVKLY 67
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
S+ D N + + + G + + + + + ++ + +H I
Sbjct: 68 YSFQDKDN--LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FI 123
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-------------------QPT-------- 174
HRD+K DNI ++ +G +K+ D GL + +P+
Sbjct: 124 HRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 175 ----------------------ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 211
A S++GTP ++APE L + Y +L D +S G+ + EM+
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 212 TCEYPYNECKNPAQIYKKVT---SGIKPASLSKVTDPQVKQFIEKCIVPASLRL---PAL 265
+ P+ P + KV + + K++ P+ I K A RL A
Sbjct: 243 VGQPPF-LAPTPTETQLKVINWENTLHIPPQVKLS-PEAVDLITKLCCSAEERLGRNGAD 300
Query: 266 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADS----CA 321
++ PF + D D P P V ++ HPMD N V +S +
Sbjct: 301 DIKAHPFF---SEVDFSSDIRTQP--APYVPKIS----HPMDTS-NFDPVEEESPWNDAS 350
Query: 322 KSNTGTW-FLTLELQRLTENN--EFTLR 346
+T TW L + E+ EFT R
Sbjct: 351 GDSTRTWDTLCSPNGKHPEHAFYEFTFR 378
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 8e-05
Identities = 61/256 (23%), Positives = 109/256 (42%), Gaps = 30/256 (11%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NII 78
+++G+G F V K + DG+ + +++ D + E+ +L L H NII
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 59
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM---------KAIKNWARQILR- 128
+ + + + E G+L + +K + ++ A ++Q+L
Sbjct: 60 NLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 129 ------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 182
G+ YL IHRDL NI V G N KI D GL+ + +++ P
Sbjct: 118 AADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGRLP 174
Query: 183 -EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGIKPAS 238
+MA E L Y D++S+G+ + E+V+ PY C A++Y+K+ G +
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYR-LE 231
Query: 239 LSKVTDPQVKQFIEKC 254
D +V + +C
Sbjct: 232 KPLNCDDEVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 54/238 (22%), Positives = 102/238 (42%), Gaps = 35/238 (14%)
Query: 20 EILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+ILG+G F +V +G D+ ++VA + ++ S ++E SE +K H N
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS--EIEEFLSEAACMKDFDHPN 62
Query: 77 IIKFYNSWVDDTNRTIN------MITELFTSGSLRQY------RKKHKNVDMKAIKNWAR 124
++K V ++ +I G L + + + ++ + +
Sbjct: 63 VMKLIG--VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQPTARS 177
I G+ YL + N IHRDL N + + V + D GL+ + Q A+
Sbjct: 121 DIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 178 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233
+ +++A E L + Y D+++FG+ + E+ T + PY +N +IY + G
Sbjct: 178 PV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRHG 231
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 20 EILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSE-----VHLLKSL 72
E LG+G F ++KG + D E+ +V +++ D+ R YSE ++ L
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEV----LLKVLDKSHRNYSESFFEAASMMSQL 56
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK-NWARQILRGLH 131
H++++ Y V M+ E GSL Y KK+KN+ + K A+Q+ LH
Sbjct: 57 SHKHLVLNYGVCVCGDESI--MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALH 114
Query: 132 YLHSHNPPIIHRDLKCDNIFV-------NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 184
+L + H ++ N+ + GN +K+ D G++I + P + P +
Sbjct: 115 FLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV-LPKEILLERIP-W 170
Query: 185 MAPELYEEEYNELV--DIYSFGMCILEM 210
+ PE E N + D +SFG + E+
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 36/129 (27%), Positives = 67/129 (51%), Gaps = 11/129 (8%)
Query: 114 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV-KIGDLGLAIVMQQ 172
+D + + +++ Q+ +G+ +L S N IHRDL NI + +G + KI D GLA ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRN 266
Query: 173 PTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 226
+ V G ++MAPE ++ Y D++S+G+ + E+ + PY ++
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
Query: 227 YKKVTSGIK 235
YK + G +
Sbjct: 327 YKMIKEGYR 335
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 52/261 (19%), Positives = 105/261 (40%), Gaps = 57/261 (21%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+++GKGAF V + + D ++ + ++ M DQL + +E +L ++
Sbjct: 7 KVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
Y S+ D + + +I E G L K+ + + + + + +H
Sbjct: 66 LYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG-- 121
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI-------------VMQQPTAR---------- 176
IHRD+K DNI ++ G +K+ D GL+ ++Q + +
Sbjct: 122 FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 177 --------------------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 209
S +GTP+++APE++ ++ Y + D +S G + E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 210 MVTCEYPYNECKNPAQIYKKV 230
+ +P +N + Y+K+
Sbjct: 241 CL-IGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 37/123 (30%), Positives = 52/123 (42%), Gaps = 32/123 (26%)
Query: 117 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----- 171
K I+ RQIL L LHS I+HRD+K NI + +G KI DLG A ++
Sbjct: 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY 312
Query: 172 QPTARSVIGTPEFMAPE-----------------------LYEEEYNELVDIYSFGMCIL 208
P + + P + APE L++ + DIYS G+ L
Sbjct: 313 IP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 209 EMV 211
+M
Sbjct: 371 QMA 373
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 21/40 (52%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169
L YLH H IIHRDLK DN+ ++ N G +K+ D GL+ V
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 51/246 (20%), Positives = 93/246 (37%), Gaps = 56/246 (22%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG GAF V A + +DV+ +Q+ + +E +L +E +++ Y
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLR-NQVAHVKAERDILAEADNEWVVRLY 67
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
S+ D N + + + G + + + + ++ + +H I
Sbjct: 68 YSFQDKDN--LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FI 123
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGL----------------------------------- 166
HRD+K DNI ++ +G +K+ D GL
Sbjct: 124 HRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 167 --------------AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 211
A Q+ A S++GTP ++APE L Y +L D +S G+ + EM+
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 212 TCEYPY 217
+ P+
Sbjct: 243 VGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 54/239 (22%), Positives = 105/239 (43%), Gaps = 34/239 (14%)
Query: 32 KGFDEV----------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+GF+++ G V ++N+E + + + L E+H+ K H NI+ +
Sbjct: 8 RGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYR 65
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK--AIKNWARQILRGLHYLHSHNPP 139
+++ D + ++T GS + H M AI + +L+ L Y+H
Sbjct: 66 ATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG-- 121
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDL--GLAIVMQQPTARSVIGTPEF-------MAPELY 190
+HR +K +I ++ +G+V + L L+++ R V P++ ++PE+
Sbjct: 122 YVHRSVKASHILISV-DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVL 180
Query: 191 EEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSGIKPASLSKVTDP 245
++ Y+ DIYS G+ E+ P+ + PA Q+ + +G P L T P
Sbjct: 181 QQNLQGYDAKSDIYSVGITACELANGHVPFKDM--PATQMLLEKLNGTVPCLLDTTTIP 237
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 30/233 (12%)
Query: 22 LGKGAFKTVYKG-FDEVDGI-EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
LG+G F +V +G ++ D I +VA + I +S ++E SE +K H N+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS--EMEDFLSEAVCMKEFDHPNVMR 64
Query: 80 FYNSWVDDTNR----TINMITELFTSGSLRQYRKKHKNVDM------KAIKNWARQILRG 129
+ + +I G L + + D + + + I G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQPTARSVIGTP 182
+ YL S + IHRDL N +N N V + D GL+ + Q A+ +
Sbjct: 125 MEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV--- 178
Query: 183 EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233
+++A E L + Y D++SFG+ + E+ T + PY +N ++IY + G
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYLRQG 230
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 37/168 (22%), Positives = 72/168 (42%), Gaps = 22/168 (13%)
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQIL 127
L+H NI++ V+ ++ E G L+ Y + +N + ++ A +I
Sbjct: 52 LQHPNILQCLGQCVEAI--PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIA 109
Query: 128 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPE 183
G+ ++H HN +H DL N F+ + VK+GD G+ + T
Sbjct: 110 AGVTHMHKHN--FLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 184 FMAPELYEEEYNELV--------DIYSFGMCILEMVTC-EYPYNECKN 222
++APEL E + L+ ++++ G+ + E+ PY+ +
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 620 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.22 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.66 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.63 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.61 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.55 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.52 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.35 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.34 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 98.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.15 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.11 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.97 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.86 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.77 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.72 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.71 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.7 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.53 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.4 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.3 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.28 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.17 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.14 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.14 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.05 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.92 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.74 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.34 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.31 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.26 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.14 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 95.91 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.82 | |
| PLN02236 | 344 | choline kinase | 95.77 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.56 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.41 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.33 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.16 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.74 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.58 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.39 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.97 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.09 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.82 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.22 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 91.9 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 89.78 | |
| PTZ00384 | 383 | choline kinase; Provisional | 88.55 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 88.33 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 88.32 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.29 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 84.97 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-90 Score=744.26 Aligned_cols=417 Identities=60% Similarity=0.967 Sum_probs=362.1
Q ss_pred eeeeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 5 DLVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 5 ~~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
..+..++.|||+++.++||+|+|.+||+|+|..+|.+|||+.++..++.+++...++++.|+++|+.|+|||||+||++|
T Consensus 31 ~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW 110 (632)
T KOG0584|consen 31 EFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSW 110 (632)
T ss_pred cccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehe
Confidence 35778999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
++..+.++++|+|+|++|+|+.|++++++++.+.++.|++|||.||.|||++.||||||||||+||||+|+.|.|||||+
T Consensus 111 ~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDL 190 (632)
T KOG0584|consen 111 VDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDL 190 (632)
T ss_pred ecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecch
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cchhhccCCCCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 165 GLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 165 Gla~~~~~~~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
|||+..+...+.+++|||+|||||++...|+..+||||||||++||+|+++||++|.++++||++|++|++|..+.++.+
T Consensus 191 GLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 191 GLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred hHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHhcCCCcCCCCCCc-------cccCCC--CCCCCchhhhccCCCCCCCCCcccccccc
Q 007055 245 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD-------LVCDPL--RLPNLVPEVMNLAHSEPHPMDIDLNHKKV 315 (620)
Q Consensus 245 ~~lk~~I~kcL~~p~~Rpsa~elL~hpff~~~~~~~-------~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (620)
|++++||++||...++|+|+.|||.||||..+.... .....+ .+.................++++... +.
T Consensus 271 Pevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~-D~ 349 (632)
T KOG0584|consen 271 PEVREFIEKCLATKSERLSAKELLKDPFFDEDGGIVELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNLNT-DE 349 (632)
T ss_pred HHHHHHHHHHhcCchhccCHHHHhhChhhccccccccccchhhcccccccccccccchhhcCCcccccccceeecCC-Cc
Confidence 999999999999899999999999999999875421 000000 11111111111011111122222111 01
Q ss_pred cccccc---CCCCCccchhhhhhhccccceeeeccccCCCC-ceEEEEEecCCCCCceeeeeecccCCCCHHHHHHHHHh
Q 007055 316 SADSCA---KSNTGTWFLTLELQRLTENNEFTLRGEKNDDD-TVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVE 391 (620)
Q Consensus 316 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~i~l~lri~d~~~~~~~i~f~f~~~~Dta~~va~EmV~ 391 (620)
+...+- ....-......+.+|...++.+.++|+++++. .++|.|||+|.+|+.|||+|+|++..|||.+||.|||+
T Consensus 350 ~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~ 429 (632)
T KOG0584|consen 350 SEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHEMVE 429 (632)
T ss_pred hhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHHHHh
Confidence 111000 11112233345667788889999999999877 99999999999999999999999999999999999999
Q ss_pred ccCCCCcCHHHHHHHHHHHHHHhCCCCCCCC
Q 007055 392 QLDLSHEDVVSIAELIDNLIMKLVPSWNPSL 422 (620)
Q Consensus 392 ~~~i~~~d~~~ia~~i~~~i~~~~~~~~~~~ 422 (620)
++.++++++..||+||+..|.+|+|.|+...
T Consensus 430 el~~~dq~v~~ia~mid~~i~~L~p~~~~~~ 460 (632)
T KOG0584|consen 430 ELEITDQPVVNIAEMIDGEISALVPNWKAST 460 (632)
T ss_pred hcCCcccchhhHHHHHhchhhhcCCccCCCC
Confidence 9999999999999999999999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-53 Score=435.40 Aligned_cols=259 Identities=29% Similarity=0.480 Sum_probs=234.8
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
...++....||+|+.|+||+|.|+.|++.+|+|.|... ..++..+++.+|+++++.++|||||++|+.|+.+.. .+
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~i 153 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EI 153 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eE
Confidence 34667789999999999999999999999999999533 346777889999999999999999999999998775 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++||||++|+|.++++..++++|..+..++++|++||.|||. ++ ||||||||+|||++ ..|.|||||||.+..+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvN-skGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVN-SKGEVKICDFGVSGILV 230 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeec-cCCCEEeccccccHHhh
Confidence 9999999999999999999999999999999999999999995 77 99999999999999 79999999999998887
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCC----CCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 172 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~----~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
+..+.+++||..|||||.+.+ .|+.++||||||+.++||++|++||... .+..+++..|..+.+|.......+++
T Consensus 231 nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~e 310 (364)
T KOG0581|consen 231 NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPE 310 (364)
T ss_pred hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHH
Confidence 778899999999999998886 5999999999999999999999999763 46678888888876666555569999
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
++.||..||+ +|++||++.|||.|||++....
T Consensus 311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 9999999998 8999999999999999986543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-53 Score=439.23 Aligned_cols=265 Identities=26% Similarity=0.371 Sum_probs=230.8
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH---HHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP---DQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~---~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
.+-.+.++|-+.+.||+|+||.|.+|+.+.||+.||||+++........ +....+.+|+++|++|+|||||+++++|
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 3445778899999999999999999999999999999999876543321 1234467999999999999999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCC---CcEEE
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKI 161 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~---G~vKI 161 (620)
... ...||||||+.||+|++.+-.++.+.+...+.+++|++.||.|||++| |+||||||+|||++ .+ -.+||
T Consensus 246 ~~~--ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~-~~~e~~llKI 320 (475)
T KOG0615|consen 246 EVP--DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLS-NDAEDCLLKI 320 (475)
T ss_pred ecC--CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEec-cCCcceEEEe
Confidence 655 457999999999999999999999999999999999999999999999 99999999999997 34 57999
Q ss_pred ccccchhhccC-CCCccccCCCCCCCccccccc----cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 162 GDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 162 ~DFGla~~~~~-~~~~~~~GTp~y~APEll~~~----y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
+|||+|+..+. ...++.||||.|.|||++..+ |..++||||+||++|-+++|.+||++...+..+.+.|.+|..+
T Consensus 321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 99999987753 457889999999999998642 4569999999999999999999999877777788999998664
Q ss_pred C--CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 237 A--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 237 ~--~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
. ......+.++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 401 f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 401 FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 3 2344568899999999997 999999999999999998643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=431.08 Aligned_cols=268 Identities=27% Similarity=0.449 Sum_probs=229.8
Q ss_pred eeeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 6 LVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 6 ~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
...|++....|++.++||.|..++||+|++..+++.||||+++++++. ...+.+.+|++.|+.++||||+++|.+|+
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 356788899999999999999999999999999999999999988753 34788999999999999999999999998
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
.+. .+|+||.||.+|++.++++.. ..++|..|..+++++|.||.|||++| .||||||+.||||+ .+|.|||+|
T Consensus 95 v~~--~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLad 169 (516)
T KOG0582|consen 95 VDS--ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLAD 169 (516)
T ss_pred ecc--eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEcC
Confidence 875 599999999999999999864 35999999999999999999999999 99999999999998 899999999
Q ss_pred ccchhhccCC-----CC-ccccCCCCCCCccccc---cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Q 007055 164 LGLAIVMQQP-----TA-RSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 234 (620)
Q Consensus 164 FGla~~~~~~-----~~-~~~~GTp~y~APEll~---~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~ 234 (620)
||.+..+... .. .+++|||+|||||++. .+|+.|+|||||||++.||++|..||+.......+..++...
T Consensus 170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~- 248 (516)
T KOG0582|consen 170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND- 248 (516)
T ss_pred ceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-
Confidence 9987433211 11 5679999999999964 369999999999999999999999999865555555555433
Q ss_pred CCCC--------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCCccc
Q 007055 235 KPAS--------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 235 ~p~~--------~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~~~~ 282 (620)
+|.. ..+..+..++.||..||+ ||.+||||++||+|+||+....+...
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~ 305 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYL 305 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhc
Confidence 3311 123346789999999998 99999999999999999987776643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-51 Score=441.50 Aligned_cols=260 Identities=33% Similarity=0.518 Sum_probs=233.9
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
++..+..++|..+++||+|||+.||.+.+..+|+.||+|+|.+..+ ......+++.+||++.++|+|||||+||++|.|
T Consensus 11 ~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l-~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED 89 (592)
T KOG0575|consen 11 VIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL-KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED 89 (592)
T ss_pred eeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh-cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec
Confidence 3445556889999999999999999999999999999999987654 345678899999999999999999999999965
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
. .++|||+|+|..|+|..++++.+.++|.+++.+++||+.||.|||+++ |||||||..|+|++ .+.+|||+||||
T Consensus 90 s--~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~-~~~~VKIgDFGL 164 (592)
T KOG0575|consen 90 S--NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLN-ENMNVKIGDFGL 164 (592)
T ss_pred C--CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeec-CcCcEEecccce
Confidence 5 569999999999999999999999999999999999999999999999 99999999999998 778999999999
Q ss_pred hhhccCC--CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 007055 167 AIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243 (620)
Q Consensus 167 a~~~~~~--~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~ 243 (620)
|+.+..+ ...+.||||.|+|||++. .+++..+||||+||++|-|++|++||.. .+..+.|.+|..... .+|...
T Consensus 165 At~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y--~~P~~l 241 (592)
T KOG0575|consen 165 ATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEY--SMPSHL 241 (592)
T ss_pred eeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCc--cccccc
Confidence 9887755 345789999999999875 5699999999999999999999999965 678889999987533 345578
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
+.++++||.++|. +|.+|||+.++|.|+||..
T Consensus 242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 242 SAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 8999999999998 8999999999999999954
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=416.68 Aligned_cols=271 Identities=25% Similarity=0.424 Sum_probs=240.7
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
.....+++.++||+|+||.||.++.+.||+.+|+|++++..+... .+.+....|..+|..++||.||+++.+|++..
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~-- 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTEE-- 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccCC--
Confidence 345678999999999999999999999999999999988766443 56778999999999999999999999997664
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
.+|+|+||+.||.|+..+++.+.++|..++.|+..|+.||.|||++| ||||||||+|||++ .+|+++|+|||+++..
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKED 175 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhc
Confidence 59999999999999999999999999999999999999999999999 99999999999998 8999999999999744
Q ss_pred c--CCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 171 Q--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 171 ~--~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
- ....++++||++|||||++. .+|+..+|+||||+++|||++|.+||.+ .+...++++|..+.. ...+...+.++
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~-~~~p~~ls~~a 253 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKL-PLPPGYLSEEA 253 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcC-CCCCccCCHHH
Confidence 3 33566789999999999765 5799999999999999999999999987 678888899988753 33556688999
Q ss_pred HHHHHHhcC-CCCCCC----CHHHHhcCCCcCCCCCCccccCCCCCC
Q 007055 248 KQFIEKCIV-PASLRL----PALELLKDPFLVTDNPKDLVCDPLRLP 289 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rp----sa~elL~hpff~~~~~~~~~~~~~~~p 289 (620)
+++|.++|+ +|.+|. .+.++-+||||...+|..+....+..|
T Consensus 254 rdll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~Pp 300 (357)
T KOG0598|consen 254 RDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPP 300 (357)
T ss_pred HHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCC
Confidence 999999998 899996 688999999999999998776555443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=395.04 Aligned_cols=270 Identities=27% Similarity=0.450 Sum_probs=242.6
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
-..|.+.+.||.|+||.|.+++++.+|..+|+|++++.++.. ..+.+...+|..+|+.+.||+++++++.|.+. ..+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~--~~l 119 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN--SNL 119 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEeeccC--CeE
Confidence 346788999999999999999999999999999998776543 46678899999999999999999999998765 469
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
||||||.+||.|+.++.+.+++++..++.++.||+.||+|||+++ |++|||||+|||+| .+|.+||.|||+|.....
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecC
Confidence 999999999999999999999999999999999999999999999 99999999999998 899999999999987666
Q ss_pred CCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 173 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 173 ~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
. ..+.||||.|+|||++. .+|+.++|+|+||+++|||+.|.+||.. .++.++|++|..+.. .+|...++++++||
T Consensus 197 r-T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl 272 (355)
T KOG0616|consen 197 R-TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLL 272 (355)
T ss_pred c-EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHH
Confidence 5 56789999999999876 5699999999999999999999999987 678999999998744 46677889999999
Q ss_pred HHhcC-CCCCC-----CCHHHHhcCCCcCCCCCCccccCCCCCCCCc
Q 007055 252 EKCIV-PASLR-----LPALELLKDPFLVTDNPKDLVCDPLRLPNLV 292 (620)
Q Consensus 252 ~kcL~-~p~~R-----psa~elL~hpff~~~~~~~~~~~~~~~p~~~ 292 (620)
.++|+ |-++| ....++..||||....|..+....+..|..+
T Consensus 273 ~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred HHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 99997 77777 4578999999999999988877667666655
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=401.18 Aligned_cols=246 Identities=31% Similarity=0.492 Sum_probs=221.0
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.++||+|.||+||++.+..+|..||+|.|+.... +....+.+..|+.+|++|+|||||++|+.-+.+++..+++
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 46889999999999999999999999999999996654 4566788999999999999999999999444556667999
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC--EEecCCCccceEecCCCCcEEEccccchh
Q 007055 95 ITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPP--IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~--IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
|||||.+|+|.++++. ++.++|+.++.++.|++.||..||+.-+. |+||||||.|||++ .+|.|||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhHh
Confidence 9999999999999874 45699999999999999999999995444 99999999999998 79999999999999
Q ss_pred hccCC--CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 007055 169 VMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 245 (620)
Q Consensus 169 ~~~~~--~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~ 245 (620)
.+... .+.+++|||.||+||.+. .+|+.++||||+||++|||+..+.||.+ .+..++.++|..+-.|+.+...++.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~ 255 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYST 255 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhh
Confidence 87665 467899999999999876 5799999999999999999999999988 5889999999999777666688899
Q ss_pred HHHHHHHHhcC-CCCCCCCH
Q 007055 246 QVKQFIEKCIV-PASLRLPA 264 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa 264 (620)
.++.+|..|+. +|..||++
T Consensus 256 ~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHHccCCcccCCCc
Confidence 99999999997 99999997
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=402.72 Aligned_cols=256 Identities=27% Similarity=0.512 Sum_probs=223.8
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|.+.+.||+|+||+||+|+++.+|..||||.|..... +++..+.+..|+.+|+.++|||||.++++.... ..+|+
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~--~~i~l 86 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD--DFIYL 86 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC--CeEEE
Confidence 34678889999999999999999999999999987654 567788899999999999999999999987544 57999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC--C---CcEEEccccchhh
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--N---GEVKIGDLGLAIV 169 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~---G~vKI~DFGla~~ 169 (620)
|||||.||+|.+|+.+++++++..++.++.||+.||++||+++ ||||||||+|||++.. + -.+||+|||+|+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999999999999999999999999999 9999999999999742 1 4689999999988
Q ss_pred ccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHH
Q 007055 170 MQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQ 246 (620)
Q Consensus 170 ~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~~~~ 246 (620)
+... ...+.+|+|-|||||++. ++|+.|+|+||+|+++|+|++|+.||.. .++.++...+..+.. .+.++...++.
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~~s~~ 243 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAELSNP 243 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhhccCc
Confidence 8755 466789999999999884 7799999999999999999999999987 567777777776644 33445556667
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
..+++...|+ ++..|.+..+-+.|+|+....
T Consensus 244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 244 LRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 7788888887 899999999999999997644
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=409.47 Aligned_cols=258 Identities=26% Similarity=0.532 Sum_probs=224.9
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH-HHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN 89 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~-~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~ 89 (620)
....|++++.||+|+||+|++|.+..+|+.||+|+++........ ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~- 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT- 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence 344678999999999999999999999999999987765332122 34566779999999999 999999999886554
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
.+|+||||+.||+|++++...+++.|..++.+++||+.|++|||++| |+||||||+|||++.+.+.+||+|||++..
T Consensus 94 -~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 -KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred -eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 49999999999999999999999999999999999999999999999 999999999999994339999999999987
Q ss_pred c--cCCCCccccCCCCCCCcccccc-c-cC-ccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC-
Q 007055 170 M--QQPTARSVIGTPEFMAPELYEE-E-YN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT- 243 (620)
Q Consensus 170 ~--~~~~~~~~~GTp~y~APEll~~-~-y~-~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~- 243 (620)
. ......+.+|||.|+|||++.+ . |+ .++||||+|++||.|++|+.||.+ .+...++.++..+.. .++...
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~--~~p~~~~ 247 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEF--KIPSYLL 247 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCc--cCCCCcC
Confidence 7 3446788999999999999875 4 64 789999999999999999999987 667777777777643 244444
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+++++.+|.+||+ +|.+|+++.+++.||||+..
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 9999999999998 89999999999999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=412.03 Aligned_cols=260 Identities=27% Similarity=0.472 Sum_probs=228.4
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l 92 (620)
..|.+++.||+|+|++|++|.++.+++++|||++.++.+.. +....-+..|-..|.+| .||.|+++|..|.|+. .+
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~--sL 149 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE--SL 149 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--ce
Confidence 36789999999999999999999999999999987654322 23334577899999999 8999999999998775 59
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
|+|+||+++|+|.++|++.+.|++...+.++.||+.||+|||++| ||||||||+|||++ .+|++||.|||.|..+..
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd-~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLD-KDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEc-CCCcEEEeeccccccCCh
Confidence 999999999999999999999999999999999999999999999 99999999999998 799999999999975532
Q ss_pred C-------------CC--ccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 173 P-------------TA--RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 173 ~-------------~~--~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
. .. .+++||..|.+||++.. ..+..+|||+|||++|+|+.|.+||.+ .++-.++++|..- .
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l--~ 303 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQAL--D 303 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHh--c
Confidence 1 11 46899999999999875 478899999999999999999999987 5777778877763 3
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCCccc
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~~~~ 282 (620)
-.++...++.+++||+++|+ +|++|+|+.+|..||||...+|..+.
T Consensus 304 y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw 350 (604)
T KOG0592|consen 304 YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW 350 (604)
T ss_pred ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence 34666778999999999998 99999999999999999999988753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=400.74 Aligned_cols=257 Identities=33% Similarity=0.546 Sum_probs=217.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.+..++.||+|+||+||++.++.+|...|+|.+...+ ... .+.+.+|+.+|.+|+|||||++++.........+++
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 3567899999999999999999999999999998652 222 677999999999999999999999632222247999
Q ss_pred EEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC-
Q 007055 95 ITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~- 172 (620)
.|||+++|+|.+++++.+ ++++..++.+.+||+.||.|||++| +|||||||+|||++..+|.+||+|||++.....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999999999988 7999999999999999999999999 999999999999983379999999999976652
Q ss_pred ----CCCccccCCCCCCCccccccccC--ccchhhhhHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCCCCCCCCcH
Q 007055 173 ----PTARSVIGTPEFMAPELYEEEYN--ELVDIYSFGMCILEMVTCEYPYNEC-KNPAQIYKKVTSGIKPASLSKVTDP 245 (620)
Q Consensus 173 ----~~~~~~~GTp~y~APEll~~~y~--~~~DIwSlGiilyELltG~~Pf~~~-~~~~~i~~~i~~~~~p~~~~~~~~~ 245 (620)
.......|||.|||||++...+. .++|||||||++.||+||..||.+. .....++........| .++...++
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~ 250 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSD 250 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCH
Confidence 22446789999999999884433 4999999999999999999999873 3334444444444334 67778899
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
++++||.+|++ +|.+||||.+||.|||++....
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999998 9999999999999999987544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=403.64 Aligned_cols=267 Identities=23% Similarity=0.405 Sum_probs=233.0
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
.+.-+.|.+..+||+||||.||+|.-+.||..+|+|++++.... ...+.+.++.|..+|...++|+||++|.+|.+.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~-- 213 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK-- 213 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC--
Confidence 34556788999999999999999999999999999999877653 456788899999999999999999999999766
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
.++|+||||++||++..++.+.+.|++..++.|+.+++.|++.||++| +|||||||+|+||| ..|++||.||||+.-
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTG 290 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccch
Confidence 479999999999999999999999999999999999999999999999 99999999999998 899999999999731
Q ss_pred ccC-------------------------CC------------------------CccccCCCCCCCcccccc-ccCccch
Q 007055 170 MQQ-------------------------PT------------------------ARSVIGTPEFMAPELYEE-EYNELVD 199 (620)
Q Consensus 170 ~~~-------------------------~~------------------------~~~~~GTp~y~APEll~~-~y~~~~D 199 (620)
+.. .. +.+.+|||.|||||++.+ +|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 100 00 114689999999998764 5999999
Q ss_pred hhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCcC
Q 007055 200 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLV 274 (620)
Q Consensus 200 IwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~~~~lk~~I~kcL~~p~~Rps---a~elL~hpff~ 274 (620)
+||||||+||||.|.+||.. .++.+.+++|........++ ...++++++||.+||.+|..|.. +.|+-.||||+
T Consensus 371 wWSLG~ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~ 449 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFK 449 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccc
Confidence 99999999999999999987 78999999988765332222 23468999999999999999985 88999999999
Q ss_pred CCCCCcccc
Q 007055 275 TDNPKDLVC 283 (620)
Q Consensus 275 ~~~~~~~~~ 283 (620)
..+|..+..
T Consensus 450 ~v~W~~l~~ 458 (550)
T KOG0605|consen 450 GVDWDHLRE 458 (550)
T ss_pred cCCcchhhc
Confidence 999988754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=411.29 Aligned_cols=255 Identities=31% Similarity=0.542 Sum_probs=226.1
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
.+|.-.++||+|+.|.||.|....+++.||||++.+... ...+-+.+|+.+|+.++|+|||+|+++|...+ .+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d--eLW 346 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVGD--ELW 346 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcccc--eeE
Confidence 467888999999999999999999999999999987643 23456899999999999999999999987764 589
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC-
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~- 172 (620)
+||||++||+|.+.+.... ++|.++..++++++.||+|||.++ |+|||||.+|||+. .+|.+||+|||++..+..
T Consensus 347 VVMEym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEeecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeeeeccccc
Confidence 9999999999999887655 999999999999999999999999 99999999999997 899999999999976543
Q ss_pred -CCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 173 -PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 173 -~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
....+.+|||.|||||++. ..|++++||||||++++||+-|++||........+|.....|......+...++.+++|
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 3566789999999999886 56999999999999999999999999874555566666677766667777889999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 251 IEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
+.+||+ ++.+|++|.|||.||||+...+
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKMAKP 531 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence 999998 9999999999999999976544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=382.45 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=212.9
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|....++|+|+||+||+++++.||+.||||++.-+ ..++.-.+...+||++|++|+|||+|.+.++| ...+.+++
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrklhL 78 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKLHL 78 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHH--HhcceeEE
Confidence 356678899999999999999999999999988533 23455567788999999999999999999987 45567999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
|+|||+..-|.++-....+++...++.+++|++.|+.|||+++ +|||||||+|||++ .+|.+||||||+|+.+..+
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcCCc
Confidence 9999988556555444457999999999999999999999999 99999999999998 8999999999999887643
Q ss_pred -CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc------------------
Q 007055 174 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------------ 232 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~------------------ 232 (620)
.-+.++-|.+|+|||++-+ +|+.++|||++||++.||++|++.|.+..+.+++|.....
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 3456788999999998765 6999999999999999999999999999999998865542
Q ss_pred -CCC-C-----CCCC---CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 233 -GIK-P-----ASLS---KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 233 -~~~-p-----~~~~---~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
|.. | +++. ...+..+.+|+.+||. ||.+|++.+++|.||||.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 111 1 1111 1134578899999998 999999999999999994
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=408.48 Aligned_cols=257 Identities=24% Similarity=0.457 Sum_probs=229.2
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
..|-| ++++.||.|+.|.|.+|+|..||+.+|||+|.+.. ..+......+.+||-+|+.+.||||+++|++|.. +.
T Consensus 10 tiGpw-kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~ 85 (786)
T KOG0588|consen 10 TIGPW-KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQ 85 (786)
T ss_pred cccce-eccccccCCCCceehhhhcccccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCCeeeeeeeecc--Cc
Confidence 34445 89999999999999999999999999999998653 2334455678899999999999999999999854 46
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
.+|+|.||++||.|++|+-++|++++.++.++++||+.|+.|||..+ |+||||||+|+|++ ..+.|||+|||.|...
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd-~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLD-VKNNIKIADFGMASLE 162 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhh-cccCEeeeccceeecc
Confidence 79999999999999999999999999999999999999999999999 99999999999998 5667999999999654
Q ss_pred -cCCCCccccCCCCCCCccccccc-c-CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 171 -QQPTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 171 -~~~~~~~~~GTp~y~APEll~~~-y-~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
...-..+.||+|+|.|||++.+. | +.++||||.|||||.|+||..||.+ .|...++.+|..|... ++...++++
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~ea 239 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISSEA 239 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCHHH
Confidence 34456788999999999998865 5 5799999999999999999999986 7899999999998664 457789999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
++||.+||. ||++|.|.+|+++|||+....
T Consensus 240 QdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 240 QDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 999999996 999999999999999998654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=393.24 Aligned_cols=255 Identities=26% Similarity=0.347 Sum_probs=214.8
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|+..++||+|+||.||+|++..||+.||+|+|.+... .+.......+||.+|++|+||||+++.+..++.....+||
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45677899999999999999999999999999987653 2233455779999999999999999999988776678999
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
|+|||+. +|.-++... -+|++.+++.+++||+.||+|||++| |+|||||+.||||| ++|.+||+|||+|+.+...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccCC
Confidence 9999987 777777663 47999999999999999999999999 99999999999998 8999999999999876544
Q ss_pred C---CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCC-------
Q 007055 174 T---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASL------- 239 (620)
Q Consensus 174 ~---~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~------- 239 (620)
. .+..+.|.+|.|||++-+ .|+.++|+||.||||.||++|++.|.+....+|+.....-.-.| ..|
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 3 455678999999998764 59999999999999999999999999877767765444321000 000
Q ss_pred -----------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 240 -----------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 240 -----------------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
.+..++...+|+..+|. +|.+|.||.++|+|+||..
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 12346788899999998 9999999999999999943
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=376.78 Aligned_cols=256 Identities=28% Similarity=0.438 Sum_probs=221.1
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.++.+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 78 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RFLYM 78 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--CeEEE
Confidence 468999999999999999999999999999998754321 223456788999999999999999999987544 57999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
||||+++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC-
Confidence 9999999999999999889999999999999999999999999 99999999999998 7899999999998765432
Q ss_pred CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 175 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .+...++..+..+.. .++...++.++++|.+
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~ 231 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIKK 231 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHHH
Confidence 334679999999998764 589999999999999999999999976 556677777766532 3455668899999999
Q ss_pred hcC-CCCCCCC-----HHHHhcCCCcCCCCCCc
Q 007055 254 CIV-PASLRLP-----ALELLKDPFLVTDNPKD 280 (620)
Q Consensus 254 cL~-~p~~Rps-----a~elL~hpff~~~~~~~ 280 (620)
||+ +|.+|++ +.+++.||||....+..
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 264 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD 264 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence 998 8999995 99999999998766544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=381.74 Aligned_cols=261 Identities=24% Similarity=0.413 Sum_probs=225.2
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.-..|++.+.||+|+||.||+|.++.+|+.||+|.++..... .....+.+.+|+.+|+.++||||++++++|.++ ..
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 92 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NR 92 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CE
Confidence 345679999999999999999999999999999998754322 223456788999999999999999999998654 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcC
Confidence 9999999999999999999889999999999999999999999999 99999999999998 78999999999987554
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 172 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .++..++..+..+.. .++...++.+++|
T Consensus 170 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 245 (329)
T PTZ00263 170 DR-TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDL 245 (329)
T ss_pred CC-cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCc--CCCCCCCHHHHHH
Confidence 32 234679999999998764 488999999999999999999999976 566777777776643 3455678899999
Q ss_pred HHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCccc
Q 007055 251 IEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 251 I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~ 282 (620)
|.+||+ +|.+|++ +.+++.||||...++..+.
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 999998 8999997 7999999999987665543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=400.10 Aligned_cols=268 Identities=24% Similarity=0.429 Sum_probs=234.7
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l 92 (620)
..+++.++||+|.||+|++|..+.+++.+|||.+++..+.+ .++.+.++.|.+++... +||.++.+|.+|+.. .++
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~--~~l 444 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTK--EHL 444 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccC--CeE
Confidence 46889999999999999999999999999999999887765 46778899999998888 599999999999654 579
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc--
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-- 170 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~-- 170 (620)
|+||||+.||++.. +...+.|++..++.|+..|+.||.|||++| |||||||.+|||+| ..|++||+|||+++..
T Consensus 445 ~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEecccccccccCC
Confidence 99999999999543 344577999999999999999999999999 99999999999998 8999999999999653
Q ss_pred cCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 171 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 171 ~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
......+++|||.|||||++.+ .|+.++|+|||||+||||++|+.||.+ .++++++..|... ...++...+.++.+
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d--~~~yP~~ls~ea~~ 597 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVND--EVRYPRFLSKEAIA 597 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC--CCCCCCcccHHHHH
Confidence 3445678999999999998875 699999999999999999999999987 6788888888763 34466778899999
Q ss_pred HHHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCccccCCCCCCCC
Q 007055 250 FIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPNL 291 (620)
Q Consensus 250 ~I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p~~ 291 (620)
+++++|. +|.+|+. +.++..||||+..+|..+....++.|..
T Consensus 598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~ 645 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFV 645 (694)
T ss_pred HHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCC
Confidence 9999997 8999996 4789999999999999887766655443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=395.15 Aligned_cols=253 Identities=30% Similarity=0.538 Sum_probs=223.0
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
-|+..+.||+|+||.||+|.|..+++.||+|++..+. .+...+.+.+|+.+|.++++|||.++|++|+... .+++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~g~--~Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT--KLWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheeecc--cHHH
Confidence 3566699999999999999999999999999998764 4567788999999999999999999999998875 4889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
+||||.||++.+.++..+.+++..+.-++++++.||.|||.++ .+|||||+.|||+. .+|.||++|||++..+...
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s-~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLS-ESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEe-ccCcEEEEecceeeeeechh
Confidence 9999999999999999888899999999999999999999999 99999999999998 6799999999999766543
Q ss_pred -CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 174 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
...+++|||.|||||++.+ +|+.++||||||+++|||++|++|+.++.....+ ..|.+ ..|+.+....++.+++||
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-flIpk-~~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-FLIPK-SAPPRLDGDFSPPFKEFV 243 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-EeccC-CCCCccccccCHHHHHHH
Confidence 3468899999999998875 7999999999999999999999999886542221 22222 345667778899999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 252 EKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
..||. +|..||+|.+||+|+|++...
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 99998 899999999999999998844
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=394.54 Aligned_cols=250 Identities=30% Similarity=0.504 Sum_probs=222.4
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|.+.+.||+|+||.||+|+.+.|++.||+|.+.+.. ..+.+...+.+|+++++.|+|||||.++++| ++...+|+
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~v 78 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWV 78 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEE
Confidence 3567789999999999999999999999999987543 4677889999999999999999999999988 44567999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
|+|||.| +|+.++...+.++|+.++.++.|++.||.|||+++ |+|||+||.|||+. .+|.+|+||||+|+.+...+
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccCc
Confidence 9999987 99999999999999999999999999999999999 99999999999997 78999999999998765543
Q ss_pred --CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 175 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 175 --~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
.++.-|||.|||||++++ .|+..+|.||+||++|||.+|++||.. ....++.+.|... |..++...+..+++|+
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl 231 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVNFL 231 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHHHH
Confidence 456789999999999875 599999999999999999999999975 4556666777654 4445557889999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 252 EKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
..+|. ||..|.+..+|+.|||.+.
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhh
Confidence 99997 8999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=379.60 Aligned_cols=255 Identities=24% Similarity=0.437 Sum_probs=218.1
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEecc
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 99 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~ 99 (620)
++||+|+||.||+|.+..+|+.||+|+++.... ........+.+|+.+++.++||||++++++|... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEeCC
Confidence 479999999999999999999999999875432 2234556788999999999999999999988654 4799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCCCcc
Q 007055 100 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARS 177 (620)
Q Consensus 100 ~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~~~~ 177 (620)
.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++.... ......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccc
Confidence 99999999999889999999999999999999999999 99999999999998 78999999999986432 223345
Q ss_pred ccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 007055 178 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256 (620)
Q Consensus 178 ~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~ 256 (620)
.+||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+...+...+..+. ..++...++.+++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 679999999998864 589999999999999999999999976 45566666665442 23456678999999999998
Q ss_pred -CCCCCC-----CHHHHhcCCCcCCCCCCcccc
Q 007055 257 -PASLRL-----PALELLKDPFLVTDNPKDLVC 283 (620)
Q Consensus 257 -~p~~Rp-----sa~elL~hpff~~~~~~~~~~ 283 (620)
+|.+|| ++.++++||||...++.....
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~ 264 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQ 264 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence 899999 899999999999877665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=383.52 Aligned_cols=262 Identities=23% Similarity=0.384 Sum_probs=218.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.+..+|+.||+|+++..... .......+.+|+.++..++||||+++++.|.+. ..+|+
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~l 78 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYL 78 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEE
Confidence 468899999999999999999999999999999754322 234456788999999999999999999988654 46999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCcccccccc
Confidence 9999999999999999899999999999999999999999999 99999999999998 7899999999998643211
Q ss_pred ------------------------------------CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCC
Q 007055 174 ------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYP 216 (620)
Q Consensus 174 ------------------------------------~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~P 216 (620)
.....+||+.|+|||++. ..|+.++|||||||++|||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 012457999999999876 4589999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHHHHhcCC---CCCCCCHHHHhcCCCcCCCCCCcccc
Q 007055 217 YNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKDLVC 283 (620)
Q Consensus 217 f~~~~~~~~i~~~i~~~~~p~~~~~--~~~~~lk~~I~kcL~~---p~~Rpsa~elL~hpff~~~~~~~~~~ 283 (620)
|.+ .++...+..+........++. ..+++++++|.+++.+ +..||++.|+++||||+..++..+..
T Consensus 236 f~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~ 306 (363)
T cd05628 236 FCS-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRE 306 (363)
T ss_pred CCC-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHh
Confidence 976 456677777765432222222 3578999999997654 34678999999999999887766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=358.65 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=212.1
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|...++||+|+||.||+|.|..||+.||||+|+..+... .......+||++|+.++||||+.+.++|...+ .+.+
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~--~l~l 78 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVFPHKS--NLSL 78 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhccCCC--ceEE
Confidence 4567889999999999999999999999999999775432 22345889999999999999999999996554 5889
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
|+||++. +|...++.. ..++...++.|+.++++||+|||++. |+||||||.|+|++ .+|.+||+|||+|+.+..+
T Consensus 79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFGSP 154 (318)
T ss_pred EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccCCC
Confidence 9999975 888888754 56999999999999999999999999 99999999999998 8999999999999987765
Q ss_pred CCc--cccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCC--------
Q 007055 174 TAR--SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASL-------- 239 (620)
Q Consensus 174 ~~~--~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~--~~~p~~~-------- 239 (620)
... ..+-|.+|.|||++-| .|+..+||||.||++.||+-|.+-|.+..+.+|+...+.. ...+..|
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 432 2377999999997754 5999999999999999999999888887777776554432 1111111
Q ss_pred ---------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 240 ---------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 240 ---------------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
-...+..+.+|+.++|. +|.+|+++.|+|+||||++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 12235677999999998 9999999999999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=389.45 Aligned_cols=258 Identities=27% Similarity=0.373 Sum_probs=216.6
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l 92 (620)
.+|.+.++||.|+||.||+|..+.+|..||||+++.+-. +-++ -.-.+|++.|++|+ |||||++++++.+... .+
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~--s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~-~L 85 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY--SWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-IL 85 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc--cHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eE
Confidence 345789999999999999999999999999999875432 1122 22458999999998 9999999999877664 89
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 93 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
|+|||||+. +|.++++.. +.|++..++.|+.||++||+|+|.+| +.||||||+|||+.+ +..|||+|||+|+...
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~-~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISG-NDVIKIADFGLAREVR 161 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecc-cceeEecccccccccc
Confidence 999999975 899988754 56999999999999999999999999 999999999999984 5699999999998876
Q ss_pred CC-CCccccCCCCCCCcccc-c-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------
Q 007055 172 QP-TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------------- 235 (620)
Q Consensus 172 ~~-~~~~~~GTp~y~APEll-~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------------- 235 (620)
.. ..+.++.|.+|+|||++ + +-|+.++|||++||+++|+.+.++.|.+....+++++...---.
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 55 45667899999999965 3 45999999999999999999999999998888898876532100
Q ss_pred -----------CCC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 236 -----------PAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 236 -----------p~~---~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
+.. +-...++++.++|.+||. ||.+||||.++|+||||+.....
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 111 112257899999999999 99999999999999999875443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=383.04 Aligned_cols=255 Identities=35% Similarity=0.543 Sum_probs=214.6
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeE-EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~-VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
..|.+....+.+.+.||+|+||+||+|... |.. ||+|++...... ....+.|.+|+.+|.+|+|||||+|++++.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~--~~~~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFD--DESRKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 345555666677888999999999999775 555 999999865432 223778999999999999999999999876
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC-cEEEc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIG 162 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G-~vKI~ 162 (620)
.... .+.+||||+++|+|.+++.+ .+.++...+..|+.||+.|++|||++++ ||||||||+|||++ .++ ++||+
T Consensus 110 ~~~~-~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~-~~~~~~KI~ 186 (362)
T KOG0192|consen 110 SPPG-SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVD-LKGKTLKIA 186 (362)
T ss_pred CCCC-ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEc-CCCCEEEEC
Confidence 5532 68899999999999999987 6789999999999999999999999987 99999999999998 676 99999
Q ss_pred cccchhhccC--CCCccccCCCCCCCccccccc---cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 007055 163 DLGLAIVMQQ--PTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 237 (620)
Q Consensus 163 DFGla~~~~~--~~~~~~~GTp~y~APEll~~~---y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~ 237 (620)
|||+++.... .......||+.|||||++++. |+.++||||||+++|||+||+.||.+... .++...+..+...+
T Consensus 187 DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp 265 (362)
T KOG0192|consen 187 DFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRP 265 (362)
T ss_pred CCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCC
Confidence 9999976654 334447899999999999854 99999999999999999999999998766 55544444333444
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 238 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 238 ~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.++...++.+..+++.||. +|..||+..+++.
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 4555688999999999997 9999999998764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=366.20 Aligned_cols=258 Identities=26% Similarity=0.469 Sum_probs=226.8
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
.+...|.+.++||+|+|+.||++.+..||+.+|+|+|+.....+. ..+.+.+|+++-+.|+|||||++++... ...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~--~~~ 83 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQ--EES 83 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhc--ccc
Confidence 455667889999999999999999999999999999988776543 6678999999999999999999999764 346
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC--CCcEEEccccchh
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAI 168 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~G~vKI~DFGla~ 168 (620)
..|+|+|+++||+|..-|-+.-.++|..+..+++|||.+|.|||.++ |||||+||.|+++-.+ ..-+||+|||+|.
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEE
Confidence 89999999999999887766677899999999999999999999999 9999999999999532 3468999999998
Q ss_pred hccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCc
Q 007055 169 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD 244 (620)
Q Consensus 169 ~~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~~ 244 (620)
..+.. .....+|||.|||||+++. .|+.++|||+.|++||-|+.|.+||.+ .+...+|+.|..+.. |.+.....+
T Consensus 162 ~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 162 EVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred EeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCC
Confidence 77643 3556799999999999874 699999999999999999999999987 578889999998754 444556678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
++++++|++||. +|++|.|+.|+|+|||+..
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 999999999997 9999999999999999976
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=378.22 Aligned_cols=265 Identities=24% Similarity=0.416 Sum_probs=224.9
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg-~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
.-..|++.+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+.+|+.+++.++||||++++++|.+. .
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~ 104 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--S 104 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--C
Confidence 3446789999999999999999877665 78999998754332 234556788999999999999999999998654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
.+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeec
Confidence 79999999999999999999899999999999999999999999999 99999999999998 7899999999998755
Q ss_pred cCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 171 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 171 ~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..||.. .++..+++.+..+.. .++...++.+++
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 257 (340)
T PTZ00426 182 DT-RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKH 257 (340)
T ss_pred CC-CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 43 2345689999999998764 589999999999999999999999986 566677777776543 345567889999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCccccCCC
Q 007055 250 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 286 (620)
Q Consensus 250 ~I~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~ 286 (620)
+|.+||+ +|.+|+ ++.++++||||...++.......+
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~ 300 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNV 300 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 9999998 899995 899999999999877665444333
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=379.52 Aligned_cols=259 Identities=23% Similarity=0.432 Sum_probs=218.0
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+|+.+|+.++||||++++++|.+. ..+++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~l 78 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDE--NYLYL 78 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CeEEE
Confidence 478999999999999999999999999999999754322 234456688999999999999999999988654 47999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||+.+|+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceeccccc
Confidence 9999999999999998889999999999999999999999999 99999999999998 7899999999998543211
Q ss_pred ---------------------------------------CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhc
Q 007055 174 ---------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC 213 (620)
Q Consensus 174 ---------------------------------------~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG 213 (620)
...+.+||+.|+|||++. ..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 011347999999999875 4589999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCcCCCCCCc
Q 007055 214 EYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKD 280 (620)
Q Consensus 214 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~~~~lk~~I~kcL~~p~~Rps---a~elL~hpff~~~~~~~ 280 (620)
..||.. .+....+..+........++ ...++.+++||.+||.+|.+|++ +.++|.||||....+..
T Consensus 236 ~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~ 306 (364)
T cd05599 236 YPPFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEH 306 (364)
T ss_pred CCCCCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 999976 45556666665543322222 23578999999999999999998 99999999998766543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=374.52 Aligned_cols=258 Identities=21% Similarity=0.354 Sum_probs=218.4
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.+..+|+.||+|+++.... ........+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~l 78 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD--EYLYL 78 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--CEEEE
Confidence 46899999999999999999999999999999975432 2234456788999999999999999999988654 57999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~-~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT-Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc-c
Confidence 9999999999999998889999999999999999999999999 99999999999998 789999999999865443 3
Q ss_pred CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CC---CCCCcHHH
Q 007055 175 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SL---SKVTDPQV 247 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~---~~---~~~~~~~l 247 (620)
....+||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+..+.+..+....... .. ....++++
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEA 233 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence 455689999999998764 589999999999999999999999976 45666655555432211 11 12347899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCCc
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 280 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~~ 280 (620)
++||.+||. +|.+||++.++++||||....+..
T Consensus 234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~ 267 (333)
T cd05600 234 WDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNE 267 (333)
T ss_pred HHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence 999999998 788999999999999999765543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=370.55 Aligned_cols=257 Identities=29% Similarity=0.435 Sum_probs=217.2
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc---CCCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD---DTNR 90 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~---~~~~ 90 (620)
++|...+.||+|+||.|..|.++.+|+.||||++.. ...+.-..++..+|+.+|+.++|+||+.+++.+.. +.-.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~--~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN--PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhh--hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 344458999999999999999999999999998862 23456778999999999999999999999998865 2335
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
-+|+|+|+| +.+|.+.++.++.++...++.++.|||.||.|+|+.+ |+||||||.|+|++ .+..+||+|||+|+..
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n-~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLN-ADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeec-cCCCEEeccccceeec
Confidence 799999999 4589999999888999999999999999999999999 99999999999999 7889999999999877
Q ss_pred c----CCCCccccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc------------
Q 007055 171 Q----QPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------ 232 (620)
Q Consensus 171 ~----~~~~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~------------ 232 (620)
. ....+.++-|.+|.|||++. .+|+.++||||.|||+.||++|++.|.+.....|+...+..
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 4 34456778899999999764 56999999999999999999999999886655554322211
Q ss_pred ------------CCCC-CC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 233 ------------GIKP-AS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 233 ------------~~~p-~~---~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
...| .+ .-+..++.+.+|+++||+ +|.+|+|++|+|.||||..-
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 0111 11 123568999999999999 99999999999999999763
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=371.06 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=214.4
Q ss_pred EceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCC
Q 007055 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 101 (620)
Q Consensus 22 LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~g 101 (620)
||+|+||+||+|.+..+|+.||+|.++.... ........+.+|+.+|++++||||++++++|... ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence 7999999999999999999999999875432 2334566788999999999999999999988654 578999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC--CCCcccc
Q 007055 102 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVI 179 (620)
Q Consensus 102 GsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~--~~~~~~~ 179 (620)
|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ......+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCcccccc
Confidence 999999998889999999999999999999999999 99999999999998 789999999999864322 2234567
Q ss_pred CCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-C
Q 007055 180 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 257 (620)
Q Consensus 180 GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~ 257 (620)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...++..+..+ +..++...++.+++||.+||. +
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCC
Confidence 9999999998764 589999999999999999999999976 4566666666654 334556678999999999998 8
Q ss_pred CCCCC---CHHHHhcCCCcCCCCCCc
Q 007055 258 ASLRL---PALELLKDPFLVTDNPKD 280 (620)
Q Consensus 258 p~~Rp---sa~elL~hpff~~~~~~~ 280 (620)
|.+|| ++.++|.||||...+...
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~~~~ 257 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLSWKK 257 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCCHHH
Confidence 99997 589999999999865544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=380.21 Aligned_cols=259 Identities=23% Similarity=0.382 Sum_probs=215.1
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.++.+|+.||+|.+...... .....+.+.+|+++++.++||||++++++|.+. ..+|+
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~l 78 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QYLYL 78 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CeeEE
Confidence 468899999999999999999999999999998754321 234567788999999999999999999998654 46999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||+++|+|.+++...+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeeccccccccccc
Confidence 9999999999999998889999999999999999999999999 99999999999998 7899999999998532110
Q ss_pred ------------------------------------------------CCccccCCCCCCCccccc-cccCccchhhhhH
Q 007055 174 ------------------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFG 204 (620)
Q Consensus 174 ------------------------------------------------~~~~~~GTp~y~APEll~-~~y~~~~DIwSlG 204 (620)
.....+||+.|+|||++. ..|+.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 001357999999999876 4599999999999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHHHHhcCCCCC---CCCHHHHhcCCCcCCCCCC
Q 007055 205 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 205 iilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~~~~lk~~I~kcL~~p~~---Rpsa~elL~hpff~~~~~~ 279 (620)
|++|||+||..||.. .+....+..+........++. ..++++++||.+||.+|.+ |+++.+++.||||...++.
T Consensus 236 vil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~ 314 (377)
T cd05629 236 AIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWD 314 (377)
T ss_pred hhhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 999999999999976 455556666654333222222 4678999999999986555 5699999999999876543
Q ss_pred c
Q 007055 280 D 280 (620)
Q Consensus 280 ~ 280 (620)
.
T Consensus 315 ~ 315 (377)
T cd05629 315 T 315 (377)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=363.75 Aligned_cols=261 Identities=22% Similarity=0.362 Sum_probs=215.8
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|+||+||+|.+..+|+.||+|.+....... ......+.+|+.+++.++|+||++++++|.+. ..+++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEE
Confidence 678999999999999999999999999999987554322 23345678899999999999999999988654 468999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 96 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCC
Confidence 9999999999887643 46899999999999999999999999 99999999999998 7889999999998654322
Q ss_pred -CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 174 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~---~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
......||+.|+|||++. ..|+.++|||||||++|+|++|+.||...... ..+...+.. .+..++...++.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~ 233 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAK 233 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHH
Confidence 234567999999999886 45899999999999999999999999764332 222333322 22334556788999
Q ss_pred HHHHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCccccC
Q 007055 249 QFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCD 284 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~ 284 (620)
+||.+||+ +|.+||+ +.++++||||...+++.+...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN 275 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence 99999998 8999997 899999999998877665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=378.32 Aligned_cols=262 Identities=23% Similarity=0.413 Sum_probs=219.4
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.++.+|+.||+|+++..... .......+.+|+.++..++||||++++++|.+. ..+++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~l 78 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLYL 78 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEE
Confidence 468899999999999999999999999999999754322 234556788999999999999999999988654 57999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||+++|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCccccccc
Confidence 9999999999999998889999999999999999999999999 99999999999998 7899999999997533211
Q ss_pred ------------------------------------CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCC
Q 007055 174 ------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYP 216 (620)
Q Consensus 174 ------------------------------------~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~P 216 (620)
.....+||+.|+|||++. ..|+.++|||||||++|||+||+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 012457999999999876 4599999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHHHHhcCCCCCCC---CHHHHhcCCCcCCCCCCcccc
Q 007055 217 YNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKDLVC 283 (620)
Q Consensus 217 f~~~~~~~~i~~~i~~~~~p~~~~~--~~~~~lk~~I~kcL~~p~~Rp---sa~elL~hpff~~~~~~~~~~ 283 (620)
|.+ .++...+..+........++. ..++.++++|.+++.+|.+|+ ++.+++.||||...++..+..
T Consensus 236 f~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~ 306 (360)
T cd05627 236 FCS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRE 306 (360)
T ss_pred CCC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhc
Confidence 976 456666666665332222222 257899999999888888888 489999999999987766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=374.79 Aligned_cols=259 Identities=23% Similarity=0.408 Sum_probs=219.1
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.+..+|+.||+|+++..... .......+.+|+.++..++||||++++++|.+. ..+++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDE--EHLYL 78 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecC--CeEEE
Confidence 468999999999999999999999999999999755432 224456788999999999999999999988654 46999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCcccC
Confidence 9999999999999998888999999999999999999999999 99999999999998 78999999999986543322
Q ss_pred -------------------------------CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCC
Q 007055 175 -------------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN 222 (620)
Q Consensus 175 -------------------------------~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~ 222 (620)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||... +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD-T 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC-C
Confidence 234579999999998764 5899999999999999999999999874 4
Q ss_pred HHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCCCCCC-HHHHhcCCCcCCCCCCc
Q 007055 223 PAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDNPKD 280 (620)
Q Consensus 223 ~~~i~~~i~~~~~p~~~~--~~~~~~lk~~I~kcL~~p~~Rps-a~elL~hpff~~~~~~~ 280 (620)
....+..+........++ ...++.+++||.+||.+|.+|++ +.++|+||||....+..
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~~ 295 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWEN 295 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHHH
Confidence 555566665522222222 23589999999999999999999 99999999998765443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=377.82 Aligned_cols=259 Identities=22% Similarity=0.363 Sum_probs=213.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+|+.+++.++||||++++++|.+. ..+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEE
Confidence 468899999999999999999999999999999765432 234567789999999999999999999998654 46999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCccccccc
Confidence 9999999999999999889999999999999999999999999 99999999999998 7899999999987432100
Q ss_pred ------------------------------------------------CCccccCCCCCCCccccc-cccCccchhhhhH
Q 007055 174 ------------------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFG 204 (620)
Q Consensus 174 ------------------------------------------------~~~~~~GTp~y~APEll~-~~y~~~~DIwSlG 204 (620)
...+.+||+.|+|||++. ..|+.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 012457999999999876 4589999999999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcHHHHHHHHHhcC---CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 205 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV---PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 205 iilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~~~~lk~~I~kcL~---~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
|++|||+||..||.... .......+........+ ....++++++||.+++. ++..|+++.+++.||||....+.
T Consensus 236 ~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 236 VILFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred hHHHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 99999999999997643 44444444332211112 22468899999999653 45569999999999999887654
Q ss_pred c
Q 007055 280 D 280 (620)
Q Consensus 280 ~ 280 (620)
.
T Consensus 315 ~ 315 (381)
T cd05626 315 S 315 (381)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=377.94 Aligned_cols=259 Identities=23% Similarity=0.351 Sum_probs=215.5
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|.+.++||+|+||+||+|.+..+++.||+|.+..... ........+.+|+.+++.++||||++++++|.+. ..+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEEE
Confidence 46889999999999999999999999999999875432 1234566788999999999999999999998754 47999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC--
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-- 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~-- 172 (620)
|||||++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCccccccc
Confidence 9999999999999998888999999999999999999999999 99999999999998 789999999999742210
Q ss_pred -----------------------------------------------CCCccccCCCCCCCccccc-cccCccchhhhhH
Q 007055 173 -----------------------------------------------PTARSVIGTPEFMAPELYE-EEYNELVDIYSFG 204 (620)
Q Consensus 173 -----------------------------------------------~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlG 204 (620)
....+.+||+.|+|||++. ..|+.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0012357999999999875 4699999999999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCcCCCCCC
Q 007055 205 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPK 279 (620)
Q Consensus 205 iilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~~~~lk~~I~kcL~~p~~Rps---a~elL~hpff~~~~~~ 279 (620)
|++|||++|+.||... ++......+........ .....+++++++|.+++.+|.+|++ +.++++||||+...+.
T Consensus 236 vil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 236 VILYEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHHHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 9999999999999864 44444444443322222 2234688999999998889999987 9999999999876554
Q ss_pred c
Q 007055 280 D 280 (620)
Q Consensus 280 ~ 280 (620)
.
T Consensus 315 ~ 315 (382)
T cd05625 315 S 315 (382)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=377.78 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=214.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+|+.+|+.++||||+++++.|.+. ..+++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~l 78 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYF 78 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEEE
Confidence 478999999999999999999999999999998654321 123456688999999999999999999988654 57999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC--
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-- 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~-- 172 (620)
||||+++|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..+..
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCccccccc
Confidence 9999999999999999888999999999999999999999999 99999999999998 789999999999742210
Q ss_pred -------------------------------------------CCCccccCCCCCCCcccccc-ccCccchhhhhHHHHH
Q 007055 173 -------------------------------------------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCIL 208 (620)
Q Consensus 173 -------------------------------------------~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiily 208 (620)
......+||+.|+|||++.+ .++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00123579999999998764 5899999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCcHHHHHHHHHhcCCCCCCC---CHHHHhcCCCcCCCCCCc
Q 007055 209 EMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKD 280 (620)
Q Consensus 209 ELltG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~~~~lk~~I~kcL~~p~~Rp---sa~elL~hpff~~~~~~~ 280 (620)
+|++|+.||.+. ++......+....... ......++.++++|.+|+.+|.+|+ ++.++++||||.......
T Consensus 236 ell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~ 311 (376)
T cd05598 236 EMLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFAS 311 (376)
T ss_pred ehhhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHH
Confidence 999999999874 4444444444322211 1223467899999999888999999 999999999998765443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=369.82 Aligned_cols=254 Identities=23% Similarity=0.441 Sum_probs=215.6
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEecc
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 99 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~ 99 (620)
+.||+|+||.||+|.+..+|..||+|.++.... ........+.+|+.+++.++||||++++++|... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCC
Confidence 479999999999999999999999999875432 2234556788899999999999999999988654 4799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC--CCCcc
Q 007055 100 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARS 177 (620)
Q Consensus 100 ~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~--~~~~~ 177 (620)
++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCcccc
Confidence 99999999998889999999999999999999999999 99999999999998 789999999999864322 22345
Q ss_pred ccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 007055 178 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256 (620)
Q Consensus 178 ~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~ 256 (620)
..||+.|+|||++. +.++.++|||||||++|+|++|+.||.. .+.......+.... ..++...++.++++|.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 67999999999876 4589999999999999999999999976 44555555554432 23455678999999999998
Q ss_pred -CCCCCC-----CHHHHhcCCCcCCCCCCccc
Q 007055 257 -PASLRL-----PALELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 257 -~p~~Rp-----sa~elL~hpff~~~~~~~~~ 282 (620)
+|.+|+ ++.++++||||....+....
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 263 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 263 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 899998 89999999999987665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=367.31 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=215.6
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
...|++.+.||+|+||.||+|.+..+|..||+|.+.... .....+++.+|+++|+.++||||+++++++... ..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence 467899999999999999999999999999999987532 344567799999999999999999999998765 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
++||||+++|+|.+++...+.+++..+..++.|++.||.|||+. + |+||||||+|||++ .+|.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEc-CCCcEEEccCccccccc
Confidence 99999999999999999888899999999999999999999985 5 99999999999998 78999999999987665
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHH--------------------
Q 007055 172 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-------------------- 230 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i-------------------- 230 (620)
........||+.|+|||++.+ .++.++|||||||++|+|+||+.||... +...+...+
T Consensus 156 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCcccc
Confidence 555556789999999998764 5899999999999999999999999653 222222211
Q ss_pred --------------------------HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 231 --------------------------TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 231 --------------------------~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
.....+.......++++++||.+||+ +|.+|||+.++|+||||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 11111211223467899999999998 9999999999999999986443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=369.04 Aligned_cols=260 Identities=27% Similarity=0.395 Sum_probs=225.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.+++.+.||+|..|+||+|....++..+|+|++.+... ...+...++..|.++|+.++||.++.+|..|. ...+++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe--t~~~~c 153 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-ASRKKLKRAQTEREILSLLDHPFLPTLYASFE--TDKYSC 153 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH-hhhhHHHHHHHHHHHHHhcCCCccchhhheee--ccceeE
Confidence 456778899999999999999999999999999987654 33566788999999999999999999999884 456899
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 94 MITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
++||||+||+|..+++++ +.+++..++.|+..|+.||+|||..| ||+|||||+||||. ++|+|-|.||.++....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCC
Confidence 999999999999999876 46999999999999999999999999 99999999999997 89999999998862110
Q ss_pred ----------------------------------C-C-----------------------CCccccCCCCCCCcccccc-
Q 007055 172 ----------------------------------Q-P-----------------------TARSVIGTPEFMAPELYEE- 192 (620)
Q Consensus 172 ----------------------------------~-~-----------------------~~~~~~GTp~y~APEll~~- 192 (620)
. . ...+++||-+|+|||++.+
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0124689999999999986
Q ss_pred ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC----HHHH
Q 007055 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP----ALEL 267 (620)
Q Consensus 193 ~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rps----a~el 267 (620)
+.+.++|+|+|||++|||+.|..||.+..+.+.+.+.+.+...-+..+ ..+..+++||+++|+ +|.+|+. |.|+
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 599999999999999999999999999888888888777654432222 557899999999998 8999998 9999
Q ss_pred hcCCCcCCCCCCc
Q 007055 268 LKDPFLVTDNPKD 280 (620)
Q Consensus 268 L~hpff~~~~~~~ 280 (620)
-+||||+..+|.-
T Consensus 390 K~HpFF~gVnWaL 402 (459)
T KOG0610|consen 390 KRHPFFEGVNWAL 402 (459)
T ss_pred hcCccccCCChhh
Confidence 9999999999983
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=370.60 Aligned_cols=253 Identities=24% Similarity=0.447 Sum_probs=215.6
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEecc
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 99 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~ 99 (620)
++||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+++.++||||+++++++... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCC
Confidence 469999999999999999999999999975432 2334567788999999999999999999988654 4789999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC--CCCcc
Q 007055 100 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARS 177 (620)
Q Consensus 100 ~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~--~~~~~ 177 (620)
++|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCccccccc
Confidence 99999999998889999999999999999999999999 99999999999998 789999999999864322 22345
Q ss_pred ccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 007055 178 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256 (620)
Q Consensus 178 ~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~ 256 (620)
.+||+.|+|||++. ..++.++|||||||++|+|++|+.||.. .+...+...+..+ ...++...++.+++||.+||+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME--DIKFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccC--CccCCCCCCHHHHHHHHHHcC
Confidence 67999999999886 4589999999999999999999999976 3455555555443 223556678999999999998
Q ss_pred -CCCCCC-----CHHHHhcCCCcCCCCCCcc
Q 007055 257 -PASLRL-----PALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 257 -~p~~Rp-----sa~elL~hpff~~~~~~~~ 281 (620)
+|.+|+ ++.++++||||...++..+
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~ 262 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQDV 262 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 899997 8999999999988766544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=374.94 Aligned_cols=258 Identities=22% Similarity=0.423 Sum_probs=217.3
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH----------HHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP----------DQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~----------~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
.|++.+.||+|.||.|.+|++..+|+.||||++.+.+..... ...+++++||.+|++|.|||||+++++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 478899999999999999999999999999999866532211 1246899999999999999999999987
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
-+.....+|||+|||..|.+...-.....+++.+++.|++.++.||+|||.+| ||||||||+|+|++ .+|+|||+||
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~-~~g~VKIsDF 254 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLS-SDGTVKISDF 254 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEc-CCCcEEeecc
Confidence 77777899999999999998755443334999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCC-------CCccccCCCCCCCccccccc-----cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Q 007055 165 GLAIVMQQP-------TARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 232 (620)
Q Consensus 165 Gla~~~~~~-------~~~~~~GTp~y~APEll~~~-----y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~ 232 (620)
|.+...... .....+|||.|||||++.++ -+.+.||||+|++||.|+.|++||.+ .....++.+|..
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn 333 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVN 333 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhc
Confidence 998755222 12246899999999987652 35789999999999999999999987 566778888876
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 233 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 233 ~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.....+........++++|.++|. +|..|.+..++..|||....
T Consensus 334 ~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 533222223457899999999997 89999999999999999764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=382.51 Aligned_cols=256 Identities=30% Similarity=0.540 Sum_probs=228.4
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|.+.+++|+|+||.+++++++..+..+|||+|..... +....+...+|+.++++++|||||.++++|+.++ ..++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEE
Confidence 456789999999999999999999999999999998764 3445557899999999999999999999998654 4699
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 94 MITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+||+||+||+|.+.+++.+ .++++.+..|+.|++.||.|||++. |+||||||.|||++ .++.|||+|||+|+.++
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLT-KDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcc-ccCceeecchhhhhhcC
Confidence 9999999999999998764 5999999999999999999999888 99999999999998 67888999999999887
Q ss_pred CC--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 172 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 172 ~~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
.. .+.+++|||.||.||++.+ +|+.++||||||||+|||++-+.+|.. .+...+..++..+. -.+++..++.+++
T Consensus 158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~-~~Plp~~ys~el~ 235 (426)
T KOG0589|consen 158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL-YSPLPSMYSSELR 235 (426)
T ss_pred CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc-CCCCCccccHHHH
Confidence 76 5678999999999999986 599999999999999999999999987 67777777777765 3346777899999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 249 QFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+|..||. +|..||++.+||.+|.++...
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 99999998 899999999999999987543
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=368.35 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=213.9
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
+.||+|+||+||+|.+..+|+.||+|++....... ......+..|.. +++.++||||++++++|... ..+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcC
Confidence 47999999999999999999999999987554322 223344555554 56889999999999988654 478999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~~~ 176 (620)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccc
Confidence 999999999998889999999999999999999999999 99999999999998 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 177 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 177 ~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+. ..++...++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKP--LRLKPNISVSARHLLEGLL 231 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHh
Confidence 5679999999998764 589999999999999999999999976 45666777766543 2344456889999999999
Q ss_pred C-CCCCCCCH----HHHhcCCCcCCCCCCccccCCC
Q 007055 256 V-PASLRLPA----LELLKDPFLVTDNPKDLVCDPL 286 (620)
Q Consensus 256 ~-~p~~Rpsa----~elL~hpff~~~~~~~~~~~~~ 286 (620)
+ +|.+||++ .+++.||||....+..+....+
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~ 267 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKI 267 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccC
Confidence 8 89999997 6999999998877655544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=365.72 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=207.3
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC---Ce
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RT 91 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~---~~ 91 (620)
.|++.++||+|+||.||+|.+..+|..||+|.++... .......++.+|+.+++.++||||+++++++..... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 3789999999999999999999999999999986432 122344578899999999999999999998865432 35
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCccccccc
Confidence 899999995 689999998888999999999999999999999999 99999999999998 78999999999986442
Q ss_pred CC-----CCccccCCCCCCCccccc---cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHH--------------HH
Q 007055 172 QP-----TARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY--------------KK 229 (620)
Q Consensus 172 ~~-----~~~~~~GTp~y~APEll~---~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~--------------~~ 229 (620)
.. .....+||+.|+|||++. ..++.++|||||||++|+|+||+.||.+.....++. ..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 21 123457999999999875 358999999999999999999999997643222110 11
Q ss_pred HHc-----------CCCCCCC---CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 230 VTS-----------GIKPASL---SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 230 i~~-----------~~~p~~~---~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+.. ...+..+ ....++.+.++|.+||+ +|.+||++.|+|+||||+...
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 100 0011111 12356789999999998 999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=374.55 Aligned_cols=260 Identities=26% Similarity=0.443 Sum_probs=225.7
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDT 88 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~ 88 (620)
.....+|.+.+.||+|.||.||+|.++.||+.+|+|.+++..... ....+.+.+|+.+|+++. |||||.+++.|.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~- 108 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDP- 108 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-
Confidence 345567899999999999999999999999999999998766533 335677999999999998 99999999998655
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC---CCcEEEcccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGDLG 165 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~---~G~vKI~DFG 165 (620)
..+++|||+|.||.|++.+.+. .+++..+..+++||+.|+.|||+.| |+||||||+|+|+... ++.+|++|||
T Consensus 109 -~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 109 -DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred -CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 4799999999999999999877 5999999999999999999999999 9999999999999643 3589999999
Q ss_pred chhhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCC
Q 007055 166 LAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSK 241 (620)
Q Consensus 166 la~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~ 241 (620)
++...... .....+|||.|+|||++. ..|+..+||||+|+++|.|++|..||.+ .+.......+..+.. +.....
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~ 263 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWD 263 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCcc
Confidence 99776653 456789999999999988 6799999999999999999999999987 455556667776643 233344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
..+..+++||.++|. +|.+|+|+.++|+|||++..
T Consensus 264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 264 DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 558899999999998 99999999999999999875
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=361.98 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=205.6
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.++.+|+.||+|+++.... ......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeEE
Confidence 457899999999999999999999999999999875432 12234567899999999999999999988654 4789
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+||||+. ++|.+++..+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSV 155 (303)
T ss_pred EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceeccC
Confidence 9999996 5777776654 57999999999999999999999999 99999999999998 789999999999864332
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---C-----------
Q 007055 173 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---I----------- 234 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~---~----------- 234 (620)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..+.......+... .
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 2 2344678999999998753 48899999999999999999999998765544333322110 0
Q ss_pred ---CCCCCC-------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 235 ---KPASLS-------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 235 ---~p~~~~-------------~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
.+..+. ...++.+++||.+||+ +|.+|||+.|+|+||||+...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 000000 0124678999999998 8999999999999999987543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=367.62 Aligned_cols=253 Identities=23% Similarity=0.416 Sum_probs=214.8
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
++||+|+||+||+|.++.+|+.||+|.++..... .....+.+..|+.++..+ +||||++++++|... ..+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcC
Confidence 4799999999999999999999999998754321 223456677888888876 799999999988654 578999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~~~ 176 (620)
+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCccc
Confidence 999999999998889999999999999999999999999 99999999999998 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 177 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 177 ~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
...||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+.. .++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence 5679999999998864 589999999999999999999999976 566677777765432 344567889999999999
Q ss_pred C-CCCCCCCH------HHHhcCCCcCCCCCCcc
Q 007055 256 V-PASLRLPA------LELLKDPFLVTDNPKDL 281 (620)
Q Consensus 256 ~-~p~~Rpsa------~elL~hpff~~~~~~~~ 281 (620)
+ +|.+|+++ .++++||||....+..+
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~ 264 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 8 99999998 89999999988765543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=365.72 Aligned_cols=252 Identities=28% Similarity=0.427 Sum_probs=214.0
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC---e
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR---T 91 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~---~ 91 (620)
.|+-.+++|+|+||.||+|...+++++||||++-.++... .+|+++|+.++|||||++..+|...... +
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 5777899999999999999999999999999987554322 2699999999999999998888765444 7
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 92 INMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
+.+||||++. +|.++++. +.+++...++-++.||++||+|||++| |+||||||+|+|+|...|.+||||||.|
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 7889999975 88888774 577999999999999999999999999 9999999999999988899999999999
Q ss_pred hhccCC-CCccccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Q 007055 168 IVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG----------- 233 (620)
Q Consensus 168 ~~~~~~-~~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~----------- 233 (620)
+.+... ...+++.|..|+|||++- .+|+.++||||.||++.||+-|++-|.+....+|+...+.--
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 876544 456788899999999765 469999999999999999999999999877667765544310
Q ss_pred -----------CCCCC----CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 234 -----------IKPAS----LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 234 -----------~~p~~----~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.++.. +.+..++++.+|+.++|+ +|.+|.++.|+|.||||....
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 11111 344568999999999999 999999999999999997643
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=357.87 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=216.1
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|.....|++|+||.||+|+|+.|++.||+|+++.++-. ...--.-.+||.+|.+++|||||.+-.+.+..+-..+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek--~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK--EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc--CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 456778999999999999999999999999999876421 111223679999999999999999999988877788999
Q ss_pred EEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
|||||+. +|+.++..-+ +|...+++.++.|+|.||+|||.+. |+||||||+|+|++ +.|.+||+|||+|+.+..+
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhhcCC
Confidence 9999986 8999988765 8999999999999999999999998 99999999999998 8999999999999988766
Q ss_pred --CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------C-
Q 007055 174 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-----------A- 237 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-----------~- 237 (620)
..+..+.|.+|.|||++-+ .|++++|+||+|||+.||+++++.|.+....+|+.+.+..--.| +
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 3455678999999997654 59999999999999999999999999987778876655421000 0
Q ss_pred ----C------------CCCC-CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 238 ----S------------LSKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 238 ----~------------~~~~-~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
. +... .+....+|+..+|. +|.+|.||.|.|+|.||..
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 0 1111 34677899999998 9999999999999999986
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=365.38 Aligned_cols=258 Identities=21% Similarity=0.371 Sum_probs=214.7
Q ss_pred EEEEEEEceeCCeEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCe
Q 007055 16 LQYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~ 91 (620)
|++.+.||+|+||+||+|.+. .+|..||+|.+............+.+.+|+.+++.+ +||||++++++|..+ ..
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~ 79 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--AK 79 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--CE
Confidence 689999999999999999864 578999999987544333344556788999999999 599999999987544 56
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCcccc
Confidence 8999999999999999998888999999999999999999999999 99999999999998 78999999999986543
Q ss_pred CC---CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCC---CCHHHHHHHHHcCCCCCCCCCCC
Q 007055 172 QP---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASLSKVT 243 (620)
Q Consensus 172 ~~---~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~---~~~~~i~~~i~~~~~p~~~~~~~ 243 (620)
.. ......||+.|+|||++.+ .++.++|||||||++|+|+||..||... .....+...+... ...++...
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 234 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--DPPFPSFI 234 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC--CCCCCCCC
Confidence 22 2234679999999998864 3788999999999999999999999642 2334444444433 22345567
Q ss_pred cHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCc
Q 007055 244 DPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKD 280 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~ 280 (620)
++.++++|.+||+ +|.+|| ++.++++||||+...+..
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 277 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEA 277 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 8999999999998 899999 888999999998765544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=365.83 Aligned_cols=259 Identities=19% Similarity=0.325 Sum_probs=217.9
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.++.+|+.||+|.++.... ........+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~l 78 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYL 78 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEE
Confidence 47899999999999999999999999999999985432 2234556788999999999999999999987654 46899
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
||||+++|+|.+++.+. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCCC
Confidence 99999999999999886 67999999999999999999999999 99999999999998 7899999999999655432
Q ss_pred C---CccccCCCCCCCccccc-------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--C
Q 007055 174 T---ARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--K 241 (620)
Q Consensus 174 ~---~~~~~GTp~y~APEll~-------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~ 241 (620)
. .....||+.|+|||++. ..++.++|||||||++|+|++|..||... +....+..+........++ .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 234 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPEDP 234 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCCC
Confidence 2 23357999999999874 34788999999999999999999999774 4455555555443322222 2
Q ss_pred CCcHHHHHHHHHhcCCCCCCCCHHHHhcCCCcCCCCCCc
Q 007055 242 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD 280 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~~p~~Rpsa~elL~hpff~~~~~~~ 280 (620)
..++.+++||.+||.+|.+||++.+++.||||....+..
T Consensus 235 ~~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 235 KVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred CCCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHHH
Confidence 467899999999999999999999999999998866544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=356.58 Aligned_cols=252 Identities=19% Similarity=0.335 Sum_probs=206.5
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.++.+++.||+|+++.... .....+.+.+|+.+++.++||||++++++|... ..+++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 77 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLYL 77 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecC--CEEEE
Confidence 47899999999999999999999999999999875432 233456788999999999999999999988544 57999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||+.++.|..+......+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCcccccccc
Confidence 9999999888777666677999999999999999999999999 99999999999998 7899999999999765432
Q ss_pred --CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CC---------------
Q 007055 174 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI--------------- 234 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~--------------- 234 (620)
......||+.|+|||++. ..++.++|||||||++|+|++|+.||............... +.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 223457899999999875 45899999999999999999999999764433332221110 00
Q ss_pred ----CCC---------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 235 ----KPA---------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 235 ----~p~---------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.|. ......++.+++||.+||+ +|.+|||+.++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112356789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=364.98 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=214.6
Q ss_pred EEEceeCCeEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEE
Q 007055 20 EILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~---~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
+.||+|+||.||+|.+. .+|+.||+|.++.............+.+|+.+|+.++||||++++++|..+ ..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 68999999999999864 578999999998654333334456678999999999999999999988654 4689999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCC
Q 007055 97 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPT 174 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~ 174 (620)
||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... ...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCc
Confidence 99999999999999889999999999999999999999999 99999999999998 78999999999986432 222
Q ss_pred CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 175 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+.......+..+.. .++...++.+++||.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL--NLPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 345679999999998764 588999999999999999999999976 445555566655432 3455678899999999
Q ss_pred hcC-CCCCCC-----CHHHHhcCCCcCCCCCCcc
Q 007055 254 CIV-PASLRL-----PALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 254 cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 281 (620)
||+ +|.+|| ++.+++.||||....+...
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~ 267 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL 267 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 998 899999 8999999999987665544
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=371.55 Aligned_cols=262 Identities=20% Similarity=0.361 Sum_probs=217.8
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
......|++.+.||+|+||.||+|.+..+|..||+|.++..... .......+.+|+.+++.++||||++++++|.++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-- 115 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-- 115 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 34445689999999999999999999999999999998754321 223345578899999999999999999987654
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++||||+++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~ 191 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceee
Confidence 5799999999999999998764 5899999999999999999999999 99999999999998 789999999999865
Q ss_pred ccCC---CCccccCCCCCCCcccccc-----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 170 MQQP---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 170 ~~~~---~~~~~~GTp~y~APEll~~-----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
.... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+ .+....+..+........++.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCC
Confidence 5332 2235679999999998753 378899999999999999999999976 455666777765543333333
Q ss_pred --CCcHHHHHHHHHhcC-CCCC--CCCHHHHhcCCCcCCCCCC
Q 007055 242 --VTDPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 242 --~~~~~lk~~I~kcL~-~p~~--Rpsa~elL~hpff~~~~~~ 279 (620)
..+.++++||.+||. +|.+ |+++.++++||||+...+.
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 468899999999998 5665 9999999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=363.80 Aligned_cols=257 Identities=22% Similarity=0.356 Sum_probs=218.1
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC-CcceEEeEEEcCCCCeEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp-NIVkl~~~f~~~~~~~l~l 94 (620)
|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+..|+.++..++|+ +|++++++|... ..+|+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF 78 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence 6889999999999999999999999999999875432 2234556788899999999765 577888887654 46999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc--cC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQ 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~--~~ 172 (620)
||||+++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCCC
Confidence 9999999999999998889999999999999999999999999 99999999999998 7899999999998542 22
Q ss_pred CCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 173 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 173 ~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
......+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+ .+....+..+.... ..++...++.++++|
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li 232 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSIC 232 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Confidence 23445679999999998764 589999999999999999999999976 45666677776543 234566789999999
Q ss_pred HHhcC-CCCCCCCH-----HHHhcCCCcCCCCCCcc
Q 007055 252 EKCIV-PASLRLPA-----LELLKDPFLVTDNPKDL 281 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa-----~elL~hpff~~~~~~~~ 281 (620)
.+||. +|.+|+++ .++++||||...++..+
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~ 268 (324)
T cd05587 233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL 268 (324)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 99998 89999976 89999999998766544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=367.67 Aligned_cols=252 Identities=23% Similarity=0.433 Sum_probs=213.9
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEecc
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 99 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~ 99 (620)
+.||+|+||.||+|.+..+|..||+|.++.... ........+.+|+++++.++||||++++++|... ..+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 479999999999999999999999999975432 2234556778899999999999999999987654 4799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCCCc
Q 007055 100 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 176 (620)
Q Consensus 100 ~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~~~ 176 (620)
.+|+|..++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccc
Confidence 999999999988899999999999999999999997 67 99999999999998 78999999999986432 22334
Q ss_pred cccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 177 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 177 ~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
...||+.|+|||++. ..++.++|||||||++|+|+||..||.+ .+...+...+... ...++...++.+++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME--EIRFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHh
Confidence 567999999999876 4589999999999999999999999976 4455565655543 22345567899999999999
Q ss_pred C-CCCCCC-----CHHHHhcCCCcCCCCCCc
Q 007055 256 V-PASLRL-----PALELLKDPFLVTDNPKD 280 (620)
Q Consensus 256 ~-~p~~Rp-----sa~elL~hpff~~~~~~~ 280 (620)
+ +|.+|+ ++.++++||||....+..
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~ 262 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQD 262 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 8 899997 899999999998765544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=356.55 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=203.1
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.+..++..||+|.++.... ......+.+|+.+++.++||||+++++++..+ ..++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEE
Confidence 357899999999999999999999999999999875432 12234577899999999999999999987654 4789
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+||||+.+ +|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSV 155 (288)
T ss_pred EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeeccC
Confidence 99999975 8999887654 5799999999999999999999999 99999999999998 789999999999865432
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C-----------
Q 007055 173 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--K----------- 235 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~--~----------- 235 (620)
. ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+......+ ..+.... .
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL-HLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChHHhhccccc
Confidence 2 2334578999999998753 5899999999999999999999999774433332 2221100 0
Q ss_pred --------CC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 236 --------PA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 236 --------p~-------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
|. ......++++++||.+||+ +|.+|||+.|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 0012346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=364.86 Aligned_cols=252 Identities=18% Similarity=0.369 Sum_probs=211.1
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
++||+|+||.||+|.+..+|+.||+|+++.... ........+.+|+.+++.+ +||||++++++|.+. ..+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeC
Confidence 479999999999999999999999999985432 2334556788999999998 799999999988654 478999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~~~ 176 (620)
+++|+|.+++.+.+++++..++.++.||+.||.|||+++ ++||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCccc
Confidence 999999999988889999999999999999999999999 99999999999998 78999999999986421 22334
Q ss_pred cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 177 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 177 ~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||... .....+++.+... +..++...++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCCCCCCHHH
Confidence 5689999999998764 5899999999999999999999999531 1223344545443 223455678899
Q ss_pred HHHHHHhcC-CCCCCCC------HHHHhcCCCcCCCCCC
Q 007055 248 KQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPK 279 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rps------a~elL~hpff~~~~~~ 279 (620)
+++|.+||+ +|.+|++ +.++++||||....+.
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 999999998 8999987 7899999999775543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=370.45 Aligned_cols=260 Identities=20% Similarity=0.367 Sum_probs=215.0
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
.....|++.+.||+|+||.||+|.+..+++.||+|.+...... .......+.+|+.+++.++||||++++++|.++ .
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~ 116 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--K 116 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--C
Confidence 3445689999999999999999999999999999998754321 223445678899999999999999999988654 5
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
.+++||||+++|+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceec
Confidence 799999999999999999765 5899999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCCC---CccccCCCCCCCcccccc-----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC-
Q 007055 171 QQPT---ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK- 241 (620)
Q Consensus 171 ~~~~---~~~~~GTp~y~APEll~~-----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~- 241 (620)
.... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+........++.
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~ 271 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPED 271 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCc
Confidence 4322 245679999999998753 278899999999999999999999976 455556666655433222332
Q ss_pred -CCcHHHHHHHHHhcCCC---CCCCCHHHHhcCCCcCCCCC
Q 007055 242 -VTDPQVKQFIEKCIVPA---SLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 242 -~~~~~lk~~I~kcL~~p---~~Rpsa~elL~hpff~~~~~ 278 (620)
..++.++++|.+||.++ ..|+++.|+++||||+...+
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 35789999999999743 34889999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=362.78 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=212.9
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHH---HhCCCCCcceEEeEEEcCCCCeE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL---KSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL---~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
|++.+.||+|+||.||+|.+..+|+.||+|.++..... .....+.+.+|++++ +.++||||++++++|... ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEE
Confidence 57899999999999999999999999999999755322 223456677776665 566899999999988654 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
|+||||+.+|+|..++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 ~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCC
Confidence 999999999999988764 56999999999999999999999999 99999999999998 789999999999864322
Q ss_pred --CCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 173 --PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 173 --~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .+...+...+..+.. .++...++.+.+
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 230 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAIS 230 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHH
Confidence 22345689999999998764 589999999999999999999999976 455566666655422 244557889999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCcc
Q 007055 250 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 250 ~I~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 281 (620)
+|.+||+ +|.+|| ++.++++||||....+...
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~ 268 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHH
Confidence 9999998 899999 6999999999988665543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=363.27 Aligned_cols=253 Identities=22% Similarity=0.358 Sum_probs=214.8
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
++||+|+||.||+|.+..+|+.||+|.++.... ......+.+..|..++..+ +||||++++++|... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeC
Confidence 469999999999999999999999999875432 2234556677899998866 899999999998654 468999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~~~ 176 (620)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCcccc
Confidence 999999999998889999999999999999999999999 99999999999998 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 177 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 177 ~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
...||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+..+.. .++...+++++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 5679999999998764 589999999999999999999999976 456666666665432 234456889999999999
Q ss_pred C-CCCCCC-------CHHHHhcCCCcCCCCCCcc
Q 007055 256 V-PASLRL-------PALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 256 ~-~p~~Rp-------sa~elL~hpff~~~~~~~~ 281 (620)
+ +|.+|+ ++.++++||||....+..+
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~ 265 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL 265 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence 8 899999 8999999999987666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=361.00 Aligned_cols=259 Identities=22% Similarity=0.349 Sum_probs=218.5
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~l 94 (620)
|++.+.||+|+||.||+|.+..++..||+|.++.... ......+.+..|..++..+ +||+|+++++++... ..+++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF 78 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence 6789999999999999999999999999999875432 2233445677788888877 588999999987554 47999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--C
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--Q 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~ 172 (620)
||||+++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCC
Confidence 9999999999999998889999999999999999999999999 99999999999998 78999999999986432 2
Q ss_pred CCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 173 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 173 ~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
......+||+.|+|||++. ..++.++|||||||++|||+||+.||.+ .+...++..+.... ..++...++.++++|
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~li 232 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN--VAYPKSMSKEAVAIC 232 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCcCCHHHHHHH
Confidence 2334568999999999876 4599999999999999999999999976 45666666666543 234556789999999
Q ss_pred HHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCcccc
Q 007055 252 EKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVC 283 (620)
Q Consensus 252 ~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~ 283 (620)
.+||+ +|.+|++ ..+++.||||...++.....
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~ 270 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 270 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence 99998 8999998 48999999999877665443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=360.39 Aligned_cols=252 Identities=24% Similarity=0.428 Sum_probs=210.9
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh-CCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
++||+|+||.||+|.+..+++.||+|.++..... .....+.+..|..++.. ++||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence 4799999999999999999999999999754321 22344556667777765 4899999999987644 579999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~~~ 176 (620)
+++|+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccc
Confidence 999999999998889999999999999999999999999 99999999999998 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 177 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 177 ~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+++..+.... ..++...++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDR--PHFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHc
Confidence 5679999999998764 589999999999999999999999976 45666666665532 2345567889999999999
Q ss_pred C-CCCCCCCH-HHHhcCCCcCCCCCCc
Q 007055 256 V-PASLRLPA-LELLKDPFLVTDNPKD 280 (620)
Q Consensus 256 ~-~p~~Rpsa-~elL~hpff~~~~~~~ 280 (620)
. +|.+||++ .+++.||||....+..
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~ 258 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGIDWER 258 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCCHHH
Confidence 8 89999986 4899999998876544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=377.52 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=205.1
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC-----
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----- 87 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~----- 87 (620)
.+.|++.++||+|+||+||+|.+..+|+.||+|++.... ....+|+.+|+.++||||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 456899999999999999999999999999999885321 1234799999999999999999887542
Q ss_pred -CCCeEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 88 -TNRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 88 -~~~~l~lV~Ey~~gGsL~~~i~----~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
....+++||||+++ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeee
Confidence 22367899999975 6766654 3467999999999999999999999999 99999999999998555689999
Q ss_pred cccchhhccCC-CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---
Q 007055 163 DLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--- 236 (620)
Q Consensus 163 DFGla~~~~~~-~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--- 236 (620)
|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|||++|.+||.+.....++...+.....|
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99999755432 3345688999999998753 58999999999999999999999998765555544433211000
Q ss_pred -----------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 237 -----------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 237 -----------------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
..++...++++++||.+||+ +|.+|||+.|+|.||||....
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 01223356789999999998 999999999999999997643
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=353.44 Aligned_cols=252 Identities=26% Similarity=0.429 Sum_probs=207.4
Q ss_pred EceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCC
Q 007055 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 101 (620)
Q Consensus 22 LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~g 101 (620)
||+|+||+||+|.+..+|+.||+|.+...... .....+.+..|+.+++.++||||++++++|... ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence 79999999999999999999999998754322 223446678899999999999999999987544 468999999999
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC--CC
Q 007055 102 GSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 175 (620)
Q Consensus 102 GsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~--~~ 175 (620)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++...... ..
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccc
Confidence 999988743 456999999999999999999999999 99999999999998 7899999999998654332 23
Q ss_pred ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 176 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 176 ~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~---~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
....||+.|+|||++. ..++.++|||||||++|+|++|+.||...... ..+...+... +..++...++.+++++
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHH
Confidence 3457999999999876 45889999999999999999999999753322 2222333222 3344556788999999
Q ss_pred HHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCcc
Q 007055 252 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 252 ~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 281 (620)
.+||+ +|.+|| +++++++||||+..++..+
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 268 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL 268 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence 99998 899999 8899999999988666554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=360.16 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=211.8
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
++||+|+||.||+|.++.+|..||+|.++..... .....+.+..|..++..+ +||||++++++|.+. ..+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECC
Confidence 4799999999999999999999999999754321 123445567788888754 899999999988654 579999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc--cCCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~--~~~~~~ 176 (620)
+.+|+|..++...+.+++..+..++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++... ......
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCcee
Confidence 999999999998888999999999999999999999999 99999999999998 7899999999998642 222344
Q ss_pred cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 177 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 177 ~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...+.+.+..+. ..++...++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHc
Confidence 5679999999998864 589999999999999999999999976 45666666665442 2345567889999999999
Q ss_pred C-CCCCCCCH-HHHhcCCCcCCCCCCc
Q 007055 256 V-PASLRLPA-LELLKDPFLVTDNPKD 280 (620)
Q Consensus 256 ~-~p~~Rpsa-~elL~hpff~~~~~~~ 280 (620)
. +|.+|+++ .++++||||....+..
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~~~ 258 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINWTA 258 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCHHH
Confidence 8 89999998 5899999998866543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=345.06 Aligned_cols=254 Identities=24% Similarity=0.444 Sum_probs=226.8
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.+.+++.||+|-||.||+|+.+.++-.||+|++-++..... ....++.+|+++-..|+||||+++|++|.+.. .+|
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~-~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~--riy 98 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKT-QVEHQLRREIEIQSHLRHPNILRLYGYFHDSK--RIY 98 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHh-cchhhhhheeEeecccCCccHHhhhhheeccc--eeE
Confidence 457899999999999999999999999999999877664332 33466899999999999999999999998764 699
Q ss_pred EEEeccCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 94 MITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~--~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++||.+.|+|...+. +.+++++.....+++|++.||.|||.++ ||||||||+|+|+. ..|.+||+|||-+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCceeecC
Confidence 9999999999999998 6778999999999999999999999999 99999999999996 88999999999997776
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 172 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
.....+.+||..|.|||+.++ .++..+|+|++|++.||++.|..||.. ....+.|++|.+-. ..++..++..++++
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes-~~~~etYkrI~k~~--~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES-QSHSETYKRIRKVD--LKFPSTISGGAADL 252 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh-hhhHHHHHHHHHcc--ccCCcccChhHHHH
Confidence 667788999999999999885 599999999999999999999999976 44788888887642 23446788999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 251 IEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
|.+||+ +|.+|++..|++.|||+...
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHhc
Confidence 999998 89999999999999998753
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=361.08 Aligned_cols=256 Identities=26% Similarity=0.430 Sum_probs=213.4
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
....|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+++++.++||||++++++|.+. ..
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 77 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GE 77 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CE
Confidence 3467799999999999999999999999999999887542 234556789999999999999999999998764 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
+++||||+.+|+|.+++...+.+++..+..++.||+.||.|||+. + ++||||||+|||++ .+|.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhh
Confidence 999999999999999999888899999999999999999999974 6 99999999999998 7899999999998765
Q ss_pred cCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHH---------------------
Q 007055 171 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--------------------- 228 (620)
Q Consensus 171 ~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~--------------------- 228 (620)
.........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 155 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCC
Confidence 5444455679999999998865 58899999999999999999999996532 222211
Q ss_pred -----------------------HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 229 -----------------------KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 229 -----------------------~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.+.....+.......+.++++||.+||+ +|.+|||+.|++.||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 1111111211122356889999999998 99999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=360.69 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=211.7
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
++||+|+||.||+|.+..+|+.||+|.+....... ......+..|+. +++.++||||++++++|.+. ..+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcC
Confidence 47999999999999999999999999987543322 223344555554 67889999999999987554 478999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC--CCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~--~~~~ 176 (620)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccc
Confidence 999999999988888999999999999999999999999 99999999999998 789999999999864322 2234
Q ss_pred cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 177 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 177 ~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+... +..++...+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHc
Confidence 5679999999998764 589999999999999999999999976 4566677777654 33455567889999999999
Q ss_pred C-CCCCCCCH----HHHhcCCCcCCCCCCccc
Q 007055 256 V-PASLRLPA----LELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 256 ~-~p~~Rpsa----~elL~hpff~~~~~~~~~ 282 (620)
+ +|.+|+++ .++++||||...++..+.
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSPINWDDLY 263 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHh
Confidence 8 89999876 499999999887665543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=361.63 Aligned_cols=254 Identities=25% Similarity=0.418 Sum_probs=210.8
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHH-HHHHhCCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV-HLLKSLKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei-~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
+.||+|+||+||+|.+..+++.||+|++........ .....+..|. .+++.++||||++++++|... ..+++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeC
Confidence 479999999999999999999999999875433222 2223444444 457889999999999988654 468999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~~~ 176 (620)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcc
Confidence 999999999998888999999999999999999999999 99999999999998 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 177 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 177 ~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+... +..+....++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK--PLQLKPNITNSARHLLEGLL 231 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHc
Confidence 5679999999998764 589999999999999999999999976 4556666666543 23344567889999999999
Q ss_pred C-CCCCCCCHH----HHhcCCCcCCCCCCccc
Q 007055 256 V-PASLRLPAL----ELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 256 ~-~p~~Rpsa~----elL~hpff~~~~~~~~~ 282 (620)
+ +|.+|+++. ++++|+||...++..+.
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPINWDDLI 263 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCCCHHHHH
Confidence 8 899999876 89999999887766554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.00 Aligned_cols=261 Identities=20% Similarity=0.354 Sum_probs=217.4
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
......|++.+.||+|+||.||+|.++.+++.||+|.+...... .......+.+|+.+++.++||||+++++.|.+.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-- 115 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-- 115 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--
Confidence 34456789999999999999999999999999999998754322 223445678899999999999999999988654
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++||||+++|+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~ 191 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMK 191 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeE
Confidence 5799999999999999998764 5899999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCC---CCccccCCCCCCCcccccc-----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC-
Q 007055 170 MQQP---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS- 240 (620)
Q Consensus 170 ~~~~---~~~~~~GTp~y~APEll~~-----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~- 240 (620)
.... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+....+..+........++
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCC
Confidence 5432 2235679999999998753 278999999999999999999999976 56666777776544332232
Q ss_pred -CCCcHHHHHHHHHhcCCCC---CCCCHHHHhcCCCcCCCCC
Q 007055 241 -KVTDPQVKQFIEKCIVPAS---LRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 241 -~~~~~~lk~~I~kcL~~p~---~Rpsa~elL~hpff~~~~~ 278 (620)
...++.++++|.+||.+|. .|+++.++++||||....+
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 3468899999999998543 3789999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=359.66 Aligned_cols=252 Identities=22% Similarity=0.387 Sum_probs=214.2
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
++||+|+||+||+|.+..++..||+|.++.... ........+.+|+.+++.+ +||||++++++|... ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence 479999999999999999999999999875432 2234456678899999888 799999999988654 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc--cCCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~--~~~~~~ 176 (620)
+.+|+|..++.+.+.+++..+..++.||+.||.|||+++ ++||||||+|||++ .+|.+||+|||++... ......
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCccc
Confidence 999999999998889999999999999999999999999 99999999999998 7899999999998542 222334
Q ss_pred cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 177 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 177 ~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+..... .++...++.+++||.+||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHc
Confidence 5679999999998764 589999999999999999999999976 456666666655422 345567889999999999
Q ss_pred C-CCCCCCCH-----HHHhcCCCcCCCCCCc
Q 007055 256 V-PASLRLPA-----LELLKDPFLVTDNPKD 280 (620)
Q Consensus 256 ~-~p~~Rpsa-----~elL~hpff~~~~~~~ 280 (620)
+ +|.+||++ .+++.||||....+..
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~ 262 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDWDK 262 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 8 99999999 9999999998866543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=358.76 Aligned_cols=252 Identities=24% Similarity=0.434 Sum_probs=211.6
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh-CCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
+.||+|+||+||+|.+..+++.||+|.++..... ..........|..++.. ++||||++++++|.+. ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeC
Confidence 4799999999999999999999999998754321 12334556778888876 4999999999988654 469999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc--cCCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~--~~~~~~ 176 (620)
+++|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++... ......
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCcee
Confidence 999999999998888999999999999999999999999 99999999999998 7899999999998642 222334
Q ss_pred cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 177 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 177 ~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++...+.... ..++...+..+++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDN--PCYPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHh
Confidence 5679999999998764 589999999999999999999999976 45566666665432 2344557889999999999
Q ss_pred C-CCCCCCCHH-HHhcCCCcCCCCCCc
Q 007055 256 V-PASLRLPAL-ELLKDPFLVTDNPKD 280 (620)
Q Consensus 256 ~-~p~~Rpsa~-elL~hpff~~~~~~~ 280 (620)
. +|.+||++. +++.||||....+..
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~ 258 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREIDWSA 258 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCCHHH
Confidence 8 899999997 899999999876654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=360.61 Aligned_cols=252 Identities=19% Similarity=0.373 Sum_probs=210.3
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
+.||+|+||.||+|.+..+++.||+|.++.... ........+.+|+.++.++ +||||++++++|... ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeC
Confidence 479999999999999999999999999986532 2334556788899988877 899999999988654 468999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~~~ 176 (620)
+++|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCccc
Confidence 999999999988889999999999999999999999999 99999999999998 78999999999986432 22234
Q ss_pred cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 177 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 177 ~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+.+.+... ...++...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHH
Confidence 5679999999998764 5899999999999999999999999521 1122344444443 223556678899
Q ss_pred HHHHHHhcC-CCCCCCC------HHHHhcCCCcCCCCCC
Q 007055 248 KQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPK 279 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rps------a~elL~hpff~~~~~~ 279 (620)
+++|.+||+ +|.+|++ ..++++||||...++.
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 999999998 8999998 4799999999876654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=361.24 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=210.0
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
++||+|+||+||+|.++.+|+.||+|++...... .......+..|.. +++.++||||++++++|... ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcC
Confidence 4699999999999999999999999998754322 2233445556655 57789999999999988654 468999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~~~ 176 (620)
+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcc
Confidence 999999999998889999999999999999999999999 99999999999998 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 177 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 177 ~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+.... ..+....+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKP--LVLRPGASLTAWSILEELL 231 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHh
Confidence 5679999999998764 589999999999999999999999976 45666666665542 2233456789999999999
Q ss_pred C-CCCCCCCH----HHHhcCCCcCCCCCCcc
Q 007055 256 V-PASLRLPA----LELLKDPFLVTDNPKDL 281 (620)
Q Consensus 256 ~-~p~~Rpsa----~elL~hpff~~~~~~~~ 281 (620)
. +|.+||++ .+++.||||....+..+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~ 262 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESLSWTDL 262 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 8 89999876 58999999987665543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=375.80 Aligned_cols=250 Identities=32% Similarity=0.539 Sum_probs=221.4
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEecc
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 99 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~ 99 (620)
-+||+|.||+||.|+|..|....|||.|.-++ ....+-+..||.+.++|+|.|||++.+++ ..++++-+.||-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecC
Confidence 38999999999999999999999999987443 34456688999999999999999999986 3445788899999
Q ss_pred CCCCHHHHHH-hCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC--C
Q 007055 100 TSGSLRQYRK-KHKNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 174 (620)
Q Consensus 100 ~gGsL~~~i~-~~~~l--~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~--~ 174 (620)
+||+|..++. +.+++ +|.++..+.+||+.||.|||.+. |||||||-+||||+...|.+||+|||.++.+..- .
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 9999999876 56888 89999999999999999999999 9999999999999988999999999999766543 4
Q ss_pred CccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 175 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
..++.||..|||||++.. +|+.++|||||||++.||+||++||.+..++...+-++---...++++...+.+++.||
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 567899999999999874 59999999999999999999999999988887776666555556677777889999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 252 EKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+|.. +|.+||+|.+||.+||++..+
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccCC
Confidence 99998 899999999999999998764
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=363.94 Aligned_cols=254 Identities=28% Similarity=0.531 Sum_probs=217.7
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|.+.++||+|+||+||+|.|+++|..||||+|..+ .+++.+.+||.+|++++.|++|++|++|+.... +|+|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD--LWIV 106 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD--LWIV 106 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc--eEee
Confidence 34668899999999999999999999999998754 467789999999999999999999999886654 8999
Q ss_pred EeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 96 TELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~-~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||..|+..+++. +++++++.++..+++..|.||+|||... -||||||..|||++ .+|..||+|||.|-.+...
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhccccchhhhhH
Confidence 99999999999875 5678999999999999999999999987 79999999999998 7899999999999766543
Q ss_pred -CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcHHHHH
Q 007055 174 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQ 249 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~~~~lk~ 249 (620)
...+++|||.|||||++.. +|+.++||||||++..||+.|++||.+......+ -.|.. .+|+.+ +..++.++.+
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-FMIPT-~PPPTF~KPE~WS~~F~D 261 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-FMIPT-KPPPTFKKPEEWSSEFND 261 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-EeccC-CCCCCCCChHhhhhHHHH
Confidence 4567899999999999975 6999999999999999999999999874332222 22222 233333 3456889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCcCCCCCCccc
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~~~~ 282 (620)
||++||. +|.+|.||.+|++|||++......++
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~ 295 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIM 295 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHH
Confidence 9999998 89999999999999999987766543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=349.53 Aligned_cols=254 Identities=25% Similarity=0.454 Sum_probs=217.9
Q ss_pred EEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH----HHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCe
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP----DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~----~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~ 91 (620)
.-.+.||+|..++|.++.++.||.+.|+|++.......+. .-.+.-.+|+.+|+++ .||+|+++.++| ++...
T Consensus 20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es~sF 97 (411)
T KOG0599|consen 20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ESDAF 97 (411)
T ss_pred ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cCcch
Confidence 3568999999999999999999999999998765432222 2345567899999998 699999999987 44567
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++|+|+|+.|.|++|+...-.++++..+++++|++.|++|||.++ ||||||||+|||++ ++-.+||+|||+++.+.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILld-dn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLD-DNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeec-cccceEEeccceeeccC
Confidence 9999999999999999999999999999999999999999999999 99999999999998 78899999999998776
Q ss_pred CC-CCccccCCCCCCCcccccc-------ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCC
Q 007055 172 QP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSK 241 (620)
Q Consensus 172 ~~-~~~~~~GTp~y~APEll~~-------~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~ 241 (620)
.. ..+..||||+|.|||.++. +|+..+|+|++|+++|-|+.|.+||.. .....+...|..|.... +-..
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCcchh
Confidence 54 5678899999999997752 488999999999999999999999976 33445567777775532 2233
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
..+..++++|.+||+ +|.+|.|++|+|.||||.+.
T Consensus 254 dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 467889999999998 99999999999999999653
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=348.36 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=200.3
Q ss_pred eEEEEEEEceeCCeEEEEEEEcc-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCcceEEeEEEc---C
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVD---D 87 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~-tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpNIVkl~~~f~~---~ 87 (620)
.|++.+.||+|+||+||+|.+.. +|..||+|.++..... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 57899999999999999999864 5789999998754322 12223455677776665 69999999998753 2
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
....+++|+||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEcccc
Confidence 3456899999996 6899998764 45899999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCC---
Q 007055 166 LAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PAS--- 238 (620)
Q Consensus 166 la~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~--- 238 (620)
++...... ......||+.|+|||++. ..++.++|||||||++|||++|..||.+......+...+..... +..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 98655433 234567899999999875 46899999999999999999999999875444433332221100 000
Q ss_pred -------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 239 -------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 239 -------------------~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+....++.++++|.+||+ +|.+|||+.|+|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 112356788999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=356.15 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=216.8
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l~l 94 (620)
|++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+..|+.++..+. ||+|++++++|... ..+|+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence 57889999999999999999999999999998754321 2344566788999998886 56778888887554 46999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC--
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-- 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~-- 172 (620)
||||+++|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCC
Confidence 9999999999999999889999999999999999999999999 99999999999998 789999999999864322
Q ss_pred CCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 173 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 173 ~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .+...+...+.... ..++...++.+++++
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li 232 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSIC 232 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHH
Confidence 22345679999999998764 589999999999999999999999976 45666666666543 234556788999999
Q ss_pred HHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCccc
Q 007055 252 EKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 252 ~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~ 282 (620)
.+||+ +|.+|++ ..++++||||...++..+.
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~ 269 (323)
T cd05615 233 KGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE 269 (323)
T ss_pred HHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHh
Confidence 99998 8999997 5799999999987765543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=349.15 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=213.4
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.++||+|+||+||+|.+..+|+.||+|++...... .......+.+|+.+++.++||||+++++.+... ..+++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEE
Confidence 67889999999999999999999999999998754332 222345577899999999999999999987554 479999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 96 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCC
Confidence 9999999999887653 46999999999999999999999999 99999999999998 7899999999998654322
Q ss_pred -CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 174 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~---~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
.....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+..... .+...+.. .+..++...++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE--DQEEYSEKFSEAAR 233 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh--cccccCcccCHHHH
Confidence 223457999999999876 458899999999999999999999998643322 12222222 12334455788999
Q ss_pred HHHHHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCccc
Q 007055 249 QFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~ 282 (620)
+||.+||+ +|.+|| ++.++++||||...+++.+.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 273 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLE 273 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHh
Confidence 99999998 999999 89999999999987766653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=359.09 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=212.4
Q ss_pred EEEceeCCeEEEEEEE---ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEE
Q 007055 20 EILGKGAFKTVYKGFD---EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d---~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
+.||+|+||.||++.+ ..+|..||+|+++.... ......++.+|+.+|++++||||++++++|.+. ..+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEE
Confidence 5799999999999986 46889999999975432 123345678899999999999999999988654 5789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC--C
Q 007055 97 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 174 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~--~ 174 (620)
||+.+|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...... .
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCc
Confidence 99999999999988888999999999999999999999999 99999999999998 7899999999998654332 2
Q ss_pred CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 175 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+..... .++...++.++++|.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 345679999999998764 588999999999999999999999976 455555555554322 3445678899999999
Q ss_pred hcC-CCCCCCC-----HHHHhcCCCcCCCCCCcc
Q 007055 254 CIV-PASLRLP-----ALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 254 cL~-~p~~Rps-----a~elL~hpff~~~~~~~~ 281 (620)
||+ +|.+||+ +.+++.||||....+..+
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL 265 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHH
Confidence 998 8999999 778999999988665443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=359.60 Aligned_cols=251 Identities=23% Similarity=0.468 Sum_probs=223.3
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
+|.+.+.||+|.||.|-+|.+...|+.||||.|++.++ .++.++-.+++||++|..|+||||+.+|++|. +...+++
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-kdeqDlvhIRREIeIMSsLNHPhII~IyEVFE--NkdKIvi 130 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE--NKDKIVI 130 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc-ccHHHHHHHHHHHHHHhhcCCCceeehhhhhc--CCceEEE
Confidence 56889999999999999999999999999999987665 45677888999999999999999999999884 4456999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||..+|.|.+|+...+.+++.+++.+++||++|+.|||.++ ++|||||.+|||+| .|+.+||+|||++..+...
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD-~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLD-QNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeec-CCCCeeeeccchhhhhcccc
Confidence 9999999999999999999999999999999999999999999 99999999999998 7899999999999877654
Q ss_pred CCccccCCCCCCCccccccc-c-CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 174 TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 174 ~~~~~~GTp~y~APEll~~~-y-~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
...++||+|-|.+||++.+. | ++.+|-||||++||-|+.|..||.+ .+...+.+.|..|...++ ..+..+.-+|
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP---~~PSdA~gLI 283 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREP---ETPSDASGLI 283 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCC---CCCchHHHHH
Confidence 56789999999999998865 5 6789999999999999999999987 567777788887754322 2245688899
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 252 EKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
+.||. +|.+|.|+.++-.|-|+.-
T Consensus 284 RwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HHHHhcCcccchhHHHHhhhheeec
Confidence 99995 9999999999999999853
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=372.73 Aligned_cols=254 Identities=30% Similarity=0.514 Sum_probs=219.4
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
.+.||+|+||.||.|.|..+.+.||||++..... ++.+..+.+.+||..|++|+|||+|.|.++|..+. +.|+||||
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--TaWLVMEY 107 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--TAWLVMEY 107 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--hHHHHHHH
Confidence 4679999999999999999999999999987764 44556678999999999999999999999997664 67889999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCCcc
Q 007055 99 FTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 177 (620)
Q Consensus 99 ~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~ 177 (620)
|- |+-.+++.-+ +++.+..|..|+.+.|.||+|||+++ .||||||..|||++ ..|.|||+|||.|..... +.+
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~~P--Ans 181 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLADFGSASIMAP--ANS 181 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeeccccchhhcCc--hhc
Confidence 96 5888888765 56999999999999999999999999 99999999999998 899999999999976543 578
Q ss_pred ccCCCCCCCcccc----ccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 178 VIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 178 ~~GTp~y~APEll----~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
++|||.|||||++ .|.|+-++||||||++..||+-.++|+...+....+|. |..+-.|.-....++..+++|+..
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-IAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-HHhcCCCCCCCchhHHHHHHHHHH
Confidence 9999999999975 36799999999999999999999999987554455554 444444544456789999999999
Q ss_pred hcC-CCCCCCCHHHHhcCCCcCCCCCCccc
Q 007055 254 CIV-PASLRLPALELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 254 cL~-~p~~Rpsa~elL~hpff~~~~~~~~~ 282 (620)
||+ -|.+|||++++|+|+|.....|..++
T Consensus 261 CLqKipqeRptse~ll~H~fv~R~Rp~tvi 290 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKHRFVLRERPPTVI 290 (948)
T ss_pred HHhhCcccCCcHHHHhhcchhccCCCchHH
Confidence 998 68999999999999999887765543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=357.17 Aligned_cols=254 Identities=20% Similarity=0.372 Sum_probs=213.0
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
++||+|+||.||+|.+..+++.||+|+++.... ......+.+.+|+.++.++ +||||++++++|.+. ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeC
Confidence 479999999999999999999999999975432 2234566788999999888 699999999988654 469999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~~~ 176 (620)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCcee
Confidence 999999999998889999999999999999999999999 99999999999998 78999999999986422 22334
Q ss_pred cccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCC------CCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 177 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC------KNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 177 ~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~------~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||... .....+...+... +..++...+..+++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence 568999999999876 45899999999999999999999999532 2233445555443 33456677899999
Q ss_pred HHHHhcC-CCCCCCC------HHHHhcCCCcCCCCCCcc
Q 007055 250 FIEKCIV-PASLRLP------ALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 250 ~I~kcL~-~p~~Rps------a~elL~hpff~~~~~~~~ 281 (620)
+|.+||+ +|.+|++ ..+++.||||...++..+
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~ 271 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHH
Confidence 9999998 8999998 469999999998765443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.38 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=212.2
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-cceEEeEEEcCC----CC
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDT----NR 90 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN-IVkl~~~f~~~~----~~ 90 (620)
|...++||+|+||+||+|.++.+|+.||+|++....-. +..-....+|+.+|+.|+|+| ||++++++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44557799999999999999999999999999876421 112244689999999999999 999999987654 24
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 91 TINMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~----~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
.+++|+||+. -+|.+|+...+ .++...++.+++||+.||+|||+++ |+||||||+||||+ ++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeeccch
Confidence 7999999996 49999998765 5888999999999999999999999 99999999999998 799999999999
Q ss_pred hhhccCC--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCC-
Q 007055 167 AIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASL- 239 (620)
Q Consensus 167 a~~~~~~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~- 239 (620)
|+...-+ .....++|.+|.|||++-+ .|+..+||||+|||++||++++..|.+..+.+++......--.| ..|
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 9866533 3456789999999997754 49999999999999999999999999887777766554421111 001
Q ss_pred ---------------------C---CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 240 ---------------------S---KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 240 ---------------------~---~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
. +..++...+++.+||+ +|.+|.||..+|.||||....
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 0 1123588999999999 999999999999999998754
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=364.01 Aligned_cols=255 Identities=24% Similarity=0.420 Sum_probs=220.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
-|.+.+.||+|-|++|.+|+|..||++||+|+|.+.+.. ......+++|++.|+.++|||||++|++. +....+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD--~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyL 94 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD--TLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYL 94 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc--hhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEE
Confidence 467889999999999999999999999999999877652 23445699999999999999999999964 55567999
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc-C
Q 007055 95 ITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-Q 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~-~ 172 (620)
|+|+=.+|+|++||-++ ..+.|..++.|+.||+.|+.|||+.. +|||||||+||.+-.+.|.|||.|||++..+. .
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999999877 46999999999999999999999999 99999999999776688999999999996554 4
Q ss_pred CCCccccCCCCCCCcccccc-ccC-ccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 173 PTARSVIGTPEFMAPELYEE-EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 173 ~~~~~~~GTp~y~APEll~~-~y~-~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
....+.||+..|.|||++-+ .|+ +++||||||+|||.|++|+.||.+.++ .+...+|.... -.++.+++.+++++
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-SETLTmImDCK--YtvPshvS~eCrdL 249 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-SETLTMIMDCK--YTVPSHVSKECRDL 249 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-hhhhhhhhccc--ccCchhhhHHHHHH
Confidence 45778899999999997765 475 789999999999999999999988544 44444555432 34677889999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 251 IEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
|..||+ +|.+|.+.+|+..|+|++....
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccCCCC
Confidence 999998 9999999999999999987654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=354.77 Aligned_cols=259 Identities=19% Similarity=0.349 Sum_probs=212.2
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.+..+|+.||+|.++..... .....+.+.+|+.+++.++||||++++++|.++ ..+++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLYL 78 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEEE
Confidence 478999999999999999999999999999998753321 233456688999999999999999999988654 57999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCCC
Confidence 9999999999999986 457999999999999999999999999 99999999999997 7899999999998654322
Q ss_pred C---CccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCC
Q 007055 174 T---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---LSK 241 (620)
Q Consensus 174 ~---~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~---~~~ 241 (620)
. ....+||+.|+|||++. +.++.++|||||||++|+|++|+.||.. .+..+.+..+........ ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 234 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDVT 234 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCccC
Confidence 1 12346999999999875 3478899999999999999999999976 445555555554322111 122
Q ss_pred CCcHHHHHHHHHhcCC---CCCCCCHHHHhcCCCcCCCCCCc
Q 007055 242 VTDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKD 280 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~~---p~~Rpsa~elL~hpff~~~~~~~ 280 (620)
..++.+++||.+||.. +..|+++.++|+||||....+..
T Consensus 235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 3678999999999863 34578999999999998765543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.74 Aligned_cols=252 Identities=33% Similarity=0.576 Sum_probs=213.5
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
|++.+.||+|++|.||+|.+..+|.+||+|.+....... .......+.+|+.++++++||||+++++++.+. ..+++
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~ 81 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETLSI 81 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeEEE
Confidence 678999999999999999999999999999987543211 123456788999999999999999999998655 47999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
|+||+++++|.+++...+.+++..++.++.|++.||.|||+.+ ++||||+|+||+++ .++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceeccccc
Confidence 9999999999999998888999999999999999999999999 99999999999998 78999999999986443221
Q ss_pred -----CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 175 -----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 175 -----~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
.....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.......... .+........++...+..++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHhccCCCCCCCccCCHHHH
Confidence 134568899999998865 48899999999999999999999997754443333 33333344456667789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 249 QFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
++|.+||. +|.+||++.++|+||||
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 99999998 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=357.96 Aligned_cols=254 Identities=30% Similarity=0.413 Sum_probs=203.5
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC----
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---- 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~---- 89 (620)
+.|++.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||++++++|.....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45689999999999999999999999999999986442 233455678899999999999999999998865432
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++||||+.+ +|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCCccc
Confidence 357999999975 5666554 35899999999999999999999999 99999999999998 789999999999865
Q ss_pred ccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------------
Q 007055 170 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------------- 232 (620)
Q Consensus 170 ~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~--------------- 232 (620)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+..
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 4332 2345678999999998764 5899999999999999999999999865433222111100
Q ss_pred ------CC-C-C----------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 233 ------GI-K-P----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 233 ------~~-~-p----------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
.. . + .......++.+++||.+||+ +|.+|||+.|+|.||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00 0 0 00112345789999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.42 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=208.6
Q ss_pred EceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 22 LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
||+|+||+||+|.+..+|+.||+|++....... .........|..++..+ +||||++++++|... ..+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcC
Confidence 799999999999999999999999987543322 23344456677777665 799999999988654 468999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--CCCCc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 176 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--~~~~~ 176 (620)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCcc
Confidence 999999999998889999999999999999999999999 99999999999998 78999999999986432 22344
Q ss_pred cccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 007055 177 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254 (620)
Q Consensus 177 ~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kc 254 (620)
..+||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+..++++.+..+.... .....++.+++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHH
Confidence 5689999999998753 488999999999999999999999976 55666777776553322 1234678999999999
Q ss_pred cC-CCCCCC----CHHHHhcCCCcCCCCCCc
Q 007055 255 IV-PASLRL----PALELLKDPFLVTDNPKD 280 (620)
Q Consensus 255 L~-~p~~Rp----sa~elL~hpff~~~~~~~ 280 (620)
|. +|.+|| ++.+++.||||....+..
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~ 263 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADIDWDL 263 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence 98 899998 689999999998765443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=374.50 Aligned_cols=254 Identities=29% Similarity=0.500 Sum_probs=217.4
Q ss_pred EEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEE
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
.|...||.|+||.||+|..+.++...|-|.|.. ++.+.++.+.-||++|..|+||+||++++.|+.+++ +||+.
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk--Lwili 108 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK--LWILI 108 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc--eEEEE
Confidence 456679999999999999999999999998864 357788999999999999999999999998877754 88888
Q ss_pred eccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC--C
Q 007055 97 ELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--P 173 (620)
Q Consensus 97 Ey~~gGsL~~~i~-~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~--~ 173 (620)
|||.||-...++- -..++.+.+|..+++|++.||.|||+++ |||||||..|||++ -+|.|+|+|||.+..... .
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeecccccccchhHHh
Confidence 9999999988764 4567999999999999999999999999 99999999999998 899999999999854322 2
Q ss_pred CCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHH
Q 007055 174 TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQ 246 (620)
Q Consensus 174 ~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~~~~ 246 (620)
...+++|||.|||||++. ..|+.++||||||++|.||+.+++|-++. ++....-+|...-+| ...+..++..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-npMRVllKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-chHHHHHHHhhcCCCcccCcchhhhH
Confidence 456899999999999763 35999999999999999999999999874 555555555443333 3456778999
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCCc
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 280 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~~ 280 (620)
+++|+.+||. +|..||++.+||+|||++....+.
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCcccccCCcch
Confidence 9999999998 899999999999999998665543
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=336.71 Aligned_cols=256 Identities=34% Similarity=0.570 Sum_probs=215.3
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
.|++.++||+|+||.||+|.+..+|..||+|.+...... ......+.+.+|+.+++.++||||++++++|.+.....++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 468899999999999999999999999999998654322 2234567889999999999999999999998766566789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+|+||+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCccccccccc
Confidence 99999999999999998888999999999999999999999999 99999999999998 7899999999998654321
Q ss_pred -----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 174 -----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 174 -----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
......|+..|+|||++. ..++.++||||||+++|+|++|+.||........+.+ +.........+...+..+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPVLPPHVSDHC 238 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-HhcCCCCCCCchhhCHHH
Confidence 223456899999999875 4588999999999999999999999976544444433 333323333455567889
Q ss_pred HHHHHHhcCCCCCCCCHHHHhcCCCcC
Q 007055 248 KQFIEKCIVPASLRLPALELLKDPFLV 274 (620)
Q Consensus 248 k~~I~kcL~~p~~Rpsa~elL~hpff~ 274 (620)
.++|.+|+.+|.+||++.|+++|||+.
T Consensus 239 ~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 239 RDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 999999999999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.41 Aligned_cols=251 Identities=32% Similarity=0.588 Sum_probs=207.8
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|+||+||+|.+..+++.||+|.+..... .........+|+.++++++||||+++++++.+ ...+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhccccccccccccccccccc--ccccccc
Confidence 7899999999999999999999999999999986542 12223344569999999999999999999876 3568899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc--cCC
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~--~~~ 173 (620)
|||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.++|+|||.+... ...
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccccccccc
Confidence 999999999999998888999999999999999999999999 99999999999998 8899999999998642 233
Q ss_pred CCccccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCCCCC--CCCcHHH
Q 007055 174 TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLS--KVTDPQV 247 (620)
Q Consensus 174 ~~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~--~~~~i~~~i~~~~~p~~~~--~~~~~~l 247 (620)
......+|+.|+|||++. ..++.++||||||+++|+|++|..||.... +.............+.... ....+.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 345567899999999887 458999999999999999999999998752 1222222222211111111 1124799
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+++|.+||. +|.+||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999998 89999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=372.77 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=220.6
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
-...++.|++.+.||+|+||+||+|.+..+|+.||+|.+..... +......+.+|+.++..++|+||++++..|....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34456788999999999999999999999999999999876543 3456677889999999999999999998775432
Q ss_pred C------CeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc
Q 007055 89 N------RTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 158 (620)
Q Consensus 89 ~------~~l~lV~Ey~~gGsL~~~i~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~ 158 (620)
. ..+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-SNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-CCCC
Confidence 2 2478999999999999998643 46899999999999999999999998 99999999999998 7899
Q ss_pred EEEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Q 007055 159 VKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 233 (620)
Q Consensus 159 vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 233 (620)
+||+|||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+...++..+..+
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~ 260 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAG 260 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcC
Confidence 999999998654322 2345689999999998874 599999999999999999999999976 4566666666655
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 234 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 234 ~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
..+ .++...+++++++|.+||. +|.+||++.++|.|||++.
T Consensus 261 ~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 261 RYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 443 3455678999999999998 8999999999999999865
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.71 Aligned_cols=260 Identities=19% Similarity=0.360 Sum_probs=213.4
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.++.+++.||+|.+...... .......+.+|+.++..++||||++++++|.+. ..+|+
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~l 78 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLYL 78 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEE
Confidence 478999999999999999999999999999998753321 233455688899999999999999999988654 57999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
||||+.||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccCC
Confidence 9999999999999987 467999999999999999999999999 99999999999998 7899999999998655433
Q ss_pred C---CccccCCCCCCCcccccc------ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---C
Q 007055 174 T---ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS---K 241 (620)
Q Consensus 174 ~---~~~~~GTp~y~APEll~~------~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~---~ 241 (620)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+........++ .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~ 234 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHIT 234 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCccc
Confidence 2 123579999999998753 478899999999999999999999976 44555566665432222222 2
Q ss_pred CCcHHHHHHHHHhcCCCCC---CCCHHHHhcCCCcCCCCCCcc
Q 007055 242 VTDPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~~p~~---Rpsa~elL~hpff~~~~~~~~ 281 (620)
..+..++++|.+||..+.+ |+++.++++||||....+...
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~ 277 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI 277 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence 3578999999999974333 568999999999988765543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=354.05 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=207.7
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 81 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~ 81 (620)
+|.+..+.|++.++||+|+||.||+|.+ ..++..||+|.++... .......+.+|+.+|..+ +||||++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~ 77 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLL 77 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEE
Confidence 3677788899999999999999999975 3456789999886332 234456789999999999 899999999
Q ss_pred eEEEcCCCCeEEEEEeccCCCCHHHHHHhC--------------------------------------------------
Q 007055 82 NSWVDDTNRTINMITELFTSGSLRQYRKKH-------------------------------------------------- 111 (620)
Q Consensus 82 ~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~-------------------------------------------------- 111 (620)
+++... ...+++||||+++|+|.+++...
T Consensus 78 ~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (338)
T cd05102 78 GACTKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS 156 (338)
T ss_pred eEecCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence 987644 34688999999999999998753
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC----CC
Q 007055 112 ------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TA 175 (620)
Q Consensus 112 ------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~----~~ 175 (620)
..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...... ..
T Consensus 157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~ 233 (338)
T cd05102 157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRK 233 (338)
T ss_pred cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcc
Confidence 24778889999999999999999998 99999999999998 7899999999999654322 11
Q ss_pred ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 176 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 176 ~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
....+++.|+|||++. ..++.++|||||||++|||++ |..||.+......+...+..+..+ ..+...++.++++|.+
T Consensus 234 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 312 (338)
T cd05102 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLA 312 (338)
T ss_pred cCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHH
Confidence 2345678899999775 458999999999999999997 999998755445555555554333 3455678899999999
Q ss_pred hcC-CCCCCCCHHHHhc
Q 007055 254 CIV-PASLRLPALELLK 269 (620)
Q Consensus 254 cL~-~p~~Rpsa~elL~ 269 (620)
||. +|.+|||+.++++
T Consensus 313 cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 313 CWQGDPKERPTFSALVE 329 (338)
T ss_pred HccCChhhCcCHHHHHH
Confidence 998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=342.73 Aligned_cols=262 Identities=26% Similarity=0.459 Sum_probs=222.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+.+|++++++++||||+++++++.+. ..+++
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 78 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYL 78 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEEE
Confidence 578999999999999999999999999999998754321 234557789999999999999999999988654 46899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||+|.|||++ .+|.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC-
Confidence 9999999999999998899999999999999999999999999 99999999999998 7899999999998765443
Q ss_pred CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 175 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
.....|++.|+|||.+. ..++.++||||||+++|+|++|..||... +.....+.+..+.. .++...++.++++|.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~ 231 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGKV--RFPSFFSPDAKDLIRN 231 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCc--cCCccCCHHHHHHHHH
Confidence 34457899999999775 45788999999999999999999999764 45555666654432 3445568999999999
Q ss_pred hcC-CCCCCC-----CHHHHhcCCCcCCCCCCccccCCC
Q 007055 254 CIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 286 (620)
Q Consensus 254 cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~ 286 (620)
||. +|.+|+ ++.|++.||||....+..+....+
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 270 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKI 270 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccC
Confidence 998 899999 899999999998877655543333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=362.20 Aligned_cols=248 Identities=27% Similarity=0.363 Sum_probs=200.5
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
....|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|+.|+||||++++++|... ..
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~ 157 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYN--KF 157 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEEC--Ce
Confidence 34568999999999999999999999999999996431 2367899999999999999999988654 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
.++|+|++. ++|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPV 233 (391)
T ss_pred eEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCcccccc
Confidence 889999985 789999988888999999999999999999999999 99999999999998 78999999999986432
Q ss_pred C---CCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCC-------HHHHHHHHHc-CCC----
Q 007055 172 Q---PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKN-------PAQIYKKVTS-GIK---- 235 (620)
Q Consensus 172 ~---~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~-------~~~i~~~i~~-~~~---- 235 (620)
. ......+||+.|+|||++. ..|+.++|||||||++|||++|..||.+... ..++...+.. +..
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 2 2233568999999999876 4599999999999999999999988754211 1111111110 000
Q ss_pred ----------------------CCCCC-----CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 236 ----------------------PASLS-----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 236 ----------------------p~~~~-----~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
+...+ ...+.++++||.+||+ +|.+||||.|+|+||||+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 10000 0135678999999998 9999999999999999976
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.97 Aligned_cols=252 Identities=29% Similarity=0.429 Sum_probs=199.4
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCcceEEeEEEcC---CC
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDD---TN 89 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpNIVkl~~~f~~~---~~ 89 (620)
|++.+.||+|+||+||+|.++.+|+.||+|.++...... .....+.+|+.+++.+ +||||++++++|... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 688999999999999999999999999999987543211 1122345677666655 799999999987643 23
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 90 RTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
..+++|+||+. ++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccCcc
Confidence 46899999997 4898888764 34899999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C-C----C---
Q 007055 168 IVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-I-K----P--- 236 (620)
Q Consensus 168 ~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~-~-~----p--- 236 (620)
...... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+......+.+.+... . . +
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 765433 234467899999999875 458999999999999999999999997654433332222110 0 0 0
Q ss_pred ---------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 237 ---------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 237 ---------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.......+..++++|.+||+ +|.+|||+.|+|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00112346788999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=356.01 Aligned_cols=251 Identities=27% Similarity=0.470 Sum_probs=205.0
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||++++++|.+. ..++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC--CeEE
Confidence 34678899999999999999999999999999986432 334556789999999999999999999987544 5689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||||+.+|+|... ...++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceecccc
Confidence 99999999998653 34678889999999999999999999 99999999999998 7899999999998765432
Q ss_pred --CCccccCCCCCCCcccccc-----c-cCccchhhhhHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCC
Q 007055 174 --TARSVIGTPEFMAPELYEE-----E-YNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVT 243 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~-----~-y~~~~DIwSlGiilyELltG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~ 243 (620)
.....+||+.|+|||++.. . ++.++|||||||++|||++|+.||..... .......+... .+.......
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 300 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-QPPEAPATA 300 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-CCCCCCCcc
Confidence 2345689999999998742 2 34689999999999999999999974322 12222233222 223344567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
++.+++||.+||. +|.+||++.|+|+||||....
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 8899999999998 899999999999999998753
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.92 Aligned_cols=259 Identities=18% Similarity=0.352 Sum_probs=213.1
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.++||+|+||+||++.++.+++.||+|.+...... .......+.+|+.++..++||||+++++++.+. ..+++
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYL 78 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEE
Confidence 468999999999999999999999999999998653321 223345578899999999999999999988654 46899
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
||||+.+|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheecccC
Confidence 9999999999999987 467999999999999999999999999 99999999999998 7899999999998644222
Q ss_pred ---CCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---C
Q 007055 174 ---TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS---K 241 (620)
Q Consensus 174 ---~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~---~ 241 (620)
.....+||+.|+|||++. +.++.++|||||||++|||++|+.||.. .+..+.+..+........++ .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~ 234 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVT 234 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCccc
Confidence 122357999999999874 3488999999999999999999999976 45566666665543222222 3
Q ss_pred CCcHHHHHHHHHhcCC---CCCCCCHHHHhcCCCcCCCCCCc
Q 007055 242 VTDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKD 280 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~~---p~~Rpsa~elL~hpff~~~~~~~ 280 (620)
..++.+++||.+||.. +..|+++.++++||||....+..
T Consensus 235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~ 276 (332)
T cd05623 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276 (332)
T ss_pred cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence 4688999999999963 34478999999999998876544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=335.89 Aligned_cols=255 Identities=33% Similarity=0.562 Sum_probs=213.4
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
|++.+.||+|+||.||+|.+..+|..||+|.+...... ........+.+|+.+++.++||||+++++++.......+++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 57889999999999999999999999999998755322 12345567889999999999999999999887666678999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
++||+++++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 84 ~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 84 FMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCcccccccc
Confidence 9999999999999998888999999999999999999999998 99999999999998 7889999999998654321
Q ss_pred ----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 174 ----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 174 ----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
......++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+...... ...+.++...++.++
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ-PTNPQLPSHISEHAR 239 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC-CCCCCCchhcCHHHH
Confidence 1223568899999998764 4889999999999999999999999875444444443332 233445566788999
Q ss_pred HHHHHhcCCCCCCCCHHHHhcCCCcC
Q 007055 249 QFIEKCIVPASLRLPALELLKDPFLV 274 (620)
Q Consensus 249 ~~I~kcL~~p~~Rpsa~elL~hpff~ 274 (620)
++|..|+.+|.+||++.|+++||||+
T Consensus 240 ~li~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 240 DFLGCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHhcCChhhCcCHHHHhcCcccc
Confidence 99954445999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.77 Aligned_cols=254 Identities=29% Similarity=0.383 Sum_probs=203.7
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC----C
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----N 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~----~ 89 (620)
+.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......++.+|+.+++.++||||++++++|.... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45689999999999999999999999999999986432 23445577889999999999999999999886533 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++||||+.+ +|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCccccc
Confidence 357999999975 66666653 5899999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Q 007055 170 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-------------- 233 (620)
Q Consensus 170 ~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~-------------- 233 (620)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+..-
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 5433 2345679999999998764 58999999999999999999999997643322221111100
Q ss_pred --------CC------C-----------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 234 --------IK------P-----------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 234 --------~~------p-----------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
.. + .......+..+++||.+||+ +|.+|||+.|+|+||||..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 00 0 00112235678999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=367.56 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=213.5
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccC-CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~t-g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++|||||+++++|... ..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CE
Confidence 44589999999999999999999888 889999976533 234456678899999999999999999998655 47
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 92 INMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
+++||||+++|+|.+++.. ..++++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DFgla 216 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeCcCc
Confidence 9999999999999987753 456899999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCC----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 007055 168 IVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 168 ~~~~~~----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+..+..+ .++..
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~ 294 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-PFPCP 294 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-CCCcc
Confidence 755432 2345679999999998864 589999999999999999999999976 4555666666554333 23455
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
.++.+++||.+||. +|.+||++.++|.|||++.
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 67899999999998 8999999999999999964
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=341.96 Aligned_cols=242 Identities=22% Similarity=0.319 Sum_probs=206.8
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc--CCCCeEEEEEe
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD--DTNRTINMITE 97 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~--~~~~~l~lV~E 97 (620)
..||+|+++.||+|.. +|+.||+|.++.... ......+.+.+|+.+|++++||||+++++++.+ +....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 6799999999999977 799999999875432 233445778899999999999999999999877 44567899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEecCCCCcEEEccccchhhccCCCCc
Q 007055 98 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 176 (620)
Q Consensus 98 y~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~ 176 (620)
|+++|+|.+++...+.+++.....++.|++.||.|||+. + ++||||||+||+++ .+|.+||+|||++...... ..
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~-~~ 178 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSP-PF 178 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhccc-cc
Confidence 999999999999888899999999999999999999984 6 88999999999998 7899999999998765432 23
Q ss_pred cccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 177 SVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 177 ~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
..+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+..+++..+..+.....++...++.+++||.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4578999999998864 689999999999999999999999986 456666666655444444555678999999999
Q ss_pred hcC-CCCCCCCHHHHhc
Q 007055 254 CIV-PASLRLPALELLK 269 (620)
Q Consensus 254 cL~-~p~~Rpsa~elL~ 269 (620)
||+ +|.+|||+.|++.
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 998 9999999999985
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=384.69 Aligned_cols=263 Identities=25% Similarity=0.441 Sum_probs=221.0
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.-..|++.+.||+|+||+||+|.+..++..||+|.+..... .......+..|+.+|+.|+|||||+++++|.+.....
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 33467999999999999999999999999999999876543 3345677899999999999999999999998877778
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCEEecCCCccceEecC--------
Q 007055 92 INMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHN-----PPIIHRDLKCDNIFVNG-------- 154 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~-----~~IiHrDLKp~NILl~~-------- 154 (620)
+|+||||+.+|+|.+++.. .+.+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 9999999999999999875 357999999999999999999999854 34999999999999952
Q ss_pred --------CCCcEEEccccchhhccCC-CCccccCCCCCCCccccc---cccCccchhhhhHHHHHHHHhcCCCCCCCCC
Q 007055 155 --------NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKN 222 (620)
Q Consensus 155 --------~~G~vKI~DFGla~~~~~~-~~~~~~GTp~y~APEll~---~~y~~~~DIwSlGiilyELltG~~Pf~~~~~ 222 (620)
..+.+||+|||++...... .....+||+.|+|||++. ..++.++|||||||++|+|+||..||.....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 1345899999999765433 234568999999999874 2488999999999999999999999987777
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 223 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 223 ~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
..++...+..+... .....++.+.+||..||. +|.+||++.++|.|||+....+
T Consensus 249 ~~qli~~lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 249 FSQLISELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHHHHHHhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 77776666654322 223457899999999998 8999999999999999975543
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=343.09 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=210.9
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.+..+|..||+|.++... ......++.+|++++++++||||++++++|.++ ..+++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEE
Confidence 4789999999999999999999999999999886432 244556788999999999999999999998654 47899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
|+||+++|+|.+++.+.+.+++..+..++.||+.||.|||+ ++ ++||||||+|||++ .+|.+||+|||++......
T Consensus 77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCccccccc
Confidence 99999999999999988899999999999999999999997 57 99999999999998 7899999999998665544
Q ss_pred CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------------------
Q 007055 174 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------------- 232 (620)
Q Consensus 174 ~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-------------------- 232 (620)
......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... .......+..
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCC
Confidence 4556789999999998764 48899999999999999999999996532 2222221111
Q ss_pred ----------------CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 233 ----------------GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 233 ----------------~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
...|.......++.+++||.+||. +|.+||++.++++||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 111111112357789999999998 89999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=365.31 Aligned_cols=254 Identities=19% Similarity=0.307 Sum_probs=199.3
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC------CCcceEEeEEEc
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH------ENIIKFYNSWVD 86 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H------pNIVkl~~~f~~ 86 (620)
.+.|++.++||+|+||+||+|.+..+++.||+|+++... .....+..|+.+++.++| ++|++++++|..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 456799999999999999999999999999999986321 222345567777766654 458889998765
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCC--------
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNG-------- 157 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G-------- 157 (620)
+ ...+++||+++ +++|.+++.+++.+++..++.++.||+.||.|||+ .+ ||||||||+|||++ .++
T Consensus 203 ~-~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~-~~~~~~~~~~~ 277 (467)
T PTZ00284 203 E-TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILME-TSDTVVDPVTN 277 (467)
T ss_pred C-CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEe-cCCcccccccc
Confidence 4 35788999988 78999999888899999999999999999999998 48 99999999999997 343
Q ss_pred --------cEEEccccchhhccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007055 158 --------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 228 (620)
Q Consensus 158 --------~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~ 228 (620)
.+||+|||++.... ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+..+...+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~- 355 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH- 355 (467)
T ss_pred cccCCCCceEEECCCCccccCc-cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-
Confidence 49999999875432 23345789999999998764 59999999999999999999999997754433222
Q ss_pred HHHc--CCCCCC-------------------------------------C-CCCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 007055 229 KVTS--GIKPAS-------------------------------------L-SKVTDPQVKQFIEKCIV-PASLRLPALEL 267 (620)
Q Consensus 229 ~i~~--~~~p~~-------------------------------------~-~~~~~~~lk~~I~kcL~-~p~~Rpsa~el 267 (620)
.+.. +..|.. + ....++.+.+||.+||+ +|.+|||+.|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 1111 000000 0 01124678899999998 99999999999
Q ss_pred hcCCCcCCCCC
Q 007055 268 LKDPFLVTDNP 278 (620)
Q Consensus 268 L~hpff~~~~~ 278 (620)
|+||||....+
T Consensus 436 L~Hp~~~~~~~ 446 (467)
T PTZ00284 436 TTHPYVLKYYP 446 (467)
T ss_pred hcCccccccCC
Confidence 99999987443
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=337.95 Aligned_cols=251 Identities=29% Similarity=0.523 Sum_probs=209.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.++||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++... ...++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEE
Confidence 4688899999999999999999999999999986432 344556788999999999999999999998765 46889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
|+||+++|+|..+ ..+++..+..++.||+.||.|||+++ |+|+||||+|||++ .+|.+||+|||++.......
T Consensus 77 v~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 77 CTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred EEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceeccccc
Confidence 9999999999765 35789999999999999999999999 99999999999998 78999999999997665555
Q ss_pred CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 175 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKN------PAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~------~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
....+||+.|+|||++. ..++.++||||||+++|+|++|..||..... +......+.....+.......++++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 55678999999999876 4589999999999999999999999964221 2233333333333332334467899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
++||.+||+ +|.+||++.|++.||||+..+
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 999999998 899999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=341.60 Aligned_cols=258 Identities=22% Similarity=0.361 Sum_probs=210.7
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.++||+|+||+||+|.+..+++.||+|.+...... .......+.+|+.+++.++|+||+++++.+.+. ..+++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEE
Confidence 56789999999999999999999999999998754332 223345677899999999999999999987654 479999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 96 TELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
|||+.+|+|.+++...+ .+++.++..++.|++.||.|||+++ |+||||||+||+++ .++.++|+|||++......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCCC
Confidence 99999999999886543 5899999999999999999999998 99999999999998 7889999999998654322
Q ss_pred -CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 174 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA--QIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~--~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
......||+.|+|||++. ..++.++||||||+++|+|++|+.||....... .....+... .+..++...++.+++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (285)
T cd05630 156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARS 234 (285)
T ss_pred ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHH
Confidence 223457999999999876 458999999999999999999999997643221 112222111 122345567889999
Q ss_pred HHHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCc
Q 007055 250 FIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKD 280 (620)
Q Consensus 250 ~I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~ 280 (620)
||.+||+ +|.+||| +.|+++||||.......
T Consensus 235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05630 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKR 271 (285)
T ss_pred HHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHH
Confidence 9999998 8999999 99999999998765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=355.56 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=208.0
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC---CeE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTI 92 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~---~~l 92 (620)
|++.+.||+|+||+||+|.+..+|+.||+|.+.... .......++.+|+.+|+.++||||+++++++..... ..+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 567899999999999999999999999999885321 233445678899999999999999999998865431 268
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
|+|+||+. ++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+|||++ .+|.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeeccc
Confidence 99999996 689888888888999999999999999999999999 99999999999998 789999999999865432
Q ss_pred C---CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------------
Q 007055 173 P---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------------- 232 (620)
Q Consensus 173 ~---~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~--------------- 232 (620)
. ......+|+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.. +......+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS-PIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 2 2234578999999998764 47899999999999999999999997643 3332222211
Q ss_pred ---------CCCCC------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 233 ---------GIKPA------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 233 ---------~~~p~------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
...++ .+....++++++||.+||+ +|.+|||+.|+|.||||....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 11111 1223357889999999998 999999999999999998743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=352.26 Aligned_cols=253 Identities=28% Similarity=0.398 Sum_probs=204.0
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC----C
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----N 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~----~ 89 (620)
..|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||++++++|.... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45689999999999999999999999999999986432 23345567889999999999999999999875432 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+|+||||+.+ +|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCccc
Confidence 468999999975 67777653 4889999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCCC-CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Q 007055 170 MQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------------ 235 (620)
Q Consensus 170 ~~~~~-~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------------ 235 (620)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.... ..+..+.....
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHhhhH
Confidence 54332 345679999999998764 5899999999999999999999999764433 33222221100
Q ss_pred ---------C-------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 236 ---------P-------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 236 ---------p-------------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
| .......+..+++||.+||+ +|.+|||+.++|+||||..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 00111234678999999998 9999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.03 Aligned_cols=251 Identities=31% Similarity=0.543 Sum_probs=217.6
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||.|+||.||+|.+..+|..||+|.++.... .....+++..|+.+++.++||||+++++++.......++++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 6788999999999999999999999999999875543 34556778999999999999999999999887777789999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 96 TELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLH-----SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLH-----s~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
+||+++++|.+++.. ...+++..++.++.||+.||.||| +.+ ++||||||+||+++ .++.+||+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEecccc
Confidence 999999999999876 357999999999999999999999 777 99999999999998 789999999999
Q ss_pred hhhccCCC--CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 007055 167 AIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243 (620)
Q Consensus 167 a~~~~~~~--~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~ 243 (620)
+....... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||... +...+...+..+..+ .++...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 234 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPYRY 234 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCcccc
Confidence 87655433 345678999999998764 5888999999999999999999999874 456666666665433 455567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+..+.+++.+||. +|.+||++.++|+|||+
T Consensus 235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 235 SSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 8899999999998 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=331.37 Aligned_cols=255 Identities=31% Similarity=0.550 Sum_probs=216.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
.|++.+.||+|+||.||+|.+..+|..||+|.+...... ........+.+|+.+++.++||||+++++++.+.....++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 468999999999999999999999999999988653221 2334567789999999999999999999998776667789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+++||+++++|.+++...+.+++..++.|+.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECccccccccccc
Confidence 99999999999999988888999999999999999999999999 99999999999998 7889999999998654321
Q ss_pred -----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 174 -----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 174 -----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+.+ +.....++.++...++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK-IATQPTKPMLPDGVSDAC 238 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH-HHcCCCCCCCCcccCHHH
Confidence 1234568999999998764 488999999999999999999999987544444443 333333445666778899
Q ss_pred HHHHHHhcCCCCCCCCHHHHhcCCCc
Q 007055 248 KQFIEKCIVPASLRLPALELLKDPFL 273 (620)
Q Consensus 248 k~~I~kcL~~p~~Rpsa~elL~hpff 273 (620)
++||.+||++|..||++.++|.|||.
T Consensus 239 ~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 239 RDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHhcCcccCccHHHHhcCCCC
Confidence 99999999989999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=343.83 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=203.8
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.++.++..||+|.++..... .....+.+|+.+++.++||||+++++++..+ ..+++
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 81 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTL 81 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC---CcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEE
Confidence 468999999999999999999999999999998754321 2234567899999999999999999988654 46899
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVP 157 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecCCC
Confidence 9999975 888877654 45899999999999999999999999 99999999999998 7899999999998654322
Q ss_pred --CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CC-----------
Q 007055 174 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IK----------- 235 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~---~~----------- 235 (620)
......+|+.|+|||++.+ .++.++|||||||++|+|+||+.||.+....+. ...+... ..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchh
Confidence 2234568999999998753 488999999999999999999999976433322 2221110 00
Q ss_pred -------CC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 236 -------PA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 236 -------p~-------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+. ......+++++++|.+||. +|.+|||+.|+|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00 0112357789999999998 999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=344.56 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=193.2
Q ss_pred EEEEceeCCeEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEE
Q 007055 19 DEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~--~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
+.+||+|+||+||+|.++ .+++.||+|.+..... ...+.+|+.+|+.++||||++++++|.......+++|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 468999999999999965 4778999998864321 23467899999999999999999998877777899999
Q ss_pred eccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec---CCCCcEEEccc
Q 007055 97 ELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDL 164 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~---------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~---~~~G~vKI~DF 164 (620)
||+. ++|.+++... ..+++..++.+++||+.||.|||+++ |+||||||+|||+. ..+|.+||+||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9986 5888887532 25899999999999999999999999 99999999999994 25679999999
Q ss_pred cchhhccCC-----CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCH---------HHHHH
Q 007055 165 GLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIYK 228 (620)
Q Consensus 165 Gla~~~~~~-----~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~---------~~i~~ 228 (620)
|++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...... .++..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 999765432 2235678999999998754 4899999999999999999999999643211 11111
Q ss_pred HHHcCCCC------------C-----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 007055 229 KVTSGIKP------------A-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 272 (620)
Q Consensus 229 ~i~~~~~p------------~-----------------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpf 272 (620)
.+.....| . ......+..+.+||.+||+ +|.+|||++|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 11100000 0 0001134578899999998 9999999999999999
Q ss_pred c
Q 007055 273 L 273 (620)
Q Consensus 273 f 273 (620)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=338.72 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=203.7
Q ss_pred EceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCC
Q 007055 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 101 (620)
Q Consensus 22 LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~g 101 (620)
||+|+||.||+|.++.+|+.||+|.+....... ......+..|+++++.++||||+++++++... ..+++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecCCC
Confidence 799999999999999999999999987543321 22334466799999999999999999987544 578999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-CCccc
Q 007055 102 GSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSV 178 (620)
Q Consensus 102 GsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~-~~~~~ 178 (620)
|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++...... .....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeecc
Confidence 99998886543 5899999999999999999999999 99999999999998 7899999999998654432 22345
Q ss_pred cCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 007055 179 IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254 (620)
Q Consensus 179 ~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~---~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kc 254 (620)
.||+.|+|||++. ..++.++|||||||++|+|++|..||..... ...+.........+. .....+++++++|.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHH
Confidence 7899999999875 4589999999999999999999999975332 223333333322221 2235688999999999
Q ss_pred cC-CCCCCCCH----HHHhcCCCcCCCCCCc
Q 007055 255 IV-PASLRLPA----LELLKDPFLVTDNPKD 280 (620)
Q Consensus 255 L~-~p~~Rpsa----~elL~hpff~~~~~~~ 280 (620)
|+ +|.+||++ .++++||||+..++..
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~ 264 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINFPR 264 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence 98 89999999 6788999998765544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.00 Aligned_cols=250 Identities=28% Similarity=0.553 Sum_probs=211.2
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|++|.||+|.++.+++.||+|.+..... .....+.+.+|+.+++.++||||+++++.|... ...+++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv 78 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIV 78 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEE
Confidence 6899999999999999999999999999999875432 234556788999999999999999999987533 3568999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 96 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||+++++|.+++... ..+++.+++.++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEeccc
Confidence 9999999999998763 45899999999999999999999999 99999999999998 7899999999998655332
Q ss_pred --CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 174 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
......|++.|+|||++.+ .++.++||||||+++|+|++|+.||... +.......+..+..+ ..+...++++.+|
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 233 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKLP-PMPKDYSPELGEL 233 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCC-CCccccCHHHHHH
Confidence 2334578999999998764 5889999999999999999999999764 444444445554433 2445678899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 251 IEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
|.+||+ +|.+||++.++++||||
T Consensus 234 i~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 234 IATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=331.92 Aligned_cols=252 Identities=32% Similarity=0.522 Sum_probs=210.1
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc--CCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~--~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
|++.+.||+|+||+||+|.+ .+|..+|+|.++..... ........+.+|+++++.++|+||+++++++.+. ..++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 78 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTIS 78 (265)
T ss_pred ccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEE
Confidence 57889999999999999986 48899999998754321 1233456788999999999999999999988654 5799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC-
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~- 172 (620)
+|+||+++|+|.+++.+.+.+++..+..++.||+.||+|||+.+ ++|+||+|+||+++ .+|.+||+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhc
Confidence 99999999999999998888999999999999999999999999 99999999999998 789999999999865421
Q ss_pred -------CCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 173 -------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 173 -------~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
.......|++.|+|||++.+ .++.++||||||+++|+|++|..||...................+.++...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS 235 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence 11234568999999998764 5889999999999999999999999765444444333332122334555678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
..+++||.+||. +|.+||++.++|.||||
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 899999999997 89999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=349.86 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=206.3
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+.. .|++.+.||+|+||+||+|.+..++..||+|.+.... ........+.+|+.+|+.++||||++++++|...
T Consensus 10 ~~~~~~-~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07878 10 VWEVPE-RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA 86 (343)
T ss_pred Hhhhhh-hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence 344444 4588999999999999999999999999999986432 1223456678999999999999999999987543
Q ss_pred CC----CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 88 TN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 88 ~~----~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
.. ..++++++++ +++|.++++. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|
T Consensus 87 ~~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~D 161 (343)
T cd07878 87 TSIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILD 161 (343)
T ss_pred ccccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcC
Confidence 21 3578999988 7899887764 56999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CC----
Q 007055 164 LGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IK---- 235 (620)
Q Consensus 164 FGla~~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~--~~---- 235 (620)
||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...... ...+... ..
T Consensus 162 fg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 239 (343)
T cd07878 162 FGLARQADD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ-LKRIMEVVGTPSPEV 239 (343)
T ss_pred CccceecCC-CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCCHHH
Confidence 999975543 2345679999999998764 488999999999999999999999976433222 2222110 00
Q ss_pred -------------------C-C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 236 -------------------P-A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 236 -------------------p-~---~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+ . ......++.+.+||.+||. +|.+|||+.|+|.||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0 0 0011245678999999998 99999999999999999763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.76 Aligned_cols=249 Identities=31% Similarity=0.569 Sum_probs=213.6
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|.+.+.||+|++|.||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++... ...++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIV 77 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEE
Confidence 5788999999999999999999999999999876543 245567789999999999999999999988654 578999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 96 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccCc
Confidence 9999999999998764 56899999999999999999999998 99999999999998 7899999999998654432
Q ss_pred --CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 174 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
......|++.|+|||++.+ .++.++||||||+++++|++|+.||... +.......+..+..+. ++...++.++++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFPP-VSQMYSQQLAQL 232 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC-CccccCHHHHHH
Confidence 2234578999999998764 5889999999999999999999999764 4556666666554433 344678899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 251 IEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
|.+||+ +|.+||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999998 89999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=337.60 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=203.5
Q ss_pred EEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH---HHHhCCCCCcceEEeEEEcCCCCeEEEEEe
Q 007055 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH---LLKSLKHENIIKFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 21 ~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~---iL~~L~HpNIVkl~~~f~~~~~~~l~lV~E 97 (620)
+||+|+||.||+|.+..+|..||+|.+........ .......+|.. ++...+||||+.+++++..+ ..+++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEe
Confidence 48999999999999999999999999875543221 22222334443 34445899999999988654 46889999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCCcc
Q 007055 98 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 177 (620)
Q Consensus 98 y~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~ 177 (620)
|+++|+|.+++..++.+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..........
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccC
Confidence 9999999999998889999999999999999999999999 99999999999998 78999999999986554444445
Q ss_pred ccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 178 VIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 178 ~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~--~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
..||+.|+|||.+. ..++.++|||||||++|+|++|..||...... ..+.... . ..+..++...++.++++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-L-TVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-h-cCCcCCccccCHHHHHHHHH
Confidence 67999999999875 34889999999999999999999999753322 2221211 1 12334455678899999999
Q ss_pred hcC-CCCCCC-----CHHHHhcCCCcCCCCCCcc
Q 007055 254 CIV-PASLRL-----PALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 254 cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 281 (620)
||. +|.+|+ ++.++++||||+..+....
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence 998 899999 6999999999998765554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=344.50 Aligned_cols=267 Identities=23% Similarity=0.423 Sum_probs=232.5
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.+.+.++||+|.||.|-+++.+.+|+.+|+|+++++-+. ..++...-..|-++|+.++||.+..+..+|+. +..+++
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevii-akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drlCF 245 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVII-AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRLCF 245 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhee-ehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceEEE
Confidence 356778999999999999999999999999999866443 45666777889999999999999999888854 457999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc--cC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQ 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~--~~ 172 (620)
||||..||.|+-.+.+.+.+++...+.+...|+.||.|||+++ ||+||||.+|.|++ ++|++||.|||+++.- ..
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhccccc
Confidence 9999999999999999999999999999999999999999999 99999999999998 8999999999998642 34
Q ss_pred CCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 173 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 173 ~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
....++||||+|+|||++.. .|+.++|+|.+|+++|||++|+.||.. .+...++..|.-+ ...++...+++++.++
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~e--d~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILME--DLKFPRTLSPEAKTLL 399 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhh--hccCCccCCHHHHHHH
Confidence 46778999999999999975 599999999999999999999999987 4555566666543 3346677889999999
Q ss_pred HHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCccccCCCCCCC
Q 007055 252 EKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPN 290 (620)
Q Consensus 252 ~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p~ 290 (620)
..+|. +|.+|+. |.|+.+|+||...+|...+.+.+..|.
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPf 444 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPF 444 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCC
Confidence 99997 8999985 889999999999999887766665443
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=334.82 Aligned_cols=249 Identities=27% Similarity=0.484 Sum_probs=207.8
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.+++.++||||+++++++... ..+++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~~~l 83 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DKLWI 83 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEE
Confidence 4578899999999999999999999999999987542 23345678899999999999999999988654 46899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
|+||+++|+|.+++...+.+++.+++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeeeEccCcc
Confidence 9999999999999998889999999999999999999999999 99999999999998 7889999999998654322
Q ss_pred -CCccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHH
Q 007055 174 -TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQ 246 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~~~~ 246 (620)
......|++.|+|||++. +.++.++|||||||++|+|++|..||..................+..+.. ..+..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 223457899999999863 34889999999999999999999999764433333333333333322221 35678
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPF 272 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpf 272 (620)
+++||.+||+ +|.+||++.+++.|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999998 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=333.33 Aligned_cols=252 Identities=30% Similarity=0.542 Sum_probs=207.9
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCC--
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT-- 88 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~-- 88 (620)
.|+| ++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.+ +||||++++++|....
T Consensus 5 ~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 5 AGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhh-hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 3444 78899999999999999999999999999986432 2235678899999998 7999999999987543
Q ss_pred --CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 89 --NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 89 --~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
...+++|+||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l~Df 155 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDF 155 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEEccC
Confidence 24689999999999999998864 36899999999999999999999998 99999999999998 7889999999
Q ss_pred cchhhccCC--CCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 165 GLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 165 Gla~~~~~~--~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
|++...... ......|++.|+|||++. ..|+.++|||||||++|+|++|..||.... +......+.....+
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~ 234 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAP 234 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhcCCCC
Confidence 998654322 234567899999999874 248889999999999999999999997643 33333333333333
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.......+..+++||.+||. +|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 33344567899999999998 89999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.04 Aligned_cols=255 Identities=30% Similarity=0.511 Sum_probs=210.5
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccC--CHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~--~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
|+..+.||+|+||.||+|.+..+|..||+|.+....... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 79 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--SHFN 79 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--CeEE
Confidence 577899999999999999999999999999987543211 123457789999999999999999999988544 4688
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+|+||+.+++|.+++.+.+.+++..+..|+.||+.||.|||+++ ++||||+|+||+++..+..+||+|||++......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999998889999999999999999999999999 9999999999999844447999999998655432
Q ss_pred C------CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCc
Q 007055 174 T------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 174 ~------~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
. .....||..|+|||++. ..++.++||||||+++|+|++|+.||..... .......+.....+...+...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 22346889999999876 4588999999999999999999999964332 2222223323333445556678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
+.+++++.+||. +|.+||++.++|+||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 899999999997 899999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=337.95 Aligned_cols=250 Identities=26% Similarity=0.461 Sum_probs=202.4
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|+||.||+|.+..+|..||+|.++.... .......+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv 77 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLV 77 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEE
Confidence 6789999999999999999999999999999875432 122234577899999999999999999988654 468999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 96 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
+||+. ++|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 78 FEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPV 153 (284)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCCCC
Confidence 99997 577777764 567999999999999999999999999 99999999999998 7899999999998754432
Q ss_pred -CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Q 007055 174 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------- 236 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-------------- 236 (620)
......+++.|+|||++.+ .++.++|||||||++|+|+||..||....+....+..+.....+
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 2234567899999998754 37899999999999999999999975545544433333211000
Q ss_pred ----C---------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 237 ----A---------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 237 ----~---------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
. ......++.+++||.+||. +|.+|||+.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112356889999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.59 Aligned_cols=253 Identities=23% Similarity=0.395 Sum_probs=205.5
Q ss_pred EEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHH---HHHHHhCCCCCcceEEeEEEcCCCCeEEEEEe
Q 007055 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE---VHLLKSLKHENIIKFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 21 ~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~E---i~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~E 97 (620)
+||+|+||.||+|.+..+|+.||+|.+......... .......| +.+++...||||++++++|... ..+++|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch-hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEe
Confidence 489999999999999999999999998755432211 11223333 3455566899999999987654 46899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCCcc
Q 007055 98 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 177 (620)
Q Consensus 98 y~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~ 177 (620)
|+.||+|.+++.+.+.+++..++.|+.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..........
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCccCCcC
Confidence 9999999999998888999999999999999999999998 99999999999998 78899999999987655444556
Q ss_pred ccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 178 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 178 ~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
..|++.|+|||++.+ .++.++||||||+++|+|++|..||..... .......... .+..++...++.++++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHH
Confidence 689999999998863 488999999999999999999999976422 2222222221 2334555568999999999
Q ss_pred hcC-CCCCCC-----CHHHHhcCCCcCCCCCCcc
Q 007055 254 CIV-PASLRL-----PALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 254 cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 281 (620)
||. +|.+|| ++.++++||||....+...
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 998 899999 9999999999998776554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.81 Aligned_cols=258 Identities=23% Similarity=0.378 Sum_probs=211.4
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|+..+.||+|+||+||+|.+..+|+.||+|.+...... .......+.+|+++|+.++|+||+++++.+..+ ..+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEE
Confidence 56788999999999999999999999999998754332 223345578899999999999999999987654 478999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 96 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||+.+|+|.+++... .++++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCCC
Confidence 9999999999887653 46999999999999999999999999 99999999999998 6789999999998654322
Q ss_pred -CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCCCCCCCCCCcHHHH
Q 007055 174 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~---i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
......|++.|+|||++. ..++.++|||||||++|+|++|..||........ +...+... +..++...++.+.
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 233 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAK 233 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHH
Confidence 234567999999999875 4589999999999999999999999976433222 22222222 2234455678999
Q ss_pred HHHHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCcc
Q 007055 249 QFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~ 281 (620)
+|+.+||+ +|.+||+ +.+++.||||.....+..
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 272 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL 272 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHH
Confidence 99999998 8999999 889999999998765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=333.34 Aligned_cols=250 Identities=28% Similarity=0.450 Sum_probs=203.1
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|++|.||+|.+..+|..||+|.++.... .......+.+|+.+++.++||||+++++++.++ ..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLI 77 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEE
Confidence 6889999999999999999999999999999875432 222345678899999999999999999998754 468999
Q ss_pred EeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 96 TELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~---~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
|||+. ++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGI 153 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecCC
Confidence 99997 6888887653 46899999999999999999999999 99999999999998 789999999999865432
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------
Q 007055 173 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------ 236 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p------------ 236 (620)
. ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||.+................+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 2 1233467899999998754 47889999999999999999999998754444333222110000
Q ss_pred --------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 237 --------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 237 --------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.......+++++++|.+||. +|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00122357889999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=332.81 Aligned_cols=253 Identities=28% Similarity=0.494 Sum_probs=214.3
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++.+... ..+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEE
Confidence 4577889999999999999999999999999987542 234556788999999999999999999988665 57999
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 95 ITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
++||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+ ++||||||+||+++ .+|.++|+|||.+.....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhHH
Confidence 99999999999999876 789999999999999999999999 88 99999999999998 689999999999865544
Q ss_pred CCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCC----CCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 173 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 173 ~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~----~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
.......+++.|+|||.+.+ .++.++||||||+++|+|++|..||... .......+.+.....+.......++.+
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 154 SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 33334778999999998754 5889999999999999999999999764 233344445555443333333378899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
++||.+||. +|.+||++.+++.||||+.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 999999997 8999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.16 Aligned_cols=261 Identities=29% Similarity=0.474 Sum_probs=215.9
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
...-....|++.+.||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++.|...
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 334445577899999999999999999999999999999875432 2346688999999999999999999988754
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
...++|+||+++|+|.+++.. ..+++.++..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 90 --~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg~~ 163 (296)
T cd06654 90 --DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFC 163 (296)
T ss_pred --CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccccc
Confidence 478999999999999999865 45899999999999999999999999 99999999999997 7899999999998
Q ss_pred hhccCC--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 168 IVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 168 ~~~~~~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
...... ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||........++.....+..+...+...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (296)
T ss_pred hhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccC
Confidence 654332 2234578999999998764 4789999999999999999999999764443444443333333333345567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
+.++++|.+||. +|.+||++.+++.||||....+
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 889999999998 8999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=334.89 Aligned_cols=259 Identities=28% Similarity=0.465 Sum_probs=215.3
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.++.|++.+.||+|+||.||+|.+..+|..||+|.+... .....+.+.+|+.+++.++||||+++++++..+ ..
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 83 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD--GK 83 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--Ce
Confidence 346789999999999999999999999999999998643 345667788999999999999999999988654 46
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 92 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
+++||||+++++|..++.+ ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKN 160 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccceec
Confidence 8999999999999987754 456899999999999999999999998 99999999999997 6899999999988543
Q ss_pred cCC--CCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCC
Q 007055 171 QQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSK 241 (620)
Q Consensus 171 ~~~--~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~ 241 (620)
... ......+++.|+|||++. ..++.++|||||||++|+|++|..||... +....+..+.....+ ...+.
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQPS 239 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcCCCccCCCCc
Confidence 222 223457899999999874 23678999999999999999999999764 344444444443332 22344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCCc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 280 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~~ 280 (620)
..+..+.++|.+||. +|.+||++.++++||||....+..
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 567899999999998 899999999999999998765543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=329.06 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=214.3
Q ss_pred EceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCC
Q 007055 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 101 (620)
Q Consensus 22 LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~g 101 (620)
||.|++|.||+|.+..++..||+|.+...... .....+.+.+|+.+++.++||||+++++++.+. ..+++|+||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCC
Confidence 69999999999999999999999998755432 234457799999999999999999999987654 468899999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-CCccccC
Q 007055 102 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIG 180 (620)
Q Consensus 102 GsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~-~~~~~~G 180 (620)
++|.+++.+...+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .+|.++|+|||++...... ......|
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccC
Confidence 999999998888999999999999999999999999 99999999999998 6899999999998765443 2334578
Q ss_pred CCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-C
Q 007055 181 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 257 (620)
Q Consensus 181 Tp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~ 257 (620)
++.|+|||.+. ..++.++|+||||+++|+|++|..||.... ++...+..+..+......+...++.+++||.+||. +
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 99999999875 458899999999999999999999997644 25566666665444445555568899999999997 8
Q ss_pred CCCCCC-----HHHHhcCCCcCCCCC
Q 007055 258 ASLRLP-----ALELLKDPFLVTDNP 278 (620)
Q Consensus 258 p~~Rps-----a~elL~hpff~~~~~ 278 (620)
|.+||+ +.|+++||||...++
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCCCC
Confidence 999999 999999999987554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=344.75 Aligned_cols=251 Identities=22% Similarity=0.438 Sum_probs=201.7
Q ss_pred EEEEEcee--CCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 18 YDEILGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 18 i~e~LG~G--~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
+.++||+| +|++||++.++.+|+.||+|.++.... .....+.+.+|+.+++.++||||++++++|..+ ..+++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEE
Confidence 56789999 789999999999999999999875432 234456688899999999999999999998765 468999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 96 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||+++|+|.+++..+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++++||+........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccc
Confidence 9999999999999764 45899999999999999999999999 99999999999998 7889999999865322111
Q ss_pred ---------CCccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----
Q 007055 174 ---------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---- 237 (620)
Q Consensus 174 ---------~~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~---- 237 (620)
......++..|+|||++.+ .|+.++|||||||++|+|++|..||............+. +..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-CCccccccc
Confidence 1123356788999998763 488999999999999999999999976443333222221 11100
Q ss_pred ----------------------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 238 ----------------------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 238 ----------------------------------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
......++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0112246789999999998 99999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=336.74 Aligned_cols=260 Identities=22% Similarity=0.374 Sum_probs=213.7
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.|++.+.||+|+||+||+|.+..+|+.||+|.+...... .......+..|+.+++.++||||+++++.+.+. ..++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CEEE
Confidence 3578999999999999999999999999999999765432 223556789999999999999999999987543 5789
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 94 MITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+.+ ++||||||+||+++ .+|.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhccc
Confidence 999999999999998764 56999999999999999999999999 99999999999998 78999999999975432
Q ss_pred CC-------------------------------CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCC
Q 007055 172 QP-------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNE 219 (620)
Q Consensus 172 ~~-------------------------------~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~ 219 (620)
.. .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 11 1123478999999998764 588899999999999999999999977
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC----HHHHhcCCCcCCCCCCc
Q 007055 220 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP----ALELLKDPFLVTDNPKD 280 (620)
Q Consensus 220 ~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rps----a~elL~hpff~~~~~~~ 280 (620)
...... +..+.....+.......++.++++|.+||. +|.+||+ +.++|.||||+...+..
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 235 SNRDET-FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred CchHHH-HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence 544433 333333222222222268899999999997 8999999 99999999998765443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=328.51 Aligned_cols=251 Identities=33% Similarity=0.578 Sum_probs=209.9
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC-----HHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~-----~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
|.+...||+|++|.||+|.+..++..||+|.+........ ....+.+.+|+.+++.++||||+++++++... .
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--D 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--C
Confidence 4578899999999999999999999999998875533221 12345688999999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
..++|+||+++++|.+++...+.+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCccc
Confidence 68899999999999999999889999999999999999999999999 99999999999998 7899999999998655
Q ss_pred cCC--------CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 171 QQP--------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 171 ~~~--------~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
... ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+......+ ..+..... +.++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~~~ 234 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENAS-PEIPS 234 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccCC-CcCCc
Confidence 421 1123468899999998764 5888999999999999999999999875444433 33333322 23445
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
..+..++++|.+||+ +|.+||++.++++||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 578899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=333.38 Aligned_cols=255 Identities=28% Similarity=0.515 Sum_probs=211.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
.+|++.+.||+|+||.||+|.+..++..+|+|.+... .....+.+.+|+.+++.++||||++++++|... ...+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~ 78 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLW 78 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEE
Confidence 3467889999999999999999999999999988543 345567788999999999999999999988764 4688
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+|+||+.+|+|..++.+ ..++++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.....
T Consensus 79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEccccccccccc
Confidence 99999999999988754 467999999999999999999999999 99999999999998 789999999999864432
Q ss_pred C--CCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCC
Q 007055 173 P--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVT 243 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~ 243 (620)
. ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.... .......+..... ....+...
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRW 234 (282)
T ss_pred cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCcccc
Confidence 2 223457899999999873 237789999999999999999999997643 3333333333322 22334556
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
+..+++||.+||+ +|.+||++.++++||||.....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 7899999999998 8999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=357.86 Aligned_cols=251 Identities=26% Similarity=0.449 Sum_probs=208.8
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-C-----CCcceEEeEEEcCC
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-H-----ENIIKFYNSWVDDT 88 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-H-----pNIVkl~~~f~~~~ 88 (620)
+|.+.++||+|+||.|.+|.|..|++.||||+|+.. +....+...|+.+|..|+ | -|||+++++|....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 668999999999999999999999999999999743 455667788999999997 4 39999999997764
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC-CCCcEEEcccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLG 165 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~G~vKI~DFG 165 (620)
.+++|+|++. .+|.++++.+ .+++...++.+++||+.||.+||+.+ |||+||||+|||+.. ....|||+|||
T Consensus 262 --HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 --HLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred --ceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecc
Confidence 5899999995 6999999976 46999999999999999999999999 999999999999962 22379999999
Q ss_pred chhhccCCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC--------
Q 007055 166 LAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-------- 235 (620)
Q Consensus 166 la~~~~~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~-------- 235 (620)
.|+....... +++-+..|+|||++- ..|+.+.||||||||++||++|.+.|.+....+++...+.- |.+
T Consensus 337 SSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 337 SSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 9987766554 788899999999765 57999999999999999999999889886666665433321 000
Q ss_pred --------------------------------------------CCC-------CCCCCcHHHHHHHHHhcC-CCCCCCC
Q 007055 236 --------------------------------------------PAS-------LSKVTDPQVKQFIEKCIV-PASLRLP 263 (620)
Q Consensus 236 --------------------------------------------p~~-------~~~~~~~~lk~~I~kcL~-~p~~Rps 263 (620)
|.. +....+..+.+||.+||. +|.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 000 001224578999999998 9999999
Q ss_pred HHHHhcCCCcCCC
Q 007055 264 ALELLKDPFLVTD 276 (620)
Q Consensus 264 a~elL~hpff~~~ 276 (620)
+.++|+||||...
T Consensus 496 p~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 496 PAQALNHPFLTGT 508 (586)
T ss_pred HHHHhcCcccccc
Confidence 9999999999853
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.51 Aligned_cols=251 Identities=29% Similarity=0.524 Sum_probs=206.9
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCC----
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT---- 88 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~---- 88 (620)
..|++.+.||+|++|.||+|.++.+++.||+|.+.... ...+.+.+|+.+++++ +||||++++++|....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 45589999999999999999999999999999887442 2346688999999999 7999999999987643
Q ss_pred CCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 89 NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
...+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~-~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEc-cCCeEEECCC
Confidence 4568999999999999998865 357999999999999999999999999 99999999999998 6899999999
Q ss_pred cchhhccCC--CCccccCCCCCCCcccccc------ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 165 GLAIVMQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 165 Gla~~~~~~--~~~~~~GTp~y~APEll~~------~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
|++...... ......|++.|+|||++.. .++.++|||||||++|+|++|..||........+. .+..+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~ 236 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF-KIPRNPPP 236 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH-HhhccCCC
Confidence 998644322 2334578999999998742 36788999999999999999999997643333333 33333222
Q ss_pred CC-CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 237 AS-LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 237 ~~-~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.. .+...+..+++||.+||. +|.+|||+.+++.|||+
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 21 122356789999999997 99999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.26 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=206.8
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
.+.|++.+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEE
Confidence 446789999999999999999999999999999986432 22345678899999999999999999998654 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
++||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++ .+|.+||+|||++.....
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCccceeecc
Confidence 999999999999999988888999999999999999999999998 99999999999997 788999999999865533
Q ss_pred CC--CccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCc
Q 007055 173 PT--ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTD 244 (620)
Q Consensus 173 ~~--~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~~ 244 (620)
.. .....|++.|+|||.+. ..++.++|||||||++|+|++|+.||..................+..+ ....+
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWS 238 (267)
T ss_pred cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccC
Confidence 22 23457899999999763 347889999999999999999999996543222222222222222222 12357
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPF 272 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpf 272 (620)
..+++||.+||. +|.+||++.++|.|+|
T Consensus 239 ~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 239 STFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 899999999998 8999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=335.88 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=204.9
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.|++.+.||+|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---CchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeEE
Confidence 3578999999999999999999999999999998754321 2234567899999999999999999998654 4689
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+|+||+. ++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSI 156 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccCC
Confidence 9999997 5888887754 56899999999999999999999999 99999999999998 789999999999865432
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CC----------
Q 007055 173 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IK---------- 235 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~---~~---------- 235 (620)
. ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||.......+ ...+... ..
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhcc
Confidence 2 2234467999999998754 478899999999999999999999987443322 2221110 00
Q ss_pred --------CC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 236 --------PA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 236 --------p~-------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
|. ......++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 0112357789999999998 899999999999999997644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=334.80 Aligned_cols=260 Identities=30% Similarity=0.511 Sum_probs=215.2
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
+....+.|++.+.||.|+||+||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 88 (296)
T cd06655 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLVG- 88 (296)
T ss_pred cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEecC-
Confidence 3444456899999999999999999999999999999987542 22346688999999999999999999988654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..+++|+||+.+|+|..++... .+++.++..++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||++.
T Consensus 89 -~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~ 163 (296)
T cd06655 89 -DELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCA 163 (296)
T ss_pred -ceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccch
Confidence 4689999999999999988754 5899999999999999999999999 99999999999998 78999999999986
Q ss_pred hccCCC--CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 007055 169 VMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 245 (620)
Q Consensus 169 ~~~~~~--~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~ 245 (620)
...... .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||..................+...+...++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSP 243 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCH
Confidence 543322 234578999999998764 48899999999999999999999997754333333332223223334455688
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
.+++||.+||. +|.+||++.+++.||||+...+
T Consensus 244 ~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 99999999998 8999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=320.63 Aligned_cols=253 Identities=38% Similarity=0.620 Sum_probs=219.6
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|++|.||+|.+..+|..|++|.+..... .....+.+.+|+.++++++||||+++++.+.+.....+++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 5788999999999999999999999999999875542 24567789999999999999999999998876544679999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC-
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~- 174 (620)
+||+++++|.+++.....+++..+..++.|++.||.|||+++ ++|+||+|+||+++ .+|.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEcccccEEecccccc
Confidence 999999999999998889999999999999999999999998 99999999999998 68999999999987655443
Q ss_pred ---CccccCCCCCCCccccccc-cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 175 ---ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 175 ---~~~~~GTp~y~APEll~~~-y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
.....+++.|+|||.+.+. ++.++||||||+++|+|++|..||....+.......+........++...++.+++|
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence 3456789999999987654 889999999999999999999999876655555555554344445666678999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 251 IEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
|.+||. +|.+||++.+++.||||
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHhCcCChhhCCCHHHHhhCCCC
Confidence 999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=330.55 Aligned_cols=255 Identities=29% Similarity=0.516 Sum_probs=215.9
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||.|++|.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++++.++ ..+++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEE
Confidence 3578899999999999999999999999999987543 234456688999999999999999999998765 57899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
|+||+++++|.+++... ++++..++.++.||+.||.|||+++ ++||||+|+||+++ .+|.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeecccc
Confidence 99999999999999875 7999999999999999999999999 99999999999998 7899999999999765543
Q ss_pred -CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 174 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
......|++.|+|||.+.+ .++.++||||||+++|+|+||..||... ++......+..+..+.......++.+.+++
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHHH
Confidence 2344578999999998764 5899999999999999999999999763 455555555555443322222778999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 252 EKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
.+||. +|.+||++.++++||||+.....
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 99997 89999999999999999875543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=329.66 Aligned_cols=257 Identities=27% Similarity=0.473 Sum_probs=213.0
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|+..+.||.|++|.||+|.+..+++.||+|.+.... ......++.+|+++++.++||||++++++|.+.....+++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 3678999999999999999999999999999987542 2345577899999999999999999999988777778999
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 95 ITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeeccccccc
Confidence 9999999999988653 345899999999999999999999999 99999999999998 7889999999998655
Q ss_pred cCCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCC----CCHHHHHHHHHcCCCCC---CCC--
Q 007055 171 QQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPA---SLS-- 240 (620)
Q Consensus 171 ~~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~----~~~~~i~~~i~~~~~p~---~~~-- 240 (620)
.........++..|+|||.+. ..++.++||||||+++|+|++|..||... ....+....+.....+. ...
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd06621 156 VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235 (287)
T ss_pred cccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence 444444556889999999775 45899999999999999999999999764 23334444444322211 111
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
...++.+++||.+||. +|.+|||+.|++.||||+...
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 2246789999999998 899999999999999996644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.68 Aligned_cols=260 Identities=30% Similarity=0.488 Sum_probs=214.4
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
..-..+.|++.+.||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~- 88 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVG- 88 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 33444667899999999999999999999999999999875432 2345688999999999999999999998654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..+++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+||+++ .+|.++|+|||++.
T Consensus 89 -~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg~~~ 163 (297)
T cd06656 89 -DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCA 163 (297)
T ss_pred -CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCccce
Confidence 468999999999999999865 45899999999999999999999998 99999999999998 78999999999986
Q ss_pred hccCC--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 007055 169 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 245 (620)
Q Consensus 169 ~~~~~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~ 245 (620)
..... ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||........++.....+..+...+...++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T cd06656 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSA 243 (297)
T ss_pred EccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCH
Confidence 54332 2234578999999998764 58899999999999999999999997644333333322223233334455678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
.+++||.+||. +|.+||++.++|+||||+...+
T Consensus 244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 89999999998 8999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=336.52 Aligned_cols=247 Identities=28% Similarity=0.455 Sum_probs=192.4
Q ss_pred EEEEEceeCCeEEEEEEEcc--CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 18 YDEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~--tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
.+.+||+|+||+||+|.+.. ++..||+|.+..... ...+.+|+.+|+.++||||++++++|.......+++|
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 45689999999999998654 678999998864321 2346789999999999999999999987777789999
Q ss_pred EeccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec---CCCCcEEEcc
Q 007055 96 TELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGD 163 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~---------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~---~~~G~vKI~D 163 (620)
+||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ..+|.+||+|
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 999864 777776522 24889999999999999999999999 99999999999994 2567999999
Q ss_pred ccchhhccCC-----CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCH---------HHHH
Q 007055 164 LGLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIY 227 (620)
Q Consensus 164 FGla~~~~~~-----~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~---------~~i~ 227 (620)
||++...... ......||+.|+|||++.+ .++.++|||||||++|||+||+.||...... .++.
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 9999755432 2234578999999998754 4889999999999999999999999643211 1111
Q ss_pred HHHHc-CCC-----------C-----------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 007055 228 KKVTS-GIK-----------P-----------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 271 (620)
Q Consensus 228 ~~i~~-~~~-----------p-----------------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hp 271 (620)
..+.. +.. + .......+..++++|.+||+ +|.+|||+.|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 11100 000 0 00011235678899999998 999999999999999
Q ss_pred Cc
Q 007055 272 FL 273 (620)
Q Consensus 272 ff 273 (620)
||
T Consensus 316 ~f 317 (317)
T cd07867 316 YF 317 (317)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=323.41 Aligned_cols=252 Identities=35% Similarity=0.582 Sum_probs=212.6
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
|+..+.||+|+||.||+|.+..++..||+|.+...... ..++..+.+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l 79 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLYI 79 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEEE
Confidence 56789999999999999999999999999998764322 2344567799999999999999999999987544 46899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
|+||+++++|.+++.+.+.+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ .++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceeccccc
Confidence 9999999999999998888999999999999999999999999 99999999999998 78999999999986544332
Q ss_pred -CccccCCCCCCCcccccc-c-cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 175 -ARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 175 -~~~~~GTp~y~APEll~~-~-y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
.....|++.|+|||.+.. . ++.++|+||||+++|+|++|+.||........... +........++...++.+++|+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HHhcccCCCcCCCcCHHHHHHH
Confidence 345678999999997653 3 78999999999999999999999977553333333 3332233345556789999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCc
Q 007055 252 EKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.+||. +|.+||++.++|.|||+
T Consensus 236 ~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 236 LKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHhhcCcccCcCHHHHhcCCCC
Confidence 99998 89999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=322.32 Aligned_cols=250 Identities=28% Similarity=0.496 Sum_probs=213.9
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.++||.|+||.||.+.+..+|..|++|.+..... +......+.+|+.++++++|+||++++++|.+. ..+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEE
Confidence 36899999999999999999999999999999876543 334566788999999999999999999998764 57899
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 95 ITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+|||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++ .++.+||+|||++.....
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGS 153 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEccc
Confidence 99999999999999875 46899999999999999999999999 99999999999998 788999999999865433
Q ss_pred CC--CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 173 PT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 173 ~~--~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
.. .....|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..+....+..+..+. .....+..+++
T Consensus 154 ~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd08221 154 EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELIS 231 (256)
T ss_pred ccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHH
Confidence 32 345678999999998764 478899999999999999999999976 45555565555543332 33556789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+|.+||. +|.+||++.++|+|||+
T Consensus 232 ~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 232 LVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHcccCcccCCCHHHHhhCcCC
Confidence 9999997 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=327.59 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=213.1
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|+||.||+|.+..+|..||+|.+..... ......+.+.+|++++++++||||++++++|.. ...+++|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 6899999999999999999999999999999975443 223456789999999999999999999998754 3579999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-C
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-T 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~-~ 174 (620)
+||+.+++|.+++.....+++..+..|+.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...... .
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCcc
Confidence 999999999999988888999999999999999999999999 99999999999998 7899999999998655433 2
Q ss_pred CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 175 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
.....|+..|+|||++.+ .++.++|+||||+++|+|++|..||..... .......... .....+...++.+.++|
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAI 233 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHH
Confidence 344578999999998764 478999999999999999999999986543 3444443332 23334455678999999
Q ss_pred HHhcC-CCCCCCCH--HHHhcCCCc
Q 007055 252 EKCIV-PASLRLPA--LELLKDPFL 273 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa--~elL~hpff 273 (620)
.+||. +|.+||++ .|++.||||
T Consensus 234 ~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 234 NKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHccCChhHcCCccHHHHhcCCCC
Confidence 99998 99999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=324.41 Aligned_cols=249 Identities=31% Similarity=0.530 Sum_probs=208.5
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||.|+||+||+|.+..+|..||+|.+..... ......+.+|+.+++.++||||+++++.+... ...++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEE
Confidence 57899999999999999999999999999998865432 22567789999999999999999999988654 46899
Q ss_pred EEeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 95 ITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~---~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
|+|++.+++|.+++... ..+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLG-EDGSVKIADFGVSASLA 153 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccchHHHhc
Confidence 99999999999999764 45899999999999999999999999 99999999999998 68899999999986554
Q ss_pred CCC------CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---
Q 007055 172 QPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--- 240 (620)
Q Consensus 172 ~~~------~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--- 240 (620)
... .....|++.|+|||.+.. .++.++|+||||+++|+|++|+.||..... ...+........+ .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~ 231 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLTLQNDPP-SLETGA 231 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHHhcCCCC-CcCCcc
Confidence 322 134578999999998754 488999999999999999999999976443 3334444333222 121
Q ss_pred --CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 241 --KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 241 --~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
...++.+++|+.+||. +|.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 2456889999999998 89999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=330.19 Aligned_cols=251 Identities=29% Similarity=0.522 Sum_probs=208.1
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcC----C
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD----T 88 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~----~ 88 (620)
..|++.+.||+|+||.||+|.+..+++.||+|.+... ......+..|+.+++.+ +||||++++++|+.. .
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 3458889999999999999999999999999988643 23345688899999998 799999999998643 2
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
...++++|||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||+
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l~dfg~ 167 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGV 167 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCcc
Confidence 45789999999999999998764 45889999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC--CCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 007055 167 AIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 238 (620)
Q Consensus 167 a~~~~~~--~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~ 238 (620)
+...... ......|++.|+|||++. ..++.++|||||||++|+|++|..||........+. .+.....+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~ 246 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPPPKL 246 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hHhhCCCCCC
Confidence 8654322 234567899999999764 347889999999999999999999997654333332 3333333333
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 239 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 239 ~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.....+..+.+||.+||+ +|.+||++.|+|+||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 344578899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=328.70 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=204.5
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
.|++.+.||+|+||.||+|.+..+|..||+|.++.... . ....++..|+.. ++.++||||+++++++... ..++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--S-QEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--c-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEE
Confidence 46899999999999999999999999999999875421 1 223445556664 6777999999999998654 4589
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 94 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
+||||++ |+|.+++.. ...+++..++.++.||+.||.|||++ + ++||||||+||+++ .++.+||+|||++.
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~ 152 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISG 152 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeeccccc
Confidence 9999996 688777654 34689999999999999999999997 7 99999999999998 78999999999987
Q ss_pred hccCCCC-ccccCCCCCCCcccccc-----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 007055 169 VMQQPTA-RSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 169 ~~~~~~~-~~~~GTp~y~APEll~~-----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
....... ....|++.|+|||++.+ .++.++|+|||||++|+|++|+.||.......+....+..+..+......
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd06617 153 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232 (283)
T ss_pred ccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence 5543322 23568999999998753 46889999999999999999999997544443333444444333333344
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+.++++||.+||. +|.+||++.+++.||||....
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 67899999999998 899999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=323.15 Aligned_cols=250 Identities=28% Similarity=0.503 Sum_probs=209.9
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||.|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 76 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR--DKLW 76 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC--CEEE
Confidence 35689999999999999999999999999999987543 23557789999999999999999999988654 4699
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||+|+||+++ .+|.+||+|||++.....
T Consensus 77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchhhhh
Confidence 999999999999998876 78999999999999999999999999 99999999999998 789999999999865443
Q ss_pred C--CCccccCCCCCCCcccccc----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCc
Q 007055 173 P--TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTD 244 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~~----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~~ 244 (620)
. ......+++.|+|||++.+ .++.++|||||||++|+|+||..||.+................+.. .....+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence 2 2334578999999998753 5888999999999999999999999875544444333333222222 122346
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPF 272 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpf 272 (620)
..+++||.+||. +|..||++.+++.|||
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 789999999998 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=332.19 Aligned_cols=253 Identities=28% Similarity=0.540 Sum_probs=212.0
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.+..+|..||+|.+... ........+.+|+.++++++||||+++++++... ..+++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEE
Confidence 468899999999999999999999999999988643 1344557789999999999999999999987654 57899
Q ss_pred EEeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 95 ITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~---~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
|+||+++++|..++... ..+++..+..++.||+.||.|||+ ++ ++||||||+||+++ .++.+||+|||++...
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVN-GNGQVKLCDFGVSGNL 153 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEEC-CCCCEEEeecCCcccc
Confidence 99999999999998763 479999999999999999999996 57 99999999999998 6899999999998766
Q ss_pred cCCCCccccCCCCCCCcccccc-------ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHH---HHHcCCCCCCCC
Q 007055 171 QQPTARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK---KVTSGIKPASLS 240 (620)
Q Consensus 171 ~~~~~~~~~GTp~y~APEll~~-------~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~---~i~~~~~p~~~~ 240 (620)
.........|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.... ...... .+..+ .+..++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~-~~~~~~ 231 (286)
T cd06622 154 VASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDG-DPPTLP 231 (286)
T ss_pred cCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhc-CCCCCC
Confidence 5555556678999999998743 25789999999999999999999996533 222222 23333 233445
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
...++.+++||.+||+ +|.+||++.+++.||||....
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 5578999999999998 899999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=329.45 Aligned_cols=253 Identities=27% Similarity=0.447 Sum_probs=206.3
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCC---
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT--- 88 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~--- 88 (620)
...|.+.+.||+|+||.||+|.+..+|+.+|+|.+.... .....+.+|+.+++.+ +||||++++++|...+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 445689999999999999999999999999999886321 2235577899999999 8999999999987543
Q ss_pred CCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 89 NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
...+++|+||+++|+|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+||
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl~df 172 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKLVDF 172 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEeec
Confidence 2468999999999999998763 457899999999999999999999998 99999999999998 7889999999
Q ss_pred cchhhccCCC--CccccCCCCCCCcccccc------ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 165 GLAIVMQQPT--ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 165 Gla~~~~~~~--~~~~~GTp~y~APEll~~------~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
|++....... .....|++.|+|||++.. .++.++|||||||++|+|++|+.||........+ ..+..+..+
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-~~~~~~~~~ 251 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-FKIPRNPPP 251 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-HHHhcCCCC
Confidence 9986543322 234578999999998753 2678999999999999999999999864433333 333333222
Q ss_pred C-CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 237 A-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 237 ~-~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
. ..+......++++|.+||+ +|.+||++.++|.||||+
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1 1223356789999999998 899999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=331.92 Aligned_cols=253 Identities=31% Similarity=0.554 Sum_probs=212.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++++... ..+++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 79 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE--NKLWI 79 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--CeEEE
Confidence 457889999999999999999999999999998643 345567788999999999999999999988654 47899
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
||||+++|+|..++.+. +.+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccchhhccc
Confidence 99999999999998764 56999999999999999999999999 99999999999998 7899999999988654322
Q ss_pred --CCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCc
Q 007055 174 --TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTD 244 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~~ 244 (620)
......||+.|+|||++. ..++.++||||||+++|+|++|+.||... +.......+..+..+ ...+...+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWS 235 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccCC
Confidence 223457899999999864 23677999999999999999999999764 444444555544332 22344567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
..+.++|.+||. +|.+||++.++|+||||....
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 899999999998 899999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=332.77 Aligned_cols=260 Identities=22% Similarity=0.392 Sum_probs=215.3
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.+++.++||||+++++++... ..+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RHLCM 78 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CEEEE
Confidence 46889999999999999999999999999999875432 2234456788999999999999999999987543 57899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||++||+|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCc
Confidence 9999999999999998888999999999999999999999999 99999999999998 7899999999987531100
Q ss_pred ----------------CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 174 ----------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 174 ----------------~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
......|++.|+|||.+. ..++.++|||||||++|+|++|..||.+ ....++...+..+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIE 234 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccC
Confidence 111245788999999765 5689999999999999999999999976 4555666665544322
Q ss_pred -CCCCCCCcHHHHHHHHHhcC-CCCCCCC---HHHHhcCCCcCCCCCCcc
Q 007055 237 -ASLSKVTDPQVKQFIEKCIV-PASLRLP---ALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 237 -~~~~~~~~~~lk~~I~kcL~-~p~~Rps---a~elL~hpff~~~~~~~~ 281 (620)
+......++.++++|.+||+ +|.+||+ +.++|.||||........
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~ 284 (305)
T cd05609 235 WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL 284 (305)
T ss_pred CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence 22223567889999999998 8999998 799999999987655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.81 Aligned_cols=250 Identities=29% Similarity=0.503 Sum_probs=210.9
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.+++.++||||+++++.+... ..+++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALMIV 77 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEEEE
Confidence 6899999999999999999999999999999876543 334567799999999999999999999987543 578999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 96 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||+|+||+++..++.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999999764 35899999999999999999999999 9999999999999855667899999998755433
Q ss_pred C-CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 174 T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 174 ~-~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
. .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+..+..+ .++...++.++++|
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~~li 233 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-LPALVLKIMSGTFA-PISDRYSPDLRQLI 233 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-hHHHHHHHHhcCCC-CCCCCcCHHHHHHH
Confidence 2 234578999999998764 47889999999999999999999997744 34444444443322 34445688999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCc
Q 007055 252 EKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.+||. +|.+|||+.|+|.||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=377.86 Aligned_cols=262 Identities=21% Similarity=0.380 Sum_probs=227.6
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
...|.+.++||+|+||.|.++.++.|++.+|+|++++-..... .....|..|.++|..-+.+-|+.++..|.|+ .++
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr-~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~--~~L 150 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR-AETACFREERDIMVFGNSEWIVQLHYAFQDE--RYL 150 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc-hhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc--cce
Confidence 3467889999999999999999999999999999986444332 3345588899999999999999999999766 579
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
|+||||++||+|..++.++.+++++-++.|+..|+.||.-||+.| +|||||||+|||++ .+|+|||+|||.+..+..
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCC
Confidence 999999999999999999999999999999999999999999999 99999999999998 899999999999866653
Q ss_pred C-C--CccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--C
Q 007055 173 P-T--ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--K 241 (620)
Q Consensus 173 ~-~--~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~ 241 (620)
. . ....+|||.|++||++. +.|+..+|+||+||++|||+.|+.||+. ......|.+|..-.....+| .
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~ 306 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDET 306 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCccc
Confidence 3 2 34568999999999884 3599999999999999999999999986 56677788887653333333 3
Q ss_pred CCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCcCCCCCCcc
Q 007055 242 VTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~~p~~Rps---a~elL~hpff~~~~~~~~ 281 (620)
.++.++++||.+.+.+|..|.. +.++-.||||....|..+
T Consensus 307 ~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~i 349 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNI 349 (1317)
T ss_pred ccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhh
Confidence 4789999999999999999988 999999999999998554
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=328.15 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=206.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.++.+|+.||+|.+..... .....+.+.+|+.+++.++||||++++++|... ..+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 77 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLHL 77 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEEE
Confidence 57899999999999999999999999999998864432 122334578899999999999999999988654 46889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
||||+++++|..++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCCc
Confidence 9999999999988877778999999999999999999999998 99999999999998 78999999999986554332
Q ss_pred --CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--C---------------
Q 007055 175 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--G--------------- 233 (620)
Q Consensus 175 --~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~--~--------------- 233 (620)
.....++..|+|||.+.+ .++.++||||||+++|+|++|+.||.+..+...+...... .
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 234568899999998754 4789999999999999999999999875554444332210 0
Q ss_pred --C-CCCC--------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 234 --I-KPAS--------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 234 --~-~p~~--------~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
. .|.. .....+..+.+||.+||+ +|.+||++.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 0000 012346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=322.60 Aligned_cols=253 Identities=30% Similarity=0.538 Sum_probs=217.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|++|.||+|.+..+|+.||+|++..... ......+.+|+..+..++||||+++++++... ..+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEE
Confidence 36789999999999999999999999999999875432 24567789999999999999999999988655 57899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
|+||+++++|.+++.....+++..+..++.||+.||.|||+ .+ ++||||+|+||+++ .+|.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENT 153 (264)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceecccC
Confidence 99999999999999988889999999999999999999999 98 99999999999998 7899999999998765443
Q ss_pred CCc--cccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCCCCCCC-CcHHH
Q 007055 174 TAR--SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKV-TDPQV 247 (620)
Q Consensus 174 ~~~--~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~--~~~~i~~~i~~~~~p~~~~~~-~~~~l 247 (620)
... ...+++.|+|||.+.+ .++.++|+||||+++|+|+||..||.... ...+....+.....+. ++.. .+..+
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 232 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS-LPAEEFSPEF 232 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC-CCcccCCHHH
Confidence 322 4568999999998764 58889999999999999999999997764 5556666666544443 3333 78899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+++|.+||. +|.+||++.+++.|||++..
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999998 89999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=331.76 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=213.0
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
.+.|++.+.||+|+||+||+|.+..+|..||+|.+.... .......+.+|+++++.++||||+++++++... ..+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEE
Confidence 356788899999999999999999999999999886432 234557789999999999999999999998765 578
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
++|+||+++|+|.+++.+.+.+++..+..++.|++.||.|||+ ++ ++||||||+||+++ .++.++|+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchh
Confidence 9999999999999999988889999999999999999999997 57 99999999999998 78999999999986554
Q ss_pred CCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCH----------HHHHHHHHcCCCCCCCC
Q 007055 172 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP----------AQIYKKVTSGIKPASLS 240 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~----------~~i~~~i~~~~~p~~~~ 240 (620)
........|+..|+|||++. +.++.++|||||||++|+|+||..||...... ......+.....+....
T Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 156 NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 44444567999999999765 56889999999999999999999999753321 12223333322222222
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
...+..+.+||.+||+ +|.+||++.|+++||||...
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 2366789999999998 89999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=327.97 Aligned_cols=251 Identities=25% Similarity=0.459 Sum_probs=204.6
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcC---CC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD---TN 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~---~~ 89 (620)
..|++.+.||+|+||.||+|.+..+|..+|+|.+.... .....+.+|+.+++.+ +||||+++++++... ..
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 34589999999999999999999999999999875321 1234577899999999 799999999987542 33
Q ss_pred CeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 90 RTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
..+++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~kl~dfg 169 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFG 169 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCEEEccCC
Confidence 578999999999999998753 356899999999999999999999998 99999999999998 78899999999
Q ss_pred chhhccCC--CCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C
Q 007055 166 LAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P 236 (620)
Q Consensus 166 la~~~~~~--~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p 236 (620)
++...... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||........+.. +..... +
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~~~~~~ 248 (286)
T cd06638 170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRNPPPT 248 (286)
T ss_pred ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-ccccCCCc
Confidence 98654332 233457999999999874 2378899999999999999999999977544333322 222222 2
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
...+...+..++++|.+||+ +|.+||++.|+|.||||
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22344567889999999998 89999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.86 Aligned_cols=248 Identities=31% Similarity=0.505 Sum_probs=204.9
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEe
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~E 97 (620)
....||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++++... ..+++|+|
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 85 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFME 85 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEe
Confidence 346899999999999999999999999988643 234556789999999999999999999987654 57899999
Q ss_pred ccCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 98 LFTSGSLRQYRKKH-KNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 98 y~~gGsL~~~i~~~-~~l--~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
|+++++|.+++... ..+ ++..+..++.||+.||+|||+++ |+||||||+||+++..++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 99999999998764 455 88999999999999999999998 9999999999999855789999999998654322
Q ss_pred -CCccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 174 -TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||.....................++...++.+++
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence 2234468999999998753 378999999999999999999999976544333322222212233455667889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
|+.+||. +|.+||++.+++.||||
T Consensus 244 li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCCHHHHHhCCCC
Confidence 9999998 89999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=349.15 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=201.9
Q ss_pred CceEEEEEEEceeCCeEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~--~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
...|++.+.||+|+||.||+|... .++..||+|.+.... ...+|+.+|+.++||||++++++|... .
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~~~~--~ 159 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAYRWK--S 159 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeEeeC--C
Confidence 346899999999999999999754 467899999875321 245799999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
.+++|||++. ++|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKL 235 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCcccccc
Confidence 6899999996 689999988888999999999999999999999999 99999999999998 7899999999998654
Q ss_pred cCC----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCH---HHHHHHHHc----------
Q 007055 171 QQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTS---------- 232 (620)
Q Consensus 171 ~~~----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~---~~i~~~i~~---------- 232 (620)
... ......||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.... .++...+..
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 332 2234679999999998864 5899999999999999999999999764321 112111110
Q ss_pred ---------------CCCC-CCCC-----CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 233 ---------------GIKP-ASLS-----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 233 ---------------~~~p-~~~~-----~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
...+ ...+ ...+..+++||.+||+ +|.+||++.|+|.||||....+.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 0000 0011 1235678999999998 99999999999999999875443
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.55 Aligned_cols=251 Identities=23% Similarity=0.406 Sum_probs=205.4
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v 77 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFVLV 77 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeEEE
Confidence 6899999999999999999999999999999876542 223456788999999999999999999998654 578999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 96 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
+||+ +++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEc-CCCcEEEeeeeecccccCCC
Confidence 9999 9999999865 456999999999999999999999999 99999999999998 68999999999987654432
Q ss_pred ---CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 007055 175 ---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------- 236 (620)
Q Consensus 175 ---~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p------------- 236 (620)
.....|++.|+|||.+.+ .++.++||||||+++|+|+||..||.+..+.......+.....+
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 334578999999998753 37899999999999999999988886644333322222110000
Q ss_pred -------C-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 237 -------A-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 237 -------~-------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
. ......+..++++|.+||. +|.+||++.++|.||||.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0112346889999999998 899999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.54 Aligned_cols=251 Identities=33% Similarity=0.601 Sum_probs=211.8
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
+|++.+.||+|+||.||+|.+..++..||+|.++..... ....+.+..|+.+++.++||||+++++.+.. ...+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEE
Confidence 368899999999999999999999999999998765432 4567889999999999999999999997654 357899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
|+||+++++|.+++...+.+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 77 FMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred EEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCCC
Confidence 9999999999999998888999999999999999999999999 99999999999998 68999999999986554321
Q ss_pred ------CccccCCCCCCCcccccc-c---cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC--
Q 007055 175 ------ARSVIGTPEFMAPELYEE-E---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV-- 242 (620)
Q Consensus 175 ------~~~~~GTp~y~APEll~~-~---y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~-- 242 (620)
.....+++.|+|||++.+ . ++.++||||||+++|+|++|+.||....+.......+..+. +..++..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQ 232 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC-CCCCCcccc
Confidence 113467899999998763 2 78899999999999999999999977554444444444432 2223333
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.++.+++||.+||+ +|.+||++.+++.|||+
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 48899999999997 89999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=322.14 Aligned_cols=248 Identities=32% Similarity=0.564 Sum_probs=206.9
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||.||+|.+..++..||+|.+.... ..+.+.+|+++++.++||||+++++++.+. ..++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEE
Confidence 35688999999999999999999999999999986432 256789999999999999999999988765 5689
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+++||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++ .++.+||+|||++.....
T Consensus 75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchhccc
Confidence 99999999999999875 456899999999999999999999998 99999999999998 788999999999876543
Q ss_pred CC--CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCcHHHH
Q 007055 173 PT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-KPASLSKVTDPQVK 248 (620)
Q Consensus 173 ~~--~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~-~p~~~~~~~~~~lk 248 (620)
.. .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||......... ..+.... .....+...+..+.
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FMIPNKPPPTLSDPEKWSPEFN 230 (256)
T ss_pred CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-hhhccCCCCCCCchhhcCHHHH
Confidence 32 334568999999998764 5889999999999999999999999764332222 2222211 11222334578899
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 249 QFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+||.+||+ +|.+||++.++|.||||
T Consensus 231 ~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 231 DFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99999997 89999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.76 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=207.9
Q ss_pred EceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCC
Q 007055 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 101 (620)
Q Consensus 22 LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~g 101 (620)
||+|+||+||+|.+..+|+.||+|.+...... .......+.+|+.+|+.++||||++++++|... ..+++||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCC
Confidence 69999999999999999999999998754322 223445677899999999999999999987544 468999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-CCccc
Q 007055 102 GSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSV 178 (620)
Q Consensus 102 GsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~-~~~~~ 178 (620)
++|.+++.+.+ .+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++...... .....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccc
Confidence 99999997765 7999999999999999999999999 99999999999998 7899999999998655432 23345
Q ss_pred cCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 007055 179 IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254 (620)
Q Consensus 179 ~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~---~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kc 254 (620)
.+++.|+|||.+. +.++.++||||||+++|+|++|+.||..... ...+...+.. .+...+...++.++++|.+|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 6889999999875 4588999999999999999999999976432 2222222221 23345556789999999999
Q ss_pred cC-CCCCCC-----CHHHHhcCCCcCCCCCCcc
Q 007055 255 IV-PASLRL-----PALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 255 L~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 281 (620)
|+ +|.+|| ++.+++.||||...++...
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~ 265 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL 265 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence 98 899999 8999999999988776554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.00 Aligned_cols=250 Identities=23% Similarity=0.421 Sum_probs=204.4
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
+.||+|+||.||+|.+..+|+.||+|.+....... ......+..|..+ ...++||||++++++|... ..+++|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEec
Confidence 56999999999999999999999999986543211 2223344555554 4556899999999988644 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCCccc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 178 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~~ 178 (620)
+.+|+|.+++...+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++..... ....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~--~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKKF 153 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccc--cccC
Confidence 999999999998888999999999999999999999999 99999999999998 788999999999864332 3345
Q ss_pred cCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhc
Q 007055 179 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 179 ~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~~~~lk~~I~kcL 255 (620)
.|++.|+|||.+.+ .++.++||||||+++|+|++|..||.. .+....+..+..+.. +.......++.++++|.+||
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 68999999998764 478999999999999999999999976 445555555544322 33334456889999999999
Q ss_pred C-CCCCCCCH---HHHhcCCCcCCCCC
Q 007055 256 V-PASLRLPA---LELLKDPFLVTDNP 278 (620)
Q Consensus 256 ~-~p~~Rpsa---~elL~hpff~~~~~ 278 (620)
+ +|.+||++ .|+|.||||...+|
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 8 89999955 79999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=323.07 Aligned_cols=249 Identities=20% Similarity=0.325 Sum_probs=205.2
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
+....|++.+.||+|+||.||+|.+. ..+..||+|.++... +......+.+|+..++.++||||+++++++...
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 34567899999999999999999775 467899999987432 334456788999999999999999999988654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++||||+++|+|.+++.+. +.+++..+..++.||+.||+|||+++ ++||||||+|||++ .++.+|++|||.
T Consensus 79 --~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~ 153 (266)
T cd05064 79 --NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRR 153 (266)
T ss_pred --CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCcc
Confidence 4689999999999999998874 57899999999999999999999999 99999999999998 789999999998
Q ss_pred hhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+....... .....+++.|+|||.+. +.++.++|||||||++|||++ |+.||.+. ....+.+.+..+..+ ..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 231 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIKAVEDGFRL-PAPR 231 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCC
Confidence 75432221 11234567899999875 568999999999999999775 99999764 455566666665443 3455
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+.+++.+||+ +|.+||++.++++
T Consensus 232 ~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 232 NCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 678899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=319.23 Aligned_cols=250 Identities=26% Similarity=0.483 Sum_probs=211.2
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||++.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++... ...++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEEE
Confidence 36899999999999999999999999999999876543 234456789999999999999999999987543 57899
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 95 ITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
|+||+.+++|.+++.... .+++.++..|+.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNS 153 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecCc
Confidence 999999999999987643 5899999999999999999999999 99999999999998 688999999999865433
Q ss_pred C--CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 173 P--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
. ......|++.|+|||++. +.++.++|+||||+++|+|++|..||... +...+...+..+..+. .+...+..+++
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd08218 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIRGSYPP-VSSHYSYDLRN 231 (256)
T ss_pred chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHhcCCCCC-CcccCCHHHHH
Confidence 2 123456899999999876 45788999999999999999999999764 4555555555554432 34456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+|.+||. +|.+||++.++|.||||
T Consensus 232 li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 232 LVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHhhCChhhCcCHHHHhhCcCC
Confidence 9999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=322.02 Aligned_cols=250 Identities=26% Similarity=0.459 Sum_probs=209.9
Q ss_pred EceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCC
Q 007055 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 101 (620)
Q Consensus 22 LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~g 101 (620)
||.|+||.||+|.+..+|+.||+|.+..... ......+.+.+|+++++.++||||+++++.+.. ...+++|+||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCC
Confidence 6899999999999999999999999875432 223556778999999999999999999998754 4578999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC--------
Q 007055 102 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------- 173 (620)
Q Consensus 102 GsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~-------- 173 (620)
++|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccc
Confidence 999999998889999999999999999999999999 99999999999998 7899999999998643322
Q ss_pred --CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 174 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
......+++.|+|||.+. ..++.++||||||+++|+|++|..||.. .........+..+..+.......++.+.+|
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 223456889999999765 4588899999999999999999999976 445566666655433322222248899999
Q ss_pred HHHhcC-CCCCCCCH---HHHhcCCCcCCCCC
Q 007055 251 IEKCIV-PASLRLPA---LELLKDPFLVTDNP 278 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa---~elL~hpff~~~~~ 278 (620)
|.+||+ +|.+||++ .++|+||||...+|
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 999998 89999999 99999999987543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.79 Aligned_cols=250 Identities=27% Similarity=0.459 Sum_probs=203.2
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||.|++|.||+|.++.+|..||+|.++.... .......+.+|++++++++||||+++++++.+. ...++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLV 77 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEEEE
Confidence 6889999999999999999999999999998875432 222335688999999999999999999987544 468999
Q ss_pred EeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 96 TELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
|||+. ++|..++.. ...+++..++.++.||+.||+|||+++ ++||||+|+||+++ .++.+||+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVP 153 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcccC
Confidence 99996 689888865 356899999999999999999999999 99999999999998 7899999999998654332
Q ss_pred --CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC------------
Q 007055 174 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA------------ 237 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~------------ 237 (620)
......+++.|+|||++.+ .++.++||||||+++|+|+||+.||..........+.+.....+.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 2233467899999998764 268899999999999999999999977554444433332111110
Q ss_pred --------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 238 --------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 238 --------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
......++.++++|.+||+ +|.+||++.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112356789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=342.24 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=194.4
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||.||+|.+..++..||+|..... ....|+.+++.++||||++++++|... ...+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 133 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITC 133 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeE
Confidence 3589999999999999999999999999999974321 134699999999999999999998765 4688
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+|+||+. |+|.+++.. .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCcccccccc
Confidence 9999995 577777754 567999999999999999999999999 99999999999998 788999999999864332
Q ss_pred -CCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCC----------HHHHHHHHHc-CCCCCCC
Q 007055 173 -PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKN----------PAQIYKKVTS-GIKPASL 239 (620)
Q Consensus 173 -~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~----------~~~i~~~i~~-~~~p~~~ 239 (620)
.......||+.|+|||++. ..|+.++|||||||++|||+++..|+..... ...+...+.. +..|..+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 2334567999999999876 4589999999999999999986655533211 1112221111 1111111
Q ss_pred C------------------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 240 S------------------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 240 ~------------------------------~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
+ ...+..+.+||.+||+ +|.+|||+.|+|+||||+.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1 1235567789999998 9999999999999999975
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.51 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=207.2
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
...|++.+.||+|+||.||+|.+..+|+.||+|.++..... ......+.+|+.++++++||||+++++++.......+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 45689999999999999999999999999999998754321 1122345679999999999999999999887666678
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 93 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
++|+||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceeeecC
Confidence 999999974 78888775 367999999999999999999999999 99999999999998 78999999999987654
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C----------
Q 007055 172 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P---------- 236 (620)
Q Consensus 172 ~~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p---------- 236 (620)
.. ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.... ....+..+..... +
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-EIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCChhhchhhhc
Confidence 32 2233456889999998753 47899999999999999999999997644 4433333322100 0
Q ss_pred -----------CCC------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 237 -----------ASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 237 -----------~~~------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
..+ ....++.+++||.+||+ +|.+|||+.++|.||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000 01247888999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=351.11 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=198.7
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
+..|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|++|+|||||++++++... ...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~ 235 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLT 235 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEE
Confidence 4467899999999999999999999999999996431 2256899999999999999999987654 468
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 93 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
++|+|++. ++|..++... +.+++.+++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 236 ~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 236 CLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceecc
Confidence 88999995 6888887654 56999999999999999999999999 99999999999998 78899999999997553
Q ss_pred CCC----CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCC-------CHHHHHHHHHcCCCC-CC
Q 007055 172 QPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-------NPAQIYKKVTSGIKP-AS 238 (620)
Q Consensus 172 ~~~----~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~-------~~~~i~~~i~~~~~p-~~ 238 (620)
... .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ...++.+.+...... ..
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 321 224579999999998764 58999999999999999999886653211 123444444332110 00
Q ss_pred -----------------------------CC--CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 239 -----------------------------LS--KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 239 -----------------------------~~--~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
+. ...++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 0235688999999998 9999999999999999974
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=327.61 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=206.4
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
|++.+.||+|+||.||+|.+..+|+.||+|.+....... .......+..|+++++.++||||+++++++.+ ...+++
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 79 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNINL 79 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEEE
Confidence 678899999999999999999999999999997654321 12234557789999999999999999999876 357899
Q ss_pred EEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
||||+ +|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeeccCC
Confidence 99999 899999998776 7999999999999999999999999 99999999999998 7899999999998755433
Q ss_pred --CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C------------
Q 007055 174 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P------------ 236 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p------------ 236 (620)
......+++.|+|||.+.+ .++.++|||||||++|+|++|..||.+..... ...++..... |
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhccccc
Confidence 2233457889999998753 47899999999999999999987776644333 2333221100 0
Q ss_pred -------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 237 -------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 237 -------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.......+..+++||.+||. +|.+||++.|+|.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 00112346789999999998 89999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.92 Aligned_cols=262 Identities=25% Similarity=0.381 Sum_probs=210.8
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHH----------HHHHHHHHHHHHHhCCCCCc
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD----------QLERLYSEVHLLKSLKHENI 77 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~----------~~~~l~~Ei~iL~~L~HpNI 77 (620)
-.++.+||+.+.+.||+|+||+||+|.+..+|+.||+|.+.......... ....+.+|+.+++.++||||
T Consensus 3 ~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred ccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 35788999989999999999999999999999999999987543221100 01247789999999999999
Q ss_pred ceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC
Q 007055 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 157 (620)
Q Consensus 78 Vkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G 157 (620)
++++++|... ..+++||||+. |+|.+++.....+++..+..++.||+.||.|||+++ ++||||+|+||+++ .+|
T Consensus 83 v~~~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~ 156 (335)
T PTZ00024 83 MGLVDVYVEG--DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKG 156 (335)
T ss_pred eeeeEEEecC--CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCC
Confidence 9999998654 47899999997 699999988888999999999999999999999999 99999999999998 789
Q ss_pred cEEEccccchhhccC----------------CCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCC
Q 007055 158 EVKIGDLGLAIVMQQ----------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNE 219 (620)
Q Consensus 158 ~vKI~DFGla~~~~~----------------~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~ 219 (620)
.+||+|||++..... .......+++.|+|||.+.+ .++.++|||||||++|+|++|..||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999865441 11123356889999998754 378999999999999999999999976
Q ss_pred CCCHHHHHHHHHcC---CCCC-----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 007055 220 CKNPAQIYKKVTSG---IKPA-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 272 (620)
Q Consensus 220 ~~~~~~i~~~i~~~---~~p~-----------------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpf 272 (620)
......+ ..+... ..+. ......+..+++||.+||. +|.+||++.|+|.|||
T Consensus 237 ~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 237 ENEIDQL-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred CCHHHHH-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 5443332 222110 0000 0012346789999999998 8999999999999999
Q ss_pred cCCC
Q 007055 273 LVTD 276 (620)
Q Consensus 273 f~~~ 276 (620)
|+..
T Consensus 316 ~~~~ 319 (335)
T PTZ00024 316 FKSD 319 (335)
T ss_pred cCCC
Confidence 9864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=327.87 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=206.4
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.|++.+.||+|+||.||+|.+..+|..||+|.++..... ......+.+|+.++++++||||+++++++.......++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 3567889999999999999999999999999999755432 22334577899999999999999999998877557899
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+|+||+. ++|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+|||++ .+|.+||+|||++.....
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccC
Confidence 9999997 49999887654 5999999999999999999999999 99999999999998 789999999999875544
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------
Q 007055 173 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------------- 235 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------------- 235 (620)
. ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||........ ..++.....
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhcc
Confidence 3 2234567899999998754 368899999999999999999999976443332 222211000
Q ss_pred ----------------CCCCCCC-CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 236 ----------------PASLSKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 236 ----------------p~~~~~~-~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
...++.. .++.++++|.+||+ +|.+|||+.|+|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0112222 47789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=320.84 Aligned_cols=253 Identities=30% Similarity=0.513 Sum_probs=207.1
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccC------CHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~------~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
|.+.+.||+|+||.||+|.+..+|+.||+|.++...... .....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 80 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-- 80 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC--
Confidence 578899999999999999999999999999886532211 112345688899999999999999999987543
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++|+||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeecccccc
Confidence 568899999999999999998888999999999999999999999998 99999999999998 789999999999865
Q ss_pred ccCC----CCccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCC
Q 007055 170 MQQP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASL 239 (620)
Q Consensus 170 ~~~~----~~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~---p~~~ 239 (620)
.... ......|++.|+|||.+.. .++.++|+||||+++|+|++|..||.................. +...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 4322 1233468899999998753 3788999999999999999999999764443333332222211 2223
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
....+..++++|.+||. +|.+||++.++|+||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 33457899999999998 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.41 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=206.0
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEe
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 82 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~ 82 (620)
|.+....|++.+.||+|+||+||+|.+ ..++..||+|+++... .....+.+.+|+.+|+.+ +||||+++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 344445789999999999999999964 4567899999986432 233456788999999999 8999999999
Q ss_pred EEEcCCCCeEEEEEeccCCCCHHHHHHhCC--------------------------------------------------
Q 007055 83 SWVDDTNRTINMITELFTSGSLRQYRKKHK-------------------------------------------------- 112 (620)
Q Consensus 83 ~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~-------------------------------------------------- 112 (620)
+|.+. ...++||||+++|+|.+++....
T Consensus 107 ~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (375)
T cd05104 107 ACTVG--GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD 184 (375)
T ss_pred eeccC--CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence 88654 45889999999999999986421
Q ss_pred -------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 113 -------------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 113 -------------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~DfG~a 261 (375)
T cd05104 185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLA 261 (375)
T ss_pred cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEE-CCCcEEEecCccc
Confidence 4788899999999999999999999 99999999999998 6889999999998
Q ss_pred hhccCCCC----ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 168 IVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 168 ~~~~~~~~----~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
........ ....+++.|+|||++. ..++.++|||||||++|||++ |..||........+.+.+..+..+. .+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 340 (375)
T cd05104 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-SPE 340 (375)
T ss_pred eeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-CCC
Confidence 65433221 1223466799999876 458999999999999999998 8999987655666666666654432 334
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..+.+++++|.+||+ +|.+||++.++++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=319.12 Aligned_cols=251 Identities=28% Similarity=0.476 Sum_probs=209.1
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.|++.+.||+|+||.||+|.+..+|..||+|.++.... ........+.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEE
Confidence 357899999999999999999999999999998875433 2345556788999999999999999999988754 4688
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 94 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
+|+||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~~ 155 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECcccccee
Confidence 99999999999988753 345899999999999999999999999 99999999999997 788999999999865
Q ss_pred ccCCC--CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcH
Q 007055 170 MQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDP 245 (620)
Q Consensus 170 ~~~~~--~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~~~ 245 (620)
..... .....|++.|+|||.+. ..++.++||||||+++|+|++|+.||.... +...+...+.....++......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08228 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235 (267)
T ss_pred ccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 44322 23457899999999775 458899999999999999999999996533 334555565554444444455678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.++++|.+||. +|.+||++.++|+.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 89999999998 89999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=323.55 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=199.8
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||.||+|.+..+|..||+|.+...... .....+.+|+.+++.++|+||+++++++... ...+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE---GVPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC---CCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--CeEE
Confidence 4678999999999999999999999999999998654321 1223467899999999999999999988654 4788
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+|+||+. ++|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+|||++ .+|.+||+|||++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSI 155 (291)
T ss_pred EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEeccccccccCC
Confidence 9999996 677666554 456889999999999999999999999 99999999999998 789999999999864332
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------
Q 007055 173 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------------- 235 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------------- 235 (620)
. ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||............+.....
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 2 2234467999999998754 4788999999999999999999999765544333322211000
Q ss_pred ------------CCCC----C-CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 236 ------------PASL----S-KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 236 ------------p~~~----~-~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+..+ . ...++.+.+++.+||+ +|.+|||+.|+|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 0 0125688999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=384.30 Aligned_cols=253 Identities=30% Similarity=0.528 Sum_probs=223.5
Q ss_pred EEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEE
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
+.+..||.|.||.||.|.+..||+..|+|.+++.+.. ......+.+|..+|..|+|||+|++|++=++. ..++|.|
T Consensus 1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~IFM 1313 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYIFM 1313 (1509)
T ss_pred ccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecH--HHHHHHH
Confidence 4678999999999999999999999999999876543 34456688999999999999999999965444 4588889
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC--
Q 007055 97 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 174 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~-- 174 (620)
|||.+|+|.+.+...+-.++...+.+..|++.||+|||++| ||||||||.|||++ .+|.+|++|||.|.......
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecccceeEecCchhc
Confidence 99999999999998888889899999999999999999999 99999999999998 89999999999996554432
Q ss_pred ----CccccCCCCCCCcccccc----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 175 ----ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 175 ----~~~~~GTp~y~APEll~~----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
....+|||-|||||++.+ +...++|||||||+++||+||+.||....+.-+|+-+|..|.+|..... .+++
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LSSE 1469 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hhHh
Confidence 346789999999998854 4678999999999999999999999999999999999999988875544 8899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.++||+.||. ||..|+++.|||.|.|-+...
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 9999999997 999999999999999876543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=313.13 Aligned_cols=249 Identities=31% Similarity=0.556 Sum_probs=214.3
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||.|+||.||+|.+..++..||+|.+..... .......+.+|+++++.++|||++++++.+... ..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv 77 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIV 77 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEE
Confidence 6889999999999999999999999999999875542 235566788999999999999999999998765 578999
Q ss_pred EeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 96 TELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLS 154 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceeecc
Confidence 9999999999998764 67999999999999999999999998 99999999999998 78999999999986554
Q ss_pred CC--CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 172 QP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 172 ~~--~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
.. ......|++.|+|||.+. ..++.++|+||||+++++|++|..||... +...+........ ...++...+..++
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (258)
T cd08215 155 STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQ-YPPIPSQYSSELR 232 (258)
T ss_pred cCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCC-CCCCCCCCCHHHH
Confidence 43 234457899999999765 45889999999999999999999999764 4555555555443 3345556788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 249 QFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+++.+||. +|.+||++.++|.||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.34 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=208.0
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|+++++.++||||++++++|... ..+++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~i 77 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRLYL 77 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEEEE
Confidence 47899999999999999999999999999998865432 233456789999999999999999999998663 57899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
|+||+.++.|..+..+...+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARP 154 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCCCc
Confidence 9999999888877777777999999999999999999999999 99999999999998 7899999999998655433
Q ss_pred --CCccccCCCCCCCccccc-c-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCC------------
Q 007055 174 --TARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIK------------ 235 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~-~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~--~~~------------ 235 (620)
......+++.|+|||++. . .++.++||||||+++|+|++|+.||.+......+...... ...
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 233467899999999875 3 5789999999999999999999999875544433322110 000
Q ss_pred -------C--------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 236 -------P--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 236 -------p--------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+ ..++...++.+++||.+||. +|.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01223347889999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.17 Aligned_cols=252 Identities=25% Similarity=0.413 Sum_probs=204.2
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEe
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 82 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg-----~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~ 82 (620)
|.+..+.|++.+.||+|+||.||+|.+..+| ..||+|.++... .....+.+.+|+.+++.+ +||||+++++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 3445567899999999999999999865444 579999986442 234566788999999999 8999999999
Q ss_pred EEEcCCCCeEEEEEeccCCCCHHHHHHhC---------------------------------------------------
Q 007055 83 SWVDDTNRTINMITELFTSGSLRQYRKKH--------------------------------------------------- 111 (620)
Q Consensus 83 ~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~--------------------------------------------------- 111 (620)
+|... ..+++||||+++|+|.+++...
T Consensus 110 ~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (374)
T cd05106 110 ACTHG--GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV 187 (374)
T ss_pred EecCC--CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence 88654 4689999999999999988542
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 112 -------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 112 -------------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
.++++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMN 264 (374)
T ss_pred cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccC
Confidence 24788899999999999999999999 99999999999998 788999999999865433
Q ss_pred CCCc----cccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 173 PTAR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 173 ~~~~----~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
.... ...+++.|+|||++. +.++.++|||||||++|+|++ |..||............+..+..+ ..+...+++
T Consensus 265 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 343 (374)
T cd05106 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPDFAPPE 343 (374)
T ss_pred CcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-cCCCCCCHH
Confidence 2211 223466899999775 569999999999999999997 999997754444455555544333 344456899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 247 VKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
++++|.+||+ +|.+||++.++++
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=326.49 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=195.8
Q ss_pred CceEEEEEEEceeCCeEEEEEEEc----------------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDE----------------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~----------------~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN 76 (620)
...|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+|+.++|||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCC
Confidence 345689999999999999999753 245689999886432 3445667899999999999999
Q ss_pred cceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 007055 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------------------NVDMKAIKNWARQILRGLHYLHSHN 137 (620)
Q Consensus 77 IVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~-------------------~l~e~~i~~i~~QIl~gL~yLHs~~ 137 (620)
|+++++++.+.. .+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++
T Consensus 81 iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 81 IIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred eeEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999987654 5899999999999999986532 3677889999999999999999999
Q ss_pred CCEEecCCCccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh
Q 007055 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 212 (620)
Q Consensus 138 ~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt 212 (620)
|+||||||+|||++ .++.+||+|||++....... .....+++.|+|||++. +.++.++|||||||++|+|++
T Consensus 159 --ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 159 --FVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred --ccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 99999999999998 78999999999986543322 12334578999999765 568999999999999999987
Q ss_pred --cCCCCCCCCCHHHHHHHHHc----CC--CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 213 --CEYPYNECKNPAQIYKKVTS----GI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 213 --G~~Pf~~~~~~~~i~~~i~~----~~--~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+..||.+.. ..+....+.. .. .....+...+..+++||.+||. +|.+|||+.++..
T Consensus 236 ~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 236 LCKEQPYGELT-DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred ccCCCCCCcCC-HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 567887643 3333332221 10 1111233457899999999998 8999999999843
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=327.78 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=209.6
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
.+.|++.+.||+|+||+||+|.+..+|+.||+|.+..... ......+.+.+|+.+++.++||||++++++|.+. ...
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--~~~ 90 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--HTA 90 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC--CeE
Confidence 3457899999999999999999999999999999865432 2344556788999999999999999999998765 458
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 93 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
++|+||+. |+|.+++.. .+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .+|.+||+|||++....
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVS 166 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEeecCcceecC
Confidence 89999997 577776654 457999999999999999999999999 99999999999998 78999999999986443
Q ss_pred CCCCccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 172 QPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
. .....|++.|+|||++. +.++.++||||||+++|+|+||..||......... ..+.....+.......+..+
T Consensus 167 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 167 P--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred C--CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH-HHHhcCCCCCCCchhhCHHH
Confidence 2 23457899999999763 45888999999999999999999999764333333 33333333333334467889
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+++|.+||. +|.+||++.+++.||||....
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 999999998 899999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=323.51 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=202.4
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCC---C
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN---R 90 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~---~ 90 (620)
.|++.+.||+|+||.||+|.+..+|..||+|.++.... .......+.+|+.+++.+. ||||+++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 36899999999999999999999999999998865432 1223356788999999995 6999999998765432 2
Q ss_pred eEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 91 TINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~-----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
.+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++..++.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecc
Confidence 47899999985 788887642 35799999999999999999999999 99999999999998448899999999
Q ss_pred chhhccCC--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----
Q 007055 166 LAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---- 237 (620)
Q Consensus 166 la~~~~~~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~---- 237 (620)
++...... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+........+....-..|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98654322 1223467899999997753 478999999999999999999999987554444433222100000
Q ss_pred ---------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 238 ---------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 238 ---------------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
......++.+++||.+||+ +|.+||++.|+|.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0112357889999999998 899999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=335.12 Aligned_cols=254 Identities=28% Similarity=0.409 Sum_probs=204.0
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC---
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 89 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~--- 89 (620)
.+.|++.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||++++++|.....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 345689999999999999999999999999999886432 233445678899999999999999999998864332
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 90 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 90 -~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..+|+||||+. ++|.+++... +++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccce
Confidence 35799999996 5888887654 899999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCCC-CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------
Q 007055 169 VMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----------- 235 (620)
Q Consensus 169 ~~~~~~-~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~----------- 235 (620)
...... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||........ +..+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhh
Confidence 554332 23456899999999775 4589999999999999999999999976433222 222211000
Q ss_pred ----------C----CC----------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 236 ----------P----AS----------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 236 ----------p----~~----------------~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
+ .. .....++.+++||.+||+ +|.+|||+.|+|.||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0 00 012345678999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=327.61 Aligned_cols=259 Identities=31% Similarity=0.504 Sum_probs=211.7
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
.-..+.|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-- 88 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLVG-- 88 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeeeC--
Confidence 334456789999999999999999999999999999986432 23346688999999999999999999988665
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
...++|+||+++|+|.+++.+. .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~~~~ 164 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQ 164 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCcceec
Confidence 4588999999999999998764 5889999999999999999999999 99999999999998 788999999998854
Q ss_pred ccCC--CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 170 MQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 170 ~~~~--~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
.... ......|++.|+|||.+. +.++.++||||||+++|+|++|+.||.......++......+......+...+..
T Consensus 165 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (293)
T cd06647 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 244 (293)
T ss_pred ccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHH
Confidence 4322 223456899999999775 4588999999999999999999999976443333322222222222233345778
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
++++|.+||. +|.+||++.+++.||||+..++
T Consensus 245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 9999999998 8999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=321.59 Aligned_cols=249 Identities=21% Similarity=0.320 Sum_probs=198.7
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l~l 94 (620)
|++.+.||+|+||.||+|.+..++..||+|.++.... .... ....+|+.++.++. ||||+++++++.+.....+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 5788999999999999999999999999998864321 1122 23457889998885 999999999988765567999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
|+||+. |+|.+++.. .+.+++..+..++.||+.||.|||+++ ++||||||+||+++ . |.+||+|||++......
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~-~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIK-D-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEc-C-CCeEEEecccccccccC
Confidence 999997 477777765 457899999999999999999999999 99999999999998 4 99999999999755433
Q ss_pred C-CccccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Q 007055 174 T-ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---------------- 234 (620)
Q Consensus 174 ~-~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~---------------- 234 (620)
. .....+++.|+|||.+. +.++.++|||||||++|||++|..||.+.. .......+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN-ELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC-HHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2 23456899999999764 347889999999999999999999997643 333222221100
Q ss_pred CCCCC-----------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 235 KPASL-----------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 235 ~p~~~-----------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
....+ ....+..++++|.+||. +|.+||++.++|.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00001 12346899999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.09 Aligned_cols=254 Identities=29% Similarity=0.555 Sum_probs=210.4
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
.+|.....||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++.+... ...+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~ 95 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELW 95 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEE
Confidence 4556678899999999999999999999999988643 234556788999999999999999999988654 4689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+|+||+++++|.+++.. +.+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEccCcchhhcccc
Confidence 99999999999998864 46899999999999999999999999 99999999999998 7899999999998654322
Q ss_pred --CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHH
Q 007055 174 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQ 249 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~~~~lk~ 249 (620)
......|++.|+|||.+.+ .++.++||||||+++|||++|..||... ........+.....+. ......+..+++
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPRVKDSHKVSSVLRG 250 (292)
T ss_pred cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCccccccccCHHHHH
Confidence 2234578999999998764 5889999999999999999999999763 4444444444433221 122345788999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
||.+||. +|.+|||+.++|.||||....+
T Consensus 251 li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 251 FLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 9999998 8999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=322.01 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=206.9
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg-----~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
..|++.+.||+|+||.||+|.+...+ ..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-
Confidence 45789999999999999999886655 789999876332 344556789999999999999999999987654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEe
Q 007055 89 NRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 152 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 152 (620)
...++++||+++|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||++
T Consensus 81 -~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~ 157 (283)
T cd05048 81 -QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV 157 (283)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEE
Confidence 4688999999999999999765 45888999999999999999999999 9999999999999
Q ss_pred cCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHH
Q 007055 153 NGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 226 (620)
Q Consensus 153 ~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i 226 (620)
+ .++.+||+|||++...... ......+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ .....+
T Consensus 158 ~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~ 235 (283)
T cd05048 158 G-EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEV 235 (283)
T ss_pred c-CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 8 7889999999998644222 122345688999999765 568999999999999999998 9999976 455667
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 227 ~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
...+..+..+. .+...++.+.+++.+||+ +|.+||++.+++++
T Consensus 236 ~~~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77776654443 455678999999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=348.68 Aligned_cols=233 Identities=31% Similarity=0.461 Sum_probs=198.6
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
.+-||.|+.|.||+|.. .++.||||+|+-- -..+|+.|++|+||||+.|.++| .....++|||||
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVC--tqsPcyCIiMEf 193 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVC--TQSPCYCIIMEF 193 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeee--cCCceeEEeeec
Confidence 46799999999999954 5889999987521 12588999999999999999977 445689999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-CCcc
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS 177 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~-~~~~ 177 (620)
|..|-|...++...++.......|.++|+.|+.|||.+. |||||||.-||||. .+..|||+|||.++..... +..+
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~STkMS 270 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILIS-YDDVVKISDFGTSKELSDKSTKMS 270 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEee-ccceEEeccccchHhhhhhhhhhh
Confidence 999999999999999999999999999999999999999 99999999999998 6779999999999776544 4567
Q ss_pred ccCCCCCCCccccccc-cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 007055 178 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256 (620)
Q Consensus 178 ~~GTp~y~APEll~~~-y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~ 256 (620)
++||..|||||+++.+ .+.++|||||||+||||+||+.||.+.... .|.--+-........+...+.-++-||+.||.
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-eeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 8999999999999854 899999999999999999999999763222 22222222333345666778899999999997
Q ss_pred -CCCCCCCHHHHhcC
Q 007055 257 -PASLRLPALELLKD 270 (620)
Q Consensus 257 -~p~~Rpsa~elL~h 270 (620)
+|..||+..++|.|
T Consensus 350 sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLH 364 (904)
T ss_pred cCCCCCccHHHHHHH
Confidence 89999999999988
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=357.66 Aligned_cols=254 Identities=21% Similarity=0.385 Sum_probs=207.9
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEE-Ec
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSW-VD 86 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f-~~ 86 (620)
..+.+-.+++.++|.+|||+.||+|.+...|.+||+|++-. .++...+.+.+||++|+.|+ |+|||.|+++. ..
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~----~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV----NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec----CCHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 34556678999999999999999999999999999998753 35778888999999999996 99999999943 22
Q ss_pred C---C-CCeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEE
Q 007055 87 D---T-NRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 160 (620)
Q Consensus 87 ~---~-~~~l~lV~Ey~~gGsL~~~i~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vK 160 (620)
. . ...+.+.||||.||.|-+++.. +.+|++.++.+|+.|++.|+++||.+.|||||||||-+||||+ .+|..|
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~K 186 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYK 186 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEE
Confidence 1 1 2468889999999999999874 4569999999999999999999999999999999999999998 789999
Q ss_pred EccccchhhccCCC--Cc---------cccCCCCCCCccccc---c-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHH
Q 007055 161 IGDLGLAIVMQQPT--AR---------SVIGTPEFMAPELYE---E-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 225 (620)
Q Consensus 161 I~DFGla~~~~~~~--~~---------~~~GTp~y~APEll~---~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~ 225 (620)
|||||.|+..-... .. ...-||.|+|||++. + ..++|+|||+|||+||-||..+.||.+....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-- 264 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-- 264 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence 99999985322111 11 124699999999764 3 4899999999999999999999999764222
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 007055 226 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 272 (620)
Q Consensus 226 i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpf 272 (620)
.|..+....+....++..+++||..||+ +|.+||++.+++.+-+
T Consensus 265 ---aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 265 ---AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ---eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 2334433333334578899999999998 8999999999886533
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.19 Aligned_cols=251 Identities=27% Similarity=0.459 Sum_probs=200.0
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|++|+||+|.++.+|+.||+|.+...... .....+.+|+.+++.++||||+++++++.+. ...+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTK--KTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecC--CeEE
Confidence 4578999999999999999999999999999998754321 1123466899999999999999999988644 5789
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+||||+.+ +|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.....
T Consensus 80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSV 155 (291)
T ss_pred EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccCC
Confidence 99999984 899988764 46899999999999999999999999 99999999999998 789999999999864322
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---C----------
Q 007055 173 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---K---------- 235 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~---~---------- 235 (620)
. ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.+..........+.... .
T Consensus 156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 2223457889999998753 488999999999999999999999976543333222221100 0
Q ss_pred ------------CCCC---CCCCc--HHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 236 ------------PASL---SKVTD--PQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 236 ------------p~~~---~~~~~--~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+..+ ....+ ..+.++|.+||. +|.+||++.++|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01122 778899999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.69 Aligned_cols=253 Identities=28% Similarity=0.564 Sum_probs=212.2
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|.-.+.||+|++|.||+|.+..++..||+|.++... ....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~~~~ 92 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--DELW 92 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--CeEE
Confidence 35566689999999999999999999999999886432 23445688999999999999999999988654 4688
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+|+||+++++|.+++.. +++++..+..++.||+.||+|||+++ ++||||+|+||+++ .+|.++|+|||++......
T Consensus 93 ~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 93 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred EEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccchhhccC
Confidence 99999999999999887 67999999999999999999999999 99999999999998 7899999999987644332
Q ss_pred --CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCcHHHHH
Q 007055 174 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTDPQVKQ 249 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~-~~~~~~~~lk~ 249 (620)
......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.. .++......+.....+.. .....+..+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (285)
T cd06648 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRS 247 (285)
T ss_pred CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHH
Confidence 2234578999999998764 588999999999999999999999976 455555566665533221 12236789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
||.+||. +|.+||++.+++.||||....
T Consensus 248 li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 248 FLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHcccChhhCcCHHHHccCcccccCC
Confidence 9999998 899999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.84 Aligned_cols=276 Identities=24% Similarity=0.383 Sum_probs=230.6
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
+..+..+++.-++||+|+||.||-+.-..||+.+|.|.+.++.+.. ........+|-.+|..++.+.||.+-..|. +
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAfe--T 256 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAFE--T 256 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeeec--C
Confidence 3455667888899999999999999999999999999887655432 334455788999999999999999977774 4
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
...+++|+..|.||+|.-.|-+.+ .|+++.+..|+.+|+.||++||..+ ||+|||||+|||+| ++|+|+|+|+|+
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGL 333 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGL 333 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccce
Confidence 456999999999999999888776 7999999999999999999999999 99999999999998 899999999999
Q ss_pred hhhccCCC-CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~-~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~---~~i~~~i~~~~~p~~~~~ 241 (620)
|..+.... .+..+||.+|||||++.+ .|+..+|+|||||++|||+.|+.||...... +++-+++.. .+..++.
T Consensus 334 Avei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~ 411 (591)
T KOG0986|consen 334 AVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSD 411 (591)
T ss_pred EEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhccc
Confidence 98766544 345599999999999875 4999999999999999999999999753221 233334433 3566777
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCccccCCCCCCCCc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPNLV 292 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p~~~ 292 (620)
..+++++++.+.+|. +|++|+. +.++-.||||+..+++.+....+..|..+
T Consensus 412 kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiP 468 (591)
T KOG0986|consen 412 KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIP 468 (591)
T ss_pred ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCC
Confidence 789999999999998 8988874 67999999999999988765555445444
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=323.16 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=212.7
Q ss_pred EEEEEEEceeCCeEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCe
Q 007055 16 LQYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~ 91 (620)
|++.+.||+|+||.||+|.+. .+|..||+|.++...........+.+.+|+.+++.+ +||||+++++.|..+ ..
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~ 79 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--TK 79 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--Ce
Confidence 688999999999999999875 489999999987543322334456788999999999 699999999987544 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++|+||+++++|.+++...+.+++..+..++.||+.||.|||+++ ++||||+|+|||++ .++.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceecc
Confidence 8899999999999999998888999999999999999999999999 99999999999998 78999999999986543
Q ss_pred CC---CCccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCC
Q 007055 172 QP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 172 ~~---~~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~ 242 (620)
.. ......|++.|+|||.+.. .++.++||||||+++|+|++|..||.... ....+...+.... ..++..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 234 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQE 234 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--CCCCcc
Confidence 32 2234568999999998753 47789999999999999999999996422 2233333333322 234556
Q ss_pred CcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCcc
Q 007055 243 TDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 281 (620)
.++.+.+++.+||+ +|.+|| ++.+++.||||+..++..+
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence 78899999999998 899997 8999999999998876443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=326.13 Aligned_cols=253 Identities=29% Similarity=0.473 Sum_probs=200.5
Q ss_pred EEEEEEEceeCCeEEEEEEEcc--CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~--tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
|++.+.||+|+||.||+|.+.. +|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.....++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 6889999999999999999988 899999999876431 1223345678899999999999999999999877667899
Q ss_pred EEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC----CCcEEEccc
Q 007055 94 MITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----NGEVKIGDL 164 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~-----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~----~G~vKI~DF 164 (620)
+|+||+.+ +|.+++..+ ..+++..++.++.||+.||.|||+++ ++||||||+||+++ . +|.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~-~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVM-GEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEc-CCCCccceEEECCC
Confidence 99999975 677766432 36899999999999999999999999 99999999999998 6 789999999
Q ss_pred cchhhccCC-----CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHH--------HHHHH
Q 007055 165 GLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------QIYKK 229 (620)
Q Consensus 165 Gla~~~~~~-----~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~--------~i~~~ 229 (620)
|++...... ......+|+.|+|||++.+ .++.++||||||+++|+|++|+.||....... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998654322 1234578999999997754 47899999999999999999999997533211 00000
Q ss_pred HHc------------------------CCCCCCCC-----------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 230 VTS------------------------GIKPASLS-----------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 230 i~~------------------------~~~p~~~~-----------~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+.. .......+ ...+..+.++|.+||+ +|.+|||+.|++.||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 00000011 1456789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=320.02 Aligned_cols=249 Identities=28% Similarity=0.498 Sum_probs=202.1
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||.|++|.||+|.+..+|..||+|.++.... ......+.+|+.+++.++||||++++++|.+.. .+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 76 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTEN--KLMLV 76 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEEEE
Confidence 6889999999999999999999999999999876532 223355778999999999999999999987654 58899
Q ss_pred EeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 96 TELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~---~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+||+.+ +|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.++|+|||++.....
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGI 152 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcC
Confidence 999985 888887654 35899999999999999999999999 99999999999998 789999999999865433
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------
Q 007055 173 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------ 236 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p------------ 236 (620)
. ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+..........+.....|
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 2 2234567899999998754 47889999999999999999999998755443322222110000
Q ss_pred ---CC-----------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 237 ---AS-----------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 237 ---~~-----------~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.. +....++.++++|.+||+ +|.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112346789999999997 99999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.60 Aligned_cols=246 Identities=27% Similarity=0.456 Sum_probs=208.5
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|+||.||++.+..++..||+|.++... .....+.+.+|+.+++.++||||++++++|.+. ..+++|
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 76 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIV 76 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEE
Confidence 688999999999999999999999999999987543 234557788999999999999999999988654 579999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 96 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeeccc
Confidence 9999999999988653 45899999999999999999999999 99999999999997 7899999999998655432
Q ss_pred --CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 174 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
......|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..+ .++...+..+++|
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 231 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYK-PLPSHYSYELRSL 231 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCC-CCCcccCHHHHHH
Confidence 2334678999999998864 488999999999999999999999976 4555555555555333 2445567899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCC
Q 007055 251 IEKCIV-PASLRLPALELLKDP 271 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hp 271 (620)
|.+||. +|.+||++.+++.--
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhcc
Confidence 999998 999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.94 Aligned_cols=254 Identities=23% Similarity=0.384 Sum_probs=206.7
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEe
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 82 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~ 82 (620)
|.+.++.|++.+.||+|+||.||+|.+. .+++.||+|+++... .....+.+.+|+.+++++ +||||+++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~ 78 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLG 78 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheee
Confidence 6677788999999999999999999753 356899999886432 234456788999999999 8999999999
Q ss_pred EEEcCCCCeEEEEEeccCCCCHHHHHHhC---------------------------------------------------
Q 007055 83 SWVDDTNRTINMITELFTSGSLRQYRKKH--------------------------------------------------- 111 (620)
Q Consensus 83 ~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~--------------------------------------------------- 111 (620)
++.... ..+++++||+++|+|.+++...
T Consensus 79 ~~~~~~-~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (337)
T cd05054 79 ACTKPG-GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE 157 (337)
T ss_pred eEecCC-CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence 876543 5788999999999999998642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC----Ccc
Q 007055 112 ----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARS 177 (620)
Q Consensus 112 ----------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~ 177 (620)
..+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++....... ...
T Consensus 158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~ 234 (337)
T cd05054 158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGD 234 (337)
T ss_pred cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccC
Confidence 25789999999999999999999998 99999999999998 68899999999997543221 223
Q ss_pred ccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 178 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 178 ~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
..+++.|+|||++. ..++.++|||||||++|||++ |..||.+......+...+..+..+ ..+...++.+.+++.+||
T Consensus 235 ~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl 313 (337)
T cd05054 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCW 313 (337)
T ss_pred CCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHc
Confidence 45677899999765 569999999999999999998 999997644334444445444332 334556789999999999
Q ss_pred C-CCCCCCCHHHHhcC
Q 007055 256 V-PASLRLPALELLKD 270 (620)
Q Consensus 256 ~-~p~~Rpsa~elL~h 270 (620)
+ +|.+||++.|+++|
T Consensus 314 ~~~p~~RPs~~ell~~ 329 (337)
T cd05054 314 HNNPEDRPTFSELVEI 329 (337)
T ss_pred cCChhhCcCHHHHHHH
Confidence 8 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=347.55 Aligned_cols=256 Identities=28% Similarity=0.460 Sum_probs=223.6
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
-.|.+...||+|.|++|.+|.+..||..||||.++... .+...++.+.+|+++|+.|+|||||++|.+.. ....+|
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~--ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~--t~~~ly 131 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ--LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE--TEATLY 131 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcc--cChHHHHHHHHHHHHHHhcCCcceeeeeeeee--ecceeE
Confidence 46789999999999999999999999999999987654 34555667999999999999999999999764 446799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||||+.+|.+++|+.+++++.+..++.++.|+++|++|||+++ |+|||||++|||++ .+..+||+|||++..+...
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~-~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLD-ENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccc-cccceeeeccccceeeccc
Confidence 99999999999999999999999999999999999999999999 99999999999998 6778999999999877644
Q ss_pred -CCccccCCCCCCCccccccc--cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 174 -TARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~~--y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
...+++|+|.|.|||++.+. .++.+|+||+|+++|-|+.|..||.+ .+...+..++..+... ++...+-+++++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~r--Ip~~ms~dce~l 285 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYR--IPFYMSCDCEDL 285 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeec--ccceeechhHHH
Confidence 56789999999999998864 46889999999999999999999987 4555565666555443 333456789999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 251 IEKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
|+++|+ +|.+|++..++..|+|.......
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 999998 89999999999999999765544
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=308.65 Aligned_cols=247 Identities=33% Similarity=0.601 Sum_probs=207.6
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|.+.+.||+|++|.||+|.+..+|..|++|.+..... .....+.+|+.+++.++||||+++++.+... ...+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~ 75 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIV 75 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEE
Confidence 6788999999999999999999999999999875432 3557789999999999999999999988665 468899
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 96 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
+||+++++|.+++... +.+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeeccccccccccc
Confidence 9999999999999876 67999999999999999999999998 99999999999998 68999999999986655433
Q ss_pred -CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCcHHHHHHH
Q 007055 175 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTDPQVKQFI 251 (620)
Q Consensus 175 -~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~-~~~~~~~~lk~~I 251 (620)
.....|+..|+|||.+.+ .++.++||||||+++|+|++|+.||........+..... ...+.. ....++..+.+||
T Consensus 153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 231 (253)
T cd05122 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFL 231 (253)
T ss_pred cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHH
Confidence 345678999999998764 478899999999999999999999976533333333222 222221 1222378999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCC
Q 007055 252 EKCIV-PASLRLPALELLKDPF 272 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpf 272 (620)
.+||+ +|.+||++.++|.|||
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHccCChhhCCCHHHHhcCCC
Confidence 99998 8999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=321.54 Aligned_cols=251 Identities=33% Similarity=0.570 Sum_probs=207.9
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCcceEEeEEEcCCCCe
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpNIVkl~~~f~~~~~~~ 91 (620)
.|++.+.||+|+||.||+|.+..+|..||+|.++... .......+.+|+.+++.++ ||||++++++|.+. ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CE
Confidence 4677899999999999999999999999999886432 2344567889999999996 99999999988654 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
.++||||+.+++|.+++... .+++..+..++.||+.||.|||+.+ ++||||+|+||+++ .+|.++|+|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecC
Confidence 89999999999999998764 7999999999999999999999999 99999999999998 68999999999986554
Q ss_pred CCC--CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC-CCcHH
Q 007055 172 QPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK-VTDPQ 246 (620)
Q Consensus 172 ~~~--~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~-~~~~~ 246 (620)
... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.. .......+... .++.+.. ..++.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~ 230 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKS-KPPRLEDNGYSKL 230 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhccccC-CCCCCCcccCCHH
Confidence 332 234578999999998754 36889999999999999999999997643 33222222222 2233333 36789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+.+|+.+||. +|.+||++.+++.||||+..
T Consensus 231 ~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 231 LREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 9999999998 89999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.08 Aligned_cols=250 Identities=27% Similarity=0.490 Sum_probs=207.8
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|.+.+.||+|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+... ..+++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~lv 77 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLFIV 77 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEEEE
Confidence 6889999999999999999999999999999876532 223456688999999999999999999987543 578999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 96 TELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||+++++|.+++.+.. .+++..+..|+.|++.||.|||+++ ++|+||||+||+++..+..+||+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999999987654 4799999999999999999999999 9999999999999844346799999998665433
Q ss_pred C--CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 174 T--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 174 ~--~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
. .....|++.|+|||++. ..++.++|+||||+++++|++|..||... +.......+..+..+ ......+..++++
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFA-PISPNFSRDLRSL 233 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCC-CCCCCCCHHHHHH
Confidence 2 23346899999999775 45889999999999999999999999764 444444444444332 2334457799999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 251 IEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
|.+||. +|.+||++.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=330.73 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=202.9
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC---C
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---N 89 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~---~ 89 (620)
++.|++.+.||+|+||.||+|.+..+|..||+|.+.... ......++.+|+.+++.++||||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 466789999999999999999999999999999986322 2234566888999999999999999998765433 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++|+||+. ++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~ 155 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARI 155 (336)
T ss_pred ceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECcccceee
Confidence 35899999996 488877754 56999999999999999999999999 99999999999998 789999999999865
Q ss_pred ccCC-----CCccccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHH------------
Q 007055 170 MQQP-----TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV------------ 230 (620)
Q Consensus 170 ~~~~-----~~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i------------ 230 (620)
.... ......||+.|+|||.+. ..++.++||||||+++|+|++|+.||.+...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 4322 122357899999999764 358899999999999999999999997643222111100
Q ss_pred --HcCC-------CC--C--C---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 231 --TSGI-------KP--A--S---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 231 --~~~~-------~p--~--~---~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.... .+ . . .....++.+.+||.+||. +|.+||++.+++.||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000 00 0 0 112346789999999998 89999999999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.02 Aligned_cols=249 Identities=25% Similarity=0.423 Sum_probs=208.8
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+..+.|.+.+.||+|+||.||+|.+..++..||+|.+... ......+.+|+.+++.++||||+++++++..+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 74 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE- 74 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCC-
Confidence 455667789999999999999999999999999999987632 22346688999999999999999999987654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||+
T Consensus 75 -~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~ 150 (263)
T cd05052 75 -PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGL 150 (263)
T ss_pred -CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCcc
Confidence 4688999999999999998764 35899999999999999999999998 99999999999997 789999999999
Q ss_pred hhhccCCCCc---cccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~~~---~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+......... ...+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+ .+.......+..+..+ ..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 228 (263)
T cd05052 151 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPE 228 (263)
T ss_pred ccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCC
Confidence 8765433221 223466899999776 458899999999999999998 9999976 4566666777665443 3455
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+++++++|.+||. +|.+||++.++++
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 678899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=327.79 Aligned_cols=253 Identities=28% Similarity=0.545 Sum_probs=209.7
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.|.....||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||++++++|... ...+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~ 94 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELW 94 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEE
Confidence 455566789999999999999999999999999865432 2345688999999999999999999988654 4689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+|+||+++++|..++.. ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++......
T Consensus 95 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred EEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhcccc
Confidence 99999999999998765 56899999999999999999999999 99999999999998 7899999999998654332
Q ss_pred --CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHHH
Q 007055 174 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQ 249 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~~~~lk~ 249 (620)
......|++.|+|||++.+ .++.++|||||||++|+|++|+.||... .+......+.....+ .......++.+.+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 249 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRD 249 (297)
T ss_pred cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHH
Confidence 2344678999999998764 5889999999999999999999999763 444444444433222 1223345788999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
||.+||+ +|.+||++.++++||||....
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 250 FLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 9999998 899999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=332.58 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=204.2
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC---
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 89 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~--- 89 (620)
+..|++.+.||.|+||.||+|.++.+|..||+|.+...+. ...+.+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 5667899999999999999999999999999999875542 344668889999999999999999987654332
Q ss_pred ---------CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEE
Q 007055 90 ---------RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 160 (620)
Q Consensus 90 ---------~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vK 160 (620)
..+++|+||+. ++|.+++.. +.+++..++.++.||+.||.|||+++ ++||||||+||+++..++.+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 589888764 46999999999999999999999999 999999999999985677899
Q ss_pred EccccchhhccCCC-----CccccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Q 007055 161 IGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 233 (620)
Q Consensus 161 I~DFGla~~~~~~~-----~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 233 (620)
|+|||++....... .....|++.|+|||++. ..++.++|||||||++|+|++|+.||......... ..+...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QLILES 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHh
Confidence 99999986543221 12346789999999764 34888999999999999999999999764433322 222111
Q ss_pred C------------------------CCC----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 234 I------------------------KPA----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 234 ~------------------------~p~----~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
. .+. ......+.++++||.+||+ +|.+||++.++|.||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 0 000 0112356789999999998 8999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.12 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=198.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC------
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT------ 88 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~------ 88 (620)
.|++.+.||+|+||.||+|.+..+|..||+|.+...... ......+.+|+.++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc--CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 468999999999999999999999999999998654321 122344678999999999999999999876543
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 89 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
....++|+||+.+ +|.+++... ..+++.+++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCcEEECcCCCc
Confidence 2367999999964 787777654 36899999999999999999999999 99999999999998 7899999999998
Q ss_pred hhccCCC------CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCC
Q 007055 168 IVMQQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKP 236 (620)
Q Consensus 168 ~~~~~~~------~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~---~~~p 236 (620)
....... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+.. ...+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~-~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT-EQHQLTLISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCh
Confidence 6543221 123467889999997754 37889999999999999999999997643 3222111111 1110
Q ss_pred CC---------------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 237 AS---------------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 237 ~~---------------------------~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.. .....++.+++||.+||. +|.+||++.++|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00 011235678899999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=321.71 Aligned_cols=252 Identities=27% Similarity=0.436 Sum_probs=204.5
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+.+|+++++.++||||++++++|.. ....++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 77 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYL 77 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEE
Confidence 46889999999999999999999999999998764332 22344568889999999999999999998854 457899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
|+||+.+++|..+......+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCCc
Confidence 9999999999988877777999999999999999999999998 99999999999998 7899999999998654332
Q ss_pred -CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc------------------
Q 007055 174 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------------ 232 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~------------------ 232 (620)
......+++.|+|||++.+ .++.++||||||+++|+|++|+.||...............
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 2234568999999998753 4788999999999999999999999764433322221110
Q ss_pred -CCC-CC--------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 233 -GIK-PA--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 233 -~~~-p~--------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+.. +. ......+..+++|+.+||. +|.+||++.++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 00 0012346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.91 Aligned_cols=252 Identities=23% Similarity=0.413 Sum_probs=203.7
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
|....+.|++.+.||+|+||+||+|.+. .++..||+|.++... .......+.+|+.+++.++||||++++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~ 77 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 5566778999999999999999999865 346789999875332 23345668899999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKHK----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 153 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~----------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 153 (620)
+... ..+++||||+++|+|.+++...+ .+++..+..++.|++.||.|||+++ ++||||||+||+++
T Consensus 78 ~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~ 153 (277)
T cd05062 78 VSQG--QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA 153 (277)
T ss_pred EcCC--CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc
Confidence 7543 46889999999999999987532 3577889999999999999999998 99999999999998
Q ss_pred CCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHH
Q 007055 154 GNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 227 (620)
Q Consensus 154 ~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~ 227 (620)
.++.+||+|||++....... .....+++.|+|||++. +.++.++|||||||++|||++ |..||.+. +.....
T Consensus 154 -~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~-~~~~~~ 231 (277)
T cd05062 154 -EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-SNEQVL 231 (277)
T ss_pred -CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHH
Confidence 78999999999986443221 11234578899999876 458999999999999999999 78899764 455555
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 228 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 228 ~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..+..+..+ ..+...+..++++|.+||+ +|.+||++.|++++
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 232 RFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 555544332 3345567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=320.57 Aligned_cols=253 Identities=30% Similarity=0.562 Sum_probs=211.9
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|+..+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEE
Confidence 4567788999999999999999999999999987543 244567789999999999999999999988654 47999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
||||+++|+|.+++.. +++++..+..++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEcccccceeccCCc
Confidence 9999999999999875 56899999999999999999999998 99999999999998 78899999999986543322
Q ss_pred --CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 175 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 175 --~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
.....++..|+|||++.+ .++.++|+||||+++|+|+||..||.+.. +......+..+ .++.+....+..+.++|
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~li 233 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKN-NPPTLTGEFSKPFKEFI 233 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhcC-CCCCCchhhhHHHHHHH
Confidence 234568899999998754 58899999999999999999999997643 44433333333 23344555678899999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 252 EKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
.+||. +|.+||++.++++||||.....
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 234 DACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHcccCcccCcCHHHHHhChHhhhcch
Confidence 99998 8999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=322.35 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=202.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l~ 93 (620)
.|...+.||+|+||.||++.+..+|..||+|.+..... ......+.+|+.++.++. ||||+++++++..+ ...+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEE
Confidence 34566889999999999999999999999999875432 245567889999999996 99999999988764 3577
Q ss_pred EEEeccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 94 MITELFTSGSLRQYRK-----KHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~-----~~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
++|||+.. +|.++.. ..+.+++..+..++.|++.||+|||+. + ++||||||+||+++ .++.+||+|||++
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~ 155 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGIS 155 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchh
Confidence 89999864 5544322 346799999999999999999999974 7 99999999999998 7889999999998
Q ss_pred hhccCC-CCccccCCCCCCCcccccc----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---
Q 007055 168 IVMQQP-TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--- 239 (620)
Q Consensus 168 ~~~~~~-~~~~~~GTp~y~APEll~~----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~--- 239 (620)
...... ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.......+....+..+..|...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd06616 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235 (288)
T ss_pred HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence 655433 2234568999999998764 48899999999999999999999997654333333333333222221
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
....++.+.+||.+||+ +|.+||++.+++.||||+...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 12367899999999998 899999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=348.03 Aligned_cols=251 Identities=33% Similarity=0.511 Sum_probs=215.9
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
-.|.+.-..+.+.+.||+|.||+||+|++-. .||||.++.... ++++++.|++|+.++++-+|.||+-|.+++..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 4577777788899999999999999998854 499999987764 56789999999999999999999999999865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
.. +.+|+-+|.|.+|..++... -+|+..+...|++||++|+.|||.++ |||||||..|||+. +++.|||+|||
T Consensus 460 p~---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PP---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFG 533 (678)
T ss_pred Cc---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEeccc
Confidence 43 48999999999999988654 46999999999999999999999999 99999999999997 67999999999
Q ss_pred chhhccC----CCCccccCCCCCCCcccccc----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--
Q 007055 166 LAIVMQQ----PTARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-- 235 (620)
Q Consensus 166 la~~~~~----~~~~~~~GTp~y~APEll~~----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-- 235 (620)
++..... .......|...|||||+++. .|+..+||||||+++|||+||+.||. ..+.+++.-.+..|..
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~p 612 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMP 612 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCc
Confidence 9854322 22334457789999998863 48999999999999999999999999 6889999988988843
Q ss_pred -CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 236 -PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 236 -p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+.......+.++++|+..||. ++.+||...+||.
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 334445567799999999998 8999999999886
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.74 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=203.9
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|++|+||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 78 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLYL 78 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEEE
Confidence 46899999999999999999999999999998865432 223345678899999999999999999998654 47899
Q ss_pred EEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 95 ITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
||||+. ++|.+++..... +++..++.++.||+.||.|||+++ ++||||+|+||+++..++.+||+|||++.....
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 999996 578887765443 588999999999999999999998 999999999999985567899999999865432
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------
Q 007055 173 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------ 236 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p------------ 236 (620)
. ......+++.|+|||.+.+ .++.++||||||+++|+|+||+.||........+.+.+..-..|
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 2 2234567899999998754 47889999999999999999999997644444443332210000
Q ss_pred -----------C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 237 -----------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 237 -----------~---~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
. ......++.++++|.+||+ +|.+||++.++|.||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0112356789999999998 89999999999999999864
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=320.42 Aligned_cols=250 Identities=28% Similarity=0.461 Sum_probs=203.0
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+++++.++||||+++++++.+. ...++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEE
Confidence 4678999999999999999999999999999875532 122335678899999999999999999988654 578999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 96 TELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||+. ++|.+++.... .+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVP 152 (283)
T ss_pred EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCcEEEeecccccccCCC
Confidence 99995 69999998766 7999999999999999999999998 99999999999998 6899999999998654322
Q ss_pred --CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 007055 174 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------- 236 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p------------- 236 (620)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||.......+..+.+.....|
T Consensus 153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 2233467899999997754 37889999999999999999999997654433333322110000
Q ss_pred -------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 237 -------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 237 -------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.......+..+.++|.+||+ +|.+||++.|++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123456789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=331.59 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=207.0
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC---
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 89 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~--- 89 (620)
++.|++.+.||+|+||+||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 4557899999999999999999999999999999864321 22334567789999999999999999998764432
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++|+||+. ++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCccccc
Confidence 35899999996 689999988889999999999999999999999999 99999999999998 789999999999865
Q ss_pred ccCC--CCccccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---C---------
Q 007055 170 MQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---G--------- 233 (620)
Q Consensus 170 ~~~~--~~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~---~--------- 233 (620)
.... ......++..|+|||.+. ..++.++|||||||++|+|++|+.||.+.. .......+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD-YVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCChHHhhhc
Confidence 5432 233457899999999765 358899999999999999999999997532 2111111110 0
Q ss_pred ---------------CCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 234 ---------------IKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 234 ---------------~~p--~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
..+ .......++.+++||.+||+ +|.+|||+.++|+||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 01123457889999999998 89999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.52 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=204.2
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
+....|++.+.||+|+||+||+|.+..+|. .||+|.++.. ......+++.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 345568999999999999999999876665 4899987632 234456778899999999999999999998865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
. ..++|+||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 81 ~---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG 154 (316)
T cd05108 81 S---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFG 154 (316)
T ss_pred C---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEcccc
Confidence 3 3678999999999999998754 6899999999999999999999999 99999999999997 78899999999
Q ss_pred chhhccCCCC----ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 007055 166 LAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASL 239 (620)
Q Consensus 166 la~~~~~~~~----~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~ 239 (620)
++........ ....+++.|+|||++. ..++.++||||||+++|||++ |..||.+ ....++...+..+..++ .
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~ 232 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-Q 232 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCCC-C
Confidence 9976543221 1223467899999775 468999999999999999998 9999976 34555555555544332 3
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+...+..+.+++.+||. +|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 233 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 44567889999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.04 Aligned_cols=244 Identities=28% Similarity=0.513 Sum_probs=199.8
Q ss_pred EEEEEEEceeCCeEEEEEEEc----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 16 LQYDEILGKGAFKTVYKGFDE----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
+.+.+.||.|+||.||+|... ..+..|+||.++.. ......+.+.+|++.+++++||||+++++++.... .
T Consensus 1 ~~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~ 75 (259)
T PF07714_consen 1 IKLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--P 75 (259)
T ss_dssp EEEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--S
T ss_pred CEEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeecccccccccccccccccccccccc--c
Confidence 357899999999999999887 56789999998532 34556788999999999999999999999988443 4
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 92 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
+++|+||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ ++||+|+|+|||++ .++.+||+|||++..
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~-~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLD-SNGQVKLSDFGLSRP 152 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEE-TTTEEEEESTTTGEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccc
Confidence 88999999999999999987 67999999999999999999999999 99999999999998 788999999999865
Q ss_pred ccCC----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 007055 170 MQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243 (620)
Q Consensus 170 ~~~~----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~ 243 (620)
.... ......+...|+|||.+.. .++.++||||||+++|||++ |+.||.+. +..++...+..+..+. .+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~ 230 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNC 230 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccch
Confidence 5221 1223456778999998864 58999999999999999999 78999775 6777777776664433 45567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+..+.++|..||. +|.+||++.++++
T Consensus 231 ~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 231 PKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp BHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 8899999999997 8999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=312.20 Aligned_cols=249 Identities=30% Similarity=0.512 Sum_probs=207.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.+..+|..||+|.++.... ......+.+.+|+.++++++|+||++++++|... ...++
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~l 79 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNI 79 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 57899999999999999999999999999999875443 2234467789999999999999999999998765 46899
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 95 ITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
||||+++|+|..++.. ...+++.+++.|+.||+.||.|||+++ ++||||+|+||+++ .+|.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceeeec
Confidence 9999999999999864 245899999999999999999999999 99999999999998 7899999999998654
Q ss_pred cCC--CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 171 QQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 171 ~~~--~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
... ......|++.|+|||.+. ..++.++||||||+++|+|++|..||.... +.......+..+..++......+..
T Consensus 157 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred cCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence 332 223457899999999775 458999999999999999999999996533 3334455555554444333356789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 247 VKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
++++|.+||. +|.+||++.++++
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999998 8999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.61 Aligned_cols=256 Identities=35% Similarity=0.592 Sum_probs=213.9
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
....|.+.+.||+|++|.||+|.+..++..||+|.+..... ..+.+.+|+++++.++||||+++++++... ..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 89 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVG--DE 89 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CE
Confidence 44567888999999999999999999999999999875421 456688999999999999999999998765 57
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 92 INMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
+++|+||+.+++|.+++...+ .+++..+..++.||+.||.|||++| ++|+||+|+||+++ .+|.++|+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQL 166 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccchhhhh
Confidence 899999999999999999877 8999999999999999999999998 99999999999998 7899999999998644
Q ss_pred cCC--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCcHH
Q 007055 171 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-SGIKPASLSKVTDPQ 246 (620)
Q Consensus 171 ~~~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~-~~~~p~~~~~~~~~~ 246 (620)
... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||... ++......+. ....+.......+..
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKWSPE 245 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhhCCHH
Confidence 332 2234468899999997764 5899999999999999999999999764 3333333333 332222223336789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
+++||.+||+ +|.+||++.++|.||||....+
T Consensus 246 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 246 FKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 9999999998 8999999999999999988443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.38 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=204.9
Q ss_pred CceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.+.|.+.+.||+|+||.||+|.+. .++..||+|.++... ..+..+.+.+|+++|+.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 455788999999999999999874 346899999886432 233557799999999999999999999998765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHK--------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 153 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~--------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 153 (620)
..+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~ 156 (280)
T cd05049 81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG 156 (280)
T ss_pred --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc
Confidence 46899999999999999997643 4788999999999999999999999 99999999999998
Q ss_pred CCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHH
Q 007055 154 GNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 227 (620)
Q Consensus 154 ~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~ 227 (620)
.++.+||+|||++...... ......+++.|+|||++. +.++.++|||||||++|+|++ |..||.+. +.....
T Consensus 157 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~ 234 (280)
T cd05049 157 -YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVI 234 (280)
T ss_pred -CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHH
Confidence 7899999999998643221 122345678999999876 458999999999999999999 99999764 455566
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 228 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 228 ~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+..+. .+...+..+++++.+||+ +|.+||++.|++.
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6666654433 344578899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=308.61 Aligned_cols=249 Identities=35% Similarity=0.611 Sum_probs=212.7
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|++|.||+|.+..+|+.||+|.+..... .....+.+.+|++++++++|||++++++++.+. ..++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 77 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYII 77 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEE
Confidence 6789999999999999999999999999999876542 235667899999999999999999999987654 578999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCC
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 175 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~ 175 (620)
+||+++++|.+++...+.+++..+..++.|++.||.|||+++ ++||||+|+||+++ .+|.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEC-CCCCEEEeccccceecCCCcc
Confidence 999999999999998889999999999999999999999999 99999999999998 689999999999975544332
Q ss_pred --ccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 007055 176 --RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252 (620)
Q Consensus 176 --~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~ 252 (620)
....+++.|+|||.+.+ .++.++||||||+++|+|++|..||........... +.... ...++...+..++++|.
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQDD-HPPLPEGISPELKDFLM 232 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HhccC-CCCCCCCCCHHHHHHHH
Confidence 34578999999997753 478899999999999999999999976543333333 33222 23355567889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCc
Q 007055 253 KCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 253 kcL~-~p~~Rpsa~elL~hpff 273 (620)
+||. +|.+||++.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9998 89999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=331.67 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=208.5
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC--CCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TNR 90 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~--~~~ 90 (620)
++.|.+.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+|+.++||||++++++|... ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 4678899999999999999999999999999999875322 223456678899999999999999999987543 235
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
.+++|+||+. |+|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEecccccceee
Confidence 7899999995 689999988888999999999999999999999999 99999999999998 7899999999998654
Q ss_pred cCCC------CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CC-------
Q 007055 171 QQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI------- 234 (620)
Q Consensus 171 ~~~~------~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~------- 234 (620)
.... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+.....++...+.. +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 3221 224578999999998753 4889999999999999999999999764333222111110 00
Q ss_pred -----------------CCCC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 235 -----------------KPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 235 -----------------~p~~---~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+.. +....++.+++||.+||+ +|.+||++.++|.||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0000 113357889999999998 899999999999999998643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.80 Aligned_cols=248 Identities=26% Similarity=0.431 Sum_probs=207.4
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+..+.+++.+.||+|-||.||+|.... ...||+|.++.... ..+.+.+|+++|++|+|+|||++|+++..+
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 466667778888999999999999998753 23799999875432 124477999999999999999999987554
Q ss_pred CCCeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
. .+|||||||+.|+|.+|++. .+.+...+...++.||+.|++||++++ +|||||...||||+ +++.+||+|||
T Consensus 274 ~--piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFG 348 (468)
T KOG0197|consen 274 E--PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFG 348 (468)
T ss_pred C--ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcccc
Confidence 3 69999999999999999987 567999999999999999999999999 99999999999998 88899999999
Q ss_pred chhhccCCCCccccC---CCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 166 LAIVMQQPTARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 166 la~~~~~~~~~~~~G---Tp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
+|+......-....| ..-|.|||.+. +.++.++|||||||+|+||+| |+.||.+ ....+..+.+..|...+. |
T Consensus 349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyRlp~-P 426 (468)
T KOG0197|consen 349 LARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYRLPR-P 426 (468)
T ss_pred cccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCcCCC-C
Confidence 998544332221112 34699999776 679999999999999999998 8899877 556677788888876543 4
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELL 268 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL 268 (620)
...++++-+++..||. +|.+|||...+.
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 4588999999999998 899999998654
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=318.15 Aligned_cols=259 Identities=23% Similarity=0.385 Sum_probs=207.5
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
|.+....|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.+++.++||||++++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 77 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGV 77 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 4455667899999999999999999765 245689999876332 23344568889999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 153 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~----------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 153 (620)
+.+. ...++||||+++|+|.+++... ..++...+..++.||+.||.|||+++ |+||||||+||+++
T Consensus 78 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~ 153 (288)
T cd05061 78 VSKG--QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA 153 (288)
T ss_pred EcCC--CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc
Confidence 7544 4689999999999999999753 23466788999999999999999999 99999999999998
Q ss_pred CCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHH
Q 007055 154 GNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 227 (620)
Q Consensus 154 ~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~ 227 (620)
.++.+||+|||+++...... .....++..|+|||.+. +.++.++|||||||++|||++ |+.||.+ .......
T Consensus 154 -~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~ 231 (288)
T cd05061 154 -HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVL 231 (288)
T ss_pred -CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHH
Confidence 78999999999986443221 12234577899999876 458999999999999999998 7889976 4555566
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc------CCCcCCCC
Q 007055 228 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK------DPFLVTDN 277 (620)
Q Consensus 228 ~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~------hpff~~~~ 277 (620)
+.+..+..+. .+...++.+++++.+||+ +|.+||++.++++ ||||....
T Consensus 232 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 232 KFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred HHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 6555543332 334457899999999998 8999999999986 89987654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=323.87 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=219.2
Q ss_pred eeeeeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEe
Q 007055 4 LDLVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 82 (620)
Q Consensus 4 ~~~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~ 82 (620)
+++-.++++.+|---.++||-|-.|.|..+.++.||+++|+|++.- ..+.++|+++.-.. .|||||.+++
T Consensus 52 m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---------s~KARrEVeLHw~~s~h~~iV~Iid 122 (400)
T KOG0604|consen 52 MDFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---------SPKARREVELHWMASGHPHIVSIID 122 (400)
T ss_pred cchhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---------CHHHHhHhhhhhhhcCCCceEEeeh
Confidence 4556677777776556899999999999999999999999997641 24467899876555 7999999999
Q ss_pred EEEc--CCCCeEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CC
Q 007055 83 SWVD--DTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NN 156 (620)
Q Consensus 83 ~f~~--~~~~~l~lV~Ey~~gGsL~~~i~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~ 156 (620)
+|.. ....++.+|||.|+||.|+..++.++. ++|+++..|++||..|+.|||+.+ |.||||||+|+|..+ .|
T Consensus 123 VyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 123 VYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred hhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCC
Confidence 8743 334689999999999999999998765 999999999999999999999999 999999999999963 45
Q ss_pred CcEEEccccchhhcc-CCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCC---HHHHHHHHH
Q 007055 157 GEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVT 231 (620)
Q Consensus 157 G~vKI~DFGla~~~~-~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~---~~~i~~~i~ 231 (620)
..+||+|||+|+... .....+.+-||.|.|||++. +.|+...|+||+|+++|-|++|.+||..... ...+..+|.
T Consensus 201 a~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~ 280 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR 280 (400)
T ss_pred cceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh
Confidence 679999999997655 34456778899999999987 5699999999999999999999999965332 234556676
Q ss_pred cCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 232 SGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 232 ~~~~--p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.|.. |.+-...++..++++|+++|. +|++|.|+.+++.|||+....
T Consensus 281 ~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 281 TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 6643 444445568899999999997 999999999999999997643
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.16 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=200.7
Q ss_pred cCceEEEEEEEceeCCeEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.+|||++.+.||+|+||+||++. ...++..||+|.++... .......+.+|+++|+.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 47899999999999999998764 34578899999886432 233456788999999999999999999988766
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
....+++||||+.+|+|.+++... .+++..+..++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~ 154 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLA 154 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeecccc
Confidence 666799999999999999999765 5999999999999999999999999 99999999999998 7889999999998
Q ss_pred hhccCCC-----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHH--------------HHH
Q 007055 168 IVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------------QIY 227 (620)
Q Consensus 168 ~~~~~~~-----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~--------------~i~ 227 (620)
....... .....++..|+|||.+. ..++.++||||||+++|+|+||..||....... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 7554321 12234566799999875 458999999999999999999999986432110 011
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 228 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 228 ~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+.. ...+...+..+++++.+||. +|++||++.+++.
T Consensus 235 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111111 12344567899999999998 8999999999885
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=310.53 Aligned_cols=249 Identities=31% Similarity=0.507 Sum_probs=213.1
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|+||.||+|.+..+|+.+|+|.+..... .......+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 77 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIV 77 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEE
Confidence 6889999999999999999999999999999875442 234556788999999999999999999988655 578999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 96 TELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+||+++++|.+++.+ ...+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGISKVLK 154 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEe-cCCcEEEeeccchhhhc
Confidence 999999999999876 356899999999999999999999999 99999999999998 68899999999997665
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 172 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
........|++.|+|||.+.+ .++.++|+||||+++|+|++|..||... +...+...+..+..+. .+...+.+++++
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 232 (256)
T cd08530 155 KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYPP-IPPIYSQDLQNF 232 (256)
T ss_pred cCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCC-CchhhCHHHHHH
Confidence 554455678999999998754 4888999999999999999999999764 4555555555544333 334677899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 251 IEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
|.+||. +|.+||++.++|+||++
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 233 IRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHcCCCcccCCCHHHHhcCCCC
Confidence 999998 89999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.47 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=204.6
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.+.....+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 578899999999999999999999999999998653 123334567889999999999999999999876534679999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 96 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
+||+++ +|..++... ..+++..++.++.||+.||+|||+++ ++|+||+|+||+++ .+|.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCC
Confidence 999974 898888765 57999999999999999999999999 99999999999998 78999999999986554432
Q ss_pred ---CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CC---------
Q 007055 175 ---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PA--------- 237 (620)
Q Consensus 175 ---~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~---p~--------- 237 (620)
.....+++.|+|||.+.+ .++.++||||||+++|+|+||+.||....... ....+..... +.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccch
Confidence 233467889999997653 47899999999999999999999997754333 3222221100 00
Q ss_pred -----------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 238 -----------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 238 -----------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.+....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0111237789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=314.39 Aligned_cols=248 Identities=21% Similarity=0.365 Sum_probs=203.0
Q ss_pred EEEEEEEceeCCeEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC---
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 89 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~--- 89 (620)
|++.+.||+|+||.||+|.+..+ +..||+|.++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 46789999999999999987654 48899999875432 34556779999999999999999999998765432
Q ss_pred -CeEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 90 -RTINMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 90 -~~l~lV~Ey~~gGsL~~~i~~~------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
...++|+||+++|+|..++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ +++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEEC
Confidence 3478999999999999988542 35899999999999999999999998 99999999999998 78899999
Q ss_pred cccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 163 DLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 163 DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
|||++....... .....+++.|+|||.+. ..++.++|||||||++|||++ |..||.+ ....+++..+..+..+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRL 234 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC
Confidence 999986543321 11223467899999876 458999999999999999999 8899976 4455666666655433
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..+...++.+.++|.+||+ +|.+||++.|++++
T Consensus 235 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 -KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3455678899999999998 89999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.12 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=199.0
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC----
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---- 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~---- 89 (620)
+.|++.+.||+|+||.||+|.+..+|..||+|.+....... .....+.+|+++++.++||||+++++.+.+...
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 46689999999999999999999999999999987543211 122346789999999999999999998765432
Q ss_pred --CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 90 --RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 90 --~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++|+||+.+ +|...+.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||+
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~ 161 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGL 161 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECcCcc
Confidence 368999999975 66666554 457999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCC-------------CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 007055 167 AIVMQQPT-------------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 231 (620)
Q Consensus 167 a~~~~~~~-------------~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~ 231 (620)
+....... .....|++.|+|||++.+ .++.++|||||||++|+|++|..||.+..... ....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 86443211 123467899999997753 47899999999999999999999997644332 222222
Q ss_pred cC---CCCCC------------------C-------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 232 SG---IKPAS------------------L-------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 232 ~~---~~p~~------------------~-------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
.. ..+.. . .....+.+.+||.+||. +|.+|||+.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 10 00000 0 01223678899999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=310.81 Aligned_cols=241 Identities=24% Similarity=0.421 Sum_probs=206.0
Q ss_pred EEEceeCCeEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEE
Q 007055 20 EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~t---g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
+.||+|+||.||+|.+... +..||+|.++.... ....+.+.+|+.+++.++||||+++++++.. ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence 4799999999999999866 99999999875432 2246778999999999999999999998865 45799999
Q ss_pred eccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 97 ELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~---------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
||+++|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~-~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVG-EDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEEC-CCCcEEEcccccc
Confidence 999999999999875 77999999999999999999999999 99999999999998 7799999999999
Q ss_pred hhccCC----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 168 IVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 168 ~~~~~~----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
...... ......+++.|+|||.+.. .++.++||||||+++|+|++ |..||... ...++...+..+..+ ..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 230 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PKPE 230 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCc
Confidence 765442 2344567899999998764 68999999999999999999 69999774 566677777765433 3445
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..++++.+++.+||. +|.+||++.+++.+
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 568899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=314.01 Aligned_cols=258 Identities=22% Similarity=0.268 Sum_probs=207.3
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
+..+.+.+|++.+.||+|||+-||++....++..+|+|+|... +.++.+...+|++..++++|||+++++++.+.+
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 3456788889999999999999999999999999999999854 357788899999999999999999999876543
Q ss_pred ---CCCeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEE
Q 007055 88 ---TNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 160 (620)
Q Consensus 88 ---~~~~l~lV~Ey~~gGsL~~~i~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vK 160 (620)
.....|+++.|+..|+|.+.+.+. ..+++.++..|+.+|++||.+||...||++||||||.|||+. ..|.++
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-~~~~~v 169 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-DSGLPV 169 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec-CCCceE
Confidence 335799999999999999998753 369999999999999999999999999999999999999997 689999
Q ss_pred EccccchhhccCC-----C------CccccCCCCCCCcccccc----ccCccchhhhhHHHHHHHHhcCCCCCCCCCH-H
Q 007055 161 IGDLGLAIVMQQP-----T------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNP-A 224 (620)
Q Consensus 161 I~DFGla~~~~~~-----~------~~~~~GTp~y~APEll~~----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~-~ 224 (620)
|.|||.++...-. . ......|..|.|||++.- ..++++|||||||++|.|+.|..||...... .
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 9999998643211 0 012346899999999863 3688999999999999999999999531000 0
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 225 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 225 ~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+.-.+..+....+-...++..+.++|+.||+ +|.+||++.+++.+
T Consensus 250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00001111111111123378899999999998 99999999999864
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=311.62 Aligned_cols=240 Identities=23% Similarity=0.409 Sum_probs=197.0
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEecc
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 99 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~ 99 (620)
+.||+|+||.||+|.+..+|..||+|.+... ...+....+.+|+++++.++||||+++++++... ..+++|+||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeec
Confidence 4699999999999999999999999987532 2345557799999999999999999999987654 4688999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCCcc-
Q 007055 100 TSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS- 177 (620)
Q Consensus 100 ~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~- 177 (620)
.+++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..........
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCccccccccccc
Confidence 999999998764 46899999999999999999999999 99999999999998 78899999999986543221111
Q ss_pred ---ccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 007055 178 ---VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252 (620)
Q Consensus 178 ---~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~ 252 (620)
..++..|+|||.+. +.++.++||||||+++|+|++ |..||... ........+.....+ ..+...+..+.+|+.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 230 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVRL-PCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCcccCCHHHHHHHH
Confidence 12245799999875 458899999999999999998 88898653 444445555444332 345566889999999
Q ss_pred HhcC-CCCCCCCHHHHhc
Q 007055 253 KCIV-PASLRLPALELLK 269 (620)
Q Consensus 253 kcL~-~p~~Rpsa~elL~ 269 (620)
+||+ +|.+||++.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.47 Aligned_cols=240 Identities=23% Similarity=0.357 Sum_probs=194.0
Q ss_pred EEEEEE--EceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeE
Q 007055 16 LQYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 16 y~i~e~--LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l 92 (620)
|.+.+. ||+|+||.||++.++.+|..+|+|.+....... .|+.....+ +||||++++++|.... .+
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~~~--~~ 84 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTTLK--GH 84 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEecCC--ee
Confidence 345444 599999999999999999999999987543211 122222222 7999999999987654 69
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC-cEEEccccchhhcc
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQ 171 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G-~vKI~DFGla~~~~ 171 (620)
++||||+++|+|.+++...+.+++..++.++.||+.||.|||+.+ ++||||||+||+++ .++ .++|+|||++....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYD-RAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEe-CCCCeEEEecCccceecC
Confidence 999999999999999998889999999999999999999999999 99999999999998 555 99999999986543
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCCcHH
Q 007055 172 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA----QIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~----~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
.. ....|++.|+|||++.+ .++.++||||||+++|+|++|..||....... .+.... ..+....+..++.
T Consensus 162 ~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 236 (267)
T PHA03390 162 TP--SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKN 236 (267)
T ss_pred CC--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCcccccCHH
Confidence 32 23468999999998764 58999999999999999999999997533221 121222 2233444568899
Q ss_pred HHHHHHHhcC-CCCCCCC-HHHHhcCCCcC
Q 007055 247 VKQFIEKCIV-PASLRLP-ALELLKDPFLV 274 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rps-a~elL~hpff~ 274 (620)
+++||.+||+ +|.+|++ ..++|+||||.
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 9999999998 8999997 59999999996
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=316.03 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=204.1
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
..++.|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSF 79 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 455778999999999999999999987 78999999875332 2334456889999999999999999999876
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC--C
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--N 156 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~~-------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~ 156 (620)
+.. ..++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++.. +
T Consensus 80 ~~~--~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 80 ERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred cCC--CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCC
Confidence 553 5789999999999999997653 4899999999999999999999999 9999999999999732 2
Q ss_pred CcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHH
Q 007055 157 GEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 230 (620)
Q Consensus 157 G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i 230 (620)
..+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+. ....+...+
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~~ 234 (277)
T cd05036 156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFV 234 (277)
T ss_pred cceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHH
Confidence 369999999987553221 11223356899999875 559999999999999999997 99999864 444555555
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 231 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 231 ~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.....+ ..+...++.+.+|+.+||+ +|.+||++.++|+|
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 235 TGGGRL-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 544332 3345567899999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=311.95 Aligned_cols=248 Identities=24% Similarity=0.431 Sum_probs=205.0
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+....|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 73 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE- 73 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-
Confidence 5677889999999999999999999865 56779999876432 2346788999999999999999999987544
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++|+||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ++||||||+||+++ .++.+||+|||+
T Consensus 74 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~ 149 (261)
T cd05072 74 -EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGL 149 (261)
T ss_pred -CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCcc
Confidence 4588999999999999998753 56899999999999999999999998 99999999999998 789999999999
Q ss_pred hhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+....... .....++..|+|||.+. +.++.++|||||||++|+|+| |..||.. .........+..+...+ ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 227 (261)
T cd05072 150 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRMP-RME 227 (261)
T ss_pred ceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCC
Confidence 97554322 12234567899999876 458889999999999999998 9999976 34555556666554433 334
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+.+++.+||. +|.+||++.++++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 567899999999998 8999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.53 Aligned_cols=250 Identities=30% Similarity=0.490 Sum_probs=210.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l~ 93 (620)
.|.+.+.||+|+||.||+|.+..+|..||+|.+..... ........+.+|+.++++++ ||||+++++++... ..++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~ 78 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLY 78 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEE
Confidence 46899999999999999999999999999999875433 22344567889999999998 99999999987543 5689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||||+.+++|.+++.+.+.+++..++.|+.|++.||.|||+++ ++|+||+|+||+++ .+|.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCCc
Confidence 99999999999999999889999999999999999999999999 99999999999997 7899999999998654332
Q ss_pred C----------------------CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 007055 174 T----------------------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 230 (620)
Q Consensus 174 ~----------------------~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i 230 (620)
. .....|++.|+|||.+. ..++.++||||||+++++|++|+.||.... ....+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHH
Confidence 1 12346789999999765 458889999999999999999999998643 34444444
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH----HHHhcCCCc
Q 007055 231 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELLKDPFL 273 (620)
Q Consensus 231 ~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa----~elL~hpff 273 (620)
... ...++...++.+.+||.+||. +|.+||++ .++|+||||
T Consensus 235 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 235 LKL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred Hhc--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 432 223344568899999999997 89999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=326.90 Aligned_cols=264 Identities=29% Similarity=0.416 Sum_probs=211.8
Q ss_pred eeeeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 5 DLVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 5 ~~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
+...|.+.++ |++.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+|+.++||||+++++++
T Consensus 7 ~~~~~~~~~~-y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 7 NKTIWEVPDR-YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred hhhhhccccc-eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 3456776666 578999999999999999999999999999986432 2334456788999999999999999999988
Q ss_pred EcCCC----CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEE
Q 007055 85 VDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 160 (620)
Q Consensus 85 ~~~~~----~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vK 160 (620)
..... ..+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+|
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~k 158 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELK 158 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEE
Confidence 65432 2468999998 7799988764 56999999999999999999999999 99999999999998 789999
Q ss_pred EccccchhhccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---
Q 007055 161 IGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--- 235 (620)
Q Consensus 161 I~DFGla~~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--- 235 (620)
|+|||++...... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||............+.....
T Consensus 159 l~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 159 ILDFGLARQTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred EeecccccccccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999998654332 234567999999998764 4788999999999999999999999875433332222111100
Q ss_pred ----------------------C---CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 236 ----------------------P---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 236 ----------------------p---~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+ ..+....++.+.++|.+||. +|.+|||+.+++.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 01123457789999999998 899999999999999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=314.31 Aligned_cols=247 Identities=22% Similarity=0.349 Sum_probs=201.8
Q ss_pred EEEEEEceeCCeEEEEEEEccCCe--EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC----CC
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NR 90 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg~--~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~----~~ 90 (620)
.++++||+|+||.||+|.+..++. .||+|.++... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 467899999999999999887775 69999886542 24456678899999999999999999999765422 23
Q ss_pred eEEEEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 91 TINMITELFTSGSLRQYRKK------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~------~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
..++|+||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCC
Confidence 57889999999999998742 234899999999999999999999998 99999999999997 7899999999
Q ss_pred cchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCC
Q 007055 165 GLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 238 (620)
Q Consensus 165 Gla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 238 (620)
|++....... .....+++.|+|||.+. ..++.++||||||+++|+|++ |+.||.. .....++..+..+..+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~- 234 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK- 234 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-
Confidence 9987553321 12234677899999876 458999999999999999999 8999976 45566777777654433
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 239 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 239 ~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+...+..++++|.+||+ +|.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 334567789999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=316.00 Aligned_cols=252 Identities=32% Similarity=0.565 Sum_probs=211.1
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
-|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||++++++|... ..+++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEE
Confidence 3567889999999999999999999999999876443 234456788999999999999999999998654 46889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
|+||+++|+|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++ .+|.++|+|||++......
T Consensus 80 v~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 80 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccch
Confidence 9999999999999875 46899999999999999999999999 99999999999998 7899999999998644332
Q ss_pred -CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 174 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||... .+......+..+. ++.+....+..+.++|
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i 233 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNN-PPTLEGNYSKPLKEFV 233 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc-chHHHHHHHhcCC-CCCCCcccCHHHHHHH
Confidence 2234568999999998764 5788999999999999999999999763 4444444444332 3345556788999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 252 EKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+||. +|.+||++.++++||||....
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 99997 899999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.74 Aligned_cols=268 Identities=23% Similarity=0.393 Sum_probs=238.5
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
+++...||-||||.|=++.-......+|+|++++.++.. ..+.+.++.|-++|..++.|.||++|..|-+ .+++||+
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~kyvYmL 498 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SKYVYML 498 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--chhhhhh
Confidence 456678999999999998766555568999998777654 3566889999999999999999999998844 4689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC-CC
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PT 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~-~~ 174 (620)
||-|-||.|+..+...+.|++.+.+.++..++.|++|||++| ||+|||||+|.+++ .+|-+||.|||+|+.... ..
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCCc
Confidence 999999999999999999999999999999999999999999 99999999999998 899999999999987654 45
Q ss_pred CccccCCCCCCCccc-cccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 175 ARSVIGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 175 ~~~~~GTp~y~APEl-l~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
..+++|||+|.|||+ +..+.+.++|.||||+++|||+||.+||++ .++...|+.|.+|+.-..+|+.....+.++|++
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~ 654 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKK 654 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence 778999999999995 567799999999999999999999999987 789999999999999989999999999999998
Q ss_pred hcC-CCCCCCC-----HHHHhcCCCcCCCCCCccccCCCCCCC
Q 007055 254 CIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPN 290 (620)
Q Consensus 254 cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p~ 290 (620)
+-. .|.+|+. +.++-+|.||..-+|..+....++.|.
T Consensus 655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi 697 (732)
T KOG0614|consen 655 LCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPI 697 (732)
T ss_pred HHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCc
Confidence 665 8999986 889999999999999887655554443
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=316.95 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=204.7
Q ss_pred cCceEEEEEEEceeCCeEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
.+..|.+.+.||+|+||.||++.+ ..++..||+|.+... .......+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 456789999999999999999986 345678999987632 34456678999999999999999999998865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHK-------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 153 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~-------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 153 (620)
. ..+++|+||+++|+|.+++..++ .+++..+..++.||+.||+|||+++ ++||||||+||+++
T Consensus 79 ~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~ 154 (288)
T cd05093 79 G--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG 154 (288)
T ss_pred C--CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence 4 46889999999999999997654 4899999999999999999999999 99999999999998
Q ss_pred CCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHH
Q 007055 154 GNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 227 (620)
Q Consensus 154 ~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~ 227 (620)
.++.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||... ......
T Consensus 155 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~ 232 (288)
T cd05093 155 -ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVI 232 (288)
T ss_pred -cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHH
Confidence 78999999999986443221 22334578899999876 458999999999999999998 89999764 455566
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 228 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 228 ~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+..+ ..+...++.+++|+.+||+ +|.+|||+.+++.
T Consensus 233 ~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 233 ECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 666665433 2344567899999999998 8999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=322.35 Aligned_cols=250 Identities=30% Similarity=0.548 Sum_probs=207.7
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|+..+.||+|+||.||+|.+..+|..||+|.+.... .....+.+.+|+.+++.++||||++++++|... ..+++|
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKLWII 80 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccC--CceEEE
Confidence 445678999999999999999999999999886442 234556789999999999999999999988654 468999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC-
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~- 174 (620)
+||+++++|.+++.. +.+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEccccccccccCcch
Confidence 999999999998865 56899999999999999999999998 99999999999997 78999999999986544322
Q ss_pred -CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 007055 175 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252 (620)
Q Consensus 175 -~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~ 252 (620)
.....|+..|+|||.+.+ .++.++|||||||++|+|++|..||... .+......+..+. +..+....+..+.++|.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQYSKPFKEFVE 234 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCC-CCCCCcccCHHHHHHHH
Confidence 223468899999998764 5888999999999999999999999753 3333333333332 23344456788999999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 253 KCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 253 kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+||+ +|.+||++.++++||||...
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHccCCcccCcCHHHHHHhHHHHHH
Confidence 9998 89999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=313.25 Aligned_cols=251 Identities=24% Similarity=0.409 Sum_probs=206.2
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~t-----g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
|.+....|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 77 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEE
Confidence 445566789999999999999999988654 4899999875332 23445678899999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 153 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~----------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 153 (620)
+... ..+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||++
T Consensus 78 ~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~ 153 (277)
T cd05032 78 VSTG--QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA 153 (277)
T ss_pred EcCC--CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc
Confidence 7654 4688999999999999998653 23678899999999999999999999 99999999999998
Q ss_pred CCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHH
Q 007055 154 GNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 227 (620)
Q Consensus 154 ~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~ 227 (620)
.+|.+||+|||+++...... .....+|..|+|||.+. +.++.++|||||||++|||++ |..||.+ .+.....
T Consensus 154 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~ 231 (277)
T cd05032 154 -EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVL 231 (277)
T ss_pred -CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHH
Confidence 78999999999986543321 22345678999999775 458899999999999999998 9999976 4566666
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 228 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 228 ~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+.+..+..+ ..+...+..+.++|.+||+ +|.+|||+.+++.
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 232 KFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 666654332 3444568899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=321.58 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=216.2
Q ss_pred ceEEEE-EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCe
Q 007055 14 LFLQYD-EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 14 r~y~i~-e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~ 91 (620)
.+|++. +.||+|+|+.|.-+....+|.++|+|+|.+. ....+.++++|++++.++ .|+||+.++++|.+++ .
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~ 150 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--R 150 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--e
Confidence 345554 7899999999999999999999999998754 234567899999999999 5999999999986654 5
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCC--CcEEEccccchhh
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIV 169 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~--G~vKI~DFGla~~ 169 (620)
+|+|||-|.||.|...|.+++.|++.++.++.+.|+.||.|||.+| |.||||||+|||-...+ .-||||||.++..
T Consensus 151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccc
Confidence 9999999999999999999999999999999999999999999999 99999999999986333 2589999998743
Q ss_pred ccC---------CCCccccCCCCCCCccccc---c---ccCccchhhhhHHHHHHHHhcCCCCCCCC-------------
Q 007055 170 MQQ---------PTARSVIGTPEFMAPELYE---E---EYNELVDIYSFGMCILEMVTCEYPYNECK------------- 221 (620)
Q Consensus 170 ~~~---------~~~~~~~GTp~y~APEll~---~---~y~~~~DIwSlGiilyELltG~~Pf~~~~------------- 221 (620)
... +...+.+|+.+|||||+.. + .|+.++|.||||||+|-|+.|.+||.+.=
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 321 1233568888999999653 2 39999999999999999999999996521
Q ss_pred -CHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 222 -NPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 222 -~~~~i~~~i~~~~~--p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
-...+++.|..|.. |..-...++.+.+++|..+|+ ++..|.+|.++|+|||++...+.
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 13457788888754 443445578899999999998 89999999999999999876554
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=335.46 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=206.6
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFY 81 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~ 81 (620)
.|.+....|++.+.||+|+||+||+|.+.. ++..||+|.++... .....+.+.+|+++|+.+. ||||++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 566666778899999999999999998643 34679999886432 2344567899999999996 99999999
Q ss_pred eEEEcCCCCeEEEEEeccCCCCHHHHHHhC--------------------------------------------------
Q 007055 82 NSWVDDTNRTINMITELFTSGSLRQYRKKH-------------------------------------------------- 111 (620)
Q Consensus 82 ~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~-------------------------------------------------- 111 (620)
++|.+. ..+++|||||++|+|.+++.+.
T Consensus 108 ~~~~~~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 108 GACTKS--GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEccC--CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 998654 4689999999999999987642
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCC
Q 007055 112 ----------------------------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 145 (620)
Q Consensus 112 ----------------------------------------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 145 (620)
..+++..+..++.||+.||.|||+++ |+||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~di 263 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDL 263 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCC
Confidence 24778888999999999999999999 999999
Q ss_pred CccceEecCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCC
Q 007055 146 KCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNE 219 (620)
Q Consensus 146 Kp~NILl~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~ 219 (620)
||+|||++ .++.+||+|||++...... ......+++.|+|||++. ..++.++|||||||++|+|++ |..||..
T Consensus 264 kp~Nill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 264 AARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred ChHhEEEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 99999998 6889999999998654322 122345778899999775 458999999999999999997 9999977
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 220 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 220 ~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
......++..+..+..+ ..+...++.++++|.+||+ +|.+||++.++.+
T Consensus 343 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 343 MIVDSTFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred cchhHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 55555666666665443 2445567899999999998 8999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=313.78 Aligned_cols=249 Identities=31% Similarity=0.516 Sum_probs=206.8
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||.||+|.+..+|..||+|.+...+. ........+.+|+.+++.++||||++++++|... ..+++
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNI 79 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEE
Confidence 46788999999999999999999999999998875442 2234556788999999999999999999998765 46889
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 95 ITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
++||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhcc
Confidence 9999999999998864 356899999999999999999999999 99999999999998 7889999999998655
Q ss_pred cCCC--CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 171 QQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKN-PAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 171 ~~~~--~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~-~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
.... .....|++.|+|||.+. ..++.++||||||+++|+|++|..||.+... .....+.+.....+.......++.
T Consensus 157 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08229 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236 (267)
T ss_pred ccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence 4322 23457899999999875 4588899999999999999999999975332 234445555444444444557889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 247 VKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
++++|.+||+ +|.+|||+.++++
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999998 9999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=314.52 Aligned_cols=253 Identities=23% Similarity=0.429 Sum_probs=212.2
Q ss_pred EEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEEEE
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
++...||.|+.|.|+++..+.+|...|+|.+... .+.++..++++.++++... +.|+||+.|++|+.+.. +++.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt---~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V~Ic 169 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--VFIC 169 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeeccc---CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--HHHH
Confidence 3456799999999999999999999999998754 3677889999999987666 59999999999987765 6667
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 96 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
||.|.. -+..++++ .++++|..+-.+..-++.||.||..+. +|||||+||+|||+| ..|.||+||||++-.+-...
T Consensus 170 MelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-cCCCEEeecccccceeeccc
Confidence 798842 34445544 467999999999999999999997653 399999999999998 89999999999996554443
Q ss_pred C-ccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHH
Q 007055 175 A-RSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQV 247 (620)
Q Consensus 175 ~-~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~~~~l 247 (620)
+ ..-.|.+.|||||.+. ..|+..+||||||++++||+||++||.+|...-+...+|....+ +.++. ..++.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCHHH
Confidence 3 3447999999999885 34999999999999999999999999999988888888887544 33332 268999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
++|+..||+ ++.+||--.+||+|||+....+
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 999999998 8999999999999999976443
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=313.48 Aligned_cols=247 Identities=25% Similarity=0.415 Sum_probs=203.4
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
....|++.++||+|+||+||+|.+..+|. .||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 45678999999999999999999877776 48999876432 344556788999999999999999999987643
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..++++||+++|+|.+++... +.+++..+..|+.||+.||.|||+++ ++||||||+|||++ +++.+||+|||+
T Consensus 82 ---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~ 155 (279)
T cd05109 82 ---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGL 155 (279)
T ss_pred ---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCc
Confidence 367899999999999998764 56999999999999999999999999 99999999999997 788999999999
Q ss_pred hhhccCCCC----ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 167 AIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 167 a~~~~~~~~----~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
+........ ....+++.|+|||.+. +.++.++|||||||++|||++ |..||.. .....+...+..+..+. .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~ 233 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QP 233 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CC
Confidence 875543221 1223467899999765 558999999999999999998 8999965 34555555555543332 34
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
...++.+.++|.+||. +|..||++.+++.
T Consensus 234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 234 PICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4578899999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=318.83 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=208.1
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 81 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~ 81 (620)
.|......|.+.+.||+|+||.||+|.+ ..++..||+|.++... .....+.+.+|+.+++++ +||||++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 105 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLL 105 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEE
Confidence 4566667889999999999999999975 3456789999876432 234556789999999999 799999999
Q ss_pred eEEEcCCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcE
Q 007055 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 159 (620)
Q Consensus 82 ~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~v 159 (620)
+++... ..+++|+||+++|+|.+++.... .+++.++..++.||+.||.|||+++ ++||||||+||+++ .++.+
T Consensus 106 ~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~ 180 (302)
T cd05055 106 GACTIG--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIV 180 (302)
T ss_pred EEEecC--CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeE
Confidence 988654 46899999999999999987643 3899999999999999999999999 99999999999997 78899
Q ss_pred EEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcC
Q 007055 160 KIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233 (620)
Q Consensus 160 KI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~ 233 (620)
||+|||++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||..........+.+..+
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~ 260 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG 260 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC
Confidence 999999986543321 11234678899999765 458999999999999999998 999998765555555666555
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 234 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 234 ~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+ ..+...++.+++|+.+||. +|.+||++.+++.
T Consensus 261 ~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 261 YRM-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 433 3344567899999999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=310.29 Aligned_cols=239 Identities=23% Similarity=0.372 Sum_probs=199.8
Q ss_pred EEceeCCeEEEEEEE--ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 21 ILGKGAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 21 ~LG~G~fg~Vy~a~d--~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
.||+|+||.||+|.+ +.++..||+|+++... ......+.+.+|+.+++.++||||+++++++.. ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEec
Confidence 589999999999964 5678999999886442 234556778999999999999999999997642 346889999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC----
Q 007055 99 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---- 174 (620)
Q Consensus 99 ~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~---- 174 (620)
+++|+|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCCeee
Confidence 999999999988888999999999999999999999999 99999999999998 78899999999986553322
Q ss_pred -CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 175 -ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 175 -~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
.....+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .+...+...+..+..+ ..+...++.++++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 11223467899999876 458889999999999999998 9999976 4566677777766543 34556789999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 007055 252 EKCIV-PASLRLPALELLK 269 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~ 269 (620)
.+||+ +|.+||++.++..
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99998 8999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=309.96 Aligned_cols=246 Identities=23% Similarity=0.424 Sum_probs=205.0
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+..+.|++.+.||+|+||.||+|.. .|..||+|.++.. ...+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 456677889999999999999999965 4888999987532 23456889999999999999999999765443
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++|+||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||+
T Consensus 73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~ 148 (256)
T cd05082 73 -GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGL 148 (256)
T ss_pred -CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCcc
Confidence 46889999999999999987654 4889999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 167 AIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 167 a~~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
+....... ....++..|+|||++.+ .++.++|||||||++|+|++ |+.||.. .+...+...+..+..+ ..+...+
T Consensus 149 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 225 (256)
T cd05082 149 TKEASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCP 225 (256)
T ss_pred ceeccccC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCC
Confidence 86443322 23345678999998764 58899999999999999998 9999975 4566666777665443 3455678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+.++++|.+||. +|.+|||+.++++
T Consensus 226 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 226 PVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.35 Aligned_cols=254 Identities=28% Similarity=0.478 Sum_probs=208.7
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|...+.||+|+||+||+|.+..+|..||+|.+..... ........+.+|+.+++.++||||+++++++.+. ...|+|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEE
Confidence 4566789999999999999999999999999875432 2334556788999999999999999999998765 468899
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 96 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
+||+. |+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++.... .
T Consensus 100 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~dfg~~~~~~--~ 173 (313)
T cd06633 100 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSS--P 173 (313)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEeecCCCcccC--C
Confidence 99996 577776654 456899999999999999999999999 99999999999997 78899999999885432 2
Q ss_pred CccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 175 ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
.....|++.|+|||++. +.++.++||||||+++|+|++|..||........... +.....+.......+..+++|
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHhcCCCCCCccccCHHHHHH
Confidence 33567899999999873 4488899999999999999999999977544444443 333333433444567789999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 251 IEKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
|.+||+ +|.+||++.+++.||||....+.
T Consensus 253 i~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~ 282 (313)
T cd06633 253 VDYCLQKIPQERPASAELLRHDFVRRDRPA 282 (313)
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCCchh
Confidence 999998 89999999999999999875433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.22 Aligned_cols=257 Identities=26% Similarity=0.364 Sum_probs=208.0
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCe
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~ 91 (620)
...|.+.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++++ +||||++++++|.......
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 345678999999999999999999999999999885322 1233445678899999999 9999999999987666667
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++|+||+. ++|..++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhccc
Confidence 899999997 5999998776 7899999999999999999999999 99999999999998 78999999999986443
Q ss_pred CC-------CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------
Q 007055 172 QP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------- 235 (620)
Q Consensus 172 ~~-------~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------- 235 (620)
.. ......||+.|+|||.+.+ .++.++||||||+++|+|+||+.||.+........+.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 22 2234578999999997643 4788999999999999999999999765443332221111100
Q ss_pred ---------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 236 ---------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 236 ---------------------p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+.......+..+.+||.+||+ +|.+||++.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 011122357889999999998 89999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=336.62 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=211.1
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEc
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 86 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~ 86 (620)
+..+.||.|.+.++||.||.+.||++.... ...+|+|++.... .....+..+.+|+.+|.+| .|.+||++|+|=+.
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 456789999999999999999999998654 4566777665443 3556778899999999999 59999999997554
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCH-HHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHKNVDM-KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e-~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
+.++||||||=+ -+|..++++.....+ -.++.|.+|+|.|+.++|++| |||.||||.|+|+- .|.+||+|||
T Consensus 432 --d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFG 504 (677)
T KOG0596|consen 432 --DGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFG 504 (677)
T ss_pred --CceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeec
Confidence 468999999864 589999988765433 588999999999999999999 99999999999985 6999999999
Q ss_pred chhhccCCC----CccccCCCCCCCcccccc------------ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007055 166 LAIVMQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 229 (620)
Q Consensus 166 la~~~~~~~----~~~~~GTp~y~APEll~~------------~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~ 229 (620)
+|......+ ..+-+||+.||+||.+.. ..++++||||||||||+|+.|+.||....+....+..
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~a 584 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHA 584 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHh
Confidence 997766554 335689999999996631 1567899999999999999999999876555555555
Q ss_pred HHcCCCCCCCCCCCcHH-HHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 230 VTSGIKPASLSKVTDPQ-VKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 230 i~~~~~p~~~~~~~~~~-lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
|........++...++. +.++++.||+ +|.+||++.+||+|||++.
T Consensus 585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 55543334555555444 9999999998 9999999999999999975
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=313.85 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=203.2
Q ss_pred ceEEEEEEEceeCCeEEEEEEE----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFD----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
..|++.+.||+|+||+||+|.. ..++..||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI---NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-- 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--
Confidence 4578999999999999999985 346689999988643 2344556788999999999999999999987654
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEe
Q 007055 90 RTINMITELFTSGSLRQYRKKH-----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 152 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~-----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 152 (620)
...++||||+++|+|.+++... ..+++.++..++.|++.||.|||+++ ++||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE
Confidence 4588999999999999998532 24788899999999999999999999 9999999999999
Q ss_pred cCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHH
Q 007055 153 NGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 226 (620)
Q Consensus 153 ~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i 226 (620)
+ .++.+||+|||++...... ......++..|+|||.+. +.++.++|||||||++|||++ |..||.+ .....+
T Consensus 158 ~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~ 235 (283)
T cd05090 158 G-EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEV 235 (283)
T ss_pred c-CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 8 7889999999999654322 123345677899999875 458999999999999999998 9999976 345566
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 227 ~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
...+.....+ ..+...++.+++++.+||+ +|.+||++.+++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6666654433 3455678899999999998 89999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=325.44 Aligned_cols=250 Identities=24% Similarity=0.407 Sum_probs=199.0
Q ss_pred EEEcee--CCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEe
Q 007055 20 EILGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 20 e~LG~G--~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~E 97 (620)
..||+| +|++||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.++||||++++++|... ..+++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEe
Confidence 456766 999999999999999999999875432 344567889999999999999999999998764 46899999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC--
Q 007055 98 LFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 173 (620)
Q Consensus 98 y~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~-- 173 (620)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++ ++||||||+||+++ .++.+|++||+.+......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCc
Confidence 99999999998865 35899999999999999999999998 99999999999998 7889999999865322111
Q ss_pred C-------CccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C------
Q 007055 174 T-------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P------ 236 (620)
Q Consensus 174 ~-------~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p------ 236 (620)
. .....++..|+|||++.+ .++.++|||||||++|+|++|..||............+..... |
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence 0 111234667999998764 3789999999999999999999999875544443333221100 0
Q ss_pred -------------------------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 237 -------------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 237 -------------------------------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.......++.+++||.+||+ +|.+|||+.|+|+||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00112245678999999998 99999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=308.46 Aligned_cols=246 Identities=23% Similarity=0.410 Sum_probs=206.9
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+..+.|++.+.||.|+||.||+|.+. |+.||+|.++... ...+++.+|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 71 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-- 71 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcC--
Confidence 3456778899999999999999999764 8899999986432 245778999999999999999999998765
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||+
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~ 148 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGL 148 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEccccc
Confidence 356889999999999999998765 6999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 167 AIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 167 a~~~~~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
+........ ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...+
T Consensus 149 ~~~~~~~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 225 (256)
T cd05039 149 AKEASQGQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCP 225 (256)
T ss_pred ccccccccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCC
Confidence 876533222 334466799999775 568889999999999999997 9999976 4556666666655433 3345568
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+.+.++|.+||. +|.+||++.+++.
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHH
Confidence 899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.13 Aligned_cols=248 Identities=25% Similarity=0.425 Sum_probs=203.9
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+..+.|++.+.||+|++|.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 73 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE- 73 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecC-
Confidence 3456677899999999999999999875 457899999864332 235588899999999999999999987554
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++|+||+.+++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||+
T Consensus 74 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~ 149 (261)
T cd05068 74 -EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGL 149 (261)
T ss_pred -CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcce
Confidence 45889999999999999997654 6899999999999999999999998 99999999999998 789999999999
Q ss_pred hhhccCCCCccccC---CCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPTARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~~~~~~G---Tp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+............| +..|+|||.+. ..++.++||||||+++|+|+| |+.||.+ .+.......+.....+ ..+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 227 (261)
T cd05068 150 ARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGYRM-PCPP 227 (261)
T ss_pred EEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCC
Confidence 87654332222223 35799999876 458899999999999999999 9999976 4455566666555332 2344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+++++.+||. +|.+||++.++++
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=326.92 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=206.3
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEe
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 82 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~ 82 (620)
|.+....|++.+.||+|+||+||+|.+ ..+++.||+|.++... .......+.+|+.+|..+ +||||+++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 78 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLG 78 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcc
Confidence 566677889999999999999999984 4578899999986432 234456788999999999 6899999999
Q ss_pred EEEcCCCCeEEEEEeccCCCCHHHHHHhC---------------------------------------------------
Q 007055 83 SWVDDTNRTINMITELFTSGSLRQYRKKH--------------------------------------------------- 111 (620)
Q Consensus 83 ~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~--------------------------------------------------- 111 (620)
++.... ..+++||||+++|+|.+++...
T Consensus 79 ~~~~~~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (343)
T cd05103 79 ACTKPG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS 157 (343)
T ss_pred eeecCC-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCc
Confidence 876543 4688999999999999998642
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC-
Q 007055 112 ----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 174 (620)
Q Consensus 112 ----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~- 174 (620)
..+++..+..|+.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~ 234 (343)
T cd05103 158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPD 234 (343)
T ss_pred cccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcc
Confidence 23678888999999999999999999 99999999999998 78899999999986543221
Q ss_pred ---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 175 ---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 175 ---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
.....+++.|+|||.+. ..++.++||||||+++|+|++ |..||........+...+..+..+ ..+...++.+.+
T Consensus 235 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 313 (343)
T cd05103 235 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQ 313 (343)
T ss_pred hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHH
Confidence 11234567899999765 458999999999999999997 999997755555555555555433 234456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcC
Q 007055 250 FIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~h 270 (620)
++..||+ +|.+||++.++++|
T Consensus 314 ~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 314 TMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=315.49 Aligned_cols=260 Identities=23% Similarity=0.376 Sum_probs=210.6
Q ss_pred EEEEEEEceeCCeEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCe
Q 007055 16 LQYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~ 91 (620)
|++.+.||+|+||.||+|.+. .++..||+|.++...........+.+.+|+.++.++ +||||+++++.|... ..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~~ 79 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--TK 79 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--CE
Confidence 678999999999999999864 467899999987544322334456788999999999 699999999987543 56
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++||||+.+|+|.+++.+...+++..++.|+.|++.||.|||+.+ ++||||||+||+++ .++.++|+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLD-SEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEEECccccccc
Confidence 8899999999999999988888999999999999999999999998 99999999999998 68899999999986543
Q ss_pred CCC---CccccCCCCCCCccccccc---cCccchhhhhHHHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCC
Q 007055 172 QPT---ARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 172 ~~~---~~~~~GTp~y~APEll~~~---y~~~~DIwSlGiilyELltG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~ 242 (620)
... .....|++.|+|||.+.+. .+.++||||||+++|+|++|..||.... ....+.+.+..... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 234 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKT 234 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcc
Confidence 322 2234689999999987543 6789999999999999999999995322 12333333433322 23445
Q ss_pred CcHHHHHHHHHhcC-CCCCCCC---HHHHhcCCCcCCCCCCccc
Q 007055 243 TDPQVKQFIEKCIV-PASLRLP---ALELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rps---a~elL~hpff~~~~~~~~~ 282 (620)
.++.++++|.+||+ +|.+||| +.++|+||||+...+..+.
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~ 278 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLA 278 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHh
Confidence 67899999999998 8999998 5688999999987765543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=324.44 Aligned_cols=256 Identities=30% Similarity=0.425 Sum_probs=210.1
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC---CCe
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NRT 91 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~---~~~ 91 (620)
+|++.+.||+|++|.||+|.+..+|..||+|.+.... ......+.+.+|+.+++.++||||+++++++.... ...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 3689999999999999999999999999999886432 12345567899999999999999999999876653 236
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+|+||||+. ++|.+++.+...+++..++.++.||+.||.|||+++ ++||||||+|||++ .+|.++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~-~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVN-SNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccCceEeec
Confidence 899999997 589999988888999999999999999999999999 99999999999998 67999999999987554
Q ss_pred CCC-----CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC------
Q 007055 172 QPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA------ 237 (620)
Q Consensus 172 ~~~-----~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~------ 237 (620)
... .....+|+.|+|||++.+ .++.++||||||+++|+|++|..||.... ....++.+..... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhhh
Confidence 432 344578999999998764 58899999999999999999999997744 3333333332111 00
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 238 ----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 238 ----------------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
......++.+.+||.+||. +|.+||++.++|.||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0012246789999999998 899999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=326.15 Aligned_cols=256 Identities=31% Similarity=0.453 Sum_probs=207.3
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC---
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 89 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~--- 89 (620)
+..|++.+.||+|++|.||+|.+..++..||+|.+.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 445689999999999999999999999999999876432 223445668889999999999999999987754332
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 90 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 90 -~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..+++|+||+ +++|.+++.. .++++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~~~ 166 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLAR 166 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEccccccc
Confidence 3588999998 6799998876 56999999999999999999999999 99999999999998 78999999999987
Q ss_pred hccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC--------
Q 007055 169 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA-------- 237 (620)
Q Consensus 169 ~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~-------- 237 (620)
..... .....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+.... ..+..+..... +.
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhcc
Confidence 55432 345578999999998754 4788999999999999999999999764433 33333222110 00
Q ss_pred --------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 238 --------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 238 --------------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
......++.+.+||.+||. +|.+|||+.++|.||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0112247889999999998 899999999999999998644
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=314.73 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=207.9
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 81 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~t-----g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~ 81 (620)
.+.+....|++.+.||+|+||.||+|.+... ...||+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 4556667889999999999999999988644 3789999886432 334556788999999999 899999999
Q ss_pred eEEEcCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCC
Q 007055 82 NSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 145 (620)
Q Consensus 82 ~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 145 (620)
+++... ..+++||||+++|+|..++... +.+++..+..++.||+.||.|||+++ |+||||
T Consensus 83 ~~~~~~--~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dl 158 (293)
T cd05053 83 GVCTQE--GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDL 158 (293)
T ss_pred EEEcCC--CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--cccccc
Confidence 987544 4689999999999999998642 46889999999999999999999998 999999
Q ss_pred CccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCC
Q 007055 146 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNE 219 (620)
Q Consensus 146 Kp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~ 219 (620)
||+|||++ .++.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||..
T Consensus 159 kp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 159 AARNVLVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred ceeeEEEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 99999998 78999999999997554321 11223467899999765 458999999999999999997 9999976
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 220 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 220 ~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
....+.+..+..+..+. .+...+..+.+|+.+||. +|.+|||+.+++.+
T Consensus 238 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 238 -IPVEELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred -CCHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 45566666666654433 344567899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.44 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=210.6
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
.++||.|-||+||-|+++.+|+.||||.|.+...-. .+...+++|+.+|+.+.||.||.+...| ++...+++|||-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~--kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT--KQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC--chHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehh
Confidence 379999999999999999999999999998766533 3447799999999999999999998876 455679999999
Q ss_pred cCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCC--CcEEEccccchhhccCC-C
Q 007055 99 FTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQP-T 174 (620)
Q Consensus 99 ~~gGsL~~~i~-~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~--G~vKI~DFGla~~~~~~-~ 174 (620)
+.|.-|.-++. ..+++++...+.++.|||.||.|||-+| |+|+||||+|||+...+ -++||||||+|+..... .
T Consensus 645 l~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 645 LHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 96544444443 3578999999999999999999999999 99999999999997432 47999999999887655 5
Q ss_pred CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 175 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
.++++|||.|+|||+++ .+|+..-|+||.|+|+|.-+.|..||.+..+..+..+... ...|+...+..++++.+||..
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-FMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-FMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-cccCCCchhhcCHHHHHHHHH
Confidence 67899999999999887 5699999999999999999999999987544332222221 123555566778999999999
Q ss_pred hcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 254 CIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 254 cL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+|+ +-.+|.|....|.|||++...
T Consensus 802 LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHhcchHhhccchhhhcch
Confidence 998 899999999999999998643
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.32 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=206.0
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcce
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIK 79 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk 79 (620)
-|.+..+.|.+.+.||+|+||.||+|.+.. ++..||+|.++... .......+.+|+.+++.+ +||||++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 355556778999999999999999998743 34579999886432 234556788999999999 7999999
Q ss_pred EEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 80 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
+++++... ..+++|+||+.+|+|.+++..++ .+++.++..++.||+.||.|||+++ ++||
T Consensus 89 ~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~ 164 (307)
T cd05098 89 LLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHR 164 (307)
T ss_pred EEEEEecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccc
Confidence 99988654 46889999999999999997642 4788999999999999999999998 9999
Q ss_pred CCCccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCC
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY 217 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf 217 (620)
||||+||+++ .++.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||
T Consensus 165 dlkp~Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~ 243 (307)
T cd05098 165 DLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243 (307)
T ss_pred cccHHheEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999998 78899999999986543211 11123457899999776 458999999999999999998 88888
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 218 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 218 ~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+ .+...+...+..+..+ ..+...+.+++++|.+||. +|.+||++.+++.+
T Consensus 244 ~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 244 PG-VPVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred Cc-CCHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 65 5666677666665433 3445668899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=314.36 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=202.9
Q ss_pred cCceEEEEEEEceeCCeEEEEEEE----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFD----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.+++|++.+.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 467889999999999999999974 5678999999986432 244556789999999999999999999998776
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
....+++||||+++++|.+++.+.. .+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~ 155 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGL 155 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCcc
Confidence 5567899999999999999997654 5899999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCC-----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCC--------------CHHHH
Q 007055 167 AIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--------------NPAQI 226 (620)
Q Consensus 167 a~~~~~~~-----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~--------------~~~~i 226 (620)
+....... .....++..|+|||.+. ..++.++||||||+++|+|+|+..|+.... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 86543321 12345677899999765 458899999999999999999876653211 11112
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 227 ~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
...+..+... ..+...+..+.+||.+||+ +|.+||++.+++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 236 VRVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2222233222 2334567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.45 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=210.4
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|...+.||+|+||.||+|.+..+|..||+|.+..... ...+....+.+|+.+++.++|||++++++++.+. ...++
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 102 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAWL 102 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CeEEE
Confidence 36778899999999999999999999999999875433 2344556789999999999999999999988665 35889
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
|+||+.| +|.+++.. ..++++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++.....
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIASP- 177 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecCCCccccCC-
Confidence 9999975 77777654 456899999999999999999999999 99999999999998 789999999998854332
Q ss_pred CCccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 174 TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 174 ~~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
.....|++.|+|||++. +.++.++|||||||++|+|++|..||........+ ..+..+..+.......++.+++
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHhccCCCCCCccccHHHHH
Confidence 23457899999999763 35889999999999999999999999775433333 3444433343344556789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCcCCCCCCc
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFLVTDNPKD 280 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~~ 280 (620)
+|.+||+ +|.+||++.++++|||+....+..
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 9999998 899999999999999997755443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.24 Aligned_cols=243 Identities=23% Similarity=0.425 Sum_probs=200.0
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||.||+|..+ .+..+|+|.+..... ....+.+|+.+|+.++||||+++++++... ..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLY 75 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEE
Confidence 35688999999999999999875 456799998763321 234688899999999999999999987544 4689
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+||||+++|+|.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCC
Confidence 999999999999998753 46899999999999999999999999 99999999999998 788999999999865432
Q ss_pred CCC---ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 173 PTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 173 ~~~---~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
... ....++..|+|||++. ..++.++||||||+++|+|++ |+.||.. .+..+....+..+..+ ..+...+..+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~ 230 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRL-YRPKLASMTV 230 (256)
T ss_pred CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHH
Confidence 221 1224566899999876 458899999999999999999 8999976 4555666667665443 2344567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 007055 248 KQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+++.+||+ +|.+||++.++++
T Consensus 231 ~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 231 YEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 999999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.63 Aligned_cols=239 Identities=23% Similarity=0.405 Sum_probs=198.1
Q ss_pred EEEceeCCeEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEE
Q 007055 20 EILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg---~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
++||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|+.+++.++||||+++++++.. ..+++|+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEE
Confidence 47999999999999876655 8999998875432 2345678899999999999999999997642 3478999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCC-
Q 007055 97 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA- 175 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~- 175 (620)
||+.+|+|.+++.+.+.+++..+..|+.|++.||.|||.++ ++||||||+|||++ .++.+||+|||++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCCcc
Confidence 99999999999998888999999999999999999999999 99999999999998 789999999999865533221
Q ss_pred ----ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 176 ----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 176 ----~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
....++..|+|||.+. ..++.++|||||||++|+|++ |..||... +..++...+..+.. ...+...++.+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGER-LPRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCc-CCCCCCCCHHHHH
Confidence 1112346799999776 458999999999999999998 99999764 45566666665533 3345567789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 007055 250 FIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+|.+||. +|.+||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.12 Aligned_cols=247 Identities=23% Similarity=0.415 Sum_probs=203.5
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
..|++.+.||+|+||+||+|.+..+ ...||+|.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--R 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--C
Confidence 4578999999999999999988654 5689999876432 344556788999999999999999999987544 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 91 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
.+++||||+++|+|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~ 155 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRR 155 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhc
Confidence 688999999999999998764 46899999999999999999999999 99999999999998 788999999999976
Q ss_pred ccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 007055 170 MQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243 (620)
Q Consensus 170 ~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~ 243 (620)
..... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ....+...+..+..++ .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~ 233 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKAVEDGYRLP-PPMDC 233 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCC
Confidence 54211 11223467899999876 458999999999999999998 99999764 4455556666553332 33456
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
++.+.+++.+||+ +|.+||++.+++++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.65 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=202.3
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC----
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---- 88 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~---- 88 (620)
...|++.+.||+|+||.||+|.++.+|+.||+|.++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34678999999999999999999999999999998754321 222345778999999999999999999886543
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 89 ----NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 89 ----~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
...+++|+||+++ +|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCc
Confidence 3478999999986 676766654 46999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCC---CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCC
Q 007055 164 LGLAIVMQQPT---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIK 235 (620)
Q Consensus 164 FGla~~~~~~~---~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~---~~~ 235 (620)
||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||....... ....+.. +..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCC
Confidence 99986554322 122356888999998753 37889999999999999999999997643332 2222221 111
Q ss_pred CCC-------------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 236 PAS-------------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 236 p~~-------------------------~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+.. .....++.++++|.+||. +|.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 110 012347899999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=309.23 Aligned_cols=245 Identities=23% Similarity=0.401 Sum_probs=201.4
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
...|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++... ...
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 74 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPI 74 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--Cce
Confidence 445789999999999999999876 567899998763322 124578899999999999999999987544 468
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 93 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
++|+||+++++|.+++... +.+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVL 151 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceecc
Confidence 8999999999999998764 46899999999999999999999999 99999999999998 78999999999986543
Q ss_pred CCCCccc---cCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 172 QPTARSV---IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 172 ~~~~~~~---~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
....... .++..|+|||.+. ..++.++||||||+++|+|++ |..||.. .........+..+..+ ..+...++.
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 229 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSEVVESVSAGYRL-YRPKLAPTE 229 (256)
T ss_pred cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHcCCcC-CCCCCCCHH
Confidence 3222222 2345799999876 468999999999999999999 8999976 3455666666655433 334567899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+.+++.+||. +|.+||++.++++.
T Consensus 230 ~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 230 VYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.88 Aligned_cols=247 Identities=23% Similarity=0.400 Sum_probs=200.7
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCe--EEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~--~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~ 90 (620)
+.|++.++||+|+||.||+|.++.+|. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--G 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--C
Confidence 357899999999999999999988775 4688876521 2234556789999999999 799999999987554 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC
Q 007055 91 TINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 154 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 154 (620)
.+++|+||+++|+|.+++...+ .+++..+..++.||+.||+|||+++ ++||||||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~- 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG- 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-
Confidence 6889999999999999997542 4889999999999999999999999 99999999999998
Q ss_pred CCCcEEEccccchhhccCCCCcc-ccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHH
Q 007055 155 NNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 231 (620)
Q Consensus 155 ~~G~vKI~DFGla~~~~~~~~~~-~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~ 231 (620)
.++.+||+|||++.......... ...+..|+|||.+. ..++.++|||||||++|||++ |..||.. .........+.
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~ 232 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLP 232 (297)
T ss_pred CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHh
Confidence 68899999999985432221111 22345799999875 458999999999999999997 9999976 45566666666
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 232 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 232 ~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+..+ ..+...++.+++||.+||. +|.+||++.++++.
T Consensus 233 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 233 QGYRM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55433 2345578899999999998 89999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.02 Aligned_cols=265 Identities=24% Similarity=0.429 Sum_probs=211.9
Q ss_pred eeeeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeE
Q 007055 5 DLVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 83 (620)
Q Consensus 5 ~~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~ 83 (620)
+-..|......|++.+.||+|+||.||+|.+..+|..||+|.++... .......+.+|+.++..+ .||||++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 6 DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred cceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhhee
Confidence 34456677778899999999999999999999999999999987543 223445566777766666 59999999999
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCCcEEE
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKI 161 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G~vKI 161 (620)
+.+. ..+++||||+. ++|..++.. .+.+++..+..++.||+.||.|||+ ++ ++||||+|+||+++ .++.+||
T Consensus 83 ~~~~--~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL 156 (296)
T cd06618 83 FITD--SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKL 156 (296)
T ss_pred eecC--CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEE
Confidence 8654 46899999985 577777765 4579999999999999999999997 57 99999999999998 7899999
Q ss_pred ccccchhhccCCC-CccccCCCCCCCcccccc-----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Q 007055 162 GDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 235 (620)
Q Consensus 162 ~DFGla~~~~~~~-~~~~~GTp~y~APEll~~-----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~ 235 (620)
+|||++....... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......+....+.....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (296)
T cd06618 157 CDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP 236 (296)
T ss_pred CccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC
Confidence 9999986554322 223457889999998753 3788999999999999999999999765444445555544433
Q ss_pred CC-CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 236 PA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 236 p~-~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
+. ......+..+++||.+||. +|.+||++.+++.||||.....
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 22 1222367899999999998 8999999999999999986443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.47 Aligned_cols=267 Identities=22% Similarity=0.384 Sum_probs=229.0
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~ 93 (620)
.+.+..+||+|+||.|.+|..+.+.+.+|||++++.-+.+. ++.+--..|-++|... +-|.++.++..|+.- .++|
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTm--DRLy 426 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--DRLY 426 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhh--hhee
Confidence 46788999999999999999999999999999886655443 4445556677778776 567888999888554 4699
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh--hcc
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQ 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~--~~~ 171 (620)
+||||+.||+|-..+++.+++.|..+..++..|+-||-|||++| ||+||||.+||+++ ..|+|||+|||++. ...
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIFD 503 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEec-cCCceEeeecccccccccC
Confidence 99999999999999999999999999999999999999999999 99999999999998 78999999999985 345
Q ss_pred CCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 172 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
..+.++++|||.|+|||++. +.|+.++|+||||++||||+.|++||.+ .+.+++++.|... ...+++..+.++..+
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~eh--nvsyPKslSkEAv~i 580 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEH--NVSYPKSLSKEAVAI 580 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHc--cCcCcccccHHHHHH
Confidence 56778899999999999776 6799999999999999999999999987 6788888888764 345777888999999
Q ss_pred HHHhcC-CCCCCCCH-----HHHhcCCCcCCCCCCccccCCCCCCC
Q 007055 251 IEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLRLPN 290 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa-----~elL~hpff~~~~~~~~~~~~~~~p~ 290 (620)
+...|. .|.+|+.+ .++-.||||+...|..+....+..|.
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPf 626 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPF 626 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCC
Confidence 999997 79999863 57999999999998876554444443
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.85 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=202.8
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
..+.|.+.+.||+|+||.||+|.+. .++..|++|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 4566889999999999999999854 35677999887532 23445668899999999999999999998764
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccce
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 150 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NI 150 (620)
. ..+++||||+++++|.+++..++ .+++..+..++.||+.||+|||+++ ++||||||+||
T Consensus 79 ~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Ni 154 (291)
T cd05094 79 G--DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNC 154 (291)
T ss_pred C--CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceE
Confidence 4 46899999999999999997643 3889999999999999999999999 99999999999
Q ss_pred EecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHH
Q 007055 151 FVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPA 224 (620)
Q Consensus 151 Ll~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~ 224 (620)
|++ .++.+||+|||++....... .....+++.|+|||.+. ..++.++||||||+++|+|+| |..||... +..
T Consensus 155 l~~-~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~ 232 (291)
T cd05094 155 LVG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNT 232 (291)
T ss_pred EEc-cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHH
Confidence 998 78899999999986543221 22345688999999776 458899999999999999999 99999763 445
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 225 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 225 ~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.....+..+..+. .+...+..+++++.+||+ +|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 233 EVIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 5555565554432 344567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.72 Aligned_cols=243 Identities=27% Similarity=0.476 Sum_probs=208.1
Q ss_pred EceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCC
Q 007055 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 101 (620)
Q Consensus 22 LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~g 101 (620)
||+|+||.||+|.+..+|+.||+|.+..... ........+..|+.+++.++||||+++++.+.. ...+++||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence 6999999999999999999999999876543 223456778999999999999999999998754 4579999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC--CCcccc
Q 007055 102 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI 179 (620)
Q Consensus 102 GsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~--~~~~~~ 179 (620)
++|.+++...+.+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...... ......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCc
Confidence 999999998888999999999999999999999998 99999999999998 7899999999998655432 334567
Q ss_pred CCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-C
Q 007055 180 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 257 (620)
Q Consensus 180 GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~ 257 (620)
++..|+|||...+ ..+.++|+||||+++|+|++|..||.. .+.......+... ...++...+..+++||.+||. +
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKD--PLRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcCC
Confidence 8999999998764 478899999999999999999999965 3445555666553 233555568899999999997 8
Q ss_pred CCCCCCH---HHHhcCCCc
Q 007055 258 ASLRLPA---LELLKDPFL 273 (620)
Q Consensus 258 p~~Rpsa---~elL~hpff 273 (620)
|.+||++ .+++.||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.77 Aligned_cols=246 Identities=24% Similarity=0.405 Sum_probs=199.8
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
...|++.+.||+|+||+||+|.+..+|. +|++|.+... ........+..|+..++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-- 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-- 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--
Confidence 3567899999999999999999988776 4666765422 123345668889999999999999999998642
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 89 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
...++|+||+++|+|.+++... +.+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~ 156 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVA 156 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccc
Confidence 3477899999999999999764 56899999999999999999999998 99999999999998 7899999999998
Q ss_pred hhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 168 IVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 168 ~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
...... ......++..|+|||.+. +.++.++|||||||++|||++ |..||.+. .+..+...+..+..+ ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 234 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERL-AQPQ 234 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcC-CCCC
Confidence 654322 122345677899999875 569999999999999999998 99999763 455555555555433 2344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+..++.+|+. +|.+||++.|+++
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 235 ICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 567789999999998 8999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.49 Aligned_cols=260 Identities=28% Similarity=0.402 Sum_probs=205.7
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
+|.+..+ |.+.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||++++++|...
T Consensus 10 ~~~~~~~-y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 86 (342)
T cd07879 10 VWELPER-YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSA 86 (342)
T ss_pred hhccccc-eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheeccc
Confidence 4666665 5789999999999999999999999999998864321 223345678999999999999999999987644
Q ss_pred CC----CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 88 TN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 88 ~~----~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
.. ..+++|+||+. ++|..++ ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~d 160 (342)
T cd07879 87 VSGDEFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILD 160 (342)
T ss_pred ccCCCCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEee
Confidence 32 35789999996 4777665 346899999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------
Q 007055 164 LGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------ 235 (620)
Q Consensus 164 FGla~~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------ 235 (620)
||++..... ......+|+.|+|||.+.+ .++.++|||||||++|+|++|+.||.+..... ....+.....
T Consensus 161 fg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 161 FGLARHADA-EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEF 238 (342)
T ss_pred CCCCcCCCC-CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence 999865432 2234578999999998754 48899999999999999999999998643222 2222221100
Q ss_pred ----------------C----CC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 236 ----------------P----AS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 236 ----------------p----~~---~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
+ .. .....++.+++||.+||+ +|.+||++.++|.||||....+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0 00 012356789999999998 8999999999999999987644
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.73 Aligned_cols=245 Identities=24% Similarity=0.415 Sum_probs=200.9
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
.+.|++.+.||+|+||+||+|.+.. +..||+|.+..... ..+.+.+|+.+++.++||||+++++++... ..+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 74 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPI 74 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCc
Confidence 3567899999999999999997754 45699998864322 235588999999999999999999987544 458
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 93 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||.+....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecC
Confidence 8999999999999999764 46899999999999999999999999 99999999999998 78899999999986543
Q ss_pred CCCCc---cccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 172 QPTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 172 ~~~~~---~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
..... ...++..|+|||.+. +.++.++|||||||++|+|++ |..||... +.......+..+..+ ..+...+..
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 229 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLRL-YRPHLASEK 229 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHhcCCCC-CCCCCCCHH
Confidence 32211 223456799999876 458999999999999999999 99999764 445555666655443 234456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+++++.+||+ +|.+||++.+++.+
T Consensus 230 ~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 230 VYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHh
Confidence 9999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.30 Aligned_cols=242 Identities=22% Similarity=0.362 Sum_probs=190.7
Q ss_pred EEEceeCCeEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEe
Q 007055 20 EILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~--~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~E 97 (620)
+.||+|+||.||+|... .....+|+|.+... ........+.+|+..++.++||||+++++++... ..+++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc---CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEE
Confidence 36899999999999643 34567888876532 2344456688999999999999999999987654 46899999
Q ss_pred ccCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 98 LFTSGSLRQYRKKHK-----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 98 y~~gGsL~~~i~~~~-----~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
|+++|+|.+++.... ..++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLT-ADLSVKIGDYGLALEQYP 152 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEec-CCCcEEEecccccccccc
Confidence 999999999987643 2467888999999999999999999 99999999999998 788999999999854322
Q ss_pred C----CCccccCCCCCCCcccccc--------ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC---C
Q 007055 173 P----TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---P 236 (620)
Q Consensus 173 ~----~~~~~~GTp~y~APEll~~--------~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~---p 236 (620)
. ......+++.|+|||++.. .++.++|||||||++|||++ |..||....+...+...+..+.. .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK 232 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC
Confidence 1 1223346778999998642 36789999999999999999 78899775444444444443322 2
Q ss_pred CCCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhc
Q 007055 237 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 269 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~~p~~Rpsa~elL~ 269 (620)
+.+....++.+++++..|+.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 233 PQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred CcccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 234445778899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.42 Aligned_cols=258 Identities=29% Similarity=0.427 Sum_probs=204.4
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.... .|.+.+.||+|+||.||+|.+..+|..||+|+++... ......+.+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~~-~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 13 WEVPE-RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred hhccC-ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34444 4689999999999999999999999999999886432 12334566889999999999999999999875432
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 89 ----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 89 ----~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
...++++++++ +++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~df 164 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDF 164 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEecc
Confidence 23477888876 7899888765 46999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Q 007055 165 GLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--------- 233 (620)
Q Consensus 165 Gla~~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~--------- 233 (620)
|++..... ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||....... ....+...
T Consensus 165 g~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 165 GLARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELL 242 (345)
T ss_pred cccccccc-cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 99865432 2334578999999998754 47889999999999999999999996533322 22221110
Q ss_pred -----------------CCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 234 -----------------IKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 234 -----------------~~p~---~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.... ......++.+++||.+||+ +|.+||++.++|.||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 0000 0111347789999999998 89999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.90 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=207.7
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEcc----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~----tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
+.++.|++.++||+|+||.||+|.+.. ++..||+|.+... ......+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 567788999999999999999999876 3688999987522 234566778999999999999999999998765
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKH--------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 158 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~--------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~ 158 (620)
. ....+++++|+++|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.
T Consensus 80 ~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~~ 155 (280)
T cd05043 80 D-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQ 155 (280)
T ss_pred C-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCCc
Confidence 4 34678899999999999998764 35899999999999999999999998 99999999999998 7799
Q ss_pred EEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHc
Q 007055 159 VKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 232 (620)
Q Consensus 159 vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~ 232 (620)
+||+|||+++.+.... .....++..|+|||++. ..++.++|||||||++|++++ |+.||.. .++..+...+..
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~ 234 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKD 234 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHc
Confidence 9999999997543221 12234567899999876 458999999999999999999 9999976 466677777766
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 233 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 233 ~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+..+. .....++.+++++.+||. +|++||++.+++.
T Consensus 235 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 GYRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 64433 234467899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.68 Aligned_cols=247 Identities=24% Similarity=0.317 Sum_probs=200.6
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCC----------------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDG----------------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 77 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg----------------~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI 77 (620)
..|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+++++.++||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCCE
Confidence 35689999999999999999876644 568999876442 23556778999999999999999
Q ss_pred ceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCC
Q 007055 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 146 (620)
Q Consensus 78 Vkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~-----------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLK 146 (620)
++++++|..+ ..+++|+||+.+++|.+++.+.. .+++..+..++.|++.||.|||+++ ++|||||
T Consensus 82 ~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlk 157 (296)
T cd05051 82 ARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLA 157 (296)
T ss_pred eEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccc
Confidence 9999988665 46889999999999999998766 6899999999999999999999999 9999999
Q ss_pred ccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh--cCCCCCC
Q 007055 147 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT--CEYPYNE 219 (620)
Q Consensus 147 p~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt--G~~Pf~~ 219 (620)
|+||+++ .++.++|+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++ +..||..
T Consensus 158 p~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 158 TRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999998 67999999999986543221 223456788999997764 68999999999999999998 7788876
Q ss_pred CCCHHHHHHHHHcC------CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 220 CKNPAQIYKKVTSG------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 220 ~~~~~~i~~~i~~~------~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.. ..++...+... ......+...+.++.++|.+||+ +|.+||++.++++
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 LT-DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cC-hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 43 34444443322 11112233456899999999998 8999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.51 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=199.6
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeE--EEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~--VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~ 90 (620)
..|++.+.||+|+||.||+|.+..+|.. +|+|.++.. ........+.+|+.++.++ +||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--C
Confidence 4678999999999999999999888865 466655421 2344556788999999999 899999999987544 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC
Q 007055 91 TINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 154 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 154 (620)
.+++|+||+++|+|.+++.+.+ .+++..++.++.||+.||+|||+++ ++||||||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~- 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG- 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-
Confidence 6899999999999999987543 5789999999999999999999999 99999999999998
Q ss_pred CCCcEEEccccchhhccCCC-CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHH
Q 007055 155 NNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 231 (620)
Q Consensus 155 ~~G~vKI~DFGla~~~~~~~-~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~ 231 (620)
.++.+||+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|+| |..||.. .+..+....+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~ 237 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLP 237 (303)
T ss_pred CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHh
Confidence 78899999999985322111 112234668999998764 48899999999999999998 9999975 44555666665
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 232 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 232 ~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+..+. .+...++.+.++|.+||+ +|.+||++.++|.+
T Consensus 238 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 543322 333467899999999998 89999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=309.68 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=198.2
Q ss_pred CceEEEEEEEceeCCeEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
...|++.+.||+|+||+||+|. +..+|..||+|.+... .....+.+.+|+++++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 3467899999999999999997 4568999999997643 3455677899999999999999999999876666
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 89 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
...+++|+||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~ 155 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLT 155 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCccc
Confidence 56789999999999999999764 46899999999999999999999999 99999999999997 7889999999998
Q ss_pred hhccCCCC-----ccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCH---------------HHH
Q 007055 168 IVMQQPTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------------AQI 226 (620)
Q Consensus 168 ~~~~~~~~-----~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~---------------~~i 226 (620)
........ ....++..|+|||++.+ .++.++||||||+++|||++|..|+...... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 75533221 11223456999998764 5889999999999999999988776432110 011
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 227 ~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
...+..+.. ...+...+..+.+||.+||. +|.+|||+.|++.
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 236 IELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 112222211 12334467899999999998 8999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=352.93 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=198.4
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.++||+|+||.||+|.+..+|+.||+|++.... .......+++.+|+.+++.++||||+++++++.+. ..+++
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~lyL 79 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPVYY 79 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEEEE
Confidence 4589999999999999999999999999999987432 23345567799999999999999999999987654 56899
Q ss_pred EEeccCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 95 ITELFTSGSLRQYRKKH-----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~-----------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
||||++||+|.+++... ..++...+..++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKLiD 156 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVILD 156 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEEEe
Confidence 99999999999998642 23566788999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCC--------------------CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCC
Q 007055 164 LGLAIVMQQP--------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN 222 (620)
Q Consensus 164 FGla~~~~~~--------------------~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~ 222 (620)
||++...... .....+||+.|+|||++.+ .++.++|||||||++|||+||..||.....
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 9998654110 1123579999999998764 589999999999999999999999976333
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 223 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 223 ~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.....................++.+.+++.+||. +|.+|+++.+.|.
T Consensus 237 ~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2222222111111111123467889999999998 8999988766554
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.44 Aligned_cols=253 Identities=29% Similarity=0.484 Sum_probs=208.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.|...+.||+|+||.||+|.++.++..||+|.+..... .......++.+|+.+++.++|||++++++++... ...+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 91 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAW 91 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeE
Confidence 345677899999999999999999999999999875332 2234456788999999999999999999988765 4688
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+|+||+. |+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECCcccceeecC
Confidence 9999997 577776654 456899999999999999999999998 99999999999998 689999999999865433
Q ss_pred CCCccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 173 PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 173 ~~~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
.....|++.|+|||.+. +.++.++|||||||++|+|++|..||.......... .+..+..+.......+..++
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 244 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFR 244 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-HHhhcCCCCcCcccccHHHH
Confidence 23456899999999763 347889999999999999999999997643333333 34444444444556788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 249 QFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+||.+||+ +|.+||++.+++.|||+...
T Consensus 245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 99999998 89999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.58 Aligned_cols=247 Identities=24% Similarity=0.415 Sum_probs=203.6
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+....|++.++||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 72 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-- 72 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEcc--
Confidence 4566778899999999999999999864 678899998864332 23568899999999999999999997632
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++++||+.+|+|.+++... ..+++.++..++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||+
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~ 148 (260)
T cd05067 73 -EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGL 148 (260)
T ss_pred -CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcc
Confidence 3588999999999999998753 46899999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+....... .....++..|+|||++. +.++.++||||||+++|+|++ |+.||.+. +.......+..+..+ ..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 226 (260)
T cd05067 149 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPD 226 (260)
T ss_pred eeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCC
Confidence 86554221 12234567899999876 458899999999999999999 99999864 455555666555433 3345
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+.+++++|.+||. +|.+||++++++.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.94 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=202.7
Q ss_pred cCceEEEEEEEceeCCeEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
..+.+++.++||+|+||.||+|.+ ..++..+|+|.+... .....+.+.+|+++++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 346788999999999999999974 346778999987532 34556779999999999999999999998865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceE
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHK---------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 151 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~---------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NIL 151 (620)
. ..+++|+||+++|+|.+++..++ .+++.++..++.||+.||.|||+++ ++||||||+|||
T Consensus 79 ~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil 154 (280)
T cd05092 79 G--RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCL 154 (280)
T ss_pred C--CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEE
Confidence 4 45889999999999999997653 4889999999999999999999999 999999999999
Q ss_pred ecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHH
Q 007055 152 VNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 225 (620)
Q Consensus 152 l~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~ 225 (620)
++ .++.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||... ....
T Consensus 155 ~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~ 232 (280)
T cd05092 155 VG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTE 232 (280)
T ss_pred Ec-CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHH
Confidence 98 78899999999986443221 12234578899999765 458999999999999999998 99999764 3444
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 226 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 226 i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
....+..+..+ ..+...++.+++||.+||+ +|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 233 AIECITQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHcCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 55555555433 2344567899999999998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=305.86 Aligned_cols=240 Identities=28% Similarity=0.445 Sum_probs=198.3
Q ss_pred EEEceeCCeEEEEEEEcc-CC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEE
Q 007055 20 EILGKGAFKTVYKGFDEV-DG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~-tg--~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
++||+|++|+||+|.+.. .+ ..||+|.+...... ...+.+.+|+.++++++||||+++++.+.+ ..+++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 468999999999999865 33 47999998754431 566789999999999999999999998865 5789999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 97 ELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEe-cCCEEEeccccccccccccc
Confidence 9999999999997764 6899999999999999999999999 99999999999998 67999999999986554321
Q ss_pred -----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 175 -----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 175 -----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
.....++..|+|||.+. ..++.++|||||||++|+|++ |+.||... +..++.+.+.........+...+..+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHH
Confidence 11345678899999876 458999999999999999999 99999764 45555555553222233344567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 007055 248 KQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+++.+||. +|.+||++.+++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.71 Aligned_cols=244 Identities=24% Similarity=0.431 Sum_probs=196.2
Q ss_pred CCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCCCCHH
Q 007055 26 AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR 105 (620)
Q Consensus 26 ~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~ 105 (620)
+++.||++.+..+|..||+|+++.... .......+.+|+.+++.++||||++++++|.+. ...++++||+++|+|.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSCE 87 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCCCHH
Confidence 556677777788999999999976532 345667899999999999999999999998765 4689999999999999
Q ss_pred HHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC---------C
Q 007055 106 QYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------T 174 (620)
Q Consensus 106 ~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~---------~ 174 (620)
+++... ..+++..++.+++||+.||.|||+++ |+||||||+||+++ .+|.+||+|||.+...... .
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeeccccccccccccc
Confidence 998864 45899999999999999999999999 99999999999998 7899999999987533211 1
Q ss_pred CccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Q 007055 175 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--------------- 236 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--------------- 236 (620)
.....++..|+|||++.. .|+.++|||||||++|+|++|..||............+......
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 223457889999998764 48899999999999999999999998755444444443321100
Q ss_pred ----------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 237 ----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 237 ----------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.......+..+.+||.+||. +|.+|||+.++|.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00111224678899999998 99999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.56 Aligned_cols=250 Identities=28% Similarity=0.446 Sum_probs=203.5
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|++|.||+|.+..+|+.+|+|.++.... .......+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEE
Confidence 4677899999999999999999999999999875432 223456788999999999999999999987655 568899
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 96 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
+||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++ .++.+||+|||.+.......
T Consensus 77 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred EeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCc
Confidence 999975 88777765 467999999999999999999999999 99999999999998 78999999999986554432
Q ss_pred --CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--C-----------
Q 007055 175 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--A----------- 237 (620)
Q Consensus 175 --~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~----------- 237 (620)
.....+++.|+|||.+.+ .++.++||||||+++|+|+||+.||.......++.........+ .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 223468889999997753 58899999999999999999999997755444433332211110 0
Q ss_pred --------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 238 --------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 238 --------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
......+..+++||.+||. +|.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112346789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.56 Aligned_cols=242 Identities=22% Similarity=0.333 Sum_probs=190.6
Q ss_pred EEEceeCCeEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEe
Q 007055 20 EILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~--~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~E 97 (620)
+.||+|+||.||+|.+. .++..+|+|.++... .......+.+|+.+++.++||||+++++++.+. ..+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEE
Confidence 36899999999999754 466789999876443 223345688899999999999999999987654 45889999
Q ss_pred ccCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 98 LFTSGSLRQYRKKHK-----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 98 y~~gGsL~~~i~~~~-----~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
|+++|+|.+++.... ..++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEECCccccccccC
Confidence 999999999987532 4567788899999999999999999 99999999999998 688999999999864332
Q ss_pred C----CCccccCCCCCCCcccccc--------ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC---C
Q 007055 173 P----TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---P 236 (620)
Q Consensus 173 ~----~~~~~~GTp~y~APEll~~--------~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~---p 236 (620)
. ......|++.|+|||++.+ .++.++||||||+++|||++ |+.||............+..... .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence 2 1223457889999998753 25789999999999999996 99999775444433333332211 1
Q ss_pred CCCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhc
Q 007055 237 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 269 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~~p~~Rpsa~elL~ 269 (620)
+.+....++.+++++..|+.+|.+|||+.||+.
T Consensus 233 ~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred CccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 222334577899999999989999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=312.98 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=207.9
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEc-------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcce
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIK 79 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-------~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk 79 (620)
.|.+....|.+.+.||+|+||.||+|.+. .++..||+|.+... ........+.+|+.+++.+ +||||++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHHHHHHHHHHHhhccCCCchh
Confidence 46777888999999999999999999753 34568999987632 1234557789999999999 8999999
Q ss_pred EEeEEEcCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 80 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
+++++... ..+++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||
T Consensus 86 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~ 161 (304)
T cd05101 86 LLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHR 161 (304)
T ss_pred eeEEEecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeec
Confidence 99988654 4688999999999999999764 24778889999999999999999999 9999
Q ss_pred CCCccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCC
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY 217 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf 217 (620)
||||+||+++ .++.+||+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||
T Consensus 162 dlkp~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 162 DLAARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred ccccceEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 9999999998 78999999999986553321 12234567899999775 458999999999999999998 78888
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 218 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 218 ~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+ .....+...+..+..+ ..+...+..+++||.+||. +|.+||++.++++.
T Consensus 241 ~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 241 PG-IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred cc-CCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 76 4566777777665433 2344567899999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=310.19 Aligned_cols=249 Identities=28% Similarity=0.396 Sum_probs=201.6
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l~l 94 (620)
|++.+.||+|++|+||+|.+..+++.||+|.+..... . .......+|+..++.++ ||||+++++++.+ ....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEE
Confidence 5788999999999999999999999999998764321 1 22234567999999999 9999999998866 456899
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 95 ITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
||||+ +|+|.+++.... .+++..+..++.|++.+|.|||+++ ++|+||+|+||+++ .++.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceeccC
Confidence 99999 789999887764 7899999999999999999999999 99999999999998 789999999999865543
Q ss_pred C-CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 007055 173 P-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------- 236 (620)
Q Consensus 173 ~-~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p------------- 236 (620)
. ......++..|+|||++.+ .++.++|+||||+++++|++|+.||..........+.......+
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 3 2234578999999998753 47899999999999999999999997755444443322110000
Q ss_pred -----------C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 237 -----------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 237 -----------~---~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
. ......++.+++||.+||+ +|.+||++.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 0011225789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=314.02 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=205.0
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEc-------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcce
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIK 79 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-------~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk 79 (620)
.|.+....|.+.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++.+ +||||++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeee
Confidence 35566677899999999999999999763 245679999876332 234566788999999999 6999999
Q ss_pred EEeEEEcCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 80 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
+++++.+. ..+++|+||+++|+|.+++... ..+++.++..++.||+.||.|||+++ ++||
T Consensus 83 ~~~~~~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~ 158 (314)
T cd05099 83 LLGVCTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHR 158 (314)
T ss_pred EEEEEccC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeec
Confidence 99987654 4689999999999999999753 34888999999999999999999999 9999
Q ss_pred CCCccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCC
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY 217 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf 217 (620)
||||+|||++ .++.+||+|||++....... .....+++.|+|||++. +.++.++||||||+++|+|++ |..||
T Consensus 159 dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~ 237 (314)
T cd05099 159 DLAARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237 (314)
T ss_pred cccceeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence 9999999998 78999999999996543221 11223456899999775 458999999999999999999 89999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 218 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 218 ~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.. .....++..+..+..+ ..+...+..++++|.+||. +|.+||++.+++.
T Consensus 238 ~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 238 PG-IPVEELFKLLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 66 4566677766665433 2344567789999999998 8999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=313.41 Aligned_cols=251 Identities=29% Similarity=0.536 Sum_probs=207.1
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|....+||+|+||.||+|.+..+|..||+|.+... .......+.+|+.+++.++||||++++++|... ...++|
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 95 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVV 95 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEE
Confidence 33346899999999999999999999999987533 223456688999999999999999999988654 468999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC--
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~-- 173 (620)
|||+++++|.+++.. +.+++..+..++.|++.||+|||+++ ++||||+|+||+++ .+|.++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 96 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceecccccc
Confidence 999999999998754 46899999999999999999999998 99999999999998 7899999999987544322
Q ss_pred CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHHHH
Q 007055 174 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFI 251 (620)
Q Consensus 174 ~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~~~~lk~~I 251 (620)
......|++.|+|||.+. ..++.++|+||||+++|+|++|..||... ........+.....+. ......++.+.++|
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFL 250 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhCCcccCCcccCCHHHHHHH
Confidence 223457899999999775 45889999999999999999999999763 4444444444433221 12234678999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 252 EKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+||. +|.+||++.++|.||||....
T Consensus 251 ~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 251 DRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHhCCcccCcCHHHHhcChHHhccC
Confidence 99998 899999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.90 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=209.1
Q ss_pred eeeeeccCceEEEEEEEceeCCeEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcce
Q 007055 6 LVIWSLFVLFLQYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIK 79 (620)
Q Consensus 6 ~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk 79 (620)
...|.+..+.|.+.+.||+|+||.||+|.+ ..++..||+|+++... .....+.+.+|+.+|..+. ||||++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~ 105 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVN 105 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEE
Confidence 345666677788999999999999999985 3466799999987432 2334457889999999997 999999
Q ss_pred EEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCC-----------------------------------------------
Q 007055 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------------------------------------- 112 (620)
Q Consensus 80 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~----------------------------------------------- 112 (620)
++++|... ..+++|+||+.+|+|.+++.+.+
T Consensus 106 ~~~~~~~~--~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 106 LLGACTKG--GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEccC--CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 99998654 46899999999999999986532
Q ss_pred ---------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 007055 113 ---------------------------------------------------NVDMKAIKNWARQILRGLHYLHSHNPPII 141 (620)
Q Consensus 113 ---------------------------------------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~Ii 141 (620)
.+++..+..++.||+.||.|||+.+ ++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iv 261 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CV 261 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cC
Confidence 3567778899999999999999988 99
Q ss_pred ecCCCccceEecCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCC
Q 007055 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEY 215 (620)
Q Consensus 142 HrDLKp~NILl~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~ 215 (620)
||||||+|||++ .++.+||+|||++...... ......+++.|+|||.+. ..++.++||||||+++|||++ |..
T Consensus 262 Hrdlkp~NiLl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~ 340 (401)
T cd05107 262 HRDLAARNVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGT 340 (401)
T ss_pred cccCCcceEEEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCC
Confidence 999999999998 6889999999998654221 122346788999999776 458899999999999999998 899
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 216 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 216 Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
||............+..+..+. .+...+..+.+++.+||. +|.+||++.+++..
T Consensus 341 P~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 341 PYPELPMNEQFYNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCCCchHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9987665666666666654432 345568899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=306.80 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=200.4
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+....|++.++||+|+||+||+|.+..++ .||+|.++.... ..+.+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-- 72 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-- 72 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC--
Confidence 3345556899999999999999999987664 599999874332 12468889999999999999999997632
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
...++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++ .++.+||+|||.
T Consensus 73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~ 148 (262)
T cd05071 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGL 148 (262)
T ss_pred -CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCc
Confidence 3478999999999999999764 35899999999999999999999998 99999999999998 789999999999
Q ss_pred hhhccCCCC---ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~~---~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+........ ....++..|+|||+.. ..++.++|||||||++|+|+| |..||.+. ....+...+..+..+ ....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 226 (262)
T cd05071 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPP 226 (262)
T ss_pred eeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCC-CCcc
Confidence 865443221 2234567899999765 568999999999999999999 88899764 445555655554332 2344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+.++|.+||+ +|.+||++.+++.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 567899999999998 8999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=305.60 Aligned_cols=247 Identities=24% Similarity=0.417 Sum_probs=202.2
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg---~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
...|++.+.||+|+||.||+|.+..++ ..||+|.++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-- 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 456789999999999999999987554 479999876432 234566789999999999999999999987544
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 90 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..+++||||+++|+|.+++.+. +.+++.++..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~ 154 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSR 154 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCccc
Confidence 4689999999999999999765 46899999999999999999999999 99999999999998 78899999999986
Q ss_pred hccCCCC-----ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 169 VMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 169 ~~~~~~~-----~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
....... ....+++.|+|||.+. +.++.++|+||||+++|++++ |..||.+. ........+..+..++ .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~ 232 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRLP-APM 232 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcCC-CCC
Confidence 5433211 1122356899999876 468999999999999999886 99999764 4455666666654332 334
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..++.+++++.+||+ +|.+||++.+++.
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 233 DCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=307.67 Aligned_cols=251 Identities=29% Similarity=0.434 Sum_probs=198.9
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCcceEEeEEEcCCC---
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDDTN--- 89 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpNIVkl~~~f~~~~~--- 89 (620)
|++.+.||+|+||.||+|.++.+|..||+|.++.... .......+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 5789999999999999999999999999999875432 122234466788777666 69999999999876532
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 90 RTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
..+++++||+.+ +|.+++.... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~-~~~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEc-cCCCEEEeccCcc
Confidence 248899999974 8998887643 5899999999999999999999999 99999999999998 6799999999998
Q ss_pred hhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--------
Q 007055 168 IVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P-------- 236 (620)
Q Consensus 168 ~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p-------- 236 (620)
...... ......+++.|+|||++. ..++.++|||||||++|+|++|..||...... ....++..... +
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCCC
Confidence 665433 223446789999999876 45889999999999999999999999764433 33333322100 0
Q ss_pred -------------C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 237 -------------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 237 -------------~---~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
. ......++.+.++|.+||+ +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 0011235678999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=304.10 Aligned_cols=247 Identities=25% Similarity=0.408 Sum_probs=200.2
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+....|++.+.||+|++|.||+|.+..++ .||+|.+..... ..+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 72 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-- 72 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 3345556899999999999999999886654 599998754321 23567889999999999999999987632
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
...++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||+
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~ 148 (260)
T cd05069 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGL 148 (260)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCcc
Confidence 34789999999999999997643 4889999999999999999999998 99999999999998 789999999999
Q ss_pred hhhccCCCC---ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~~---~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+........ ....++..|+|||... +.++.++||||||+++|+|+| |..||.+. ........+..+..+ ..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 226 (260)
T cd05069 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRM-PCPQ 226 (260)
T ss_pred ceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCc
Confidence 965433221 2234567899999775 458899999999999999999 99999874 444555556555333 2344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+++++.+||. +|.+||++.++++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 567899999999998 8999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=346.77 Aligned_cols=149 Identities=26% Similarity=0.400 Sum_probs=134.5
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.+..+|+.||+|+++.... ........+..|+.+++.++||||++++.++... ..+|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~ 80 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQSA--NNVY 80 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--CEEE
Confidence 457899999999999999999999999999999976543 2345567789999999999999999999887554 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
+||||+.+|+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 99999999999999998888999999999999999999999998 99999999999998 78999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.36 Aligned_cols=244 Identities=25% Similarity=0.420 Sum_probs=203.4
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.++||.|+||+||+|.+.. +..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 78 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVY 78 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeE
Confidence 356889999999999999999987 8999999986432 23445688999999999999999999987554 4688
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 94 MITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+||||+++|+|.+++... ..+++.++..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLARLIK 155 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchhhcC
Confidence 999999999999999763 46899999999999999999999999 99999999999998 78999999999997654
Q ss_pred CCC--CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 172 QPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 172 ~~~--~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
... .....+++.|+|||.+. +.++.++||||||+++|+|++ |+.||.. .+..+.+..+..+..+ ..+...++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQEI 233 (261)
T ss_pred CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCHHH
Confidence 332 12334567899999775 458899999999999999998 8999976 4455566666655433 2345667899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 007055 248 KQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.++|.+||+ +|.+|||+.+++.
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=316.04 Aligned_cols=255 Identities=31% Similarity=0.456 Sum_probs=203.7
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.+..|++.+.||.|+||.||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++||||++++++|.... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 84 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-ED 84 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-Cc
Confidence 34457899999999999999999999999999998864321 2234466889999999999999999999886543 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
.++|+||+ +++|..++.. .++++..+..++.||+.||.|||+++ ++||||+|+||+++ .+|.+||+|||++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCccccccccC
Confidence 78999998 5689888764 45889999999999999999999999 99999999999998 78999999999986543
Q ss_pred CCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----------------
Q 007055 172 QPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------------- 232 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~----------------- 232 (620)
. ......+++.|+|||.+.+ .++.++||||||+++|+|+||+.||.... .......+..
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 160 P-QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-HVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred C-CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 3 2234567899999998754 58999999999999999999999997633 2111111100
Q ss_pred -------CC--CCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 233 -------GI--KPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 233 -------~~--~p~---~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.. .+. ......++.++++|.+||+ +|.+||++.++|.||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00 000 0112356889999999998 89999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=302.80 Aligned_cols=248 Identities=25% Similarity=0.424 Sum_probs=203.4
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+..+.|++.++||+|+||+||+|.+. .+..||+|.+..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 73 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE- 73 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecC-
Confidence 4567788999999999999999999975 557899998874332 235688999999999999999999987543
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++|+||+++++|.+++.... .+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||+
T Consensus 74 -~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~ 149 (261)
T cd05034 74 -EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGL 149 (261)
T ss_pred -CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECcccc
Confidence 46899999999999999997653 6899999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+....... .....++..|+|||.+. +.++.++||||||+++|+|++ |+.||.+. +.......+..+..+. .+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~ 227 (261)
T cd05034 150 ARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGYRMP-RPP 227 (261)
T ss_pred ceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCC
Confidence 86544221 11223467899999876 458899999999999999999 99999764 4455556665543322 233
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+++++.+||. +|.+||++.+++.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 228 NCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 447899999999998 8999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=303.23 Aligned_cols=242 Identities=22% Similarity=0.378 Sum_probs=194.2
Q ss_pred EEEceeCCeEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEE
Q 007055 20 EILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~---tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
+.||+|+||.||+|.+.. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++...+ ...++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEE
Confidence 468999999999998653 4568999987532 23445677889999999999999999999765433 4577999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC--
Q 007055 97 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 173 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~-- 173 (620)
||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+|||++ .++.+||+|||++......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccCCcc
Confidence 999999999998764 45678888999999999999999998 99999999999998 7889999999998644321
Q ss_pred ----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 174 ----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 174 ----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG-~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
......+++.|+|||.+. ..++.++|||||||++|||++| ..||.. .+...+...+..+..+. .+...++.+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCPDPL 231 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHH
Confidence 112334677899999775 5689999999999999999995 555654 55556666666554332 344567889
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+++.+||. +|.+||++.+++..
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=316.89 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=202.4
Q ss_pred eEEEEEEEceeCCeEEEEEEEccC--CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcC--CC
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVD--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD--TN 89 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~t--g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~--~~ 89 (620)
.|++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+.+|+.+++.+ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 368899999999999999999988 9999999886432 1223345678899999999 599999999875432 23
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..++++++|+. ++|.+++.....+++..++.++.||+.||.|||+++ ++||||||+|||++ .+|.+||+|||++..
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARG 154 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCcee
Confidence 45788889885 689999988889999999999999999999999999 99999999999998 789999999999865
Q ss_pred ccCC------CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Q 007055 170 MQQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------- 232 (620)
Q Consensus 170 ~~~~------~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~--------- 232 (620)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ....+..
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence 4321 1234578999999997653 58899999999999999999999997643221 1111110
Q ss_pred -----------------CCCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 233 -----------------GIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 233 -----------------~~~p~---~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
..... ......+..+++||.+||+ +|.+||++.+++.||||..-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 00001 1112346889999999998 89999999999999999653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=332.71 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=213.3
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCe---E-EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGI---E-VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~---~-VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
.|.+......+.++||+|+||.||+|..+..+. . ||+|..+.+. ....+....+.+|.++|++++|||||+|||+
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 466667777888999999999999998766432 3 8999887532 2356788899999999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~-l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
.+++. .+++|||+|.||+|.+|+++.+. ++..+...++.+.+.||+|||+++ +|||||...|+|++ .++.+||+
T Consensus 230 a~~~~--Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~vKIS 304 (474)
T KOG0194|consen 230 AVLEE--PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVVKIS 304 (474)
T ss_pred EcCCC--ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeEEeC
Confidence 76654 58999999999999999999874 999999999999999999999999 99999999999997 67788999
Q ss_pred cccchhhccCCCCc--cccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCC
Q 007055 163 DLGLAIVMQQPTAR--SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 238 (620)
Q Consensus 163 DFGla~~~~~~~~~--~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 238 (620)
|||+++........ ..--...|+|||.+. +.|+.++|||||||++||+.+ |..||.+ ....++..+|.....+..
T Consensus 305 DFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 305 DFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMP 383 (474)
T ss_pred ccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCC
Confidence 99998654321111 112356899999887 459999999999999999998 8889988 566778888855445555
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 239 LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 239 ~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+...+..+..++.+|++ +|..||++.++.+
T Consensus 384 ~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 384 IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 666788899999999998 9999999998765
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=309.20 Aligned_cols=244 Identities=27% Similarity=0.423 Sum_probs=199.8
Q ss_pred EEEEEEEceeCCeEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 16 LQYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
|++.+.||+|+||+||+|.+.. ....||+|.+.... .....+.+.+|+.+++.++||||+++++.+... .
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 76 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--G 76 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--C
Confidence 5788999999999999998753 33678888876332 234557789999999999999999999987654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCC
Q 007055 91 TINMITELFTSGSLRQYRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 146 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~------------------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLK 146 (620)
..++++||+.+|+|.+++... ..+++.++..++.|++.||.|||+++ ++|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhh
Confidence 578899999999999998642 24788999999999999999999999 9999999
Q ss_pred ccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCC
Q 007055 147 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNEC 220 (620)
Q Consensus 147 p~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~ 220 (620)
|+|||++ .++.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|+|+| |..||.+
T Consensus 155 p~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~- 232 (290)
T cd05045 155 ARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG- 232 (290)
T ss_pred hheEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-
Confidence 9999998 78899999999986543221 12234567899999765 458999999999999999999 9999976
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 221 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 221 ~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+.+.+..+..+. .+...+..+++|+.+||+ +|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 56677777776654433 345567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.97 Aligned_cols=251 Identities=30% Similarity=0.508 Sum_probs=204.4
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+|.+.+.||+|+||.||+|.+..++..+++|.++...... .......+..|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceE
Confidence 3678999999999999999998888777777665432211 223345577899999999999999999987654 3588
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 94 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
+|+||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++ ++.+||+|||++..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~--~~~~~l~d~g~~~~ 154 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLK--NNLLKIGDFGVSRL 154 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEee--cCCEeecccCceee
Confidence 99999999999988753 356999999999999999999999999 99999999999996 46799999999865
Q ss_pred ccCC--CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 170 MQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 170 ~~~~--~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
.... ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||.. .........+..+..+ .++...+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (260)
T cd08222 155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTP-SLPETYSRQ 232 (260)
T ss_pred cCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCC-CCcchhcHH
Confidence 4332 223456899999999775 4578899999999999999999999975 3444444555444333 345567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
+.++|.+||. +|.+||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=303.98 Aligned_cols=247 Identities=25% Similarity=0.416 Sum_probs=200.8
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|......|++.+.||+|+||.||+|.+. ++..||+|.+..... . .+.+.+|+.+++.++||||+++++++. .
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~- 72 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--S---PESFLEEAQIMKKLRHDKLVQLYAVVS-E- 72 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--C---HHHHHHHHHHHHhcCCCceEEEEeEEC-C-
Confidence 3445567899999999999999999875 566799999875432 1 245889999999999999999999763 2
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..++++|||+++++|.+++... ..+++.+++.++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||+
T Consensus 73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~ 148 (260)
T cd05070 73 -EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGL 148 (260)
T ss_pred -CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCcee
Confidence 3478999999999999998763 45899999999999999999999999 99999999999998 788999999999
Q ss_pred hhhccCCCC---ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~~---~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+........ ....++..|+|||++. ..++.++||||||+++|+|++ |..||.+. +.......+..+..+ ..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 226 (260)
T cd05070 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRM-PCPQ 226 (260)
T ss_pred eeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCC
Confidence 865443221 1234566899999765 458899999999999999999 89999764 444555555554333 3445
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+++|+.+||. +|.+|||+.+++.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 667899999999998 8999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=302.96 Aligned_cols=238 Identities=19% Similarity=0.382 Sum_probs=195.3
Q ss_pred EEceeCCeEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 21 ILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 21 ~LG~G~fg~Vy~a~d~--~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.++++++||||+++++++.. ..+++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEe
Confidence 4899999999999775 456789999876432 34455678999999999999999999997632 357899999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCC--
Q 007055 99 FTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-- 175 (620)
Q Consensus 99 ~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~-- 175 (620)
+++|+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCccce
Confidence 999999999875 457999999999999999999999999 99999999999998 788999999999864432211
Q ss_pred ---ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 176 ---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 176 ---~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
....+++.|+|||.+. +.++.++|||||||++|+|++ |..||... ....+...+..+..+ ..+...+++++++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 230 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYAL 230 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 1112357899999876 458899999999999999996 99999774 455566666665443 3455678899999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 007055 251 IEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~ 269 (620)
|.+||. +|.+||++.++.+
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999998 8999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.50 Aligned_cols=249 Identities=24% Similarity=0.446 Sum_probs=202.2
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.....|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC
Confidence 4556688999999999999999987654 4578999875432 245567789999999999999999999987543
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..++||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||+
T Consensus 80 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~ 153 (270)
T cd05056 80 ---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGL 153 (270)
T ss_pred ---CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCce
Confidence 4679999999999999998754 5899999999999999999999999 99999999999998 688999999999
Q ss_pred hhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+....... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||..... ......+..+..+ ..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~ 231 (270)
T cd05056 154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERL-PMPP 231 (270)
T ss_pred eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcC-CCCC
Confidence 86543321 11223456899999775 458899999999999999996 9999987544 3444555554333 3345
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..++.++++|.+|+. +|.+|||+.+++..
T Consensus 232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 232 NCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 567899999999997 89999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=300.18 Aligned_cols=243 Identities=28% Similarity=0.475 Sum_probs=204.2
Q ss_pred EEEEEEceeCCeEEEEEEEccCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg----~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
.+.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--Cee
Confidence 46789999999999999998876 999999986432 223567799999999999999999999988665 568
Q ss_pred EEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 93 NMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
++||||+++++|.+++..... +++..+..++.||+.||+|||+++ ++||||||+||+++ .++.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceec
Confidence 999999999999999986554 999999999999999999999999 99999999999998 7889999999998655
Q ss_pred cCCCC-c--cccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 007055 171 QQPTA-R--SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 245 (620)
Q Consensus 171 ~~~~~-~--~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~ 245 (620)
..... . ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+...+...+..+..+. .+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPP 231 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCH
Confidence 43211 1 123678999999875 458999999999999999998 7888866 56666677776665443 3444788
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+.+++.+||. +|.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999998 8999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.97 Aligned_cols=247 Identities=21% Similarity=0.290 Sum_probs=202.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
..|++.+.||+|+||.||+|.+.. ++..||+|.++... .....+.+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~- 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE- 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-
Confidence 456788999999999999998754 36889999987432 234456788999999999999999999987654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEe
Q 007055 89 NRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 152 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 152 (620)
..+++++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||++
T Consensus 81 -~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~ 157 (283)
T cd05091 81 -QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLV 157 (283)
T ss_pred -CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEe
Confidence 3588999999999999998532 34888999999999999999999999 9999999999999
Q ss_pred cCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHH
Q 007055 153 NGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 226 (620)
Q Consensus 153 ~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i 226 (620)
+ .++.+||+|||++....... .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ .....+
T Consensus 158 ~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~ 235 (283)
T cd05091 158 F-DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDV 235 (283)
T ss_pred c-CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 8 78899999999986543221 12335678999999765 568999999999999999998 8888876 455667
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 227 ~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
...+..+..+ ..+...+..+.+++.+||+ +|.+||++.+++..
T Consensus 236 ~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 236 IEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 7777665432 3445678899999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.97 Aligned_cols=257 Identities=29% Similarity=0.439 Sum_probs=202.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
+|+....||+|+||.||+|..+.+.- .+|||+++-++-. ........+|+.+++.|+||||+.+..+|... +.
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~--tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG--TGISMSACREIALLRELKHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC--CCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cc
Confidence 57788899999999999997766543 7899998755321 11224577899999999999999999998765 57
Q ss_pred eEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC---CCcEEEc
Q 007055 91 TINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIG 162 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~-----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~---~G~vKI~ 162 (620)
.+++++||.+. +|.++|+-+ +.++...+++++.||+.|+.|||++- |+||||||.|||+.+. .|.|||+
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEee
Confidence 89999999986 888888644 35899999999999999999999987 9999999999999842 3899999
Q ss_pred cccchhhccCCC-----CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCC------CH---HHH
Q 007055 163 DLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECK------NP---AQI 226 (620)
Q Consensus 163 DFGla~~~~~~~-----~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~------~~---~~i 226 (620)
|||+++.++.+- ...++.|.+|.|||++-+ .|+.++|||+.|||+.||+|.++.|.+.. +| .++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999887652 345678999999997754 59999999999999999999998886421 11 122
Q ss_pred HHHH--HcCCCCCCC--------------------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 007055 227 YKKV--TSGIKPASL--------------------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 271 (620)
Q Consensus 227 ~~~i--~~~~~p~~~--------------------------------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hp 271 (620)
.+.+ ........| .++.++...+++.++|. ||-+|.|++++|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1111 110000000 12345668899999998 999999999999999
Q ss_pred CcCCCC
Q 007055 272 FLVTDN 277 (620)
Q Consensus 272 ff~~~~ 277 (620)
||..+.
T Consensus 339 yF~~d~ 344 (438)
T KOG0666|consen 339 YFTEDP 344 (438)
T ss_pred ccccCC
Confidence 998753
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.77 Aligned_cols=246 Identities=23% Similarity=0.397 Sum_probs=200.6
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~---~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
..|++.+.||+|+||.||+|.++.+|. .||+|.++.. ........+..|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--R 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--C
Confidence 457899999999999999999987765 6999987643 2345567899999999999999999999987544 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 91 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
.+++||||+.+|+|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~ 155 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRF 155 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCccccc
Confidence 688999999999999998764 56899999999999999999999999 99999999999998 688999999999865
Q ss_pred ccCCCC----c-ccc--CCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 170 MQQPTA----R-SVI--GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 170 ~~~~~~----~-~~~--GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
...... . ... ++..|+|||.+. +.++.++|||||||++|||++ |..||... +.......+...... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~ 233 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIEQDYRL-PPP 233 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCcC-CCc
Confidence 432211 1 111 245799999876 468999999999999999886 99999764 445555566544322 223
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
...+..+.+++.+||. +|.+||++.+++.
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 234 MDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4567889999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=315.37 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=206.5
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcce
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIK 79 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk 79 (620)
.|.+.+.+|++.+.||+|+||.||+|.+.. ++..||+|.++.. ......+.+.+|+.+++++ +||||++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 567778889999999999999999998643 2347999987632 2334567789999999999 8999999
Q ss_pred EEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 80 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
+++++... ..+++|+||+++|+|.+++.+.. .++..++..++.||+.||.|||+++ ++||
T Consensus 83 ~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~ 158 (334)
T cd05100 83 LLGACTQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHR 158 (334)
T ss_pred eeEEEccC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence 99988654 46889999999999999987532 3778889999999999999999999 9999
Q ss_pred CCCccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCC
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY 217 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf 217 (620)
||||+|||++ .++.+||+|||+++...... .....+++.|+|||++. ..++.++||||||+++|||++ |..||
T Consensus 159 dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 159 DLAARNVLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred ccccceEEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 9999999998 78899999999986543321 11223456799999875 458999999999999999998 88999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 218 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 218 ~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+ .+...+...+..+..+. .+...+..+.++|.+||+ +|.+||++.+++.+
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 238 PG-IPVEELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CC-CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 76 45666666666554432 334567899999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.84 Aligned_cols=247 Identities=23% Similarity=0.401 Sum_probs=202.7
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+....|++.+.||+|+||.||+|.+. .+..||+|.+... ....+.+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 72 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-- 72 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--
Confidence 6678889999999999999999999865 4567999987632 2234678899999999999999999998755
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
...++++||+++|+|.+++.+. ..+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||+
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~ 148 (260)
T cd05073 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGL 148 (260)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCcc
Confidence 4578999999999999999764 45788999999999999999999998 99999999999998 789999999999
Q ss_pred hhhccCCCC---ccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~~---~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+........ ....++..|+|||++.. .++.++||||||+++|+|+| |..||... +...+...+..+.... ...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~ 226 (260)
T cd05073 149 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMP-RPE 226 (260)
T ss_pred eeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCCC-Ccc
Confidence 865433221 12245677999998764 58889999999999999999 99999764 4445555565554332 334
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+.++.+++.+||+ +|.+||++.+++.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 567899999999998 8999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.15 Aligned_cols=248 Identities=28% Similarity=0.451 Sum_probs=205.2
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
+....|++.+.||+|+||+||+|.++.+|. .||+|...... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 445678999999999999999999877665 68888775432 24556778999999999999999999998865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
...++|+||+++|+|.+++... ..+++..+..|+.||+.||+|||+++ ++||||||+||+++ .++.+||+|||
T Consensus 81 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg 154 (279)
T cd05057 81 ---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFG 154 (279)
T ss_pred ---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCc
Confidence 4688999999999999998874 46999999999999999999999998 99999999999997 78899999999
Q ss_pred chhhccCCCC----ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 007055 166 LAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASL 239 (620)
Q Consensus 166 la~~~~~~~~----~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~ 239 (620)
++........ ....+++.|+|||.+. +.++.++||||||+++||+++ |..||... ....+...+..+.. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~ 232 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGER-LPQ 232 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCCC-CCC
Confidence 9975543211 1122356899999775 568999999999999999998 99999764 56666666665533 233
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+...+..+.+++.+||. +|..||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 233 PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 45577899999999997 8999999998865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=309.87 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=196.6
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccC--------------CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcc
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVD--------------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~t--------------g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIV 78 (620)
.+.|++.+.||+|+||.||+|.+..+ ...||+|.++.. ......+.+.+|+++++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence 45679999999999999999987643 246899988643 2344566799999999999999999
Q ss_pred eEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCC
Q 007055 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 146 (620)
Q Consensus 79 kl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLK 146 (620)
++++++... ..+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++|||||
T Consensus 81 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlk 156 (295)
T cd05097 81 RLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLA 156 (295)
T ss_pred eEEEEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccC
Confidence 999988654 46889999999999999986532 3688899999999999999999999 9999999
Q ss_pred ccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh--cCCCCCC
Q 007055 147 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--CEYPYNE 219 (620)
Q Consensus 147 p~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt--G~~Pf~~ 219 (620)
|+||+++ .++.+||+|||++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ +..||..
T Consensus 157 p~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 157 TRNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999998 78899999999986543221 12234567899999765 568999999999999999988 6788876
Q ss_pred CCCHHHHHHHHHc------CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 220 CKNPAQIYKKVTS------GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 220 ~~~~~~i~~~i~~------~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.. ..++...+.. .......+...++.+++||.+||+ +|.+||++.++++
T Consensus 236 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LS-DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cC-hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 43 3333333221 111122334567899999999998 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=322.23 Aligned_cols=246 Identities=27% Similarity=0.459 Sum_probs=190.3
Q ss_pred EEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEE
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
.-..+||+|+||.||+|.-. +|..||||++....... ..+|.+|+.+|.+++|||+|++++||.+... ..++|+
T Consensus 78 s~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVY 151 (361)
T KOG1187|consen 78 SESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVY 151 (361)
T ss_pred chhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEE
Confidence 34479999999999999865 44899999776433211 3449999999999999999999999987654 578999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEecCCCCcEEEccccchhhccC-
Q 007055 97 ELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 172 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~- 172 (620)
||++.|+|.+++.... .++|....+|+.+++.||+|||.. .|||||||||+.|||+| .+..+||+|||+|+....
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCcc
Confidence 9999999999987655 899999999999999999999995 45899999999999999 899999999999965543
Q ss_pred CCC-ccc-cCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCC--CH----HHHHHHHHcC-----CCCCC
Q 007055 173 PTA-RSV-IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--NP----AQIYKKVTSG-----IKPAS 238 (620)
Q Consensus 173 ~~~-~~~-~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~--~~----~~i~~~i~~~-----~~p~~ 238 (620)
... .+. .||..|+|||++. +..+.++||||||++++||+||+.|..... .. ......+..+ ..|.-
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l 310 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL 310 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence 222 222 7999999999886 579999999999999999999998876422 11 1112222222 11221
Q ss_pred CCCCCc--HH---HHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 239 LSKVTD--PQ---VKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 239 ~~~~~~--~~---lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.....+ .+ +..+...|++ +|.+||++.|+++
T Consensus 311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 102222 23 3455678998 7899999999644
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=302.05 Aligned_cols=233 Identities=23% Similarity=0.411 Sum_probs=188.3
Q ss_pred EEEceeCCeEEEEEEEccCC----------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 20 EILGKGAFKTVYKGFDEVDG----------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg----------~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence 47999999999999998877 467888765332 115678899999999999999999998876
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC-------cEEE
Q 007055 90 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-------EVKI 161 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G-------~vKI 161 (620)
...++|+||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++ .+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~-~~~~~~~~~~~~kl 149 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVA-RYGLNEGYVPFIKL 149 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEe-cCccccCCceeEEe
Confidence 34689999999999999998766 7999999999999999999999999 99999999999998 555 7999
Q ss_pred ccccchhhccCCCCccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 007055 162 GDLGLAIVMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 237 (620)
Q Consensus 162 ~DFGla~~~~~~~~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~ 237 (620)
+|||++..... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.... ........... .
T Consensus 150 ~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~---~ 223 (259)
T cd05037 150 SDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQ---H 223 (259)
T ss_pred CCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcC---C
Confidence 99999865443 233457788999998764 48899999999999999999 588886643 32222222211 1
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 238 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 238 ~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+......+.++|.+||. +|.+||++.++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1122223789999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.63 Aligned_cols=246 Identities=21% Similarity=0.318 Sum_probs=200.7
Q ss_pred ceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
..|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~- 80 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVG- 80 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-
Confidence 45789999999999999999875 368899999886432 234456788999999999999999999987654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCC
Q 007055 89 NRTINMITELFTSGSLRQYRKKHK----------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 146 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~----------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLK 146 (620)
..+++|+||+++|+|.+++.... .+++.++..++.||+.||.|||+++ ++|||||
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~ 157 (288)
T cd05050 81 -KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLA 157 (288)
T ss_pred -CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eeccccc
Confidence 45889999999999999987432 3788899999999999999999998 9999999
Q ss_pred ccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCC
Q 007055 147 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNEC 220 (620)
Q Consensus 147 p~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~ 220 (620)
|+|||++ .++.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+
T Consensus 158 p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~- 235 (288)
T cd05050 158 TRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG- 235 (288)
T ss_pred HhheEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-
Confidence 9999997 78999999999986433221 12234567899999765 568999999999999999998 8889876
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 221 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 221 ~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+..+....+..+..+. .+...+..+.+||.+||+ +|.+||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 34556666666554332 234567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=304.13 Aligned_cols=249 Identities=21% Similarity=0.342 Sum_probs=203.6
Q ss_pred CceEEEEEEEceeCCeEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
...|++.+.||+|+||+||+|.++. +...||+|.+.... .....+.+.+|++++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 3567899999999999999999764 34678888765322 233567799999999999999999999987543
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHK---------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 158 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~---------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~ 158 (620)
...++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~ 155 (275)
T cd05046 81 --EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQRE 155 (275)
T ss_pred --CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCc
Confidence 46889999999999999998766 6899999999999999999999999 99999999999998 7889
Q ss_pred EEEccccchhhccCC---CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcC
Q 007055 159 VKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233 (620)
Q Consensus 159 vKI~DFGla~~~~~~---~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~ 233 (620)
++|+|||++...... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ........+..+
T Consensus 156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~ 234 (275)
T cd05046 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAG 234 (275)
T ss_pred EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcC
Confidence 999999998543221 223345678899999765 458889999999999999999 88899764 344555555554
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 234 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 234 ~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..+...+...+..++++|.+||+ +|.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 44444445577899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=351.20 Aligned_cols=249 Identities=32% Similarity=0.561 Sum_probs=207.4
Q ss_pred EEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC---------
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--------- 87 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~--------- 87 (620)
...+.||+||||.||+++.+-+|+.+|||+|.... +.....++.+|+.+|.+|+|||||+||..|++.
T Consensus 482 EEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 482 EELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred HHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 44578999999999999999999999999998653 345667899999999999999999999998410
Q ss_pred --------------------------------------------------------------------------------
Q 007055 88 -------------------------------------------------------------------------------- 87 (620)
Q Consensus 88 -------------------------------------------------------------------------------- 87 (620)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred --------------------CC--------CeEEEEEeccCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCC
Q 007055 88 --------------------TN--------RTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNP 138 (620)
Q Consensus 88 --------------------~~--------~~l~lV~Ey~~gGsL~~~i~~~~~l-~e~~i~~i~~QIl~gL~yLHs~~~ 138 (620)
.+ ..+||-||||+..+|++++.++... .....+++++||+.||.|+|++|
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g- 717 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG- 717 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc-
Confidence 00 3578999999998888888877655 57889999999999999999999
Q ss_pred CEEecCCCccceEecCCCCcEEEccccchhhcc--------------------CCCCccccCCCCCCCcccccc----cc
Q 007055 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--------------------QPTARSVIGTPEFMAPELYEE----EY 194 (620)
Q Consensus 139 ~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~--------------------~~~~~~~~GTp~y~APEll~~----~y 194 (620)
||||||||.|||++ .++.|||+|||+|+... ....++.+||.-|+|||++.+ .|
T Consensus 718 -iIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 718 -IIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred -eeeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 99999999999998 78899999999996511 012345689999999999863 59
Q ss_pred CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 195 ~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~---~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+.|+|+|||||+++||+. ||........+...+.++..|.+ +.+ .-+.-+.+|+.+|+ +|++||||.|||++
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~-~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDP-EHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccc-cchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 999999999999999984 78766666667777777766655 222 22456789999998 99999999999999
Q ss_pred CCcCC
Q 007055 271 PFLVT 275 (620)
Q Consensus 271 pff~~ 275 (620)
.||..
T Consensus 872 ~llpp 876 (1351)
T KOG1035|consen 872 ELLPP 876 (1351)
T ss_pred cCCCc
Confidence 99974
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=338.33 Aligned_cols=259 Identities=25% Similarity=0.361 Sum_probs=190.1
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccC-CeEEEEEEeec-------------ccccCCHHHHHHHHHHHHHHHhCCCCCcce
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVD-GIEVAWNQVNI-------------EDVMQSPDQLERLYSEVHLLKSLKHENIIK 79 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~t-g~~VAiK~v~~-------------~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk 79 (620)
..|++.+.||+|+||+||+|..+.. +..++.|.++. ............+.+|+.+|+.++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 4679999999999999999876443 22222221110 111122234566889999999999999999
Q ss_pred EEeEEEcCCCCeEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC
Q 007055 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 154 (620)
Q Consensus 80 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~-----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 154 (620)
+++++... ...|+|++++. ++|..++... .......++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 228 l~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~- 301 (501)
T PHA03210 228 IEEILRSE--ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN- 301 (501)
T ss_pred EeEEEEEC--CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-
Confidence 99988655 45888999985 5777766432 23456778899999999999999999 99999999999998
Q ss_pred CCCcEEEccccchhhccCC---CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCC-CCCC-CH-HHHH
Q 007055 155 NNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECK-NP-AQIY 227 (620)
Q Consensus 155 ~~G~vKI~DFGla~~~~~~---~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf-~~~~-~~-~~i~ 227 (620)
.+|.+||+|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|||++|..|+ .... .+ .++.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 7899999999999765432 2234679999999998764 5999999999999999999998654 3221 22 2333
Q ss_pred HHHHcCC-CCC-----------------------CC-----CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 228 KKVTSGI-KPA-----------------------SL-----SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 228 ~~i~~~~-~p~-----------------------~~-----~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+.+.... ... .+ ....+..+.++|.+||+ +|.+|||+.|+|.||||....
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 2222100 000 00 01234567888999998 999999999999999998754
Q ss_pred C
Q 007055 278 P 278 (620)
Q Consensus 278 ~ 278 (620)
.
T Consensus 462 ~ 462 (501)
T PHA03210 462 E 462 (501)
T ss_pred c
Confidence 3
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.50 Aligned_cols=239 Identities=26% Similarity=0.429 Sum_probs=196.9
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEecc
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 99 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~ 99 (620)
++||+|+||.||+|.+.. |..||+|.+..... ......+.+|++++++++||||+++++++.+. ...++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcC
Confidence 479999999999999987 99999998865432 24556789999999999999999999987655 4688999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCC---
Q 007055 100 TSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 175 (620)
Q Consensus 100 ~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~--- 175 (620)
.+++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceec
Confidence 99999999865 456899999999999999999999999 99999999999998 788999999999865432111
Q ss_pred -ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 007055 176 -RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252 (620)
Q Consensus 176 -~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~ 252 (620)
....++..|+|||.+. +.++.++||||||+++|+|+| |..||... ........+..+.. ...+...+..+.+++.
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 229 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGYR-MPAPQLCPEEIYRLML 229 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCCC-CCCCccCCHHHHHHHH
Confidence 1223356799999775 458999999999999999999 88999763 44555555554432 2334566789999999
Q ss_pred HhcC-CCCCCCCHHHHhc
Q 007055 253 KCIV-PASLRLPALELLK 269 (620)
Q Consensus 253 kcL~-~p~~Rpsa~elL~ 269 (620)
+||. +|.+||++.|+|.
T Consensus 230 ~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 230 QCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9997 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.15 Aligned_cols=248 Identities=24% Similarity=0.424 Sum_probs=202.0
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~---~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
....|+..+.||+|+||.||+|.++.++. .||+|.++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 78 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF- 78 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-
Confidence 34467889999999999999999876664 79999876432 234567789999999999999999999987554
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 89 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
..+++||||+.+|+|.+++... +.+++.++..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 79 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~ 154 (268)
T cd05063 79 -KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLS 154 (268)
T ss_pred -CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccc
Confidence 4588999999999999998764 57899999999999999999999999 99999999999998 7889999999998
Q ss_pred hhccCCCCc-----cccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 168 IVMQQPTAR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 168 ~~~~~~~~~-----~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
......... ....++.|+|||++. +.++.++|||||||++|+|++ |..||... +...+...+..+... +..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~ 232 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRL-PAP 232 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCC-CCC
Confidence 654322111 112345799999876 458999999999999999998 99999764 445566666554332 233
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
...+..+.+++.+||+ +|.+||++.++++
T Consensus 233 ~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 233 MDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 3467899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=306.51 Aligned_cols=250 Identities=31% Similarity=0.470 Sum_probs=202.0
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||+|++|.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEE
Confidence 467889999999999999999999999999987653 1223345678899999999999999999987654 578999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 96 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
+||+. ++|.+++.+. ..+++..+..++.|++.||.|||+++ ++||||+|+||+++ .+|.+||+|||++.......
T Consensus 77 ~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 77 FEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred ecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCCCc
Confidence 99997 5899999887 57999999999999999999999999 99999999999998 68999999999986554322
Q ss_pred --CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------
Q 007055 175 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG----------------- 233 (620)
Q Consensus 175 --~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~----------------- 233 (620)
.....+++.|+|||.+.+ .++.++|||||||++|+|++|..||........+.+.....
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 223456788999997753 58889999999999999999999997644333322211100
Q ss_pred --CCCC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 234 --IKPA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 234 --~~p~-------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
..+. ......+..+++||.+||. +|.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000 0011236789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=288.61 Aligned_cols=253 Identities=25% Similarity=0.426 Sum_probs=202.4
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|.-.++||+|.||+||+|+...+++.||+|.++..+- .+.--....+||-+|+.|+|.|||++++....+ ..+-+|
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhsd--kkltlv 79 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhccC--ceeEEe
Confidence 3456899999999999999999999999999987652 222234578999999999999999999976444 457789
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 96 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
+|||. .+|..|... ++.++.+.++.++.|++.||.|||+++ +.||||||+|.||+ .+|.+|++|||+++.+.-+.
T Consensus 80 fe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 80 FEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPV 155 (292)
T ss_pred HHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCCce
Confidence 99996 588888765 577999999999999999999999999 99999999999998 89999999999998877653
Q ss_pred --CccccCCCCCCCccccccc--cCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHc-C-CCCCCC--------
Q 007055 175 --ARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS-G-IKPASL-------- 239 (620)
Q Consensus 175 --~~~~~GTp~y~APEll~~~--y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~-~-~~p~~~-------- 239 (620)
....+.|.+|.+|.++-+. |++..|+||.||++.|+.. |++.|.+..-.+++.+.... | .....+
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 2345679999999987653 9999999999999999986 55556664444454433321 1 000001
Q ss_pred -------CC---------CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 240 -------SK---------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 240 -------~~---------~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+. ..+..-++++.++|. +|..|.+|+++|+||||...
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 10 112356899999998 99999999999999999753
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=296.24 Aligned_cols=240 Identities=27% Similarity=0.411 Sum_probs=196.1
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEecc
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 99 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~ 99 (620)
++||+|+||.||+|.+. ++..||+|.++... .......+.+|+++++.++||||+++++++... ...++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECC
Confidence 47999999999999864 68899999876332 234445688999999999999999999987654 4688999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCC---
Q 007055 100 TSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 175 (620)
Q Consensus 100 ~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~--- 175 (620)
++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccccC
Confidence 999999998754 46899999999999999999999999 99999999999997 789999999999864432211
Q ss_pred ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 176 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 176 ~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
....+++.|+|||++. +.++.++||||||+++|+|++ |..||... ........+..+... ..+...+..+.+++.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 229 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 1223467799999876 458889999999999999998 99999764 455555566554333 2344567899999999
Q ss_pred hcC-CCCCCCCHHHHhcC
Q 007055 254 CIV-PASLRLPALELLKD 270 (620)
Q Consensus 254 cL~-~p~~Rpsa~elL~h 270 (620)
||. +|.+||++.++++.
T Consensus 230 ~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 230 CWDYKPENRPKFSELQKE 247 (250)
T ss_pred HcccCcccCCCHHHHHHH
Confidence 998 89999999998763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.97 Aligned_cols=240 Identities=25% Similarity=0.398 Sum_probs=193.9
Q ss_pred EEEceeCCeEEEEEEEccCCe--EEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEEEEE
Q 007055 20 EILGKGAFKTVYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~--~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
++||+|+||.||+|.++.+|. .+|+|.++.. ......+.+.+|+.++.++ +||||+++++++... ..+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEE
Confidence 468999999999999988876 4688876522 2344556788999999999 899999999987654 4588999
Q ss_pred eccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEE
Q 007055 97 ELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 160 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vK 160 (620)
||+++|+|.+++...+ .+++.++..++.|++.||+|||+++ ++||||||+||+++ .++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCeEE
Confidence 9999999999987543 4789999999999999999999998 99999999999998 789999
Q ss_pred EccccchhhccCCCC-ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 007055 161 IGDLGLAIVMQQPTA-RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 237 (620)
Q Consensus 161 I~DFGla~~~~~~~~-~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~ 237 (620)
|+|||++........ .....++.|+|||++. ..++.++||||||+++|||++ |..||.+ .+....+..+..+..+
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~- 230 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL- 230 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-
Confidence 999999853221111 1123356799999875 458899999999999999997 9999976 4455566666554333
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 238 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 238 ~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+...+..+.+++.+||. +|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2334567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.03 Aligned_cols=240 Identities=21% Similarity=0.342 Sum_probs=187.4
Q ss_pred EEceeCCeEEEEEEEccC--CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEec
Q 007055 21 ILGKGAFKTVYKGFDEVD--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 98 (620)
Q Consensus 21 ~LG~G~fg~Vy~a~d~~t--g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey 98 (620)
.||+|+||+||+|..... ...+++|.+... ......+.+.+|+.+++.++||||+++++.+.+. ..+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC---CChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEec
Confidence 699999999999975433 345666665432 2234567799999999999999999999988654 468999999
Q ss_pred cCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC--
Q 007055 99 FTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-- 172 (620)
Q Consensus 99 ~~gGsL~~~i~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~-- 172 (620)
+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccccCcch
Confidence 9999999998754 34677888999999999999999998 99999999999998 789999999999753211
Q ss_pred --CCCccccCCCCCCCcccccc--------ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC----CC
Q 007055 173 --PTARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK----PA 237 (620)
Q Consensus 173 --~~~~~~~GTp~y~APEll~~--------~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~----p~ 237 (620)
.......|++.|+|||++.. .++.++||||||+++|||++ |..||.... ....+..+..+.. .+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-DREVLNHVIKDQQVKLFKP 232 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhhcccccCCC
Confidence 11234568899999998742 35778999999999999997 577887644 3344443333221 12
Q ss_pred CCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhc
Q 007055 238 SLSKVTDPQVKQFIEKCIVPASLRLPALELLK 269 (620)
Q Consensus 238 ~~~~~~~~~lk~~I~kcL~~p~~Rpsa~elL~ 269 (620)
.+....++.+++++..|+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 233 QLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 33445678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=298.91 Aligned_cols=241 Identities=22% Similarity=0.413 Sum_probs=199.5
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
....|++.+.||+|+||.||++. .++..||+|.++... ..+.+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~ 72 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN---G 72 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---C
Confidence 34567899999999999999985 578899999886431 235688999999999999999999987543 3
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 92 INMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
.++|+||+.+|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||++..
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARV 149 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCcccee
Confidence 689999999999999997654 5899999999999999999999998 99999999999998 788999999999864
Q ss_pred ccCCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 170 MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 170 ~~~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
.... ......+..|+|||.+. +.++.++|+||||+++|+|++ |..||... ........+..+..+. .....++.+
T Consensus 150 ~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (254)
T cd05083 150 GSMG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKGYRME-PPEGCPADV 226 (254)
T ss_pred cccc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhCCCCCC-CCCcCCHHH
Confidence 3322 22334467899999775 468899999999999999998 99999764 4555666666654443 344567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 007055 248 KQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
++++.+||. +|..||++.+++.
T Consensus 227 ~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 227 YVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=301.10 Aligned_cols=227 Identities=17% Similarity=0.264 Sum_probs=187.6
Q ss_pred eCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCCCCH
Q 007055 25 GAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL 104 (620)
Q Consensus 25 G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL 104 (620)
|.+|.||+|.++.+|+.||+|.+.... ...+|...+....||||+++++++... ..+++||||+++|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCH
Confidence 899999999999999999999986432 123455556667899999999988654 568999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCCccccCCCCC
Q 007055 105 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 184 (620)
Q Consensus 105 ~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~~~GTp~y 184 (620)
.+++.+...+++..+..|+.|++.||.|||+++ ++||||||+||+++ .+|.++++|||.+...... .....+++.|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~-~~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDS-CDGEAVENMY 148 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhccccc-cccCCcCccc
Confidence 999988888999999999999999999999999 99999999999998 7889999999987554433 2334567889
Q ss_pred CCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC
Q 007055 185 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL 262 (620)
Q Consensus 185 ~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rp 262 (620)
+|||.+. +.++.++||||||+++|+|++|+.||.... ..+ .......++...++.++++|.+||+ +|.+|+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~--~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP--SGI-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCc--hhc-----ccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 9999876 458899999999999999999998875421 111 1111223445578899999999998 899999
Q ss_pred CH-----HHHhcCCCc
Q 007055 263 PA-----LELLKDPFL 273 (620)
Q Consensus 263 sa-----~elL~hpff 273 (620)
++ .++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 96 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.44 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=202.1
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEc----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDE----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
..++|++.+.||+|+||.||+|... .++..||+|.++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 3577889999999999999999864 3589999999875432 13567799999999999999999999988776
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
.....++|+||+++|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~ 155 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGL 155 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEccccc
Confidence 6667999999999999999998765 6999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCCC-----ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHH--------------HH
Q 007055 167 AIVMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------------QI 226 (620)
Q Consensus 167 a~~~~~~~~-----~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~--------------~i 226 (620)
+........ ....++..|+|||.+. ..++.++||||||+++|+|+||..||....... .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 976542211 1223456799999765 458899999999999999999999986532211 12
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 227 ~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
...+..+.. ...+...+.++.+++.+||. +|.+||++.|++.
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 236 LELLKEGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHcCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222222222 22234456889999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.20 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=194.2
Q ss_pred ceEEEEEEEceeCCeEEEEEEEcc----------------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEV----------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 77 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~----------------tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI 77 (620)
+.|++.+.||+|+||+||+|.+.. ++..||+|.+.... .....+.+.+|+.+++.++||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCc
Confidence 457999999999999999986432 45679999876432 34455678999999999999999
Q ss_pred ceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCC
Q 007055 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 146 (620)
Q Consensus 78 Vkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~-----------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLK 146 (620)
+++++++.... .+++||||+++|+|.+++.... .+++.++..++.||+.||+|||+++ ++|||||
T Consensus 82 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlk 157 (296)
T cd05095 82 IRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLA 157 (296)
T ss_pred ceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCC
Confidence 99999886654 5889999999999999987643 3677899999999999999999999 9999999
Q ss_pred ccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh--cCCCCCC
Q 007055 147 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--CEYPYNE 219 (620)
Q Consensus 147 p~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt--G~~Pf~~ 219 (620)
|+|||++ .++.++|+|||++....... .....+++.|+|||... +.++.++|||||||++|||++ |..||..
T Consensus 158 p~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 158 TRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred hheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999998 78999999999986543322 11234467899999654 568999999999999999998 7789976
Q ss_pred CCCHHHHHHHHHc----CC--CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 220 CKNPAQIYKKVTS----GI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 220 ~~~~~~i~~~i~~----~~--~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.. ..++...... .. .....+...++.+++|+..||+ +|.+||++.+++.
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LS-DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cC-hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 43 3333322211 10 1111233456899999999998 8999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=296.57 Aligned_cols=244 Identities=21% Similarity=0.416 Sum_probs=200.6
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+++++.++||||+++++++... ..++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPIC 75 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceE
Confidence 35789999999999999999875 467899998764322 124578899999999999999999987554 4688
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+|+||+.+|+|.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeeccc
Confidence 999999999999998764 46899999999999999999999999 99999999999998 788999999999864433
Q ss_pred CCC---ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 173 PTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 173 ~~~---~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
... ....++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+. .+...+..+
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRLY-KPRLASQSV 230 (256)
T ss_pred CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCCC-CCCCCCHHH
Confidence 221 1233567899999876 458899999999999999998 9999976 44555666666554332 244567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+|+.+||+ +|.+||++.+++++
T Consensus 231 ~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 231 YELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHcccChhhCCCHHHHHHh
Confidence 999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=303.75 Aligned_cols=236 Identities=21% Similarity=0.387 Sum_probs=188.0
Q ss_pred EEEceeCCeEEEEEEEccCCe-------EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 20 EILGKGAFKTVYKGFDEVDGI-------EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~-------~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
+.||+|+||+||+|.+..++. +||+|.+... .....+.+..|+.+++.++||||+++++++.... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--Cc
Confidence 469999999999999866554 4888876532 2344567889999999999999999999987654 47
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc--------EEEcc
Q 007055 93 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--------VKIGD 163 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~--------vKI~D 163 (620)
++||||+.+|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+||+++ .++. ++++|
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLI-REEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEe-cccccccCCCceEEecc
Confidence 89999999999999997654 5899999999999999999999999 99999999999997 3433 79999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhc-CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 164 LGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 164 FGla~~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG-~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
||++..... .....+++.|+|||++.+ .++.++||||||+++|+|++| ..||.. ..+......... ...++
T Consensus 152 ~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~~---~~~~~ 225 (258)
T cd05078 152 PGISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYED---RHQLP 225 (258)
T ss_pred cccccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHHc---cccCC
Confidence 999854432 234568899999998864 478999999999999999998 466654 333332222222 12233
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
...+..+.++|.+||+ +|.+|||+.++++.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 3455789999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.91 Aligned_cols=257 Identities=21% Similarity=0.230 Sum_probs=193.2
Q ss_pred eeeeeccCceEEEEEEEceeCCeEEEEEEEccC---CeEEEEEEeecccccCCHHH-------HHHHHHHHHHHHhCCCC
Q 007055 6 LVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQ-------LERLYSEVHLLKSLKHE 75 (620)
Q Consensus 6 ~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~v~~~~~~~~~~~-------~~~l~~Ei~iL~~L~Hp 75 (620)
.....+.++.|++.++||+|+||+||+|.+..+ +..+|+|...........+. ......+...+..++|+
T Consensus 4 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~ 83 (294)
T PHA02882 4 IPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL 83 (294)
T ss_pred eeeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence 445667788899999999999999999999887 67788776543321100000 01122344556677999
Q ss_pred CcceEEeEEEcCCC--CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec
Q 007055 76 NIIKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 153 (620)
Q Consensus 76 NIVkl~~~f~~~~~--~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 153 (620)
||+++++++..... ...+++++++. .++.+++......++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~ 160 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD 160 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc
Confidence 99999987654432 24567788774 477777777666889999999999999999999998 99999999999998
Q ss_pred CCCCcEEEccccchhhccCC---------CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCH
Q 007055 154 GNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP 223 (620)
Q Consensus 154 ~~~G~vKI~DFGla~~~~~~---------~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~ 223 (620)
.++.+||+|||+++..... ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+....
T Consensus 161 -~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 161 -GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred -CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 6789999999998654211 1223469999999998764 5899999999999999999999999875332
Q ss_pred HHH--------HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 224 AQI--------YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 224 ~~i--------~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+ ...+..+.. .....++.+.+++..|+. +|.+||+..++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 240 GNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222 222222211 123357899999999998 9999999999875
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=306.19 Aligned_cols=248 Identities=28% Similarity=0.459 Sum_probs=200.7
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
....|+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 44567889999999999999999988876 56888775332 233445688999999999999999999987543
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..++++||+++|+|.+++..++ .+++..+..|+.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 82 ---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~ 155 (303)
T cd05110 82 ---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGL 155 (303)
T ss_pred ---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEccccc
Confidence 3568999999999999987754 5899999999999999999999998 99999999999997 788999999999
Q ss_pred hhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 167 AIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 167 a~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
+....... .....+++.|+|||.+. ..++.++||||||+++|||++ |..||.+. ........+..+..+ ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~ 233 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERL-PQP 233 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCC-CCC
Confidence 97543321 12234577899999876 458999999999999999997 89999763 344444555444333 234
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
...+..+++++.+||. +|.+||++.++++.
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 234 PICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4567899999999997 89999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=298.62 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=199.0
Q ss_pred EEEEEEEceeCCeEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC---
Q 007055 16 LQYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 89 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~---tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~--- 89 (620)
|++.++||+|+||+||+|.++. +|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 4678899999999999998653 68999999986432 234456778999999999999999999998765432
Q ss_pred -CeEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 90 -RTINMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 90 -~~l~lV~Ey~~gGsL~~~i~~~------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
...+++++|+.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++ .++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEEC
Confidence 2347788999999999887432 24789999999999999999999998 99999999999998 78899999
Q ss_pred cccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 163 DLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 163 DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
|||++....... .....+++.|++||.+. +.++.++|||||||++|+|++ |..||.. .+...++..+..+..+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL 234 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC
Confidence 999987543221 12334567899999775 458899999999999999999 8899876 4455566666554332
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..+...+..+.+++.+||+ +|.+||++.+++..
T Consensus 235 -~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 -KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2334466899999999998 89999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=298.07 Aligned_cols=249 Identities=26% Similarity=0.448 Sum_probs=202.7
Q ss_pred EEEEEEEceeCCeEEEEEEEcc-CCeEEEEEEeeccccc------CCHHHHHHHHHHHHHHHh-CCCCCcceEEeEEEcC
Q 007055 16 LQYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVM------QSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDD 87 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~-tg~~VAiK~v~~~~~~------~~~~~~~~l~~Ei~iL~~-L~HpNIVkl~~~f~~~ 87 (620)
|++.+.||+|+||.||+|.+.. ++..+|+|.+...... .......++.+|+.++.. ++||||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5788999999999999999988 7899999988654321 223455667889998865 7999999999988654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCCcEEEc
Q 007055 88 TNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
...++|+||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++||||+|+||+++ .++.+||+
T Consensus 82 --~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~ 156 (269)
T cd08528 82 --DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTIT 156 (269)
T ss_pred --CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEe
Confidence 578999999999999988743 3568999999999999999999996 56 99999999999998 78999999
Q ss_pred cccchhhccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 163 DLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 163 DFGla~~~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
|||++...... ......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||.. .+.......+..+..++...
T Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd08528 157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPE 235 (269)
T ss_pred cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCc
Confidence 99998655433 3345578999999998764 488999999999999999999999976 34444445555444333333
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
...++.++++|.+||+ +|.+||++.|+..+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 4567899999999998 89999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=327.09 Aligned_cols=245 Identities=23% Similarity=0.400 Sum_probs=207.9
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 89 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~ 89 (620)
++...|.+...+|.|+|++|..+.+..+++..++|++..... ...+|+.++... +||||+++++.+. +.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~--------~~~~e~~~~~~~~~h~niv~~~~v~~--~~ 388 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD--------DNQDEIPISLLVRDHPNIVKSHDVYE--DG 388 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc--------ccccccchhhhhcCCCcceeecceec--CC
Confidence 345556788889999999999999999999999999875522 133577555554 8999999999874 44
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+|+|||++.||.|.+.+...+.+. ..+..|++||+.|+.|||.+| ||||||||+|||+++..|+++|+|||.++.
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhh
Confidence 67999999999999988887766555 788889999999999999999 999999999999954789999999999987
Q ss_pred ccCCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 170 MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 170 ~~~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
.+.. ..+.+-|..|.|||++. .+|+.++||||||++||+|++|+.||....+..+++.++..+ .+...++..++
T Consensus 466 ~~~~-~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~----~~s~~vS~~AK 540 (612)
T KOG0603|consen 466 LERS-CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP----KFSECVSDEAK 540 (612)
T ss_pred Cchh-hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC----ccccccCHHHH
Confidence 7665 33445688999999887 569999999999999999999999998766666777776543 34467899999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 249 QFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
++|..||+ +|.+||++.+++.||||
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcch
Confidence 99999998 99999999999999999
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=297.79 Aligned_cols=236 Identities=20% Similarity=0.367 Sum_probs=185.6
Q ss_pred EEEceeCCeEEEEEEEcc------------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 20 EILGKGAFKTVYKGFDEV------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~------------tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
+.||+|+||.||+|.... ....||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 468999999999997432 3346888876532 233445688899999999999999999988654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc-------E
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-------V 159 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~-------v 159 (620)
. ..++||||+++|+|..++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|. +
T Consensus 77 ~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~~~~~~~~ 151 (262)
T cd05077 77 V--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLA-REGIDGECGPFI 151 (262)
T ss_pred C--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEe-cCCccCCCCcee
Confidence 3 578999999999999998754 56999999999999999999999999 99999999999997 4443 8
Q ss_pred EEccccchhhccCCCCccccCCCCCCCccccc--cccCccchhhhhHHHHHHHH-hcCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 160 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 160 KI~DFGla~~~~~~~~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELl-tG~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
|++|||++..... .....+++.|+|||.+. ..++.++|||||||++|+|+ +|..||... ...+.. ....+..+
T Consensus 152 ~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~-~~~~~~~~ 227 (262)
T cd05077 152 KLSDPGIPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-RFYEGQCM 227 (262)
T ss_pred EeCCCCCCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHH-HHHhcCcc
Confidence 9999999854432 23456889999999875 45889999999999999998 588888653 222222 22222111
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.....++.++++|.+||+ +|.+||+..++|.+
T Consensus 228 --~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 --LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 122235789999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=300.74 Aligned_cols=236 Identities=20% Similarity=0.327 Sum_probs=185.0
Q ss_pred EEceeCCeEEEEEEEccC------------------------CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC
Q 007055 21 ILGKGAFKTVYKGFDEVD------------------------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76 (620)
Q Consensus 21 ~LG~G~fg~Vy~a~d~~t------------------------g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN 76 (620)
.||+|+||.||+|....+ ...||+|.+... .......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence 589999999999975332 246888887532 1234466888999999999999
Q ss_pred cceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC
Q 007055 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 155 (620)
Q Consensus 77 IVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 155 (620)
|+++++++.... ..++||||+++|+|..++.+ .+.+++..+..++.||+.||.|||+++ |+||||||+|||++..
T Consensus 78 iv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 999999987654 57899999999999999875 467899999999999999999999998 9999999999999721
Q ss_pred ------CCcEEEccccchhhccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHH-hcCCCCCCCCCHHHH
Q 007055 156 ------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQI 226 (620)
Q Consensus 156 ------~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELl-tG~~Pf~~~~~~~~i 226 (620)
.+.+|++|||++..... .....+++.|+|||.+.+ .++.++||||||+++|||+ +|..||.... +...
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~--~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALS--REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEK 230 (274)
T ss_pred CcccCccceeeecCCcccccccc--ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-hHHH
Confidence 23489999998753322 123457889999998754 4889999999999999995 7999997643 3332
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 227 ~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
........ ..+....+.+.++|.+||+ +|.+||++.++|++
T Consensus 231 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222211 1222345789999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=320.76 Aligned_cols=262 Identities=22% Similarity=0.354 Sum_probs=217.2
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
...|-..+.||-|+||.|.++.-..|...+|.|.+.+.++.. ..+...++.|.++|..-+.+-||++|.+|.|.+ .+
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--nL 704 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NL 704 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--ce
Confidence 344556789999999999999999999999999998877654 456677889999999999999999999998765 59
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
||||+|++||++-.++-+-+-|+|..++.|+..+..|+++.|..| +|||||||+||||| .+|+|||.||||+.-+..
T Consensus 705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeecccccccee
Confidence 999999999999999999999999999999999999999999999 99999999999998 899999999999742210
Q ss_pred C--------------------------------------------CCccccCCCCCCCccccc-cccCccchhhhhHHHH
Q 007055 173 P--------------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 207 (620)
Q Consensus 173 ~--------------------------------------------~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiil 207 (620)
. .+++.+||+.|+|||++. .+|+..+|+||.|+||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 0 112567999999999775 6799999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCcCCCCCCcc
Q 007055 208 LEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 208 yELltG~~Pf~~~~~~~~i~~~i~~~--~~p~~~~~~~~~~lk~~I~kcL~~p~~Rps---a~elL~hpff~~~~~~~~ 281 (620)
|||+.|+.||........-+ +|... ..........++++.++|.++...+..|+. +.++-.||||+...+..+
T Consensus 862 ~em~~g~~pf~~~tp~~tq~-kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfssl 939 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQY-KVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSL 939 (1034)
T ss_pred HHHhhCCCCccCCCCCccee-eeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhh
Confidence 99999999998743333222 22221 112233445689999999998888877774 678999999998876653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.40 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=214.4
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 87 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~ 87 (620)
+.+.+-+ .|.++||.|.+|.||++.++.+|+.+|+|+..... +.-+.+..|.++|+.+ .|||++.+|++|.-.
T Consensus 15 pdp~d~~-ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 15 PDPADIF-EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCCCCcc-EEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 4444445 79999999999999999999999999999876432 2334577788888887 799999999998643
Q ss_pred ---CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 88 ---TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 88 ---~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
..+.+|||||||.||+..++++.. .++.|..+..|++.++.||.+||.+. ++|||+|-+|||++ .+|.|||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT-~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT-ENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe-ccCcEEEe
Confidence 335899999999999999999864 56899999999999999999999998 99999999999999 89999999
Q ss_pred cccchhhccCC--CCccccCCCCCCCcccccc------ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Q 007055 163 DLGLAIVMQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 234 (620)
Q Consensus 163 DFGla~~~~~~--~~~~~~GTp~y~APEll~~------~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~ 234 (620)
|||++..+... ...+.+|||.|||||++.. .|+..+|+||||++..||.-|.+|+.+.. +....-.|...+
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-PmraLF~IpRNP 244 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNP 244 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-hhhhhccCCCCC
Confidence 99999776544 3457899999999998853 37889999999999999999999997744 333333333333
Q ss_pred CCCCC-CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 235 KPASL-SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 235 ~p~~~-~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+|... ++.++.++-+||..||. +-.+||+..++|+|||+...
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 33322 45678999999999997 88999999999999999843
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=296.72 Aligned_cols=240 Identities=27% Similarity=0.432 Sum_probs=193.6
Q ss_pred EEEceeCCeEEEEEEEccCC------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 20 EILGKGAFKTVYKGFDEVDG------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg------~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.||+|+||.||+|.+...+ +.||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeE
Confidence 36899999999999886544 789999875332 223456788999999999999999999988654 4588
Q ss_pred EEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC-----cEEE
Q 007055 94 MITELFTSGSLRQYRKKH-------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-----EVKI 161 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~-------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G-----~vKI 161 (620)
+|+||+++|+|.+++... ..+++.++..++.||+.||.|||+.+ ++|+||||+||+++ .++ .+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVS-EKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEe-cCCCCCCcceEE
Confidence 999999999999998642 34788999999999999999999998 99999999999998 555 8999
Q ss_pred ccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC
Q 007055 162 GDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 235 (620)
Q Consensus 162 ~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~ 235 (620)
+|||++....... .....++..|+|||.+. +.++.++|||||||++|+|+| |..||... +.......+..+..
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~ 231 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGR 231 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcCCc
Confidence 9999986543221 11234578899999876 458999999999999999998 99999763 44455555554433
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 236 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 236 p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+ ..+...+..++++|.+||. +|.+||++.++++
T Consensus 232 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 L-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred c-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2 2334567899999999998 8999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.09 Aligned_cols=260 Identities=27% Similarity=0.450 Sum_probs=211.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccC---CHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~---~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
+|-+...||+|||+.||+|+|....+.||+|+-...+--. .....+...+|.++.+.|+||-||++|++|.-++ ..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt-ds 542 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT-DS 542 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc-cc
Confidence 3347789999999999999999999999999765432101 1112344678999999999999999999997655 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec-C-CCCcEEEccccchhh
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-G-NNGEVKIGDLGLAIV 169 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~-~-~~G~vKI~DFGla~~ 169 (620)
++-|+|||+|.+|.-|++.++-+++++++.|+.||+.||.||....|||||-||||.|||+- + ..|.+||.|||++.+
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 78899999999999999999999999999999999999999999999999999999999984 1 247899999999987
Q ss_pred ccCCCC---------ccccCCCCCCCccccc-c----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHH--HHcC
Q 007055 170 MQQPTA---------RSVIGTPEFMAPELYE-E----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK--VTSG 233 (620)
Q Consensus 170 ~~~~~~---------~~~~GTp~y~APEll~-~----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~--i~~~ 233 (620)
+..... ....||-+|++||.|- + ..+.++||||+|+|+|..+.|+-||........+... |...
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 765422 2357999999999653 2 3688999999999999999999999765444444332 2221
Q ss_pred -CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 234 -IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 234 -~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
....+...+++++++.||++||+ ...+|....+|-.||||.+
T Consensus 703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 11122334678999999999999 7889999999999999976
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.13 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=207.0
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
.+..+.+++.+.||+|+||.||+|... .....||||.++-.. +....+.|++|+++|..|+|||||+|++++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 344566788999999999999999754 245789999887432 344678899999999999999999999987
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccce
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKHK--------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 150 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~~--------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NI 150 (620)
..+ ..++||+|||..|+|.+++..+. .++..+...++.||+.|+.||-++. +|||||...|+
T Consensus 559 ~~~--~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNC 634 (774)
T KOG1026|consen 559 REG--DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNC 634 (774)
T ss_pred ccC--CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhc
Confidence 654 46999999999999999996431 2788999999999999999999999 99999999999
Q ss_pred EecCCCCcEEEccccchhhccCCCCc----cccCCCCCCCcc-ccccccCccchhhhhHHHHHHHHh-cCCCCCCCCCHH
Q 007055 151 FVNGNNGEVKIGDLGLAIVMQQPTAR----SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPA 224 (620)
Q Consensus 151 Ll~~~~G~vKI~DFGla~~~~~~~~~----~~~GTp~y~APE-ll~~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~ 224 (620)
||. .+-.|||+|||+++..-...-. ...-...||||| ++.++|++++|||||||+|||+++ |..||.+..+ .
T Consensus 635 LVg-e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-~ 712 (774)
T KOG1026|consen 635 LVG-ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-Q 712 (774)
T ss_pred eec-cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-H
Confidence 996 7889999999999654322111 112356899999 567889999999999999999998 8999988554 5
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 007055 225 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 268 (620)
Q Consensus 225 ~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL 268 (620)
+..+.|..|.. ..-+...+.++..++..||+ .|.+||+.+||-
T Consensus 713 EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 713 EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 56677777766 45567789999999999998 899999999863
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.77 Aligned_cols=207 Identities=34% Similarity=0.536 Sum_probs=175.0
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC--
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-- 88 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~-- 88 (620)
-.+-|+ ..+.||+||||.||+++++.+|+.||||.++... +....++.-+|+++|++|+|||||+++++=....
T Consensus 11 ~~y~W~-~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 11 ENYLWE-MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred CCccee-ehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 334453 5789999999999999999999999999987543 3456677889999999999999999998522222
Q ss_pred --CCeEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec-CCCCc--EE
Q 007055 89 --NRTINMITELFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGE--VK 160 (620)
Q Consensus 89 --~~~l~lV~Ey~~gGsL~~~i~~---~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~-~~~G~--vK 160 (620)
...-.+|||||.||+|+.++.+ ..++++.++..++..+..||.|||.+| |+||||||+||++. +.+|+ -|
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEe
Confidence 2345789999999999999975 457999999999999999999999999 99999999999874 34353 59
Q ss_pred EccccchhhccCC-CCccccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCCCH
Q 007055 161 IGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNP 223 (620)
Q Consensus 161 I~DFGla~~~~~~-~~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~ 223 (620)
|+|||.|+.+... ...+++||+.|.+||+++ +.|+..+|.|||||++|+.+||..||-....+
T Consensus 165 LtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 165 LTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred eecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9999999877544 567899999999999998 45899999999999999999999999654444
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=326.44 Aligned_cols=259 Identities=21% Similarity=0.258 Sum_probs=181.9
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccC----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVD----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~t----g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
+......|.+.+.||+|+||.||+|.+..+ +..||+|++.... . .+....+ .++...+.++..+...|
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~--~e~~~~e--~l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----A--VEIWMNE--RVRRACPNSCADFVYGF 198 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----h--hHHHHHH--HHHhhchhhHHHHHHhh
Confidence 444556789999999999999999999999 9999999875321 1 1111111 12222333333333222
Q ss_pred E----cCCCCeEEEEEeccCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCE
Q 007055 85 V----DDTNRTINMITELFTSGSLRQYRKKHKN--------------------VDMKAIKNWARQILRGLHYLHSHNPPI 140 (620)
Q Consensus 85 ~----~~~~~~l~lV~Ey~~gGsL~~~i~~~~~--------------------l~e~~i~~i~~QIl~gL~yLHs~~~~I 140 (620)
. ......+++|+||+.+++|.+++..... .....++.++.||+.||.|||+++ |
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--I 276 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--I 276 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--E
Confidence 1 1344578999999999999998875321 123457789999999999999998 9
Q ss_pred EecCCCccceEecCCCCcEEEccccchhhccCC---CCccccCCCCCCCcccccc-----------------------cc
Q 007055 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-----------------------EY 194 (620)
Q Consensus 141 iHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~---~~~~~~GTp~y~APEll~~-----------------------~y 194 (620)
+||||||+|||++..++.+||+|||++...... .....+||+.|+|||.+.. .+
T Consensus 277 iHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred EeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 999999999999855789999999999754322 2346789999999996521 23
Q ss_pred CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------CCCC------CCCCCcHHHHHHHHHhc
Q 007055 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-------------KPAS------LSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 195 ~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~-------------~p~~------~~~~~~~~lk~~I~kcL 255 (620)
+.++|||||||++|||+++..|+.. +..+....+.... .... .....+...++||.+||
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 4567999999999999998776542 2222222222110 0000 01112345668999999
Q ss_pred C-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 256 V-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 256 ~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
+ +|.+|||+.++|+||||+...+.
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCCcc
Confidence 8 99999999999999999876553
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.23 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=211.8
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHH-HhCCCCCcceEEeEEEc
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVD 86 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL-~~L~HpNIVkl~~~f~~ 86 (620)
.|.+....++-...||.|+||+|++..|+.+|+..|+|+|.... ...+..+++.|.+.. +.-+.||||+||+..+.
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 45556666666788999999999999999999999999998653 356677889998764 55589999999999887
Q ss_pred CCCCeEEEEEeccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEE
Q 007055 87 DTNRTINMITELFTSGSLRQYRK-----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 161 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~-----~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI 161 (620)
++. -|+.||+|. -+|..+-+ +...++|..+-.+..-.+.||.||-..- .|||||+||+|||++ ..|.|||
T Consensus 135 EGd--cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILld-r~G~vKL 209 (361)
T KOG1006|consen 135 EGD--CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLD-RHGDVKL 209 (361)
T ss_pred CCc--eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEe-cCCCEee
Confidence 654 677889995 46665543 3567999999999999999999997642 399999999999999 7899999
Q ss_pred ccccchhhccCCCCcc-ccCCCCCCCccccc---cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 007055 162 GDLGLAIVMQQPTARS-VIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 237 (620)
Q Consensus 162 ~DFGla~~~~~~~~~~-~~GTp~y~APEll~---~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~ 237 (620)
||||++-.+....+.+ -.|...|||||.+. .+|+.++|+||||++|||++||.+||.+-.+.-+....+..|-+|.
T Consensus 210 CDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~ 289 (361)
T KOG1006|consen 210 CDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI 289 (361)
T ss_pred ecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe
Confidence 9999997766555444 47899999999875 3599999999999999999999999987555544455555564443
Q ss_pred CCCC----CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 238 SLSK----VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 238 ~~~~----~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
-... ..+..++.||.-||. +.+.||...+|+++||++.-
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 3222 257889999999997 88999999999999999753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=296.71 Aligned_cols=271 Identities=18% Similarity=0.316 Sum_probs=221.1
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEc
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 86 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~ 86 (620)
.|+..-..+++.++||+|+|+.|.++.++.|.+.+|+|+++++-+ +..+.++=++.|-.+..+- +||.+|-++.+|..
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~-nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc-CCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 345555678999999999999999999999999999999986543 4445556677788887766 89999999999865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
+ ..+++|.||++||+|--..+++.+++++.++.+...|..||.|||++| ||+||||.+|+|++ ..|++||.|+|.
T Consensus 323 e--srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlld-aeghikltdygm 397 (593)
T KOG0695|consen 323 E--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGM 397 (593)
T ss_pred c--ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEc-cCCceeecccch
Confidence 5 469999999999999988999999999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhc--cCCCCccccCCCCCCCccccccc-cCccchhhhhHHHHHHHHhcCCCCCC-------CCCHHHHHHHHHcCCCC
Q 007055 167 AIVM--QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNE-------CKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 167 a~~~--~~~~~~~~~GTp~y~APEll~~~-y~~~~DIwSlGiilyELltG~~Pf~~-------~~~~~~i~~~i~~~~~p 236 (620)
.+.- ......+++|||.|+|||+++++ |+..+|+|+||++++||+.|+.||.- .+..+-+++.|... .
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--q 475 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--Q 475 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--c
Confidence 8643 33456788999999999999865 99999999999999999999999942 22334456666543 2
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCC------HHHHhcCCCcCCCCCCccccCCC
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPKDLVCDPL 286 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rps------a~elL~hpff~~~~~~~~~~~~~ 286 (620)
..++...+-.+..+++.-|. +|.+|+. ..++-.||||+...|..+..+..
T Consensus 476 iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v 532 (593)
T KOG0695|consen 476 IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQV 532 (593)
T ss_pred ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhccc
Confidence 22333344455666777776 8888764 57899999999888876554433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=278.29 Aligned_cols=240 Identities=34% Similarity=0.591 Sum_probs=204.6
Q ss_pred CCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCCCCHH
Q 007055 26 AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR 105 (620)
Q Consensus 26 ~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~ 105 (620)
+||.||+|.+..+|+.||+|.+...... ...+.+.+|++.++.++|+||+++++++... ...++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHH
Confidence 6899999999999999999998754321 1157789999999999999999999987654 4688999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-CCccccCCCCC
Q 007055 106 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEF 184 (620)
Q Consensus 106 ~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~-~~~~~~GTp~y 184 (620)
.++.....++...+..++.+++.+|.|||+.+ ++|+||+|+||+++ .++.++|+|||.+...... ......+++.|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCCcCC
Confidence 99988777999999999999999999999998 99999999999998 6799999999998765443 34456789999
Q ss_pred CCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC-CcHHHHHHHHHhcC-CCCCC
Q 007055 185 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV-TDPQVKQFIEKCIV-PASLR 261 (620)
Q Consensus 185 ~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~-~~~~lk~~I~kcL~-~p~~R 261 (620)
+|||.+. ..++.++||||||+++++|++|..||....+...+...+..+..+...... .+..+.+++.+||. +|.+|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999775 558889999999999999999999997756666676666655443322222 67889999999998 89999
Q ss_pred CCHHHHhcCCCc
Q 007055 262 LPALELLKDPFL 273 (620)
Q Consensus 262 psa~elL~hpff 273 (620)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=297.01 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=202.7
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE------cC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV------DD 87 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~------~~ 87 (620)
..|.-..++|+|.||.||+|.++.+|++||+|++-.+.-. ...-....+|+++|..|+|+|++.+++.+- ..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK--eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc--cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3455668899999999999999999999999987653211 112234778999999999999999877552 12
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
...++|+|+.+|.. +|..++... .+++..+++.++++++.||.|+|... |+|||+|+.|+||+ .+|.+||+|||+
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt-~dgilklADFGl 170 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLIT-KDGILKLADFGL 170 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEc-CCceEEeecccc
Confidence 34579999999976 888888765 67999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCC------CccccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHH--HHcCCCC
Q 007055 167 AIVMQQPT------ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK--VTSGIKP 236 (620)
Q Consensus 167 a~~~~~~~------~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~--i~~~~~p 236 (620)
++.+.... .+..+.|.+|.+||++- .+|+++.|||..||++.||+|+.+-+.+..+..++... +.....+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 97554322 12235699999999765 46999999999999999999999999886555443211 1111111
Q ss_pred CCC------------------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 237 ASL------------------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 237 ~~~------------------------------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
..| +-+.+++..++++++|. ||.+|+.+.++|+|-||.++
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 111 11235688999999998 99999999999999999764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=328.38 Aligned_cols=251 Identities=23% Similarity=0.374 Sum_probs=205.1
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccC-C----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVD-G----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~t-g----~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
+.+......+.+.||+|+||.||.|.-..- | ..||+|.++.. .+......|.+|..+|+.++|||||++.++
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEe
Confidence 335566788999999999999999976543 3 34888877532 356777889999999999999999999999
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCC
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKH-------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 156 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~-------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 156 (620)
+++. ...++++|||.||+|..|++.. ..++...+..++.||+.|..||++++ +|||||.+.|+|++ ..
T Consensus 764 ~l~~--~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~-~~ 838 (1025)
T KOG1095|consen 764 CLDS--GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLD-ER 838 (1025)
T ss_pred ecCC--CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeec-cc
Confidence 8874 4577899999999999999865 35899999999999999999999999 99999999999998 56
Q ss_pred CcEEEccccchhhccCCCCcc----ccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHH
Q 007055 157 GEVKIGDLGLAIVMQQPTARS----VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 230 (620)
Q Consensus 157 G~vKI~DFGla~~~~~~~~~~----~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i 230 (620)
..|||+|||+|+..-...... ..-...|||||.+. +.++.++|||||||++||++| |..||.+..+.+.+....
T Consensus 839 r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~ 918 (1025)
T KOG1095|consen 839 RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL 918 (1025)
T ss_pred CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH
Confidence 899999999998433221111 12245799999776 679999999999999999998 889998855554444455
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 231 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 231 ~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..| ....+...+..+.+++..||+ +|.+||+...|++
T Consensus 919 ~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 919 EGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred hCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 555 333456677788899999998 9999999999987
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=278.38 Aligned_cols=257 Identities=21% Similarity=0.382 Sum_probs=211.5
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEE
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWV 85 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~ 85 (620)
+.|+ ....|++.+++|+|.|+.||.|....+.++++||+++. -....+.+|+.+|+.|. ||||+++++...
T Consensus 32 i~wg-~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 32 IDWG-NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred eecc-ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 3455 34455899999999999999999999999999999863 34467999999999997 999999999988
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
+.......+|+||..+.+..++- +.++...++.++.|+|.||.|||+.| |+|||+||.|++|+...-.++|+|+|
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred CccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecc
Confidence 88888899999999887776554 46888999999999999999999999 99999999999999777789999999
Q ss_pred chhhccCCCCc-cccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCC-CCCCCHHHHHHHHHc---------
Q 007055 166 LAIVMQQPTAR-SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTS--------- 232 (620)
Q Consensus 166 la~~~~~~~~~-~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf-~~~~~~~~i~~~i~~--------- 232 (620)
+|......... -.+.+..|--||++- ..|+.+-|+|||||++..|+..+-|| .+..+.+|+.+...-
T Consensus 179 LAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 179 LAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred hHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 99877655432 235577888999875 46999999999999999999998887 455667776543321
Q ss_pred ------CCCC-------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 233 ------GIKP-------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 233 ------~~~p-------------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
...| ..-....++++.+|+.++|. |..+|+||.|++.||||.+.
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 0001 11122357999999999998 99999999999999999764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=302.45 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=186.5
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEc----------------cCCeEEEEEEeecccccCCHH----------HHHHHHH
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDE----------------VDGIEVAWNQVNIEDVMQSPD----------QLERLYS 64 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~----------------~tg~~VAiK~v~~~~~~~~~~----------~~~~l~~ 64 (620)
.....|++.++||+|+||+||+|.+. ..++.||+|.++........+ ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 44567899999999999999999752 345789999987532110000 1122345
Q ss_pred HHHHHHhCCCCCc-----ceEEeEEEcC------CCCeEEEEEeccCCCCHHHHHHhC----------------------
Q 007055 65 EVHLLKSLKHENI-----IKFYNSWVDD------TNRTINMITELFTSGSLRQYRKKH---------------------- 111 (620)
Q Consensus 65 Ei~iL~~L~HpNI-----Vkl~~~f~~~------~~~~l~lV~Ey~~gGsL~~~i~~~---------------------- 111 (620)
|+.++.+++|.++ ++++++|... .....++|+||+.+|+|.+++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777888876654 6677766432 124578999999999999988632
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC-C--ccccCCCCCCC
Q 007055 112 --KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-A--RSVIGTPEFMA 186 (620)
Q Consensus 112 --~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~-~--~~~~GTp~y~A 186 (620)
..+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++....... . ....+||.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 12456788999999999999999998 99999999999998 67899999999986543221 1 12345899999
Q ss_pred ccccccc---------------------cC--ccchhhhhHHHHHHHHhcCC-CCCCCCCHH----------HHHHHHHc
Q 007055 187 PELYEEE---------------------YN--ELVDIYSFGMCILEMVTCEY-PYNECKNPA----------QIYKKVTS 232 (620)
Q Consensus 187 PEll~~~---------------------y~--~~~DIwSlGiilyELltG~~-Pf~~~~~~~----------~i~~~i~~ 232 (620)
||.+... |+ .+.||||+||++|+|++|.. ||....... ..+..+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 9976421 22 24799999999999999985 775321111 11122222
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcC-CC---CCCCCHHHHhcCCCcCC
Q 007055 233 GIKPASLSKVTDPQVKQFIEKCIV-PA---SLRLPALELLKDPFLVT 275 (620)
Q Consensus 233 ~~~p~~~~~~~~~~lk~~I~kcL~-~p---~~Rpsa~elL~hpff~~ 275 (620)
...........++..++|+.++|. +| .+|+|+.|+|.||||..
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 222222334467899999999997 33 68999999999999964
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.42 Aligned_cols=256 Identities=27% Similarity=0.486 Sum_probs=223.1
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|.+.+.+|.|+||.||+|+|+.+|+..|+|.|+.... +...-+.+|+-+++.++|||||.|++.+....+ +|+
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~iqqei~~~~dc~h~nivay~gsylr~dk--lwi 89 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK--LWI 89 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCC----ccccccccceeeeecCCCcChHHHHhhhhhhcC--cEE
Confidence 45689999999999999999999999999999997643 344557889999999999999999999876654 788
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
.||||.||+|.+.-.-.+.+++.++..+++..+.||+|||+.+ -+|||||-.||+++ ..|.||++|||.+..+...
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLADFGVSAQITATI 166 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecccCchhhhhhhh
Confidence 8999999999998888899999999999999999999999999 89999999999998 8899999999998766543
Q ss_pred -CCccccCCCCCCCcccc----ccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHH
Q 007055 174 -TARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQ 246 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll----~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~~~~ 246 (620)
..++++|||.|||||+- .++|+..+|||++|+...|+.-.+.|-.+......++-..+++.+|+.+.. .+++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 45689999999999964 367999999999999999999999998775555556666677777776543 46889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
+.+|++.||. +|.+||+++.+|.|||.......
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~l~~ 280 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSR 280 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccchhh
Confidence 9999999997 89999999999999999765443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=292.74 Aligned_cols=252 Identities=20% Similarity=0.343 Sum_probs=198.3
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--C----CcceEEeEEEc
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--E----NIIKFYNSWVD 86 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H--p----NIVkl~~~f~~ 86 (620)
..+|.+...||+|+||.|-.++|..++..||+|+++.- ....+..+-|+++|.++.+ | -+|.+.++|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-- 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-- 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--
Confidence 44567999999999999999999999999999998632 3344556779999999942 2 256666655
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC----------
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG---------- 154 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~---------- 154 (620)
+-.+.+++|+|.+ |-+++++++.++ +++..+++.+++|++.+++|||+.+ ++|.||||+|||+-.
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccC
Confidence 3345799999998 559999998764 6899999999999999999999999 999999999999832
Q ss_pred ---------CCCcEEEccccchhhccCCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHH
Q 007055 155 ---------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 224 (620)
Q Consensus 155 ---------~~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~ 224 (620)
++-.|+|+|||.|+...... .+.+.|.+|.|||++- -+++.++||||+||||+|+.||...|..-.+.+
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 13368999999997654443 5678899999999765 479999999999999999999999997755544
Q ss_pred H--HHHHHHcCCCCC-----------------CCC-------------------------CCCcHHHHHHHHHhcC-CCC
Q 007055 225 Q--IYKKVTSGIKPA-----------------SLS-------------------------KVTDPQVKQFIEKCIV-PAS 259 (620)
Q Consensus 225 ~--i~~~i~~~~~p~-----------------~~~-------------------------~~~~~~lk~~I~kcL~-~p~ 259 (620)
. ++++|... .|. .++ ...-.++-+||+++|. ||.
T Consensus 317 HLaMMerIlGp-~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 317 HLAMMERILGP-IPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHhhCC-CcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 3 33333321 110 000 0012357889999998 999
Q ss_pred CCCCHHHHhcCCCcCCC
Q 007055 260 LRLPALELLKDPFLVTD 276 (620)
Q Consensus 260 ~Rpsa~elL~hpff~~~ 276 (620)
+|+|+.|+|.||||...
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=298.17 Aligned_cols=253 Identities=26% Similarity=0.464 Sum_probs=204.8
Q ss_pred eeeeeeccCceEEEE-------EEEceeCCeEEEEEEEcc----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC
Q 007055 5 DLVIWSLFVLFLQYD-------EILGKGAFKTVYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 73 (620)
Q Consensus 5 ~~~~~~~~~r~y~i~-------e~LG~G~fg~Vy~a~d~~----tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~ 73 (620)
|..-..+.+|.|++. ++||.|-||.||.|.... ...-||||..+.. ..++..+.|..|.-+|+.++
T Consensus 373 dety~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d---~t~d~tekflqEa~iMrnfd 449 (974)
T KOG4257|consen 373 DETYSTPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD---CTPDDTEKFLQEASIMRNFD 449 (974)
T ss_pred cccccCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC---CChhhHHHHHHHHHHHHhCC
Confidence 334455667777665 679999999999997532 3456888876643 24566889999999999999
Q ss_pred CCCcceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEe
Q 007055 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 152 (620)
Q Consensus 74 HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 152 (620)
|||||++++++.+. .+|+|||+++-|.|+.|++.++ .++...+..++.||..||+|||+.. +|||||...|||+
T Consensus 450 HphIikLIGv~~e~---P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLV 524 (974)
T KOG4257|consen 450 HPHIIKLIGVCVEQ---PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILV 524 (974)
T ss_pred Ccchhheeeeeecc---ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheee
Confidence 99999999998654 4899999999999999999876 5999999999999999999999999 9999999999999
Q ss_pred cCCCCcEEEccccchhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHH
Q 007055 153 NGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 227 (620)
Q Consensus 153 ~~~~G~vKI~DFGla~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~ 227 (620)
. ..-.|||+|||+++.+.... +....-..-|||||-+. ..++.++|||-||+|+||++. |..||.+-.|-+.+
T Consensus 525 s-Sp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI- 602 (974)
T KOG4257|consen 525 S-SPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI- 602 (974)
T ss_pred c-CcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-
Confidence 7 56699999999998765432 22222345799999765 679999999999999999875 88999886665543
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 007055 228 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 268 (620)
Q Consensus 228 ~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL 268 (620)
-.+..|-.+ +.+...+|.+..++.+||+ +|++||...++.
T Consensus 603 ~~iEnGeRl-P~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 603 GHIENGERL-PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred EEecCCCCC-CCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 334444333 3566788999999999999 999999987654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.77 Aligned_cols=253 Identities=24% Similarity=0.380 Sum_probs=205.6
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC------CCCcceEEeEEEc
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK------HENIIKFYNSWVD 86 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~------HpNIVkl~~~f~~ 86 (620)
...|.+....|+|-|++|.+|.|...|..||||+|....++. ..=+.|+++|++|+ --++++|+..|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 345678889999999999999999999999999998654432 33467999999995 3488999888754
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~---~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
. ..++||+|.+ .-+|++.+++.+ +|..++++.|+.|++.||..|-.+| |+|.||||+|||++.....+||||
T Consensus 506 k--nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 506 K--NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred c--ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeecc
Confidence 4 5699999988 469999999876 4899999999999999999999999 999999999999996667899999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCC---
Q 007055 164 LGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK-VTSGIKPAS--- 238 (620)
Q Consensus 164 FGla~~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~-i~~~~~p~~--- 238 (620)
||.|........+.+..+..|.|||++-+ .|+...|+||.||+||||.||+..|.+..+-..+.-. -..|..|..
T Consensus 581 fGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 581 FGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred CccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 99998777766666677889999997665 6999999999999999999999999987665544211 111211100
Q ss_pred --------------------------------------------------CCCC---CcHHHHHHHHHhcC-CCCCCCCH
Q 007055 239 --------------------------------------------------LSKV---TDPQVKQFIEKCIV-PASLRLPA 264 (620)
Q Consensus 239 --------------------------------------------------~~~~---~~~~lk~~I~kcL~-~p~~Rpsa 264 (620)
++.. .-.++++|+.+||. +|.+|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 0000 01368899999998 99999999
Q ss_pred HHHhcCCCcCC
Q 007055 265 LELLKDPFLVT 275 (620)
Q Consensus 265 ~elL~hpff~~ 275 (620)
.++|+||||+.
T Consensus 741 nqAL~HpFi~~ 751 (752)
T KOG0670|consen 741 NQALKHPFITE 751 (752)
T ss_pred HHHhcCCcccC
Confidence 99999999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=294.26 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=198.9
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
...+.++++||+|-||.|.++.- ..+.+||+|.++-.. +......|.+||++|.+|+|||||.++++|+.++ .+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--Pi 610 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PL 610 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--ch
Confidence 34678999999999999999964 336999999987443 3455678999999999999999999999987654 58
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 93 NMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
++|+||++.|+|.+|+.++. ....+...+++.||+.|++||.+.+ +|||||.+.|+|++ .++++||+|||.++-+
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~-~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVD-GEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeec-CcccEEecCccccccc
Confidence 99999999999999999984 3455667789999999999999999 99999999999998 6889999999999744
Q ss_pred cCCCC----ccccCCCCCCCcc-ccccccCccchhhhhHHHHHHHHh--cCCCCCCCCCHHHHHHH--HHcCCCC---CC
Q 007055 171 QQPTA----RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKK--VTSGIKP---AS 238 (620)
Q Consensus 171 ~~~~~----~~~~GTp~y~APE-ll~~~y~~~~DIwSlGiilyELlt--G~~Pf~~~~~~~~i~~~--i~~~~~p---~~ 238 (620)
-.... ...+-...||||| ++.++++.++|+|+||+++||+++ .+.||....+.+.+.+. +.....+ ..
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 32221 2234567999999 567899999999999999999865 78999875544333221 1111111 22
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 239 LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 239 ~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+...+..+.+++.+|+. +..+|||.+++-.
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 355677889999999998 8999999999754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-33 Score=308.59 Aligned_cols=245 Identities=28% Similarity=0.412 Sum_probs=190.5
Q ss_pred eEEEEEEEceeCCeE-EEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeE
Q 007055 15 FLQYDEILGKGAFKT-VYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~-Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l 92 (620)
.+.-.+++|.|+-|+ ||+|.. .|++||+|++- .+....+.+||.+|+.. +|||||++|+ .+.+...+
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll-------~e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~ 578 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL-------EEFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFL 578 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee--CCceehHHHHh-------hHhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceE
Confidence 344457899999886 799954 68899999874 23345678999999998 6999999998 56667899
Q ss_pred EEEEeccCCCCHHHHHHhCCC-CC---HHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC----CCcEEEccc
Q 007055 93 NMITELFTSGSLRQYRKKHKN-VD---MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----NGEVKIGDL 164 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~-l~---e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~----~G~vKI~DF 164 (620)
|+..|+|.. +|.++++..+. +. --.....+.|++.||++||+.+ ||||||||+||||+.. ...++|+||
T Consensus 579 YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDf 655 (903)
T KOG1027|consen 579 YIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDF 655 (903)
T ss_pred EEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccc
Confidence 999999975 99999998521 11 1334788999999999999999 9999999999999853 247899999
Q ss_pred cchhhccCCC-----CccccCCCCCCCccccccc-cCccchhhhhHHHHHHHHhc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 007055 165 GLAIVMQQPT-----ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPA 237 (620)
Q Consensus 165 Gla~~~~~~~-----~~~~~GTp~y~APEll~~~-y~~~~DIwSlGiilyELltG-~~Pf~~~~~~~~i~~~i~~~~~p~ 237 (620)
|+++...... .....||-+|+|||++... -+.++||+||||++|..++| ..||.. ..+.-.+.+.......
T Consensus 656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~NIl~~~~~L~ 733 (903)
T KOG1027|consen 656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQANILTGNYTLV 733 (903)
T ss_pred ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--hHHhhhhhhcCcccee
Confidence 9997665432 2356799999999998754 56799999999999999986 899964 2222223333332233
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 238 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 238 ~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
.+....+.+++++|.+||. +|..||+|.++|.||||=.
T Consensus 734 ~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 734 HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 3333333499999999998 8999999999999999943
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=262.82 Aligned_cols=211 Identities=27% Similarity=0.454 Sum_probs=179.4
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEEEEE
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
-...||+|+||.|=+.++..+|...|+|.+...- +.....++.+|+++..+. .+|.+|.||+.++.+.. +++.|
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd--vwIcM 124 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD--VWICM 124 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc--EEEeH
Confidence 4567999999999999999999999999987542 345567788999876555 89999999998877654 88889
Q ss_pred eccCCCCHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 97 ELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 97 Ey~~gGsL~~~----i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
|.|. .+|..+ +++.+.++|..+-+++..++.||.|||++= .+||||+||+|||+| .+|+|||||||++-.+..
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc-cCCcEEEcccccceeehh
Confidence 9995 477655 456788999999999999999999999973 499999999999999 899999999999977766
Q ss_pred CCCcc-ccCCCCCCCcccccc-----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 173 PTARS-VIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 173 ~~~~~-~~GTp~y~APEll~~-----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
.-+.+ -.|...|||||.+.. +|+.++||||||++++||+++++||..-..+-+..+.+.....|
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 65555 578889999997752 58999999999999999999999998888888888888776544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=276.40 Aligned_cols=254 Identities=28% Similarity=0.384 Sum_probs=205.4
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC-
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 89 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~- 89 (620)
...|| --...+|.|+- .|..|.|..+++.||+|++... . .+.....+.++|..++..++|+||++++.+|.-...
T Consensus 15 v~~Ry-~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 15 VPKRY-VNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-F-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeee-eeecccCCCCc-eEEecchhhccCceehhhhcCc-c-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 33444 45678899998 8999999999999999988765 2 334556789999999999999999999998854322
Q ss_pred ---CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 90 ---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 90 ---~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+|+|||||. .+|.+.+. -.++-+.++.++.|++.|+.|||+.+ |+||||||+||+++ .++.+||.|||+
T Consensus 91 ~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 91 EEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGL 164 (369)
T ss_pred HHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccchh
Confidence 35889999996 58888877 35778899999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------
Q 007055 167 AIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---------- 234 (620)
Q Consensus 167 a~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~---------- 234 (620)
|+..... ..+.++.|..|.|||++- .+|.+.+||||+||++.||++|+..|.+....++..+.+..--
T Consensus 165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 9765555 345678899999999654 4699999999999999999999999987555455433332100
Q ss_pred ----------------------CCC-CC------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 235 ----------------------KPA-SL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 235 ----------------------~p~-~~------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
.|. .+ ++.....+++++.+||+ +|.+|.++.++|+|||++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 000 01 12234678999999998 999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=300.43 Aligned_cols=254 Identities=23% Similarity=0.414 Sum_probs=213.9
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg---~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
+...+...+++|.++||.|.||.|++|..+..| ..||||.++.. ..+.+...|+.|..+|-+++||||+++.++
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G---ytekqrrdFL~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG---YTEKQRRDFLSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC---ccHHHHhhhhhhhhhcccCCCCcEEEEEEE
Confidence 345677789999999999999999999988777 57999998743 356777889999999999999999999996
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
. ...+.+.+|+|||++|+|..++..+ +.|+.-++..+++.|+.|+.||-+.+ +|||||...|||+| .+-..|++
T Consensus 699 V--Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVN-snLvCKVs 773 (996)
T KOG0196|consen 699 V--TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVN-SNLVCKVS 773 (996)
T ss_pred E--ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeec-cceEEEec
Confidence 4 4456799999999999999998765 67999999999999999999999999 99999999999999 77889999
Q ss_pred cccchhhccCCCC--ccccC---CCCCCCccccc-cccCccchhhhhHHHHHHHH-hcCCCCCCCCCHHHHHHHHHcCCC
Q 007055 163 DLGLAIVMQQPTA--RSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIYKKVTSGIK 235 (620)
Q Consensus 163 DFGla~~~~~~~~--~~~~G---Tp~y~APEll~-~~y~~~~DIwSlGiilyELl-tG~~Pf~~~~~~~~i~~~i~~~~~ 235 (620)
|||+++.+..... .+..| ...|.|||.+. .+++.++||||||++|||.+ .|+.||.+..|.+ ..+.|..+..
T Consensus 774 DFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-VIkaIe~gyR 852 (996)
T KOG0196|consen 774 DFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VIKAIEQGYR 852 (996)
T ss_pred cccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-HHHHHHhccC
Confidence 9999987754431 22222 35899999775 67999999999999999966 4999999866554 5577777765
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 236 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 236 p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.++ +-..+..+.+|+..||+ +-..||...+|+.+
T Consensus 853 LPp-PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 853 LPP-PMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCC-CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 432 33568899999999998 78999999998864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=286.46 Aligned_cols=248 Identities=25% Similarity=0.422 Sum_probs=212.9
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|......+....+||-|.||.||.|.++.-...||+|.++-. .-..+.|+.|..+|+.++|||+|++.++|..+
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E- 335 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE- 335 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCccHHHHhhhhccC-
Confidence 555555677889999999999999999999999999988632 23568899999999999999999999987554
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+|||+|||..|+|.+|+....+ ++.-.+..++.||.+|++||..++ +|||||...|+|+. .+-.||++|||+
T Consensus 336 -pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVg-EnhiVKvADFGL 411 (1157)
T KOG4278|consen 336 -PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHIVKVADFGL 411 (1157)
T ss_pred -CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccc-ccceEEeeccch
Confidence 569999999999999999987643 677778899999999999999999 99999999999996 788999999999
Q ss_pred hhhccCCCCccccC---CCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQPTARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~~~~~~~G---Tp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
++.+...+.+...| ..-|.|||-+. ..++.++|||+||++|||++| |-.||.+ .+..+.|..+..+..-. -+.
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~-~Pe 489 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMD-GPE 489 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhcccccc-CCC
Confidence 99988765544444 34699999776 669999999999999999998 7788877 68899999998886543 345
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELL 268 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL 268 (620)
.+++.+.+|+..||+ .|++||+..|+-
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 678999999999999 999999988754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-33 Score=277.39 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=202.6
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC---CeEEE
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINM 94 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~---~~l~l 94 (620)
-.+-||.|+||+||.+.|..+|+.||+|++. .+.++-...+++.+|+.+|..++|.|++...+...-..- ..+|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3578999999999999999999999999764 344455566889999999999999999998876533221 24788
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
|+|+|.+ +|..+|..-..++.+.++-++.||++||.|||+.+ |.||||||.|.|++ .|..+||||||+++.-...
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEec-cCceEEecccccccccchhh
Confidence 9999965 88888888888999999999999999999999999 99999999999998 7889999999999865443
Q ss_pred --CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHH------------------
Q 007055 174 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT------------------ 231 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~------------------ 231 (620)
..+..+.|-.|.|||++.+ .|+.++||||.|||+.||+..+..|... ++.+-...|+
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq-~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA-GPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc-ChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 3344567899999998865 5999999999999999999999999764 3433333322
Q ss_pred ------cCCCCCCCCCC--------CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 232 ------SGIKPASLSKV--------TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 232 ------~~~~p~~~~~~--------~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+.+++.++.. ...+...++.++|. +|.+|.+..+.+.|+++....
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 12333333222 23456677777777 899999999999999987644
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=294.49 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=209.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
..+++.+.||+|.||+|++|.++.- -..||||.++..... .....|++|+.+|.+|+|||+|++|++..+ .
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~---q 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD---Q 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc---c
Confidence 3456778999999999999988653 368999998755432 266789999999999999999999998765 3
Q ss_pred eEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 91 TINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
-+.||+|++++|+|.+.+.+ ...|....+..|+.||+.|+.||.+++ +|||||...|+|+- .--.|||+|||+.+
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNllla-sprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLA-SPRTVKICDFGLMR 260 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheec-ccceeeeeccccee
Confidence 48899999999999998876 345888999999999999999999999 99999999999996 56699999999998
Q ss_pred hccCCCCccccC-----CCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 169 VMQQPTARSVIG-----TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 169 ~~~~~~~~~~~G-----Tp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
-+.......+.+ ...|+|||.++ ..++.++|||+||+++|||+| |+-||-++ ...++.+.|..+... .-++
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~erL-pRPk 338 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGERL-PRPK 338 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhccccccC-CCCC
Confidence 776554433332 34699999876 579999999999999999998 88999885 678888888855332 3456
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.++..+.+++..||. .|.+||+...|...-++...
T Consensus 339 ~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred CChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 678999999999998 89999999988755555443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=318.62 Aligned_cols=238 Identities=21% Similarity=0.323 Sum_probs=179.8
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
++..++||+|+||.||+|.+..+|..||+|.++.... ....|++.+++++|||||++++++.+.. ..++|
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv 761 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLI 761 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEE
Confidence 3456789999999999999999999999998863321 1124688999999999999999987654 57899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
|||+++|+|.+++.. +++..+..++.||+.||+|||.+ .++|+||||||+||+++ .++..++. ||.+.....
T Consensus 762 ~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 762 HEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred EeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC-CCCceEEE-ecccccccc--
Confidence 999999999999963 88999999999999999999954 34499999999999998 56677665 555433221
Q ss_pred CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCC----HHHHHHHHHcC-----CCCCCCCC---
Q 007055 175 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN----PAQIYKKVTSG-----IKPASLSK--- 241 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~----~~~i~~~i~~~-----~~p~~~~~--- 241 (620)
.....||+.|+|||++.+ .|+.++|||||||++|||+||+.||..... ........... ...+.+..
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence 223478999999998764 599999999999999999999999853211 11111111100 00011110
Q ss_pred ---CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 242 ---VTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 242 ---~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
....++.+++.+||+ +|.+||++.|+++.
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 112356788999998 89999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=271.62 Aligned_cols=134 Identities=25% Similarity=0.412 Sum_probs=113.8
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----C---CCcceEEeE
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----H---ENIIKFYNS 83 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-----H---pNIVkl~~~ 83 (620)
.+.+|-+.++||.|-|+|||+|+|+.+.+.||+|+++.. +...+....||.+|++++ | ..||+|++.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 336678999999999999999999999999999998743 234466788999999983 3 379999999
Q ss_pred EEcC--CCCeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEe
Q 007055 84 WVDD--TNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 152 (620)
Q Consensus 84 f~~~--~~~~l~lV~Ey~~gGsL~~~i~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 152 (620)
|... +...++||+|++ |.+|..+|++ ++.++...++.|++|||.||.|||..- +|||.||||+|||+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 8653 346899999999 5678888875 467999999999999999999999862 49999999999998
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=272.43 Aligned_cols=248 Identities=30% Similarity=0.496 Sum_probs=188.7
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCcceEEeEEEcC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDD 87 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpNIVkl~~~f~~~ 87 (620)
....|.+.+.+.||+|.||.||+|.+. |+.||||++...+ .+..++|.++.+. |+|+||+.|+.+=..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd-------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD-------ERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc-------hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 445688999999999999999999774 8999999986432 2446777777655 5999999998752222
Q ss_pred C--CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCEEecCCCccceEecCCCCcE
Q 007055 88 T--NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEV 159 (620)
Q Consensus 88 ~--~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs------~~~~IiHrDLKp~NILl~~~~G~v 159 (620)
. -..+|+|++|.+.|||+||+.+ ..++.....+++..++.||++||. ..|.|.|||||..||||. ++|..
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C 355 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTC 355 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcE
Confidence 2 2369999999999999999998 569999999999999999999995 246799999999999996 89999
Q ss_pred EEccccchhhccCC------CCccccCCCCCCCccccccccC-------ccchhhhhHHHHHHHHhc----------CCC
Q 007055 160 KIGDLGLAIVMQQP------TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTC----------EYP 216 (620)
Q Consensus 160 KI~DFGla~~~~~~------~~~~~~GTp~y~APEll~~~y~-------~~~DIwSlGiilyELltG----------~~P 216 (620)
-|+|+|+|-..... .....+||..|||||++....+ ..+||||||.++||++.. +.|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 99999999544332 2345689999999999976432 359999999999999863 578
Q ss_pred CCCCCC----HHHHHHHHHcCCCCCCCCCCC--cH---HHHHHHHHhcC-CCCCCCCHHHHh
Q 007055 217 YNECKN----PAQIYKKVTSGIKPASLSKVT--DP---QVKQFIEKCIV-PASLRLPALELL 268 (620)
Q Consensus 217 f~~~~~----~~~i~~~i~~~~~p~~~~~~~--~~---~lk~~I~kcL~-~p~~Rpsa~elL 268 (620)
|.+... .+++.+.+-.....+.++..+ ++ .+-++++.||. +|.-|.||--+-
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 865322 233333332222222233222 23 34567899996 899999986554
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=290.34 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=209.1
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEc----c---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcce
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDE----V---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIK 79 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~----~---tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk 79 (620)
.|.+......+.+.||.|+||.|++|.-. . ....||+|..+... ...+.+.+..|+.+|+.+ +||||+.
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhh
Confidence 56666677778889999999999999632 1 25689999876432 236678899999999999 6999999
Q ss_pred EEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 80 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
+.+++.. ...+++|+||+..|+|..|+...+ .++...+..++.||+.|++||++.. +|||
T Consensus 367 llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHR 442 (609)
T KOG0200|consen 367 LLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHR 442 (609)
T ss_pred heeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccch
Confidence 9998765 467899999999999999998765 3888999999999999999999998 9999
Q ss_pred CCCccceEecCCCCcEEEccccchhhccCCCCc---cccC--CCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCC
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIG--TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYP 216 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~---~~~G--Tp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~P 216 (620)
||.+.|||+. .+..+||+|||+|+........ ...| ...|||||.+. ..|+.++||||||+++||++| |..|
T Consensus 443 DLAaRNVLi~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 443 DLAARNVLIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP 521 (609)
T ss_pred hhhhhhEEec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence 9999999997 6779999999999754433222 1222 23599999776 469999999999999999998 8899
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 217 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 217 f~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
|.+......+++.+..|.+.. .+...++++.+++..||. +|.+||+..++..
T Consensus 522 Yp~~~~~~~l~~~l~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 522 YPGIPPTEELLEFLKEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 987655677788888887754 345568999999999998 8999999988764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=275.46 Aligned_cols=242 Identities=29% Similarity=0.448 Sum_probs=185.7
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCcceEEeEEEcCC--
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDDT-- 88 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpNIVkl~~~f~~~~-- 88 (620)
-+-+++.++||+|.||.||+|. .+++.||||++.. .+.+.+..|-++.+. ++|+||++|+++=-..+
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 3456778999999999999995 4679999999863 344567777777655 48999999998421111
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCEEecCCCccceEecCCCCcEEE
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-------NPPIIHRDLKCDNIFVNGNNGEVKI 161 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~-------~~~IiHrDLKp~NILl~~~~G~vKI 161 (620)
...+++|++|.+.|+|.+|++.+ .+++....+++..+++||+|||.- .|+|+|||||..||||. ++++..|
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccI 357 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCI 357 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEe
Confidence 33789999999999999999976 489999999999999999999963 46799999999999996 8999999
Q ss_pred ccccchhhccCC----CCccccCCCCCCCccccccccC-------ccchhhhhHHHHHHHHhcCC------------CCC
Q 007055 162 GDLGLAIVMQQP----TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTCEY------------PYN 218 (620)
Q Consensus 162 ~DFGla~~~~~~----~~~~~~GTp~y~APEll~~~y~-------~~~DIwSlGiilyELltG~~------------Pf~ 218 (620)
+|||+|..+... .....+||..|||||++++..+ ..+||||+|.+++||++... ||.
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999999766533 2334689999999999987532 25999999999999998542 232
Q ss_pred ----CCCCHHHHHHHHHcCCCCCCCCC----CC-cHHHHHHHHHhcC-CCCCCCCHH
Q 007055 219 ----ECKNPAQIYKKVTSGIKPASLSK----VT-DPQVKQFIEKCIV-PASLRLPAL 265 (620)
Q Consensus 219 ----~~~~~~~i~~~i~~~~~p~~~~~----~~-~~~lk~~I~kcL~-~p~~Rpsa~ 265 (620)
.-...+++...+...+..+.++. .. -..+++.++.||. ||..|+||.
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 01122344444444433333332 22 3578999999997 999999974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=283.78 Aligned_cols=199 Identities=29% Similarity=0.454 Sum_probs=176.9
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH----HHHHHHHHHHHHHHhCC---CCCcceEEeEEEcCC
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP----DQLERLYSEVHLLKSLK---HENIIKFYNSWVDDT 88 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~----~~~~~l~~Ei~iL~~L~---HpNIVkl~~~f~~~~ 88 (620)
|...+.||.|+||.|++|.|+++..+|+||.|.++++.-.. ..+-.+-.||++|..|+ |+||+++.++|.++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd- 641 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD- 641 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC-
Confidence 57889999999999999999999999999999877653210 11223668999999998 99999999998544
Q ss_pred CCeEEEEEeccC-CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 89 NRTINMITELFT-SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 89 ~~~l~lV~Ey~~-gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
.++|++||-.. |-+|+++|..+++++|..++.+++||+.|+++||++| |||||||-+|+.++ .+|.+||+|||.|
T Consensus 642 -d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd-~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 -DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVD-SNGFVKLIDFGSA 717 (772)
T ss_pred -CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEe-cCCeEEEeeccch
Confidence 57999999864 5689999999999999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCCCCccccCCCCCCCccccccc-c-CccchhhhhHHHHHHHHhcCCCCCC
Q 007055 168 IVMQQPTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNE 219 (620)
Q Consensus 168 ~~~~~~~~~~~~GTp~y~APEll~~~-y-~~~~DIwSlGiilyELltG~~Pf~~ 219 (620)
...+......++||..|.|||++.++ | +..-|||++|+++|-++..+.||..
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 88888888899999999999999875 4 6789999999999999999999964
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=236.99 Aligned_cols=208 Identities=38% Similarity=0.650 Sum_probs=183.2
Q ss_pred EceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCC
Q 007055 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 101 (620)
Q Consensus 22 LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~g 101 (620)
||+|++|.||++.+..+|+++++|.+...... ...+.+.+|+..++.++|++|+++++++... ...++++|++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCC
Confidence 68999999999999888999999998754321 1456789999999999999999999988654 578899999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC-CCcEEEccccchhhccCCC--Ccc
Q 007055 102 GSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPT--ARS 177 (620)
Q Consensus 102 GsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~-~G~vKI~DFGla~~~~~~~--~~~ 177 (620)
++|.+++... ..+++..+..++.+++.+|.|||+++ ++|+||+|.||+++ . ++.++|+|||.+....... ...
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~-~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLD-SDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEe-CCCCcEEEecCCceEEccCCcchhhc
Confidence 9999999876 57899999999999999999999998 99999999999998 5 7899999999987655443 445
Q ss_pred ccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 007055 178 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255 (620)
Q Consensus 178 ~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL 255 (620)
..+...|++||.+.. .++.+.|+|+||+++++| ..+.+++.+|+
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l 198 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKML 198 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHh
Confidence 668899999998865 688899999999999999 57899999999
Q ss_pred C-CCCCCCCHHHHhcCC
Q 007055 256 V-PASLRLPALELLKDP 271 (620)
Q Consensus 256 ~-~p~~Rpsa~elL~hp 271 (620)
. +|.+||++.++++|+
T Consensus 199 ~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 199 QKDPEKRPSAKEILEHL 215 (215)
T ss_pred hCCcccCcCHHHHhhCC
Confidence 7 899999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=280.91 Aligned_cols=243 Identities=30% Similarity=0.486 Sum_probs=201.0
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.+..++||+|+||+||+|.+...|+ +||||++... ........+..|.-+|.+|+|||++++.+++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---
Confidence 3456899999999999999877664 6888876533 23445577999999999999999999999876543
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 92 INMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
+.+|++|++.|.|.+|++.++ ++..+....|+.||++|+.|||.+. ++||||...||||. .-..|||.|||++..+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVk-sP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVK-SPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeec-CCCeEEEEecchhhcc
Confidence 788999999999999998764 6899999999999999999999998 99999999999997 5569999999999877
Q ss_pred cCCCCc----cccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 171 QQPTAR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 171 ~~~~~~----~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
...... ...-.+-|||=|.+. ..|+..+|||||||++||++| |..||.+ ...+++-..+..|.+ ...+...+
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCt 926 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICT 926 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCcc
Confidence 654322 112245688888665 569999999999999999998 8899977 566777777777765 44566788
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..++.+||. |+..||+++++..
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHH
Confidence 899999999997 8999999888653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=240.07 Aligned_cols=212 Identities=33% Similarity=0.553 Sum_probs=181.9
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
|++.+.||.|++|+||+|.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++++... ...+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEE
Confidence 46789999999999999999999999999998754321 2567789999999999999999999987654 468899
Q ss_pred EeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 96 TELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~-l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
+||+.+++|.+++..... +++..+..++.|++.+|.|||+++ ++|+||+|.||+++ .++.++|+|||++......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLG-MDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeCceeeEecCcc
Confidence 999999999999998777 899999999999999999999998 99999999999998 6789999999998765443
Q ss_pred --CCccccCCCCCCCcccc-c-cccCccchhhhhHHHHHHHHhcCCCCCC-CCCHHHHHHHHHcCCC
Q 007055 174 --TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTCEYPYNE-CKNPAQIYKKVTSGIK 235 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll-~-~~y~~~~DIwSlGiilyELltG~~Pf~~-~~~~~~i~~~i~~~~~ 235 (620)
......++..|++||.+ . ..++.++|||+||+++++|++|+.||.. ..+...+.+.+..+..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 23445788899999987 3 3477799999999999999999999976 5566677777777643
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=265.33 Aligned_cols=251 Identities=27% Similarity=0.441 Sum_probs=198.8
Q ss_pred CceEEEEEEEceeCCeEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 88 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~---tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~ 88 (620)
...|+..++||.|.|++||+|.+.. ..+.||+|.+.... ...++..|+++|..+ -+.||+++.+++-.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-- 106 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCFRN-- 106 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhhcc--
Confidence 3467899999999999999999988 88999999987542 234689999999999 58999999998744
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
+..+.+|+||++.....++... ++...++.+++.++.||.++|.+| ||||||||.|+|.+...+.-.|+|||+|.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence 4568899999999988888764 678999999999999999999999 99999999999999888999999999985
Q ss_pred hcc---------C-----CCC---------------------c-----------cccCCCCCCCccccc--cccCccchh
Q 007055 169 VMQ---------Q-----PTA---------------------R-----------SVIGTPEFMAPELYE--EEYNELVDI 200 (620)
Q Consensus 169 ~~~---------~-----~~~---------------------~-----------~~~GTp~y~APEll~--~~y~~~~DI 200 (620)
... . ... . ...|||+|.|||++. ..-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 110 0 000 0 135999999999765 347889999
Q ss_pred hhhHHHHHHHHhcCCCCCCCCCHHHHH-HHHH-------------cCC--------------------------------
Q 007055 201 YSFGMCILEMVTCEYPYNECKNPAQIY-KKVT-------------SGI-------------------------------- 234 (620)
Q Consensus 201 wSlGiilyELltG~~Pf~~~~~~~~i~-~~i~-------------~~~-------------------------------- 234 (620)
||.|+|++-++++.+||....+..... +.+. .|.
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 999999999999999996544322111 1100 011
Q ss_pred ---CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 235 ---KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 235 ---~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.+.......+..+.+|+.+||. +|.+|.||+++|+||||...
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0011122345688999999997 99999999999999999853
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=282.33 Aligned_cols=198 Identities=19% Similarity=0.231 Sum_probs=146.6
Q ss_pred hCCC-CCcceEEeEEEc----C-CCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 71 SLKH-ENIIKFYNSWVD----D-TNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 71 ~L~H-pNIVkl~~~f~~----~-~~~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
.++| +||++++++|.. . ....+++++||+ +++|.+++.. ...+++..++.+++||+.||.|||++| |+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 4555 588888887621 1 123577788887 6699999975 356999999999999999999999999 9999
Q ss_pred CCCccceEecC------------------CCCcEEEccccchhhccCC------------------CCccccCCCCCCCc
Q 007055 144 DLKCDNIFVNG------------------NNGEVKIGDLGLAIVMQQP------------------TARSVIGTPEFMAP 187 (620)
Q Consensus 144 DLKp~NILl~~------------------~~G~vKI~DFGla~~~~~~------------------~~~~~~GTp~y~AP 187 (620)
||||+||||+. .++.+||+|||+++..... .....+||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999951 3456777788877532110 01124689999999
Q ss_pred cccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 007055 188 ELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL 265 (620)
Q Consensus 188 Ell~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~ 265 (620)
|++. ..|+.++|||||||++|||++|..|+... ......+.....|+... ...+....++.+||. +|.+||++.
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~ 260 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSMS 260 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcChH
Confidence 9865 56999999999999999999998887532 22222222222222211 124567789999998 899999999
Q ss_pred HHhcCCCcCC
Q 007055 266 ELLKDPFLVT 275 (620)
Q Consensus 266 elL~hpff~~ 275 (620)
|+|+||||..
T Consensus 261 eil~h~~~~~ 270 (793)
T PLN00181 261 ELLQSEFINE 270 (793)
T ss_pred HHhhchhhhh
Confidence 9999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=223.57 Aligned_cols=160 Identities=26% Similarity=0.352 Sum_probs=128.6
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCCccccC
Q 007055 102 GSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 180 (620)
Q Consensus 102 GsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~~~G 180 (620)
|+|.+++... +++++.+++.|++||+.||.|||+++ ||+|||++ .++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~---~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPE---QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeeccc---cCCC
Confidence 7899999874 46999999999999999999999987 99999998 7899999 9998655432 2368
Q ss_pred CCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-----CCCCcH--HHHHHHH
Q 007055 181 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-----SKVTDP--QVKQFIE 252 (620)
Q Consensus 181 Tp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~-----~~~~~~--~lk~~I~ 252 (620)
|+.|||||++.+ .|+.++|||||||++|||+||+.||............+.....+... ....+. .+++||.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999998764 58999999999999999999999997654444444444433222211 111222 6999999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 253 KCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 253 kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
+||. +|.+||++.+++.|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 9998 8999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-27 Score=234.18 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=187.5
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCe
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~ 91 (620)
.+.|.+.+.||+|.||.+.+|.|+.++..+|+|.+.... .....|.+|.+.--.| .|.||+.-|+.-+.. .+.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~ 96 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDA 96 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhc-Cce
Confidence 345688899999999999999999999999999987542 3446688999876666 599999988864433 357
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec-CCCCcEEEccccchhhc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~-~~~G~vKI~DFGla~~~ 170 (620)
+++++||++-|+|..-+... ++.|...+.++.|+++|+.|+|+++ +||||||.+||||- .+.-.|||||||+.+..
T Consensus 97 YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 88999999999999877764 4899999999999999999999999 99999999999983 34458999999998543
Q ss_pred cCCCCccccCCCCCCCcccccc----c--cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHH---HHHHcCCCCC--CC
Q 007055 171 QQPTARSVIGTPEFMAPELYEE----E--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY---KKVTSGIKPA--SL 239 (620)
Q Consensus 171 ~~~~~~~~~GTp~y~APEll~~----~--y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~---~~i~~~~~p~--~~ 239 (620)
+.. ....--+..|.|||++.. . .++..|||.||+++|..+||..||.......+-| ..-..+..+. ..
T Consensus 174 g~t-V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 174 GTT-VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred Cce-ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 322 122223667999997642 2 5788999999999999999999997432222222 2222222221 11
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCC---CCHHHHhcCCCc
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLR---LPALELLKDPFL 273 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~R---psa~elL~hpff 273 (620)
-+..++.+..+.++-|. .+.+| .++....+.-|.
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 22345667777888887 67677 556665555554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-24 Score=214.28 Aligned_cols=252 Identities=30% Similarity=0.448 Sum_probs=204.6
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC-CcceEEeEEEcCCCCeEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp-NIVkl~~~f~~~~~~~l~l 94 (620)
|++.+.||.|+|+.||++.+. ..+|+|.+...... .......+.+|+.++..+.|+ +|+++++.+... ...++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLES-KSKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhcc-chhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEE
Confidence 678999999999999999988 78899988755432 223567799999999999988 799999988433 34789
Q ss_pred EEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC-cEEEccccchhhc
Q 007055 95 ITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVM 170 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~---~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G-~vKI~DFGla~~~ 170 (620)
+++++.+++|.+++.... .++......++.|++.++.|+|+.+ ++|||+||+||+++ ..+ .++++|||++...
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~-~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLD-RDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-CCCCeEEEeccCcceec
Confidence 999999999998887765 7999999999999999999999999 99999999999998 555 7999999998644
Q ss_pred cCC--------CCccccCCCCCCCcccccc----ccCccchhhhhHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCC
Q 007055 171 QQP--------TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIK 235 (620)
Q Consensus 171 ~~~--------~~~~~~GTp~y~APEll~~----~y~~~~DIwSlGiilyELltG~~Pf~~~~~---~~~i~~~i~~~~~ 235 (620)
... .....+||+.|+|||.+.+ .+....|+||+|++++++++|..||..... .......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 432 2356789999999998764 588899999999999999999999876553 4556666655443
Q ss_pred C-CCCCCCC------cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 236 P-ASLSKVT------DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 236 p-~~~~~~~------~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+ ....... ...+.+++.+++. +|..|.+..+...++|....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 3 1111111 2578999999998 89999999998888666543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-26 Score=232.11 Aligned_cols=265 Identities=32% Similarity=0.510 Sum_probs=204.7
Q ss_pred eeeeccCceEEEEEEEcee---CCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 7 VIWSLFVLFLQYDEILGKG---AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G---~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
..-++++||.+..+..|+. +.-.||+|.+...|.+|+|+.|+....+....+.+....-++.|-++.|.|||+++.|
T Consensus 56 leesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~y 135 (458)
T KOG1266|consen 56 LEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKY 135 (458)
T ss_pred hccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 3457899999999999975 4667999999999999999999877665555555666667788889999999999999
Q ss_pred EEcCC---CCeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCC
Q 007055 84 WVDDT---NRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 156 (620)
Q Consensus 84 f~~~~---~~~l~lV~Ey~~gGsL~~~i~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 156 (620)
|.+.. ...+.|++|||..|+|.+++++. +.+..+.+++|+.||+.||.|||+..|||+|+++.|+.|+++ ++
T Consensus 136 w~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq-~n 214 (458)
T KOG1266|consen 136 WTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ-HN 214 (458)
T ss_pred hcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec-CC
Confidence 97643 35788999999999999999753 468999999999999999999999999999999999999998 99
Q ss_pred CcEEEccccchhhcc------CCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007055 157 GEVKIGDLGLAIVMQ------QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 229 (620)
Q Consensus 157 G~vKI~DFGla~~~~------~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~ 229 (620)
|.|||+---...... ........+-++|.|||.-. ...+.++|||+||+|.++|..++.--.........-..
T Consensus 215 gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ 294 (458)
T KOG1266|consen 215 GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEEN 294 (458)
T ss_pred ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhh
Confidence 999997543321110 00111234678999999765 34677999999999999999998764432221111111
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 230 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 230 i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+.. ......++.-+.+|.+||. .|..||++.++|.||.+....
T Consensus 295 ia~-----~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 295 IAN-----VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred hhh-----heeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 111 1122334566889999998 899999999999999887644
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=218.72 Aligned_cols=248 Identities=21% Similarity=0.302 Sum_probs=200.2
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg-----~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
..+++...++-+|.||.||.|++.+.. +.|-+|.++. ..++-+...+..|--++..+.|||+..+.++.+.+
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~---~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ---HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh---cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 345778888999999999999776543 3344555432 13456677899999999999999999999987765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcE
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH--------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 159 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~--------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~v 159 (620)
. ...+.++.++.-|+|+.++... ..++..++..++.|+..|++|||+++ |||.||...|.+|+ +.-+|
T Consensus 360 ~-~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqV 435 (563)
T KOG1024|consen 360 Y-ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQV 435 (563)
T ss_pred c-CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeE
Confidence 4 4566778999899999998732 23667788889999999999999999 99999999999998 67899
Q ss_pred EEccccchhhccCCCC----ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcC
Q 007055 160 KIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233 (620)
Q Consensus 160 KI~DFGla~~~~~~~~----~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~ 233 (620)
||+|=.+++.+-...- ...-....||+||.+. ..|+.++|+||||+++|||+| |+.||.+ .+|.+++..+.+|
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdG 514 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDG 514 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhcc
Confidence 9999998875432211 1112355799999776 569999999999999999998 8899987 6899999999998
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 234 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 234 ~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.... .+...++++-.++..||+ .|.+||+.+++..
T Consensus 515 yRla-QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 YRLA-QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ceec-CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 6643 345678899999999998 8999999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=251.95 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=202.3
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecc--cccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~--~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
...|.+...++|.|++|.|+.+.........++|..... ...........+..|+-+-..|.|||++.....+.+..
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~- 394 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID- 394 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-
Confidence 345667889999999999999988888887887765422 11111122223667888888899999988766554433
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+-+||||++ +|+.++...+.+....+..+++|++.||.|+|++| |.||||||+|++++ .+|.+||+|||.+..
T Consensus 395 -~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 395 -GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASV 469 (601)
T ss_pred -cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCccee
Confidence 23334999999 99999999888999999999999999999999999 99999999999998 889999999999976
Q ss_pred ccCC------CCccccCCCCCCCcccccc-ccCc-cchhhhhHHHHHHHHhcCCCCCCCCCHHHHH-HHHHcC-----CC
Q 007055 170 MQQP------TARSVIGTPEFMAPELYEE-EYNE-LVDIYSFGMCILEMVTCEYPYNECKNPAQIY-KKVTSG-----IK 235 (620)
Q Consensus 170 ~~~~------~~~~~~GTp~y~APEll~~-~y~~-~~DIwSlGiilyELltG~~Pf~~~~~~~~i~-~~i~~~-----~~ 235 (620)
+..+ .....+|+..|+|||++.+ +|++ .+||||.|++++.|.+|+.||......++.+ ...... ..
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG 549 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence 5443 2345689999999998875 5764 6999999999999999999996544333321 111110 11
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 236 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 236 p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
|..+....+...+.+|.++|+ +|.+|.|+.++++++||+.....
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 222334456788999999998 99999999999999999986543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=224.33 Aligned_cols=176 Identities=20% Similarity=0.240 Sum_probs=134.9
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEcc-CCeEEEEEEeecccc-cCCHHHHHHHHHHHHHHHhCCCCCcce-EEeEEEc
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDV-MQSPDQLERLYSEVHLLKSLKHENIIK-FYNSWVD 86 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~-tg~~VAiK~v~~~~~-~~~~~~~~~l~~Ei~iL~~L~HpNIVk-l~~~f~~ 86 (620)
.+....|.+.+.||+|+||+||+|.+.. +|+.||+|++..... .......+.+.+|+++|+.|+|+||++ +++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3455668999999999999999999876 788889998652211 012334567999999999999999985 5441
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCC-CccceEecCCCCcEEEcccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL-KCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL-Kp~NILl~~~~G~vKI~DFG 165 (620)
...|+||||++|++|... .. .. ...|+.|++.||.|||++| |+|||| ||+|||++ .+|.+||+|||
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFG 157 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQ 157 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECc
Confidence 237899999999999732 11 11 1578999999999999999 999999 99999997 67899999999
Q ss_pred chhhccCCC----------CccccCCCCCCCccccccc-------cCccchhh
Q 007055 166 LAIVMQQPT----------ARSVIGTPEFMAPELYEEE-------YNELVDIY 201 (620)
Q Consensus 166 la~~~~~~~----------~~~~~GTp~y~APEll~~~-------y~~~~DIw 201 (620)
+|+...... .+...+++.|+|||.+..+ .+...|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 997554322 1345788999999988632 33456766
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-24 Score=234.45 Aligned_cols=246 Identities=19% Similarity=0.289 Sum_probs=201.1
Q ss_pred EEceeCCeEEEEEE---EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeEEEEE
Q 007055 21 ILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 21 ~LG~G~fg~Vy~a~---d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
++|+|+||.|+++. ....|..+|+|..+.......... .-..|..++..++ ||.+|+++..|..+. .+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDG--KLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeecccc--chhHhh
Confidence 47999999998753 344677889888765544332222 5567888898887 999999999886654 477889
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCCc
Q 007055 97 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 176 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~ 176 (620)
++..||.|+..+.....+.+...+.+...++.+++++|+.+ ++|||+|++||+++ .+|++|+.|||+++..-.....
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeec-ccCccccCCchhhhHhHhhhhc
Confidence 99999999999999899999999999999999999999999 99999999999998 7999999999999765433332
Q ss_pred cccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 007055 177 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256 (620)
Q Consensus 177 ~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~ 256 (620)
+||..|||||+.. ++..++|.||||++++||+||..||.. ++...|.... ...+...+..+++++..++.
T Consensus 154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE--LEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHh
Confidence 8999999999998 778899999999999999999999976 4455554422 22445567788899988886
Q ss_pred -CCCCCCC-----HHHHhcCCCcCCCCCCcccc
Q 007055 257 -PASLRLP-----ALELLKDPFLVTDNPKDLVC 283 (620)
Q Consensus 257 -~p~~Rps-----a~elL~hpff~~~~~~~~~~ 283 (620)
+|..|.- +.|+++|+||+..++..+..
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~ 256 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDWNELEA 256 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeHhhHhh
Confidence 7877775 47999999999988876543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-21 Score=201.23 Aligned_cols=247 Identities=21% Similarity=0.223 Sum_probs=181.0
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC----CCcceEEeEEEcCCC
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH----ENIIKFYNSWVDDTN 89 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg-~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H----pNIVkl~~~f~~~~~ 89 (620)
.|++.+.||+|+||.||+|.+..++ ..+|+|.......... ..+..|+.++..+.. +++..+++... ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCC
Confidence 6789999999999999999998875 7889888765432111 147789999988873 58888888764 344
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCC----CcEEEcc
Q 007055 90 RTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN----GEVKIGD 163 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~----G~vKI~D 163 (620)
.+-++||+++ |.+|.+++... +.++..++..++.|++.+|.+||+.| ++||||||+|+++.... -.+.|.|
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEe
Confidence 5778899988 77999998765 47999999999999999999999999 99999999999996332 3699999
Q ss_pred ccchhhcc--C------C---C-CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHH--HH
Q 007055 164 LGLAIVMQ--Q------P---T-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI--YK 228 (620)
Q Consensus 164 FGla~~~~--~------~---~-~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i--~~ 228 (620)
||+++... . . . ...+.||..|+++.... .+.+.+.|+||++.++.+|..|..||......... +.
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99997221 1 1 1 12356999999999765 45899999999999999999999999765433221 22
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 229 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 229 ~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
...............+.++..+...+-. +...+|....+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 2211111111223344566666655544 5566676655443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=223.83 Aligned_cols=226 Identities=24% Similarity=0.407 Sum_probs=171.7
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
..+....+...+.+-.|+||.||+..|+.+.+.+|+| ++.... +.+. ++.....|.+|
T Consensus 78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l---------ilRn--ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL---------ILRN--ILTFAGNPFVV---------- 135 (1205)
T ss_pred cCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch---------hhhc--cccccCCccee----------
Confidence 3455566788999999999999999999999999994 442221 1111 22222222222
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
|+-...++.-+.++... +.+++|||+-+ |+|||+||+|.+|+ .-|++|+.|||++.
T Consensus 136 -------------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 -------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSK 191 (1205)
T ss_pred -------------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhh
Confidence 66667777777776554 78999999988 99999999999998 78999999999974
Q ss_pred hcc-----------------CCCCccccCCCCCCCcccc-ccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 007055 169 VMQ-----------------QPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 230 (620)
Q Consensus 169 ~~~-----------------~~~~~~~~GTp~y~APEll-~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i 230 (620)
..- .-..+.++|||.|+|||++ +.+|+..+|+|++|+|+||.+.|+.||.+ .++++++..+
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~v 270 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQV 270 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhh
Confidence 211 0012356899999999965 57899999999999999999999999987 6777777766
Q ss_pred HcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCC---CHHHHhcCCCcCCCCCCccc
Q 007055 231 TSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRL---PALELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 231 ~~~~~--p~~~~~~~~~~lk~~I~kcL~-~p~~Rp---sa~elL~hpff~~~~~~~~~ 282 (620)
..... |+. ..-..++++++|..+|+ .|..|. .+.++.+|+||+...++.++
T Consensus 271 isd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~ll 327 (1205)
T KOG0606|consen 271 ISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLL 327 (1205)
T ss_pred hhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhh
Confidence 65322 332 33457899999999997 787776 46789999999998887544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-21 Score=193.77 Aligned_cols=214 Identities=20% Similarity=0.328 Sum_probs=173.9
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN 89 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~ 89 (620)
+.|-.|+++++||+|+||..+.|....+++.||||.-... ..+.++..|.+..+.|. .++|...|.+- ...
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG 96 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEG 96 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeeec--ccc
Confidence 4566799999999999999999999999999999965422 23456888999998884 68888887643 334
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC----CCCcEEEccc
Q 007055 90 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDL 164 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~----~~G~vKI~DF 164 (620)
.+-.||+|++ |-+|.+++.-.+ +|+.+++..++.|++.-++|+|+++ +|+|||||+|+||.. ....|.|+||
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEec
Confidence 4566889998 779999988654 6999999999999999999999999 999999999999952 2236899999
Q ss_pred cchhhccCCC---------CccccCCCCCCCccc-cccccCccchhhhhHHHHHHHHhcCCCCCCCC--CHHHHHHHHHc
Q 007055 165 GLAIVMQQPT---------ARSVIGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTS 232 (620)
Q Consensus 165 Gla~~~~~~~---------~~~~~GTp~y~APEl-l~~~y~~~~DIwSlGiilyELltG~~Pf~~~~--~~~~i~~~i~~ 232 (620)
|+|+.+..+. ..+..||..||+--. +..+-+..-|+-|||-+++..+.|..||.+.. +..+.|++|-.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 9998765442 346689999999773 44567889999999999999999999998754 34567777765
Q ss_pred CCC
Q 007055 233 GIK 235 (620)
Q Consensus 233 ~~~ 235 (620)
...
T Consensus 254 ~Kr 256 (449)
T KOG1165|consen 254 TKR 256 (449)
T ss_pred ccc
Confidence 433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=187.31 Aligned_cols=145 Identities=16% Similarity=0.168 Sum_probs=112.9
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHH----------------------HHHHHHHHHHHHHhCCCCC
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD----------------------QLERLYSEVHLLKSLKHEN 76 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~----------------------~~~~l~~Ei~iL~~L~HpN 76 (620)
...||+|+||.||+|.+. +|+.||+|+++......... ......+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 89999999997542211000 0122345999999998887
Q ss_pred cceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEecCCCccceEecCC
Q 007055 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGN 155 (620)
Q Consensus 77 IVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp~NILl~~~ 155 (620)
+...+.... .. .++||||+.|++|...+...+++++..+..++.|++.+|.|+ |++| |+||||||+|||++
T Consensus 81 v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-- 152 (190)
T cd05147 81 IPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-- 152 (190)
T ss_pred CCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE--
Confidence 744333221 11 279999999988876655567899999999999999999999 7888 99999999999997
Q ss_pred CCcEEEccccchhhccC
Q 007055 156 NGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 156 ~G~vKI~DFGla~~~~~ 172 (620)
++.++|+|||+|.....
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 47899999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.8e-21 Score=191.37 Aligned_cols=175 Identities=15% Similarity=0.128 Sum_probs=134.0
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHH------HHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER------LYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~------l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
...|+..++||.|+||.||++.+ ++..+|+|.+.... ...+....+ +.+|++.+.+|.||+|..+.+++.+
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~-~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKV-KRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhc-CchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 44579999999999999999755 47789999886433 233444444 5789999999999999999998765
Q ss_pred CCC------CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEE
Q 007055 87 DTN------RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 160 (620)
Q Consensus 87 ~~~------~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vK 160 (620)
... ...++||||++|.+|.++.. +++ ....+|+.+|..||.+| ++|||+||+||+++ .+| ++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~-~~g-i~ 174 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVS-KNG-LR 174 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEe-CCC-EE
Confidence 432 35789999999999988732 333 34669999999999999 99999999999998 677 99
Q ss_pred EccccchhhccCCCCccccCCCCCCCccccccccCccchhhhhHHHHHHHH
Q 007055 161 IGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 211 (620)
Q Consensus 161 I~DFGla~~~~~~~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELl 211 (620)
|+|||.........+... =++...|+.++|||+||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~d~---------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAKDR---------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhHHH---------HHHHhHhcccccccceeEeehHHH
Confidence 999998754422211110 023456888999999999887653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=185.51 Aligned_cols=235 Identities=21% Similarity=0.286 Sum_probs=181.1
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCcceEEeEEEcCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTN 89 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pNIVkl~~~f~~~~~ 89 (620)
+.+..|++.++||.|+||.+|+|.....|++||||.-... . .-..+..|..+.+.|++ ..|..+..++. ..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~--e~ 83 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-A-----KHPQLLYESKVYRILQGGVGIPHIRHYGT--EK 83 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-C-----CCcchhHHHHHHHHhccCCCCchhhhhcc--cc
Confidence 4556789999999999999999999999999999975422 2 22347789999999965 56666666543 33
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec--CCCCcEEEccccc
Q 007055 90 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGL 166 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~G~vKI~DFGl 166 (620)
.+-.+||+++ |-+|.+++.-. ..++.+++.-++-|++.-++|+|.++ +|||||||+|+|.. .+...+.++|||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccc
Confidence 4667899998 77999988754 56999999999999999999999999 99999999999973 2345789999999
Q ss_pred hhhccCC---------CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCC
Q 007055 167 AIVMQQP---------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGI 234 (620)
Q Consensus 167 a~~~~~~---------~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~--~~~~i~~~i~~~~ 234 (620)
|..+... ..+...||..|.+--... -+-+..-|+-|+|.++..+..|..||.+.. +..|.+++|..-.
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 9654322 234567999998765333 346778999999999999999999998854 3456777776543
Q ss_pred C---CCCCCCCCcHHHHHHHHHhcC
Q 007055 235 K---PASLSKVTDPQVKQFIEKCIV 256 (620)
Q Consensus 235 ~---p~~~~~~~~~~lk~~I~kcL~ 256 (620)
. +..+-+..+.++.-.+.-|-.
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~ 265 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRG 265 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhh
Confidence 2 233445567788888887753
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=182.31 Aligned_cols=145 Identities=18% Similarity=0.215 Sum_probs=114.3
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc--------------------CCHH--HHHHHHHHHHHHHhCCCCC
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--------------------QSPD--QLERLYSEVHLLKSLKHEN 76 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~--------------------~~~~--~~~~l~~Ei~iL~~L~HpN 76 (620)
.+.||+|+||.||+|.+. +|+.||+|+++..... .+.. ....+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 9999999998764211 0000 1223468999999999999
Q ss_pred cceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCC
Q 007055 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGN 155 (620)
Q Consensus 77 IVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~ 155 (620)
|.....++... .++||||++|+++........+++...+..++.|++.+|.++|+ +| |+||||||+||+++
T Consensus 81 i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-- 152 (190)
T cd05145 81 VPVPEPILLKK----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-- 152 (190)
T ss_pred CCCceEEEecC----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--
Confidence 86554443322 37899999998665443344678899999999999999999999 88 99999999999997
Q ss_pred CCcEEEccccchhhccC
Q 007055 156 NGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 156 ~G~vKI~DFGla~~~~~ 172 (620)
+|.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 68999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=187.64 Aligned_cols=238 Identities=18% Similarity=0.195 Sum_probs=150.7
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC----------CCcceE
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH----------ENIIKF 80 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H----------pNIVkl 80 (620)
-..|-+..++.||.|+++.||.+.|..||+++|+|++.... .......+.+++|.-....+.+ -.++.-
T Consensus 9 ~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 9 QRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp --EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred CCceEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 34456778899999999999999999999999999987665 3444567777777765555432 122222
Q ss_pred EeEEEc---------CCCC------eEEEEEeccCCCCHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCC
Q 007055 81 YNSWVD---------DTNR------TINMITELFTSGSLRQYRKK---HKN----VDMKAIKNWARQILRGLHYLHSHNP 138 (620)
Q Consensus 81 ~~~f~~---------~~~~------~l~lV~Ey~~gGsL~~~i~~---~~~----l~e~~i~~i~~QIl~gL~yLHs~~~ 138 (620)
++.... ..+. ..+++|+-+ .++|.+++.. ... +...+...+..|+++.+++||.+|
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G- 165 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG- 165 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-
Confidence 221111 1111 134566666 4688887642 221 233344566699999999999999
Q ss_pred CEEecCCCccceEecCCCCcEEEccccchhhccCCCCccccCCCCCCCcccccc---------ccCccchhhhhHHHHHH
Q 007055 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE---------EYNELVDIYSFGMCILE 209 (620)
Q Consensus 139 ~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~---------~y~~~~DIwSlGiilyE 209 (620)
++|+||+|+|+|++ .+|.++|+||+.....+..... ...+..|.+||+... .++.+.|.|+||+++|.
T Consensus 166 -lVHgdi~~~nfll~-~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 166 -LVHGDIKPENFLLD-QDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp -EEEST-SGGGEEE--TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred -eEecccceeeEEEc-CCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 99999999999998 7899999999876544333222 344678999997642 37889999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCC
Q 007055 210 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLR 261 (620)
Q Consensus 210 LltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~R 261 (620)
|++++.||..... ...... ....-...+..++.+|..+|+ +|.+|
T Consensus 243 lWC~~lPf~~~~~-~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSP-EADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGG-GSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCc-cccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999975321 110000 001111467889999999998 77766
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=177.09 Aligned_cols=184 Identities=16% Similarity=0.095 Sum_probs=138.4
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeEEEEE
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
....|++|+||+||++.. .+.+++.+.+.....-...-....+.+|+++|++|. |++|++++++ ...+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 568999999999998855 678888766653322111112235789999999995 5889999884 1368899
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCC-CccceEecCCCCcEEEccccchhhccCCCC
Q 007055 97 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL-KCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 175 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL-Kp~NILl~~~~G~vKI~DFGla~~~~~~~~ 175 (620)
||+.|.+|.+.+.. . ...++.|++.+|.++|++| |+|||| ||+|||++ .+|.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcch
Confidence 99999999754322 1 1357899999999999999 999999 79999997 788999999999974433221
Q ss_pred ------c---------cccCCCCCCCcccc---ccccCccchhhhhHHHHHHHHhcCCCCCC
Q 007055 176 ------R---------SVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEMVTCEYPYNE 219 (620)
Q Consensus 176 ------~---------~~~GTp~y~APEll---~~~y~~~~DIwSlGiilyELltG~~Pf~~ 219 (620)
. -...+|.|+.|+.- ...--...++++.|+-+|.++|+..|+.+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 11368889999843 23333678889999999999999998754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.6e-19 Score=177.39 Aligned_cols=137 Identities=19% Similarity=0.247 Sum_probs=109.2
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-----CCCCcceEEeEEEcCCC-CeE
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-----KHENIIKFYNSWVDDTN-RTI 92 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-----~HpNIVkl~~~f~~~~~-~~l 92 (620)
.+.||+|+|+.||. ++.++.. +||++..... ...+.+.+|+.+++.| +||||+++|+++..+.. ..+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 47899999999995 7778777 5898865432 2345689999999999 67999999999876542 343
Q ss_pred E-EEEec--cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCEEecCCCccceEecC---CCCcEEEcccc
Q 007055 93 N-MITEL--FTSGSLRQYRKKHKNVDMKAIKNWARQILRGL-HYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLG 165 (620)
Q Consensus 93 ~-lV~Ey--~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL-~yLHs~~~~IiHrDLKp~NILl~~---~~G~vKI~DFG 165 (620)
+ +|+|| +.+|+|.+++++. .+++. ..+++|++.++ .|||+++ |+||||||+|||++. .++.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 4 78999 5689999999774 46666 46789999888 8999999 999999999999973 23489999954
Q ss_pred ch
Q 007055 166 LA 167 (620)
Q Consensus 166 la 167 (620)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.7e-20 Score=210.68 Aligned_cols=243 Identities=21% Similarity=0.279 Sum_probs=178.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.+.+.+.||.+-|=.|.+|+|. .|. |++|++-+.+-.-+-....+...|++ ...++|||.++|-..- ...+.-||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHH
Confidence 4678999999999999999875 455 88898765543333344455556666 6677999999997743 34456788
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh--cc-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV--MQ- 171 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~--~~- 171 (620)
|-+|+.. +|.|.+...+-+..-+.+-|+.||+.||.-||..| |+|||||++||||+ .-.=+.|.||..-+- +.
T Consensus 99 vRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEe-eechhhhhcccccCCccCCC
Confidence 8899875 89999988888888899999999999999999999 99999999999998 455688999965321 11
Q ss_pred -CC-CCccccC----CCCCCCcccccc-----------c-cCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHc
Q 007055 172 -QP-TARSVIG----TPEFMAPELYEE-----------E-YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 232 (620)
Q Consensus 172 -~~-~~~~~~G----Tp~y~APEll~~-----------~-y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~ 232 (620)
++ ....+.- --+|+|||.+-. . .+++.||||+||+++||++ |++||. ..|+.+.-..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~ 250 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSG 250 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhcc
Confidence 11 1111122 347999996531 1 4568999999999999988 577773 3444333322
Q ss_pred CCC-C-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 233 GIK-P-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 233 ~~~-p-~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+.. + .-+.+..+..++++|..|++ +|++|.+|++.|+.
T Consensus 251 ~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111 1 11234456789999999998 99999999999975
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-18 Score=177.42 Aligned_cols=157 Identities=18% Similarity=0.145 Sum_probs=122.0
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEE-EccCCeEEEEEEeecccccC------------------CHH--HHHHHHHH
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGF-DEVDGIEVAWNQVNIEDVMQ------------------SPD--QLERLYSE 65 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~-d~~tg~~VAiK~v~~~~~~~------------------~~~--~~~~l~~E 65 (620)
-++.-.|+.|++.+.||+|+||.||+|. +..+|+.||+|+++...... ... ....+.+|
T Consensus 21 ~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 100 (237)
T smart00090 21 YSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE 100 (237)
T ss_pred HHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence 3455567788999999999999999999 77899999999987543110 000 11346789
Q ss_pred HHHHHhCCCC--CcceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 66 VHLLKSLKHE--NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 66 i~iL~~L~Hp--NIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
+++++++.+. .+.++++. . ..++||||+.|++|..+......+...++..++.||+.+|.+||++| .++||
T Consensus 101 ~~~L~~L~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~ 173 (237)
T smart00090 101 FRNLQRLYEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHG 173 (237)
T ss_pred HHHHHHHHhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeC
Confidence 9999999763 34445442 1 24799999999998776545556777788899999999999999987 49999
Q ss_pred CCCccceEecCCCCcEEEccccchhhccC
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
||||+||+++ ++.++|+|||.+.....
T Consensus 174 Dikp~NIli~--~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 174 DLSEYNILVH--DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCChhhEEEE--CCCEEEEEChhhhccCC
Confidence 9999999997 67999999999865443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-18 Score=175.91 Aligned_cols=197 Identities=21% Similarity=0.364 Sum_probs=145.3
Q ss_pred CCCCcceEEeEEEcC-------------------------CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 007055 73 KHENIIKFYNSWVDD-------------------------TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 127 (620)
Q Consensus 73 ~HpNIVkl~~~f~~~-------------------------~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl 127 (620)
+|||||++.+.|.++ ...++|+||.-++. +|++|+..+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence 699999999888542 33579999988864 9999987644 56777788999999
Q ss_pred HHHHHHHhCCCCEEecCCCccceEecC-CCC--cEEEccccchhhccC-----CCC---ccccCCCCCCCcccccc---c
Q 007055 128 RGLHYLHSHNPPIIHRDLKCDNIFVNG-NNG--EVKIGDLGLAIVMQQ-----PTA---RSVIGTPEFMAPELYEE---E 193 (620)
Q Consensus 128 ~gL~yLHs~~~~IiHrDLKp~NILl~~-~~G--~vKI~DFGla~~~~~-----~~~---~~~~GTp~y~APEll~~---~ 193 (620)
.|+.|||+|| |.|||||.+|||+.- +++ .+.|+|||.+-.-.. +.. -..-|.-.-||||+... .
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 999999999999842 333 578999997632211 111 12347888999998753 2
Q ss_pred ----cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH---
Q 007055 194 ----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL--- 265 (620)
Q Consensus 194 ----y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~--- 265 (620)
.-.++|.|+.|.+.||+++...||.... ...+-...-..-..+.++..+++.+++++..+|+ +|++|+++.
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 2358999999999999999999998622 2211111122223456777889999999999998 899999853
Q ss_pred HHhcCCCcC
Q 007055 266 ELLKDPFLV 274 (620)
Q Consensus 266 elL~hpff~ 274 (620)
.+|+-..+.
T Consensus 509 Nvl~LsLw~ 517 (598)
T KOG4158|consen 509 NVLNLSLWR 517 (598)
T ss_pred hHHHHHHhc
Confidence 455544333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-18 Score=169.94 Aligned_cols=239 Identities=18% Similarity=0.293 Sum_probs=180.5
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
+.+.-+|.+.-.|..|+|++. |-.++.|+++..++. ......|..|.-.|+-+.||||+.+.+.+... ..+.+|
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t--~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~i 265 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVT--ARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVII 265 (448)
T ss_pred hhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcc--hhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceEe
Confidence 334456777788999999876 445667777766542 23335588899999999999999999987544 468889
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEE--ccccchhhcc
Q 007055 96 TELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI--GDLGLAIVMQ 171 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI--~DFGla~~~~ 171 (620)
..||+-|+|...+...- .++-.++.+++.+|+.|++|||+..|-|.---|....++++ ++-+.+| +|--++.+.
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfsfqe- 343 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFSFQE- 343 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceeeeec-
Confidence 99999999999987654 36778899999999999999999986555567888899998 5555544 443333211
Q ss_pred CCCCccccCCCCCCCccccccc----cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 172 QPTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~~~----y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
....-.|.||+||.+... .-.++|+|||+++++||.|.+.||.+..+.+--.+....|..+ .++...++.+
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv-~ippgis~hm 418 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV-HIPPGISRHM 418 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc-cCCCCccHHH
Confidence 112348999999987643 3468999999999999999999998865544445555566554 3555677889
Q ss_pred HHHHHHhcC-CCCCCCCHHHH
Q 007055 248 KQFIEKCIV-PASLRLPALEL 267 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~el 267 (620)
..++.-|+. ||.+||....+
T Consensus 419 ~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred HHHHHHHhcCCCCcCCCccee
Confidence 999999998 99999976543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3e-17 Score=191.02 Aligned_cols=194 Identities=21% Similarity=0.282 Sum_probs=153.0
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCcceEEeEEEc
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVD 86 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpNIVkl~~~f~~ 86 (620)
...|..|.|...||+|+||+||+|.+.. |+.||+|+-+.... . .++=-.+++.+|+ -+.|+.++..++-
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--W-----EFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--e-----eeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3456778899999999999999999877 99999997543321 0 0122223344444 3455666655544
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC------CCCcEE
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------NNGEVK 160 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~------~~G~vK 160 (620)
.+ .-++|+||.+.|+|.+++...+.+++..+..+..|++..++.||.++ |||+||||+|++|.. .+--++
T Consensus 766 ~~--~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 766 QN--ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred CC--cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceE
Confidence 43 35679999999999999998899999999999999999999999999 999999999999941 233589
Q ss_pred Eccccchhhcc----CCCCccccCCCCCCCccccccc-cCccchhhhhHHHHHHHHhcCC
Q 007055 161 IGDLGLAIVMQ----QPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEY 215 (620)
Q Consensus 161 I~DFGla~~~~----~~~~~~~~GTp~y~APEll~~~-y~~~~DIwSlGiilyELltG~~ 215 (620)
|+|||.+..+. .......++|-.|--+|+..+. ++..+|.|.|+.+++.|+.|++
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999996443 2245567889999999998864 8999999999999999999974
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=9e-19 Score=199.03 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=202.6
Q ss_pred CceEEEEEEEceeCCeEEEEEEEcc-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR 90 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~-tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~ 90 (620)
..-|++.+.||+|+|+.|-++.... ....+|.|.+.... +......++..|..+-+.+. |+|++.+++.+.. ..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~ 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PR 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCC--Cc
Confidence 3456788899999999999987643 44567777766543 34455667778999988887 9999999997644 45
Q ss_pred eEEEEEeccCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCEEecCCCccceEecCCCC-cEEEccccc
Q 007055 91 TINMITELFTSGSLRQYR-KKHK-NVDMKAIKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGL 166 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i-~~~~-~l~e~~i~~i~~QIl~gL~yLH-s~~~~IiHrDLKp~NILl~~~~G-~vKI~DFGl 166 (620)
..+++++|..||+++..+ .... ..+......++.|+..+|.|+| ..+ +.|||+||+|.+++ .++ .+|++|||+
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~-~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLD-ESGSALKIADFGL 171 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhc-cCCCcccCCCchh
Confidence 678899999999999988 6555 6788889999999999999999 888 99999999999998 677 999999999
Q ss_pred hhhccC-CC----CccccC-CCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--C
Q 007055 167 AIVMQQ-PT----ARSVIG-TPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 236 (620)
Q Consensus 167 a~~~~~-~~----~~~~~G-Tp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p 236 (620)
|..+.. .. ....+| ++.|+|||.+.+ ...+..|+||.|+++.-|++|..|+.........+........ .
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT 251 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc
Confidence 976655 22 234578 999999998776 3678899999999999999999999654333333222222211 1
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
.......+....+++.++|. +|+.|.+.+++-.+||+..
T Consensus 252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 23344556788999999996 8999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=157.93 Aligned_cols=138 Identities=22% Similarity=0.264 Sum_probs=111.8
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEE
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~----~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV 95 (620)
+.||+|++|.||+|.+ .|..|++|.......... .....++.+|+.++..+.|++|+....++.+.. ..++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEE
Confidence 5799999999999987 788899997653322111 112346788999999999999877666655543 46789
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
|||++|++|.+++..... ....++.+++.+|.++|+++ ++|||++|.|||++ ++.++|+|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 999999999999876442 78899999999999999999 99999999999997 67899999998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.2e-18 Score=183.91 Aligned_cols=174 Identities=24% Similarity=0.477 Sum_probs=136.2
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 90 RTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~---~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
.++|+.|++|...+|.+++.+.. ..+...++.|++|+..|+.| ++ .+|||+||.||++. .+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhhhhhhhh
Confidence 36899999999999999997544 36777899999999999999 66 89999999999997 778999999999
Q ss_pred hhhccCCC--------CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 167 AIVMQQPT--------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 167 a~~~~~~~--------~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
........ ....+||+.||+||.+. ..|+.++||||||.+|+|+++ -..+|.. ......+..+..|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCC
Confidence 86443322 23458999999999887 569999999999999999998 4444422 2223445555555
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
+.+.. ..|+-..|+..+|. .|.+||++.+.-.|+|++
T Consensus 479 ~~~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 479 PEFLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hHHhh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 43332 23566789999997 899999888887777753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.8e-17 Score=175.82 Aligned_cols=195 Identities=27% Similarity=0.426 Sum_probs=152.0
Q ss_pred HHhCCCCCcceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCE-EecCCC
Q 007055 69 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI-IHRDLK 146 (620)
Q Consensus 69 L~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~I-iHrDLK 146 (620)
|+.+.|.|+.+|++..++. ...+.|.+||..|+|.+.+.. .-.++..-...++++|+.||.|||.-. | .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999999887 468889999999999999987 346888888999999999999999864 4 999999
Q ss_pred ccceEecCCCCcEEEccccchhhccC----CCCccccCCCCCCCccccccc--------cCccchhhhhHHHHHHHHhcC
Q 007055 147 CDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYEEE--------YNELVDIYSFGMCILEMVTCE 214 (620)
Q Consensus 147 p~NILl~~~~G~vKI~DFGla~~~~~----~~~~~~~GTp~y~APEll~~~--------y~~~~DIwSlGiilyELltG~ 214 (620)
..|.+++ ....+||.|||+...... .......-...|.|||+++.. -+.+.||||||++++|+++..
T Consensus 77 s~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 77 SSNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred cccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999998 788999999999865432 111111234469999988753 466799999999999999999
Q ss_pred CCCCCC---CCHHHHHHHHHc-CCC---CCCCCC-CCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 007055 215 YPYNEC---KNPAQIYKKVTS-GIK---PASLSK-VTDPQVKQFIEKCIV-PASLRLPALELL 268 (620)
Q Consensus 215 ~Pf~~~---~~~~~i~~~i~~-~~~---p~~~~~-~~~~~lk~~I~kcL~-~p~~Rpsa~elL 268 (620)
-||... ..+.++...+.. +.. |..... ...+++..++..||. +|..||++..+-
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 999753 223456666666 322 111111 234578999999998 899999988754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.2e-16 Score=153.53 Aligned_cols=134 Identities=22% Similarity=0.284 Sum_probs=105.0
Q ss_pred EEceeCCeEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEE
Q 007055 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 21 ~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~----~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
.||+|+||+||+|. .+|..|++|.......... .....++.+|++++..+.|+++....-++.... ..++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEE
Confidence 48999999999997 4678899998553322111 122466889999999999887554443334433 357899
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 97 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
||++|++|.+++..... .++.|++.+|.+||+.+ ++|||++|.||+++ ++.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999999998765331 88999999999999999 99999999999997 68999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-16 Score=155.54 Aligned_cols=144 Identities=22% Similarity=0.188 Sum_probs=110.5
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC------------------HHHHHHHHHHHHHHHhCCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS------------------PDQLERLYSEVHLLKSLKH 74 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~------------------~~~~~~l~~Ei~iL~~L~H 74 (620)
+..|.+.+.||+|+||.||+|.+. +|+.||+|.+........ .........|+.++..+.|
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 445778899999999999999875 899999998765321000 0011236789999999988
Q ss_pred CC--cceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEe
Q 007055 75 EN--IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 152 (620)
Q Consensus 75 pN--IVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 152 (620)
++ ++..++. ...++||||++|++|..+... .....++.+|+.++.++|+++ ++||||||+||++
T Consensus 93 ~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill 158 (198)
T cd05144 93 EGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILV 158 (198)
T ss_pred cCCCCCceeec------CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEE
Confidence 74 4444431 235789999999999765431 345688999999999999998 9999999999999
Q ss_pred cCCCCcEEEccccchhhccC
Q 007055 153 NGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 153 ~~~~G~vKI~DFGla~~~~~ 172 (620)
+ .++.++|+|||.+.....
T Consensus 159 ~-~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 D-DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred c-CCCcEEEEECCccccCCC
Confidence 8 689999999999854443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=172.41 Aligned_cols=137 Identities=20% Similarity=0.218 Sum_probs=107.9
Q ss_pred EEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccC----CHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~----~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
...+.||+|+||+||+|.+... .+++|+........ .....+++.+|+++++.++|++|+..+.++.+.. ..
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~ 411 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EK 411 (535)
T ss_pred CccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CC
Confidence 4578999999999999976543 44554432221111 1123466889999999999999988776665543 36
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
++||||++|++|.+++. ....++.|++.+|.|||+++ ++||||||+||+++ ++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCccccc
Confidence 78999999999999886 35689999999999999999 99999999999994 67999999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.8e-15 Score=144.30 Aligned_cols=141 Identities=22% Similarity=0.207 Sum_probs=99.7
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHH--------------------HHHHHHHHHHHhCCCC--C
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL--------------------ERLYSEVHLLKSLKHE--N 76 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~--------------------~~l~~Ei~iL~~L~Hp--N 76 (620)
.+.||+|+||+||+|.+. +|+.||+|+++........... .....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 8999999988753221100000 0113566667666544 3
Q ss_pred cceEEeEEEcCCCCeEEEEEeccCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecC
Q 007055 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNG 154 (620)
Q Consensus 77 IVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~-i~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~ 154 (620)
+.+.+... ..++||||++++.+... +.... .. ..+..++.+++.++.++|. ++ |+||||||+||+++
T Consensus 81 ~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEecC------CCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-
Confidence 45555421 25789999999543221 11111 11 6788999999999999999 88 99999999999997
Q ss_pred CCCcEEEccccchhhccC
Q 007055 155 NNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 155 ~~G~vKI~DFGla~~~~~ 172 (620)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 78999999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-14 Score=146.48 Aligned_cols=141 Identities=14% Similarity=0.179 Sum_probs=107.4
Q ss_pred EEEEc-eeCCeEEEEEEEccCCeEEEEEEeecccc----c-----CCHHHHHHHHHHHHHHHhCCCCCc--ceEEeEEEc
Q 007055 19 DEILG-KGAFKTVYKGFDEVDGIEVAWNQVNIEDV----M-----QSPDQLERLYSEVHLLKSLKHENI--IKFYNSWVD 86 (620)
Q Consensus 19 ~e~LG-~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~----~-----~~~~~~~~l~~Ei~iL~~L~HpNI--Vkl~~~f~~ 86 (620)
..+|| .||.|+||.+... +..+|+|.+..... . .......++.+|+.++..|+|++| ++.+.+...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45788 8999999999664 78899998864321 0 012334678899999999998875 666665433
Q ss_pred CCCC--eEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 87 DTNR--TINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 87 ~~~~--~l~lV~Ey~~g-GsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
.... ..++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||++| |+||||||.|||++ .++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~-~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLD-PDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEc-CCCCEEEEE
Confidence 3221 23589999997 689988865 3466543 578999999999999 99999999999998 678999999
Q ss_pred ccchhh
Q 007055 164 LGLAIV 169 (620)
Q Consensus 164 FGla~~ 169 (620)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.51 E-value=9e-14 Score=127.24 Aligned_cols=133 Identities=20% Similarity=0.115 Sum_probs=108.2
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCcceEEeEEEcCCCCeEEEE
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pNIVkl~~~f~~~~~~~l~lV 95 (620)
+.+.||+|.++.||++.+.. ..+++|.+..... ...+.+|+.+++.+.| +++++++.++... ...+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v 71 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLL 71 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEE
Confidence 35789999999999998754 6899998754321 3568889999999976 5888988865433 568899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~-~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
+||+.++.+..+ +......++.+++.+|.++|... .+++|+|++|+||+++ ..+.+++.|||.+.
T Consensus 72 ~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~ 137 (155)
T cd05120 72 MEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAG 137 (155)
T ss_pred EEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-CCcEEEEEeccccc
Confidence 999999888654 56677888999999999999852 2499999999999998 57899999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.3e-14 Score=154.09 Aligned_cols=251 Identities=24% Similarity=0.274 Sum_probs=191.5
Q ss_pred eEEEEEEEce--eCCeEEEEEEE--ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCC
Q 007055 15 FLQYDEILGK--GAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 89 (620)
Q Consensus 15 ~y~i~e~LG~--G~fg~Vy~a~d--~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~ 89 (620)
.+.+...+|. |.+|.||.+.+ ..++..+|+|.-+..- ..+....+=++|+...+.+ .|+|.++.+..|...
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~-- 190 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS-- 190 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCC--CCccccccccchhhcccccCccccccccCcccccC--
Confidence 3456688999 99999999999 8999999998733221 1122223344677777777 499999999988544
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCEEecCCCccceEecCCC-CcEEEcc
Q 007055 90 RTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILR----GLHYLHSHNPPIIHRDLKCDNIFVNGNN-GEVKIGD 163 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~-l~e~~i~~i~~QIl~----gL~yLHs~~~~IiHrDLKp~NILl~~~~-G~vKI~D 163 (620)
..+++-+|+|. .+|..+...... ++...++..+.+... ||.++|+.+ ++|-|+||+||+.. .+ ...+++|
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~-~~~~s~~~~d 266 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTT-SDWTSCKLTD 266 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecc-cccceeecCC
Confidence 46788889885 788888876555 899999999999999 999999999 99999999999997 55 7899999
Q ss_pred ccchhhccCCCCc-------cccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 164 LGLAIVMQQPTAR-------SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 164 FGla~~~~~~~~~-------~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
||+...+...... ...|...|++||+..+-++...|||++|.+.++..++..+...+.+.. +..+..+..|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~~r~~~ip 344 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQLRQGYIP 344 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC--ccccccccCc
Confidence 9998665543311 124677899999999999999999999999999999887776542211 1112223344
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
..+-...+..+...+..++. ++..|+++..++.|+++..
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 44444445566667777787 7899999999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.1e-14 Score=161.21 Aligned_cols=262 Identities=18% Similarity=0.308 Sum_probs=201.0
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
-..+.+.+-+-.|+++.++.+.-..+|-..++|......... ....+.+..+-.++-...||-++..+-.|... ...
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~-~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r--sP~ 879 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR-TNDYESIRSKSNILITPRSPAVVRSFPSFPCR--SPL 879 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhc-cccccccCCccCccccCCCCceecccCCCCCC--CCc
Confidence 334456667788999999999877777666665544332211 11233445555555556778888776655443 358
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc--
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-- 170 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~-- 170 (620)
+++++|..+|+|...+..-+..++...+.++..+..+++|||+.. +.|||++|+|++.. .+|..++.|||.....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCcccccccccc
Confidence 889999999999999998888999999999999999999999987 89999999999997 8999999999842100
Q ss_pred -----cC--------------------------CCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCC
Q 007055 171 -----QQ--------------------------PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 218 (620)
Q Consensus 171 -----~~--------------------------~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~ 218 (620)
.. .......||+.|.|||... ......+|+|++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 00 0012357899999999765 458889999999999999999999997
Q ss_pred CCCCHHHHHHHHHcCCCCCC-CCCCCcHHHHHHHHHhcC-CCCCCCCHH---HHhcCCCcCCCCCCcc
Q 007055 219 ECKNPAQIYKKVTSGIKPAS-LSKVTDPQVKQFIEKCIV-PASLRLPAL---ELLKDPFLVTDNPKDL 281 (620)
Q Consensus 219 ~~~~~~~i~~~i~~~~~p~~-~~~~~~~~lk~~I~kcL~-~p~~Rpsa~---elL~hpff~~~~~~~~ 281 (620)
. ..+.+++..+..+..|.. .+...++++++++...|. .|.+|..+. ++-.||||+...|..+
T Consensus 1037 a-~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1037 A-ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred C-cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence 6 677788877776655433 344568899999999998 899999987 8999999999887664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.9e-11 Score=132.21 Aligned_cols=167 Identities=26% Similarity=0.335 Sum_probs=128.1
Q ss_pred EEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhC
Q 007055 32 KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 111 (620)
Q Consensus 32 ~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~ 111 (620)
.|..+.+|.+|.+...+... ....+.+.+-++.|+.|+||||++|++.+..+ ..+|+|||-+. -|..++++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~--~~~ylvTErV~--Pl~~~lk~l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEE--GTLYLVTERVR--PLETVLKEL 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhccc--CceEEEeeccc--cHHHHHHHh
Confidence 57778899999998877543 24556678889999999999999999988554 47999999986 577788764
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC--CccccCCCCCCCcc
Q 007055 112 KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE 188 (620)
Q Consensus 112 ~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~--~~~~~GTp~y~APE 188 (620)
+ ...+..-+.||+.||.|||. ++ ++|++|.-+.|||+ ..|..||++|.+........ .+...---.|..|+
T Consensus 102 ~---~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 G---KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred H---HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 4 66777789999999999984 55 99999999999999 89999999998875433322 12222222345554
Q ss_pred ccccccCccchhhhhHHHHHHHHhc
Q 007055 189 LYEEEYNELVDIYSFGMCILEMVTC 213 (620)
Q Consensus 189 ll~~~y~~~~DIwSlGiilyELltG 213 (620)
..... +...|.|-|||++++++.|
T Consensus 176 ~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCcc-ccchhhhhHHHHHHHHhCc
Confidence 33211 1457999999999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.22 E-value=5e-11 Score=131.62 Aligned_cols=143 Identities=22% Similarity=0.196 Sum_probs=94.7
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH--------------------------H----HHH------HHH
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--------------------------D----QLE------RLY 63 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~--------------------------~----~~~------~l~ 63 (620)
+.||.|++|.||+|.. .+|+.||||+.+..-...-. . ... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 47999999987532100000 0 000 134
Q ss_pred HHHHHHHhC----CCCCcceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 007055 64 SEVHLLKSL----KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILR-GLHYLHSHN 137 (620)
Q Consensus 64 ~Ei~iL~~L----~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~-gL~yLHs~~ 137 (620)
+|.+.+..+ +|.+-+.+-..+.+-. ..-++||||++|++|.++.... ...+ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 455555555 2333333333332222 2357899999999998876532 1222 3445556655 467889998
Q ss_pred CCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 138 ~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
++|+|++|.||+++ .+|.++++|||++..+
T Consensus 278 --~~H~D~hPgNilv~-~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 --FFHADLHPGNIFVL-KDGKIIALDFGIVGRL 307 (437)
T ss_pred --ceeCCCCcccEEEC-CCCcEEEEeCCCeeEC
Confidence 99999999999997 7899999999998543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.6e-11 Score=135.00 Aligned_cols=140 Identities=14% Similarity=0.152 Sum_probs=93.0
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeeccccc--------------------------CCH----HHHHHHHH-----
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--------------------------QSP----DQLERLYS----- 64 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~--------------------------~~~----~~~~~l~~----- 64 (620)
+.||.|++|.||+|..+.+|+.||||+++..-.. ... +..+.+.+
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 6899999999999999888999999998632100 000 11222333
Q ss_pred -HHHHHHhC----CCCCcceEEeEEEcCCCCeEEEEEeccCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHH
Q 007055 65 -EVHLLKSL----KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHK----NVDMKAIKNWARQILRGLHYL 133 (620)
Q Consensus 65 -Ei~iL~~L----~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~--i~~~~----~l~e~~i~~i~~QIl~gL~yL 133 (620)
|...+.++ .+.+.+.+-.++.+-. ..-++||||+.|+.+.++ +...+ .+.+..+..+++||+
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------ 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------ 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence 44444433 2334444333332221 235689999999999874 33333 255555666677765
Q ss_pred HhCCCCEEecCCCccceEecCCCC----cEEEccccchhhc
Q 007055 134 HSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVM 170 (620)
Q Consensus 134 Hs~~~~IiHrDLKp~NILl~~~~G----~vKI~DFGla~~~ 170 (620)
..| ++|+|+||.||+++ .+| .++++|||+...+
T Consensus 278 -~~G--ffHaDpHPGNIlv~-~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 -RDG--FFHADMHPGNIFVS-YDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -hCC--eeeCCCChHHeEEe-cCCCCCCeEEEEecceEEEC
Confidence 367 99999999999998 566 9999999997544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-10 Score=113.77 Aligned_cols=144 Identities=15% Similarity=0.148 Sum_probs=103.8
Q ss_pred EEEEceeCCeEEEEEEEcc------CCeEEEEEEeecccc--cC-------C---------HHHHHHHH----HHHHHHH
Q 007055 19 DEILGKGAFKTVYKGFDEV------DGIEVAWNQVNIEDV--MQ-------S---------PDQLERLY----SEVHLLK 70 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~------tg~~VAiK~v~~~~~--~~-------~---------~~~~~~l~----~Ei~iL~ 70 (620)
...||.|--+.||.|.... .+..+|+|+.+.... .. . ......+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998654 358999998764310 00 0 11223333 8999999
Q ss_pred hCCC--CCcceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEecCCCc
Q 007055 71 SLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKC 147 (620)
Q Consensus 71 ~L~H--pNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp 147 (620)
+|.. -++.+.+.+ . .-++||||+.++.+..-.-+...++++.+..+..|++.+|.++ |..| ++|+||++
T Consensus 82 rl~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 9953 566777763 1 2457999997754433222333466677888899999999998 8888 99999999
Q ss_pred cceEecCCCCcEEEccccchhhccC
Q 007055 148 DNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 148 ~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
.||++. +|.+.|+|||.+.....
T Consensus 154 ~NIL~~--~~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWH--DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEE--CCcEEEEECCCceeCCC
Confidence 999996 57899999998855443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.9e-11 Score=112.22 Aligned_cols=129 Identities=20% Similarity=0.069 Sum_probs=94.3
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcc-eEEeEEEcCCCCeEEEEEe
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-KFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIV-kl~~~f~~~~~~~l~lV~E 97 (620)
.+.|+.|.++.||++... |..|++|....... ....+.+|+.+++.+.+.+++ +++.. +... -++|||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~--~~lv~e 71 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYF--DPET--GVLITE 71 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEE--eCCC--CeEEEE
Confidence 367889999999999764 88899998643211 112356799999988665554 45543 2322 368999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CEEecCCCccceEecCCCCcEEEccccchh
Q 007055 98 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP---PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 98 y~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~---~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
|++|.++... ......++.+++.+|..||..+. .++|+|++|.||+++ ++.++++|||.+.
T Consensus 72 ~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~ 135 (170)
T cd05151 72 FIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG 135 (170)
T ss_pred ecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence 9999888643 11124567899999999999872 259999999999997 5689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.9e-11 Score=132.29 Aligned_cols=245 Identities=20% Similarity=0.175 Sum_probs=172.7
Q ss_pred EEEEEEEceeCCeEEEEEEEc-cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~-~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.....||.|.|+.|+...-. .++..+++|.+...- .. ......-..|+.+...+ -|.+++.++..|....+ .|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~-~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--~~ 342 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-AT-FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--GY 342 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccc-cc-hHhhhcchhhhhHhhHhhcccccCCCCCCcccccc--cc
Confidence 457789999999999987644 688899999875432 22 22223345677777777 59999999999976554 44
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCC-CcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN-GEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~-G~vKI~DFGla~~~~~ 172 (620)
+-.|||.++++...+.--..+++...++...|++.++.++|+.. ++|+|+||+||++. ++ +.-+++|||.+..+..
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~-~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILIS-NDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeec-cchhhhhccccccccccce
Confidence 77799999998887765667899999999999999999999998 99999999999997 44 7789999999864222
Q ss_pred CCCccccCCCCCC-Ccccc-c-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 173 PTARSVIGTPEFM-APELY-E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 173 ~~~~~~~GTp~y~-APEll-~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
... ...++-.++ .+|++ + ..+..++|++|||.-+.+.+++...-..... ...+..+..|. .+.. ..++..
T Consensus 420 ~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~~~~p~-~~~~-~~~~q~ 492 (524)
T KOG0601|consen 420 SSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRSGDTPN-LPGL-KLQLQV 492 (524)
T ss_pred ecc-cccccccccccchhhccccccccccccccccccccccccCcccCccccc----ceeeecccccC-CCch-HHhhhh
Confidence 211 122233444 24544 4 3478899999999999999998743222111 12233332222 1222 256666
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
+.+.++. ++..||.+.++..|.=|.
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhcCCccccchhhhhhcccchhh
Confidence 6666665 778888898888876553
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.06 E-value=4e-09 Score=114.64 Aligned_cols=214 Identities=18% Similarity=0.252 Sum_probs=153.0
Q ss_pred CCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC--CCeEEEEEeccCC-C
Q 007055 26 AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--NRTINMITELFTS-G 102 (620)
Q Consensus 26 ~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~--~~~l~lV~Ey~~g-G 102 (620)
--.+.|+|+...+|..|++|+++..+.... ...-.-+++++++.|+|||+|.++|.... ...+++|++|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 345789999999999999999954433221 12345688999999999999999887332 2468999999986 6
Q ss_pred CHHHHHH---------------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 103 SLRQYRK---------------KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 103 sL~~~i~---------------~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
+|.++-- ...+.+|..+|.++.|+..||.++|+.| +.-+-|.|.+|+++|+ -+++|...|+.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~-~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGK-MRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCc-ceEEEecccce
Confidence 7777531 2345789999999999999999999999 8889999999999854 48899888876
Q ss_pred hhccCCCCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCcHH
Q 007055 168 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 168 ~~~~~~~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i-~~~i~~~~~p~~~~~~~~~~ 246 (620)
........ |.+. --..-|.=.||.+++.|+||..--.......+. ...|. ..++.+
T Consensus 441 Dvl~~d~~------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~---------~~yS~D 497 (655)
T KOG3741|consen 441 DVLQEDPT------------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT---------TTYSTD 497 (655)
T ss_pred eeecCCCC------------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh---------hhhhHH
Confidence 54443320 1111 123468888999999999996432221222222 22232 346778
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
++++|.-... .+.+ .++.+++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 8999888766 4444 788888865
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.7e-09 Score=104.33 Aligned_cols=144 Identities=19% Similarity=0.200 Sum_probs=105.4
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCcceEEeEEEcCC-CCeEEEEE
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDT-NRTINMIT 96 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pNIVkl~~~f~~~~-~~~l~lV~ 96 (620)
+.||.|.++.||++... +|..+++|........ .....+.+|+.+++.+.+ .++.+++.+..... ....++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 67899999999999764 3688999987543221 123457889999999975 34566766543221 12567999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 007055 97 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN--------------------------------------- 137 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~--------------------------------------- 137 (620)
||++|+++.+.+.. ..+++.....++.+++.+|.+||+..
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988775432 45777888888888888888888531
Q ss_pred ---------------CCEEecCCCccceEecCC-CCcEEEccccchh
Q 007055 138 ---------------PPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAI 168 (620)
Q Consensus 138 ---------------~~IiHrDLKp~NILl~~~-~G~vKI~DFGla~ 168 (620)
..++|+|+.|+||+++.+ ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 237999999999999842 5678999998774
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.4e-08 Score=97.91 Aligned_cols=147 Identities=20% Similarity=0.247 Sum_probs=107.2
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccC----CHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~----~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
....|-||+-+.|+++.+ .|+.+.||.=-.+.+.. .+-...+..+|.++|.++.--.|.----+|+|.....+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i- 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI- 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE-
Confidence 467889999999999965 58888888533332221 11234678899999999975555444444566666565
Q ss_pred EEEeccCC-CCHHHHHHhCC-C-CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcE--EEccccchh
Q 007055 94 MITELFTS-GSLRQYRKKHK-N-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV--KIGDLGLAI 168 (620)
Q Consensus 94 lV~Ey~~g-GsL~~~i~~~~-~-l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~v--KI~DFGla~ 168 (620)
+|||++| -++.+++.... . ........++++|=..+.-||..+ +||+||..+||++..+++.+ .++|||++.
T Consensus 88 -~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 88 -YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred -EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchh
Confidence 5699976 47888887643 2 223333788999999999999999 99999999999997555554 899999985
Q ss_pred hc
Q 007055 169 VM 170 (620)
Q Consensus 169 ~~ 170 (620)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 43
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.8e-08 Score=97.37 Aligned_cols=134 Identities=22% Similarity=0.284 Sum_probs=95.8
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHH-----HHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD-----QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~-----~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
..+++|+-+.+|.+.. -|..+++|. ...+.-..++ ..++..+|.+++..++--.|..-+-++++... -.+
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~--~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN--GLI 76 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CEE
Confidence 3578999999999954 455666664 3333222332 23556789999999865444333333355554 346
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
+|||.+|-.|++++... . ..+++.+=.-+.-||..| |+|+||.++||++. ++.+.++|||++..
T Consensus 77 ~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~--~~~i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILS--GGRIYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcC--eecCCCccceEEEe--CCcEEEEECCcccc
Confidence 88999999999998876 1 455666666677899999 99999999999997 34699999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.2e-09 Score=121.15 Aligned_cols=241 Identities=19% Similarity=0.244 Sum_probs=166.9
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-cceEEeEEEcCCCCe
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDTNRT 91 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN-IVkl~~~f~~~~~~~ 91 (620)
.+|+.+-.-+++|+++.+++++...+...+ .++|... ....-++++|.+++||| .+..++.+ +.+.+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~ 308 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDY 308 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--Ccccc
Confidence 345566667789999999999988877766 6666432 33567999999999999 55555543 44568
Q ss_pred EEEEEeccCCC-CHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 92 INMITELFTSG-SLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 92 l~lV~Ey~~gG-sL~~-~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
.+++++++.+| +-.. .-...-.+..-+.....+.-+.+|+|+|+-. -+||| ||+.. ++.+|.+||+.+..
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLLDFAVPPQ 380 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccc--ccccccccccCCcc
Confidence 89999999887 2221 1111123444556677777888999999875 58998 77774 57999999999866
Q ss_pred ccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCC-CCCcH
Q 007055 170 MQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-KPASLS-KVTDP 245 (620)
Q Consensus 170 ~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~-~p~~~~-~~~~~ 245 (620)
+... ..++..+|+.++|||+.. +.+....|.|++|.-..+|.-|..|-.. |......+..+. .+.... ..+++
T Consensus 381 L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~~g~~p~s~~L~~~~aw~~ 457 (829)
T KOG0576|consen 381 LTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPMIGNGPNSPMLTDKSAWSP 457 (829)
T ss_pred cCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC---CccccCCCCCCCCccccchhhhcCc
Confidence 5543 467788999999999654 5699999999999988899888877643 111111111111 000000 11122
Q ss_pred HH-HHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 246 QV-KQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 246 ~l-k~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.. +++...|+. .|..|+....++.|.+|..-
T Consensus 458 ~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 458 VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred ccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 22 247788887 78999999999999998653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.8e-07 Score=91.81 Aligned_cols=130 Identities=27% Similarity=0.287 Sum_probs=83.1
Q ss_pred EEEEEEEccCCeEEEEEEeecccc---------------c-------CCHHHHHHHHHHHHHHHhCCCC--CcceEEeEE
Q 007055 29 TVYKGFDEVDGIEVAWNQVNIEDV---------------M-------QSPDQLERLYSEVHLLKSLKHE--NIIKFYNSW 84 (620)
Q Consensus 29 ~Vy~a~d~~tg~~VAiK~v~~~~~---------------~-------~~~~~~~~l~~Ei~iL~~L~Hp--NIVkl~~~f 84 (620)
.||.|.. ..|..||+|+.+.... . ..........+|.+.|..+..- ++.+.+.+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899976 5788999998764310 0 0001234577899999999765 56777753
Q ss_pred EcCCCCeEEEEEeccC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCEEecCCCccceEecCCCCcEEE
Q 007055 85 VDDTNRTINMITELFT--SGSLRQYRKKHKNVDMKAIKNWARQILRGLHY-LHSHNPPIIHRDLKCDNIFVNGNNGEVKI 161 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~--gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~y-LHs~~~~IiHrDLKp~NILl~~~~G~vKI 161 (620)
.. -++||||+. |..+..+.... ++......++.+++..+.. +|..| ++|+||.+.||+++ .+.+.|
T Consensus 79 -~~----~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~--~~~~~i 147 (188)
T PF01163_consen 79 -NR----NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVD--DGKVYI 147 (188)
T ss_dssp -ET----TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEE--TTCEEE
T ss_pred -eC----CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEee--cceEEE
Confidence 22 247999998 65565544322 1245567778888885555 57888 99999999999997 348999
Q ss_pred ccccchhhcc
Q 007055 162 GDLGLAIVMQ 171 (620)
Q Consensus 162 ~DFGla~~~~ 171 (620)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999885444
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=9.1e-07 Score=91.69 Aligned_cols=137 Identities=15% Similarity=0.091 Sum_probs=93.2
Q ss_pred eEEEEEEEccCCeEEEEEEeeccccc---CC----HHHHHHHHHHHHHHHhCCCCCc--ceEEeEEEcCC---CCeEEEE
Q 007055 28 KTVYKGFDEVDGIEVAWNQVNIEDVM---QS----PDQLERLYSEVHLLKSLKHENI--IKFYNSWVDDT---NRTINMI 95 (620)
Q Consensus 28 g~Vy~a~d~~tg~~VAiK~v~~~~~~---~~----~~~~~~l~~Ei~iL~~L~HpNI--Vkl~~~f~~~~---~~~l~lV 95 (620)
..|++. ...|+.|.+|........ .+ ..-...+.+|...+..|..-+| +....+..... ...-++|
T Consensus 36 rrvvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 335554 346778999966422210 00 0001136789988888843333 33333332211 2346789
Q ss_pred EeccCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC------CCCcEEEccccc
Q 007055 96 TELFTSG-SLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------NNGEVKIGDLGL 166 (620)
Q Consensus 96 ~Ey~~gG-sL~~~i~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~------~~G~vKI~DFGl 166 (620)
||++++- +|.+++.. ....+......++++++..+.-||.+| |+|+||++.|||++. .++.+.++||+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 9999876 89999864 244667778899999999999999999 999999999999973 246899999998
Q ss_pred hh
Q 007055 167 AI 168 (620)
Q Consensus 167 a~ 168 (620)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 74
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=8.6e-07 Score=94.72 Aligned_cols=245 Identities=16% Similarity=0.246 Sum_probs=155.6
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh-CCCCCcceEEeEEE-
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWV- 85 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpNIVkl~~~f~- 85 (620)
.+...|.-+..++-||+|+-+.+|-.-.- +.-| -|+...... .... +.+..|.. -.||-+-. --.|-
T Consensus 5 ~~~~~ge~i~~gr~LgqGgea~ly~l~e~--~d~V-AKIYh~Ppp----a~~a---qk~a~la~~p~~p~~~~-rvaWPq 73 (637)
T COG4248 5 LYDVYGEPIPPGRPLGQGGEADLYTLGEV--RDQV-AKIYHAPPP----AAQA---QKVAELAATPDAPLLNY-RVAWPQ 73 (637)
T ss_pred cccccCcccCCCccccCCccceeeecchh--hchh-heeecCCCc----hHHH---HHHHHhccCCCCcchhh-hhcccH
Confidence 34455555667788999999999975322 2223 365553321 1111 12233333 35664432 11121
Q ss_pred -----cCCCCeEEEEEeccCCCC-HHHH------HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec
Q 007055 86 -----DDTNRTINMITELFTSGS-LRQY------RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 153 (620)
Q Consensus 86 -----~~~~~~l~lV~Ey~~gGs-L~~~------i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 153 (620)
......+-++|..++|.. ...+ ++..+...+.-+.+.++.|+.+.+.||.+| .+-+|+.++|+|+.
T Consensus 74 a~L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs 151 (637)
T COG4248 74 ATLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS 151 (637)
T ss_pred HHhhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee
Confidence 122334778888887742 2222 223455788999999999999999999999 89999999999997
Q ss_pred CCCCcEEEccccchhh-ccCCCCccccCCCCCCCccccc-c-----ccCccchhhhhHHHHHHHHhc-CCCCCCCCC---
Q 007055 154 GNNGEVKIGDLGLAIV-MQQPTARSVIGTPEFMAPELYE-E-----EYNELVDIYSFGMCILEMVTC-EYPYNECKN--- 222 (620)
Q Consensus 154 ~~~G~vKI~DFGla~~-~~~~~~~~~~GTp~y~APEll~-~-----~y~~~~DIwSlGiilyELltG-~~Pf~~~~~--- 222 (620)
+++.|.|.|-..-.. .+.....-.+|.++|.+||+-. + +.+...|-|.||+++++++.| +.||++...
T Consensus 152 -d~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ 230 (637)
T COG4248 152 -DDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD 230 (637)
T ss_pred -cCceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC
Confidence 789999988553322 2222233458999999999643 1 356789999999999999987 999976311
Q ss_pred -HHHHHHHHHc-----------CCCCC--CC-CCCCcHHHHHHHHHhcCC---CCCCCCHHH
Q 007055 223 -PAQIYKKVTS-----------GIKPA--SL-SKVTDPQVKQFIEKCIVP---ASLRLPALE 266 (620)
Q Consensus 223 -~~~i~~~i~~-----------~~~p~--~~-~~~~~~~lk~~I~kcL~~---p~~Rpsa~e 266 (620)
+.-.-..|.. +.+|. .+ ....++.+..+...|..+ +.-||+++.
T Consensus 231 ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 231 APNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred CCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 1111112222 22221 11 133578999999999973 568999754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.2e-08 Score=108.86 Aligned_cols=149 Identities=19% Similarity=0.307 Sum_probs=106.4
Q ss_pred HHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCCc-----------cccCCCCCCCcccccc-c
Q 007055 126 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----------SVIGTPEFMAPELYEE-E 193 (620)
Q Consensus 126 Il~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~-----------~~~GTp~y~APEll~~-~ 193 (620)
++.||.|+|.+ +.+||++|.|++|.++ .+|..||+.|+++.....+... ...-...|.|||++.. .
T Consensus 108 v~dgl~flh~s-Ak~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRS-AKVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred ccchhhhhccC-cceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 34999999987 3599999999999999 7899999999987543331110 1123557999997764 4
Q ss_pred cCccchhhhhHHHHHHHH-hcCCCCCCCCCHHHHHHHH--HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 194 YNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIYKKV--TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 194 y~~~~DIwSlGiilyELl-tG~~Pf~~~~~~~~i~~~i--~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+.++|++|||+++|-+. .|..-+.. .+....+... ..+..........+.++++=+.++|. ++..||++.+++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhc-cCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 778999999999999988 45544433 2222222111 11112223445678899999999997 8999999999999
Q ss_pred CCCcCCCC
Q 007055 270 DPFLVTDN 277 (620)
Q Consensus 270 hpff~~~~ 277 (620)
.|||....
T Consensus 265 ~~ff~D~~ 272 (700)
T KOG2137|consen 265 IPFFSDPG 272 (700)
T ss_pred ccccCCch
Confidence 99997643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=2e-06 Score=85.61 Aligned_cols=108 Identities=21% Similarity=0.215 Sum_probs=83.6
Q ss_pred HHHHHHHHHHHHhCCCCC--cceEEeEEEcCC--CCeEEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 007055 59 LERLYSEVHLLKSLKHEN--IIKFYNSWVDDT--NRTINMITELFTSG-SLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133 (620)
Q Consensus 59 ~~~l~~Ei~iL~~L~HpN--IVkl~~~f~~~~--~~~l~lV~Ey~~gG-sL~~~i~~~~~l~e~~i~~i~~QIl~gL~yL 133 (620)
..+..+|...+..|..-. +++.+.+..... ....++|||++++. +|.+++......+......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 356788998888885333 333444333221 13458899999874 7999998866678888899999999999999
Q ss_pred HhCCCCEEecCCCccceEecCCCC---cEEEccccchhh
Q 007055 134 HSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDLGLAIV 169 (620)
Q Consensus 134 Hs~~~~IiHrDLKp~NILl~~~~G---~vKI~DFGla~~ 169 (620)
|.+| |+|+|+++.|||++ .++ .+.++||+-+..
T Consensus 135 H~~g--i~H~Dl~~~NILv~-~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVD-PDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEe-CCCCceeEEEEcchhcee
Confidence 9999 99999999999998 444 789999997753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.6e-06 Score=102.33 Aligned_cols=205 Identities=22% Similarity=0.355 Sum_probs=145.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC--eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 007055 57 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134 (620)
Q Consensus 57 ~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~--~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLH 134 (620)
.++....-|+..+....|+|++.++.+-...... .+.+..++|+.-++...+..-+.++..+.+.|..+++.||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 3444455677788888999999999876554322 23445689999999999999999999999999999999999999
Q ss_pred hCCCCEEecCCCcc---ceEecCCCCcEEEc--cccchhhccCC-CCccccCCCCCCCccccccc---cCccchhhhhHH
Q 007055 135 SHNPPIIHRDLKCD---NIFVNGNNGEVKIG--DLGLAIVMQQP-TARSVIGTPEFMAPELYEEE---YNELVDIYSFGM 205 (620)
Q Consensus 135 s~~~~IiHrDLKp~---NILl~~~~G~vKI~--DFGla~~~~~~-~~~~~~GTp~y~APEll~~~---y~~~~DIwSlGi 205 (620)
+.. ..|.-|... +.-.+ ..+.+.++ ||+....+... ......-+..+.|||.+... .....|+|.+|.
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred Hhc--cceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 986 556555444 33333 34566666 88877554433 23334456678888877644 334479999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 206 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 206 ilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~-~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
....+..|..+-..... +..+ +........++..+|+. ++++|+++.++|.|||.....
T Consensus 381 l~~~~~~~~~i~~~~~~-------------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV-------------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred HHhhhhhcCcccccccc-------------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 99999988755422111 1111 11122267888999997 899999999999999997644
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.9e-06 Score=88.15 Aligned_cols=139 Identities=22% Similarity=0.217 Sum_probs=98.8
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccc-----ccCC-------------HHHHHHHHHHHHHHHhCCCC-
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIED-----VMQS-------------PDQLERLYSEVHLLKSLKHE- 75 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~-----~~~~-------------~~~~~~l~~Ei~iL~~L~Hp- 75 (620)
...++..||-|--+.||.|.+. .|.++|+|.=+... .... .-......+|.++|..|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 4567899999999999999876 78999999643221 1000 01234467899999999655
Q ss_pred -CcceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC
Q 007055 76 -NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 154 (620)
Q Consensus 76 -NIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 154 (620)
.+.+-++. ..-.+||||..|-.|....- +.+....++..|+.-+.-+-..| +||+|+.+=||+++
T Consensus 171 ~~VP~P~~~------nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~- 236 (304)
T COG0478 171 VKVPKPIAW------NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVT- 236 (304)
T ss_pred CCCCCcccc------ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEe-
Confidence 77777762 23457999999977765432 23444455555555555444667 99999999999998
Q ss_pred CCCcEEEccccchh
Q 007055 155 NNGEVKIGDLGLAI 168 (620)
Q Consensus 155 ~~G~vKI~DFGla~ 168 (620)
.+|.+.++||--+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 78999999997653
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=98.29 E-value=1e-06 Score=62.49 Aligned_cols=32 Identities=38% Similarity=0.523 Sum_probs=27.3
Q ss_pred eEEEEEecCCCC------CceeeeeecccCCCCHHHHH
Q 007055 355 VSLTLRIGDKSG------HVSNIHFVFYLNADTAISIA 386 (620)
Q Consensus 355 i~l~lri~d~~~------~~~~i~f~f~~~~Dta~~va 386 (620)
|.|+||++|+.+ +.++|+|+|++++|+|++||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 679999999998 89999999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.3e-05 Score=77.02 Aligned_cols=140 Identities=15% Similarity=0.154 Sum_probs=97.9
Q ss_pred ceeCCeEEEEEEEccCCeEEEEEEeec--ccccCCHHHHHHHHHHHHHHHhCCCCC--cceEE--eEEEcCCCCeEEEEE
Q 007055 23 GKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFY--NSWVDDTNRTINMIT 96 (620)
Q Consensus 23 G~G~fg~Vy~a~d~~tg~~VAiK~v~~--~~~~~~~~~~~~l~~Ei~iL~~L~HpN--IVkl~--~~f~~~~~~~l~lV~ 96 (620)
|+||.+.|++... .|..+-+|+-.. ......+.....+.+|+..|..|..-+ +.+.. +.--....-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 4588888998643 344677776431 111111345577999999999985322 33332 211122233567899
Q ss_pred eccCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc--EEEccccch
Q 007055 97 ELFTS-GSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLA 167 (620)
Q Consensus 97 Ey~~g-GsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~--vKI~DFGla 167 (620)
|-+.| -+|.+++... .+.+......++.+|...+.-||..| +.|+|+-+.|||++ .+|. |+++||--+
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~-~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVK-TEGKAEAGFLDLEKS 177 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeec-CCCCeeEEEEEhhcc
Confidence 97754 5898888663 34677888899999999999999999 99999999999997 4556 999999765
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.11 E-value=9.4e-05 Score=73.03 Aligned_cols=141 Identities=21% Similarity=0.241 Sum_probs=81.7
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CcceEEeEEEc-CCCCeEEEE
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNSWVD-DTNRTINMI 95 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--NIVkl~~~f~~-~~~~~l~lV 95 (620)
.+.|+.|..+.||+..... ..+++|.... ......+.+|..+++.|... .+.+++..... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESS------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCC------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 4678999999999997655 4888887542 23456688899998888533 35566653322 223457899
Q ss_pred EeccCCCCHHH----------------HHH---hC----CCCCHH---------HHHHH------------HHHHHH-HH
Q 007055 96 TELFTSGSLRQ----------------YRK---KH----KNVDMK---------AIKNW------------ARQILR-GL 130 (620)
Q Consensus 96 ~Ey~~gGsL~~----------------~i~---~~----~~l~e~---------~i~~i------------~~QIl~-gL 130 (620)
|++++|..+.. .+. .. ..+... ....+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999988877 111 11 011100 00000 111222 23
Q ss_pred HHHHh-----CCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 131 HYLHS-----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 131 ~yLHs-----~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
..++. ....++|+|+.|.||+++..+|.+-|+||+.+
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 33332 22349999999999999855677789999876
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.97 E-value=6.1e-05 Score=76.16 Aligned_cols=135 Identities=13% Similarity=0.137 Sum_probs=78.4
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--cceEEeEEEcCCCCeEEEEEe
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN--IVkl~~~f~~~~~~~l~lV~E 97 (620)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-. +.+.+.+. +......+|||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeee
Confidence 57899999999984 25567788764211 1234688999999886443 35566543 23345678999
Q ss_pred ccCCCC-HHHH--------------HHh-----C----CCCCHHHH-HHHHHH----------HHHH-HHHHH--hCCCC
Q 007055 98 LFTSGS-LRQY--------------RKK-----H----KNVDMKAI-KNWARQ----------ILRG-LHYLH--SHNPP 139 (620)
Q Consensus 98 y~~gGs-L~~~--------------i~~-----~----~~l~e~~i-~~i~~Q----------Il~g-L~yLH--s~~~~ 139 (620)
+++|.+ +... +.+ | ...+.... ..+-.+ +... ..+|. ...+.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 999863 2111 100 1 11111111 111111 1111 11222 22334
Q ss_pred EEecCCCccceEecCCCCcEEEccccchh
Q 007055 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 140 IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
++|+|+.|.||+++ .+| +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~-~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITS-GKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEc-CCC-cEEEechhcC
Confidence 79999999999998 566 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=6.8e-05 Score=84.31 Aligned_cols=143 Identities=15% Similarity=0.161 Sum_probs=86.9
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccC-------------------------C-H----HHHHH------HH
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-------------------------S-P----DQLER------LY 63 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~-------------------------~-~----~~~~~------l~ 63 (620)
+-|+.++-|.||+|.-+. |++||||+....-... . . +-.+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 568899999999998754 9999999764321000 0 0 00111 33
Q ss_pred HHHHHHHhC-----CCCCcceEEeEEEcCCCCeEEEEEeccCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 007055 64 SEVHLLKSL-----KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSH 136 (620)
Q Consensus 64 ~Ei~iL~~L-----~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~--i~~~~~l~e~~i~~i~~QIl~gL~yLHs~ 136 (620)
+|...+.++ +.|+| ++-..|.+-+. .-+++|||+.|-.+.++ ++. ..++.+.+.....++.. ..+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~-~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTT-RRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccC-CcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHhc
Confidence 455555554 23333 22222222122 24589999999888887 444 44664444333222211 112224
Q ss_pred CCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 137 ~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
| +.|.|..|.||+++ .+|.+.+.|||+...+.
T Consensus 285 g--ffHaDpHpGNi~v~-~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 G--FFHADPHPGNILVR-SDGRIVLLDFGIVGRLD 316 (517)
T ss_pred C--ccccCCCccceEEe-cCCcEEEEcCcceecCC
Confidence 6 99999999999998 78999999999875443
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00023 Score=72.11 Aligned_cols=75 Identities=15% Similarity=0.051 Sum_probs=48.7
Q ss_pred EceeCC-eEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeEEEEEecc
Q 007055 22 LGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELF 99 (620)
Q Consensus 22 LG~G~f-g~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l~lV~Ey~ 99 (620)
|-.|.. ..||+.... +..+.+|...... ...+.+|+++++.+. +-.+.+++.+.... ..-++|||++
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i 74 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAV 74 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEee
Confidence 344554 789998543 4677777654221 234667999888883 44566777755433 3567899999
Q ss_pred CCCCHHHH
Q 007055 100 TSGSLRQY 107 (620)
Q Consensus 100 ~gGsL~~~ 107 (620)
+|.+|...
T Consensus 75 ~G~~l~~~ 82 (244)
T cd05150 75 PGVPAAAL 82 (244)
T ss_pred CCccHhHh
Confidence 99777643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00044 Score=82.71 Aligned_cols=148 Identities=20% Similarity=0.288 Sum_probs=90.4
Q ss_pred EEEEceeCCeEEEEEEEccCC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCc--ceEEeEEEcCC-CCeE
Q 007055 19 DEILGKGAFKTVYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENI--IKFYNSWVDDT-NRTI 92 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg--~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNI--Vkl~~~f~~~~-~~~l 92 (620)
.+.|+.|.+..+|+......+ ..+++|+........ ....+.+|+++|+.|. |++| .+++.++.+.. ....
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~---~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ---SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc---cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 577899999999998654432 467777654322211 2245779999999995 6665 66776554321 1357
Q ss_pred EEEEeccCCCCHHH--------------------HHHh-CC------------C---CCHHHHHHHHHHH----------
Q 007055 93 NMITELFTSGSLRQ--------------------YRKK-HK------------N---VDMKAIKNWARQI---------- 126 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~--------------------~i~~-~~------------~---l~e~~i~~i~~QI---------- 126 (620)
|+||||++|..+.+ .+.. |. . .-..++..|..|.
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 79999999864321 1110 10 0 1123454444432
Q ss_pred -----HHHHHHHHhCCC---------CEEecCCCccceEecCCCCc-EEEccccchhh
Q 007055 127 -----LRGLHYLHSHNP---------PIIHRDLKCDNIFVNGNNGE-VKIGDLGLAIV 169 (620)
Q Consensus 127 -----l~gL~yLHs~~~---------~IiHrDLKp~NILl~~~~G~-vKI~DFGla~~ 169 (620)
...+.+|..+-| .+||+|++++||+++..++. +-|.||.++..
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 223556654322 29999999999999743444 57999988743
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00017 Score=72.29 Aligned_cols=139 Identities=15% Similarity=0.181 Sum_probs=82.2
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHH------HHHHHHHHHhCCC---CCcceEEeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER------LYSEVHLLKSLKH---ENIIKFYNSWV 85 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~------l~~Ei~iL~~L~H---pNIVkl~~~f~ 85 (620)
.|++.+++-......|.+- ..+|..+++|..+.... ........ ..+++..+..++. -....+|-+-.
T Consensus 32 ~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 32 NYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CceEEEeecCCCccEEEEE--EECCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 3456666666555544443 56778888887654321 11111111 1233333333322 22222222111
Q ss_pred cC---CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 86 DD---TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 86 ~~---~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
-. -....++||||++|..|.++.. +++ .+...|..++.-||..| +.|+|..|.|++++ ++.++++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~--~~~i~iI 176 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS--NNGIRII 176 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE--CCcEEEE
Confidence 11 1124568999999988876533 232 24456777889999999 99999999999997 4569999
Q ss_pred cccchh
Q 007055 163 DLGLAI 168 (620)
Q Consensus 163 DFGla~ 168 (620)
||+...
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00037 Score=70.92 Aligned_cols=142 Identities=19% Similarity=0.195 Sum_probs=93.6
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeeccccc------------------CCHHHHH--HHHHHHHHHHhCC--CCCc
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM------------------QSPDQLE--RLYSEVHLLKSLK--HENI 77 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~------------------~~~~~~~--~l~~Ei~iL~~L~--HpNI 77 (620)
-.|.+|--+.||+|.. .++..||+|+.+..... .+..... =..+|+..|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4566777889999964 56889999988653210 0001110 1346888888874 4455
Q ss_pred ceEEeEEEcCCCCeEEEEEeccCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCC
Q 007055 78 IKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGN 155 (620)
Q Consensus 78 Vkl~~~f~~~~~~~l~lV~Ey~~gGsL~~-~i~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~ 155 (620)
.+-+.++ .-.+||||+....+.. .++ .-++....+..+..+++..+.-|-. .+ +||+||+.=|||+.
T Consensus 133 P~Pi~~~------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-- 201 (268)
T COG1718 133 PEPIAFR------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-- 201 (268)
T ss_pred CCceeec------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE--
Confidence 5555542 1357999996542111 111 1223344677888888888888766 67 99999999999996
Q ss_pred CCcEEEccccchhhccCC
Q 007055 156 NGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 156 ~G~vKI~DFGla~~~~~~ 173 (620)
.|.+.|+|||-|....++
T Consensus 202 ~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 202 DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred CCeEEEEECccccccCCC
Confidence 689999999988655443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.53 E-value=1.1e-05 Score=97.27 Aligned_cols=214 Identities=14% Similarity=0.028 Sum_probs=146.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHH
Q 007055 58 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYL 133 (620)
Q Consensus 58 ~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~----~~l~e~~i~~i~~QIl~gL~yL 133 (620)
..+.+..|++.++...|+++...+.-.........|..++|+.+|.++..+-+. ..++..-+....++.+.+..-+
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence 445566777788888999999988766555666788899999999999988653 4455555656666657777777
Q ss_pred HhCC---CCEEecCCCccceEecCCCCcEEEccccchhhccCC--CCccccCCCCCCCcccccc-ccCccchhhhhHHHH
Q 007055 134 HSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCI 207 (620)
Q Consensus 134 Hs~~---~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiil 207 (620)
|+.. --.+|++||+-|.+|. -+-.+|++++|+.+...+. .....+++|.|++|++... .++.+.|||..|+-+
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIV-tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIV-TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hhcccCCccchhhhhhhhcccee-cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 7642 2379999999999998 4568999999999844332 3445678899999998764 588889999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcC
Q 007055 208 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV 274 (620)
Q Consensus 208 yELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL-~~p~~Rpsa~elL~hpff~ 274 (620)
|+..-|..||... .....+.+.....-..++...+.+.-......| -+-..||+-...+.-+.+.
T Consensus 1431 y~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9999998777421 111112222222223334443333322222222 3555778877777776664
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0008 Score=67.98 Aligned_cols=75 Identities=8% Similarity=0.009 Sum_probs=43.8
Q ss_pred EEEceeCCe-EEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC---CcceEEeEEEcCC-CCeEEE
Q 007055 20 EILGKGAFK-TVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---NIIKFYNSWVDDT-NRTINM 94 (620)
Q Consensus 20 e~LG~G~fg-~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp---NIVkl~~~f~~~~-~~~l~l 94 (620)
+.|+.|+.. .||+. +..+++|.... ......+.+|.++|+.|... .+.+.+......+ ....++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSA------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCc------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 456766666 58876 23466675331 11234688899999888532 3444444321111 124578
Q ss_pred EEeccCCCCHH
Q 007055 95 ITELFTSGSLR 105 (620)
Q Consensus 95 V~Ey~~gGsL~ 105 (620)
+|++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999986663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00076 Score=66.32 Aligned_cols=98 Identities=26% Similarity=0.207 Sum_probs=77.3
Q ss_pred HHHHHHHhCCC-CCcceEEeEEEcCCCCeEEEEEeccCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-
Q 007055 64 SEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHSHNP- 138 (620)
Q Consensus 64 ~Ei~iL~~L~H-pNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~---i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~- 138 (620)
.|.-+|+.+.+ +++++++|++ + . ++|+||...+++... +...-..++..+..++.+++..+.+++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C--G---~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC--G---R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC--C---C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58889999976 6999999987 2 2 357899987766421 2222346899999999999999999987321
Q ss_pred CEEecCCCccceEecCCCCcEEEccccchh
Q 007055 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 139 ~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
++.-.|++++|+-++ .+|.+|++|.....
T Consensus 82 ~~~lcDv~~~nfgv~-~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVN-DDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEe-CCCcEEEEechhcc
Confidence 388899999999998 78999999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0037 Score=62.05 Aligned_cols=133 Identities=20% Similarity=0.235 Sum_probs=90.3
Q ss_pred cCceEEEEEEEceeCC-eEEEEEEEccCCeEEEEEEeecccccC----------CH-------HHHHHHHHHHHHHHhC-
Q 007055 12 FVLFLQYDEILGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SP-------DQLERLYSEVHLLKSL- 72 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~f-g~Vy~a~d~~tg~~VAiK~v~~~~~~~----------~~-------~~~~~l~~Ei~iL~~L- 72 (620)
.+..+++.+.||.|+- |.||++. ..|..+|+|.+..-.... .. ....-|..|.+...+|
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk 112 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK 112 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence 3478899999999999 9999995 468899999843211110 00 1223467787766665
Q ss_pred --CCCCc--ceEEeEEEcCC----------------CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 007055 73 --KHENI--IKFYNSWVDDT----------------NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 132 (620)
Q Consensus 73 --~HpNI--Vkl~~~f~~~~----------------~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~y 132 (620)
.+.++ |+.|+++.-.. ....-||.||.+... .+.. .-+.+|++-+..
T Consensus 113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHH
Confidence 45566 99999874331 112346777766533 2222 345677788888
Q ss_pred HHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 133 LHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
+|..| |+-+|+++.|.. + -||+|||.+
T Consensus 180 ~~k~g--I~~~Dv~~~ny~-~-----G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG--IVPRDVKPRNYR-G-----GKLVDFSSS 206 (207)
T ss_pred HHHCC--eeeccCcccccc-C-----CEEEecccC
Confidence 99999 999999999964 2 278999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0021 Score=62.38 Aligned_cols=132 Identities=25% Similarity=0.231 Sum_probs=88.4
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcce-EEeEEEcCCCCeE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK-FYNSWVDDTNRTI 92 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk-l~~~f~~~~~~~l 92 (620)
...+..+.||+|.+|.||++.. .|.++|+|+-.. ......+..|.++|..+.-.++.+ +|.| +. .
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~------ds~r~~l~kEakiLeil~g~~~~p~vy~y--g~----~ 87 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRR------DSPRRNLEKEAKILEILAGEGVTPEVYFY--GE----D 87 (201)
T ss_pred hhhhhhhhhhcccccEEEEeec--cCceEEEEEecC------CcchhhHHHHHHHHHHhhhcCCCceEEEe--ch----h
Confidence 3345668899999999999965 477999986442 234456889999999998877754 5543 22 3
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCc-c-ceEecCCCCcEEEccccchhhc
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC-D-NIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp-~-NILl~~~~G~vKI~DFGla~~~ 170 (620)
++.|||..|-.|...-... +-+++ ..++..-.-|-..| |-|+.|.- . ||+++ ++.+.|+||..|+..
T Consensus 88 ~i~me~i~G~~L~~~~~~~---~rk~l----~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~--~~~~~iIDFd~At~k 156 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG---DRKHL----LRVLEKAYKLDRLG--IEHGELSRPWKNVLVN--DRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhhcCcchhhhhhcc---cHHHH----HHHHHHHHHHHHhc--cchhhhcCCceeEEec--CCcEEEEEccchhhc
Confidence 3559999987887653321 22233 33344433355556 88887763 3 66664 568999999998743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0056 Score=64.47 Aligned_cols=82 Identities=12% Similarity=0.085 Sum_probs=54.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC---CCcceEEeEEEcC-CCC
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDD-TNR 90 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H---pNIVkl~~~f~~~-~~~ 90 (620)
...-.+.||.|..+.||+.... +| .+.+|..+. . .....+..|...|+.|.- ..+.++++.+.++ ...
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g 86 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS-QG-NPMPLMARS-F-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG 86 (297)
T ss_pred hhheeeecCCccceeEEEEEcC-CC-CEEEEEecc-c-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence 4445678999999999998532 23 466676431 1 011357789999988843 3677788765432 224
Q ss_pred eEEEEEeccCCCCH
Q 007055 91 TINMITELFTSGSL 104 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL 104 (620)
.-++|||+++|+++
T Consensus 87 ~~~LVmE~i~G~~~ 100 (297)
T PRK10593 87 PDVLLLERLRGVSV 100 (297)
T ss_pred CeEEEEeccCCEec
Confidence 57899999998765
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.002 Score=72.61 Aligned_cols=142 Identities=17% Similarity=0.164 Sum_probs=85.9
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC----------------------------HHHHHHHH------HH
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----------------------------PDQLERLY------SE 65 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~----------------------------~~~~~~l~------~E 65 (620)
+-||.-+.|.||+|.-+. |+.||+|+=+ ..+... .+..+.+. +|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~-P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQH-PGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecC-cChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 678888999999998765 9999999543 221110 01122233 33
Q ss_pred HHHHH----hCCCCC------cceEEeEEEcCCCCeEEEEEeccCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHH
Q 007055 66 VHLLK----SLKHEN------IIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYL 133 (620)
Q Consensus 66 i~iL~----~L~HpN------IVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~--i~~~~~l~e~~i~~i~~QIl~gL~yL 133 (620)
.+... .+.|-+ |.++|-.+ + ..-+++||||+|..+.+. +.+.+ ++...+..-+.+...-. +
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---s-t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~q--I 317 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL---S-TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLEQ--I 317 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc---C-cceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHHH--H
Confidence 33322 234555 45554432 2 235689999999766554 44444 55554443333322211 2
Q ss_pred HhCCCCEEecCCCccceEecC---CCCcEEEccccchhhccC
Q 007055 134 HSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 134 Hs~~~~IiHrDLKp~NILl~~---~~G~vKI~DFGla~~~~~ 172 (620)
=..| ++|+|-.|.||++.. .++.+.+.|||+......
T Consensus 318 f~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2346 999999999999983 367899999999865443
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0044 Score=62.20 Aligned_cols=74 Identities=15% Similarity=0.143 Sum_probs=45.6
Q ss_pred EEEceeCCeEEEEEEEcc-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC-CcceEEeEEEcCCCCeEEEEEe
Q 007055 20 EILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~-tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp-NIVkl~~~f~~~~~~~l~lV~E 97 (620)
+.|..|-...+|+..... .+..|++|...... . ..-...+|+.+++.+... -.++++..+ +. .+|+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~----~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT----E-LIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc----c-ceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEE
Confidence 567778888999986443 35688888654221 1 111234688888888433 344555432 22 26999
Q ss_pred ccCCCCH
Q 007055 98 LFTSGSL 104 (620)
Q Consensus 98 y~~gGsL 104 (620)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.01 Score=64.96 Aligned_cols=81 Identities=21% Similarity=0.213 Sum_probs=54.9
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc--C-CHHHHHHHHHHHHHHHhCC---CCCcceEEeEEEcCCCCeE
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--Q-SPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~--~-~~~~~~~l~~Ei~iL~~L~---HpNIVkl~~~f~~~~~~~l 92 (620)
.+.||.|.+..||++.+...++.|++|+-...... . .+-..++...|.+.|+.+. -.+++++|.+ ++. .-
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~--~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE--LA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC--CC
Confidence 46799999999999998654468999985411110 1 1224567788888888862 3467778774 333 35
Q ss_pred EEEEeccCCCC
Q 007055 93 NMITELFTSGS 103 (620)
Q Consensus 93 ~lV~Ey~~gGs 103 (620)
++|||++++..
T Consensus 107 ~lVME~L~~~~ 117 (401)
T PRK09550 107 VTVMEDLSDHK 117 (401)
T ss_pred EEEEecCCCcc
Confidence 68999998744
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.011 Score=58.80 Aligned_cols=133 Identities=21% Similarity=0.367 Sum_probs=84.6
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc------------CCHHHHHHHHHHHHHHHhCC------CCCcceE
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM------------QSPDQLERLYSEVHLLKSLK------HENIIKF 80 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~------------~~~~~~~~l~~Ei~iL~~L~------HpNIVkl 80 (620)
...||+|+.=.||.--+ .....||++...... ..........+|+.-...+. +..|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35799999999997532 223567776654300 00112344566766666555 7899999
Q ss_pred EeEEEcCCCCeEEEEEeccCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC
Q 007055 81 YNSWVDDTNRTINMITELFTS------GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 154 (620)
Q Consensus 81 ~~~f~~~~~~~l~lV~Ey~~g------GsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 154 (620)
|+.. +++..+-+|+|.... -+|.++++.. .+++ .+...+.++ ..||-.++ |+.+||+|.||++..
T Consensus 83 ~G~v--eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~~f---~~~l~~~~--Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 83 YGFV--ETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALDEF---KRYLLDHH--IVIRDLNPHNIVVQR 153 (199)
T ss_pred eEEE--ecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHHHH---HHHHHHcC--CeecCCCcccEEEEe
Confidence 9964 344556778887643 4688888554 4665 444444444 44666777 999999999999963
Q ss_pred CC-C--cEEEcc
Q 007055 155 NN-G--EVKIGD 163 (620)
Q Consensus 155 ~~-G--~vKI~D 163 (620)
.. | .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 22 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0074 Score=61.70 Aligned_cols=133 Identities=19% Similarity=0.188 Sum_probs=73.7
Q ss_pred EceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceEEeEEEcCCCCeEEEEEeccC
Q 007055 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMITELFT 100 (620)
Q Consensus 22 LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vkl~~~f~~~~~~~l~lV~Ey~~ 100 (620)
+..|-...+|+.. .+|..+++|....... ...-...+|..+++.+....+ .+++.. +. -++|+||++
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~----~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILV--NE----HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEE--eC----CEEEEEecc
Confidence 4567788899885 4577888886432210 100124678888888864433 334432 22 147899999
Q ss_pred CCCHHHH--------------HHh-C------CCCCH-HHHHHHHHHH---------HHHHHHHHhC------CCCEEec
Q 007055 101 SGSLRQY--------------RKK-H------KNVDM-KAIKNWARQI---------LRGLHYLHSH------NPPIIHR 143 (620)
Q Consensus 101 gGsL~~~--------------i~~-~------~~l~e-~~i~~i~~QI---------l~gL~yLHs~------~~~IiHr 143 (620)
|..+..- +.+ | .+++. ..+..+..++ ...+..+-.. .+.++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 8665321 111 1 11221 1222322222 1112222211 1238999
Q ss_pred CCCccceEecCCCCcEEEccccchh
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
|+.|.||+++ .+| +.|+||..+.
T Consensus 152 Dl~~~Nil~~-~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 152 DVHAYNLVVT-PQG-LKLIDWEYAS 174 (256)
T ss_pred CCCcCcEEEe-CCC-CEEEeccccC
Confidence 9999999998 455 7899998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.021 Score=59.66 Aligned_cols=75 Identities=20% Similarity=0.197 Sum_probs=45.7
Q ss_pred EEEceeCCeEEEEEEEcc------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceEEeEEEcCCCCeE
Q 007055 20 EILGKGAFKTVYKGFDEV------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTI 92 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~------tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vkl~~~f~~~~~~~l 92 (620)
+.|..|-...||+..... ++..+++|...... .......+|+.+++.+....+ .+++.++ .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~---- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--PN---- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--CC----
Confidence 455567777899886533 25788888854321 112335678888888853333 4455543 22
Q ss_pred EEEEeccCCCCHH
Q 007055 93 NMITELFTSGSLR 105 (620)
Q Consensus 93 ~lV~Ey~~gGsL~ 105 (620)
.+|+||++|..+.
T Consensus 73 ~~v~e~i~G~~l~ 85 (302)
T cd05156 73 GRIEEFIPSRTLT 85 (302)
T ss_pred CchhheeCCCcCC
Confidence 2478999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.032 Score=59.95 Aligned_cols=150 Identities=18% Similarity=0.263 Sum_probs=97.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccc--------------------cCCHHHHHH--HHHHHHHHHhC
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV--------------------MQSPDQLER--LYSEVHLLKSL 72 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~--------------------~~~~~~~~~--l~~Ei~iL~~L 72 (620)
...+...|..|--+.||.|. ..+|..+|||+.+..-+ ..++..+-+ ...|++.|++|
T Consensus 145 i~~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl 223 (520)
T KOG2270|consen 145 IVEINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL 223 (520)
T ss_pred eeecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH
Confidence 44566788899999999996 45788899998764311 112222211 34688889888
Q ss_pred CCCCcceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEecCCCccceE
Q 007055 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIF 151 (620)
Q Consensus 73 ~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp~NIL 151 (620)
+.-.|.----..+ ..-++||+|+....-..-.-+.-.++...+..+-.|++.-+.-| |.+. +||.||.-=|+|
T Consensus 224 ~~aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~L 297 (520)
T KOG2270|consen 224 NNAGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLL 297 (520)
T ss_pred HhcCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhhe
Confidence 7665433222111 12457999986422221122234567677777777777766665 4455 999999999999
Q ss_pred ecCCCCcEEEccccchhhccCC
Q 007055 152 VNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 152 l~~~~G~vKI~DFGla~~~~~~ 173 (620)
+ ++|.+.|+|.+-+.....+
T Consensus 298 y--hdG~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 298 Y--HDGKLYIIDVSQSVEHDHP 317 (520)
T ss_pred E--ECCEEEEEEccccccCCCh
Confidence 9 4799999999877544433
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.014 Score=64.99 Aligned_cols=163 Identities=20% Similarity=0.283 Sum_probs=100.3
Q ss_pred HHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCE
Q 007055 61 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140 (620)
Q Consensus 61 ~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~I 140 (620)
.+.-..++++.+.|+|...+.+. ......+..+|+|++. .+|.++...+. +-..... .++ +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~-~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~--------------~~~--~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDF-SRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL--------------AHG--V 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEee-ecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc--------------ccc--c
Confidence 36667889999999999999875 3344456889999994 68999887655 2211111 112 2
Q ss_pred EecCCCccceEecCCCCcEEEccccchhhccCCCCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCC
Q 007055 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNEC 220 (620)
Q Consensus 141 iHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~ 220 (620)
.|- +.++++| .++ ... .+.+| +++||||+|.++.++..|...+..-
T Consensus 89 ~~~-------------~~~~~td-~~~---t~~--~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 89 LHL-------------NIIYITD-HFL---TKY--PSPIG---------------PKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred cee-------------hhhhccc-ccc---ccC--CCCCC---------------cchhhhhHHHHHHHHHHhhHHHHHH
Confidence 221 2333444 111 000 11112 4999999999999999998777543
Q ss_pred CCHHHHHHHHHcCCCCCCC---------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 221 KNPAQIYKKVTSGIKPASL---------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 221 ~~~~~i~~~i~~~~~p~~~---------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.+........+-...+... ....+..+.++..+|+- .|..||...++.+++-|...
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 3322222111111112111 11245677888999996 89999999999999988643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.05 Score=58.80 Aligned_cols=84 Identities=15% Similarity=0.106 Sum_probs=54.2
Q ss_pred EEceeCCeEEEEEEEccCCeEEEEEEeecccc---cCCHHHHHHHHHHHHHHHhCC--CC-CcceEEeEEEcCCCCeEEE
Q 007055 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV---MQSPDQLERLYSEVHLLKSLK--HE-NIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 21 ~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~---~~~~~~~~~l~~Ei~iL~~L~--Hp-NIVkl~~~f~~~~~~~l~l 94 (620)
.||.|....||++.+...+..|+||+-...-. ...+-..++..-|...|+... -| .++++|. +++. ...+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e--~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE--MAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc--ccee
Confidence 47999999999999864447899997542111 112444567778888887763 34 4666766 3333 3457
Q ss_pred EEeccCCC-CHHHHH
Q 007055 95 ITELFTSG-SLRQYR 108 (620)
Q Consensus 95 V~Ey~~gG-sL~~~i 108 (620)
|||+++.. .|++.+
T Consensus 78 vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 78 VMEDLSHHKIARKGL 92 (370)
T ss_pred hHhhCccchHHHHHH
Confidence 99999653 354544
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.0045 Score=69.61 Aligned_cols=70 Identities=30% Similarity=0.446 Sum_probs=58.7
Q ss_pred CCCceEEEEEecCCCC----CceeeeeecccCCCCHHHHHHHHHhccCCCCcCHHHHHHHHHHHHHHhCCCCCC
Q 007055 351 DDDTVSLTLRIGDKSG----HVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNP 420 (620)
Q Consensus 351 ~~~~i~l~lri~d~~~----~~~~i~f~f~~~~Dta~~va~EmV~~~~i~~~d~~~ia~~i~~~i~~~~~~~~~ 420 (620)
.+..++|.+|..|.++ ..|.|+|.|+++.|+++.||+|||+++++++.|...+|..+...+.++--....
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~ 388 (632)
T KOG0584|consen 315 SDPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRND 388 (632)
T ss_pred ccccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhc
Confidence 3455667788887763 356899999999999999999999999999999999999999988887765543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.084 Score=54.91 Aligned_cols=140 Identities=17% Similarity=0.123 Sum_probs=77.9
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CcceEEeE----EEcCCCCeE
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNS----WVDDTNRTI 92 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--NIVkl~~~----f~~~~~~~l 92 (620)
.+.|..|....+|+... .+..+++|+... .. ...+..|+.++..|.+. .+.+++.. +.....+..
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 45677788889998753 344688887642 11 23466788888877433 24444431 111112356
Q ss_pred EEEEeccCCCCHHH-----H------HHh-C---CCCCH--------HHH------------HHHHHHHHHHHHHHHh--
Q 007055 93 NMITELFTSGSLRQ-----Y------RKK-H---KNVDM--------KAI------------KNWARQILRGLHYLHS-- 135 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~-----~------i~~-~---~~l~e--------~~i------------~~i~~QIl~gL~yLHs-- 135 (620)
++|+++++|..+.. + +.+ | ..+.. .-. ......+..++.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 78999999866421 1 000 0 00000 000 0011112233444443
Q ss_pred ---CCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 136 ---HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 136 ---~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
....++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~-~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFD-GDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEe-CCceEEEeehhhhc
Confidence 112389999999999998 55667899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.069 Score=57.45 Aligned_cols=143 Identities=15% Similarity=0.196 Sum_probs=81.1
Q ss_pred ceEEEEEEEceeCCeEEEEEEEcc----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceEEeEEEcCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDT 88 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~----tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vkl~~~f~~~~ 88 (620)
..+.+..+-| |-.-.+|++.... ++..|++|+.... .....+ -.+|+.+++.+..-++ .++++.+ ..
T Consensus 37 ~~~~i~~l~g-GlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~----t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~--~~ 108 (344)
T PLN02236 37 EALQVIPLKG-AMTNEVFQIKWPTKEGNLGRKVLVRIYGEG----VELFFD-RDDEIRTFECMSRHGQGPRLLGRF--PN 108 (344)
T ss_pred CcEEEEEcCC-cccceeEEEEeCCCCCCCCCeEEEEEccCC----CCeeec-hHHHHHHHHHHHHcCCCCceEEEE--CC
Confidence 4455554434 8888999986432 3468888866432 111222 2568888888854444 3456654 22
Q ss_pred CCeEEEEEeccCCCCHHHH--------------HHh-CC--------CCCHHHHHHHHHHHHH-----------------
Q 007055 89 NRTINMITELFTSGSLRQY--------------RKK-HK--------NVDMKAIKNWARQILR----------------- 128 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~--------------i~~-~~--------~l~e~~i~~i~~QIl~----------------- 128 (620)
. .|++|+++.+|..- +.+ |. ......+..|+.++..
T Consensus 109 g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~ 184 (344)
T PLN02236 109 G----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLED 184 (344)
T ss_pred c----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHH
Confidence 1 37889887665321 111 10 1113344455433321
Q ss_pred HHHH----HHh--CCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 129 GLHY----LHS--HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 129 gL~y----LHs--~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
.+.. +.. ....++|+|+++.||+++..++.+.++||..+.
T Consensus 185 ~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 185 EINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1111 221 112389999999999998446789999998763
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.3 Score=51.47 Aligned_cols=29 Identities=28% Similarity=0.322 Sum_probs=23.9
Q ss_pred CEEecCCCccceEecCCCCcEEEccccchh
Q 007055 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 139 ~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
.+||+|+.|+||+++ .+...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~-~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFE-GDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEE-CCceEEEEeccccc
Confidence 499999999999997 44445799999773
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.1 Score=57.21 Aligned_cols=86 Identities=20% Similarity=0.200 Sum_probs=56.6
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeeccc-c-cCCHHHHHHHHHHHHHHHhCC--CC-CcceEEeEEEcCCCCeEE
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIED-V-MQSPDQLERLYSEVHLLKSLK--HE-NIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~-~-~~~~~~~~~l~~Ei~iL~~L~--Hp-NIVkl~~~f~~~~~~~l~ 93 (620)
.+.||.|.-..||++.+...+..|+||+-...- + ...+-..++..-|.+.|+.+. -| .++++|. .++. .-.
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e--~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV--MNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH--Hhh
Confidence 578899999999999985445679999743111 1 122345677888999888773 34 4666776 3333 345
Q ss_pred EEEeccCCC-CHHHHH
Q 007055 94 MITELFTSG-SLRQYR 108 (620)
Q Consensus 94 lV~Ey~~gG-sL~~~i 108 (620)
+|||+++.. .|++.+
T Consensus 110 ~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 110 CVMEDLSDHTILRTAL 125 (409)
T ss_pred HHHHhCcccHHHHHHH
Confidence 789999653 355554
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.11 Score=54.27 Aligned_cols=29 Identities=21% Similarity=0.340 Sum_probs=23.8
Q ss_pred CEEecCCCccceEecCCCCc-EEEccccchh
Q 007055 139 PIIHRDLKCDNIFVNGNNGE-VKIGDLGLAI 168 (620)
Q Consensus 139 ~IiHrDLKp~NILl~~~~G~-vKI~DFGla~ 168 (620)
-++|+|+.|.||+++ .+|. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~-~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILID-EDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEe-CCCCEEEEECcHhcc
Confidence 389999999999998 4354 5699999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.089 Score=55.34 Aligned_cols=141 Identities=18% Similarity=0.149 Sum_probs=76.9
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CcceEEeE----EEcCCCCe
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNS----WVDDTNRT 91 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--NIVkl~~~----f~~~~~~~ 91 (620)
..+.++.|....+|+... .+| .+++|+.... ... +.+..|+.++..|... ++.+++.. ++....+.
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~---~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKR---VKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCC---CCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 356677787789998753 344 5778876431 112 2345667777776322 23444331 11112345
Q ss_pred EEEEEeccCCCCHH-----HHH------Hh-C---CCC--------CHHHHH---------------HHHHHHHHHHHHH
Q 007055 92 INMITELFTSGSLR-----QYR------KK-H---KNV--------DMKAIK---------------NWARQILRGLHYL 133 (620)
Q Consensus 92 l~lV~Ey~~gGsL~-----~~i------~~-~---~~l--------~e~~i~---------------~i~~QIl~gL~yL 133 (620)
.+++++|++|..+. ++. .+ | ..+ ...... .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78899999885431 111 00 0 011 011100 0011223345555
Q ss_pred Hh-----CCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 134 HS-----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 134 Hs-----~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
.. ....++|+|+.+.||+++ .++.+.|+||+.+
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~-~~~~~~vIDfd~~ 215 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFD-GDSVKGVIDFYFA 215 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEE-CCceEEEeecccc
Confidence 32 223499999999999998 5666789999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.42 Score=52.61 Aligned_cols=85 Identities=18% Similarity=0.075 Sum_probs=54.2
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC---HHHHHHHHHHHHHHHhCC---CCCcceEEeEEEcCCCCe
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS---PDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~---~~~~~~l~~Ei~iL~~L~---HpNIVkl~~~f~~~~~~~ 91 (620)
-.+.||.|....||+..+. +..|+||+-........ +....+...|...|+.+. ..++.++|.+. ++ .
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--ed--~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--RT--M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--CC--C
Confidence 4678899999999998763 45688887542211111 123556667788777664 24778888753 32 2
Q ss_pred EEEEEeccCC--CCHHHHH
Q 007055 92 INMITELFTS--GSLRQYR 108 (620)
Q Consensus 92 l~lV~Ey~~g--GsL~~~i 108 (620)
-+++||++++ ..+++.+
T Consensus 110 ~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 110 ALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CEEEEeecCCcceehhhhh
Confidence 4578999977 2455443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.023 Score=60.19 Aligned_cols=137 Identities=20% Similarity=0.214 Sum_probs=91.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccc-----ccCC---------HHH----HHHHHHHHHHHHhCCC--
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIED-----VMQS---------PDQ----LERLYSEVHLLKSLKH-- 74 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~-----~~~~---------~~~----~~~l~~Ei~iL~~L~H-- 74 (620)
-+.++..||-|.-+.||.+-+. .|.+.++|.-.+.. +... ..| +-...+|+..|+.|.-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4567899999999999999764 67788888433211 1111 111 1225579999998842
Q ss_pred CCcceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC
Q 007055 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 154 (620)
Q Consensus 75 pNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 154 (620)
-.+.+.+++ ..-++|||++.|-.|.+... ..+..++ ...+..-+.-|-.+| +||+|..-=||++.
T Consensus 172 fpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~---v~d~~~l---y~~lm~~Iv~la~~G--lIHgDFNEFNimv~- 236 (465)
T KOG2268|consen 172 FPVPKPIDH------NRHCVVMELVDGYPLRQVRH---VEDPPTL---YDDLMGLIVRLANHG--LIHGDFNEFNIMVK- 236 (465)
T ss_pred CCCCCcccc------cceeeHHHhhcccceeeeee---cCChHHH---HHHHHHHHHHHHHcC--ceecccchheeEEe-
Confidence 345555552 24567999999988876542 2233333 333333444566788 99999999999997
Q ss_pred CCCcEEEccccch
Q 007055 155 NNGEVKIGDLGLA 167 (620)
Q Consensus 155 ~~G~vKI~DFGla 167 (620)
.++.++++||--.
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 7889999999754
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.39 E-value=0.28 Score=52.38 Aligned_cols=141 Identities=16% Similarity=0.208 Sum_probs=77.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceEEeEEEcCCCC
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNR 90 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vkl~~~f~~~~~~ 90 (620)
.+++..+.| |=...+|+...... +..|++++..... .. .-.-.+|..+++.+..-++ .+++.++ .. +
T Consensus 16 ~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~~-~IdR~~E~~il~~l~~~gl~P~~l~~~--~~-G 86 (330)
T PLN02421 16 DFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNT----DY-VIDRERELQAIKYLSAAGFGAKLLGVF--GN-G 86 (330)
T ss_pred ceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCc----Ce-EechHHHHHHHHHHHhcCCCCceeEEe--CC-c
Confidence 455555544 77778888864332 3478888654211 11 1112468888888865555 4455544 22 1
Q ss_pred eEEEEEeccCCCCHHH-------HH-------Hh-CC-C------C-CHHHHHHHHHHH---------------------
Q 007055 91 TINMITELFTSGSLRQ-------YR-------KK-HK-N------V-DMKAIKNWARQI--------------------- 126 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~-------~i-------~~-~~-~------l-~e~~i~~i~~QI--------------------- 126 (620)
+|.+|++|-+|.. .+ .+ |. . . -...+..|..++
T Consensus 87 ---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (330)
T PLN02421 87 ---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEE 163 (330)
T ss_pred ---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHH
Confidence 4789988765522 11 11 10 0 1 123333333332
Q ss_pred ----HHHHHH-HHhCC--CCEEecCCCccceEecCCCCcEEEccccch
Q 007055 127 ----LRGLHY-LHSHN--PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 127 ----l~gL~y-LHs~~--~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
+..+.. +...+ .-.+|.||-+.||+++..++.++++||..|
T Consensus 164 l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 164 LRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred HHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 111121 21112 127999999999999745678999999877
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.64 Score=49.58 Aligned_cols=145 Identities=14% Similarity=0.189 Sum_probs=80.4
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCcceEEeEEEcCCCCeEEEEE
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pNIVkl~~~f~~~~~~~l~lV~ 96 (620)
.+..-.|..-.+|...+. ++++++. ... ............+|..+++.+.- ..+..-++.+.++.....++||
T Consensus 30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT--GQKYVLR-KPP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeccCCcccceEEEecC--CceEEEe-cCC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 334433433345555443 7777776 221 11223345567788888888743 2334445554444334678899
Q ss_pred eccCCCC---------HH-HHHH--------h-C-------------CCCCHHHHHHHHHHH--------------HHHH
Q 007055 97 ELFTSGS---------LR-QYRK--------K-H-------------KNVDMKAIKNWARQI--------------LRGL 130 (620)
Q Consensus 97 Ey~~gGs---------L~-~~i~--------~-~-------------~~l~e~~i~~i~~QI--------------l~gL 130 (620)
+|+.|.. +. ++.. . | ......++..|..+. ..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 9998822 22 1111 0 0 011222333333333 2223
Q ss_pred HHHHhCCC------CEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 131 HYLHSHNP------PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 131 ~yLHs~~~------~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
.+|+.+-+ .++|+|+.+.||+++ ..+.+=+.||+++..
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~-~~~~~gVlDwe~~~l 228 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIID-PGRPTGVLDWELATL 228 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEe-CCCeeEEEecccccc
Confidence 45555443 399999999999998 556688999998753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.09 E-value=0.94 Score=47.71 Aligned_cols=29 Identities=10% Similarity=0.124 Sum_probs=25.2
Q ss_pred CEEecCCCccceEecCCCCcEEEccccchh
Q 007055 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 139 ~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
.++|+|+.++||+++ .++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD-ETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEc-CCCCEEEEEhhhcc
Confidence 399999999999998 57789999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.82 E-value=0.54 Score=47.64 Aligned_cols=117 Identities=19% Similarity=0.234 Sum_probs=71.8
Q ss_pred eCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEeccCCCCH
Q 007055 25 GAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL 104 (620)
Q Consensus 25 G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL 104 (620)
|+-++.-.+..+. | +..+|++......-+ ...++.+.+++.++. .|+++.. +....+-+|.|.|..-..
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~---~~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCIN---DALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKI 141 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccc---hhhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCccc
Confidence 3444444444333 2 344555544333211 123567888888764 5777763 344457788899853110
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 105 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 105 ~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
.. ..++.-=+.+|.-.|+.++..+|+|-.|+||+-| ..|.+||.|=+.
T Consensus 142 ---------~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D-~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ---------NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCD-KFGYLKLVDPVC 189 (308)
T ss_pred ---------ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeec-CCCCEEecChhh
Confidence 11 1122222456777897767799999999999998 799999998653
|
The function of this family is unknown. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.22 E-value=1.1 Score=47.26 Aligned_cols=76 Identities=18% Similarity=0.127 Sum_probs=43.3
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCcceEEeEEEcCCCCeE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpNIVkl~~~f~~~~~~~l 92 (620)
+.-.+.|+.|....+|+.. .++..+.+|.-. .. ....+..|..-|+.|. --.+.+.+.+....+. -
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~ 87 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--A 87 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--C
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC-hh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--c
Confidence 4556788889999999986 677788888765 21 1234677888888883 3346667775544433 4
Q ss_pred EEEEeccCCC
Q 007055 93 NMITELFTSG 102 (620)
Q Consensus 93 ~lV~Ey~~gG 102 (620)
++|+||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 7899999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=91.90 E-value=0.029 Score=62.20 Aligned_cols=77 Identities=19% Similarity=0.402 Sum_probs=62.9
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
.+-+...+..+.++|.|+||+|+.+..+.++-.+|||.|.... ......+..+|+..+..+.|++|++++..|....
T Consensus 44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn---~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~ 120 (516)
T KOG1033|consen 44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN---REESRSRVLREVSSLAEFEHPGIKRYFHAWYERP 120 (516)
T ss_pred hhhhhccccccccccccCccccCCccccccchhhHHHHhcccc---hhhhhhhhhccccchhhhcccchhhheeceecCC
Confidence 3334445567889999999999999999888899999987654 3445567889999999999999999999987544
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=89.78 E-value=0.82 Score=49.47 Aligned_cols=104 Identities=18% Similarity=0.250 Sum_probs=66.0
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
...+.|++|++- |+.|. .++ .-..+++..++.+-+..|.-+... .+.-||||..+||||+ .|.|-|+||-++
T Consensus 297 e~~y~yl~~kdh-gt~is-~ik---~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId--~GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPIS-IIK---ADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID--EGNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceee-eee---cccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee--cCceEEEEeeee
Confidence 345777777775 34442 222 245678888888877777666554 5699999999999997 799999999999
Q ss_pred hhccCCCCccccCCCCCCCccccccccCccchhhh
Q 007055 168 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYS 202 (620)
Q Consensus 168 ~~~~~~~~~~~~GTp~y~APEll~~~y~~~~DIwS 202 (620)
+...... .+---.+--|-++.|.-+..-+||-
T Consensus 369 Rl~~~q~---~isy~rldhp~lF~G~dd~QFeIYr 400 (488)
T COG5072 369 RLSYSQG---IISYNRLDHPDLFNGVDDYQFEIYR 400 (488)
T ss_pred ecccCCc---eeeccccCchhhhcCccceeeeHHH
Confidence 7322211 1111122234445544455566665
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.55 E-value=2.8 Score=45.90 Aligned_cols=26 Identities=31% Similarity=0.326 Sum_probs=22.5
Q ss_pred EEecCCCccceEecCCCCcEEEccccch
Q 007055 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 140 IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
.+|.||-+.||+.+ ++.+.++||-.|
T Consensus 229 fCHNDL~~gNIL~~--~~~l~lID~EYA 254 (383)
T PTZ00384 229 FCHNDLFFTNILDF--NQGIYFIDFDFA 254 (383)
T ss_pred eeeccCCcccEEec--CCCEEEEEeccc
Confidence 79999999999985 456999999766
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=88.33 E-value=1.5 Score=48.17 Aligned_cols=62 Identities=19% Similarity=0.217 Sum_probs=44.2
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEecCCCccceEecCCC
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNN 156 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp~NILl~~~~ 156 (620)
..++-+|..|-++..+++- +..+++..+.++.--..||--+ --.+ .+|.|+.|.||++-..+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecC
Confidence 5577788888888888764 3456666777766666665542 2235 99999999999996433
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=88.32 E-value=3.2 Score=42.46 Aligned_cols=69 Identities=17% Similarity=0.190 Sum_probs=42.6
Q ss_pred eEEEEEEEccCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC---CCcceEEeEEEcCCCCeEEEEEeccCCCC
Q 007055 28 KTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDDTNRTINMITELFTSGS 103 (620)
Q Consensus 28 g~Vy~a~d~~tg-~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H---pNIVkl~~~f~~~~~~~l~lV~Ey~~gGs 103 (620)
|.|..|....+| .++-+|.- .......+..|+.-|+.|.- -++.+++. ....+...|+|+||++-|.
T Consensus 27 G~inea~~v~dg~~~~FvK~n-------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~--~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 27 GDINEAWRLRDGTDPFFVKCN-------QREQLSMFTAEADGLELLARSNTITVPKVIA--VGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred ccccceeEeecCCcceEEEec-------chhhHHHHHHHHHHHHHHHhcCCccccceEE--ecCCCCeeEEEEeeccCCC
Confidence 344444444444 35666542 23344567788887777743 45666666 4456678999999998766
Q ss_pred HH
Q 007055 104 LR 105 (620)
Q Consensus 104 L~ 105 (620)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.29 E-value=7.9 Score=47.84 Aligned_cols=30 Identities=30% Similarity=0.531 Sum_probs=23.7
Q ss_pred CEEecCCCccceEecCCC-CcEE-Eccccchh
Q 007055 139 PIIHRDLKCDNIFVNGNN-GEVK-IGDLGLAI 168 (620)
Q Consensus 139 ~IiHrDLKp~NILl~~~~-G~vK-I~DFGla~ 168 (620)
.+||+|+.+.|||+++.. +.+. |+|||-+.
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 499999999999998432 1555 99999874
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=84.97 E-value=1.7 Score=45.39 Aligned_cols=28 Identities=25% Similarity=0.417 Sum_probs=23.8
Q ss_pred CCEEecCCCccceEecCCCCcEEEccccch
Q 007055 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 138 ~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
..++|+|+.+.||+++ . +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~-~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK-D-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEe-C-CcEEEEECccc
Confidence 3499999999999998 3 57899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 620 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-76 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-30 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-29 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-27 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-25 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-24 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-24 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-23 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-23 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-23 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-23 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-23 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-23 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-22 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-22 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-22 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-22 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-22 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-22 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-22 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-22 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-21 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-21 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-19 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-17 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-15 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-14 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-14 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-04 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 6e-04 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 6e-04 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 8e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 433 bits (1115), Expect = e-150
Identities = 135/265 (50%), Positives = 185/265 (69%), Gaps = 5/265 (1%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
FL++D +G+G+FKTVYKG D +EVAW ++ + + +R E +LK L+H
Sbjct: 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQH 84
Query: 75 ENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 132
NI++FY+SW + I ++TEL TSG+L+ Y K+ K + +K +++W RQIL+GL +
Sbjct: 85 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE 192
LH+ PPIIHRDLKCDNIF+ G G VKIGDLGLA + + A++VIGTPEFMAPE+YEE
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE 204
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252
+Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY++VTSG+KPAS KV P+VK+ IE
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 253 KCIVP-ASLRLPALELLKDPFLVTD 276
CI R +LL F +
Sbjct: 265 GCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 2e-67
Identities = 70/293 (23%), Positives = 133/293 (45%), Gaps = 16/293 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ +G+G+F DG + ++NI S + E EV +L ++KH NI++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQ 87
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKNWARQILRGLHYLHSHN 137
+ S+ ++ + + ++ + G L + K V I +W QI L ++H
Sbjct: 88 YRESFEENGS--LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-Y 194
I+HRD+K NIF+ +G V++GD G+A V+ AR+ IGTP +++PE+ E + Y
Sbjct: 146 --ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 254
N DI++ G + E+ T ++ + E + + K+ SG +S ++ + +
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQL 260
Query: 255 IVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPM 306
R +L+ F + + + L + + S+P P
Sbjct: 261 FKRNPRDRPSVNSILEKGF-IAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPA 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-67
Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 18/267 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G G++ K + DG + W +++ + + + L SEV+LL+ LKH NI++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 80 FYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+Y+ +D TN T+ ++ E G L + K+ + +D + + Q+ L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 136 HNPP---IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY 190
+ ++HRDLK N+F++G VK+GD GLA ++ T A++ +GTP +M+PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 191 EEE-YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248
YNE DI+S G C+L E+ P+ + ++ K+ G K + ++
Sbjct: 189 NRMSYNEKSDIWSLG-CLLYELCALMPPFTA-FSQKELAGKIREG-KFRRIPYRYSDELN 245
Query: 249 QFIEKCIVP-ASLRLPALELLKDPFLV 274
+ I + + R E+L++P ++
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-65
Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 15/264 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ +G+G F VY+ +DG+ VA +V I D+M E+ LLK L H N+IK
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIK 96
Query: 80 FYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+Y S+++D +N++ EL +G L + ++K+ + + + + + Q+ L ++HS
Sbjct: 97 YYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE 193
++HRD+K N+F+ G VK+GDLGL T A S++GTP +M+PE E
Sbjct: 155 RR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 194 -YNELVDIYSFGMCILEMVTCEYPYN-ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251
YN DI+S G + EM + P+ + N + KK+ P S +++Q +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271
Query: 252 EKCIVP-ASLRLPALELLKDPFLV 274
CI P R + +
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAKRM 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-65
Identities = 64/258 (24%), Positives = 110/258 (42%), Gaps = 16/258 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENII 78
LG G++ V+K + DG A + + P R +EV + + +H +
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCV 120
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHN 137
+ +W + + + TE SL+Q+ + ++ + + R L L +LHS
Sbjct: 121 RLEQAWEEGGI--LYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEEYNE 196
++H D+K NIF+ G G K+GD GL + + G P +MAPEL + Y
Sbjct: 178 --LVHLDVKPANIFL-GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGT 234
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256
D++S G+ ILE+ + + Q+ + A LS +++ + +
Sbjct: 235 AADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLS----SELRSVLVMMLE 290
Query: 257 P-ASLRLPALELLKDPFL 273
P LR A LL P L
Sbjct: 291 PDPKLRATAEALLALPVL 308
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 4e-64
Identities = 87/274 (31%), Positives = 129/274 (47%), Gaps = 25/274 (9%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+LGKG + VY G D + + +A ++ D + L+ E+ L K LKH+NI++
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMK--AIKNWARQILRGLHYLHSH 136
+ S+ ++ I + E GSL R K + I + +QIL GL YLH +
Sbjct: 84 YLGSFSENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE---LYE 191
I+HRD+K DN+ +N +G +KI D G + + P + GT ++MAPE
Sbjct: 142 Q--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 192 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----PASLSKVTDPQV 247
Y + DI+S G I+EM T + P+ E P KV P S+S +
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS----AEA 255
Query: 248 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 280
K FI KC P R A +LL D FL + K
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 5e-64
Identities = 67/252 (26%), Positives = 112/252 (44%), Gaps = 19/252 (7%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVA---WNQVNIEDVMQSPDQLERLYSEVHLLKSL 72
++Y++ +GKG F V+KG D VA + E + ++ + EV ++ +L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLH 131
H NI+K Y + M+ E G L K + I G+
Sbjct: 81 NHPNIVKLYGL----MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVMQQPTARSVIGTPEFMAP 187
Y+ + NPPI+HRDL+ NIF+ + K+ D GL+ + ++G ++MAP
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-SVSGLLGNFQWMAP 195
Query: 188 ELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSGIKPASLSKV 242
E E Y E D YSF M + ++T E P++E I G++P ++ +
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP-TIPED 254
Query: 243 TDPQVKQFIEKC 254
P+++ IE C
Sbjct: 255 CPPRLRNVIELC 266
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-63
Identities = 74/245 (30%), Positives = 125/245 (51%), Gaps = 14/245 (5%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L E +G G+F TV++ E G +VA + +D +++ EV ++K L+H
Sbjct: 39 LNIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHP 94
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHY 132
NI+ F + N +I +TE + GSL + + +D + + A + +G++Y
Sbjct: 95 NIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY 190
LH+ NPPI+HR+LK N+ V+ VK+ D GL+ + +++S GTPE+MAPE+
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211
Query: 191 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249
E NE D+YSFG+ + E+ T + P+ + + + + +PQV
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL-EIPRNLNPQVAA 270
Query: 250 FIEKC 254
IE C
Sbjct: 271 IIEGC 275
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 6e-63
Identities = 66/284 (23%), Positives = 114/284 (40%), Gaps = 39/284 (13%)
Query: 17 QYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+ EI +G G F V+K +DG +V + E+ EV L L H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDH 63
Query: 75 ENIIKFYNSWVDD--------------TNRTINMITELFTSGSLRQYRKKHKNVDM--KA 118
NI+ + W + + + E G+L Q+ +K + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 119 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-S 177
QI +G+ Y+HS +I+RDLK NIF+ + +VKIGD GL ++ R
Sbjct: 124 ALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTR 180
Query: 178 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236
GT +M+PE + Y + VD+Y+ G+ + E++ E + + GI
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIIS 237
Query: 237 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 279
+ K ++K + R E+L+ + +P+
Sbjct: 238 DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-61
Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 20/245 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
++ +E++G+GAF V K + +VA I+ ++S + + E+ L + H
Sbjct: 10 IEVEEVVGRGAFGVVCKA--KWRAKDVA-----IK-QIESESERKAFIVELRQLSRVNHP 61
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHY 132
NI+K Y + + ++ E GSL + +W Q +G+ Y
Sbjct: 62 NIVKLYGA----CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 133 LHSHNP-PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE 191
LHS P +IHRDLK N+ + +KI D G A +Q + G+ +MAPE++E
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-HMTNNKGSAAWMAPEVFE 176
Query: 192 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQ 249
Y+E D++S+G+ + E++T P++E PA I V +G +P L K ++
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIES 235
Query: 250 FIEKC 254
+ +C
Sbjct: 236 LMTRC 240
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-61
Identities = 63/288 (21%), Positives = 120/288 (41%), Gaps = 41/288 (14%)
Query: 17 QYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
++ I LG+G F V++ ++VD A ++ + + E++ EV L L+H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEH 62
Query: 75 ENIIKFYNSWVDDTN----------RTINMITELFTSGSLRQY---RKKHKNVDMKAIKN 121
I++++N+W++ + + +L +L+ + R + + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 122 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR----- 176
QI + +LHS ++HRDLK NIF + VK+GD GL M Q
Sbjct: 123 IFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 177 ---------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 226
+GT +M+PE Y+ VDI+S G+ + E++ YP++ +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRT 236
Query: 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
V + K L P ++ + P R A+ ++++
Sbjct: 237 LTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 5e-60
Identities = 84/292 (28%), Positives = 129/292 (44%), Gaps = 46/292 (15%)
Query: 17 QYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
++EI LG+GAF V K + +D A ++ + ++L + SEV LL SL H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVMLLASLNH 61
Query: 75 ENIIKFYNSWVDDTNR-----------TINMITELFTSGSLRQY-RKKHKNVDMKAIKNW 122
+ ++++Y +W++ N T+ + E +G+L ++ N
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 123 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------ 176
RQIL L Y+HS IIHRDLK NIF++ + VKIGD GLA + +
Sbjct: 122 FRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 177 ----------SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPA 224
S IGT ++A E+ + YNE +D+YS G+ EM+ YP++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERV 235
Query: 225 QIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
I KK+ S P K+ I I + R A LL +L
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-60
Identities = 70/248 (28%), Positives = 108/248 (43%), Gaps = 15/248 (6%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L +EI+G G F VY+ G EVA + +E + E L LKH
Sbjct: 9 LTLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
NII + + N + + E G L + + + + NWA QI RG++YLH
Sbjct: 67 NIIALRGVCLKEPNLCL--VMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHD 123
Query: 136 HNP-PIIHRDLKCDNIFVN-------GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAP 187
PIIHRDLK NI + +N +KI D GLA + T S G +MAP
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAP 183
Query: 188 ELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246
E+ +++ D++S+G+ + E++T E P+ A Y + + +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL-PIPSTCPEP 242
Query: 247 VKQFIEKC 254
+ +E C
Sbjct: 243 FAKLMEDC 250
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-59
Identities = 48/245 (19%), Positives = 95/245 (38%), Gaps = 15/245 (6%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L + L + ++KG G ++ + + D S + E L+ H
Sbjct: 12 LNFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHP 67
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYL 133
N++ + +IT GSL + VD +A + RG+ +L
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE 193
H+ P I L ++ ++ + +I + Q P + P ++APE +++
Sbjct: 128 HTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPG---RMYAPAWVAPEALQKK 183
Query: 194 ----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249
D++SF + + E+VT E P+ + N K G++P ++ P V +
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVSK 242
Query: 250 FIEKC 254
++ C
Sbjct: 243 LMKIC 247
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 3e-59
Identities = 63/275 (22%), Positives = 108/275 (39%), Gaps = 30/275 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G+G+F V++ D+ G + A +V +E E+ L I+
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------ELVACAGLSSPRIVP 114
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
Y + + +N+ EL GSL Q K+ + + Q L GL YLH+
Sbjct: 115 LYGAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-- 170
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-------PTARSVIGTPEFMAPELYEE 192
I+H D+K DN+ ++ + + D G A+ +Q T + GT MAPE+
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 193 E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----KPASLSKVTDPQV 247
+ + VDI+S +L M+ +P+ + K + P S + P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA----PLT 286
Query: 248 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 281
Q I++ + R A+EL + L
Sbjct: 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-58
Identities = 66/257 (25%), Positives = 118/257 (45%), Gaps = 30/257 (11%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ E++GKG F VY G G EVA ++IE + DQL+ EV + +HE
Sbjct: 35 LEIGELIGKGRFGQVYHGR--WHG-EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHE 89
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
N++ F + + + I IT L +L R +D+ + A++I++G+ YLH
Sbjct: 90 NVVLFMGACMSPPHLAI--ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQPTARSVIGTPEFMAP 187
+ I+H+DLK N+F + NG+V I D GL + ++ R G +AP
Sbjct: 148 AKG--ILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 188 EL----------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 237
E+ + +++ D+++ G E+ E+P+ + I ++ +G+KP
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPN 262
Query: 238 SLSKVTDPQVKQFIEKC 254
++ + C
Sbjct: 263 LSQIGMGKEISDILLFC 279
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-58
Identities = 58/281 (20%), Positives = 115/281 (40%), Gaps = 39/281 (13%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENII 78
E +G G F +V+K +DG A + + EV+ L +H +++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL--AGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGLHYLH 134
+++++W +D + + + E GSL ++ + +K+ Q+ RGL Y+H
Sbjct: 75 RYFSAWAEDDH--MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 135 SHNPPIIHRDLKCDNIFVNGNN------------------GEVKIGDLGLAIVMQQPTAR 176
S + ++H D+K NIF++ + KIGDLG + P +
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--Q 188
Query: 177 SVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 234
G F+A E+ +E + DI++ + ++ E + ++ G
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGR 244
Query: 235 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 274
P + +V + + ++ I P R A+ L+K L+
Sbjct: 245 LP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-57
Identities = 79/252 (31%), Positives = 129/252 (51%), Gaps = 23/252 (9%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
+ + +G G+F TVYKG + G +VA +N+ +P QL+ +EV +L+ +H
Sbjct: 26 ITVGQRIGSGSFGTVYKG--KWHG-DVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHV 80
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
NI+ F + I +T+ SL + +MK + + ARQ RG+ YLH
Sbjct: 81 NILLFM-GYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELY 190
+ + IIHRDLK +NIF+ + VKIGD GLA + + G+ +MAPE+
Sbjct: 138 AKS--IIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 191 EEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV---T 243
+ Y+ D+Y+FG+ + E++T + PY+ N QI + V G LSKV
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254
Query: 244 DPQVKQFIEKCI 255
++K+ + +C+
Sbjct: 255 PKRMKRLMAECL 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 8e-56
Identities = 61/279 (21%), Positives = 115/279 (41%), Gaps = 29/279 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENI 77
+ +G G V++ +E A VN+E+ L+ +E+ L L+ + I
Sbjct: 15 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
I+ Y+ + D I M+ E + L + KK K++D K++ + +L +H +H H
Sbjct: 72 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPEL---- 189
I+H DLK N + +G +K+ D G+A MQ T S +GT +M PE
Sbjct: 129 --IVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 190 --------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 241
+ + + D++S G + M + P+ + N +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 242 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 279
+ + ++ ++ C+ R+ ELL P++
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-55
Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 31/274 (11%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENI 77
+ +G G V++ +E A VN+E+ L+ +E+ L L+ + I
Sbjct: 34 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
I+ Y+ + D I M+ E + L + KK K++D K++ + +L +H +H H
Sbjct: 91 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEEE 193
I+H DLK N + +G +K+ D G+A MQ T S +GT +M PE ++
Sbjct: 148 --IVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 194 ------------YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 240
+ D++S G CIL M + P+ + N +
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262
Query: 241 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
+ + ++ ++ C+ R+ ELL P++
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-54
Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 31/280 (11%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENI 77
+ +G G V++ +E A VN+E+ L+ +E+ L L+ + I
Sbjct: 62 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
I+ Y+ + D I M+ E + L + KK K++D K++ + +L +H +H H
Sbjct: 119 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEEE 193
I+H DLK N + +G +K+ D G+A MQ T S +G +M PE ++
Sbjct: 176 --IVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 194 ------------YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 240
+ D++S G CIL M + P+ + N +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 241 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 279
+ + ++ ++ C+ R+ ELL P++
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 75/307 (24%), Positives = 124/307 (40%), Gaps = 50/307 (16%)
Query: 4 LDLVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLY 63
L L++ +Q + +GKG + V+ G + G +VA + E
Sbjct: 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEAS--WFRET-- 80
Query: 64 SEVHLLKSLKHENIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKN 121
E++ ++HENI+ F + + T + IT+ +GSL Y K +D K++
Sbjct: 81 -EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLK 138
Query: 122 WARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 175
A + GL +LH+ P I HRDLK NI V NG I DLGLA+ T
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTN 197
Query: 176 R------SVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTC--------- 213
+ +GT +M PE+ +E + + D+YSFG+ + E+
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
Query: 214 -EYPYNECKNPAQIYKKVTSG---------IKPASLSKVTDPQVKQFIEKCIVP-ASLRL 262
+ PY++ Y+ + S Q+ + + +C + RL
Sbjct: 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317
Query: 263 PALELLK 269
AL + K
Sbjct: 318 TALRVKK 324
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 75/307 (24%), Positives = 119/307 (38%), Gaps = 50/307 (16%)
Query: 4 LDLVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLY 63
L L++ + E +GKG F V++G + G EVA + + E
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERS--WFREA-- 85
Query: 64 SEVHLLKSLKHENIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKN 121
E++ L+HENI+ F + D + +++ GSL Y ++ V ++ +
Sbjct: 86 -EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIK 143
Query: 122 WARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 174
A GL +LH P I HRDLK NI V NG I DLGLA+ T
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATD 202
Query: 175 -----ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTC--------- 213
+GT +MAPE+ ++ E + DIY+ G+ E+
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
Query: 214 -EYPYNECKNP----AQIYKKVTSG-----IKPASLSKVTDPQVKQFIEKCIVP-ASLRL 262
+ PY + ++ K V I S + + + +C + RL
Sbjct: 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
Query: 263 PALELLK 269
AL + K
Sbjct: 323 TALRIKK 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 75/295 (25%), Positives = 117/295 (39%), Gaps = 50/295 (16%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
+ E +GKG + V++G G VA + D E E++ L+HE
Sbjct: 10 ITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKS--WFRET---ELYNTVMLRHE 62
Query: 76 NIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
NI+ F S + + + + IT GSL Y + +D + I GL +L
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHL 121
Query: 134 HS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGT 181
H P I HRDLK NI V NG+ I DLGLA++ Q T + +GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 182 PEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG- 233
+MAPE+ +E + + VDI++FG+ + E+ ++ + V
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 234 ------------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 269
I S T + + +++C S RL AL + K
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-47
Identities = 61/274 (22%), Positives = 111/274 (40%), Gaps = 28/274 (10%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
+ILG+GA V++G + G A + + + + ++ E +LK L H+NI+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGLHYLHS 135
K + + T R +I E GSL ++ N R ++ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 136 HNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE 191
+ I+HR++K NI K+ D G A ++ S+ GT E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 192 ---------EEYNELVDIYSFGMCIL-EMVTCE---YPYNECKNPAQIYKKVTSGIKPAS 238
++Y VD++S G T P+ + ++ K+ +G +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 239 LSKVTDPQ--VKQFIEKCIVPASLRLPALELLKD 270
+S V + + V SL LL
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-47
Identities = 79/274 (28%), Positives = 132/274 (48%), Gaps = 23/274 (8%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LGKG F ++ D A V + ++ P Q E++ E+ + +SL H++++ F+
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
+ D+ + ++ EL SL + K+ K + + + RQI+ G YLH + +I
Sbjct: 82 GFFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VI 137
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-LYEEEYNELV 198
HRDLK N+F+N + EVKIGD GLA ++ R + GTP ++APE L ++ ++ V
Sbjct: 138 HRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 199 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV 256
D++S G CI+ + P E + Y ++ P ++ P I+K +
Sbjct: 197 DVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQ 251
Query: 257 P-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 289
+ R ELL D F + P RLP
Sbjct: 252 TDPTARPTINELLNDEFFTSG------YIPARLP 279
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-47
Identities = 85/275 (30%), Positives = 136/275 (49%), Gaps = 23/275 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +GKG+F V+KG D VA +++E ++ D++E + E+ +L + K
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+Y S++ DT I M E GS + +D I R+IL+GL YLHS
Sbjct: 85 YYGSYLKDTKLWIIM--EYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEK-- 139
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEE-EYNE 196
IHRD+K N+ ++ +GEVK+ D G+A + + + +GTP +MAPE+ ++ Y+
Sbjct: 140 KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPA----QIYKKVTSGIKPASLSKVTDPQVKQFIE 252
DI+S G+ +E+ E P++E +P I K P +L +K+F+E
Sbjct: 199 KADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKN-----NPPTLEGNYSKPLKEFVE 252
Query: 253 KC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPL 286
C S R A ELLK F++ + K L
Sbjct: 253 ACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-47
Identities = 66/257 (25%), Positives = 100/257 (38%), Gaps = 27/257 (10%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L + E+LGKG F K G + E + + EV +++ L+H
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMV----MKELIRFDEETQRTFLKEVKVMRCLEHP 67
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
N++KF D +N ITE G+LR + ++A+ I G+ YLH
Sbjct: 68 NVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----------------PTARSV 178
S N IIHRDL N V N V + D GLA +M +V
Sbjct: 126 SMN--IIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 179 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 237
+G P +MAPE + Y+E VD++SFG+ + E++ + + G
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242
Query: 238 SLSKVTDPQVKQFIEKC 254
P +C
Sbjct: 243 YCPPNCPPSFFPITVRC 259
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 81/298 (27%), Positives = 138/298 (46%), Gaps = 25/298 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G G+F VY D + VA +++ QS ++ + + EV L+ L+H N I+
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
+ ++ + + M E + GS K + I L+GL YLHSHN
Sbjct: 119 YRGCYLREHTAWLVM--E-YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN- 174
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE----LYEEEY 194
+IHRD+K NI ++ G VK+GD G A +M A S +GTP +MAPE + E +Y
Sbjct: 175 -MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQY 230
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYKKVTSGIKPASLSKVTDPQVKQF 250
+ VD++S G+ +E+ + P N I + + ++ S + F
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWS----EYFRNF 285
Query: 251 IEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLAHSEPHPM 306
++ C R + LLK F++ + P ++ D + R + V E+ NL + + +
Sbjct: 286 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 343
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-46
Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 41/283 (14%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E++G GA V + +VA ++N+E + ++ L E+ + H NI+
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLE---KCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 80 FYNSWVDDTNRTINMITELFTSGSLR--------QYRKKHKNVDMKAIKNWARQILRGLH 131
+Y S+V + M +L + GS+ + K +D I R++L GL
Sbjct: 78 YYTSFVVKDELWLVM--KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTARSVIGTPEF 184
YLH + IHRD+K NI + +G V+I D G++ + + ++ +GTP +
Sbjct: 136 YLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 185 MAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC-----------KNPAQIYKKVT 231
MAPE+ E+ Y+ DI+SFG+ +E+ T PY++ +P + V
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252
Query: 232 SGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFL 273
K ++ I C R A ELL+ F
Sbjct: 253 DKEMLKKYGKS----FRKMISLCLQKDPEKRPTAAELLRHKFF 291
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-46
Identities = 55/276 (19%), Positives = 92/276 (33%), Gaps = 33/276 (11%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ LG+G F V DG A ++ E E + + H NI++
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILC----HEQQDREEAQREADMHRLFNHPNILR 90
Query: 80 FYNSWVDDTNRT--INMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYL 133
+ + ++ F G+L + K + I I RGL +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----------VIGTP 182
H+ HRDLK NI + + G+ + DLG S T
Sbjct: 151 HA--KGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 183 EFMAPELYEEE----YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYK-KVTSGIKP 236
+ APEL+ + +E D++S G C+L M+ E PY+ V + +
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 237 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDP 271
+ + + Q + + R LL
Sbjct: 267 PQSPRHS-SALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-46
Identities = 79/274 (28%), Positives = 132/274 (48%), Gaps = 23/274 (8%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LGKG F ++ D A V + ++ P Q E++ E+ + +SL H++++ F+
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
+ D+ + ++ EL SL + K+ K + + + RQI+ G YLH + +I
Sbjct: 108 GFFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VI 163
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-LYEEEYNELV 198
HRDLK N+F+N + EVKIGD GLA ++ R + GTP ++APE L ++ ++ V
Sbjct: 164 HRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222
Query: 199 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV 256
D++S G CI+ + P E + Y ++ P ++ P I+K +
Sbjct: 223 DVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQ 277
Query: 257 P-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 289
+ R ELL D F + P RLP
Sbjct: 278 TDPTARPTINELLNDEFFTSG------YIPARLP 305
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-46
Identities = 65/290 (22%), Positives = 118/290 (40%), Gaps = 31/290 (10%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
+ILG+GA V++G + G A + + + + ++ E +LK L H+NI+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGLHYLHS 135
K + + T R +I E GSL ++ N R ++ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 136 HNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE 191
+ I+HR++K NI K+ D G A ++ S+ GT E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 192 ---------EEYNELVDIYSFGMCIL-EMVTCE---YPYNECKNPAQIYKKVTSGIKPAS 238
++Y VD++S G T P+ + ++ K+ +G +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 239 LSKVTDPQVKQFIEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDPLR 287
+S V + +P S L L++L P L L D +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA----NILEADQEK 293
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 9e-46
Identities = 83/263 (31%), Positives = 132/263 (50%), Gaps = 24/263 (9%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +G+GA TVY D G EVA Q+N++ + E + +E+ +++ K+ NI+
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVN 81
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ +S++ + M E GSL +D I R+ L+ L +LHS+
Sbjct: 82 YLDSYLVGDELWVVM--EYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPEL-YEEEYNE 196
+IHRD+K DNI + +G VK+ D G I +Q +++GTP +MAPE+ + Y
Sbjct: 137 VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGI----KPASLSKVTDPQVKQFI 251
VDI+S G+ +EM+ E PY +NP + +Y T+G P LS + F+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLS----AIFRDFL 250
Query: 252 EKC-IVPASLRLPALELLKDPFL 273
+C + R A ELL+ FL
Sbjct: 251 NRCLEMDVEKRGSAKELLQHQFL 273
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 73/278 (26%), Positives = 128/278 (46%), Gaps = 25/278 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
LG GAF VYK ++ G A + + S ++LE E+ +L + H I+K
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYIVEIEILATCDHPYIVK 80
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
++ D I + E G++ + + + I+ RQ+L L++LHS
Sbjct: 81 LLGAYYHDGKLWIMI--EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR- 137
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE------LY 190
IIHRDLK N+ + G++++ D G++ + S IGTP +MAPE +
Sbjct: 138 -IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 191 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVTD--PQV 247
+ Y+ DI+S G+ ++EM E P++E NP + + K S P +L + +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSD--PPTLLTPSKWSVEF 252
Query: 248 KQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCD 284
+ F++ R A +LL+ PF+ + + +
Sbjct: 253 RDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 73/263 (27%), Positives = 126/263 (47%), Gaps = 24/263 (9%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G+G+ V ++ G +VA +++ + E L++EV +++ +H N+++
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLR----KQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
Y S++ + M E G+L ++ + I +L+ L YLH+
Sbjct: 107 MYKSYLVGEELWVLM--EFLQGGALTDIV-SQVRLNEEQIATVCEAVLQALAYLHAQG-- 161
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPEL-YEEEYNE 196
+IHRD+K D+I + +G VK+ D G I P +S++GTP +MAPE+ Y
Sbjct: 162 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGI----KPASLSKVTDPQVKQFI 251
VDI+S G+ ++EMV E PY +P Q + + S +S P ++ F+
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVS----PVLRDFL 275
Query: 252 EKC-IVPASLRLPALELLKDPFL 273
E+ + R A ELL PFL
Sbjct: 276 ERMLVRDPQERATAQELLDHPFL 298
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-45
Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 26/275 (9%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E LG+G++ +VYK + G VA QV +E L+ + E+ +++ +++K
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVK 88
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
+Y S+ +T+ I M E +GS+ R ++K + I + L+GL YLH
Sbjct: 89 YYGSYFKNTDLWIVM--EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR- 145
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYN 195
IHRD+K NI +N G K+ D G+A + +VIGTP +MAPE + E YN
Sbjct: 146 -KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYKKVTSGIK-PASLSKVTDPQVKQF 250
+ DI+S G+ +EM + PY + +P + I + P S F
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTNPPPTFRKPELWS----DNFTDF 258
Query: 251 IEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCD 284
+++C + R A +LL+ PF+ + ++ D
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRD 293
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 57/276 (20%), Positives = 126/276 (45%), Gaps = 19/276 (6%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKH 74
L+ +G G V+K G +A Q+ + ++ +R+ ++ +LKS
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSHDC 83
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
I++ + +++ +T+ + + EL + + + ++ + + + I++ L+YL
Sbjct: 84 PYIVQCFGTFITNTD--VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE----- 188
+ +IHRD+K NI ++ G++K+ D G++ + A+ G +MAPE
Sbjct: 142 EKH-GVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 189 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD--P 245
+ +Y+ D++S G+ ++E+ T ++PY CK ++ KV +P L
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSG 258
Query: 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 280
+ F++ C+ R +LL+ F+ +
Sbjct: 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 33/288 (11%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENII 78
E++G G + VYKG G A +++ D+ E + E+++LK H NI
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIA 84
Query: 79 KFYNSWVDDTNRTIN----MITELFTSGSLRQYRKKHKNVDMK--AIKNWARQILRGLHY 132
+Y +++ ++ ++ E +GS+ K K +K I R+ILRGL +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-- 188
LH H +IHRD+K N+ + N EVK+ D G++ + + R + IGTP +MAPE
Sbjct: 145 LHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 189 ----LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA----QIYKKVTSGIKPASLS 240
+ Y+ D++S G+ +EM P + +P I + +K S
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWS 260
Query: 241 KVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPLR 287
K + + FIE C + S R +L+K PF+ + V L+
Sbjct: 261 K----KFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLK 304
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-44
Identities = 64/273 (23%), Positives = 123/273 (45%), Gaps = 15/273 (5%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LGKG F VY ++ +A + + ++ +L EV + L+H NI++ Y
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-GVEHQLRREVEIQSHLRHPNILRLY 75
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
+ D T + +I E G++ + +K D + + ++ L Y HS +I
Sbjct: 76 GYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VI 131
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDI 200
HRD+K +N+ + G+ GE+KI D G ++ + GT +++ PE+ E ++E VD+
Sbjct: 132 HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDL 190
Query: 201 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIEKCIVP- 257
+S G+ E + P E + YK+++ P ++ + I + +
Sbjct: 191 WSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEFTFPDFVT----EGARDLISRLLKHN 245
Query: 258 ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 290
S R E+L+ P++ ++ K C +
Sbjct: 246 PSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 67/315 (21%), Positives = 140/315 (44%), Gaps = 32/315 (10%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKH 74
L+ +G+GA+ +V K + G +A ++ + ++L ++ +++S
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDC 80
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGL 130
I++FY + + + + EL ++ + Y+ + +D + + ++ L
Sbjct: 81 PYIVQFYGALFREGD--CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 131 HYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPE 188
++L IIHRD+K NI ++ +G +K+ D G++ + A++ G +MAPE
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 195
Query: 189 -----LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243
+ Y+ D++S G+ + E+ T +PY + + +V G P LS
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSE 254
Query: 244 D----PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNL 298
+ P F+ C+ S R ELLK PF++ + + + V ++++
Sbjct: 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA-----VEVACYVCKILDQ 309
Query: 299 AHSEP-HPMDIDLNH 312
+ P PM +D +H
Sbjct: 310 MPATPSSPMYVDHHH 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 52/272 (19%), Positives = 105/272 (38%), Gaps = 28/272 (10%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 80
+ A+ + + E+ + + + SP ++ ++ + +N +
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
I M +L +L+ + R ++ + + QI + +LHS
Sbjct: 127 LQPSSPKVYLYIQM--QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--------------SVIGTPE 183
++HRDLK NIF + VK+GD GL M Q +GT
Sbjct: 185 --LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 184 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 242
+M+PE Y+ VDI+S G+ + E++ Y ++ +I V + P ++
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKFPLLFTQ- 297
Query: 243 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
PQ ++ + P + R A +++++
Sbjct: 298 KYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 164 bits (415), Expect = 3e-43
Identities = 91/390 (23%), Positives = 138/390 (35%), Gaps = 38/390 (9%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
E LG G F V + + G +VA + SP ER E+ ++K L H N++
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 79 KFYNSWVDDTNRTIN------MITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRG 129
V D + + + E G LR+Y + +N I+ I
Sbjct: 76 SARE--VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 130 LHYLHSHNPPIIHRDLKCDNI--FVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMA 186
L YLH + IIHRDLK +NI KI DLG A + Q +GT +++A
Sbjct: 134 LRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 187 PELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 245
PEL E ++Y VD +SFG E +T P+ P Q + KV +
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 246 QVKQFIEKCIVPASL---------RLPALELLKDP-----FLVTDNPKDLVCDPLRLPNL 291
+F P L R L+ N L
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311
Query: 292 VPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKND 351
+ VMN+ H + N + S + +TG + E Q L + + L +
Sbjct: 312 LLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTG---IPEEEQELLQASGLALNSAQPL 368
Query: 352 DDTVSLTLRIGDKSGHVSNIHFVFYLNADT 381
V + + D ++ F+F
Sbjct: 369 TQYV-IDCTVIDGRQGEGDLIFLFDNRKTV 397
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-43
Identities = 64/278 (23%), Positives = 122/278 (43%), Gaps = 22/278 (7%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKH 74
L+ LG+GA+ V K G +A ++ + + +RL ++ ++++
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDC 65
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGL 130
+ FY + + + + + E SL +Q K + + + A I++ L
Sbjct: 66 PFTVTFYGALFREGD--VWICME-LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 131 HYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE 188
+LHS + +IHRD+K N+ +N G+VK+ D G++ + A+ G +MAPE
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179
Query: 189 -----LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243
L ++ Y+ DI+S G+ ++E+ +PY+ P Q K+V P +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239
Query: 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 280
+ F +C+ + R EL++ PF K
Sbjct: 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-43
Identities = 70/295 (23%), Positives = 119/295 (40%), Gaps = 50/295 (16%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
LQ E+ +G F V+K ++ VA V I +Q + EV+ L +KHE
Sbjct: 26 LQLLEVKARGRFGCVWKA--QLLNEYVA---VKIFP-IQDKQSWQNE-YEVYSLPGMKHE 78
Query: 76 NIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
NI++F + T+ +++ IT GSL + K + V + + A + RGL YL
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYL 137
Query: 134 HS--------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGT 181
H H P I HRD+K N+ + NN I D GLA+ +GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 182 PEFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI--------- 226
+MAPE+ ++ + +D+Y+ G+ + E+ + + + +
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256
Query: 227 -----------YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 269
+KK ++ + + IE+C A RL A + +
Sbjct: 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 66/309 (21%), Positives = 120/309 (38%), Gaps = 52/309 (16%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
+ LG G V+K + G+ +A +++E P ++ E+ +L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSP 91
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
I+ FY ++ D I++ E GSL Q KK + + + + +++GL YL
Sbjct: 92 YIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 136 -HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEE 193
H I+HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L
Sbjct: 150 KHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH 206
Query: 194 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD--------- 244
Y+ DI+S G+ ++EM YP A+ +
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 245 --------------------------------PQVKQFIEKCIV-PASLRLPALELLKDP 271
+ + F+ KC++ + R +L+
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326
Query: 272 FLVTDNPKD 280
F+ + ++
Sbjct: 327 FIKRSDAEE 335
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-42
Identities = 70/266 (26%), Positives = 128/266 (48%), Gaps = 20/266 (7%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LGKG+F VY+ G+EVA ++ + M ++R+ +EV + LKH +I++ Y
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKA-MYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 82 NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
N + D + ++ E+ +G + +Y + + K +++ QI+ G+ YLHSH I
Sbjct: 78 NYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--I 133
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-LYEEEYNEL 197
+HRDL N+ + N +KI D GLA ++ P + ++ GTP +++PE +
Sbjct: 134 LHRDLTLSNLLL-TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 198 VDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKC 254
D++S G C+ ++ P+ + KV P+ LS + K I +
Sbjct: 193 SDVWSLG-CMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPSFLS----IEAKDLIHQL 246
Query: 255 IVP-ASLRLPALELLKDPFLVTDNPK 279
+ + RL +L PF+ ++
Sbjct: 247 LRRNPADRLSLSSVLDHPFMSRNSST 272
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 67/369 (18%), Positives = 123/369 (33%), Gaps = 72/369 (19%)
Query: 20 EILGKGA--FKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 77
++GKG TV + G V ++N+E S + + L E+H+ K H NI
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVTFLQGELHVSKLFNHPNI 88
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK--AIKNWARQILRGLHYLHS 135
+ + +++ D + ++T GS + H M AI + +L+ L Y+H
Sbjct: 89 VPYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---------SVIGTPEFMA 186
+HR +K +I ++ +G+V + L + M R + +++
Sbjct: 147 MG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 187 PELYEE---EYNELVDIYSFGMCILEMVTCEYPY-------------------------- 217
PE+ ++ Y+ DIYS G+ E+ P+
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263
Query: 218 -NECKNPAQIYKKVTSGIKPASLSKVTDPQV----------------KQFIEKC-IVPAS 259
E + SG+ + + P F+E+C
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323
Query: 260 LRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADS 319
R A LL F + LP L+ V + + E D + +
Sbjct: 324 ARPSASTLLNHSFFKQIKRRASEA----LPELLRPVTPITNFEGSQSQ-DHSGIFGLVTN 378
Query: 320 CAKSNTGTW 328
+ W
Sbjct: 379 LEELEVDDW 387
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 63/315 (20%), Positives = 113/315 (35%), Gaps = 42/315 (13%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 78
+L +G F VY+ D G E A ++ ++ + EV +K L H NI+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLS----NEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 79 KFYNSWVD-----DTNRTINMITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGL 130
+F ++ DT + ++ G L ++ KK ++ + Q R +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV------------ 178
++H PPIIHRDLK +N+ + N G +K+ D G A + S
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLL-SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 179 --IGTPEFMAPELYE----EEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVT 231
TP + PE+ + E DI++ G CIL + ++P+ + +I
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED-GAKLRIVNGKY 266
Query: 232 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 290
S + I + RL E++ + P +
Sbjct: 267 SIPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP--ITE 320
Query: 291 LVPEVMNLAHSEPHP 305
L+ + +
Sbjct: 321 LLEQNGGYGSATLSR 335
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-41
Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 14/280 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+LGKG+F V D++ G E A ++ ++ E L EV LLK L H NI+K
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
Y + D ++ E++T G L K RQ+L G+ Y+H +
Sbjct: 91 LYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 140 IIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNE 196
I+HRDLK +N+ + + ++I D GL+ + + IGT ++APE+ Y+E
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEK 253
D++S G IL ++ P N I KKV G + KV++ K I K
Sbjct: 207 KCDVWSTG-VILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE-SAKDLIRK 264
Query: 254 CIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 292
+ S+R+ A + L ++ T + + D L N +
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAI 304
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-41
Identities = 64/262 (24%), Positives = 126/262 (48%), Gaps = 15/262 (5%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LGKG F VY ++ + +A + + + +L E+ + L+H NI++ Y
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-GVEHQLRREIEIQSHLRHPNILRMY 80
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
N + D I ++ E G L + +KH D + + ++ LHY H +I
Sbjct: 81 NYFHDRKR--IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VI 136
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDI 200
HRD+K +N+ + G GE+KI D G ++ R++ GT +++ PE+ E + ++E VD+
Sbjct: 137 HRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDL 195
Query: 201 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIEKCIVP- 257
+ G+ E + P+ + + + ++++ + +K P LS K I K +
Sbjct: 196 WCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFLS----DGSKDLISKLLRYH 250
Query: 258 ASLRLPALELLKDPFLVTDNPK 279
RLP +++ P++ ++ +
Sbjct: 251 PPQRLPLKGVMEHPWVKANSRR 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-41
Identities = 68/278 (24%), Positives = 110/278 (39%), Gaps = 30/278 (10%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENI 77
++LG GA T+ D +VA ++ E +R EV LL+ +H N+
Sbjct: 29 KDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF----SFADR---EVQLLRESDEHPNV 80
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSH 136
I+++ + D + EL + +L++Y +K +Q GL +LHS
Sbjct: 81 IRYFCTEKDRQF--QYIAIEL-CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 137 NPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVMQQP-----TARSVIGTPEFMAP 187
N I+HRDLK NI ++ N I D GL + V GT ++AP
Sbjct: 138 N--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 188 ELYEEE----YNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSGIKPASLSKV 242
E+ E+ VDI+S G +++ P+ + + K
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 243 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 279
D ++ IEK I R A +LK PF + +
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-40
Identities = 74/282 (26%), Positives = 128/282 (45%), Gaps = 25/282 (8%)
Query: 17 QYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVN----IEDVMQSPDQLERLYSEVHLLK 70
+Y + LG GA V F+ +VA ++ + D + +E+ +LK
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 130
L H IIK N D + ++ EL G L +K + K + Q+L +
Sbjct: 196 KLNHPCIIKIKNF-FDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 131 HYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAP 187
YLH + IIHRDLK +N+ + + +KI D G + ++ + + R++ GTP ++AP
Sbjct: 253 QYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 188 E----LYEEEYNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSGI---KPASL 239
E + YN VD +S G IL + Y P++E + + ++TSG P
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369
Query: 240 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 280
++V++ ++K +V R E L+ P+L ++ K
Sbjct: 370 AEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 62/272 (22%), Positives = 118/272 (43%), Gaps = 27/272 (9%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVN---IEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+G+G++ V + I A ++ +EDV +R E+ ++KSL H N
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-------DRFKQEIEIMKSLDHPN 67
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
II+ Y ++ D+T+ I ++ EL T G L + + + +L + Y H
Sbjct: 68 IIRLYETFEDNTD--IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 137 NPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEE 193
N + HRDLK +N + + +K+ D GLA + R+ +GTP +++P++ E
Sbjct: 126 N--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 183
Query: 194 YNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQVK 248
Y D +S G ++ ++ C YP +++ K+ G V+ Q +
Sbjct: 184 YGPECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVSP-QAE 239
Query: 249 QFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 279
I + + R+ +L+ L+ +
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 81/270 (30%), Positives = 127/270 (47%), Gaps = 19/270 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+LGKG+F V K D + E A +N + EV LLK L H NI+K
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMK 85
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ D ++ ++ EL+T G L K K +Q+ G+ Y+H HN
Sbjct: 86 LFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 140 IIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEEEYNE 196
I+HRDLK +NI + + ++KI D GL+ QQ T + IGT ++APE+ Y+E
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 197 LVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFI 251
D++S G IL ++ P Y + N I K+V +G ++D K I
Sbjct: 202 KCDVWSAG-VILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISD-DAKDLI 257
Query: 252 EKCIVP-ASLRLPALELLKDPFLVTDNPKD 280
K + SLR+ A + L+ P++ + ++
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 75/298 (25%), Positives = 129/298 (43%), Gaps = 25/298 (8%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVN----IEDVMQSPDQLERLYSEVHLLKSLKH 74
+ LG GA V F+ +VA ++ + D + +E+ +LK L H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
IIK N + D + ++ EL G L +K + K + Q+L + YLH
Sbjct: 75 PCIIKIKN-FFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 135 SHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE--- 188
+ IIHRDLK +N+ + + +KI D G + ++ + + R++ GTP ++APE
Sbjct: 132 ENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 189 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 242
+ YN VD +S G IL + YP + + ++TSG P ++V
Sbjct: 190 SVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEH-RTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 243 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA 299
++ ++K +V R E L+ P+L ++ K D L N + +
Sbjct: 248 SEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVL 304
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-40
Identities = 81/280 (28%), Positives = 125/280 (44%), Gaps = 15/280 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+LGKG+F V K D + E A +N + EV LLK L H NI+K
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMK 85
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ D ++ ++ EL+T G L K K +Q+ G+ Y+H HN
Sbjct: 86 LFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 140 IIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNE 196
I+HRDLK +NI + + ++KI D GL+ QQ + IGT ++APE+ Y+E
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEK 253
D++S G IL ++ P KN I K+V +G ++D K I K
Sbjct: 202 KCDVWSAG-VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD-DAKDLIRK 259
Query: 254 CIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 292
+ SLR+ A + L+ P++ + + L
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESA 299
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-39
Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 15/281 (5%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
+ LG GA+ V D+V +E A + V S +L EV +LK L H NI+
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV--STSSNSKLLEEVAVLKLLDHPNIM 99
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
K Y+ + D N ++ E + G L + +Q+L G+ YLH HN
Sbjct: 100 KLYDFFEDKRN--YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN- 156
Query: 139 PIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYN 195
I+HRDLK +N+ + + +KI D GL+ V + + +GT ++APE+ ++Y+
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYD 215
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIE 252
E D++S G IL ++ YP + +I +KV G V++ K I+
Sbjct: 216 EKCDVWSIG-VILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE-GAKDLIK 273
Query: 253 KCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 292
+ + + R+ A + L+ P++ K L
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANA 314
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-39
Identities = 80/294 (27%), Positives = 127/294 (43%), Gaps = 22/294 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVA---------WNQVNIEDVMQSPDQLERLYSEVHLLK 70
LG GA+ V ++ E A +D E +Y+E+ LLK
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 130
SL H NIIK ++ + D ++TE + G L + D N +QIL G+
Sbjct: 102 SLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159
Query: 131 HYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAP 187
YLH HN I+HRD+K +NI N + +KI D GL+ + R +GT ++AP
Sbjct: 160 CYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 188 ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTD 244
E+ +++YNE D++S G I+ ++ C YP +N I KKV G ++
Sbjct: 218 EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNIS- 275
Query: 245 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 297
+ K+ I+ + + R A E L ++ D L + +
Sbjct: 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRK 329
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 62/268 (23%), Positives = 119/268 (44%), Gaps = 25/268 (9%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
LG GAF V+ + G+E + + +S +E++ +E+ +LKSL H NII
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 79 KFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
K + + D N + ++ E G L + + K + + +Q++ L Y H
Sbjct: 84 KIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 135 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYE 191
S + ++H+DLK +NI F + + +KI D GLA + + + GT +MAPE+++
Sbjct: 142 SQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK 199
Query: 192 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-----KPASLSKVTDPQ 246
+ DI+S G ++ + + ++ +K T + L+ PQ
Sbjct: 200 RDVTFKCDIWSAG-VVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT----PQ 254
Query: 247 VKQFIEKCIVP-ASLRLPALELLKDPFL 273
+++ + R A ++L +
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 72/276 (26%), Positives = 132/276 (47%), Gaps = 22/276 (7%)
Query: 17 QYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
YD E LGKGAF V + + G+E A +N + + S ++L E + + L+H
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQH 64
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
NI++ ++S +++ ++ +L T G L + + + +QIL + Y H
Sbjct: 65 PNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 135 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPE-LY 190
S+ I+HR+LK +N+ + VK+ D GLAI + GTP +++PE L
Sbjct: 123 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 191 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 245
++ Y++ VDI++ G IL ++ YP ++E + ++Y ++ +G VT
Sbjct: 181 KDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTP- 236
Query: 246 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 280
+ K I+ + R+ A + LK P++
Sbjct: 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 71/289 (24%), Positives = 124/289 (42%), Gaps = 26/289 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLKHENII 78
E++GKG F V + + G + A V++ SP E L E + LKH +I+
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 79 KFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDM--KAIKNWARQILRGLHYLH 134
+ ++ D + M+ E L ++ ++ RQIL L Y H
Sbjct: 90 ELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 135 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-L 189
+N IIHRD+K + + N+ VK+G G+AI + + A +GTP FMAPE +
Sbjct: 148 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 190 YEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTD 244
E Y + VD++ G IL ++ Y ++++ + G P S +++
Sbjct: 206 KREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQWSHISE 261
Query: 245 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK-DLVCDPLRLPNL 291
K + + ++ + R+ E L P+L + + P + L
Sbjct: 262 -SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQL 309
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 43/228 (18%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLY---SEVHLLKSL 72
L+ E++G+G + VYKG +D VA V + + ++ + +
Sbjct: 15 LKLLELIGRGRYGAVYKG--SLDERPVA--------VKVFSFANRQNFINEKNIYRVPLM 64
Query: 73 KHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 129
+H+NI +F T ++ E + +GSL +Y H D + A + RG
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRG 123
Query: 130 LHYLHS-------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----------QQ 172
L YLH+ + P I HRDL N+ V N+G I D GL++ + +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 173 PTARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT 212
A S +GT +MAPE+ E E + VD+Y+ G+ E+
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 56/300 (18%), Positives = 114/300 (38%), Gaps = 44/300 (14%)
Query: 22 LGKGAFKTVY-----------KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
L +G F + K +++ + + D + + + +E+ ++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA--------IKNW 122
+K+E + + + +I E + S+ ++ + +D IK
Sbjct: 99 DIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 123 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 182
+ +L Y+H+ I HRD+K NI + NG VK+ D G + M + GT
Sbjct: 157 IKSVLNSFSYIHNEKN-ICHRDVKPSNILM-DKNGRVKLSDFGESEYMVDKKIKGSRGTY 214
Query: 183 EFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------ 233
EFM PE + E VDI+S G+C+ M P++ + +++ + +
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274
Query: 234 -----------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 281
K + + F++ + + R+ + + LK +L N +DL
Sbjct: 275 DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL 334
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 39/297 (13%), Positives = 81/297 (27%), Gaps = 55/297 (18%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVA------------------------WNQVNIEDVMQS 55
+LG+ + D+ G + +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 56 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS------GSLRQYRK 109
R L+K + + +I+ D + + S L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 110 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169
HK++ A Q++R L LH + ++H L+ +I ++ G V + +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQ-RGGVFLTGFEHLVR 255
Query: 170 MQQPTARSVIGTPEFMAPELYEEE------------YNELVDIYSFGMCILEMVTCEYPY 217
+ F PEL D ++ G+ I + + P
Sbjct: 256 DGARV--VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
Query: 218 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
+ + + K V+ +E + RL L+ ++ P
Sbjct: 314 TK-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 73/274 (26%), Positives = 133/274 (48%), Gaps = 22/274 (8%)
Query: 17 QYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
YD E LGKGAF V + + G+E A +N + + S ++L E + + L+H
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQH 87
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
NI++ ++S +++ ++ +L T G L + + + +QIL + Y H
Sbjct: 88 PNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 135 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LY 190
S+ I+HR+LK +N+ + VK+ D GLAI + A GTP +++PE L
Sbjct: 146 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 203
Query: 191 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 245
++ Y++ VDI++ G IL ++ YP ++E + ++Y ++ +G VT
Sbjct: 204 KDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTP- 259
Query: 246 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 278
+ K I+ + R+ A + LK P++
Sbjct: 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 66/275 (24%), Positives = 116/275 (42%), Gaps = 26/275 (9%)
Query: 18 YD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
YD E LG GAF V++ ++ G +N P + +E+ ++ L H
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINT----PYPLDKYTVKNEISIMNQLHHP 108
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGLHYL 133
+I ++++ D + +I E + G L R + +K + + I N+ RQ GL ++
Sbjct: 109 KLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVI-NYMRQACEGLKHM 165
Query: 134 HSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LY 190
H H+ I+H D+K +NI VKI D GLA + + T EF APE +
Sbjct: 166 HEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 223
Query: 191 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 245
E D+++ G + ++ E + + + V + S V+
Sbjct: 224 REPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFSSVSP- 279
Query: 246 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 279
+ K FI+ + RL + L+ P+L D+
Sbjct: 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 42/332 (12%), Positives = 91/332 (27%), Gaps = 52/332 (15%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVA------WNQVNIEDV---------------MQ 54
L +LG+ + D+ G + + ++
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 55 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS---------GSLR 105
+ Q + + +K K +D+ + + L+ L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 106 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165
+ HK++ A Q++R L LH + ++H L+ +I + G V +
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVL-DQRGGVFLTGFE 256
Query: 166 LAIVMQQPT---ARSVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYP 216
+ PE A + D ++ G+ I + + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 217 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVT 275
+ + + K V+ +E + RL L+ ++ P
Sbjct: 317 NTD-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY-- 367
Query: 276 DNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMD 307
+ + + L L E + P
Sbjct: 368 EQLRTELSAALPLYQTDGEPTREGGAPPSGTS 399
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 69/288 (23%), Positives = 126/288 (43%), Gaps = 27/288 (9%)
Query: 17 QYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+ E+LG GAF V+ + G A + + L +E+ +LK +KH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD----SSLENEIAVLKKIKH 65
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGLHY 132
ENI+ + + T+ ++ +L + G L R + K +Q+L + Y
Sbjct: 66 ENIVTLEDIYESTTH--YYLVMQLVSGGELFDRILERGVYT--EKDASLVIQQVLSAVKY 121
Query: 133 LHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-L 189
LH + I+HRDLK +N+ N ++ I D GL+ + Q + GTP ++APE L
Sbjct: 122 LHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVL 179
Query: 190 YEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTD 244
++ Y++ VD +S G I ++ C YP Y E +++++K+ G + +++
Sbjct: 180 AQKPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFWDDISE 236
Query: 245 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 291
K FI + + R + L P++ + P +
Sbjct: 237 -SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQI 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 72/285 (25%), Positives = 130/285 (45%), Gaps = 21/285 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 77
E LG G F V K ++ G+E A + S + R + EV +L+ + H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
I ++ + + T+ + +I EL + G L + + +++ + ++ +QIL G++YLH+
Sbjct: 78 ITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 138 PPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LYEE 192
I H DLK +NI + N +K+ D GLA ++ +++ GTPEF+APE + E
Sbjct: 136 --IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 193 EYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQV 247
D++S G I ++ + + +TS S ++
Sbjct: 194 PLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFFSHTSE-LA 249
Query: 248 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 291
K FI K +V RL E L+ P++ + + + + NL
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNL 294
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 69/283 (24%), Positives = 130/283 (45%), Gaps = 24/283 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
+ EILG G F V+K + G+++A + + E + +E+ ++ L H
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT----RGMKDKEEVKNEISVMNQLDHA 146
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGLHYL 133
N+I+ Y+++ + I ++ E G L R + + ++ I + +QI G+ ++
Sbjct: 147 NLIQLYDAFESKND--IVLVMEYVDGGELFDRIIDESYNLTELDTI-LFMKQICEGIRHM 203
Query: 134 HSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LY 190
H I+H DLK +NI VN + ++KI D GLA + + GTPEF+APE +
Sbjct: 204 HQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 191 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 245
+ + D++S G+ I M+ + N A+ + + + +++
Sbjct: 262 YDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNILACRWDLEDEEFQDISE- 317
Query: 246 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLR 287
+ K+FI K ++ S R+ A E LK P+L + +
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 65/315 (20%), Positives = 113/315 (35%), Gaps = 61/315 (19%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENII 78
+G+G++ V + A +N + Q +P +ER+ +EV L+K L H NI
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA--------------- 123
+ Y + D+ I ++ EL G L +
Sbjct: 92 RLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 124 -------------------------RQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNG 157
RQI LHYLH+ I HRD+K +N F +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSF 207
Query: 158 EVKIGDLGLAIVMQQPTA------RSVIGTPEFMAPEL---YEEEYNELVDIYSFGMCIL 208
E+K+ D GL+ + + GTP F+APE+ E Y D +S G +L
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLL 266
Query: 209 EMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 264
++ N A +V + + + + ++ + + + R A
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSP-LARDLLSNLLNRNVDERFDA 325
Query: 265 LELLKDPFLVTDNPK 279
+ L+ P++ + K
Sbjct: 326 MRALQHPWISQFSDK 340
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 72/285 (25%), Positives = 131/285 (45%), Gaps = 21/285 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL--ERLYSEVHLLKSLKHENI 77
E LG G F V K ++ G+E A + S + E + EV +L+ + H NI
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
I ++ + + T+ + +I EL + G L + + +++ + ++ +QIL G++YLH+
Sbjct: 78 ITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 138 PPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LYEE 192
I H DLK +NI + N +K+ D GLA ++ +++ GTPEF+APE + E
Sbjct: 136 --IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 193 EYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQV 247
D++S G I ++ + + +T+ S+ ++
Sbjct: 194 PLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITAVSYDFDEEFFSQTSE-LA 249
Query: 248 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 291
K FI K +V RL E L+ P++ + + + + NL
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNL 294
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 50/276 (18%), Positives = 101/276 (36%), Gaps = 33/276 (11%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENI 77
+LG+GAF VY+ + ++ + P + + LK
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN-----WARQILRGLHY 132
+KFY++ + ++ EL++ G+L +KN K + +A ++L +
Sbjct: 130 MKFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 133 LHSHNPPIIHRDLKCDNIFVNG----------NNGEVKIGDLGLAIVMQQP----TARSV 178
+H IIH D+K DN + + + + DLG +I M+ +
Sbjct: 188 VHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 179 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 237
T F E L + +N +D + + M+ Y + + + + +
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHL 305
Query: 238 SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPF 272
+ +F + +P LP+L+LL+
Sbjct: 306 DMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 68/275 (24%), Positives = 126/275 (45%), Gaps = 21/275 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 77
E LG G F V K + G E A + + S + R + EV++L+ ++H NI
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
I ++ + + T+ + +I EL + G L + + +++ + +QIL G+HYLHS
Sbjct: 71 ITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 128
Query: 138 PPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LYEE 192
I H DLK +NI + N N +K+ D G+A ++ +++ GTPEF+APE + E
Sbjct: 129 --IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 193 EYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQV 247
D++S G I ++ E + +++ S ++
Sbjct: 187 PLGLEADMWSIG-VITYILLSGASPFLGE--TKQETLTNISAVNYDFDEEYFSNTSE-LA 242
Query: 248 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 281
K FI + +V R+ + L+ ++ +++
Sbjct: 243 KDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 73/289 (25%), Positives = 135/289 (46%), Gaps = 24/289 (8%)
Query: 17 QYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
+Y E LGKGAF V + + G E A +N + + S ++L E + + LKH
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKH 69
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
NI++ ++S ++ + +I +L T G L + + + +QIL + + H
Sbjct: 70 PNIVRLHDSISEEGH--HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 135 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-L 189
++HR+LK +N+ + VK+ D GLAI ++ GTP +++PE L
Sbjct: 128 QMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 190 YEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTD 244
++ Y + VD+++ G IL ++ YP ++E + ++Y+++ +G VT
Sbjct: 186 RKDPYGKPVDLWACG-VILYILLVGYPPFWDE--DQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 245 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP-KDLVCDPLRLPNL 291
+ K I K + S R+ A E LK P++ + + + L
Sbjct: 243 -EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCL 290
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 55/275 (20%), Positives = 113/275 (41%), Gaps = 27/275 (9%)
Query: 18 YD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
Y E LG+G F V++ + + V + E+ +L +H
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYM-----AKFVKVKGTDQVLVKKEISILNIARHR 61
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKNWARQILRGLHYL 133
NI+ + S+ + MI E + + + R ++ + I ++ Q+ L +L
Sbjct: 62 NILHLHESFESMEE--LVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 134 HSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LY 190
HSHN I H D++ +NI + + +KI + G A ++ R + PE+ APE
Sbjct: 119 HSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 191 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 245
+ + D++S G ++ ++ E QI + + + + +++
Sbjct: 177 HDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISI- 232
Query: 246 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 279
+ F+++ +V R+ A E L+ P+L +
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 27/273 (9%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
LG+GA VY+ + A + + + +E+ +L L H NIIK
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK------KIVRTEIGVLLRLSHPNIIK 112
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ T I+++ EL T G L + + + +QIL + YLH +
Sbjct: 113 LKEIFETPTE--ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG-- 168
Query: 140 IIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LYEEEYN 195
I+HRDLK +N+ + + +KI D GL+ +++ ++V GTP + APE L Y
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG 228
Query: 196 ELVDIYSFG--MCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQVK 248
VD++S G IL C + Y+E + +++++ + +V+ K
Sbjct: 229 PEVDMWSVGIITYIL---LCGFEPFYDE-RGDQFMFRRILNCEYYFISPWWDEVSL-NAK 283
Query: 249 QFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 280
+ K IV RL + L+ P++
Sbjct: 284 DLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 21/274 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL--ERLYSEVHLLKSLKHENI 77
E LG G F V K ++ G++ A + S + E + EV +LK ++H N+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
I + + + T+ + +I EL G L + + +++ + + +QIL G++YLHS
Sbjct: 77 ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 138 PPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LYEE 192
I H DLK +NI + N +KI D GLA + +++ GTPEF+APE + E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 193 EYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQV 247
D++S G I ++ + + V++ + S +
Sbjct: 193 PLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFSNTSA-LA 248
Query: 248 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 280
K FI + +V R+ + L+ P++ + +
Sbjct: 249 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 47/299 (15%), Positives = 86/299 (28%), Gaps = 47/299 (15%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ E L G V+ D + A +V S +LERL+ L E
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFAL-KVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 76 N------------------------IIKFYNSWVDDTNRTINMITELFTS------GSLR 105
+ + D ++ + +L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 106 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165
+ + A+ Q++R L S ++H DN+F+ +G + +GD+
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFI-MPDGRLMLGDVS 239
Query: 166 LAIVMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECK 221
+ T P AP + + ++ + G+ I + P+
Sbjct: 240 AL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 222 NPAQIYKKVTSGIKPA------SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
+ K S P VK I + + RL LE ++ P
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 63/254 (24%), Positives = 109/254 (42%), Gaps = 35/254 (13%)
Query: 16 LQYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDV----MQSPDQLERLYSEVH 67
L+Y LGKG F +V + G VA V PDQ E+
Sbjct: 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVA--------VKQLQHSGPDQQRDFQREIQ 76
Query: 68 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQI 126
+LK+L + I+K+ +++ ++ E SG LR + ++H+ +D + ++ QI
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 127 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP 182
+G+ YL S +HRDL NI V + VKI D GLA ++ R +P
Sbjct: 137 CKGMEYLGSRR--CVHRDLAARNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 183 EF-MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASL 239
F APE L + ++ D++SFG+ + E+ T C+ + ++
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP----- 248
Query: 240 SKVTDPQVKQFIEK 253
++ + +E+
Sbjct: 249 ---ALSRLLELLEE 259
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 74/279 (26%), Positives = 137/279 (49%), Gaps = 21/279 (7%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKF 80
+GKG F V + G EVA + I D Q +P L++L+ EV ++K L H NI+K
Sbjct: 23 IGKGNFAKVKLARHILTGREVA---IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
+ V +T +T+ +I E + G + Y H + K ++ RQI+ + Y H I
Sbjct: 80 FE--VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--I 135
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYE-EEYN-EL 197
+HRDLK +N+ + + +KI D G + + G P + APEL++ ++Y+
Sbjct: 136 VHRDLKAENLLL-DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 198 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCI 255
VD++S G+ + +V+ P++ +N ++ ++V G P +S + +++ +
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRIPFYMS----TDCENLLKRFL 249
Query: 256 VP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 293
V R +++KD ++ + +D + P P L
Sbjct: 250 VLNPIKRGTLEQIMKDRWINAGHEEDEL-KPFVEPELDI 287
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 37/290 (12%)
Query: 17 QYD--EILGKGAFKTVYKGFDEVDGIEVA--------WNQVNIEDVMQSPDQLERLYSEV 66
Y+ EILG+G V + + E A + E+V + + + EV
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK---EV 74
Query: 67 HLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 125
+L+ + H NII+ +++ +T ++ +L G L Y + + K + R
Sbjct: 75 DILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 126 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEF 184
+L + LH N I+HRDLK +NI ++ ++ +K+ D G + + R V GTP +
Sbjct: 133 LLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 189
Query: 185 MAPE-------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI- 234
+APE Y + VD++S G I+ + P ++ + + + SG
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTLLAGSPPFWHR--KQMLMLRMIMSGNY 246
Query: 235 --KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 281
+D VK + + +V R A E L PF +++
Sbjct: 247 QFGSPEWDDYSDT-VKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 68/288 (23%), Positives = 122/288 (42%), Gaps = 26/288 (9%)
Query: 18 YD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
YD E LG GAF V++ + G A V E + E+ + L+H
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT----PHESDKETVRKEIQTMSVLRHP 214
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSL-RQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
++ ++++ DD + MI E + G L + +H + + RQ+ +GL ++H
Sbjct: 215 TLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 135 SHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LYE 191
+N +H DLK +NI F + E+K+ D GL + + + GT EF APE
Sbjct: 273 ENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 330
Query: 192 EEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQ 246
+ D++S G + ++ E N + + V S ++ S +++
Sbjct: 331 KPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISE-D 386
Query: 247 VKQFIEKCIVP-ASLRLPALELLKDPFLVTDN--PKDLVCDPLRLPNL 291
K FI K ++ + R+ + L+ P+L N +D R +
Sbjct: 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 434
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 63/304 (20%), Positives = 119/304 (39%), Gaps = 34/304 (11%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENI 77
++LG G V + F G + A ++ + EV +I
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCA---------LKLLYDSPKARQEVDHHWQASGGPHI 84
Query: 78 IKFYNSWVDDTN--RTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGLHYL 133
+ + + + + R + +I E G L R + + + R I + +L
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 134 HSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LY 190
HSHN I HRD+K +N+ + + + +K+ D G A Q ++ TP ++APE L
Sbjct: 145 HSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLG 202
Query: 191 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKN--PAQIYKKVTSG---IKPASLSKVT 243
E+Y++ D++S G I+ ++ C +P Y+ + +++ G S+V+
Sbjct: 203 PEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261
Query: 244 DPQVKQFIEKCIVP-ASLRLPALELLKDPFL-----VTDNPKDLVCDPLRLPNLVPEVMN 297
+ KQ I + + RL + + P++ V P + EV
Sbjct: 262 E-DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKE 320
Query: 298 LAHS 301
S
Sbjct: 321 EMTS 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 69/249 (27%), Positives = 110/249 (44%), Gaps = 24/249 (9%)
Query: 16 LQYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
L++ + LGKG F +V + G VA ++ + + L E+ +LKS
Sbjct: 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKS 67
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGL 130
L+H+NI+K+ R + +I E GSLR Y +KHK +D + + QI +G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--PEF-M 185
YL + IHRDL NI V N VKIGD GL + + + P F
Sbjct: 128 EYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 186 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244
APE L E +++ D++SFG+ + E+ T Y E G ++
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDK--QGQMIV 238
Query: 245 PQVKQFIEK 253
+ + ++
Sbjct: 239 FHLIELLKN 247
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 59/299 (19%), Positives = 122/299 (40%), Gaps = 19/299 (6%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG+G++ V + D A + + + + P+ + E+ LL+ L+H+N+I+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
+ ++ + + M+ E G K + + Q++ GL YLHS I
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--I 130
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELY--EEEY 194
+H+D+K N+ + G +KI LG+A + A G+P F PE+ + +
Sbjct: 131 VHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189
Query: 195 N-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFI 251
+ VDI+S G+ + + T YP+ N ++++ + G P P + +
Sbjct: 190 SGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSYAIPGDCG----PPLSDLL 244
Query: 252 EKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDID 309
+ + + R ++ + + +P P+ + P+ D+
Sbjct: 245 KGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDLH 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-34
Identities = 66/299 (22%), Positives = 111/299 (37%), Gaps = 51/299 (17%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENI 77
++ILG G+ TV G VA ++ D + E+ LL +S H N+
Sbjct: 20 EKILGYGSSGTVVFQ-GSFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNV 71
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSL-------RQYRKKHKNVDMKAIKNWARQILRGL 130
I++Y S D + + EL + +L + K + RQI G+
Sbjct: 72 IRYYCSETTDRF--LYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 131 HYLHSHNPPIIHRDLKCDNIFVN------------GNNGEVKIGDLGLAIVMQ------Q 172
+LHS IIHRDLK NI V+ N + I D GL + +
Sbjct: 129 AHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 173 PTARSVIGTPEFMAPEL--------YEEEYNELVDIYSFGMCILEMVTCEYP--YNECKN 222
+ GT + APEL + +DI+S G +++ ++
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 223 PAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 279
+ I + + S + L + + I + I R A+++L+ P + K
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 63/277 (22%), Positives = 115/277 (41%), Gaps = 23/277 (8%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENI 77
+ LG+G F V + + G E A + D + E+ +L+ K +
Sbjct: 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRV 91
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
I + + + + I +I E G + + + V + +QIL G++YLH
Sbjct: 92 INLHEVYENTSE--IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 136 HNPPIIHRDLKCDNI-FVNGN-NGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LYE 191
+N I+H DLK NI + G++KI D G++ + R ++GTPE++APE L
Sbjct: 150 NN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY 207
Query: 192 EEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQ 246
+ D+++ G+ I M+ E + + Y ++ + S V+
Sbjct: 208 DPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQETYLNISQVNVDYSEETFSSVSQ-L 263
Query: 247 VKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 282
FI+ +V R A L +L + ++L
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 69/249 (27%), Positives = 110/249 (44%), Gaps = 24/249 (9%)
Query: 16 LQYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
L++ + LGKG F +V + G VA ++ + + L E+ +LKS
Sbjct: 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKS 98
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGL 130
L+H+NI+K+ R + +I E GSLR Y +KHK +D + + QI +G+
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--PEF-M 185
YL + IHRDL NI V N VKIGD GL + + + P F
Sbjct: 159 EYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215
Query: 186 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244
APE L E +++ D++SFG+ + E+ T Y E G ++
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDK--QGQMIV 269
Query: 245 PQVKQFIEK 253
+ + ++
Sbjct: 270 FHLIELLKN 278
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 83/339 (24%), Positives = 138/339 (40%), Gaps = 69/339 (20%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+++G G+F V++ EVA I+ V+Q E+ +++ +KH N++
Sbjct: 46 KVIGNGSFGVVFQAKLVESD-EVA-----IKKVLQDK---RFKNRELQIMRIVKHPNVVD 96
Query: 80 ----FYNSWVDDTNRTINMITELFTS---GSLRQYRKKHKNVDMKAIKNWARQILRGLHY 132
FY++ +N++ E + R Y K + + M IK + Q+LR L Y
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY- 190
+HS I HRD+K N+ ++ +G +K+ D G A I++ S I + + APEL
Sbjct: 157 IHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIF 214
Query: 191 -EEEYNELVDIYSFGMCIL-EMVTCE--------------------YPYNE---CKNPAQ 225
Y +DI+S G C++ E++ + P E NP
Sbjct: 215 GATNYTTNIDIWSTG-CVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273
Query: 226 IYKKVTSGIKPASLSKV----TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPK 279
+ K I+P SKV T P I + + P S RL A+E L PF
Sbjct: 274 MEHKFPQ-IRPHPFSKVFRPRTPPDAIDLISRLLEYTP-SARLTAIEALCHPFF------ 325
Query: 280 DLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD 318
D LR + + P + +++S
Sbjct: 326 ----DELRTGE-----ARMPNGRELPPLFNWTKEELSVR 355
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 56/240 (23%), Positives = 108/240 (45%), Gaps = 33/240 (13%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVA----------------------WNQVNIEDVMQSPDQL 59
+GKG++ V ++E D A + +Q +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 60 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 119
E++Y E+ +LK L H N++K D + M+ EL G + + + +A
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 120 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RS 177
+ + +++G+ YLH IIHRD+K N+ V G +G +KI D G++ + A +
Sbjct: 141 F-YFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 178 VIGTPEFMAPEL---YEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 233
+GTP FMAPE + ++ + +D+++ G+ + V + P+ + + ++ K+ S
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQ 255
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 61/283 (21%), Positives = 111/283 (39%), Gaps = 29/283 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSL----K 73
+LGKG F TV+ G D ++VA + V+ EV LL +
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGS-LRQYRKKHKNVDMKAIKNWARQILRGLHY 132
H +I+ + +T ++ E L Y + + + + Q++ + +
Sbjct: 97 HPGVIRLLD--WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE- 191
HS ++HRD+K +NI ++ G K+ D G ++ GT + PE
Sbjct: 155 CHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISR 212
Query: 192 EEYN-ELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQV 247
+Y+ ++S G+ +L +MV + P+ +++ PA +S P
Sbjct: 213 HQYHALPATVWSLGI-LLYDMVCGDIPFER-------DQEILEAELHFPAHVS----PDC 260
Query: 248 KQFIEKCIVPA-SLRLPALELLKDPFLVTDNPKDLVCDPLRLP 289
I +C+ P S R E+L DP++ T + P
Sbjct: 261 CALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGP 303
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 65/278 (23%), Positives = 124/278 (44%), Gaps = 30/278 (10%)
Query: 17 QYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL----ERLYSEVHLLK 70
+YD +++G+G V + G E A + + SP+QL E E H+L+
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 71 SLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 129
+ H +II +S+ + + ++ +L G L Y + + K ++ R +L
Sbjct: 155 QVAGHPHIITLIDSYESSSF--MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 188
+ +LH++N I+HRDLK +NI ++ +N ++++ D G + ++ R + GTP ++APE
Sbjct: 213 VSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 189 -------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KP 236
Y + VD+++ G IL + P ++ + + + G
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACG-VILFTLLAGSPPFWHR--RQILMLRMIMEGQYQFSS 326
Query: 237 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
+ VK I + + RL A + L+ PF
Sbjct: 327 PEWDDRSST-VKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 15 FLQYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
FL+ LG+G F V + G +VA V + + L E+ +L+
Sbjct: 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVA---VKSLKPESGGNHIADLKKEIEILR 78
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRG 129
+L HENI+K+ +D I +I E SGSL++Y K+K +++K +A QI +G
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF- 184
+ YL S +HRDL N+ V + +VKIGD GL ++ T + +P F
Sbjct: 139 MDYLGSRQ--YVHRDLAARNVLV-ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 185 MAPE-LYEEEYNELVDIYSFGMCILEMVT 212
APE L + ++ D++SFG+ + E++T
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-33
Identities = 74/312 (23%), Positives = 126/312 (40%), Gaps = 65/312 (20%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+++G G+F VY+ G VA I+ V+Q E+ +++ L H NI++
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVA-----IKKVLQDK---RFKNRELQIMRKLDHCNIVR 111
Query: 80 ----FYNSWVDDTNRTINMITELFTS---GSLRQYRKKHKNVDMKAIKNWARQILRGLHY 132
FY+S +N++ + R Y + + + + +K + Q+ R L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY- 190
+HS I HRD+K N+ ++ + +K+ D G A +++ S I + + APEL
Sbjct: 172 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 229
Query: 191 -EEEYNELVDIYSFGMCIL-EMVTCE--------------------YPYNE---CKNPAQ 225
+Y +D++S G C+L E++ + P E NP
Sbjct: 230 GATDYTSSIDVWSAG-CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN- 287
Query: 226 IYKKVT-SGIKPASLSKV----TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNP 278
Y + IK +KV T P+ + + P + RL LE F
Sbjct: 288 -YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP-TARLTPLEACAHSFF----- 340
Query: 279 KDLVCDPLRLPN 290
D LR PN
Sbjct: 341 -----DELRDPN 347
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 56/283 (19%), Positives = 111/283 (39%), Gaps = 26/283 (9%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHE--NI 77
LG G F +VY G D + VA V + + R+ EV LLK + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 78 IKFYNSWVDDTNRTINMITELFT-SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
I+ + + + +I E L + + + + +++ Q+L + + H+
Sbjct: 111 IRLLD--WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 168
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN 195
++HRD+K +NI ++ N GE+K+ D G +++ GT + PE Y+
Sbjct: 169 G--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 226
Query: 196 -ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIE 252
++S G+ + +MV + P+ +++ G +S + + I
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQVFFRQRVS----SECQHLIR 275
Query: 253 KCIVPASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLPNLVPE 294
C+ P E+ P++ + L +L P
Sbjct: 276 WCLALRPSDRPTFEEIQNHPWMQDVLLPQETA-EIHLHSLSPG 317
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 66/304 (21%), Positives = 122/304 (40%), Gaps = 32/304 (10%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 73
D+ LG+G+F K + A ++ E+ LK +
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEANTQKEITALKLCEG 64
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
H NI+K + + D + ++ EL G L + KK K+ R+++ + ++
Sbjct: 65 HPNIVKLHEVFHDQLH--TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 134 HSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE- 188
H ++HRDLK +N+ F + +N E+KI D G A + ++ T + APE
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 189 LYEEEYNELVDIYSFGMCILEMVTCEYP-------YNECKNPAQIYKKVTSG---IKPAS 238
L + Y+E D++S G IL + C + +I KK+ G + +
Sbjct: 181 LNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 239 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 297
V+ + K I+ + + RL L + +L + +PL P+++
Sbjct: 240 WKNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS--NPLMTPDILGSSGA 296
Query: 298 LAHS 301
H+
Sbjct: 297 AVHT 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 16 LQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
+ ++LG GAF TVYKG E I VA + SP + + E +++ S
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMAS 73
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGL 130
+ + ++ + + T+ +IT+L G L Y ++HK N+ + + NW QI +G+
Sbjct: 74 VDNPHVCRLLG--IC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGT--P-EFMA 186
+YL ++HRDL N+ V VKI D GLA ++ + G P ++MA
Sbjct: 131 NYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 187 PE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
E + Y D++S+G+ + E++T PY+ ++I + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 16 LQYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
L+ LG+G F V ++ G VA V P E+ +L++
Sbjct: 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA---VKALKADAGPQHRSGWKQEIDILRT 89
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 131
L HE+IIK+ D ++ ++ E GSLR Y +H + + + +A+QI G+
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMA 148
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MA 186
YLH+ + IHRDL N+ + N+ VKIGD GLA + + R +P F A
Sbjct: 149 YLHAQH--YIHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205
Query: 187 PE-LYEEEYNELVDIYSFGMCILEMVT 212
PE L E ++ D++SFG+ + E++T
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 66/267 (24%), Positives = 119/267 (44%), Gaps = 15/267 (5%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG+GA+ V + V VA V+++ + P+ +++ E+ + K L HEN++KFY
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 71
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
+ E + G L + + + + Q++ G+ YLH I
Sbjct: 72 G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--IT 127
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPE-LYEEEYN- 195
HRD+K +N+ ++ +KI D GLA V + ++ GT ++APE L E++
Sbjct: 128 HRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
E VD++S G+ + M+ E P+++ + Q Y + K D + K +
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 256 VP-ASLRLPALELLKDPFLVTDNPKDL 281
V S R+ ++ KD + K
Sbjct: 247 VENPSARITIPDIKKDRWYNKPLKKGA 273
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 22 LGKGAFKTVYKG--FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G+G + VYK D D + A Q+ + S E+ LL+ LKH N+I
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRELKHPNVIS 82
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA---------IKNWARQILRGL 130
++ +R + ++ + + L K H+ +K+ QIL G+
Sbjct: 83 LQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-- 185
HYLH++ ++HRDLK NI V G G VKI D+G A + P P +
Sbjct: 142 HYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 186 ---APELY--EEEYNELVDIYSFGMCIL-EMVT 212
APEL Y + +DI++ G CI E++T
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 231
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 67/296 (22%), Positives = 125/296 (42%), Gaps = 17/296 (5%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG+GA+ V + V VA V+++ + P+ +++ E+ + K L HEN++KFY
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 71
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
+ E + G L + + + + Q++ G+ YLH I
Sbjct: 72 G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--IT 127
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE-EEYN- 195
HRD+K +N+ ++ +KI D GLA V + ++ GT ++APEL + E++
Sbjct: 128 HRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIY-KKVTSGIKPASLSKVTDPQVKQFIEKC 254
E VD++S G+ + M+ E P+++ + Q Y K+ D + K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSAPLALLHKI 245
Query: 255 IVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDID 309
+V S R+ ++ KD + K + + + +D
Sbjct: 246 LVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFS 301
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 57/276 (20%), Positives = 116/276 (42%), Gaps = 30/276 (10%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENI 77
++LG G V + F++ + A ++D + EV L + +I
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKM--LQDC-------PKARREVELHWRASQCPHI 117
Query: 78 IKFYNSWVD--DTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGLHYL 133
++ + + + + + ++ E G L R + + + + I + YL
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 134 HSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPE-L 189
HS N I HRD+K +N+ + + N +K+ D G A + + TP ++APE L
Sbjct: 178 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235
Query: 190 YEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQ--IYKKVTSGI---KPASLSKV 242
E+Y++ D++S G I+ ++ C YP Y+ + ++ G S+V
Sbjct: 236 GPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 243 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 277
++ +VK I + + R+ E + P+++
Sbjct: 295 SE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 59/225 (26%), Positives = 88/225 (39%), Gaps = 16/225 (7%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L E +G+G F V+ G D VA E + PD + E +LK H
Sbjct: 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLP--PDLKAKFLQEARILKQYSHP 172
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
NI++ V + I ++ EL G + R + + +K + G+ YL
Sbjct: 173 NIVRLIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-L 189
S IHRDL N V N +KI D G++ + G + APE L
Sbjct: 231 SKC--CIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 190 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
Y+ D++SFG+ + E + PY N Q + V G
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKG 331
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 29/211 (13%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 75
E +G+G + TV+K + VA +V ++ D E + S E+ LLK LKH+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLLKELKHK 61
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLH 134
NI++ ++ V +++ + ++ E F L++Y D + +K++ Q+L+GL + H
Sbjct: 62 NIVRLHD--VLHSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APEL 189
S N ++HRDLK N+ +N NGE+K+ + GLA P R + E + P++
Sbjct: 119 SRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPV-RCY--SAEVVTLWYRPPDV 172
Query: 190 Y--EEEYNELVDIYSFGMCIL-EMVTCEYPY 217
+ Y+ +D++S G CI E+ P
Sbjct: 173 LFGAKLYSTSIDMWSAG-CIFAELANAGRPL 202
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 64/287 (22%), Positives = 118/287 (41%), Gaps = 28/287 (9%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVN----IEDVMQSPDQLERLYSEVHLLKSLKHE 75
LG GAF V+ D+ EV + +ED +L ++ E+ +L ++H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGS-LRQYRKKHKNVDMKAIKNWARQILRGLHYLH 134
NIIK + + + ++ E SG L + +H +D RQ++ + YL
Sbjct: 90 NIIKVLD--IFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYE-E 192
+ IIHRD+K +NI + + +K+ D G A +++ + GT E+ APE+
Sbjct: 148 LKD--IIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGN 204
Query: 193 EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQ 249
Y ++++S G+ L + E NP ++ P +S ++
Sbjct: 205 PYRGPELEMWSLGV-TLYTLVFEE------NPFCELEETVEAAIHPPYLVS----KELMS 253
Query: 250 FIEKCIVP-ASLRLPALELLKDPFLVTD-NPKDLVCDPLRLPNLVPE 294
+ + P R +L+ DP++ N D + + N
Sbjct: 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPES 300
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 30/277 (10%)
Query: 17 QYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLK 73
Y+ E +G G++ + + +E A V I + +S E+ LL+ +
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFA---VKI--IDKSKRDPTE---EIEILLRYGQ 74
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
H NII + V D + + ++TEL G L + K + I + + YL
Sbjct: 75 HPNIITLKD--VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132
Query: 134 HSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE 188
H+ ++HRDLK NI +GN ++I D G A ++ + T F+APE
Sbjct: 133 HAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190
Query: 189 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECK-NPAQIYKKVTSG---IKPASLSK 241
L + Y+ DI+S G +L + Y N P +I ++ SG + +
Sbjct: 191 VLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249
Query: 242 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 277
V+D K + K + RL A +L+ P++V +
Sbjct: 250 VSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 70/265 (26%), Positives = 119/265 (44%), Gaps = 24/265 (9%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLKHEN 76
+ LG G TVY D + I+VA + + + L+R EVH L H+N
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
I+ + +D + M E +L +Y + H + + N+ QIL G+ + H
Sbjct: 73 IVSMIDVDEEDDCYYLVM--EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-E 192
I+HRD+K NI + +N +KI D G+A + + + V+GT ++ +PE + E
Sbjct: 131 R--IVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQVKQFI 251
+E DIYS G+ + EM+ E P+N + I K + + P + V + Q +
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDSV-PNVTTDV-RKDIPQSL 244
Query: 252 EKCIVPASLRLP------ALELLKD 270
I+ A+ + E+ D
Sbjct: 245 SNVILRATEKDKANRYKTIQEMKDD 269
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 23/228 (10%)
Query: 16 LQYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLK 70
L+ E LG G+F V +G + VA V DV+ P+ ++ EV+ +
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVA---VKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRG 129
SL H N+I+ Y V + M+TEL GSL +KH+ + + + +A Q+ G
Sbjct: 77 SLDHRNLIRLYG--V-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EF 184
+ YL S IHRDL N+ + + VKIGD GL + P +
Sbjct: 134 MGYLESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 185 MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 230
APE L ++ D + FG+ + EM T + P+ +QI K+
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKI 237
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 75
LG+G + VYK D V VA ++ +E + E + EV LLK L+H
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLE------HEEEGVPGTAIREVSLLKELQHR 93
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
NII+ + V N +++I E + L++Y K+ +V M+ IK++ Q++ G+++ HS
Sbjct: 94 NIIELKS--VIHHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 136 HNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----A 186
+HRDLK N+ ++ +KIGD GLA P + T E +
Sbjct: 151 RR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF---THEIITLWYRP 205
Query: 187 PELY--EEEYNELVDIYSFGMCIL-EMVT 212
PE+ Y+ VDI+S CI EM+
Sbjct: 206 PEILLGSRHYSTSVDIWSIA-CIWAEMLM 233
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 74/267 (27%), Positives = 124/267 (46%), Gaps = 19/267 (7%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G F V G ++ G +VA +N ++S D + ++ E+ LK +H +IIK Y
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
V T M+ E + G L Y KH V+ + +QIL + Y H H ++
Sbjct: 78 Q--VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VV 133
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYE-EEYN-ELV 198
HRDLK +N+ ++ + KI D GL+ +M R+ G+P + APE+ Y V
Sbjct: 134 HRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEV 192
Query: 199 DIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCI 255
DI+S G+ IL + C P+++ ++ ++KK+ G+ P L+ V + +
Sbjct: 193 DIWSCGV-ILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLN----RSVATLLMHML 246
Query: 256 VP-ASLRLPALELLKDPFLVTDNPKDL 281
R ++ + + D P L
Sbjct: 247 QVDPLKRATIKDIREHEWFKQDLPSYL 273
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 22/202 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ LG+G + TVYKG ++ VA ++ +E +P R EV LLK LKH NI+
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 64
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNP 138
++ + T +++ ++ E + L+QY N+ +M +K + Q+LRGL Y H
Sbjct: 65 LHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK- 120
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APELY--E 191
++HRDLK N+ +N GE+K+ D GLA PT E + P++
Sbjct: 121 -VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY---DNEVVTLWYRPPDILLGS 175
Query: 192 EEYNELVDIYSFGMCIL-EMVT 212
+Y+ +D++ G CI EM T
Sbjct: 176 TDYSTQIDMWGVG-CIFYEMAT 196
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 65/307 (21%), Positives = 124/307 (40%), Gaps = 47/307 (15%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENI 77
+++LG+GA V + + E A V I + + R++ EV +L + H N+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYA---VKIIEKQPGHIR-SRVFREVEMLYQCQGHRNV 73
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
++ + ++ ++ E GS+ + K ++ + + + L +LH+
Sbjct: 74 LELIEFFEEEDR--FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 138 PPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ---------QPTARSVIGTPEFMA 186
I HRDLK +NI + VKI D L ++ P + G+ E+MA
Sbjct: 132 --IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 187 PE------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECK-------------NPAQ 225
PE Y++ D++S G IL ++ YP C
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLG-VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 226 IYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 281
+++ + G + ++ K I K +V A RL A ++L+ P++ P++
Sbjct: 249 LFESIQEGKYEFPDKDWAHISC-AAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307
Query: 282 VCDPLRL 288
+ P+ L
Sbjct: 308 LPTPMVL 314
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 26/206 (12%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE----RLYSEVHLLKSLKHE 75
+ LG+G F TVYK D+ VA ++ + ++ D + R E+ LL+ L H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLLQELSHP 72
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLH 134
NII +++ +N I+++ + F L K + V IK + L+GL YLH
Sbjct: 73 NIIGLLDAFGHKSN--ISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APEL 189
H I+HRDLK +N+ ++ NG +K+ D GLA P R+ T + + APEL
Sbjct: 130 QHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPN-RAY--THQVVTRWYRAPEL 183
Query: 190 Y--EEEYNELVDIYSFGMCIL-EMVT 212
Y VD+++ G CIL E++
Sbjct: 184 LFGARMYGVGVDMWAVG-CILAELLL 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 16 LQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
+ ++LG GAF TVYKG E I VA + SP + + E +++ S
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMAS 73
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGL 130
+ + ++ + T+ +IT+L G L Y ++HK N+ + + NW QI +G+
Sbjct: 74 VDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG-TP-EFMA 186
+YL ++HRDL N+ V VKI D GLA + ++ + G P ++MA
Sbjct: 131 NYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 187 PE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
E + Y D++S+G+ + E++T PY+ ++I + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 4e-30
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E LG G + TVYKG ++ G+ VA +V ++ +P R E+ L+K LKHENI++
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKELKHENIVR 67
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA------IKNWARQILRGLHYL 133
Y+ V T + ++ E F L++Y + +K + Q+L+GL +
Sbjct: 68 LYD--VIHTENKLTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APE 188
H + I+HRDLK N+ +N G++K+GD GLA P + E + AP+
Sbjct: 125 HENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTF---SSEVVTLWYRAPD 178
Query: 189 LY--EEEYNELVDIYSFGMCIL-EMVT 212
+ Y+ +DI+S G CIL EM+T
Sbjct: 179 VLMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 30/206 (14%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 75
E +G+G + VYK D I VA ++ ++ + E + S E+ LLK L H
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRI-VALKRIRLD------AEDEGIPSTAIREISLLKELHHP 79
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLH 134
NI+ + V + R + ++ E F L++ ++K IK + Q+LRG+ + H
Sbjct: 80 NIVSLID--VIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APEL 189
H I+HRDLK N+ +N ++G +K+ D GLA P T E + AP++
Sbjct: 137 QHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSY---THEVVTLWYRAPDV 190
Query: 190 Y--EEEYNELVDIYSFGMCIL-EMVT 212
++Y+ VDI+S G CI EM+T
Sbjct: 191 LMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 30/206 (14%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 75
E +G+G + VYK + A ++ +E + E + S E+ +LK LKH
Sbjct: 8 EKIGEGTYGVVYKAQNNYGET-FALKKIRLE------KEDEGIPSTTIREISILKELKHS 60
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLH 134
NI+K Y+ V T + + ++ E L++ + + K++ Q+L G+ Y H
Sbjct: 61 NIVKLYD--VIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APEL 189
++HRDLK N+ +N GE+KI D GLA P R T E + AP++
Sbjct: 118 DRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV-RKY--THEIVTLWYRAPDV 171
Query: 190 Y--EEEYNELVDIYSFGMCIL-EMVT 212
++Y+ +DI+S G CI EMV
Sbjct: 172 LMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 68/306 (22%), Positives = 126/306 (41%), Gaps = 36/306 (11%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G G F D++ VA + + E + E+ +SL+H NI++F
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAID-----ENVQREIINHRSLRHPNIVRFK 82
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
V T + +I E + G L + + + +Q+L G+ Y HS I
Sbjct: 83 E--VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--IC 138
Query: 142 HRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYE-EEYN-EL 197
HRDLK +N ++G+ +KI D G + + +S +GTP ++APE+ +EY+ ++
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI 198
Query: 198 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--------LSKVTDPQVKQ 249
D++S G+ + M+ YP+ E + Y+K I +S P+
Sbjct: 199 ADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYSIPDDIRIS----PECCH 253
Query: 250 FIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL---------VPEVMNLA 299
I + V + R+ E+ + + + P DL+ + + +M +
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQII 313
Query: 300 HSEPHP 305
P
Sbjct: 314 SEATIP 319
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 47/242 (19%), Positives = 97/242 (40%), Gaps = 41/242 (16%)
Query: 16 LQYDEILGKGAFKTVYKG-------FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 68
L ++E LG+G F ++KG + ++ EV ++ + E + +
Sbjct: 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNYSESFFEAASM 65
Query: 69 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQIL 127
+ L H++++ Y V ++ E GSL Y KK+KN +++ A+Q+
Sbjct: 66 MSKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 128 RGLHYLHSHNPPIIHRDLKCDNIFVN-------GNNGEVKIGDLGLAIVMQQPTARSVIG 180
+H+L + +IH ++ NI + GN +K+ D G+ + +V+
Sbjct: 124 AAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI--------SITVLP 173
Query: 181 TPEF------MAPE--LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVT 231
+ PE + N D +SFG + E+ + + P + + + +
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYE 232
Query: 232 SG 233
Sbjct: 233 DR 234
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 48/203 (23%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHENII 78
+G+G++ V+K + G VA + D R E+ +LK LKH N++
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLKHPNLV 65
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHN 137
V R ++++ E + ++ +++ V +K+ Q L+ +++ H HN
Sbjct: 66 NLLE--VFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APELY-- 190
IHRD+K +NI + + +K+ D G A ++ P+ E +PEL
Sbjct: 123 --CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYY---DDEVATRWYRSPELLVG 176
Query: 191 EEEYNELVDIYSFGMCIL-EMVT 212
+ +Y VD+++ G C+ E+++
Sbjct: 177 DTQYGPPVDVWAIG-CVFAELLS 198
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 53/229 (23%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 16 LQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
L+ ++LG G F TV+KG E I V + + + + + + + S
Sbjct: 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVC---IKVIEDKSGRQSFQAVTDHMLAIGS 71
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGL 130
L H +I++ ++ ++T+ GSL + ++H+ + + + NW QI +G+
Sbjct: 72 LDHAHIVRLLGLC---PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTP-EFMA 186
+YL H ++HR+L N+ + + +V++ D G+A ++ S TP ++MA
Sbjct: 129 YYLEEHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 187 PE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
E ++ +Y D++S+G+ + E++T PY + A++ + G
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-AEVPDLLEKG 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 85/331 (25%), Positives = 148/331 (44%), Gaps = 27/331 (8%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIED--VMQSPDQLERLYSEVHLLKSLKHENIIK 79
LG+G+F V +VA + +++ D R+ E+ LK L+H +IIK
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
Y+ V T I M+ E + G L Y + K + + + +QI+ + Y H H
Sbjct: 74 LYD--VITTPTDIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK-- 128
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEYN-E 196
I+HRDLK +N+ ++ +N VKI D GL+ +M ++ G+P + APE+ + Y
Sbjct: 129 IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKC 254
VD++S G+ + M+ P+++ + ++KKV S + P LS P + I +
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLS----PGAQSLIRRM 242
Query: 255 IVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHK 313
IV R+ E+ +DP+ + P L + + E D +
Sbjct: 243 IVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIVE 302
Query: 314 KVSADSCAKSN--TGTWFLTLELQRLTENNE 342
+ +D ++N + L E Q + E E
Sbjct: 303 ALRSD---ENNEVKEAYNLLHENQVIQEKLE 330
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 51/228 (22%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 19 DEILGKGAFKTVYKGF--DEVDGIEVAWNQVNI----EDVMQSPDQLERLYSEVHLLKSL 72
D+ LG G F TV KG+ + VA + + P + L +E ++++ L
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVA-----VKILKNEAN-DPALKDELLAEANVMQQL 75
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 132
+ I++ + + ++ E+ G L +Y +++++V K I Q+ G+ Y
Sbjct: 76 DNPYIVRMIG--IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAP 187
L N +HRDL N+ + KI D GL+ + + ++ P ++ AP
Sbjct: 133 LEESN--FVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189
Query: 188 E-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
E + +++ D++SFG+ + E + + PY K ++ + G
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKG 236
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 72/323 (22%), Positives = 115/323 (35%), Gaps = 78/323 (24%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ G+G F TV G ++ G+ VA I+ V+Q P R + L L H NI++
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVA-----IKKVIQDPRFRNRELQIMQDLAVLHHPNIVQ 83
Query: 80 ----FYNSWVDDTNRT-INMITELFTS---GSLRQYRKKHKNVDMKAIKNWARQILRGLH 131
FY D +N++ E R Y ++ IK + Q++R +
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIG 143
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM------ 185
LH + + HRD+K N+ VN +G +K+ D G A+ + + E
Sbjct: 144 CLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS--------AKKLSPS-EPNVAYICS 194
Query: 186 ----APELY--EEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKN------------PA 224
APEL + Y VDI+S G CI EM+ E + +
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVG-CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253
Query: 225 QIYKKVTSG--------IKPASLSKV-------TDPQVKQFIEKCIV--PASLRLPALEL 267
++ +K+ K S V + + + P R+ E
Sbjct: 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP-EERMKPYEA 312
Query: 268 LKDPFLVTDNPKDLVCDPLRLPN 290
L P+ D L P
Sbjct: 313 LCHPYF----------DELHDPA 325
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 57/227 (25%), Positives = 106/227 (46%), Gaps = 19/227 (8%)
Query: 16 LQYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 72
+ + ILG+G F VY+G + + I VA +D D E+ SE ++K+L
Sbjct: 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCT--LDNKEKFMSEAVIMKNL 70
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLH 131
H +I+K + +I EL+ G L Y + ++ + + ++ QI + +
Sbjct: 71 DHPHIVKLIG--II-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT--P-EFMAPE 188
YL S N +HRD+ NI V + VK+GD GL+ ++ T P ++M+PE
Sbjct: 128 YLESIN--CVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 184
Query: 189 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+ + D++ F +C+ E+++ + P+ +N + + G
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKG 230
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 75/312 (24%), Positives = 124/312 (39%), Gaps = 56/312 (17%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 78
++G+G++ V K ++ G VA + D + R E+ LLK L+HEN++
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR---EIKLLKQLRHENLV 87
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHN 137
V + ++ E F ++ + N +D + ++ + QI+ G+ + HSHN
Sbjct: 88 NLLE--VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APELY-- 190
IIHRD+K +NI V+ +G VK+ D G A + P E APEL
Sbjct: 145 --IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY---DDEVATRWYRAPELLVG 198
Query: 191 EEEYNELVDIYSFGMCIL-EMVTCEYPY--------------------NE------CKNP 223
+ +Y + VD+++ G C++ EM E P KNP
Sbjct: 199 DVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 224 AQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNP 278
++ + L + V +KC+ P R ELL F D
Sbjct: 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK-RPFCAELLHHDFFQMDGF 315
Query: 279 KDLVCDPLRLPN 290
+ L+L
Sbjct: 316 AERFSQELQLKV 327
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 48/202 (23%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKF 80
LG+G + V++ + + +V + P + +++ E+ +L++L+ NII
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNIITL 96
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
+ D +RT ++ E + +Q + + D I+ + +IL+ L Y HS I
Sbjct: 97 ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMG--I 151
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPE--LYEEEYN 195
+HRD+K N+ ++ + ++++ D GLA Q+ R + + F PE + + Y+
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--VASRYFKGPELLVDYQMYD 209
Query: 196 ELVDIYSFGMCIL-EMVTCEYP 216
+D++S G C+L M+ + P
Sbjct: 210 YSLDMWSLG-CMLASMIFRKEP 230
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-28
Identities = 77/270 (28%), Positives = 129/270 (47%), Gaps = 17/270 (6%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G F V G E+ G +VA +N ++S D + ++ E+ LK +H +IIK Y
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
V T I M+ E + G L Y K+ +D K + +QIL G+ Y H H ++
Sbjct: 83 Q--VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VV 138
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYE-EEYN-ELV 198
HRDLK +N+ ++ + KI D GL+ +M R+ G+P + APE+ Y V
Sbjct: 139 HRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEV 197
Query: 199 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV 256
DI+S G+ + ++ P+++ + ++KK+ GI P L+ P V ++ +
Sbjct: 198 DIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLN----PSVISLLKHMLQ 252
Query: 257 P-ASLRLPALELLKDPFLVTDNPKDLVCDP 285
R ++ + + D PK L +
Sbjct: 253 VDPMKRATIKDIREHEWFKQDLPKYLFPED 282
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 21/210 (10%)
Query: 17 QY--DEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 73
QY + G +Y D V+G V + + +E L +
Sbjct: 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVV---LKGLVHSGDAEAQAMAMAERQFLAEVV 137
Query: 74 HENIIKFYNSWVDDTNRTINMIT----ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 129
H +I++ +N +V+ T+R + + E SL++ + + V +AI + +IL
Sbjct: 138 HPSIVQIFN-FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA-EAI-AYLLEILPA 194
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL 189
L YLHS +++ DLK +NI + ++K+ DLG + + GTP F APE+
Sbjct: 195 LSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAVSRINSFGY--LYGTPGFQAPEI 248
Query: 190 YEEEYNELVDIYSFGMCIL-EMVTCEYPYN 218
DIY+ G L + N
Sbjct: 249 VRTGPTVATDIYTVG-RTLAALTLDLPTRN 277
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 18/225 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
+ LG G + VY+G + + VA + ED M+ +E E ++K +KH
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAV-KTLKEDTME----VEEFLKEAAVMKEIKHP 276
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYL 133
N+++ V +ITE T G+L Y ++ + V + A QI + YL
Sbjct: 277 NLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-L 189
N IHR+L N V G N VK+ D GL+ +M TA + P ++ APE L
Sbjct: 335 EKKN--FIHRNLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 190 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+++ D+++FG+ + E+ T PY +Q+Y+ +
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 435
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 57/227 (25%), Positives = 103/227 (45%), Gaps = 19/227 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 72
++ +G+G F V++G + VA E+ E ++
Sbjct: 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTS--DSVREKFLQEALTMRQF 73
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLH 131
H +I+K V T + +I EL T G LR + + K ++D+ ++ +A Q+ L
Sbjct: 74 DHPHIVKLIG--V-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT--P-EFMAPE 188
YL S +HRD+ N+ V+ N+ VK+GD GL+ M+ T P ++MAPE
Sbjct: 131 YLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 187
Query: 189 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+ + D++ FG+C+ E++ P+ KN + ++ +G
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENG 233
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 20/226 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
+ LG G + VY+G + + VA + ED M+ E E ++K +KH
Sbjct: 15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEV----EEFLKEAAVMKEIKHP 69
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYL 133
N+++ V +ITE T G+L Y ++ + V + A QI + YL
Sbjct: 70 NLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE- 188
N IHRDL N V N+ VK+ D GL+ +M T + G +F APE
Sbjct: 128 EKKN--FIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGA-KFPIKWTAPES 183
Query: 189 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
L +++ D+++FG+ + E+ T PY +Q+Y+ +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 20/225 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
+ + LG G F V G + +VA + E M + + E + L H
Sbjct: 10 ITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIK-EGSMSEDEFFQ----EAQTMMKLSHP 63
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
++KFY V I ++TE ++G L Y R K ++ + + G+ +L
Sbjct: 64 KLVKFYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-L 189
SH IHRDL N V+ + VK+ D G+ + S +GT +F APE
Sbjct: 122 SHQ--FIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVF 177
Query: 190 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+ +Y+ D+++FG+ + E+ + + PY+ N +++ KV+ G
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQG 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 73/380 (19%), Positives = 137/380 (36%), Gaps = 107/380 (28%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ LG G+F V + FD G A ++ V+Q P E+ ++K L H NIIK
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFA-----LKKVLQDP---RYKNRELDIMKVLDHVNIIK 64
Query: 80 ----FYNSWVDDTNRT--------------------------------INMITELFTS-- 101
FY + ++ +N+I E
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 102 -GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 160
L+ + + +++ M I + Q+ R + ++HS I HRD+K N+ VN + +K
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLK 182
Query: 161 IGDLGLAIVMQQPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL 208
+ D G A+ +I + E APEL EY +D++S G C+
Sbjct: 183 LCDFGS--------AKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVF 232
Query: 209 -EMVTCE--YPYNECKN------------PAQIYKKVTSG--------IKPASLSKV--- 242
E++ + + + + ++ +K K+
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292
Query: 243 -TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVT-DNPKDL-VCDPLRLPNL----VP 293
T +E+ + P LR+ E + PF N + V + P+ +P
Sbjct: 293 GTPSLAIDLLEQILRYEP-DLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIP 351
Query: 294 EVMNLAHSEPHPMDIDLNHK 313
++ N + E + ++ ++
Sbjct: 352 QLFNFSPYELSIIPGNVLNR 371
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 69/212 (32%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLK-- 73
+G GA+ TVYK D G VA V + L EV LL+ L+
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVREVALLRRLEAF 71
Query: 74 -HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQIL 127
H N+++ + + D + ++ E LR Y K + A IK+ RQ L
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 128 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-- 185
RGL +LH++ I+HRDLK +NI V + G VK+ D GLA + A TP +
Sbjct: 131 RGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL----TPVVVTL 183
Query: 186 ---APE-LYEEEYNELVDIYSFGMCIL-EMVT 212
APE L + Y VD++S G CI EM
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 20/225 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L + + +G G F V+ G+ + +VA + E M D +E E ++ L H
Sbjct: 10 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR-EGAMSEEDFIE----EAEVMMKLSHP 63
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 134
+++ Y V I ++TE G L Y + + + + + G+ YL
Sbjct: 64 KLVQLYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-L 189
+IHRDL N V G N +K+ D G+ + S GT +F +PE
Sbjct: 122 EAC--VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVF 177
Query: 190 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
Y+ D++SFG+ + E+ + + PY N +++ + +++G
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 66/314 (21%), Positives = 118/314 (37%), Gaps = 75/314 (23%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+ LG G V+ D VA ++ + D + E+ +++ L H+N
Sbjct: 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV----KHALREIKIIRRLDHDN 69
Query: 77 IIKFYN------------SWVDDTNRTINMITEL--------FTSGSLRQYRKKHKNVDM 116
I+K + ++ ++ E G L ++H
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL---EEH----- 121
Query: 117 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 176
+ + Q+LRGL Y+HS N ++HRDLK N+F+N + +KIGD GLA +M +
Sbjct: 122 --ARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 177 SVIGTPE-----FMAPE--LYEEEYNELVDIYSFGMCIL-EMVT---------------- 212
+ + +P L Y + +D+++ G CI EM+T
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQL 236
Query: 213 --------CEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIV--PAS 259
E E + +Y + L+++ + F+E+ + P
Sbjct: 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296
Query: 260 LRLPALELLKDPFL 273
RL A E L P++
Sbjct: 297 -RLTAEEALSHPYM 309
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 20/225 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L + + LG G F V G +VA + E M + +E E ++ +L HE
Sbjct: 26 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIK-EGSMSEDEFIE----EAKVMMNLSHE 79
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
+++ Y V R I +ITE +G L Y R+ + + + + + YL
Sbjct: 80 KLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-L 189
S +HRDL N VN VK+ D GL+ + S +G+ +F PE L
Sbjct: 138 SKQ--FLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVL 193
Query: 190 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+++ DI++FG+ + E+ + + PY N ++ + + G
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQG 237
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 64/214 (29%), Positives = 92/214 (42%), Gaps = 27/214 (12%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
Q +LG+GA+ V + G VA ++ P R E+ +LK KHEN
Sbjct: 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKHEN 70
Query: 77 IIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
II +N D+ N +I EL + L + D I+ + Q LR + L
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDH-IQYFIYQTLRAVKVL 128
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFM------ 185
H N +IHRDLK N+ +N N ++K+ D GLA I G M
Sbjct: 129 HGSN--VIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 186 ----APE--LYEEEYNELVDIYSFGMCIL-EMVT 212
APE L +Y+ +D++S G CIL E+
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFL 218
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 53/235 (22%), Positives = 96/235 (40%), Gaps = 42/235 (17%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+ ++G G++ V + +D+++ VA + I V + +R+ E+ +L L H++
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKK--ILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 77 IIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
++K + + + ++ E+ S ++ + + IK +L G+ Y+
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------------------IVMQQPT 174
HS I+HRDLK N VN + VK+ D GLA M T
Sbjct: 173 HSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 175 ARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVTCEYP 216
+ APE L +E Y E +D++S G CI E++
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKE 283
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 19/227 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 72
++ +G+G F V++G + VA S E+ E ++
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQF 448
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLH 131
H +I+K T + +I EL T G LR + + K +D+ ++ +A Q+ L
Sbjct: 449 DHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT--P-EFMAPE 188
YL S +HRD+ N+ V+ N+ VK+GD GL+ M+ T P ++MAPE
Sbjct: 506 YLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 562
Query: 189 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+ + D++ FG+C+ E++ P+ KN + ++ +G
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENG 608
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 20/232 (8%)
Query: 14 LFLQYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
L + ++E++G+G F VY G ++ I A V + + ++ + +E ++K
Sbjct: 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFLTEGIIMK 81
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRG 129
H N++ + + ++ G LR + R + N +K + + Q+ +G
Sbjct: 82 DFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 140
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----- 184
+ YL S +HRDL N ++ VK+ D GLA M SV
Sbjct: 141 MKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 185 -MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233
MA E L +++ D++SFG+ + E++T PY + I + G
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 248
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 20/232 (8%)
Query: 14 LFLQYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
+ D ++GKG F VY G I+ A ++ + Q+E E L++
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMR 77
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRG 129
L H N++ + +++ G L Q+ R +N +K + ++ Q+ RG
Sbjct: 78 GLNHPNVLALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF--- 184
+ YL +HRDL N ++ + VK+ D GLA I+ ++ +
Sbjct: 137 MEYLAEQK--FVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVK 193
Query: 185 -MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
A E L + D++SFG+ + E++T PY + + G
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQG 244
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 64/248 (25%), Positives = 117/248 (47%), Gaps = 15/248 (6%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 80
ILG+G+F TV + E A + +++ +++ + E ++ L H +K
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPFFVKL 95
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 140
Y ++ DD + +G L +Y +K + D + + +I+ L YLH I
Sbjct: 96 YFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--I 151
Query: 141 IHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPE-LYEEEYN 195
IHRDLK +NI +N + ++I D G A +Q A S +GT ++++PE L E+
Sbjct: 152 IHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 210
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
+ D+++ G I ++V P+ N I++K+ + P+ + +EK +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEKLL 267
Query: 256 VP-ASLRL 262
V A+ RL
Sbjct: 268 VLDATKRL 275
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 65/271 (23%), Positives = 108/271 (39%), Gaps = 31/271 (11%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLKHEN 76
EILG G V+ D D +VA V + D+ + P R E +L H
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 77 IIKFYNSWVDDTNRT----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 132
I+ Y++ +T I M E +LR + K + L++
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVM--EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----SVIGTPEFMAP 187
H + IIHRD+K NI + VK+ D G+A + +VIGT ++++P
Sbjct: 132 SHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 188 ELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDP 245
E + + D+YS G + E++T E P+ +P + Y+ V P S
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPS---ARHE 244
Query: 246 QVKQFIEKCIVPASLRLP------ALELLKD 270
+ ++ ++ A + P A E+ D
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G GA+ +V D+ G +VA + + QS +R Y E+ LLK ++HEN+I
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKK--LSRPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 80 FYN----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+ + ++ + L++ + I+ Q+L+GL Y+HS
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHS 144
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEE 193
++HRDLK N+ VN + E+KI D GLA V+ T + APE L
Sbjct: 145 AG--VVHRDLKPGNLAVNE-DCELKILDFGLARHADAEMTGYVV-TRWYRAPEVILSWMH 200
Query: 194 YNELVDIYSFGMCIL-EMVT 212
YN+ VDI+S G CI+ EM+T
Sbjct: 201 YNQTVDIWSVG-CIMAEMLT 219
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 61/292 (20%), Positives = 114/292 (39%), Gaps = 57/292 (19%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVA-------WNQVNIEDVMQSPDQLERLYSEVHLL 69
+ G++ V G D +GI VA + +++ +R+ E+ LL
Sbjct: 25 TVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 70 KSLKHENIIKFYN---SWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 125
H NI+ + + + + ++TEL + L Q + + + I+ +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYH 142
Query: 126 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 185
IL GLH LH ++HRDL NI + NN ++ I D L AR
Sbjct: 143 ILLGLHVLHEAG--VVHRDLHPGNILLADNN-DITICDFNL--------ARE-DTADANK 190
Query: 186 ----------APE--LYEEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKNPAQIYKKV 230
APE + + + +LVD++S G C++ EM + + + N Q+ K+
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAG-CVMAEMFNRKALFRGSTFYN--QL-NKI 246
Query: 231 TSGI---KPASLSKVTDPQVKQFIEKCI-----VPASLRLP-----ALELLK 269
+ K + + P + ++ + + +P AL+L+
Sbjct: 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA 298
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-27
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 20/225 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ + LG+G F V+ G VA M E E ++K L+HE
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWN-GTTRVAIK-TLKPGTMSP----EAFLQEAQVMKKLRHE 239
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYL 133
+++ Y + I ++TE + GSL + K K + + + + A QI G+ Y+
Sbjct: 240 KLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-L 189
N +HRDL+ NI V N K+ D GLA +++ TAR P ++ APE
Sbjct: 297 ERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 190 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+ D++SFG+ + E+ T PY N ++ +V G
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 397
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 78
+G+G F V+K G +VA +V +E+ + P R E+ +L+ LKHEN++
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLLKHENVV 79
Query: 79 KFY------NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLH 131
S + +I ++ + F L + IK + +L GL+
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG-TPE-----FM 185
Y+H + I+HRD+K N+ + +G +K+ D GLA T +
Sbjct: 139 YIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 195
Query: 186 APELY--EEEYNELVDIYSFGMCIL-EMVT 212
PEL E +Y +D++ G CI+ EM T
Sbjct: 196 PPELLLGERDYGPPIDLWGAG-CIMAEMWT 224
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 51/246 (20%), Positives = 96/246 (39%), Gaps = 43/246 (17%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI----EDVMQSPDQLERLYSEVHLLKS 71
+LGKG F +V + ++ + ++ +V + D++ + +E E +K
Sbjct: 25 FTLGRMLGKGEFGSVREA--QLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKE 81
Query: 72 LKHENIIKFY----NSWVDDTNRTINMITELFTSGSLRQYRKKHK------NVDMKAIKN 121
H ++ K S +I G L + + N+ ++ +
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 122 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 181
+ I G+ YL S N IHRDL N + + V + D GL+ R +
Sbjct: 142 FMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCVADFGLS--------RKIYSG 190
Query: 182 PEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 227
+ +A E L + Y D+++FG+ + E++T + PY +N A+IY
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIY 249
Query: 228 KKVTSG 233
+ G
Sbjct: 250 NYLIGG 255
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-27
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 20/225 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ + LG+G F V+ G VA M E E ++K L+HE
Sbjct: 269 LRLEVKLGQGCFGEVWMGTWN-GTTRVAIK-TLKPGTMSP----EAFLQEAQVMKKLRHE 322
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYL 133
+++ Y + I ++TE + GSL + K K + + + + A QI G+ Y+
Sbjct: 323 KLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-L 189
N +HRDL+ NI V N K+ D GLA +++ TAR P ++ APE
Sbjct: 380 ERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436
Query: 190 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+ D++SFG+ + E+ T PY N ++ +V G
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 480
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 20/229 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 72
+ ++I+G G V G V G + VA + + + L SE ++
Sbjct: 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYT-ERQRRDFL-SEASIMGQF 107
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLH 131
H NII+ V R ++TE +GSL + + H + + R + G+
Sbjct: 108 DHPNIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT--P-EFMA 186
YL +HRDL N+ V+ N K+ D GL+ V++ A + G P + A
Sbjct: 166 YLSDLG--YVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 187 PE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
PE + ++ D++SFG+ + E++ E PY N + V G
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEG 270
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-27
Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 37/226 (16%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
++G+G++ VY +D+ VA + + + + +R+ E+ +L LK +
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKK--VNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 77 IIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
II+ Y+ + D + ++ E+ S L++ K + + IK +L G +++
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--------------IVMQQPTARSVI 179
H IIHRDLK N +N + VK+ D GLA + +
Sbjct: 146 HESG--IIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 180 GTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 212
+ + APE L +E Y + +DI+S G CI E++
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLN 247
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 10 SLFVLFLQYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 67
+F + +Y + +G+GA+ V +D ++ + VA +++ + +R E+
Sbjct: 21 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIK 77
Query: 68 LLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWAR 124
+L +HENII + T + ++ +L + L + K + I +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDH-ICYFLY 135
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 183
QILRGL Y+HS N ++HRDLK N+ +N ++KI D GLA V + T
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 184 ----FMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 212
+ APE L + Y + +DI+S G CIL EM++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVG-CILAEMLS 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 21/230 (9%)
Query: 16 LQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
+ +++G G F VYKG + VA + +++ L E ++
Sbjct: 46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYT-EKQRVDFL-GEAGIMGQ 102
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGL 130
H NII+ V + + +ITE +G+L ++ ++ + + R I G+
Sbjct: 103 FSHHNIIRLEG--VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT--P-EFM 185
YL + N +HRDL NI VN N K+ D GL+ V++ + G P +
Sbjct: 161 KYLANMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 186 APE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
APE + ++ D++SFG+ + E++T E PY E N ++ K + G
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDG 266
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 46/225 (20%), Positives = 94/225 (41%), Gaps = 20/225 (8%)
Query: 19 DEILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
D LG G F +V +G I+VA + + E + E ++ L +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHS 135
I++ V + ++ E+ G L ++ K + + + + Q+ G+ YL
Sbjct: 72 IVRLIG--VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAPE-L 189
N +HRDL N+ + + KI D GL+ + + P ++ APE +
Sbjct: 129 KN--FVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 190 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+++ D++S+G+ + E ++ + PY + K ++ + G
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQG 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 35/213 (16%)
Query: 20 EILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLK- 73
+G+GA+ V+K D G VA +V ++ E + EV +L+ L+
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT------GEEGMPLSTIREVAVLRHLET 70
Query: 74 --HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQI 126
H N+++ ++ D + ++ E L Y K + IK+ Q+
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 127 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM- 185
LRGL +LHSH ++HRDLK NI V ++G++K+ D GLA + A T +
Sbjct: 130 LRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL----TSVVVT 182
Query: 186 ----APE-LYEEEYNELVDIYSFGMCIL-EMVT 212
APE L + Y VD++S G CI EM
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 51/244 (20%), Positives = 103/244 (42%), Gaps = 40/244 (16%)
Query: 16 LQYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 72
L +ILG+G F +V +G ++ ++VA + +++ S ++E SE +K
Sbjct: 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDF 93
Query: 73 KHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHK------NVDMKAIKNWA 123
H N+I+ ++ +++ I +I G L Y + ++ ++ + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 183
I G+ YL + N +HRDL N + + V + D GL ++ +
Sbjct: 154 VDIALGMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFGL--------SKKIYSGDY 202
Query: 184 F------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKK 229
+ +A E L + Y D+++FG+ + E+ T PY +N ++Y
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDY 261
Query: 230 VTSG 233
+ G
Sbjct: 262 LLHG 265
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 53/232 (22%), Positives = 100/232 (43%), Gaps = 20/232 (8%)
Query: 14 LFLQYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
L + ++E++G+G F VY G ++ I A V + + ++ + +E ++K
Sbjct: 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFLTEGIIMK 145
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRG 129
H N++ + + ++ G LR + R + N +K + + Q+ +G
Sbjct: 146 DFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 204
Query: 130 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE------ 183
+ +L S +HRDL N ++ VK+ D GLA M SV
Sbjct: 205 MKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 184 FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233
+MA E L +++ D++SFG+ + E++T PY + I + G
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 312
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 50/223 (22%), Positives = 97/223 (43%), Gaps = 20/223 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ + +GKG F V G + G +VA + D + +E ++ L+H
Sbjct: 23 LKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIK-NDATA-----QAFLAEASVMTQLRHS 74
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYL 133
N+++ + + + ++TE GSL Y + + + ++ + + YL
Sbjct: 75 NLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-EFMAPE-LYE 191
+N +HRDL N+ V+ +N K+ D GL + P ++ APE L E
Sbjct: 134 EGNN--FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALRE 188
Query: 192 EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
++++ D++SFG+ + E+ + PY + +V G
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 230
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 20/229 (8%)
Query: 16 LQYDEILGKGAFKTVYKG---FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 72
+ D+++G G F V G I VA + + + L E ++
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYT-EKQRRDFL-GEASIMGQF 103
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLH 131
H NII+ V ++ + ++TE +GSL + +KH + + R I G+
Sbjct: 104 DHPNIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT--P-EFMA 186
YL +HRDL NI +N N K+ D GL V++ A + G P + +
Sbjct: 162 YLSDMG--YVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 187 PE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
PE + ++ D++S+G+ + E+++ E PY E N + K V G
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEG 266
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 51/228 (22%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 78
+ LGKGA+ V+K D G VA + I D Q+ +R + E+ +L L HENI+
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKK--IFDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 79 KFYNSWVDDTNRTINMITEL--------FTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 130
N D +R + ++ + + L H + Q+++ +
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL---EPVH-------KQYVVYQLIKVI 122
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------------IVMQQPTARS 177
YLHS ++HRD+K NI +N VK+ D GL+ + +
Sbjct: 123 KYLHSGG--LLHRDMKPSNILLNA-ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 178 VIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 212
+ APE L +Y + +D++S G CIL E++
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILC 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 70/210 (33%), Positives = 101/210 (48%), Gaps = 36/210 (17%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G GA+ +V FD G+ VA + QS +R Y E+ LLK +KHEN+I
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 80 FYN----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+ + + + ++T L + L K + + ++ QILRGL Y+HS
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM---------- 185
+ IIHRDLK N+ VN + E+KI D GL AR T + M
Sbjct: 151 AD--IIHRDLKPSNLAVNEDC-ELKILDFGL--------ARH---TADEMTGYVATRWYR 196
Query: 186 APE--LYEEEYNELVDIYSFGMCIL-EMVT 212
APE L YN+ VDI+S G CI+ E++T
Sbjct: 197 APEIMLNWMHYNQTVDIWSVG-CIMAELLT 225
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 20/225 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ ++ LG G F V+ +VA M L E +++K+L+H+
Sbjct: 190 LKLEKKLGAGQFGEVWMATYN-KHTKVAVK-TMKPGSMSVEAFLA----EANVMKTLQHD 243
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYL 133
++K + T I +ITE GSL + K + + + +++ QI G+ ++
Sbjct: 244 KLVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-L 189
N IHRDL+ NI V+ + KI D GLA V++ TAR P ++ APE +
Sbjct: 301 EQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 357
Query: 190 YEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233
+ D++SFG+ ++E+VT PY NP ++ + + G
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERG 401
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 63/239 (26%), Positives = 120/239 (50%), Gaps = 15/239 (6%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
LG G+F V + G A ++ + V++ Q+E +E +L+++ ++K
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
S+ D++N + M+ E G + + ++ + +A QI+ YLHS + +I
Sbjct: 108 FSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 163
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 200
+RDLK +N+ ++ G +++ D G A ++ T ++ GTPE +APE + + YN+ VD
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKGYNKAVDW 221
Query: 201 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIEKCIVP 257
++ G+ I EM P+ P QIY+K+ SG ++ P+ S +K + +
Sbjct: 222 WALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHFS----SDLKDLLRNLLQV 275
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 57/244 (23%), Positives = 95/244 (38%), Gaps = 40/244 (16%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSE 65
+ LG+G+F VY+G VA V E + S + +E
Sbjct: 27 ITMSRELGQGSFGMVYEG--------VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 66 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY----------RKKHKNVD 115
++K ++++ V + +I EL T G L+ Y
Sbjct: 79 ASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 116 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 175
+ + A +I G+ YL+++ +HRDL N V + VKIGD G+ + +
Sbjct: 137 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDY 193
Query: 176 RSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 229
G M+PE L + + D++SFG+ + E+ T E PY N Q+ +
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRF 252
Query: 230 VTSG 233
V G
Sbjct: 253 VMEG 256
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ +G GA V +D + VA + + Q+ +R Y E+ L+K + H+NII
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKK--LSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 80 FYNSWVDDTNRT----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
N + + + ++ EL + +L Q + +D + + Q+L G+ +LHS
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS 145
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FMAPE-L 189
IIHRDLK NI V ++ +KI D GLA + S + TP + APE +
Sbjct: 146 AG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 190 YEEEYNELVDIYSFGMCIL-EMVT 212
Y E VDI+S G CI+ EM+
Sbjct: 199 LGMGYKENVDIWSVG-CIMGEMIK 221
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 2e-25
Identities = 45/225 (20%), Positives = 94/225 (41%), Gaps = 20/225 (8%)
Query: 19 DEILGKGAFKTVYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
D LG G F +V +G + I+VA + + E + E ++ L +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHS 135
I++ + ++ E+ G L ++ + + + + Q+ G+ YL
Sbjct: 398 IVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAPE-L 189
N +HR+L N+ + N KI D GL+ + + P ++ APE +
Sbjct: 455 KN--FVHRNLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 190 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+++ D++S+G+ + E ++ + PY + K P ++ + G
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQG 555
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 51/274 (18%), Positives = 106/274 (38%), Gaps = 47/274 (17%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENI 77
++LG G V + F++ + A ++D + EV L + +I
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKM--LQDC-------PKARREVELHWRASQCPHI 73
Query: 78 IKFYNSWVD--DTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGLHYL 133
++ + + + + + ++ E G L R + + + + I + YL
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 134 HSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE 191
HS N I HRD+K +N+ + + N +K+ D G A E
Sbjct: 134 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------AKETTG 172
Query: 192 EEYNELVDIYSFGMCILEMVTCEYP----YNECKNPAQIYKKVTSGI---KPASLSKVTD 244
E+Y++ D++S G I+ ++ C YP + + ++ G S+V++
Sbjct: 173 EKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231
Query: 245 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 277
+VK I + + R+ E + P+++
Sbjct: 232 -EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 20/225 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ E LG G F V+ G+ +VA + + M L E +L+K L+H+
Sbjct: 15 LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLA----EANLMKQLQHQ 68
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYL 133
+++ Y T I +ITE +GSL + K + + + + A QI G+ ++
Sbjct: 69 RLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-L 189
N IHRDL+ NI V+ KI D GLA +++ TAR P ++ APE +
Sbjct: 126 EERN--YIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 190 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
+ D++SFG+ + E+VT PY NP ++ + + G
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERG 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 53/260 (20%), Positives = 93/260 (35%), Gaps = 28/260 (10%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLKHEN 76
++G+G VY+ D V VA + + E + P R+ E L+ +
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
++ ++ D ++M L L ++ + RQI L H+
Sbjct: 96 VVPIHDFGEIDGQLYVDM--RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-E 192
HRD+K +NI V + + D G+A + +GT +MAPE +
Sbjct: 154 G--ATHRDVKPENILV-SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 193 EYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251
DIY+ C+L E +T PY + + + + I S P +
Sbjct: 211 HATYRADIYALT-CVLYECLTGSPPY-QGDQLSVMGAHINQAIPRPS---TVRPGIPVAF 265
Query: 252 EKCIVPASLRLPALELLKDP 271
+ I + K+P
Sbjct: 266 DAVIARG--------MAKNP 277
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ +G GA+ V D G +VA + + QS +R Y E+ LLK ++HEN+I
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 80 FYNSWVDDTNRT----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+ + D ++ + L + KH+ + I+ Q+L+GL Y+H+
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHA 146
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEE 193
IIHRDLK N+ VN + E+KI D GLA V+ T + APE L
Sbjct: 147 AG--IIHRDLKPGNLAVNE-DCELKILDFGLARQADSEMTGYVV-TRWYRAPEVILNWMR 202
Query: 194 YNELVDIYSFGMCIL-EMVT 212
Y + VDI+S G CI+ EM+T
Sbjct: 203 YTQTVDIWSVG-CIMAEMIT 221
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 51/228 (22%), Positives = 116/228 (50%), Gaps = 20/228 (8%)
Query: 57 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 116
+++ ++ E+ +++ L+H ++ + S+ D+ + + M+ +L G LR + +++ +
Sbjct: 57 NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED--MFMVVDLLLGGDLRYHLQQNVHFKE 114
Query: 117 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-A 175
+ +K + +++ L YL + IIHRD+K DNI ++ +G V I D +A ++ + T
Sbjct: 115 ETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQI 171
Query: 176 RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKK 229
++ GT +MAPE++ Y+ VD +S G+ E++ PY + +I
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
Query: 230 VTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD-PFL 273
+ + P++ S ++ ++K + P R L +++ P++
Sbjct: 232 FETTVVTYPSAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 28/238 (11%)
Query: 16 LQYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
+ LG GAF VY+G ++ ++VA + + S E ++
Sbjct: 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIIS 88
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------KNVDMKAIKNWA 123
H+NI++ V + ++ EL G L+ + ++ ++ M + + A
Sbjct: 89 KFNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGT 181
R I G YL ++ IHRD+ N + G KIGD G+A + + + G
Sbjct: 147 RDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 182 PEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233
M PE E + D +SFG+ + E+ + PY N ++ + VTSG
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG 261
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 57/255 (22%), Positives = 103/255 (40%), Gaps = 53/255 (20%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLL 69
L+ + LG+GAF V + + GI+ + E S + L SE+ +L
Sbjct: 29 LKLGKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 70 KSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------K 112
+ H N++ + + +I E G+L Y +
Sbjct: 85 IHIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 113 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172
+ ++ + ++ Q+ +G+ +L S IHRDL NI ++ N VKI D GL
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGL------ 194
Query: 173 PTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYN 218
AR + P++ MAPE +++ Y D++SFG+ + E+ + PY
Sbjct: 195 --ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 219 ECKNPAQIYKKVTSG 233
K + +++ G
Sbjct: 253 GVKIDEEFCRRLKEG 267
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 61/257 (23%), Positives = 102/257 (39%), Gaps = 61/257 (23%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---------SPDQLERLYSEV 66
+ LG+GAF V+ +N +D M + + E
Sbjct: 17 IVLKRELGEGAFGKVFLA--------ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREA 68
Query: 67 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--------------- 111
LL +L+HE+I+KFY V + M+ E G L ++ + H
Sbjct: 69 ELLTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 112 -KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170
+ + + + A QI G+ YL S + +HRDL N V N VKIGD G+
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGM---- 179
Query: 171 QQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYP 216
+R V T + M PE + ++ D++SFG+ + E+ T + P
Sbjct: 180 ----SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 217 YNECKNPAQIYKKVTSG 233
+ + N ++ + +T G
Sbjct: 236 WFQLSN-TEVIECITQG 251
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/248 (22%), Positives = 96/248 (38%), Gaps = 44/248 (17%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---------SPDQLERLYSEV 66
+ LG+GAF V+ N + +D M S + E
Sbjct: 43 IVLKWELGEGAFGKVFLA--------ECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94
Query: 67 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--------------- 111
LL L+H++I++F+ V R + M+ E G L ++ + H
Sbjct: 95 ELLTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 112 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171
+ + + A Q+ G+ YL + +HRDL N V VKIGD G++ +
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIY 209
Query: 172 QPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 225
V G M PE + ++ D++SFG+ + E+ T + P+ + N +
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TE 268
Query: 226 IYKKVTSG 233
+T G
Sbjct: 269 AIDCITQG 276
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 50/229 (21%), Positives = 97/229 (42%), Gaps = 32/229 (13%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ + +GKG F V G + G +VA + D + +E ++ L+H
Sbjct: 195 LKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIK-NDATA-----QAFLAEASVMTQLRHS 246
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYL 133
N+++ + + + ++TE GSL Y + + + ++ + + YL
Sbjct: 247 NLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-------FMA 186
+N +HRDL N+ V+ +N K+ D GL + T + + A
Sbjct: 306 EGNN--FVHRDLAARNVLVSEDN-VAKVSDFGL--------TKEASSTQDTGKLPVKWTA 354
Query: 187 PE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
PE L E++++ D++SFG+ + E+ + PY + +V G
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 402
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 34/209 (16%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ +G GA V +D V VA + + Q+ +R Y E+ L+K + H+NII
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKK--LSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 80 FYN----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
N + + + ++ EL + +L Q + +D + + Q+L G+ +LHS
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS 182
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM---------- 185
IIHRDLK NI V + +KI D GL AR+ GT M
Sbjct: 183 AG--IIHRDLKPSNIVVKSDC-TLKILDFGL--------ART-AGTSFMMTPYVVTRYYR 230
Query: 186 APE-LYEEEYNELVDIYSFGMCIL-EMVT 212
APE + Y E VDI+S G CI+ EMV
Sbjct: 231 APEVILGMGYKENVDIWSVG-CIMGEMVR 258
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 36/245 (14%)
Query: 16 LQYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
+++ E LG+ F VYKG VA + + E E L
Sbjct: 11 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAE--GPLREEFRHEAMLRA 67
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNV 114
L+H N++ V ++ ++MI + G L ++ +
Sbjct: 68 RLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 115 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174
+ + QI G+ YL SH+ ++H+DL N+ V VKI DLGL +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKISDLGLFREVYAAD 182
Query: 175 ARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 228
++G MAPE + +++ DI+S+G+ + E+ + PY N + +
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVE 241
Query: 229 KVTSG 233
+ +
Sbjct: 242 MIRNR 246
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 28/238 (11%)
Query: 16 LQYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
+ LG GAF VY+G ++ ++VA + + S E ++
Sbjct: 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIIS 129
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWA 123
H+NI++ V + ++ EL G L+ + ++ + ++ M + + A
Sbjct: 130 KFNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGT 181
R I G YL ++ IHRD+ N + G KIGD G+A + + G
Sbjct: 188 RDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 182 PEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 233
M PE E + D +SFG+ + E+ + PY N ++ + VTSG
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG 302
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 57/261 (21%), Positives = 98/261 (37%), Gaps = 64/261 (24%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSE 65
L + + LG GAF V + A+ + + M + E L SE
Sbjct: 25 LSFGKTLGAGAFGKVVEA--------TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 66 VHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------------- 111
+ +L L H NI+ +ITE G L + ++
Sbjct: 77 LKVLSYLGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 112 -----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166
+D++ + +++ Q+ +G+ +L S N IHRDL NI + + KI D GL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL-THGRITKICDFGL 191
Query: 167 AIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC 213
AR + + MAPE ++ Y D++S+G+ + E+ +
Sbjct: 192 --------ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 214 -EYPYNECKNPAQIYKKVTSG 233
PY ++ YK + G
Sbjct: 244 GSSPYPGMPVDSKFYKMIKEG 264
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 61/257 (23%), Positives = 105/257 (40%), Gaps = 60/257 (23%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSE 65
LQ+ + LG GAF V + A+ + V++ D+ E L SE
Sbjct: 48 LQFGKTLGAGAFGKVVEA--------TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 66 VHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKN-- 121
+ ++ L +HENI+ + +ITE G L + R+K + ++
Sbjct: 100 LKIMSHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 122 -----------WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170
++ Q+ +G+ +L S N IHRD+ N+ + N KIGD GL
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVAKIGDFGL---- 210
Query: 171 QQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYP 216
AR ++ + MAPE +++ Y D++S+G+ + E+ + P
Sbjct: 211 ----ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 217 YNECKNPAQIYKKVTSG 233
Y ++ YK V G
Sbjct: 267 YPGILVNSKFYKLVKDG 283
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 61/262 (23%), Positives = 104/262 (39%), Gaps = 62/262 (23%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLL 69
L + LG+G F V K ++ + E+ S +L L SE ++L
Sbjct: 25 LVLGKTLGEGEFGKVVKA--TAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80
Query: 70 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------------------ 111
K + H ++IK Y + + +I E GSLR + ++
Sbjct: 81 KQVNHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 112 ------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165
+ + M + ++A QI +G+ YL ++HRDL NI V ++KI D G
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGR-KMKISDFG 195
Query: 166 LAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 212
L +R V + MA E L++ Y D++SFG+ + E+VT
Sbjct: 196 L--------SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 213 C-EYPYNECKNPAQIYKKVTSG 233
PY +++ + +G
Sbjct: 248 LGGNPYPGIPP-ERLFNLLKTG 268
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 61/262 (23%), Positives = 98/262 (37%), Gaps = 61/262 (23%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLL 69
L++ ++LG GAF V GI + + E S + E L SE+ ++
Sbjct: 47 LEFGKVLGSGAFGKVMNA--TAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 102
Query: 70 KSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN------- 121
L HENI+ + I +I E G L Y + + +
Sbjct: 103 TQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 122 ----------------WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165
+A Q+ +G+ +L + +HRDL N+ V VKI D G
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGK-VVKICDFG 217
Query: 166 LAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 212
L AR ++ + MAPE L+E Y D++S+G+ + E+ +
Sbjct: 218 L--------ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
Query: 213 C-EYPYNECKNPAQIYKKVTSG 233
PY A YK + +G
Sbjct: 270 LGVNPYPGIPVDANFYKLIQNG 291
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 67/241 (27%), Positives = 115/241 (47%), Gaps = 19/241 (7%)
Query: 22 LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 77
LG G+F V+ + ++V + E V++ Q+E E +L + H I
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKV----LKKEIVVRL-KQVEHTNDERLMLSIVTHPFI 68
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
I+ + ++ D I MI + G L +K + K +A ++ L YLHS +
Sbjct: 69 IRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNE 196
II+RDLK +NI ++ NG +KI D G A + T ++ GTP+++APE + + YN+
Sbjct: 127 --IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNK 182
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256
+D +SFG+ I EM+ P+ N + Y+K+ + + VK + + I
Sbjct: 183 SIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLIT 239
Query: 257 P 257
Sbjct: 240 R 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 49/266 (18%), Positives = 87/266 (32%), Gaps = 70/266 (26%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSE 65
++Y +G+GAF V++ A + E S D E
Sbjct: 49 IEYVRDIGEGAFGRVFQA--------RAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 100
Query: 66 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------------- 111
L+ + NI+K + + ++ E G L ++ +
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 112 ----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 161
+ ARQ+ G+ YL +HRDL N V N VKI
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKI 215
Query: 162 GDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCIL 208
D GL+ R++ + M PE ++ Y D++++G+ +
Sbjct: 216 ADFGLS--------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267
Query: 209 EMVT-CEYPYNECKNPAQIYKKVTSG 233
E+ + PY + ++ V G
Sbjct: 268 EIFSYGLQPYYGMAH-EEVIYYVRDG 292
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 51/257 (19%), Positives = 112/257 (43%), Gaps = 28/257 (10%)
Query: 21 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
++G+GAF V K +V +++ ++ ++++ + E ++
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKL----LSKFEMIKR-SDSAFFWEERDIMAFANSPW 130
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+++ + ++ DD + M+ E G L + V K + + +++ L +HS
Sbjct: 131 VVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 187
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPEL---- 189
IHRD+K DN+ ++ +G +K+ D G + M + + +GTP++++PE+
Sbjct: 188 G--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 190 -YEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTD--P 245
+ Y D +S G+ + EM+ + P Y + + Y K+ + + D
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMNHKNSLTFPDDNDISK 302
Query: 246 QVKQFIEKCIVPASLRL 262
+ K I + +RL
Sbjct: 303 EAKNLICAFLTDREVRL 319
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 58/247 (23%), Positives = 105/247 (42%), Gaps = 26/247 (10%)
Query: 21 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+LG+G F V+ K ++ + + + + E +L +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-----KGYQGAMVEKKILAKVHSRF 246
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHY 132
I+ ++ +T + ++ + G + + + + QI+ GL +
Sbjct: 247 IVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-L 189
LH N II+RDLK +N+ ++ ++G V+I DLGLA + Q + GTP FMAPE L
Sbjct: 305 LHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 190 YEEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQ 246
EEY+ VD ++ G+ + EM+ P+ E ++ ++V + P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFSPA 419
Query: 247 VKQFIEK 253
K F E
Sbjct: 420 SKDFCEA 426
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 66/257 (25%), Positives = 106/257 (41%), Gaps = 57/257 (22%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--------EDVMQSPDQLERLYSEVH 67
L + LG+GAF V E GI+ + + +D + L L SE+
Sbjct: 37 LTLGKPLGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 92
Query: 68 LLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--------------- 111
++K + KH+NII + + +I E + G+LR+Y +
Sbjct: 93 MMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 112 -KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170
+ + K + + Q+ RG+ YL S IHRDL N+ V NN +KI D GL
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGL---- 203
Query: 171 QQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYP 216
AR + + MAPE L++ Y D++SFG+ + E+ T P
Sbjct: 204 ----ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 217 YNECKNPAQIYKKVTSG 233
Y +++K + G
Sbjct: 260 YPGIPV-EELFKLLKEG 275
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 65/257 (25%), Positives = 105/257 (40%), Gaps = 57/257 (22%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--------EDVMQSPDQLERLYSEVH 67
L + LG+G F V E GI+ + + +D + L L SE+
Sbjct: 83 LTLGKPLGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 138
Query: 68 LLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--------------- 111
++K + KH+NII + + +I E + G+LR+Y +
Sbjct: 139 MMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 112 -KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170
+ + K + + Q+ RG+ YL S IHRDL N+ V NN +KI D GLA
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLA--- 250
Query: 171 QQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYP 216
R + + MAPE L++ Y D++SFG+ + E+ T P
Sbjct: 251 -----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 217 YNECKNPAQIYKKVTSG 233
Y +++K + G
Sbjct: 306 YPGIPV-EELFKLLKEG 321
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 64/255 (25%), Positives = 103/255 (40%), Gaps = 53/255 (20%)
Query: 16 LQYDEILGKGAFKTVYKG--FDEVDGIEVAWNQVNI----EDVMQSPDQLERLYSEVHLL 69
L + LG+GAF V +V + D + L L SE+ ++
Sbjct: 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMM 128
Query: 70 KSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------K 112
K + KH+NII + + +I E + G+LR+Y + +
Sbjct: 129 KMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 113 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172
+ K + + A Q+ RG+ YL S IHRDL N+ V +N +KI D GLA
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLA----- 238
Query: 173 PTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYN 218
R + + MAPE L++ Y D++SFG+ + E+ T PY
Sbjct: 239 ---RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295
Query: 219 ECKNPAQIYKKVTSG 233
+++K + G
Sbjct: 296 GVPV-EELFKLLKEG 309
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 6e-22
Identities = 41/170 (24%), Positives = 82/170 (48%), Gaps = 9/170 (5%)
Query: 88 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 147
T ++ I +L G L + +H ++ +A +I+ GL ++H+ +++RDLK
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKP 320
Query: 148 DNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGM 205
NI ++ +G V+I DLGLA + + +GT +MAPE Y+ D +S G
Sbjct: 321 ANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 206 CILEMVTCEYPY--NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253
+ +++ P+ ++ K+ +I + + L P+++ +E
Sbjct: 380 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEG 427
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 80
ILG+G F VYKG DG VA ++ E Q + +EV ++ H N+++
Sbjct: 37 ILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHRNLLRL 92
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW-ARQ-----ILRGLHYLH 134
+ T R + + +GS+ + + + +W RQ RGL YLH
Sbjct: 93 RGFCMTPTERLL--VYPYMANGSVASCL--RERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 135 SH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPE 188
H +P IIHRD+K NI ++ E +GD GLA +M + V GT +AP
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAP- 204
Query: 189 LYEEEY------NELVDIYSFGMCILEMVTCEYPYNECKNPAQ 225
EY +E D++ +G+ +LE++T + ++ +
Sbjct: 205 ----EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 57/270 (21%), Positives = 113/270 (41%), Gaps = 50/270 (18%)
Query: 21 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
++G+GAF V K D+V +++ + M + E +L + +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKIL-----NKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 77 IIKFYNSWVDDTNRTINMIT------ELFTSGSLRQYRKKHKNVDMKAIKNWAR----QI 126
I + ++ DD N + ++ +L T L ++ + AR ++
Sbjct: 136 ITTLHYAFQDDNN--LYLVMDYYVGGDLLTL--LSKFEDRLPE-------EMARFYLAEM 184
Query: 127 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPE 183
+ + +H + +HRD+K DNI ++ NG +++ D G + + +GTP+
Sbjct: 185 VIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 184 FMAPELYEEE------YNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIK- 235
+++PE+ + Y D +S G+C+ EM+ E P Y E + + Y K+ + +
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKER 299
Query: 236 ---PASLSKVTDPQVKQFIEKCIVPASLRL 262
P ++ V K I + I RL
Sbjct: 300 FQFPTQVTDV-SENAKDLIRRLICSREHRL 328
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHE 75
+G+G F VYKG+ V+ VA ++ + + +L++ E+ ++ +HE
Sbjct: 34 VGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTE-ELKQQFDQEIKVMAKCQHE 90
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVD----MKAIKNWARQILR 128
N+++ D + ++ +GSL + K + A
Sbjct: 91 NLVELLGFSSDGDDLC--LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN---- 144
Query: 129 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS--VIGTPEF 184
G+++LH IHRD+K NI ++ KI D GLA T + ++GT +
Sbjct: 145 GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAY 201
Query: 185 MAPELYEEEYNELVDIYSFGMCILEMVT 212
MAPE E DIYSFG+ +LE++T
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 31/240 (12%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL- 72
+++ +++G+G F V K + DG ++ A ++ E + E+ +L L
Sbjct: 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKD--DHRDFAGELEVLCKLG 83
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW---------- 122
H NII + + + E G+L + +K + ++
Sbjct: 84 HHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 123 ------ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 176
A + RG+ YL IHRDL NI V N KI D GL+ + +
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKK 198
Query: 177 SVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
++ P +MA E L Y D++S+G+ + E+V+ PY A++Y+K+ G
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 257
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 52/244 (21%), Positives = 103/244 (42%), Gaps = 23/244 (9%)
Query: 21 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
+LGKG F V + ++ + + + +E +L+ +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----KGEAMALNEKQILEKVNSRF 245
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGLHYLH 134
++ ++ +T + ++ L G L+ Y +A +I GL LH
Sbjct: 246 VVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPE-LYEE 192
I++RDLK +NI ++ ++G ++I DLGLA+ + + T + +GT +MAPE + E
Sbjct: 304 RER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 193 EYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249
Y D ++ G + EM+ + P+ + ++ + V P S+ PQ +
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERFSPQARS 418
Query: 250 FIEK 253
+
Sbjct: 419 LCSQ 422
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 38/124 (30%), Positives = 69/124 (55%), Gaps = 9/124 (7%)
Query: 123 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 180
A +I L YLHS N I++RDLK +NI ++ + G + + D GL + T + G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCG 201
Query: 181 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PA 237
TPE++APE L+++ Y+ VD + G + EM+ P+ +N A++Y + + ++
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKP 260
Query: 238 SLSK 241
+++
Sbjct: 261 NITN 264
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 22 LGKGAFKTVY---KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
LGKG + V+ K G A + ++++ +E ++L+ +KH I+
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
++ T + +I E + G L ++ + +I L +LH
Sbjct: 85 DLIYAF--QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG- 141
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYN 195
II+RDLK +NI +N + G VK+ D GL + + GT E+MAPE L +N
Sbjct: 142 -IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSK 241
VD +S G + +M+T P+ +N + K+ + P L++
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYLTQ 246
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 47/261 (18%), Positives = 107/261 (40%), Gaps = 30/261 (11%)
Query: 21 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
++G+GAF V K +V +++ + M ++ E +L +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIM-----NKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSL-RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
I + + ++ D+ + ++ E + G L K + + + + + +I+ + +H
Sbjct: 123 ITQLHFAFQDENY--LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPEL--- 189
+HRD+K DNI ++ G +++ D G + +GTP++++PE+
Sbjct: 181 LG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 190 -----YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSK 241
Y D ++ G+ EM + P+ + A+ Y K+ + + +
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTAETYGKIVHYKEHLSLPLVDE 296
Query: 242 VTDPQVKQFIEKCIVPASLRL 262
+ + FI++ + P RL
Sbjct: 297 GVPEEARDFIQRLLCPPETRL 317
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 33/208 (15%)
Query: 21 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHENIIK 79
++G G F VYKG DG +VA + E Q +E+ L +H +++
Sbjct: 46 LIGHGVFGKVYKGVLR-DGAKVALKRRTPESS-----QGIEEFETEIETLSFCRHPHLVS 99
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWAR--QIL----RGLH 131
+ + I + +G+L++ Y + M +W + +I RGLH
Sbjct: 100 LIGFCDERNEMIL--IYKYMENGNLKRHLYGSDLPTMSM----SWEQRLEICIGAARGLH 153
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFM 185
YLH IIHRD+K NI ++ N KI D G++ + T V GT ++
Sbjct: 154 YLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTV--VKGTLGYI 208
Query: 186 APELYEEEY-NELVDIYSFGMCILEMVT 212
PE + + E D+YSFG+ + E++
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 53/229 (23%), Positives = 110/229 (48%), Gaps = 20/229 (8%)
Query: 22 LGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 77
LGKG F V K +++ +V I D++ +E +L++ +H +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVAHTVTESRVLQNTRHPFL 67
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
++ T+ + + E G L + + + + + + +I+ L YLHS +
Sbjct: 68 TALKYAF--QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 194
+++RD+K +N+ ++ +G +KI D GL + T ++ GTPE++APE L + +Y
Sbjct: 126 --VVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSK 241
VD + G+ + EM+ P+ ++ ++++ + I+ P +LS
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLSP 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 8e-20
Identities = 38/122 (31%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 182
++ L +LHS II+RDLK +NI ++ G +K+ D GL+ + + A S GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 183 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 239
E+MAPE + + + D +SFG+ + EM+T P+ + K+ + + P L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFL 249
Query: 240 SK 241
S
Sbjct: 250 SP 251
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 14/128 (10%)
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGT 181
+I+ L +LH II+RD+K +NI ++ +NG V + D GL+ + + A GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 182 PEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSG-I 234
E+MAP++ +++ VD +S G+ + E++T P+ E + A+I +++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
Query: 235 K-PASLSK 241
P +S
Sbjct: 284 PYPQEMSA 291
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 29/217 (13%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK------ 73
LG G F TV+ D V+ VA ++ V E E+ LL+ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVA-----MKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 74 -----HENIIKFYNS--WVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWAR 124
+I+K + + M+ E+ +L KK+++ + +K ++
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEV-LGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFV-----NGNNGEVKIGDLGLAIVMQQPTARSVI 179
Q+L GL Y+H IIH D+K +N+ + N ++KI DLG A + + I
Sbjct: 139 QLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNSI 196
Query: 180 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY 215
T E+ +PE L + DI+S I E++T ++
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 123 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 180
+ +I L+YLH II+RDLK DN+ ++ G +K+ D G+ + T + G
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 181 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 229
TP ++APE L E+Y VD ++ G+ + EM+ P++ + +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 55/241 (22%), Positives = 111/241 (46%), Gaps = 23/241 (9%)
Query: 22 LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 77
LGKG F V K +++ +V + D++ +E +L++ +H +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-----DEVAHTLTENRVLQNSRHPFL 210
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
S+ T+ + + E G L + + + + + +I+ L YLHS
Sbjct: 211 TALKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 194
+++RDLK +N+ ++ + G +KI D GL + T ++ GTPE++APE L + +Y
Sbjct: 269 N-VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY 326
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIE 252
VD + G+ + EM+ P+ ++ ++++ + I+ P +L P+ K +
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTLG----PEAKSLLS 381
Query: 253 K 253
Sbjct: 382 G 382
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 182
+I+ GL +LHS I++RDLK DNI ++ +G +KI D G+ ++ + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 183 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 239
+++APE L ++YN VD +SFG+ + EM+ + P+ ++ +++ + P L
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWL 241
Query: 240 SKVTDPQVKQFIEKCIVPASLRLPALELLKD-PF 272
K + + + RL ++ P
Sbjct: 242 EKEAKDLLVKLFVRE---PEKRLGVRGDIRQHPL 272
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 36/122 (29%), Positives = 64/122 (52%), Gaps = 9/122 (7%)
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 182
+I+ L +LH II+RDLK DN+ ++ G K+ D G+ + T + GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 183 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 239
+++APE L E Y VD ++ G+ + EM+ P+ E +N +++ + + + P L
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWL 247
Query: 240 SK 241
+
Sbjct: 248 HE 249
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 38/122 (31%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 182
+I GL +L S II+RDLK DN+ ++ + G +KI D G+ + T ++ GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 183 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 239
+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P S+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244
Query: 240 SK 241
SK
Sbjct: 245 SK 246
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 123 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 180
+ +I L+YLH II+RDLK DN+ ++ G +K+ D G+ + T + G
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 181 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 229
TP ++APE L E+Y VD ++ G+ + EM+ P++ + +
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 2e-18
Identities = 39/124 (31%), Positives = 71/124 (57%), Gaps = 9/124 (7%)
Query: 123 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 180
A +I GL +L S II+RDLK DN+ ++ G +KI D G+ + T ++ G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFCG 504
Query: 181 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPA 237
TP+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPK 563
Query: 238 SLSK 241
S+SK
Sbjct: 564 SMSK 567
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 23/205 (11%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--- 75
+++GKG+F V K +D VA ++ V + E+ +L+ L+ +
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVA-----LKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 76 ---NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGL 130
N+I N M EL S +L + KK+K + ++ +A IL+ L
Sbjct: 157 NTMNVIHMLE-NFTFRNHIC-MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 131 HYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 188
LH + IIH DLK +NI +K+ D G + Q + I + + APE
Sbjct: 214 DALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-TYIQSRFYRAPEV 270
Query: 189 LYEEEYNELVDIYSFGMCIL-EMVT 212
+ Y +D++S G CIL E++T
Sbjct: 271 ILGARYGMPIDMWSLG-CILAELLT 294
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 27/257 (10%), Positives = 60/257 (23%), Gaps = 48/257 (18%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
G ++ D +VA V+ + D L+ S L + +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVD-PQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
+ + + E GSL++ + + + H
Sbjct: 95 RVLDVVHTRAGGLVVA--EWIRGGSLQEVADTSPSPVGAI--RAMQSLAAAADAAHRAG- 149
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELV 198
+ + V +G+V + M +
Sbjct: 150 -VALSIDHPSRVRV-SIDGDVVLAYPA---TMPDANPQD--------------------- 183
Query: 199 DIYSFGMCILEMVTCEYPYNECKNPAQI---YKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
DI G + ++ +P E + + + + D
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA---DIDRD--------- 231
Query: 256 VPASLRLPALELL-KDP 271
+P + A + D
Sbjct: 232 IPFQISAVAARSVQGDG 248
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 21/204 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---- 75
++GKG+F V K +D V+ VA I+ + L + EV LL+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVA-----IKIIKNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 76 --NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLH 131
I+ N ++ E+ S +L + V + + +A+Q+ L
Sbjct: 115 KYYIVHLKR-HFMFRNHLC-LVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 132 YLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-L 189
+L + IIH DLK +NI N +KI D G + + Q I + + +PE L
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-QYIQSRFYRSPEVL 230
Query: 190 YEEEYNELVDIYSFGMCIL-EMVT 212
Y+ +D++S G CIL EM T
Sbjct: 231 LGMPYDLAIDMWSLG-CILVEMHT 253
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 34/158 (21%), Positives = 67/158 (42%), Gaps = 9/158 (5%)
Query: 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 141
+S ++ + + + ++ + ++ Q+ +G+ +L S I
Sbjct: 158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CI 215
Query: 142 HRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTP---EFMAPE-LYEEEYNE 196
HRDL NI + VKI D GLA + + P ++MAPE +++ Y
Sbjct: 216 HRDLAARNILL-SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 197 LVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 233
D++SFG+ + E+ + PY K + +++ G
Sbjct: 275 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 41/209 (19%), Positives = 74/209 (35%), Gaps = 29/209 (13%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLER--LYSEVHLLKS 71
L+ + LG+GAF V + + GI+ + M + E L SE+ +L
Sbjct: 24 LKLGKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 72 L-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 130
+ H N++ + +I E G+L Y + +N + K + +G
Sbjct: 82 IGHHLNVVNLL-GACTKPGGPLMVIVEFCKFGNLSTYLRSKRN-EFVPYKTKGARFRQGK 139
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 190
Y+ + I DLK + + G + +S+ E APE
Sbjct: 140 DYVGA-----IPVDLKRRLDSITSSQSSASSGFVE---------EKSLSDVEEEEAPEDL 185
Query: 191 EEEYNELVDIYSF------GMCILEMVTC 213
+++ L + + GM L C
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASRKC 214
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 35/193 (18%), Positives = 68/193 (35%), Gaps = 39/193 (20%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G G F +Y F + A + V +E + L+SE+ + + ++ I
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVE-----YQENGPLFSELKFYQRVAKKDCI--- 96
Query: 82 NSWVDDTNRTINMITELFTSG-------------------SLRQYRKKHKNVDMKAIKNW 122
W++ I + SG L++ ++ +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156
Query: 123 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQQ 172
++L L Y+H + +H D+K N+ + N +V + D GL+ Q+
Sbjct: 157 GIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 173 PTARSVIGTPEFM 185
+ GT EF
Sbjct: 215 NPRKGHNGTIEFT 227
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 47/226 (20%), Positives = 89/226 (39%), Gaps = 45/226 (19%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---- 75
+G G F V + A ++ V E +LK ++++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYA-----VKVVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 76 -NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLHY 132
NI+K++ + + +I E SL + ++ ++ IK + +IL+ L+Y
Sbjct: 96 NNIVKYHG-KFMYYDH-MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 133 LHSHNPPIIHRDLKCDNIFVN------------------------GNNGEVKIGDLGLAI 168
L + + H DLK +NI ++ + +K+ D G A
Sbjct: 153 LRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 169 VMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 212
S+I T ++ APE + ++ D++SFG C+L E+ T
Sbjct: 211 FKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG-CVLAELYT 254
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 44/177 (24%), Positives = 68/177 (38%), Gaps = 24/177 (13%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKF 80
+G G+F +Y G D G EVA + +E V QL E + K ++ I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVA---IKLECVKTKHPQLHI---ESKIYKMMQGGVGIPTI 70
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ M+ EL SL + +K + A Q++ + Y+HS N
Sbjct: 71 RWCGAEGDYNV--MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 140 IIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFM 185
IHRD+K DN + V I D GLA + +++ GT +
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 44/221 (19%), Positives = 87/221 (39%), Gaps = 39/221 (17%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---- 75
LG+G F V + D G QV ++ + E E+++LK +K +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKS----QVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 76 --NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLH 131
+ + W + + + EL + ++ K++ + +++ A Q+ L
Sbjct: 81 KFLCVLMSD-WFNFHGH-MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGN------------------NGEVKIGDLGLAIVMQQP 173
+LH + + H DLK +NI + N +++ D G A +
Sbjct: 138 FLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE- 194
Query: 174 TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 212
+++ T + PE + E + + D++S G CIL E
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPCDVWSIG-CILFEYYR 234
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 2e-12
Identities = 105/687 (15%), Positives = 201/687 (29%), Gaps = 209/687 (30%)
Query: 16 LQYDEILG--KGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 73
QY +IL + AF + D D + ++ I+ ++ S D + L S K
Sbjct: 16 YQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS-K 74
Query: 74 HENIIKFYNSWVDDTN------------RTINMITELFTSGSLRQYR-----KKHKNV-- 114
E +++ + V N R +M+T ++ R Y K+ NV
Sbjct: 75 QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY-NVSR 133
Query: 115 --DMKAIKNWARQILRGLHYLHSHNPPIIH---------------RDLKCDNIFVNG--- 154
++ + LR + +I K
Sbjct: 134 LQPYLKLRQALLE-LRPAKNV------LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW 186
Query: 155 -NNGEVKIGDLGLAI-------VMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC 206
N + L + + T+RS + + + E L+ + C
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 207 --ILEMV----TCEYPYNECKNPAQI-----YKKVTSGIKPASLSKVT-DPQVKQFIEKC 254
+L V CK I +K+VT + A+ + ++ D
Sbjct: 247 LLVLLNVQNAKAWNAFNLSCK----ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD- 301
Query: 255 IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKK 314
LL K L C P LP EV+ +P + +
Sbjct: 302 --------EVKSLLL---------KYLDCRPQDLP---REVLTT-----NPRRLSI---- 332
Query: 315 VSADSCAKSNTGTW--FLTLELQRLTENNEFTLRGEKNDDDT---VSLTLRIGDKSGHVS 369
A+S + TW + + +LT E +L + + L
Sbjct: 333 -IAESI-RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL------------ 378
Query: 370 NIHFVFYLNADTAISIAEEMVEQL--DLSHEDVVSIAELIDNLIMK--LVPSWNPSLGST 425
VF +A I ++ + D+ DV ++ N + K LV ST
Sbjct: 379 ---SVFPPSAH----IPTILLSLIWFDVIKSDV----MVVVNKLHKYSLVEKQPKE--ST 425
Query: 426 ASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDS 485
S + L+ + +K E + + + Y +
Sbjct: 426 ISIPSIYLE---------LKVKLENEYALHRSIVD--------------HYNIPKTFDSD 462
Query: 486 DISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSE 545
D+ + D Y + + H + + ++L + +
Sbjct: 463 DLIPPYL---------------DQYFYSHIGH-HLKNIEHPERMTLFRMVFLD------- 499
Query: 546 TSFIDS---CSGMSKNLSFSSISSLS--------LADKE-HSDGL---------KLELDA 584
F++ + N S S +++L + D + + L K+E +
Sbjct: 500 FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENL 559
Query: 585 INSKYQQCFQELLRQREDEM--ENARK 609
I SKY + L ++ + E ++
Sbjct: 560 ICSKYTDLLRIALMAEDEAIFEEAHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 7e-04
Identities = 38/244 (15%), Positives = 80/244 (32%), Gaps = 61/244 (25%)
Query: 4 LDLVIWSLFVLFLQYDEILGKGAFKTVYKGF----DEVDGI-----EVAWNQVNIEDVMQ 54
L +I + L+ E ++ ++ I + W V DVM
Sbjct: 355 LTTII-ESSLNVLEPAE------YRKMFDRLSVFPPSAH-IPTILLSLIWFDVIKSDVMV 406
Query: 55 SPDQL-----------ERLYS--EVHLLKSLK-------HENIIKFYNSW--VDDTNRTI 92
++L E S ++L +K H +I+ YN D +
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP 466
Query: 93 NMITELFTS--GS-LRQYRKKHKNVDMKAIK---NWARQILRGLHYLHSHNPPIIH--RD 144
+ + F S G L+ + + + + Q +R + + I++ +
Sbjct: 467 PYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQ 526
Query: 145 LKC--DNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-------FMAPE--LYEEE 193
LK I N E + + L + + ++I + MA + ++EE
Sbjct: 527 LKFYKPYICDNDPKYERLVNAI-LDFLPK--IEENLICSKYTDLLRIALMAEDEAIFEEA 583
Query: 194 YNEL 197
+ ++
Sbjct: 584 HKQV 587
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 64/325 (19%), Positives = 120/325 (36%), Gaps = 83/325 (25%)
Query: 20 EILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--- 75
+ LG+GAF V + D + G VA ++ V E SE+ +L+ L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVA-----VKIVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 76 ---NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGL 130
++ W + I ++ EL S + K++ + + I+ A QI + +
Sbjct: 75 STFRCVQMLE-WFEHHGH-ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGN------------------NGEVKIGDLGLAIVMQQ 172
++LHS+ + H DLK +NI + N ++K+ D G A +
Sbjct: 132 NFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189
Query: 173 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL----------------EMVTC-- 213
+++ T + APE + +++ D++S G CIL E +
Sbjct: 190 -HHSTLVSTRHYRAPEVILALGWSQPCDVWSIG-CILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 214 -----------------------EYPYNECKNPAQIYKKVTSGIKPASLSK-VTDPQVKQ 249
++E + + + +K LS+ V ++
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 250 FIEKCIVP-ASLRLPALELLKDPFL 273
I+K + + R+ E LK PF
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 15/150 (10%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKF 80
+G G+F +Y G + EVA + +E+V QL E + + L+ I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLY---ESKIYRILQGGTGIPNV 68
Query: 81 YNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPP 139
V+ ++ +L SL + + +K + A Q++ + ++HS +
Sbjct: 69 RWFGVEGDYNV--LVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 140 IIHRDLKCDNIFV--NGNNGEVKIGDLGLA 167
+HRD+K DN + +V I D GLA
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 36/155 (23%), Positives = 59/155 (38%), Gaps = 17/155 (10%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENI 77
+ +G G F + G + VA + +E + QL E K L + I
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVA---IKLEPMKSRAPQLHL---EYRFYKQLGSGDGI 67
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH 136
+ Y M+ EL SL + +K + A Q++ + Y+HS
Sbjct: 68 PQVYYFGPCGKYNA--MVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 137 NPPIIHRDLKCDNIFV----NGNNGEVKIGDLGLA 167
N +I+RD+K +N + N + I D LA
Sbjct: 125 N--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 27/194 (13%), Positives = 59/194 (30%), Gaps = 38/194 (19%)
Query: 22 LGKGAFKTVYKGFDEVDGI--------EVA----------WNQVNIEDVMQSPDQLERLY 63
+ +Y+ + + +N+ N P Q+ +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 64 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKN 121
L S I V ++ SL+ + +++
Sbjct: 110 K----LYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLGR-SLQSALDVSPKHVLSERSVLQ 163
Query: 122 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQ 171
A ++L L +LH + +H ++ +NIFV+ + +V + G A +
Sbjct: 164 VACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 172 QPTARSVIGTPEFM 185
+ + G EF+
Sbjct: 222 EGSRSPHEGDLEFI 235
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 32/173 (18%), Positives = 69/173 (39%), Gaps = 21/173 (12%)
Query: 1 MLLLDLVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE 60
M + V+ + + +G+G+F +++G + ++ +VA + E QL
Sbjct: 1 MSGQNNVVGVHYKV----GRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLR 53
Query: 61 RLYSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKA 118
E K L I Y + + ++ +L SL + +K
Sbjct: 54 D---EYRTYKLLAGCTGIPNVYYFGQEGLHNV--LVIDLLGP-SLEDLLDLCGRKFSVKT 107
Query: 119 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLA 167
+ A+Q+L + +H + +++RD+K DN + N + + + D G+
Sbjct: 108 VAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 59/256 (23%), Positives = 95/256 (37%), Gaps = 69/256 (26%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-------- 73
LG G F TV+ +D VA + + V + E E+ LLKS++
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVA---MKV--VKSAEHYTETALDEIRLLKSVRNSDPNDPN 99
Query: 74 HENIIKFYNS-WVDDTNRT-INMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRG 129
E +++ + + N T I M+ E+ L ++ K + + +K +Q+L+G
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEV-LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 130 LHYLHSHNPPIIHRDLKCDNIFV------------------------------------- 152
L YLH+ IIH D+K +NI +
Sbjct: 159 LDYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 153 -----------NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 200
N +VKI DLG A + + I T ++ + E L YN DI
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-TEDIQTRQYRSLEVLIGSGYNTPADI 276
Query: 201 YSFGMCILEMVTCEYP 216
+S E+ T +Y
Sbjct: 277 WSTACMAFELATGDYL 292
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 7e-10
Identities = 52/334 (15%), Positives = 95/334 (28%), Gaps = 81/334 (24%)
Query: 9 WSLFVLFLQYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIED----VMQSPDQLERL 62
+S + + +G+G F V++ D VA + IE E +
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 63 YSEVHLLKSL---------KHENIIKFYNSWV----------------DDTNRTINMITE 97
E+ + K L + E I + + T + N +
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 98 LFTSG-------------SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 144
F L Q R K ++ K+ Q+ L + HRD
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAE-ASLRFEHRD 187
Query: 145 LKCDNIFVNGNNG-------------------EVKIGDLGLAIVMQQPTARSVIGTPEFM 185
L N+ + + +V I D L+ + + V+ M
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI---VVFCDVSM 244
Query: 186 APELYEEEYNELVDIYSFGMCILEMVTCEY-PYNECK-----NPAQIYKKVTSGIKPASL 239
+L+ + + DIY EY PY+ + +
Sbjct: 245 DEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPA 304
Query: 240 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 273
K ++++F + +S A +LL L
Sbjct: 305 MKQIKRKIQEFHRTMLNFSS----ATDLLCQHSL 334
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 39/192 (20%), Positives = 66/192 (34%), Gaps = 34/192 (17%)
Query: 22 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81
+G+G F +Y D V + + V P L++E+ + I+ +
Sbjct: 43 IGQGGFGCIYLA-DMNSSESVGSDAPCVVKVE--PSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 82 NSWVDDTNRTI----------------N-MITELFTSGSLRQYRKKHKNV-DMKAIKNWA 123
+ MI + F S L++ + + K + +
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQLS 158
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQQP 173
+IL L Y+H H +H D+K N+ +N N +V + D GLA
Sbjct: 159 LRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216
Query: 174 TARSVIGTPEFM 185
R GT EF
Sbjct: 217 PKRCHDGTIEFT 228
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 5e-06
Identities = 20/73 (27%), Positives = 33/73 (45%), Gaps = 6/73 (8%)
Query: 348 EKNDDDTVSLTLRIGD----KSGHVSN--IHFVFYLNADTAISIAEEMVEQLDLSHEDVV 401
+ + + L LRI D K + N I F F L D +A+EMVE + D
Sbjct: 19 DDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHK 78
Query: 402 SIAELIDNLIMKL 414
++A+ I + + +
Sbjct: 79 TMAKAIKDRVSLI 91
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 620 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 99.55 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 99.04 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.93 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.29 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.06 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.82 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.82 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.51 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.05 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.95 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.92 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.21 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.19 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.95 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.8 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.76 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.09 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.61 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.55 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 87.91 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.01 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-63 Score=513.43 Aligned_cols=268 Identities=51% Similarity=0.937 Sum_probs=245.0
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
+...+.||||++.++||+|+||+||+|.++.+|+.||+|.+..... .....+++.+|+.+|++|+|||||++|++|.+
T Consensus 19 ~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 96 (290)
T 3fpq_A 19 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp EEECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cCcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 4456789999999999999999999999999999999999976543 45667889999999999999999999999865
Q ss_pred C--CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 87 D--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 87 ~--~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
. ....+|||||||+||+|.+++.+.+.+++..++.|++||+.||.|||+++++||||||||+|||+++.+|.+||+||
T Consensus 97 ~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred ccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeC
Confidence 3 34579999999999999999999999999999999999999999999999889999999999999866899999999
Q ss_pred cchhhccCCCCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 165 GLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 165 Gla~~~~~~~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
|+|+........+.+|||.|||||++.+.|+.++|||||||++|||+||+.||.+..+..+++..+..+..|..++...+
T Consensus 177 Gla~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 177 GLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred cCCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence 99987766667788999999999999989999999999999999999999999988888999999999888877888889
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+++++||.+||+ +|.+|||+.|+|+||||++.
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 999999999998 89999999999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-58 Score=482.57 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=229.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+++|+.|+|||||++|++|.++ ..+|+
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~yi 109 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYF 109 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEE
Confidence 4899999999999999999999999999999998654321 23456799999999999999999999998754 57999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
|||||+||+|.+++.+.+.+++..++.|++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEc-CCCCEEEEEcCCceecCCCC
Confidence 9999999999999999999999999999999999999999999 99999999999998 7899999999999765422
Q ss_pred ---CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 174 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 174 ---~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
...+.+|||.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. .++...++++++
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~d 263 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKARD 263 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHHH
Confidence 3456799999999999875 599999999999999999999999976 577788888877643 355678899999
Q ss_pred HHHHhcC-CCCCCCCHHH------HhcCCCcCCCCCCccc
Q 007055 250 FIEKCIV-PASLRLPALE------LLKDPFLVTDNPKDLV 282 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~e------lL~hpff~~~~~~~~~ 282 (620)
||.+||+ +|.+|||+.| +++||||+..++..+.
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 303 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence 9999998 9999999987 5899999998887764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=482.82 Aligned_cols=254 Identities=30% Similarity=0.546 Sum_probs=223.2
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
.+|++.+.||+|+||+||+|.++.+|+.||||+++..+.. ..+.+.+|+.+|+.|+|||||++|++|.++ ..+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~ 147 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELW 147 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----SGGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 4689999999999999999999999999999999865432 234588999999999999999999999765 4699
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
||||||+||+|.+++.+ +++++..++.|++||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+.....
T Consensus 148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEC-CCCCEEEecCcCceecCCC
Confidence 99999999999999976 56999999999999999999999999 99999999999998 7899999999999766443
Q ss_pred --CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHH
Q 007055 174 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQ 249 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~~~~lk~ 249 (620)
...+.+|||.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+..+++..+..+..+. ......++++++
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSCHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 3567899999999998874 599999999999999999999999987 56777777777664432 233456899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
||.+||+ +|.+|||+.|+|+||||+...+
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 9999998 9999999999999999987543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-57 Score=482.08 Aligned_cols=254 Identities=26% Similarity=0.451 Sum_probs=218.6
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.++.+|+.||||+++.... .....+++.+|+.+|++|+|||||++|++|.++ ..+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~~y 99 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEEN--GSLY 99 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEE
Confidence 357999999999999999999999999999999986543 456678899999999999999999999998765 5799
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 94 MITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+|||||+||+|.+++...+ .+++..++.|++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+...
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEEC-TTCCEEECSTTEESCCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCCEEEcccccceeec
Confidence 9999999999999997543 5799999999999999999999999 99999999999998 78999999999997664
Q ss_pred CC--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 172 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 172 ~~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
.. ...+.+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+..|+ ++...+++++
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~-~~~~~s~~~~ 254 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPP-VSLHYSYDLR 254 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCHHHH
T ss_pred CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCC-CCccCCHHHH
Confidence 33 2346789999999999875 599999999999999999999999977 56777777777765543 4556789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 249 QFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+||.+||+ +|.+|||+.|+|+||||+..
T Consensus 255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 99999998 99999999999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-57 Score=466.99 Aligned_cols=255 Identities=26% Similarity=0.509 Sum_probs=210.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.++.+|+.||+|+++..... .....+++.+|+.+|+.|+|||||+++++|.++ ..+|+
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~i 90 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--DEIIM 90 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEE
Confidence 468999999999999999999999999999999865432 234456799999999999999999999998654 57999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||| +|+|.+++.+.+++++..++.|++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTCCEEECCSSCC-------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEEC-CCCCEEEeecCCCeecCCCC
Confidence 99999 7899999999999999999999999999999999999 99999999999998 7899999999999765443
Q ss_pred CCccccCCCCCCCccccccc-c-CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 174 TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 174 ~~~~~~GTp~y~APEll~~~-y-~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
...+.+|||.|||||++.+. | +.++|||||||++|+|+||+.||.+ .+...+++.+..+.. .++...++++++||
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 243 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVY--TLPKFLSPGAAGLI 243 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHH
Confidence 34567999999999998754 4 6899999999999999999999976 577788888887643 35567899999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 252 EKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
.+||+ +|.+|||+.|+|+||||+...|.
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~~~p~ 272 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKVDLPE 272 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHTTCCG
T ss_pred HHHccCChhHCcCHHHHHcCcccccCCCh
Confidence 99998 99999999999999999865543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=474.90 Aligned_cols=264 Identities=22% Similarity=0.327 Sum_probs=222.0
Q ss_pred ceEEEEEEEceeCCeEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
..|++.+.||+|+||+||+|.+. .+++.||+|+++...... ....++.+|+++|++|+|||||++|++|.++ .
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~ 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQTE--G 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEEET--T
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--C
Confidence 46899999999999999999884 478999999997654321 1223578899999999999999999998765 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
.+|+|||||+||+|.+++.+.+.+++..++.|++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+..
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTSCEEEESSEEEEC-
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEc-CCCCEEecccccceec
Confidence 79999999999999999999999999999999999999999999999 99999999999998 7899999999999754
Q ss_pred cC--CCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 171 QQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 171 ~~--~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
.. ....+.+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+.. .++...++++
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 253 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKL--GMPQFLSPEA 253 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCcCCHHH
Confidence 32 33457799999999998874 599999999999999999999999976 567777777776543 3556789999
Q ss_pred HHHHHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCccccCCCC
Q 007055 248 KQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLR 287 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~ 287 (620)
++||.+||+ +|.+||| ++|+|+||||+..++..+....+.
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~ 299 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIH 299 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCC
Confidence 999999998 9999998 479999999999887765444343
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-56 Score=485.16 Aligned_cols=254 Identities=30% Similarity=0.549 Sum_probs=223.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
.+|++.+.||+|+||+||+|.++.+|+.||||+++.... ...+.+.+|+.+|+.|+|||||++|++|.+. ..+|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~ 224 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELW 224 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEE
Confidence 568999999999999999999999999999999986542 2235688999999999999999999999765 4699
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
||||||+||+|.+++.. +++++..++.|++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+.....
T Consensus 225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~-~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEEC-TTCCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEecCccceECCCC
Confidence 99999999999999875 56999999999999999999999999 99999999999998 7899999999999766443
Q ss_pred --CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHH
Q 007055 174 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQ 249 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~~~~lk~ 249 (620)
...+.+|||.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+...++..+..+..+. ......++++++
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCCHHHHH
Confidence 3567899999999998874 599999999999999999999999987 56777777777664432 334457899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
||.+||+ +|.+|||+.|+|+||||+...+
T Consensus 380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 9999998 9999999999999999987543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=467.24 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=213.6
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.-.+|++.++||+|+||+||+|.++.+|+.||||+++.... ..+|+.+|+.|+|||||++|++|.++ ..
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~--~~ 124 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREG--PW 124 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEET--TE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 34578999999999999999999999999999999986532 23699999999999999999998765 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC-cEEEccccchhhc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVM 170 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G-~vKI~DFGla~~~ 170 (620)
+|||||||+||+|.+++++.+++++..++.|++||+.||.|||+++ ||||||||+|||++ .+| .+||+|||+|+..
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLS-SDGSRAALCDFGHALCL 201 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEC-TTSCCEEECCCTTCEEC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEe-CCCCEEEEeeCCCCeEc
Confidence 9999999999999999999999999999999999999999999999 99999999999998 566 6999999999765
Q ss_pred cCC-------CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCC
Q 007055 171 QQP-------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSK 241 (620)
Q Consensus 171 ~~~-------~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~ 241 (620)
... ....++|||.|||||++.+ .|+.++|||||||++|||+||+.||.+.. ...++..+..+..+ ..++.
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~ 280 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF-RGPLCLKIASEPPPIREIPP 280 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC-CSCCHHHHHHSCCGGGGSCT
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHHcCCCCchhcCc
Confidence 432 1234689999999998875 59999999999999999999999998743 44445555554433 34666
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHH-------------hcCCCcCC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALEL-------------LKDPFLVT 275 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~el-------------L~hpff~~ 275 (620)
..++.+++||.+||+ +|.+|||+.|+ |+|||+.+
T Consensus 281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 789999999999998 99999999997 57888865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=450.91 Aligned_cols=252 Identities=23% Similarity=0.436 Sum_probs=202.1
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC------
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN------ 89 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~------ 89 (620)
|++.+.||+|+||+||+|.++.+|+.||+|+++... .....+++.+|+.+|++|+|||||++|++|.+.+.
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 899999999999999999999999999999997543 35566789999999999999999999999976542
Q ss_pred ----CeEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 90 ----RTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 90 ----~~l~lV~Ey~~gGsL~~~i~~~~~---l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
..+|+|||||++|+|.+++...+. .++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~-~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC-CCCcEEEc
Confidence 358999999999999999987765 455678999999999999999999 99999999999998 78999999
Q ss_pred cccchhhccCCC--------------CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHH
Q 007055 163 DLGLAIVMQQPT--------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 227 (620)
Q Consensus 163 DFGla~~~~~~~--------------~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~ 227 (620)
|||+|+...... ..+.+|||.|||||++.+ .|+.++|||||||++|||++ ||....+.....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 999997654321 234589999999998875 59999999999999999996 886533333344
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 228 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 228 ~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
..+.....|+.+ ...++.+++||.+||+ +|.+|||+.|+|+||||+..+
T Consensus 238 ~~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 238 TDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 445544433322 2235678899999998 899999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=461.05 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=215.6
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC----C
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----T 88 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~----~ 88 (620)
+..|++.+.||+|+||+||+|.++.+|+.||||+++... ......+++.+|+.+|+.|+|||||+++++|... .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 456799999999999999999999999999999996443 3455667899999999999999999999987543 3
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
...+|+|||||. |+|.+++.+.+++++..++.|++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~-~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCB
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccC-CCCCEEEeecceee
Confidence 357999999996 689999999999999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccC------CCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCC-
Q 007055 169 VMQQ------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPA- 237 (620)
Q Consensus 169 ~~~~------~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~--~~p~- 237 (620)
.+.. ....+.+||+.|||||++.+ .|+.++||||+||++|||++|+.||.+. +....+..|... ..+.
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-NYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-SHHHHHHHHHHHHCCCCGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhcCCCChH
Confidence 5432 23456799999999998764 4799999999999999999999999874 444444433221 1110
Q ss_pred -----------------------C---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 238 -----------------------S---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 238 -----------------------~---~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
. +....++++++||.+||+ +|.+||||.|+|+||||+..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0 012357899999999998 99999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-53 Score=478.20 Aligned_cols=272 Identities=21% Similarity=0.354 Sum_probs=232.4
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc--CCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~--~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
-..|++.++||+|+||+||+|.++.+|+.||+|+++..... ...........++.+++.++|||||+++++|.+. .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--~ 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--D 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--S
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--C
Confidence 34689999999999999999999999999999999865432 1222333344557778888999999999999765 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
.+|||||||+||+|.+++.+.+.+++..++.|++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+..
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld-~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEe-CCCCEEecccceeeec
Confidence 79999999999999999999999999999999999999999999999 99999999999998 7899999999999887
Q ss_pred cCCCCccccCCCCCCCccccc-c-ccCccchhhhhHHHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 171 QQPTARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 171 ~~~~~~~~~GTp~y~APEll~-~-~y~~~~DIwSlGiilyELltG~~Pf~~~--~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
......+.+|||.|||||++. + .|+.++|||||||++|||++|..||.+. .+...+...+... +..++...+++
T Consensus 343 ~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~~~p~~~S~~ 420 (689)
T 3v5w_A 343 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPE 420 (689)
T ss_dssp SSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred CCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CCCCCccCCHH
Confidence 777778889999999999885 3 5999999999999999999999999753 3445566666654 33456678999
Q ss_pred HHHHHHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCccccCCCCCCCC
Q 007055 247 VKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPNL 291 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p~~ 291 (620)
+++||.+||+ +|.+|++ +.|+++||||+..+|..+....+..|..
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~ 471 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 471 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCcc
Confidence 9999999998 9999998 7999999999999998876555544433
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=436.92 Aligned_cols=251 Identities=30% Similarity=0.492 Sum_probs=212.2
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+.-..+++.++||+|+||+||+|.+.. .||||+++... .+....+.+.+|+.+|++|+|||||++++++..
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 103 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK- 103 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence 366777788999999999999999997643 59999987543 356677889999999999999999999997643
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++|||||++|+|.+++... +++++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+
T Consensus 104 --~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~-~~~~~Ki~DFGl 178 (307)
T 3omv_A 104 --DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLH-EGLTVKIGDFGL 178 (307)
T ss_dssp --SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEE-TTEEEEECCCSS
T ss_pred --CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEEC-CCCcEEEeeccC
Confidence 3478999999999999999765 57999999999999999999999998 99999999999998 789999999999
Q ss_pred hhhccCC----CCccccCCCCCCCcccccc----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 007055 167 AIVMQQP----TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 238 (620)
Q Consensus 167 a~~~~~~----~~~~~~GTp~y~APEll~~----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~ 238 (620)
|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..+...+...+..+..++.
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD 258 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC
Confidence 9755322 2345689999999998852 4899999999999999999999999987778888888877755433
Q ss_pred ---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 239 ---LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 239 ---~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+...++.+++||.+||+ +|.+|||+.|++.
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 445678999999999998 8999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=434.41 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=216.9
Q ss_pred eeeeeeccCceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcce
Q 007055 5 DLVIWSLFVLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79 (620)
Q Consensus 5 ~~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk 79 (620)
|-..+.+....|.+.+.||+|+||+||+|.+. .+|..||||+++.. +....+.+.+|+++|++|+|||||+
T Consensus 4 d~~~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~ 79 (299)
T 4asz_A 4 DTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVK 79 (299)
T ss_dssp GGSCCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred hhhhcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCcc
Confidence 33445566667899999999999999999875 46899999998632 4566778999999999999999999
Q ss_pred EEeEEEcCCCCeEEEEEeccCCCCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCC
Q 007055 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 146 (620)
Q Consensus 80 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~-------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLK 146 (620)
+|+++.+. ..+++|||||++|+|.+++.++ ..+++..+..|+.||+.||.|||+++ |||||||
T Consensus 80 l~g~~~~~--~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlK 155 (299)
T 4asz_A 80 FYGVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLA 155 (299)
T ss_dssp EEEEECSS--SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEEEEeeC--CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccC
Confidence 99998654 4589999999999999999764 36999999999999999999999999 9999999
Q ss_pred ccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCC
Q 007055 147 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNEC 220 (620)
Q Consensus 147 p~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~ 220 (620)
|+|||++ .++.+||+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+
T Consensus 156 p~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~- 233 (299)
T 4asz_A 156 TRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ- 233 (299)
T ss_dssp GGGEEEC-GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-
T ss_pred HhhEEEC-CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-
Confidence 9999998 78999999999997654322 23457999999999886 569999999999999999999 8999987
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 221 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 221 ~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
.+..++...+..+..+. .+...++++++||.+||+ +|.+|||+.+++ +||+
T Consensus 234 ~~~~~~~~~i~~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 234 LSNNEVIECITQGRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp SCHHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 56777888888876543 456678999999999998 899999999984 4654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=441.09 Aligned_cols=251 Identities=18% Similarity=0.352 Sum_probs=204.1
Q ss_pred ceEEEEEEEceeCCeEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~ 89 (620)
..|++.+.||+|+||+||+|.++ .+++.||+|.+.... ...++.+|+++|+.+ +|||||+++++|.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-- 92 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-- 92 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--
Confidence 44699999999999999999885 468999999886432 234578999999998 699999999998765
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+|+|||||+||+|.++++ .+++..++.+++||+.||+|||++| |+||||||+|||++.+.|.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 57999999999999999984 5999999999999999999999999 999999999999985558999999999964
Q ss_pred ccCC------------------------------CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCC
Q 007055 170 MQQP------------------------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPY 217 (620)
Q Consensus 170 ~~~~------------------------------~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf 217 (620)
.... ...+.+|||.|||||++.+ .|+.++||||+||++|||+||+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 3221 1234589999999998764 4899999999999999999999999
Q ss_pred CCCCCHHHHHHHHHc--C--------------------------------------CCC------------CCCCCCCcH
Q 007055 218 NECKNPAQIYKKVTS--G--------------------------------------IKP------------ASLSKVTDP 245 (620)
Q Consensus 218 ~~~~~~~~i~~~i~~--~--------------------------------------~~p------------~~~~~~~~~ 245 (620)
....+.......+.. | ..| .......++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 776655443332211 0 000 011234578
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
++++||.+||+ +|.+|+||.|+|+||||+..+
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 99999999998 999999999999999998643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=431.81 Aligned_cols=251 Identities=22% Similarity=0.362 Sum_probs=209.2
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
+.+..+.+.+.++||+|+||+||+|.+. .+|+.||||+++.. +....+.|.+|+++|++|+|||||+++++
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3455567899999999999999999864 47899999998632 45667889999999999999999999999
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCcc
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKH---------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 148 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~---------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~ 148 (620)
|.+. ..+++|||||++|+|.+++.++ +++++.++..|+.||+.||.|||+++ ||||||||+
T Consensus 112 ~~~~--~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~ 187 (329)
T 4aoj_A 112 CTEG--RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATR 187 (329)
T ss_dssp ECSS--SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred EEEC--CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHh
Confidence 8654 4589999999999999999764 35899999999999999999999999 999999999
Q ss_pred ceEecCCCCcEEEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCC
Q 007055 149 NIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKN 222 (620)
Q Consensus 149 NILl~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~ 222 (620)
|||++ .++.+||+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+ .+
T Consensus 188 NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~ 265 (329)
T 4aoj_A 188 NCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LS 265 (329)
T ss_dssp GEEEE-TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SC
T ss_pred hEEEC-CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CC
Confidence 99998 7899999999999765332 2234679999999998764 59999999999999999999 8999987 45
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 223 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 223 ~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..++...+..+..+ ..+...++++++||.+||+ +|.+|||+.|++.+
T Consensus 266 ~~~~~~~i~~g~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 266 NTEAIDCITQGREL-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCC-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 67777888777554 3456788999999999998 89999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=426.30 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=211.1
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
+.-..+++.+.||+|+||+||+|.. ..+++.||||.++... .....+.|.+|+.+|++|+|||||++++++.
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 4445678999999999999999985 3578999999986432 2334567999999999999999999999986
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 149 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~N 149 (620)
++ ..+++|||||++|+|.+++... ..+++..+..|+.||+.||.|||+++ ||||||||+|
T Consensus 100 ~~--~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~N 175 (308)
T 4gt4_A 100 KD--QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRN 175 (308)
T ss_dssp SS--SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EC--CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccc
Confidence 54 4588999999999999999653 35899999999999999999999999 9999999999
Q ss_pred eEecCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCH
Q 007055 150 IFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNP 223 (620)
Q Consensus 150 ILl~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~ 223 (620)
||++ .++.+||+|||+++..... .....+||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+.
T Consensus 176 ILl~-~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~ 253 (308)
T 4gt4_A 176 VLVY-DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSN 253 (308)
T ss_dssp EEEC-GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCH
T ss_pred eEEC-CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCH
Confidence 9998 7899999999999765332 234568999999999876 569999999999999999998 8999987 567
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 224 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 224 ~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.++...+..+..++ .+...++.+.+++.+||+ +|.+|||+.|++++
T Consensus 254 ~~~~~~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 254 QDVVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77888888776543 456678999999999998 89999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=458.83 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=223.1
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.++.+|+.||+|++... .....+.+.+|+.+|+.|+|||||+++++|.+. ..+|
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 230 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMV 230 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEE
Confidence 3579999999999999999999999999999998754 345567799999999999999999999998654 5799
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC-CCCcEEEccccchhhcc
Q 007055 94 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~G~vKI~DFGla~~~~ 171 (620)
||||||.||+|.+++.. .+.+++..++.|++||+.||.|||+++ |+||||||+|||++. ..|.+||+|||+|+.+.
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999999999864 467999999999999999999999999 999999999999973 24899999999998765
Q ss_pred CC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHH
Q 007055 172 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQV 247 (620)
Q Consensus 172 ~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~~~~l 247 (620)
.. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+..+.+..+..+.. +.......++++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 43 3456789999999998875 599999999999999999999999987 566677777776533 233345678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
++||.+||+ +|.+|||+.|+|+||||+..++
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 999999998 9999999999999999987654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=430.66 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=217.9
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCcceEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFY 81 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~t-----g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pNIVkl~ 81 (620)
.|.+....|++.+.||+|+||+||+|.+..+ ++.||+|.++.. ......+.+.+|+.+|.+++| ||||+++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~---~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc---cChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 3556667899999999999999999987654 478999998643 234566789999999999976 8999999
Q ss_pred eEEEcCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCC
Q 007055 82 NSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 145 (620)
Q Consensus 82 ~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 145 (620)
++|..+. ..+++|||||++|+|.+++... ..+++..+..|+.||+.||.|||+++ ||||||
T Consensus 135 g~~~~~~-~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDL 211 (353)
T 4ase_A 135 GACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 211 (353)
T ss_dssp EEECCTT-SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEecC-CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCcc
Confidence 9876543 4688999999999999999753 34899999999999999999999999 999999
Q ss_pred CccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCC
Q 007055 146 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNE 219 (620)
Q Consensus 146 Kp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~ 219 (620)
||+|||++ .++.+||+|||+|+...... ....+||+.|||||++. +.|+.++|||||||++|||+| |+.||.+
T Consensus 212 K~~NILl~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 212 AARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp SGGGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CccceeeC-CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99999998 78999999999997654322 23467999999999876 569999999999999999998 9999988
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 220 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 220 ~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
......+.+.+..+..+. .+...+++++++|.+||+ +|.+|||+.|+++|
T Consensus 291 ~~~~~~~~~~i~~g~~~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCCSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 776777888888876553 456678999999999998 89999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=403.61 Aligned_cols=268 Identities=51% Similarity=0.937 Sum_probs=242.9
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
+..+..+++|++.+.||+|+||+||+|.+..++..||+|.+..... .....+.+.+|+.+++.++||||++++++|..
T Consensus 19 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 19 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred hhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 4567789999999999999999999999999999999999875543 45667889999999999999999999999865
Q ss_pred C--CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 87 D--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 87 ~--~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
. ....+++||||+++|+|.+++...+.+++..++.|+.||+.||.|||+++++|+||||||+|||++..+|.+||+||
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 3 34678999999999999999999889999999999999999999999998789999999999999767889999999
Q ss_pred cchhhccCCCCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 165 GLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 165 Gla~~~~~~~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
|++............||+.|+|||++.+.++.++|||||||++|+|++|+.||....+...++..+..+..+..++...+
T Consensus 177 g~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T 1t4h_A 177 GLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred CCcccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCC
Confidence 99977666666677899999999999888999999999999999999999999998888999999988888777777888
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 999999999998 89999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=406.22 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=195.0
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC--C
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--R 90 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~--~ 90 (620)
.|.|.+.+.||+|+||+||+|.+ +|+.||||+++... ........|+..+.+++|||||++++++.++.. .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 46789999999999999999987 69999999986432 122223457777788999999999999876543 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCEEecCCCccceEecCCCCcEEEccc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~------~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
.+++|||||++|+|.+++.+. ++++..+..++.|++.||+|||++ .++||||||||+|||++ .+|.+||+||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DF 152 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADL 152 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCC
T ss_pred EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeC
Confidence 689999999999999999865 599999999999999999999987 23499999999999998 7899999999
Q ss_pred cchhhccCCC------CccccCCCCCCCcccccc-------ccCccchhhhhHHHHHHHHhcCCCCCCC-----------
Q 007055 165 GLAIVMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNEC----------- 220 (620)
Q Consensus 165 Gla~~~~~~~------~~~~~GTp~y~APEll~~-------~y~~~~DIwSlGiilyELltG~~Pf~~~----------- 220 (620)
|+|+...... ....+||+.|||||++.+ .|+.++|||||||++|||+||..||...
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 9997654332 234589999999998864 3778999999999999999997665321
Q ss_pred ---CCHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 221 ---KNPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 221 ---~~~~~i~~~i~~~~~p~~~~~~-----~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.....+.+.+......+.++.. ..+.+.+++.+||+ +|.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1234455555444333333322 12468899999998 99999999998863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=400.74 Aligned_cols=254 Identities=25% Similarity=0.478 Sum_probs=224.0
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+++.+|+.+|+.++||||+++++++... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 90 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--KTLY 90 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEE
Confidence 456899999999999999999999999999999976542 456678899999999999999999999988644 5799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||||+++|+|.+++...+++++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEc-CCCCEEEeeccCceecCCC
Confidence 99999999999999999899999999999999999999999999 99999999999998 7899999999999765433
Q ss_pred -CCccccCCCCCCCccccccc-c-CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 174 -TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~~-y-~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+ .+...+...+..+..+ ++...++.+++|
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 244 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCENL 244 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHH
Confidence 34567899999999988654 4 5799999999999999999999976 5677777777776443 345578999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 251 IEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
|.+||+ +|.+|||+.|+|+||||....
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999998 999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=404.73 Aligned_cols=264 Identities=23% Similarity=0.432 Sum_probs=228.2
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.++.+|+.||+|+++..... .......+.+|+.+|+.++||||++++++|.+. ..++
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~ 81 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEEE
Confidence 4679999999999999999999999999999999754321 122346688999999999999999999998654 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc--
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-- 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~-- 171 (620)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEEC-CCCCEEEeeccchhhcccC
Confidence 99999999999999999889999999999999999999999999 99999999999998 78999999999997532
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 172 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+...++..+..+. ..++...++++++|
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~l 235 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSL 235 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHH
Confidence 234456789999999998864 599999999999999999999999976 56667777776543 23556678999999
Q ss_pred HHHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCccccCCC
Q 007055 251 IEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 286 (620)
Q Consensus 251 I~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~ 286 (620)
|.+||+ +|.+|| ++.|+++||||...++..+....+
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~ 277 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 277 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 999998 999999 899999999999988776654433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=409.23 Aligned_cols=267 Identities=21% Similarity=0.392 Sum_probs=224.8
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCe
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~ 91 (620)
-..|++.++||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|+.+|+.+ +||||++++++|.+. ..
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~ 98 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DR 98 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CE
Confidence 35689999999999999999999999999999999754321 123456688999999988 799999999998654 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+|+||||+.||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEEC-CCCCEEEccccceeecc
Confidence 9999999999999999999899999999999999999999999999 99999999999998 78999999999997432
Q ss_pred --CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 172 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 172 --~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+...++..+..+.. .++...++.++
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~ 252 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLHEDAT 252 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 223456789999999998864 599999999999999999999999976 567777777776533 34556789999
Q ss_pred HHHHHhcC-CCCCCCCH------HHHhcCCCcCCCCCCccccCCCCC
Q 007055 249 QFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVCDPLRL 288 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa------~elL~hpff~~~~~~~~~~~~~~~ 288 (620)
+||.+||+ +|.+||++ .|+++||||+..++..+....+..
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~ 299 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEP 299 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCC
Confidence 99999998 89999998 899999999998877654444433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=392.97 Aligned_cols=259 Identities=29% Similarity=0.483 Sum_probs=221.1
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
......|++.+.||+|+||+||+|.+..+|+.||+|.+...... ..+.+.+|+.+++.++||||++++++|...
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 89 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVG-- 89 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc----HHHHHHHHHHHHhcCCCCCCCeEeEEEEEC--
Confidence 33445678999999999999999999999999999998765422 235688999999999999999999998765
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++||||+.+|+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQ 165 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEE
T ss_pred CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEC-CCCCEEEeeCCCcee
Confidence 4689999999999999999875 5999999999999999999999999 99999999999998 789999999999865
Q ss_pred ccCC--CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 170 MQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 170 ~~~~--~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
.... .....+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+.............+......+...++.
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHH
T ss_pred cCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHH
Confidence 5433 234568999999999876 4599999999999999999999999987554445555555544444455567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
+++||.+||+ +|.+|||+.|+|+||||+...+
T Consensus 246 ~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 9999999998 9999999999999999986543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=398.38 Aligned_cols=268 Identities=28% Similarity=0.433 Sum_probs=229.4
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.-..|++.+.||+|+||.||+|.++.+|+.||+|+++...... ....+.+.+|+.+++.++||||++++++|.+. ..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~ 80 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQ 80 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CE
Confidence 3456899999999999999999999999999999997543211 12346688999999999999999999998654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECS
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEc-CCCCEEEeecCcceecC
Confidence 9999999999999999999999999999999999999999999999 99999999999998 78999999999997654
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 172 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
. .....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+....+..+..+.. .++...+++++++
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 233 (318)
T 1fot_A 158 D-VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDL 233 (318)
T ss_dssp S-CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred C-ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHH
Confidence 3 3346789999999998764 599999999999999999999999987 456666777766532 3456678999999
Q ss_pred HHHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCccccCCCCCC
Q 007055 251 IEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 289 (620)
Q Consensus 251 I~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~~~p 289 (620)
|.+||. +|.+|| ++.++++||||+...+..+....+..|
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p 278 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 278 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCC
Confidence 999998 899999 899999999999888776654444333
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=402.89 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=224.8
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC--HHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~--~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.....+|++.+.||+|+||+||+|.++.+|+.||+|.++....... ....+.+.+|+.+|+.++||||++++++|.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 3455678999999999999999999999999999999986543221 11346788999999999999999999998654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC----cEEEcc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGD 163 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G----~vKI~D 163 (620)
..+++||||++||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++ .+||+|
T Consensus 88 --~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~~~~vkl~D 162 (361)
T 2yab_A 88 --TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLL-DKNIPIPHIKLID 162 (361)
T ss_dssp --SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CTTSSSCCEEECC
T ss_pred --CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-CCCCCccCEEEEe
Confidence 579999999999999999998889999999999999999999999999 99999999999997 444 799999
Q ss_pred ccchhhccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CC
Q 007055 164 LGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SL 239 (620)
Q Consensus 164 FGla~~~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~--~~ 239 (620)
||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+.... ..
T Consensus 163 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 241 (361)
T 2yab_A 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEF 241 (361)
T ss_dssp CSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHH
T ss_pred cCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchh
Confidence 9999765443 3456789999999998875 599999999999999999999999987 46667777777654321 22
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
....++.+++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 34568899999999998 9999999999999999986543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=409.75 Aligned_cols=270 Identities=19% Similarity=0.341 Sum_probs=226.6
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 88 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~ 88 (620)
.+.-..|++.++||+|+||+||+|.++.+|+.||+|+++.... ......+.+.+|..+|.++ +||||++++++|.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~-~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~- 125 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE- 125 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT-C----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-
Confidence 3445678999999999999999999999999999999986543 2334456688999999887 899999999998654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..+++||||+.||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 126 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 126 -SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCK 201 (396)
T ss_dssp -SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCB
T ss_pred -CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEC-CCCCEEEeecceee
Confidence 579999999999999999999899999999999999999999999999 99999999999998 78999999999997
Q ss_pred hc--cCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCC--------CCHHHHHHHHHcCCCCC
Q 007055 169 VM--QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPA 237 (620)
Q Consensus 169 ~~--~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~--------~~~~~i~~~i~~~~~p~ 237 (620)
.. ........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||... .....++..+.... .
T Consensus 202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~ 279 (396)
T 4dc2_A 202 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--I 279 (396)
T ss_dssp CCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--C
T ss_pred ecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--c
Confidence 53 2234556789999999998764 5999999999999999999999999642 22344566666543 3
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCH------HHHhcCCCcCCCCCCccccCCCC
Q 007055 238 SLSKVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVCDPLR 287 (620)
Q Consensus 238 ~~~~~~~~~lk~~I~kcL~-~p~~Rpsa------~elL~hpff~~~~~~~~~~~~~~ 287 (620)
.++...++.+++||.+||+ +|.+||++ .|+++||||+..++..+....+.
T Consensus 280 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~ 336 (396)
T 4dc2_A 280 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV 336 (396)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSC
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCC
Confidence 3556688999999999998 99999985 79999999999888765544343
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=396.75 Aligned_cols=263 Identities=18% Similarity=0.347 Sum_probs=225.7
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCe
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~ 91 (620)
-..|++.+.||+|+||.||+|.++.+|+.||+|+++.... ......+.+.+|+.+++.+ +||||++++++|.+. ..
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~ 84 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR 84 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CE
Confidence 3567999999999999999999999999999999986543 3456677889999999988 899999999998654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCGGGCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEEecccccccc
Confidence 9999999999999999998889999999999999999999999999 99999999999998 78999999999997532
Q ss_pred --CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCC--------CCHHHHHHHHHcCCCCCCCC
Q 007055 172 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 172 --~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~ 240 (620)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||... .....++..+.... ..++
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCC
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCC
Confidence 233456789999999998764 5999999999999999999999999642 23345566666543 2355
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCH------HHHhcCCCcCCCCCCcccc
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVC 283 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa------~elL~hpff~~~~~~~~~~ 283 (620)
...++.+++||.+||+ +|.+||++ .|+++||||...++..+..
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~ 289 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ 289 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHT
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHh
Confidence 6678999999999998 99999995 7999999999887765433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=401.34 Aligned_cols=268 Identities=23% Similarity=0.385 Sum_probs=231.1
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.-..|++.+.||+|+||.||+|.++.+|+.||+|+++...... ....+.+.+|+.+|+.++||||++++++|.+. ..
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 115 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SN 115 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CE
Confidence 3456899999999999999999999999999999997543211 12346788999999999999999999998654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECS
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEEC-CCCCEEEcccccceecc
Confidence 9999999999999999999889999999999999999999999999 99999999999998 78999999999997654
Q ss_pred CCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 172 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
.. ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+..+++..+..+.. .++...++.++++
T Consensus 193 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 268 (350)
T 1rdq_E 193 GR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDL 268 (350)
T ss_dssp SC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHH
T ss_pred CC-cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 43 34568999999999876 4599999999999999999999999976 567778888877643 3456678999999
Q ss_pred HHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCccccCCCCCC
Q 007055 251 IEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 289 (620)
Q Consensus 251 I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p 289 (620)
|.+||+ +|.+||+ +.++++||||...++..+....+..|
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p 313 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCC
Confidence 999998 9999998 99999999999888766544444333
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=403.23 Aligned_cols=267 Identities=23% Similarity=0.414 Sum_probs=228.0
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 89 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~ 89 (620)
..-..|++.++||+|+||.||+|.++.+|+.||+|.++...... ....+.+..|..++..+ +||||++++++|.+.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-- 90 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-- 90 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--
Confidence 34567899999999999999999999999999999997543211 12345678899999876 999999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKE 167 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEEC-CCCCEEEeEChhhhh
Confidence 469999999999999999998889999999999999999999999999 99999999999998 789999999999975
Q ss_pred cc--CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 170 MQ--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 170 ~~--~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
.. .......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+...++..+..+.. .++...++.
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~ 244 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKE 244 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHH
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCC--CCCcccCHH
Confidence 42 234556789999999998764 599999999999999999999999976 567777777776532 345667899
Q ss_pred HHHHHHHhcC-CCCCCCCHH-HHhcCCCcCCCCCCccccCCC
Q 007055 247 VKQFIEKCIV-PASLRLPAL-ELLKDPFLVTDNPKDLVCDPL 286 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~-elL~hpff~~~~~~~~~~~~~ 286 (620)
+++||.+||+ +|.+||++. ++++||||+..++..+....+
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~ 286 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI 286 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCS
T ss_pred HHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCC
Confidence 9999999998 999999998 999999999988776544433
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=391.96 Aligned_cols=267 Identities=24% Similarity=0.335 Sum_probs=216.1
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
..+....|++.+.||+|+||.||+|.+. .+|+.||+|+++.............+.+|+.+|+.++||||++++++|.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3455677899999999999999999985 6899999999976544333445566889999999999999999999986
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
.. ..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 92 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg 166 (327)
T 3a62_A 92 TG--GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFG 166 (327)
T ss_dssp CS--SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTSCEEECCCS
T ss_pred cC--CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEEC-CCCcEEEEeCC
Confidence 54 468999999999999999998889999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccC--CCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 007055 166 LAIVMQQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 166 la~~~~~--~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
++..... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+ .+.......+..... .++..
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~ 243 (327)
T 3a62_A 167 LCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL--NLPPY 243 (327)
T ss_dssp CC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCC--CCCTT
T ss_pred cccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC--CCCCC
Confidence 9865432 2344568999999999876 4589999999999999999999999976 455666666665432 34456
Q ss_pred CcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCcccc
Q 007055 243 TDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVC 283 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~ 283 (620)
.++.+++||.+||. +|.+|| ++.|+|+||||+..++..+..
T Consensus 244 ~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~ 290 (327)
T 3a62_A 244 LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLA 290 (327)
T ss_dssp SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHT
T ss_pred CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhh
Confidence 78999999999998 899999 889999999999877766543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=385.35 Aligned_cols=257 Identities=23% Similarity=0.439 Sum_probs=213.6
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC----------------------HHHHHHHHHHHHHHH
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----------------------PDQLERLYSEVHLLK 70 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~----------------------~~~~~~l~~Ei~iL~ 70 (620)
...|++.+.||+|+||.||+|.+..+|+.||+|++........ ....+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3457999999999999999999999999999999976542111 122456889999999
Q ss_pred hCCCCCcceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccce
Q 007055 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 150 (620)
Q Consensus 71 ~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NI 150 (620)
.++||||+++++++.+.....+++||||+++|+|.+++. .+.+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHE
Confidence 999999999999988766678999999999999988654 457999999999999999999999999 99999999999
Q ss_pred EecCCCCcEEEccccchhhccCCC--CccccCCCCCCCccccccc----cCccchhhhhHHHHHHHHhcCCCCCCCCCHH
Q 007055 151 FVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPA 224 (620)
Q Consensus 151 Ll~~~~G~vKI~DFGla~~~~~~~--~~~~~GTp~y~APEll~~~----y~~~~DIwSlGiilyELltG~~Pf~~~~~~~ 224 (620)
|++ .+|.+||+|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.. ....
T Consensus 169 l~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~ 246 (298)
T 2zv2_A 169 LVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIM 246 (298)
T ss_dssp EEC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHH
T ss_pred EEC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHH
Confidence 998 78999999999997654332 3456899999999988643 47889999999999999999999976 4555
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 225 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 225 ~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
.+...+.....+.......++.+++||.+||. +|.+||++.|+|+||||+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 66666665544433345678999999999998 999999999999999995
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=399.45 Aligned_cols=269 Identities=21% Similarity=0.337 Sum_probs=229.1
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~ 90 (620)
.-..|++.++||+|+||.||+|.++.+|+.||+|+++...... ....+.+..|..+|..+ +||||++++++|.+. .
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~ 94 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--D 94 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--S
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--C
Confidence 3456899999999999999999999999999999997643211 12346688999999988 899999999998654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEc-CCCcEEEEeCCccccc
Confidence 79999999999999999998889999999999999999999999999 99999999999998 7899999999999753
Q ss_pred c--CCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 171 Q--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 171 ~--~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
. .......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+ .+...++..+..+.. .++...++++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 248 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEA 248 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHH
Confidence 2 23455678999999999876 4599999999999999999999999976 567777777776533 3456678999
Q ss_pred HHHHHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCccccCCCCCC
Q 007055 248 KQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 289 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p 289 (620)
++||.+||. +|.+||+ +.++++||||+..++..+....+..|
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p 296 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 296 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCC
Confidence 999999998 8999994 69999999999888776544444333
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=381.53 Aligned_cols=255 Identities=23% Similarity=0.397 Sum_probs=212.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.++++++||||++++++|.+. ..+++
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 78 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTL 78 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEEE
Confidence 57999999999999999999999999999999986542 334557788999999999999999999998754 47899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||+.++.+..+....+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCSCC
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecCCcc
Confidence 9999987555555555778999999999999999999999999 99999999999998 7899999999999765433
Q ss_pred -CCccccCCCCCCCcccccc-c-cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C-CC----------
Q 007055 174 -TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--K-PA---------- 237 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~-~-y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~--~-p~---------- 237 (620)
......||+.|+|||++.+ . ++.++|||||||++|+|++|..||....+.......+.... . +.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 3345688999999998754 3 89999999999999999999988766666666555543210 0 00
Q ss_pred --------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 238 --------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 238 --------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
......++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1122357899999999998 99999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=408.30 Aligned_cols=260 Identities=26% Similarity=0.422 Sum_probs=223.3
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
.+.+.+.|++.+.||+|+||+||+|.++.+|+.||+|.+..... .....+.+.+|+.+|+.++||||++++++|.+.
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~- 82 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEE- 82 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-
Confidence 34455678999999999999999999999999999999986543 344567799999999999999999999988654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~DFGl 166 (620)
..+++||||+.||+|.+++...+.+++..+..+++||+.||.|||+++ |+||||||+|||++. .++.+||+|||+
T Consensus 83 -~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 83 -GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp -SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred -CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 578999999999999999999999999999999999999999999999 999999999999973 357899999999
Q ss_pred hhhccCCC--CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCC
Q 007055 167 AIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSK 241 (620)
Q Consensus 167 a~~~~~~~--~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~ 241 (620)
+....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+... .....
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 238 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWD 238 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTT
T ss_pred eEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccc
Confidence 97655432 345689999999998875 599999999999999999999999976 5667777777766442 22334
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
..++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 578999999999998 9999999999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=409.55 Aligned_cols=268 Identities=19% Similarity=0.325 Sum_probs=222.7
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
.....|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+++.++||||++++++|.+. .
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~ 142 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--R 142 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--C
Confidence 34567899999999999999999999999999999987532211 11123477899999999999999999998754 5
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
.+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeEC-CCCCEEEeccceeEee
Confidence 79999999999999999876 46999999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCCC---CccccCCCCCCCcccccc-c----cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCC
Q 007055 171 QQPT---ARSVIGTPEFMAPELYEE-E----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLS 240 (620)
Q Consensus 171 ~~~~---~~~~~GTp~y~APEll~~-~----y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~ 240 (620)
.... ..+.+||+.|+|||++.+ . |+.++|||||||++|||++|+.||.+ .+....+..+..+.. +.+..
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTT
T ss_pred ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCc
Confidence 4432 346789999999998753 2 78999999999999999999999986 567777777765421 11222
Q ss_pred CCCcHHHHHHHHHhcC-CCCC--CCCHHHHhcCCCcCCCCCCccccCCC
Q 007055 241 KVTDPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPKDLVCDPL 286 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~--Rpsa~elL~hpff~~~~~~~~~~~~~ 286 (620)
...++++++||.+||. +|.+ |+++.|+++||||+..++..+....+
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~ 346 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDT 346 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGS
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhccc
Confidence 3578999999999998 5666 99999999999999987765443333
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=403.99 Aligned_cols=270 Identities=20% Similarity=0.396 Sum_probs=229.4
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
.+.-..|++.+.||+|+||.||+|.+..+|+.||+|.+....... ....+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-- 87 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-- 87 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence 344567899999999999999999999999999999997543211 22346788999999999999999999998755
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++||||+.||+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAM 164 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEC-CCCCEEEeccceeee
Confidence 469999999999999999999989999999999999999999999999 99999999999998 789999999999976
Q ss_pred ccCC-CCccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCCCCCCCCC
Q 007055 170 MQQP-TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 170 ~~~~-~~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~--~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
.... .....+||+.|+|||++. ..|+.++|||||||++|+|++|+.||... .....+...+.... ..++..
T Consensus 165 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~ 242 (384)
T 4fr4_A 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSA 242 (384)
T ss_dssp CCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCTT
T ss_pred ccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCCc
Confidence 5433 345678999999999885 24899999999999999999999999743 33455555555442 334556
Q ss_pred CcHHHHHHHHHhcC-CCCCCCC-HHHHhcCCCcCCCCCCccccCCCC
Q 007055 243 TDPQVKQFIEKCIV-PASLRLP-ALELLKDPFLVTDNPKDLVCDPLR 287 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rps-a~elL~hpff~~~~~~~~~~~~~~ 287 (620)
.++.+++||.+||. +|.+||+ +.++++||||...++..+....+.
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~ 289 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLI 289 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCC
Confidence 78999999999998 8999998 899999999999888776554443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=391.12 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=217.4
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
+...|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 79 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NI 79 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC--Ce
Confidence 34567999999999999999999999999999999875432 22345688999999999999999999988654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECE
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEe-CCCCEEEEEeeccceec
Confidence 8999999999999999998888999999999999999999999999 99999999999998 78999999999997543
Q ss_pred CC----CCccccCCCCCCCcccccc-c-cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 007055 172 QP----TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 245 (620)
Q Consensus 172 ~~----~~~~~~GTp~y~APEll~~-~-y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~ 245 (620)
.. .....+||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.........+................++
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCH
Confidence 22 2345689999999998864 3 4778999999999999999999998765554555555544333333345688
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
.+++||.+||+ +|.+|||+.|+|+||||+....
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999998 9999999999999999986543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=388.98 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=220.7
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~--~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
....+|++.+.||+|+||+||+|.++.+|..||+|.++........ ...+.+.+|+.+|+.++||||++++++|.+.
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 86 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK- 86 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-
Confidence 4456789999999999999999999999999999999865432211 1346788999999999999999999998654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC----cEEEccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDL 164 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G----~vKI~DF 164 (620)
..+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+||
T Consensus 87 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~-~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 87 -TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL-DRNVPKPRIKIIDF 162 (326)
T ss_dssp -SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEES-CSSSSSCCEEECCC
T ss_pred -CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEe-cCCCCCCCEEEEEC
Confidence 578999999999999999998889999999999999999999999999 99999999999997 555 7999999
Q ss_pred cchhhccC-CCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCC
Q 007055 165 GLAIVMQQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLS 240 (620)
Q Consensus 165 Gla~~~~~-~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~ 240 (620)
|++..... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+. ........+...... ....
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHHhcCCCcCcccc
Confidence 99976543 2345568999999999886 45999999999999999999999999764 455555555543222 1222
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
...++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 4567899999999998 999999999999999998654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=394.44 Aligned_cols=257 Identities=25% Similarity=0.458 Sum_probs=222.2
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
....|++.+.||+|+||.||+|.++.+|+.||+|+++.... .....+.+.+|+.+++.++||||++++++|.+. ..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~ 102 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SF 102 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CE
Confidence 34568999999999999999999999999999999986543 455667899999999999999999999988654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC--CCcEEEccccchhh
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIV 169 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~G~vKI~DFGla~~ 169 (620)
+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.. ++.+||+|||++..
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 8999999999999999998889999999999999999999999999 9999999999999732 35699999999976
Q ss_pred ccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCcH
Q 007055 170 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDP 245 (620)
Q Consensus 170 ~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~~~ 245 (620)
.... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+.... ......++
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 5533 3345689999999998875 599999999999999999999999976 45667777776654322 22234688
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
.+++||.+||+ +|.+||++.++|+||||..
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999998 9999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=408.28 Aligned_cols=266 Identities=23% Similarity=0.405 Sum_probs=218.3
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
....|++.++||+|+||.||+|.+..+|+.||+|+++.... ........+.+|+.+|+.++||||++++++|... ..
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~ 222 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DR 222 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEET--TE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CE
Confidence 34568999999999999999999999999999999975432 2234456788999999999999999999998765 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
+++||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEEC-SSSCEEECCCCCCCTT
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEEC-CCCCEEEccCCCceec
Confidence 89999999999999999998999999999999999999999998 88 99999999999998 7899999999999753
Q ss_pred cC--CCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 171 QQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 171 ~~--~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
.. ......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+ .+...+...+..... .++...++.+
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~ 376 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLGPEA 376 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHH
Confidence 32 2345678999999999876 4599999999999999999999999976 456666666665432 3455678999
Q ss_pred HHHHHHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCccccCCC
Q 007055 248 KQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 286 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~ 286 (620)
++||.+||+ +|.+|| ++.|+|+||||...++..+....+
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~ 421 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL 421 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcC
Confidence 999999998 999999 999999999999887766544433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=393.73 Aligned_cols=263 Identities=21% Similarity=0.391 Sum_probs=217.3
Q ss_pred eeeccCceEEEEEEEcee--CCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 8 IWSLFVLFLQYDEILGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G--~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
.+.+.+..|++.+.||+| +||+||+|.+..+|+.||+|+++.... .....+.+.+|+.+++.++|||||+++++|.
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 455677888999999999 999999999999999999999986542 4556778899999999999999999999987
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
+. ..+++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|
T Consensus 97 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~d 171 (389)
T 3gni_B 97 AD--NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSG 171 (389)
T ss_dssp ET--TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECC
T ss_pred EC--CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcc
Confidence 65 4699999999999999999876 67999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccC---------CCCccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 007055 164 LGLAIVMQQ---------PTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 231 (620)
Q Consensus 164 FGla~~~~~---------~~~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~ 231 (620)
||.+..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+......+...+.
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 998753211 12234579999999998765 589999999999999999999999987554444333221
Q ss_pred cCCC-------------------------------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 007055 232 SGIK-------------------------------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALEL 267 (620)
Q Consensus 232 ~~~~-------------------------------------------p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~el 267 (620)
.... ...+....++.+++||.+||+ +|.+|||+.|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 1100 111334567899999999998 99999999999
Q ss_pred hcCCCcCCCC
Q 007055 268 LKDPFLVTDN 277 (620)
Q Consensus 268 L~hpff~~~~ 277 (620)
|+||||+...
T Consensus 332 l~hp~f~~~~ 341 (389)
T 3gni_B 332 LNHSFFKQIK 341 (389)
T ss_dssp TTSGGGGGC-
T ss_pred hcCHHHHHHh
Confidence 9999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=399.33 Aligned_cols=268 Identities=23% Similarity=0.387 Sum_probs=221.7
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCcceEEeEEEcCCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpNIVkl~~~f~~~~~~ 90 (620)
....|++.++||+|+||.||+|.++.+|+.||+|+++...... ......+.+|..+ ++.++||||++++++|.+. .
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--~ 112 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--D 112 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECS--S
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--C
Confidence 4457899999999999999999999999999999998665432 3344567777776 5778999999999998754 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCBCGGG
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEeeCcccccc
Confidence 79999999999999999999889999999999999999999999999 99999999999998 7899999999999753
Q ss_pred c--CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 171 Q--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 171 ~--~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
. .......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+...++..+.... ..++...++.+
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~ 266 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP--LQLKPNITNSA 266 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSC--CCCCSSSCHHH
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcc--cCCCCCCCHHH
Confidence 3 234556789999999998764 599999999999999999999999976 56777777777652 33455678999
Q ss_pred HHHHHHhcC-CCCCCCCH----HHHhcCCCcCCCCCCccccCCCCC
Q 007055 248 KQFIEKCIV-PASLRLPA----LELLKDPFLVTDNPKDLVCDPLRL 288 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa----~elL~hpff~~~~~~~~~~~~~~~ 288 (620)
++||.+||+ +|.+||++ .++++||||+..++..+....+..
T Consensus 267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~p 312 (373)
T 2r5t_A 267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITP 312 (373)
T ss_dssp HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred HHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCC
Confidence 999999998 89999997 699999999998887765544433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=408.63 Aligned_cols=264 Identities=19% Similarity=0.349 Sum_probs=221.2
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
+....|++.++||+|+||+||+|.++.+|+.||+|+++...... ......+.+|+.++..++||||++++++|.+. .
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~ 147 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDD--N 147 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--S
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--C
Confidence 34567899999999999999999999999999999997532211 11223478899999999999999999998654 5
Q ss_pred eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 91 TINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
.+|+||||+.+|+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~-~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLK 224 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEc-CCCCEEEcchhhhhh
Confidence 69999999999999999987 578999999999999999999999999 99999999999998 789999999999965
Q ss_pred ccCCC---CccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCC
Q 007055 170 MQQPT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPA 237 (620)
Q Consensus 170 ~~~~~---~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~---~p~ 237 (620)
..... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+ .+..+.+..+.... ..+
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCC
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCC
Confidence 54322 23468999999999875 3589999999999999999999999986 56666666665421 112
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCC--CCCHHHHhcCCCcCCCCCCcc
Q 007055 238 SLSKVTDPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 238 ~~~~~~~~~lk~~I~kcL~-~p~~--Rpsa~elL~hpff~~~~~~~~ 281 (620)
......++++++||.+||. +|.+ |+++.|+++||||+..++..+
T Consensus 304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 2223478999999999997 5555 899999999999999888775
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=404.57 Aligned_cols=265 Identities=20% Similarity=0.347 Sum_probs=222.0
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
......|++.++||+|+||.||+|.++.+|+.||+|+++..... .....+.+.+|+.+|..++||||++++++|.+.
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-- 133 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQDE-- 133 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS--
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--
Confidence 34456789999999999999999999999999999999753321 112234578899999999999999999998754
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 90 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..+|+||||++||+|.+++.+.+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld-~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCL 210 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeec-CCCCEEEeechhhe
Confidence 57999999999999999998754 7999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCCC---CccccCCCCCCCccccc--------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---
Q 007055 169 VMQQPT---ARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--- 234 (620)
Q Consensus 169 ~~~~~~---~~~~~GTp~y~APEll~--------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~--- 234 (620)
...... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+ .+....+..+....
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHL 289 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHC
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCc
Confidence 654332 23468999999999875 3589999999999999999999999977 56666666665421
Q ss_pred CCCCCCCCCcHHHHHHHHHhcCCCCCC---CCHHHHhcCCCcCCCCCCcc
Q 007055 235 KPASLSKVTDPQVKQFIEKCIVPASLR---LPALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 235 ~p~~~~~~~~~~lk~~I~kcL~~p~~R---psa~elL~hpff~~~~~~~~ 281 (620)
..+.+....++++++||.+||.+|.+| +++.|+++||||+..++..+
T Consensus 290 ~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 290 SLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp CCC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred CCCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 222234567899999999999988877 59999999999999888775
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=387.72 Aligned_cols=253 Identities=21% Similarity=0.343 Sum_probs=217.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.+..+|+.||+|.+... ......+.+|+.+|+.++||||++++++|.+. ..++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 77 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESM--EELV 77 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEEE
Confidence 4568999999999999999999999999999998643 23456788999999999999999999998664 4699
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC-CCcEEEccccchhhcc
Q 007055 94 MITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~-~G~vKI~DFGla~~~~ 171 (620)
+||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.. ++.+||+|||++....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999999999999998754 7999999999999999999999999 9999999999999832 7899999999997654
Q ss_pred CC-CCccccCCCCCCCccccccc-cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHH
Q 007055 172 QP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQV 247 (620)
Q Consensus 172 ~~-~~~~~~GTp~y~APEll~~~-y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~~~~l 247 (620)
.. ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+ .+...+...+..+..+.. .....++++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 33 23456799999999988754 89999999999999999999999987 455666666665543221 223567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
++||.+||. +|.+|||+.|+|+||||+..
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999998 89999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=377.43 Aligned_cols=256 Identities=24% Similarity=0.406 Sum_probs=212.0
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
....|++.+.||+|+||+||+|.+..+|..||+|.+..... ....+.+.+|+.+|+.++||||++++++|.+. ..
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 94 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY--HN 94 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHheecC--Ce
Confidence 34567999999999999999999999999999999976542 22346788999999999999999999998654 56
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEcccc
Q 007055 92 INMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLG 165 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~DFG 165 (620)
+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++. .++.+||+|||
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 8999999999999998854 367999999999999999999999999 999999999999952 45789999999
Q ss_pred chhhccCC-CCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCC
Q 007055 166 LAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVT 243 (620)
Q Consensus 166 la~~~~~~-~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~ 243 (620)
++...... ......||+.|+|||++.+.++.++||||||+++|+|++|+.||.+ .........+...... .......
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~ 251 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKEPNYAVECRPL 251 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCC--CCC
T ss_pred cceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhhccCCcccccccCcC
Confidence 99765433 3445679999999999988899999999999999999999999987 4455555555443322 2222336
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 7899999999998 8999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=370.44 Aligned_cols=259 Identities=25% Similarity=0.469 Sum_probs=222.2
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
+...|++.+.||+|+||+||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 79 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SF 79 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--CE
Confidence 45667999999999999999999999999999999976543 455667899999999999999999999988644 56
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEccccchhh
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIV 169 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~DFGla~~ 169 (620)
.++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++. .++.+||+|||++..
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 8999999999999999998889999999999999999999999999 999999999999972 234599999999965
Q ss_pred ccCCC-CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcH
Q 007055 170 MQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDP 245 (620)
Q Consensus 170 ~~~~~-~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~~~ 245 (620)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+ .+.......+..+.. +.......++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp CCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred cccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccCH
Confidence 54432 345689999999998765 589999999999999999999999977 456666666665543 2223345789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 99999999998 999999999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=381.44 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=208.0
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
.....|++.+.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||++++++|.+. .
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 92 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE--R 92 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS--S
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC--C
Confidence 34456799999999999999999985 599999999875432 233456788999999999999999999988544 5
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 91 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
.+++||||+.+ +|.+++... ..+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARA 168 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEEC-CCCCEEEccCcCcee
Confidence 68999999985 777777654 45999999999999999999999999 99999999999998 789999999999976
Q ss_pred ccCC--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCC----
Q 007055 170 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SGIKPASL---- 239 (620)
Q Consensus 170 ~~~~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~--~~~~p~~~---- 239 (620)
.... ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+......+..... ....+..+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 5432 2345578999999998754 489999999999999999999999987555444333222 11111111
Q ss_pred ---------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 240 ---------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 240 ---------------------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
....++++++||.+||+ +|.+|||+.|+|+||||+..++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 12346789999999998 9999999999999999997654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=386.05 Aligned_cols=258 Identities=24% Similarity=0.405 Sum_probs=219.7
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCcceEEeEEEc
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVD 86 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pNIVkl~~~f~~ 86 (620)
.+..++.|++.+.||+|+||+||+|.+ .+|+.||+|++.... ......+.+.+|+.+|+.++| |||+++++++..
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 356789999999999999999999988 468999999997654 245566789999999999987 999999998865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
. ..+++||| +.+|+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ +|.+||+|||+
T Consensus 81 ~--~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~--~~~~kl~DFG~ 153 (343)
T 3dbq_A 81 D--QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGI 153 (343)
T ss_dssp S--SEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSS
T ss_pred C--CEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE--CCcEEEeeccc
Confidence 4 57999999 568899999999999999999999999999999999999 99999999999996 58999999999
Q ss_pred hhhccCCC----CccccCCCCCCCccccc------------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 007055 167 AIVMQQPT----ARSVIGTPEFMAPELYE------------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 230 (620)
Q Consensus 167 a~~~~~~~----~~~~~GTp~y~APEll~------------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i 230 (620)
+....... ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||....+.......+
T Consensus 154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 233 (343)
T 3dbq_A 154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233 (343)
T ss_dssp SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH
Confidence 97654332 23568999999999874 458889999999999999999999998766666666666
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 231 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 231 ~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.....+..++...++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 234 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 66555666777788899999999998 89999999999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=390.33 Aligned_cols=258 Identities=22% Similarity=0.350 Sum_probs=205.5
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
....|++.+.||+|+||+||+|.+..+|+.||+|++..... ..+.+.+|+.+++.++||||++++++|.+. ..
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 90 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 90 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC--CE
Confidence 45567999999999999999999999999999999975432 124578999999999999999999998754 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC--cEEEccccchhh
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIV 169 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G--~vKI~DFGla~~ 169 (620)
+++||||+.+|+|.+++...+++++..++.|++||+.||.|||++| |+||||||+|||++ .++ .+||+|||++..
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~-~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLD-GSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEEC-SSSSCCEEECCCCCC--
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCceEEEeecCcccc
Confidence 8999999999999999998889999999999999999999999999 99999999999997 444 499999999864
Q ss_pred ccC-CCCccccCCCCCCCcccccc-ccCcc-chhhhhHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCC
Q 007055 170 MQQ-PTARSVIGTPEFMAPELYEE-EYNEL-VDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVT 243 (620)
Q Consensus 170 ~~~-~~~~~~~GTp~y~APEll~~-~y~~~-~DIwSlGiilyELltG~~Pf~~~~~---~~~i~~~i~~~~~p~~~~~~~ 243 (620)
... ......+||+.|+|||++.+ .++.+ +|||||||++|+|++|+.||.+... .......+.............
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence 332 23455689999999998754 45544 8999999999999999999976433 234444454443333333356
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
++.+++||.+||+ +|.+|||+.|+|+||||....+.
T Consensus 248 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 284 (361)
T 3uc3_A 248 SPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPA 284 (361)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCch
Confidence 8999999999998 99999999999999999765443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=376.03 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=205.0
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.+ .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++... ..+++
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 77 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVL 77 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEE
T ss_pred cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEEE
Confidence 478999999999999999998 6899999999875432 122235678999999999999999999998654 46899
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
||||+.+ +|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIP 153 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC-
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEeECccccccCcc
Confidence 9999985 899988764 67999999999999999999999999 99999999999998 7899999999999765432
Q ss_pred --CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCC----------
Q 007055 174 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPA---------- 237 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~--~~~p~---------- 237 (620)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...... .....
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 2345578999999998754 4899999999999999999999999875444443333221 00000
Q ss_pred --------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 238 --------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 238 --------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.+....++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1123467899999999998 99999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=387.68 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=206.9
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
...+|++.+.||+|+||+||+|.+..+++.||+|+++... ..+.+.+|+.+|+.++||||++++++|.+. ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 122 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TE 122 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecC--Ce
Confidence 3456899999999999999999999999999999987432 235578899999999999999999998654 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEccccchhh
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIV 169 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~DFGla~~ 169 (620)
+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||++..
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 8999999999999999998888999999999999999999999999 999999999999962 378999999999976
Q ss_pred ccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcH
Q 007055 170 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDP 245 (620)
Q Consensus 170 ~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~~~ 245 (620)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........++..+.....+ ..+....++
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 5443 2345689999999998875 58999999999999999999999998877777677777665432 233455788
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+++||.+||. +|.+|||+.|+|+||||....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999999998 999999999999999998643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=370.75 Aligned_cols=254 Identities=22% Similarity=0.408 Sum_probs=219.9
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
..++|++.+.||+|+||+||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||++++++|.+. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN--TD 80 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Ce
Confidence 45678999999999999999999999999999999875432 2346788999999999999999999998654 56
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEe---cCCCCcEEEccccchh
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAI 168 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl---~~~~G~vKI~DFGla~ 168 (620)
+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||++ + .++.+||+|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDS-PDSPLKLIDFGLAA 157 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSS-TTCCEEECCCTTCE
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCC-CCCcEEEEecccce
Confidence 8999999999999999998889999999999999999999999999 9999999999999 5 67899999999997
Q ss_pred hccCC-CCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcH
Q 007055 169 VMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDP 245 (620)
Q Consensus 169 ~~~~~-~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~~~ 245 (620)
..... ......||+.|+|||++.+.++.++||||||+++|+|++|+.||.. .+.......+..+..+.. .....++
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred eccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 55433 3456689999999999988899999999999999999999999987 455566666665533221 1124678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 99999999998 8999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=390.51 Aligned_cols=258 Identities=25% Similarity=0.444 Sum_probs=215.0
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC-HHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~-~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
+...|++.+.||+|+||+||+|.++.+|+.||+|+++....... ....+.+.+|+.+++.++||||++++++|.+. .
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~ 99 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--G 99 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--T
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--C
Confidence 45678999999999999999999999999999999975432211 11346789999999999999999999998764 5
Q ss_pred eEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEccc
Q 007055 91 TINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDL 164 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~DF 164 (620)
.+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+||
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecC
Confidence 799999999999998887543 35899999999999999999999999 999999999999973 2235999999
Q ss_pred cchhhccCCC--CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--C
Q 007055 165 GLAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--L 239 (620)
Q Consensus 165 Gla~~~~~~~--~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--~ 239 (620)
|++....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ ....++..+..+..... .
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~ 255 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQ 255 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHH
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCccc
Confidence 9997654432 345689999999998864 599999999999999999999999976 34556666665533221 1
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
....++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 23567899999999998 9999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=391.74 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=204.4
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l 92 (620)
+.|++.+.||+|+||+||+|.+..+|+.||+|++... ........++.+|+.+|+.+. ||||++++++|...+...+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc--ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4569999999999999999999999999999998633 234566788999999999997 9999999999987766789
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
|+|||||. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++....
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLN-AECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEc-CCCCEEecCCcccccccc
Confidence 99999997 589998876 57999999999999999999999999 99999999999998 789999999999965422
Q ss_pred -----------------------CCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHH
Q 007055 173 -----------------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 227 (620)
Q Consensus 173 -----------------------~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~ 227 (620)
......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 12234689999999998754 58999999999999999999999998754444433
Q ss_pred HHHHcCCCCC--------------------------------------------CCCCCCcHHHHHHHHHhcC-CCCCCC
Q 007055 228 KKVTSGIKPA--------------------------------------------SLSKVTDPQVKQFIEKCIV-PASLRL 262 (620)
Q Consensus 228 ~~i~~~~~p~--------------------------------------------~~~~~~~~~lk~~I~kcL~-~p~~Rp 262 (620)
..+.....|. ......++++++||.+||+ +|.+||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 3221110110 0112457899999999998 999999
Q ss_pred CHHHHhcCCCcCCC
Q 007055 263 PALELLKDPFLVTD 276 (620)
Q Consensus 263 sa~elL~hpff~~~ 276 (620)
|+.|+|+||||+..
T Consensus 322 t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 322 SANDALKHPFVSIF 335 (388)
T ss_dssp CHHHHTTSTTTTTT
T ss_pred CHHHHhCCHHHHHh
Confidence 99999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=407.97 Aligned_cols=262 Identities=29% Similarity=0.475 Sum_probs=227.1
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
......|++.++||+|+||+||+|.+..+|+.||+|++...... .....+.+.+|+.+|++++||||++++++|.+.
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 98 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK-- 98 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence 34456789999999999999999999999999999999765432 223456789999999999999999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec--CCCCcEEEccccch
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA 167 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~G~vKI~DFGla 167 (620)
..+++||||+.+|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ ..++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 579999999999999999999999999999999999999999999999 99999999999995 25789999999999
Q ss_pred hhccCC-CCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCc
Q 007055 168 IVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTD 244 (620)
Q Consensus 168 ~~~~~~-~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~~ 244 (620)
...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+...+...+..+..+... ....+
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 255 (484)
T 3nyv_A 177 THFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVS 255 (484)
T ss_dssp HHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSC
T ss_pred EEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCC
Confidence 766543 3345689999999999988999999999999999999999999987 5667777777776543332 24568
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 256 ~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 899999999998 899999999999999998644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=392.74 Aligned_cols=258 Identities=24% Similarity=0.408 Sum_probs=220.6
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC--CCCcceEEeEEEc
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVD 86 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~--HpNIVkl~~~f~~ 86 (620)
....++.|++.+.||+|+||+||+|.+.. |+.||+|++..... .....+.+.+|+.+|+.|+ ||||+++++++..
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 34567889999999999999999999875 99999999976542 4566788999999999996 5999999998875
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
. ..+++||| +.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ +|.+||+|||+
T Consensus 128 ~--~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~--~~~~kl~DFG~ 200 (390)
T 2zmd_A 128 D--QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGI 200 (390)
T ss_dssp S--SEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES--SSCEEECCCSS
T ss_pred C--CEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE--CCeEEEEecCc
Confidence 5 46999999 668899999999889999999999999999999999999 99999999999996 58999999999
Q ss_pred hhhccCCC----CccccCCCCCCCcccccc------------ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 007055 167 AIVMQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 230 (620)
Q Consensus 167 a~~~~~~~----~~~~~GTp~y~APEll~~------------~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i 230 (620)
+....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||....+.......+
T Consensus 201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~ 280 (390)
T 2zmd_A 201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280 (390)
T ss_dssp SCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred cccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH
Confidence 97654322 345689999999998753 58899999999999999999999998766666666666
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 231 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 231 ~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
........++...++.+++||.+||. +|.+||++.|+|+||||+..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 66555555666778899999999998 99999999999999999753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=394.15 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=212.9
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.+..+|+.||+|++...... ......++.+|+.+|+.++||||+++++++... ..+++
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 86 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--TDIVM 86 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEE
Confidence 458999999999999999999999999999998753221 111235688999999999999999999998654 46899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||+ +|+|.+++...+++++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEEC-TTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEc-CCCCEEEEEeccceeccCCc
Confidence 99999 7899999988889999999999999999999999999 99999999999998 7899999999999765433
Q ss_pred CCccccCCCCCCCccccccc-c-CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 174 TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 174 ~~~~~~GTp~y~APEll~~~-y-~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+.. ...+...+..+ ...++...++.+++||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-~~~~~~~i~~~--~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVNSC--VYVMPDFLSPGAQSLI 239 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS-STTCBCCCCSS--CCCCCTTSCHHHHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHcC--CCCCcccCCHHHHHHH
Confidence 34567899999999988754 4 789999999999999999999997632 22222222221 2234556789999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 252 EKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
.+||+ +|.+|||+.|+++||||+...+
T Consensus 240 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred HHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 99998 9999999999999999986543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=378.77 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=221.8
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~--~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
....++|++.+.||+|+||.||+|.++.+|+.||+|.++........ ...+.+.+|+.+++.++||||++++++|.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 44556789999999999999999999999999999999865432211 1356788999999999999999999988654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC----cEEEcc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGD 163 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G----~vKI~D 163 (620)
..+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+|
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~-~~~~~~~~~kl~D 162 (321)
T 2a2a_A 88 --TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLL-DKNIPIPHIKLID 162 (321)
T ss_dssp --SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CTTSSSCCEEECC
T ss_pred --CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEe-cCCCCcCCEEEcc
Confidence 578999999999999999998888999999999999999999999999 99999999999998 555 799999
Q ss_pred ccchhhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCC
Q 007055 164 LGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASL 239 (620)
Q Consensus 164 FGla~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~ 239 (620)
||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+.......+...... ...
T Consensus 163 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~ 241 (321)
T 2a2a_A 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEF 241 (321)
T ss_dssp CTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHH
T ss_pred CccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccChhh
Confidence 9999765443 334567999999999876 4589999999999999999999999976 4555566666554332 122
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
....++.+++||.+||. +|.+|||+.|+|+||||....
T Consensus 242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 24567899999999998 899999999999999998654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=383.08 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=206.4
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.-..|++.+.||+|+||+||+|.+..+|+.||+|+++.... .....+.+.+|+.+|+.++||||+++++++.+. ..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 107 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--HR 107 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEET--TE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecC--CE
Confidence 34467999999999999999999999999999999875432 233456678999999999999999999998765 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec----CCCCcEEEccccch
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLA 167 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~----~~~G~vKI~DFGla 167 (620)
+++||||+. |+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ ..++.+||+|||++
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 899999998 599999999999999999999999999999999999 99999999999995 24556999999999
Q ss_pred hhccCC--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCC--
Q 007055 168 IVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASL-- 239 (620)
Q Consensus 168 ~~~~~~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~-- 239 (620)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.....| ..+
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 765433 3345678999999998764 48999999999999999999999998755444444433221111 000
Q ss_pred -----------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 240 -----------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 240 -----------------------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
....++++++||.+||+ +|.+|||+.|+|+||||+..++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 01156889999999998 9999999999999999998654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=373.15 Aligned_cols=257 Identities=23% Similarity=0.411 Sum_probs=217.0
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.-..|++.+.||+|+||+||+|.+..++..||+|.+...... .......+.+|+.+++.++||||++++++|.+. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 83 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TR 83 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CE
Confidence 345679999999999999999999999999999998654321 112245688999999999999999999998654 56
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++||||+++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEEC-TTSCEEECSCCEESCC-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEc-CCCCEEEEeccccccCC
Confidence 8999999999999999998889999999999999999999999999 99999999999998 78999999999986655
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 172 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..... .++...++.+++|
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 237 (279)
T 3fdn_A 161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDL 237 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHH
T ss_pred cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCC--CCCCcCCHHHHHH
Confidence 555566789999999998765 478999999999999999999999976 556666666665432 3455678999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 251 IEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
|.+||. +|.+||++.|+|+||||+...
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCc
Confidence 999998 899999999999999998644
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=404.56 Aligned_cols=259 Identities=29% Similarity=0.438 Sum_probs=220.1
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC---------HHHHHHHHHHHHHHHhCCCCCcceEEe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS---------PDQLERLYSEVHLLKSLKHENIIKFYN 82 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~---------~~~~~~l~~Ei~iL~~L~HpNIVkl~~ 82 (620)
.+..|++.+.||+|+||+||+|.++.+|..||+|++........ ....+.+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45668999999999999999999999999999999976542211 123467899999999999999999999
Q ss_pred EEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC---cE
Q 007055 83 SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EV 159 (620)
Q Consensus 83 ~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G---~v 159 (620)
+|.+. ..+++|||||++|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ .++ .+
T Consensus 114 ~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLE-NKNSLLNI 188 (504)
T ss_dssp EEECS--SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES-STTCCSSE
T ss_pred EEEcC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEe-cCCCCccE
Confidence 98654 579999999999999999998889999999999999999999999999 99999999999998 444 69
Q ss_pred EEccccchhhccCC-CCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 007055 160 KIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 238 (620)
Q Consensus 160 KI~DFGla~~~~~~-~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~ 238 (620)
||+|||++...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+...+...+..+.....
T Consensus 189 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp EECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCC
T ss_pred EEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCC
Confidence 99999999765443 3456789999999999988899999999999999999999999987 566777777777654322
Q ss_pred C--CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 239 L--SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 239 ~--~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
. ....++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 1 24568899999999998 99999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=405.24 Aligned_cols=259 Identities=31% Similarity=0.500 Sum_probs=222.8
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
....|++.++||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.+|++++||||+++++++.+. ..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 95 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDS--SS 95 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC--CE
Confidence 3456899999999999999999999999999999997543222 2346788999999999999999999988654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEccccchhh
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIV 169 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~DFGla~~ 169 (620)
+++|||||.+|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++. .++.+||+|||++..
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999999999988889999999999999999999999999 999999999999952 456899999999976
Q ss_pred ccCC-CCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHH
Q 007055 170 MQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQ 246 (620)
Q Consensus 170 ~~~~-~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~~~~ 246 (620)
.... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+...+...+..+..+...+ ...++.
T Consensus 174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 174 FQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp BCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred CCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 5443 3455689999999999998999999999999999999999999987 56667777777665443322 346889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+++||.+||+ +|.+|||+.++|+||||+...
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 9999999998 999999999999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=403.18 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=217.5
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.++.+|..||+|++....... .....+.+|+.+|+.++||||++++++|.+. ..++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 112 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--RNYY 112 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEE
Confidence 36899999999999999999999999999999997654322 2346688999999999999999999998654 5789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEccccchhhcc
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~DFGla~~~~ 171 (620)
+|||||.+|+|.+++.....+++..++.+++||+.||.|||+++ |+||||||+|||++. .++.+||+|||++....
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999999999998889999999999999999999999999 999999999999973 24569999999997654
Q ss_pred CC-CCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHH
Q 007055 172 QP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVK 248 (620)
Q Consensus 172 ~~-~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~~~~lk 248 (620)
.. .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+...+...+..+..+.. .....++.++
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred CCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 43 3456789999999999988899999999999999999999999987 566677777776644322 2245788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 249 QFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+||.+||+ +|.+|||+.++|+||||+..
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 99999998 99999999999999999763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=383.57 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=215.3
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCe
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~ 91 (620)
...|++.+.||+|+||+||+|.++.+|+.||+|+++.... ...+|++++.++ +||||++++++|.+. ..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~ 90 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDG--KY 90 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECS--SE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcC--CE
Confidence 4567999999999999999999999999999999975432 134688888887 799999999998654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCC---CcEEEccccchh
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAI 168 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~---G~vKI~DFGla~ 168 (620)
+|+||||+.||+|.+++.+.+.+++..+..++.||+.||.|||++| |+||||||+|||+...+ +.+||+|||++.
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999999999999999999999999999999999999999 99999999999985333 359999999997
Q ss_pred hccCC--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCCCC--CCCC
Q 007055 169 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPA--SLSK 241 (620)
Q Consensus 169 ~~~~~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~--~~~~~i~~~i~~~~~p~--~~~~ 241 (620)
..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+. .....+...+..+..+. ....
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 65433 3446689999999998875 4999999999999999999999999753 45677777777765432 2345
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
..++.+++||.+||. +|.+||++.++|+||||..
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 678999999999998 9999999999999999964
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=377.32 Aligned_cols=262 Identities=27% Similarity=0.390 Sum_probs=206.3
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC-HHHHHHHHHHHHHHHhC---CCCCcceEEeEEEc
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSL---KHENIIKFYNSWVD 86 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~-~~~~~~l~~Ei~iL~~L---~HpNIVkl~~~f~~ 86 (620)
.....|++.+.||+|+||+||+|.+..+|+.||+|.+........ ......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 345567999999999999999999999999999999975432111 11123456677776666 59999999999876
Q ss_pred CCCC---eEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEE
Q 007055 87 DTNR---TINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 161 (620)
Q Consensus 87 ~~~~---~l~lV~Ey~~gGsL~~~i~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI 161 (620)
.... .+++||||+. |+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEEC-TTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEE
Confidence 5432 6899999997 599999987754 999999999999999999999999 99999999999998 7899999
Q ss_pred ccccchhhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCC-
Q 007055 162 GDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP- 236 (620)
Q Consensus 162 ~DFGla~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~--~~p- 236 (620)
+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.. .......+... ..+
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-EADQLGKIFDLIGLPPE 240 (308)
T ss_dssp CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-HHHHHHHHHHHHCCCCT
T ss_pred eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCh
Confidence 999999765433 345568999999999875 569999999999999999999999998744 44333333221 111
Q ss_pred CCC----------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 237 ASL----------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 237 ~~~----------------------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
..+ ....++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 111 12457899999999998 999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=377.69 Aligned_cols=252 Identities=29% Similarity=0.547 Sum_probs=216.3
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|+..+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||++++++|... ..+++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVG--EELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEE
Confidence 57888999999999999999999999999999875432 2345688999999999999999999998765 46899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 120 v~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp EECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSS
T ss_pred EEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCcEEEeeeeeeeecccCc
Confidence 9999999999999875 46999999999999999999999999 99999999999998 7899999999998765433
Q ss_pred -CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHHH
Q 007055 174 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQF 250 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~~~~lk~~ 250 (620)
......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+..+....+.....+. ......++.+++|
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 274 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDF 274 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCHHHHHH
T ss_pred cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCHHHHHH
Confidence 3345689999999998764 589999999999999999999999976 45666666666554432 2233467899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 251 IEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
|.+||+ +|.+|||+.++|+||||....
T Consensus 275 i~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 275 LERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHccCChhhCcCHHHHhcChhhccCC
Confidence 999998 899999999999999998644
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=375.22 Aligned_cols=259 Identities=22% Similarity=0.375 Sum_probs=209.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||++++++|.+. ..++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeEE
Confidence 34689999999999999999999999999999886442 3445567788999999999999999999998654 4689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++......
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC--
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEc-CCCCEEEeeCCCchhccCc
Confidence 99999999999999998889999999999999999999999999 99999999999998 7899999999999765432
Q ss_pred --CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--C--------------
Q 007055 174 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--G-------------- 233 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~--~-------------- 233 (620)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+............. .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2345689999999998754 5899999999999999999999999875444433322110 0
Q ss_pred ---CC---CCCC------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 234 ---IK---PASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 234 ---~~---p~~~------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
.. +... ....++.+.+||.+||. +|.+|||+.|+|+||||+.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 00 0000 12457789999999998 99999999999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=377.61 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=207.5
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCeE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~l 92 (620)
+.|++.++||+|+||+||+|.+..+|+.||+|++.... .......+...|+..+..+ +||||++++++|.+. ..+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~ 132 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GIL 132 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC--CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc--cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEE
Confidence 56899999999999999999999999999999876432 2334445555666555554 999999999998654 569
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 93 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
++||||+ +|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLG-PRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-GGGCEEECCCTTCEECC
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEccceeeeecc
Confidence 9999999 67888887764 46999999999999999999999999 99999999999997 78999999999987654
Q ss_pred CC-CCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 172 QP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 172 ~~-~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
.. ......||+.|+|||++.+.++.++|||||||++|||++|..||.. ......+..+..+..++...++.+++|
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 209 TAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp ------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred cCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHHHH
Confidence 33 2344579999999999988999999999999999999999777654 223445555555555566678999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 251 IEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
|.+||+ +|.+|||+.|+|+||||++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHcCCChhhCcCHHHHHhCccccC
Confidence 999998 8999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=385.62 Aligned_cols=260 Identities=26% Similarity=0.442 Sum_probs=219.6
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
.+....|++.+.||+|+||+||+|.+..+|..||+|++... ......+.+.+|+.+++.++||||++++++|.+.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 103 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-- 103 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc---cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--
Confidence 44566789999999999999999999999999999998754 2455667899999999999999999999998765
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..+++||||+++|+|.+++...+.+++..+..++.||+.||.|||+. + |+||||||+|||++ .+|.+||+|||++.
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSG 180 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEEC-CCCCEEEEECCCCc
Confidence 46899999999999999999988999999999999999999999995 8 99999999999998 78999999999997
Q ss_pred hccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHH---------------------
Q 007055 169 VMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI--------------------- 226 (620)
Q Consensus 169 ~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i--------------------- 226 (620)
...........||+.|+|||++.+ .++.++|||||||++|+|++|+.||... +...+
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC-CHHHHHHHHC----------------
T ss_pred ccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccCCCCCCCccc
Confidence 665555566789999999998764 5899999999999999999999999763 33222
Q ss_pred ---------------------HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 227 ---------------------YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 227 ---------------------~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
...+.....+.......++++++||.+||+ +|.+|||+.|+|+||||+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 222233333333344568899999999998 9999999999999999986543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=388.93 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=218.2
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
.++|++.+.||+|+||+||+|.+..+|+.||+|.+... .......+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~ 123 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEM 123 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--CEE
Confidence 45689999999999999999999999999999998743 234556789999999999999999999998654 579
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC-CCCcEEEccccchhhc
Q 007055 93 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVM 170 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~G~vKI~DFGla~~~ 170 (620)
++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||++...
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999999999987654 7999999999999999999999999 999999999999973 3578999999999765
Q ss_pred cCCC-CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHH
Q 007055 171 QQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQ 246 (620)
Q Consensus 171 ~~~~-~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~~~~ 246 (620)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......+..... +.......++.
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred CCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 4432 344579999999998864 589999999999999999999999987 445555555554432 22333457899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 9999999998 899999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=410.20 Aligned_cols=265 Identities=23% Similarity=0.360 Sum_probs=226.9
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
+....|++.++||+|+||.||+|.++.+|+.||+|++....... ......+.+|+.+|+.++||||++++++|.+. .
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETK--D 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--C
Confidence 45667899999999999999999999999999999997543221 12345688999999999999999999998654 5
Q ss_pred eEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 91 TINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
.+|+||||++||+|.+++...+. +++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld-~~g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEe-CCCCeEEEecccce
Confidence 79999999999999999987654 999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCC
Q 007055 169 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVT 243 (620)
Q Consensus 169 ~~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~ 243 (620)
..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.... ....+...+... +..++...
T Consensus 335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~ 412 (576)
T 2acx_A 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERF 412 (576)
T ss_dssp ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTS
T ss_pred ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccC
Confidence 65433 3345689999999998765 59999999999999999999999997643 345666666654 34456678
Q ss_pred cHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCcccc
Q 007055 244 DPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVC 283 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~ 283 (620)
++++++||.+||. +|.+|| ++.|+++||||+..++..+..
T Consensus 413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~ 458 (576)
T 2acx_A 413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGA 458 (576)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHT
T ss_pred CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhc
Confidence 8999999999998 999999 799999999999988766543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=390.05 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=208.3
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC---
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 89 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~--- 89 (620)
...|++.+.||+|+||+||+|.+..+|+.||+|+++.. .......+++.+|+.+|+.++||||+++++++.....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST--TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch--hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 44568999999999999999999999999999998643 2345667889999999999999999999999865532
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+|+||||+. |+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLART 178 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEEC-CCCCEEEccCCCccc
Confidence 56899999986 599999999888999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCC------------------------CCccccCCCCCCCcccc-c-cccCccchhhhhHHHHHHHHhcCCC-------
Q 007055 170 MQQP------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTCEYP------- 216 (620)
Q Consensus 170 ~~~~------------------------~~~~~~GTp~y~APEll-~-~~y~~~~DIwSlGiilyELltG~~P------- 216 (620)
.... .....+||+.|+|||++ . ..|+.++|||||||++|||++|..|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 4322 13567899999999975 3 4599999999999999999985433
Q ss_pred ----CCCCCC-----------------HHHHH-----------------------HHHHcCCCCCC-----CCCCCcHHH
Q 007055 217 ----YNECKN-----------------PAQIY-----------------------KKVTSGIKPAS-----LSKVTDPQV 247 (620)
Q Consensus 217 ----f~~~~~-----------------~~~i~-----------------------~~i~~~~~p~~-----~~~~~~~~l 247 (620)
|.+... ..++. ..+........ .....++.+
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 322110 11111 11111100000 013468899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCCc
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 280 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~~ 280 (620)
++||.+||+ +|.+|||+.|+|+||||+......
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 999999998 999999999999999999865443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=377.50 Aligned_cols=258 Identities=23% Similarity=0.375 Sum_probs=207.9
Q ss_pred cCceEEE-EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCC
Q 007055 12 FVLFLQY-DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 89 (620)
Q Consensus 12 ~~r~y~i-~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~ 89 (620)
+...|++ .++||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.+|.++ +||||++++++|.+.
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-- 83 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-- 83 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--
Confidence 3445667 478999999999999999999999999987542 22346788999999985 799999999998764
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc---EEEccccc
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE---VKIGDLGL 166 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~---vKI~DFGl 166 (620)
..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCE-HPNQVSPVKICDFDL 160 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEES-CSSSSCSEEECCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEc-cCCCcCceEEEEccC
Confidence 479999999999999999998889999999999999999999999999 99999999999998 4444 99999999
Q ss_pred hhhccCC---------CCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCC---------
Q 007055 167 AIVMQQP---------TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKN--------- 222 (620)
Q Consensus 167 a~~~~~~---------~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~--------- 222 (620)
+...... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 8644311 123456999999999875 3489999999999999999999999976432
Q ss_pred -----HHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 223 -----PAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 223 -----~~~i~~~i~~~~~p~~--~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
...+...+..+..... .....++.+++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 2345556655533211 113467899999999998 9999999999999999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=367.49 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=218.5
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
...|++.+.||+|+||.||+|.+..+|+.||+|.++.... ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEE
Confidence 3567999999999999999999999999999999875542 23557789999999999999999999988654 568
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
++||||+++|+|.+++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEc-cCCCEEEeeCCCccccCC
Confidence 999999999999999988888999999999999999999999999 99999999999998 789999999999865432
Q ss_pred C----CCccccCCCCCCCcccccc-c-cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 173 P----TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 173 ~----~~~~~~GTp~y~APEll~~-~-y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
. ......||+.|+|||++.+ . ++.++||||||+++|+|++|+.||.........+..+.............++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 237 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHH
Confidence 2 2345679999999998864 3 37789999999999999999999987655444555555443332233456889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
++++|.+||. +|.+|||+.|+++||||+...
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 9999999998 899999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=379.22 Aligned_cols=252 Identities=23% Similarity=0.420 Sum_probs=207.5
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC----
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---- 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~---- 89 (620)
..|++.+.||+|+||.||+|.++.+|+.||+|+++... .....+.+.+|+.+|+.++||||++++++|.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 45799999999999999999999999999999997543 33456779999999999999999999999876432
Q ss_pred ---------------------------------------------------CeEEEEEeccCCCCHHHHHHhCCC---CC
Q 007055 90 ---------------------------------------------------RTINMITELFTSGSLRQYRKKHKN---VD 115 (620)
Q Consensus 90 ---------------------------------------------------~~l~lV~Ey~~gGsL~~~i~~~~~---l~ 115 (620)
..+++|||||++|+|.+++.+... .+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 248999999999999999987654 56
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC--------------CCccccCC
Q 007055 116 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--------------TARSVIGT 181 (620)
Q Consensus 116 e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~--------------~~~~~~GT 181 (620)
+..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...... .....+||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 6678999999999999999999 99999999999998 7899999999999755432 22345799
Q ss_pred CCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCC
Q 007055 182 PEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PAS 259 (620)
Q Consensus 182 p~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~ 259 (620)
+.|+|||++.+ .++.++|||||||++|+|++|..|+. ........+.....|.. ....++.+++||.+||+ +|.
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~ 315 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLL-FTQKYPQEHMMVQDMLSPSPT 315 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHHCSSGG
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCcc-cccCChhHHHHHHHHccCCCC
Confidence 99999998764 58999999999999999999877653 23344444444433321 12235778999999998 899
Q ss_pred CCCCHHHHhcCCCcCC
Q 007055 260 LRLPALELLKDPFLVT 275 (620)
Q Consensus 260 ~Rpsa~elL~hpff~~ 275 (620)
+|||+.|+|+||||+.
T Consensus 316 ~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 316 ERPEATDIIENAIFEN 331 (332)
T ss_dssp GSCCHHHHHHSTTCCC
T ss_pred cCCCHHHHhhchhhhc
Confidence 9999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=379.19 Aligned_cols=255 Identities=27% Similarity=0.506 Sum_probs=197.5
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
...|++.+.||+|+||+||+|.++.+|+.||+|.++.... ....+.+.+|+.+|+.++||||+++++++.++ ..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIHTE--NKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--CeE
Confidence 3467899999999999999999999999999999975532 22335678999999999999999999988544 579
Q ss_pred EEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 93 NMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
++||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEc-CCCCEEECcCcc
Confidence 99999998 5999988754 35999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCC---
Q 007055 167 AIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPA--- 237 (620)
Q Consensus 167 a~~~~~~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~--~~~p~--- 237 (620)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. .......+.. +..+.
T Consensus 155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-DEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCSCCTTTC
T ss_pred ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhHh
Confidence 9765432 3345689999999998764 48999999999999999999999998754 3333333321 11000
Q ss_pred ---------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 238 ---------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 238 ---------------------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
......++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 0112457899999999998 999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=373.56 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=219.9
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
.....|++.+.||+|+||+||+|.+..+|+.||+|.++... ....+.+.+|+.+++.++||||++++++|.+. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 79 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYEST--T 79 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhcccC--C
Confidence 34556799999999999999999999999999999997543 12335688999999999999999999988654 5
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec--CCCCcEEEccccchh
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAI 168 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~G~vKI~DFGla~ 168 (620)
.+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||++. ..++.+||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 78999999999999999988889999999999999999999999999 99999999999992 267899999999997
Q ss_pred hccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcH
Q 007055 169 VMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDP 245 (620)
Q Consensus 169 ~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~~~ 245 (620)
...........||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+...+..+..+ .......++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 158 MEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp CCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred ecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCCH
Confidence 655544455679999999998864 589999999999999999999999976 4566667777665432 233456789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+++||.+||. +|.+||++.++|+||||....
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 99999999998 999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=383.13 Aligned_cols=255 Identities=29% Similarity=0.483 Sum_probs=217.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.|++.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+|+.++||||++++++|... ..++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEE
Confidence 457899999999999999999999999999999975432 2344567799999999999999999999998765 4789
Q ss_pred EEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~-~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+||||+. |+|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEeeccCceecCC
Confidence 9999997 57877775 4567999999999999999999999999 99999999999998 789999999999975543
Q ss_pred CCCccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 173 PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 173 ~~~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
....+||+.|+|||++. +.++.++|||||||++|||++|+.||.+......+ ..+..+..+.......++.++
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~ 283 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESPALQSGHWSEYFR 283 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSCCCCCCCTTSCHHHH
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCCCCCCCCCHHHH
Confidence 34568999999999873 45899999999999999999999999875444444 444455455555567789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 249 QFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
+||.+||+ +|.+|||+.++|+||||....+
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 99999998 8999999999999999976543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=369.94 Aligned_cols=262 Identities=23% Similarity=0.408 Sum_probs=222.6
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
....+....|++.+.||+|+||.||+|.+..++..||+|.+....... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp ---CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 344455667899999999999999999999999999999987543211 1223568899999999999999999999865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
. ..+++||||+++|+|.+++...+.+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||+
T Consensus 86 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 86 R--KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMG-YKGELKIADFGW 160 (284)
T ss_dssp S--SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTCCEEECCCTT
T ss_pred C--CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEc-CCCCEEEecccc
Confidence 4 578999999999999999998889999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 007055 167 AIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 245 (620)
Q Consensus 167 a~~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~ 245 (620)
+............||+.|+|||++.+ .++.++||||||+++|+|++|..||... ........+.... ..++...++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~--~~~~~~~~~ 237 (284)
T 2vgo_A 161 SVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-SHTETHRRIVNVD--LKFPPFLSD 237 (284)
T ss_dssp CEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTC--CCCCTTSCH
T ss_pred cccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC-CHhHHHHHHhccc--cCCCCcCCH
Confidence 87665555566789999999998765 5899999999999999999999999763 4555555555432 234556789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+++||.+||. +|.+||++.++|+||||+...
T Consensus 238 ~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 99999999998 999999999999999998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=386.35 Aligned_cols=257 Identities=29% Similarity=0.427 Sum_probs=208.2
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC---
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 89 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~--- 89 (620)
.+.|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+++.+|+.+|+.++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 345689999999999999999999999999999986432 345567789999999999999999999999865432
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 90 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 90 -~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLAR 176 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEc-CCCCEEEEeeeccc
Confidence 3578999999 8899999886 56999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCC---------
Q 007055 169 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP--------- 236 (620)
Q Consensus 169 ~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~p--------- 236 (620)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.. +..+
T Consensus 177 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 177 QADS-EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp ECCS-SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cccc-ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 6543 3455689999999998764 5999999999999999999999999875444443332221 1100
Q ss_pred ---------------C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 237 ---------------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 237 ---------------~---~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
. .+....++.+++||.+||+ +|.+|||+.|+|+||||....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 1223457899999999998 999999999999999998643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=396.27 Aligned_cols=261 Identities=21% Similarity=0.345 Sum_probs=198.1
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC---CC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NR 90 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~---~~ 90 (620)
..|++.++||+|+||+||+|.++.+|+.||+|++... .......+++.+|+.+|+.++|||||+++++|.... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECST--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh--hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4568999999999999999999999999999998643 234566788999999999999999999999986543 25
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
.+|+||||+ +|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++..
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTV 206 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBCT
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEEC-CCCCEeecccccchhc
Confidence 799999998 5799999998889999999999999999999999999 99999999999998 7899999999999754
Q ss_pred cCC-----------------------------CCccccCCCCCCCcccc-c-cccCccchhhhhHHHHHHHHh-------
Q 007055 171 QQP-----------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVT------- 212 (620)
Q Consensus 171 ~~~-----------------------------~~~~~~GTp~y~APEll-~-~~y~~~~DIwSlGiilyELlt------- 212 (620)
... .....+||+.|+|||++ . ..|+.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 321 22346889999999975 3 459999999999999999999
Q ss_pred ----cCCCCCCCCC--------------------HHHHHHHH--H--------------------cCCC---C---CCCC
Q 007055 213 ----CEYPYNECKN--------------------PAQIYKKV--T--------------------SGIK---P---ASLS 240 (620)
Q Consensus 213 ----G~~Pf~~~~~--------------------~~~i~~~i--~--------------------~~~~---p---~~~~ 240 (620)
|+++|.+... ..++...+ . .... . ....
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 6666654321 11111110 0 0000 0 0111
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCCc
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 280 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~~ 280 (620)
...++++++||.+||+ +|.+|||+.|+|+||||+......
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 2347899999999998 999999999999999999865543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=381.17 Aligned_cols=268 Identities=22% Similarity=0.308 Sum_probs=219.3
Q ss_pred eeeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 6 LVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 6 ~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
+..+......|++.+.||+|+||+||+|.+..+|+.||+|+++... ........++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 82 (311)
T 3ork_A 4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 82 (311)
T ss_dssp CCCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT-TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEE
T ss_pred CCCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc-cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeee
Confidence 3455666777899999999999999999999999999999997543 234566778999999999999999999999987
Q ss_pred cCCCC--eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 86 DDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 86 ~~~~~--~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
..... .+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~D 159 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMD 159 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTSCEEECC
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEc-CCCCEEEee
Confidence 65432 56899999999999999998889999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCC-----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 007055 164 LGLAIVMQQP-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 237 (620)
Q Consensus 164 FGla~~~~~~-----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~ 237 (620)
||++...... .....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+..........+.....+.
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239 (311)
T ss_dssp CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc
Confidence 9999755332 2234579999999998764 589999999999999999999999987544444444454433322
Q ss_pred -CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 238 -SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 238 -~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
......++.++++|.+||+ +|.+||++.++|.|+|++...
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 2234568899999999998 899999999999999997543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=385.83 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=207.8
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC---
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--- 87 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~--- 87 (620)
...+.|++.+.||+|+||+||+|.+..+|+.||+|++...... ..+|+.+|+.++||||++++++|...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 4456789999999999999999999999999999998744321 23699999999999999999998653
Q ss_pred ---------------------------------CCCeEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHH
Q 007055 88 ---------------------------------TNRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGL 130 (620)
Q Consensus 88 ---------------------------------~~~~l~lV~Ey~~gGsL~~~i~----~~~~l~e~~i~~i~~QIl~gL 130 (620)
...++++||||+++ +|.+.+. ..+.+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 23468999999985 7666554 467899999999999999999
Q ss_pred HHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-CCccccCCCCCCCcccccc--ccCccchhhhhHHHH
Q 007055 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCI 207 (620)
Q Consensus 131 ~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~-~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiil 207 (620)
.|||++| |+||||||+|||++..+|.+||+|||++...... ......||+.|+|||++.+ .|+.++|||||||++
T Consensus 155 ~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 155 GFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999999 9999999999999866899999999999755433 3456689999999998754 489999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------------C--------CCCCCCcHHHHHHHHHhcC-CCCC
Q 007055 208 LEMVTCEYPYNECKNPAQIYKKVTSGIKP------------------A--------SLSKVTDPQVKQFIEKCIV-PASL 260 (620)
Q Consensus 208 yELltG~~Pf~~~~~~~~i~~~i~~~~~p------------------~--------~~~~~~~~~lk~~I~kcL~-~p~~ 260 (620)
|+|++|+.||.+.....++...+.....| . .++...++.+++||.+||+ +|.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999998865555554443311110 0 0234467889999999998 9999
Q ss_pred CCCHHHHhcCCCcCCC
Q 007055 261 RLPALELLKDPFLVTD 276 (620)
Q Consensus 261 Rpsa~elL~hpff~~~ 276 (620)
|||+.|+|+||||+..
T Consensus 313 R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHL 328 (383)
T ss_dssp SCCHHHHHTSGGGHHH
T ss_pred CCCHHHHhcCHHHHHH
Confidence 9999999999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=401.42 Aligned_cols=255 Identities=27% Similarity=0.468 Sum_probs=221.2
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||.||+|.+..+|+.||+|+++..... .....+.+.+|+.+|+.++||||+++++++... ..++
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~ 92 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDIF 92 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 4578999999999999999999999999999999754321 112346789999999999999999999988654 5799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~-~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECCTT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEe-cCCCeEEEeccchhhcccc
Confidence 99999999999999998889999999999999999999999999 99999999999998 7899999999999765443
Q ss_pred -CCccccCCCCCCCccccccc-c-CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 174 -TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~~-y-~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+ .+...++..+..+... .+...++.+++|
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~L 246 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFY--TPQYLNPSVISL 246 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTCCC--CCTTCCHHHHHH
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCcC--CCccCCHHHHHH
Confidence 34567899999999988754 4 6899999999999999999999987 4556667777766432 345578999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 251 IEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
|.+||+ +|.+|||+.|+++||||+...
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 999998 999999999999999998643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=379.99 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=197.5
Q ss_pred cCceEEEE---EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcC
Q 007055 12 FVLFLQYD---EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDD 87 (620)
Q Consensus 12 ~~r~y~i~---e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~ 87 (620)
+-..|.+. +.||+|+||+||+|.+..+|+.||+|++... ....+.+|+.+++.+. ||||++++++|.+.
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 33455665 7899999999999999999999999998642 2345778999999997 99999999998654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC---cEEEccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDL 164 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G---~vKI~DF 164 (620)
..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+||
T Consensus 79 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~~kl~Df 153 (325)
T 3kn6_A 79 --LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFT-DENDNLEIKIIDF 153 (325)
T ss_dssp --SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEE-C----CEEEECCC
T ss_pred --CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEe-cCCCcccEEEecc
Confidence 578999999999999999999999999999999999999999999999 99999999999997 344 8999999
Q ss_pred cchhhccCC--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCC------CCHHHHHHHHHcCCC
Q 007055 165 GLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC------KNPAQIYKKVTSGIK 235 (620)
Q Consensus 165 Gla~~~~~~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~------~~~~~i~~~i~~~~~ 235 (620)
|++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||... .....+...+..+..
T Consensus 154 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 154 GFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp TTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred ccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 999754332 3345678999999998864 5999999999999999999999999753 233556677766543
Q ss_pred CCCC--CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 236 PASL--SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 236 p~~~--~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+... ....++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 3221 13467899999999998 899999999999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=365.16 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=224.3
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
+-....+.|++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 87 (294)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred eCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 334566788999999999999999999999999999999875543 3456677899999999999999999999988654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++
T Consensus 88 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~ 162 (294)
T 2rku_A 88 --DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLA 162 (294)
T ss_dssp --SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred --CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEc-CCCCEEEEeccCc
Confidence 578999999999999999998889999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccC--CCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 168 IVMQQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 168 ~~~~~--~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
..... .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. ......+..+..+.. .++...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~ 239 (294)
T 2rku_A 163 TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHIN 239 (294)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSC
T ss_pred eecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhccC--CCccccC
Confidence 75542 23345679999999998764 488999999999999999999999976 445555555555432 3455678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+.++++|.+||. +|.+|||+.++|+||||...
T Consensus 240 ~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 240 PVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 999999999998 89999999999999999764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=375.42 Aligned_cols=258 Identities=23% Similarity=0.371 Sum_probs=214.2
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
..+..+..|++.++||+|+||+||+|.+..+|+.||+|+++...... ..+.+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (319)
T ss_dssp EEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred cccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc---hHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence 34567788999999999999999999999999999999987544322 345678999999999999999999998877
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEe----cCCCCcEE
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVK 160 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~~---l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl----~~~~G~vK 160 (620)
....+++||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||+ + .++.+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~k 156 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYK 156 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTT-SCEEEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCC-CCceEE
Confidence 76788999999999999999986543 999999999999999999999999 9999999999998 5 567899
Q ss_pred EccccchhhccCC-CCccccCCCCCCCccccc---------cccCccchhhhhHHHHHHHHhcCCCCCCCCCH---HHHH
Q 007055 161 IGDLGLAIVMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIY 227 (620)
Q Consensus 161 I~DFGla~~~~~~-~~~~~~GTp~y~APEll~---------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~---~~i~ 227 (620)
|+|||++...... ......||+.|+|||++. ..++.++|||||||++|||+||+.||...... ..+.
T Consensus 157 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 157 LTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred EccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 9999999765443 334567999999999874 45889999999999999999999999653332 3334
Q ss_pred HHHHcCCCCC-----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 007055 228 KKVTSGIKPA-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 271 (620)
Q Consensus 228 ~~i~~~~~p~-----------------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hp 271 (620)
..+..+..+. .+....++.+++||.+||+ +|.+|||+.|+|+||
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 4444332211 1122235688999999998 999999999999997
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=382.36 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=210.5
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.+.|++.+.||+|+||+||+|.+..++..||+|++....... .....+.+.+|+.+++.++||||++++++|.+. ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE--QY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC--Ce
Confidence 356799999999999999999999999999999997653321 334567899999999999999999999998654 57
Q ss_pred EEEEEeccCCCCHHHHHHhC----------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 007055 92 INMITELFTSGSLRQYRKKH----------------------------------------KNVDMKAIKNWARQILRGLH 131 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~----------------------------------------~~l~e~~i~~i~~QIl~gL~ 131 (620)
+++||||+++|+|.+++... ..+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999999999998521 12467889999999999999
Q ss_pred HHHhCCCCEEecCCCccceEecCCCC--cEEEccccchhhccCC------CCccccCCCCCCCccccc---cccCccchh
Q 007055 132 YLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYE---EEYNELVDI 200 (620)
Q Consensus 132 yLHs~~~~IiHrDLKp~NILl~~~~G--~vKI~DFGla~~~~~~------~~~~~~GTp~y~APEll~---~~y~~~~DI 200 (620)
|||+++ |+||||||+|||++ .++ .+||+|||++...... ......||+.|+|||++. ..++.++||
T Consensus 183 ~LH~~~--ivH~Dlkp~NIll~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 183 YLHNQG--ICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHTT--EECCCCCGGGEEES-CSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHCC--ccccCCChhhEEEe-cCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 999999 99999999999997 455 8999999999654321 134567999999999875 458999999
Q ss_pred hhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 201 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 201 wSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
|||||++|+|++|+.||.+.. .......+........ .....++.+++||.+||. +|.+||++.++|+||||+...
T Consensus 260 wslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVN-DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 999999999999999998754 4444444444333222 222367899999999998 999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=365.94 Aligned_cols=259 Identities=26% Similarity=0.466 Sum_probs=220.5
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.....++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 456899999999999999999999999999999976532 456677899999999999999999999998876667899
Q ss_pred EEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCEEecCCCccceEecCCCCcEEEccccc
Q 007055 94 MITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~---~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ .+++||||||+|||++ .+|.+||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~dfg~ 162 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGL 162 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCCCH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecCch
Confidence 999999999999998754 34999999999999999999999987 3499999999999998 789999999999
Q ss_pred hhhccCCC--CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 007055 167 AIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243 (620)
Q Consensus 167 a~~~~~~~--~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~ 243 (620)
+....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+...+..+..+ .++...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~ 240 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRY 240 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-CCCTTS
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhcccc-cCCccc
Confidence 97654432 234579999999998764 589999999999999999999999976 4566667777766543 345567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
++.++++|.+||. +|.+||++.|+|+|+|+....
T Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 8999999999998 899999999999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=399.05 Aligned_cols=254 Identities=28% Similarity=0.370 Sum_probs=202.6
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC----C
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----N 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~----~ 89 (620)
+.|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+++.+|+.+|+.++||||++++++|.... .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 44689999999999999999999999999999997542 24566778999999999999999999999986543 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+|+||||+.++ |.+.+. ..+++..++.+++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEe-CCCCEEEEEEEeeee
Confidence 4789999999865 666654 35999999999999999999999999 99999999999998 789999999999976
Q ss_pred ccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----------
Q 007055 170 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---------- 237 (620)
Q Consensus 170 ~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~---------- 237 (620)
.... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++...+.....|.
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 6543 3456789999999998764 699999999999999999999999987544444333222100000
Q ss_pred ---------CCCCC--------------------CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 238 ---------SLSKV--------------------TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 238 ---------~~~~~--------------------~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
..... .++++++||.+||+ +|.+|||+.|+|+||||..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00000 15679999999998 9999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=367.06 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=205.4
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
.+....|++.+.||+|+||+||+|.+..+|+.||+|+++... ......+.+.++..+++.++||||+++++++.+.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-- 78 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-- 78 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--
Confidence 455677899999999999999999999999999999987442 1223334455566668889999999999998765
Q ss_pred CeEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEecCCCCcEEEccc
Q 007055 90 RTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~----~~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
..+++||||+. |+|.+++. ..+.+++..++.++.||+.||.|||++ + |+||||||+||+++ .++.+||+||
T Consensus 79 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~Df 154 (290)
T 3fme_A 79 GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDF 154 (290)
T ss_dssp SSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEEC-TTCCEEBCCC
T ss_pred CCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeec
Confidence 45889999997 48777665 356899999999999999999999998 8 99999999999998 7889999999
Q ss_pred cchhhccCCC-CccccCCCCCCCccccc-----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 007055 165 GLAIVMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 238 (620)
Q Consensus 165 Gla~~~~~~~-~~~~~GTp~y~APEll~-----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~ 238 (620)
|++....... .....||+.|+|||++. ..++.++|||||||++|+|+||+.||..................+..
T Consensus 155 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T 3fme_A 155 GISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC
T ss_pred CCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc
Confidence 9997654433 33457999999999862 35889999999999999999999999876666666555555555555
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 239 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 239 ~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.....++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 555678999999999998 89999999999999999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=415.88 Aligned_cols=268 Identities=21% Similarity=0.344 Sum_probs=230.8
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCCe
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~~ 91 (620)
-..|++.++||+|+||.||+|.++.+|+.||+|+++...... ....+.+..|..+|..+ +||||++++++|.+ ...
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~ 416 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 416 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence 345799999999999999999999999999999997543211 22346688899999988 79999999998854 357
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+|+||||+.||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEEC-SSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEc-CCCcEEEeecceeeccc
Confidence 9999999999999999999899999999999999999999999999 99999999999998 78999999999997532
Q ss_pred --CCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 172 --QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 172 --~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
.....+.+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+ .+..+++..+..+.. .++...+++++
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~ 570 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAV 570 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSCC--CCCTTSCHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHH
Confidence 33455678999999999876 5699999999999999999999999987 577788888877533 35567889999
Q ss_pred HHHHHhcC-CCCCCCCH-----HHHhcCCCcCCCCCCccccCCCCCC
Q 007055 249 QFIEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLRLP 289 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa-----~elL~hpff~~~~~~~~~~~~~~~p 289 (620)
+||.+||+ +|.+||++ .|+++||||+..++..+....+..|
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp 617 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 617 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCS
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCC
Confidence 99999998 89999997 9999999999988877655444433
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=371.78 Aligned_cols=262 Identities=30% Similarity=0.494 Sum_probs=212.3
Q ss_pred eeeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 6 LVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 6 ~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
...+.+....|++.+.||+|+||+||+|.+ +|..||+|++.... ......+.+.+|+.+|++++||||++++++|.
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD--FHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC--CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 344566677889999999999999999976 68999999987543 24566678999999999999999999999886
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~~~---l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
+. ..+++||||+.+|+|.+++.+.+. +++..+..++.||+.||.|||+++++|+||||||+|||++ .+|.+||+
T Consensus 105 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~ 181 (309)
T 3p86_A 105 QP--PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVC 181 (309)
T ss_dssp ST--TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEEC
T ss_pred EC--CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEEC
Confidence 54 458899999999999999987654 9999999999999999999999988899999999999998 78999999
Q ss_pred cccchhhccCC--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 007055 163 DLGLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 239 (620)
Q Consensus 163 DFGla~~~~~~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~ 239 (620)
|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .+..+....+........+
T Consensus 182 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~ 260 (309)
T 3p86_A 182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEI 260 (309)
T ss_dssp CCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCC
T ss_pred CCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCC
Confidence 99999754433 2345689999999998865 489999999999999999999999976 4566666666555555566
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc--CCCcCC
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLK--DPFLVT 275 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~--hpff~~ 275 (620)
+...++.+++||.+||. +|.+|||+.++++ .+++..
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 77789999999999998 8999999999987 455543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=403.22 Aligned_cols=265 Identities=23% Similarity=0.379 Sum_probs=225.5
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
.....|++.++||+|+||.||+|.++.+|+.||+|++....... ....+.+.+|+.+|+.++||||++++++|.+. .
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~ 258 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--T 258 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--C
Confidence 44567899999999999999999999999999999997543211 12346688999999999999999999998654 5
Q ss_pred eEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 91 TINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~-~~g~vkL~DFGl 335 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGL 335 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTT
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEe-CCCCEEEeecce
Confidence 699999999999999999764 36999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCC--CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCCCCC
Q 007055 167 AIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 167 a~~~~~~~--~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~ 240 (620)
+....... ....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.... ....+...+..... .++
T Consensus 336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p 413 (543)
T 3c4z_A 336 AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYP 413 (543)
T ss_dssp CEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCC
T ss_pred eeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCC
Confidence 97654332 345689999999998865 59999999999999999999999997643 35667777765432 345
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCcccc
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVC 283 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~ 283 (620)
...++.+++||.+||+ +|.+||+ +.++++||||+..++..+..
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~ 462 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEA 462 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHT
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHc
Confidence 6678999999999998 9999996 58999999999988766543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=378.44 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=208.7
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----CCCcceEEeEEE
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----HENIIKFYNSWV 85 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-----HpNIVkl~~~f~ 85 (620)
..+..|++.++||+|+||+||+|.+..+|+.||+|+++. .......+..|+.+++.+. ||||++++++|.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 445678999999999999999999999999999999863 2345566788999999996 999999999987
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC---------
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--------- 154 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--------- 154 (620)
.. ..+++||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 107 ~~--~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 107 YY--DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp ET--TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEE
T ss_pred EC--CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccc
Confidence 65 4689999999 999999998764 5999999999999999999999999 999999999999962
Q ss_pred ---------------CCCcEEEccccchhhccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCC
Q 007055 155 ---------------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYN 218 (620)
Q Consensus 155 ---------------~~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~ 218 (620)
.++.+||+|||++..... ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 378999999999975433 3346689999999998764 69999999999999999999999997
Q ss_pred CCCCHHHHHHHHHcCCCCCC------------------------CC--------------------CCCcHHHHHHHHHh
Q 007055 219 ECKNPAQIYKKVTSGIKPAS------------------------LS--------------------KVTDPQVKQFIEKC 254 (620)
Q Consensus 219 ~~~~~~~i~~~i~~~~~p~~------------------------~~--------------------~~~~~~lk~~I~kc 254 (620)
.. +.......+.....+.. ++ ...++.+.+||.+|
T Consensus 261 ~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 261 TH-EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CS-SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CC-cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 74 34443333332111100 00 11236788999999
Q ss_pred cC-CCCCCCCHHHHhcCCCcC
Q 007055 255 IV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 255 L~-~p~~Rpsa~elL~hpff~ 274 (620)
|+ +|.+|||+.|+|+||||+
T Consensus 340 L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCSSGGGSCCHHHHTTSGGGC
T ss_pred hcCChhhCCCHHHHhcCcccC
Confidence 98 999999999999999995
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=394.90 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=210.7
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccC----CHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~----~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
...|++.+.||+|+||+||+|.+..+|+.||+|++....... .......+.+|+.+|++++||||++++++|..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 456799999999999999999999999999999998654321 11223358899999999999999999998743
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~DFGl 166 (620)
..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccc
Confidence 347899999999999999998889999999999999999999999999 999999999999972 234699999999
Q ss_pred hhhccCC-CCccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CC
Q 007055 167 AIVMQQP-TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SL 239 (620)
Q Consensus 167 a~~~~~~-~~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~--~~ 239 (620)
+...... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||........+...+..+..+. ..
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 9766543 345678999999999874 4588899999999999999999999987655555666666654332 12
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
....++.+++||.+||+ +|.+||++.|+|+||||+...
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 23467899999999998 999999999999999998643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=361.89 Aligned_cols=253 Identities=23% Similarity=0.398 Sum_probs=209.6
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~ 90 (620)
....|++.+.||+|+||+||+|.+..+|+.||+|.++.... .......+.+|+..+..+ +||||++++++|.+. .
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~ 84 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--D 84 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--T
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--C
Confidence 34567999999999999999999999999999999875432 234556788999999999 999999999998665 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC------------
Q 007055 91 TINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------------ 154 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~------------ 154 (620)
.+++||||+++|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccc
Confidence 789999999999999999865 67999999999999999999999999 999999999999972
Q ss_pred ------CCCcEEEccccchhhccCCCCccccCCCCCCCccccccc--cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHH
Q 007055 155 ------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 226 (620)
Q Consensus 155 ------~~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~~--y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i 226 (620)
..+.+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..|+... ..
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~ 236 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQ 236 (289)
T ss_dssp -------CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HH
T ss_pred cccccCCceEEEEcccccccccCCc--cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hH
Confidence 2347999999998765443 334699999999988654 567999999999999999999877542 22
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 227 ~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
...+..+..+ .++...++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 237 WHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHHTTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHHcCCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 3444444333 3456678999999999998 899999999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=385.10 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=209.5
Q ss_pred cCceEEE--EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 12 FVLFLQY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 12 ~~r~y~i--~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
.+.+|++ .+.||+|+||.||+|.+..+|+.||+|+++... ....+.+.+|+.+|+.++||||++++++|.+.
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 158 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESK-- 158 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--
Confidence 3445566 578999999999999999999999999987542 34567799999999999999999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec-CCCCcEEEccccch
Q 007055 90 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA 167 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~-~~~G~vKI~DFGla 167 (620)
..+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+. ..++.+||+|||++
T Consensus 159 ~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 159 NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp SEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 4689999999999999988654 46999999999999999999999999 99999999999983 25689999999999
Q ss_pred hhccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCC
Q 007055 168 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVT 243 (620)
Q Consensus 168 ~~~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~ 243 (620)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. +.......+..... +.......
T Consensus 237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 315 (373)
T 2x4f_A 237 RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-NDAETLNNILACRWDLEDEEFQDI 315 (373)
T ss_dssp EECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCSCSGGGTTS
T ss_pred eecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCChhhhccC
Confidence 765443 3345679999999998764 5899999999999999999999999874 44444555544322 12222456
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
++++++||.+||+ +|.+|||+.|+|+||||...
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 8899999999998 89999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=378.59 Aligned_cols=256 Identities=23% Similarity=0.449 Sum_probs=217.5
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH----HHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP----DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 88 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~----~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~ 88 (620)
..|++.+.||+|+||.||+|.+..+|+.||+|++......... ...+.+.+|+.+++.+ +||||++++++|...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS- 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS-
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC-
Confidence 4578999999999999999999999999999998765422222 2245688999999999 899999999998654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..+++||||+.+|+|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.
T Consensus 173 -~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~-~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 173 -SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSC 248 (365)
T ss_dssp -SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCE
T ss_pred -CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEecCccc
Confidence 578999999999999999998888999999999999999999999999 99999999999998 78999999999987
Q ss_pred hccCC-CCccccCCCCCCCcccccc-------ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-
Q 007055 169 VMQQP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL- 239 (620)
Q Consensus 169 ~~~~~-~~~~~~GTp~y~APEll~~-------~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~- 239 (620)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+.......+..+......
T Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCHH
T ss_pred ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCc
Confidence 65433 3456789999999998753 488899999999999999999999976 4555566666655433221
Q ss_pred -CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 240 -SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 240 -~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
....++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 13457889999999998 9999999999999999963
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=376.18 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=212.5
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc----CCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~----~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
....|++.+.||+|+||.||+|.+..+|+.||+|.+...... ........+.+|+.+|+.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 445679999999999999999999999999999998754321 1122334588999999999999999999987543
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC---cEEEccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDL 164 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G---~vKI~DF 164 (620)
. +++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+||
T Consensus 88 ~---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLS-SQEEDCLIKITDF 161 (322)
T ss_dssp S---EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-SSSSSCCEEECCC
T ss_pred c---eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-cCCCCCeEEEccC
Confidence 2 7899999999999999998889999999999999999999999999 99999999999997 333 5999999
Q ss_pred cchhhccCCC-CccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--
Q 007055 165 GLAIVMQQPT-ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-- 237 (620)
Q Consensus 165 Gla~~~~~~~-~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-- 237 (620)
|++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||........+...+..+..+.
T Consensus 162 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T 2ycf_A 162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241 (322)
T ss_dssp TTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred ccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence 9997654332 23457999999999863 4588999999999999999999999987655545555555543321
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 238 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 238 ~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
......++.+++||.+||. +|.+||++.++|+||||+...
T Consensus 242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 1223467899999999998 999999999999999998644
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=371.95 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=223.4
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
....+.|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|+.+++.++||||++++++|.+.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 113 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-- 113 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 3456788999999999999999999999999999999875543 3456677899999999999999999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATK 190 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEc-CCCCEEEeeccCcee
Confidence 579999999999999999998889999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCC--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 170 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 170 ~~~~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. ......+..+..+.. .++...++.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~ 267 (335)
T 2owb_A 191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPV 267 (335)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHH
T ss_pred cccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcCCC--CCCccCCHH
Confidence 5422 3345679999999998764 588999999999999999999999976 445555555554422 345567899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+++||.+||. +|.+||++.|+|+||||...
T Consensus 268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 268 AASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 9999999998 89999999999999999764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=375.55 Aligned_cols=263 Identities=22% Similarity=0.359 Sum_probs=214.5
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~~ 90 (620)
.++|+...+.||+|+||+||+|.+..+|+.||+|+++.... .......+.+|+.+++.+ .||||++++++|.+. .
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--~ 102 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYENT--S 102 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--S
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--C
Confidence 34454444999999999999999999999999999875432 223456788999999999 569999999998644 5
Q ss_pred eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEccccc
Q 007055 91 TINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGL 166 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~DFGl 166 (620)
.+++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++. .+|.+||+|||+
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 689999999999999998653 67999999999999999999999999 999999999999973 268999999999
Q ss_pred hhhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCC
Q 007055 167 AIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKV 242 (620)
Q Consensus 167 a~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~ 242 (620)
+...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||... +....+..+..... +......
T Consensus 181 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 181 SRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-DNQETYLNISQVNVDYSEETFSS 259 (327)
T ss_dssp CEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTTTTT
T ss_pred ccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHhcccccCchhhcc
Confidence 9765443 334568999999999876 45899999999999999999999999774 44455444444322 3334455
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCCcc
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~~~ 281 (620)
.++.+++||.+||+ +|.+|||+.++|+||||+..++..+
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 78899999999998 8999999999999999998776554
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=361.95 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=219.6
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccC-C----HHHHHHHHHHHHHHHhCC-CCCcceEEeEEE
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-S----PDQLERLYSEVHLLKSLK-HENIIKFYNSWV 85 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~-~----~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~ 85 (620)
+...|++.+.||+|+||.||+|.++.+|+.||+|.++...... . ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3456799999999999999999999999999999997653211 1 233466889999999995 999999999885
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
.. ..+++||||+.+|+|.+++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||
T Consensus 95 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg 169 (298)
T 1phk_A 95 TN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFG 169 (298)
T ss_dssp CS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCT
T ss_pred cC--CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEc-CCCcEEEeccc
Confidence 43 579999999999999999998889999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCC-CCccccCCCCCCCccccc-------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 007055 166 LAIVMQQP-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 237 (620)
Q Consensus 166 la~~~~~~-~~~~~~GTp~y~APEll~-------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~ 237 (620)
++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.. .+.......+..+....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCC
T ss_pred chhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCccc
Confidence 98765433 344567999999999874 2478899999999999999999999976 45555666665554332
Q ss_pred C--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 238 S--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 238 ~--~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
. .....++.+++||.+||. +|.+|||+.++|+||||+....
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 2 223467899999999998 8999999999999999987543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=371.54 Aligned_cols=253 Identities=21% Similarity=0.345 Sum_probs=210.0
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCe
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~ 91 (620)
...|++.+.||+|+||+||+|.+..+|+.||+|+++... .+.+.+|+.+|+.++ ||||+++++++.+.....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 456799999999999999999999999999999986321 356889999999997 999999999998766678
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
.++||||+.+++|.+++.. +++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+|||++....
T Consensus 108 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999999998754 899999999999999999999999 99999999999998444489999999997554
Q ss_pred CC-CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------------cCCC
Q 007055 172 QP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-------------SGIK 235 (620)
Q Consensus 172 ~~-~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~-------------~~~~ 235 (620)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||............+. ....
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 33 3445689999999998764 589999999999999999999999966554433222211 1100
Q ss_pred ----------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 236 ----------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 236 ----------------------p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+.......++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 011122267899999999998 999999999999999998754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=369.26 Aligned_cols=258 Identities=22% Similarity=0.429 Sum_probs=217.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.|++.+.||+|+||.||+|.+..+|..||+|.++...........+.+.+|+.+++.++||||+++++++.......++
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 34589999999999999999999999999999997654332234567799999999999999999999998776667899
Q ss_pred EEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 94 MITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+||||+.+| |.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-CCCcEEeeccccccccC
Confidence 999999877 7777765 456999999999999999999999999 99999999999998 78999999999996543
Q ss_pred CC----CCccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 172 QP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 172 ~~----~~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+ .+...+...+..+.. .++...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~~ 237 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDCG 237 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSSC
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCccC
Confidence 21 2235579999999998764 257899999999999999999999976 556666777766533 3455678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
+.+.+||.+||. +|.+|||+.|+++||||+...+
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 999999999998 8999999999999999987544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=367.52 Aligned_cols=258 Identities=27% Similarity=0.458 Sum_probs=212.1
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
..+.|++.+.||+|+||.||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 90 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHD--GK 90 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---C
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--Ce
Confidence 4456799999999999999999999999999999986442 23456788999999999999999999998765 46
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 92 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
+++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKN 167 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTSCEEECCCHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEC-CCCCEEEEECCCCccc
Confidence 8999999999999998876 467999999999999999999999999 99999999999998 7899999999997543
Q ss_pred cC--CCCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCC
Q 007055 171 QQ--PTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSK 241 (620)
Q Consensus 171 ~~--~~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~ 241 (620)
.. .......||+.|+|||++. ..++.++||||||+++|+|++|..||... +.......+.....+ ...+.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 246 (302)
T 2j7t_A 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTLLTPS 246 (302)
T ss_dssp HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSSGG
T ss_pred cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHhccCCcccCCcc
Confidence 21 2234567999999999873 35889999999999999999999999874 444444444444333 23345
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
..++.++++|.+||. +|.+|||+.++|+||||......
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 568899999999998 99999999999999999875543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=369.70 Aligned_cols=258 Identities=28% Similarity=0.502 Sum_probs=213.8
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 88 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~ 88 (620)
......|++.+.||+|+||.||+|.+..+|+.||+|++..... ..+.+.+|+.+++.+ +||||++++++|....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3345567999999999999999999999999999999875431 235688999999999 8999999999987643
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 89 ----NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 89 ----~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
...+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~kl~ 171 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLV 171 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEEC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEc-CCCCEEEe
Confidence 46799999999999999999875 56999999999999999999999999 99999999999998 78999999
Q ss_pred cccchhhccCC--CCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Q 007055 163 DLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 234 (620)
Q Consensus 163 DFGla~~~~~~--~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~ 234 (620)
|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+. +.......+....
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNP 250 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSC
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcCc
Confidence 99998765432 234567999999999874 35889999999999999999999999774 4444445555555
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 235 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 235 ~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.+.......++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 5555556678999999999998 99999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=370.45 Aligned_cols=268 Identities=27% Similarity=0.497 Sum_probs=193.9
Q ss_pred eeeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 6 LVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 6 ~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
...|.+....|++.+.||+|+||+||+|.+..+|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 83 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFV 83 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEE
T ss_pred ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence 34577778889999999999999999999999999999998865432 234567889999999999999999999987
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKK--------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 157 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~--------~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G 157 (620)
... .+++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|
T Consensus 84 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~ 158 (303)
T 2vwi_A 84 VKD--ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDG 158 (303)
T ss_dssp SSS--CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTC
T ss_pred ecC--CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEc-CCC
Confidence 654 58899999999999999874 456999999999999999999999999 99999999999998 789
Q ss_pred cEEEccccchhhccCC-------CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007055 158 EVKIGDLGLAIVMQQP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 228 (620)
Q Consensus 158 ~vKI~DFGla~~~~~~-------~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~ 228 (620)
.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........
T Consensus 159 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 238 (303)
T 2vwi_A 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238 (303)
T ss_dssp CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH
T ss_pred CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH
Confidence 9999999998654322 1234579999999998864 589999999999999999999999987554444433
Q ss_pred HHHcCCCC-------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCCcc
Q 007055 229 KVTSGIKP-------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL 281 (620)
Q Consensus 229 ~i~~~~~p-------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~~~ 281 (620)
.+...... .......++.++++|.+||. +|.+||++.++|+||||+....+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~ 299 (303)
T 2vwi_A 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF 299 (303)
T ss_dssp HHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--------
T ss_pred HhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCcc
Confidence 33322111 12234567899999999998 8999999999999999987655443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=385.02 Aligned_cols=255 Identities=20% Similarity=0.335 Sum_probs=203.3
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHH-HhCCCCCcceEEeEEEc--C
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVD--D 87 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL-~~L~HpNIVkl~~~f~~--~ 87 (620)
+.++|+.+.++||+|+||+||+|.++.+|+.||+|+++.. ..+.+|+.++ +.++||||++++++|.. .
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 4456665568999999999999999999999999998622 2466788887 55689999999998854 3
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC--CCcEEEcc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGD 163 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~G~vKI~D 163 (620)
+...+|+|||||.||+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++.. +|.+||+|
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECC
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEe
Confidence 3457999999999999999998754 5999999999999999999999999 9999999999999832 78999999
Q ss_pred ccchhhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCC--C
Q 007055 164 LGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIK--P 236 (620)
Q Consensus 164 FGla~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~---~i~~~i~~~~~--p 236 (620)
||++...... .....+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+..... .+...+..+.. +
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 9999755432 345678999999999886 459999999999999999999999997643211 13344444322 2
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.......++++++||.+||. +|.+|||+.|+|+||||...
T Consensus 288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 22234578899999999998 99999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=364.19 Aligned_cols=260 Identities=25% Similarity=0.395 Sum_probs=216.4
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC--HHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~--~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
..+.|++.+.||+|+||+||+|.+..+|+.||+|.++....... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 80 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-- 80 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--
Confidence 45678999999999999999999999999999999986543221 11356789999999999999999999988654
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC----cEEEcccc
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLG 165 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G----~vKI~DFG 165 (620)
..+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++ .+||+|||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLL-DKNVPNPRIKLIDFG 157 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES-CSSSSSCCEEECCCT
T ss_pred CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEe-cCCCCCCceEEEecc
Confidence 568999999999999999998888999999999999999999999999 99999999999997 455 89999999
Q ss_pred chhhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCC
Q 007055 166 LAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSK 241 (620)
Q Consensus 166 la~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~ 241 (620)
++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+ .+.......+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T 3bhy_A 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFS 236 (283)
T ss_dssp TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCCHHHHT
T ss_pred cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCcchhcc
Confidence 99755432 334567999999999886 4589999999999999999999999977 44555555555443221 1224
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
..++.+++||.+||. +|.+||++.++|+||||+...
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 567899999999998 899999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=377.43 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=208.2
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC-----
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----- 88 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~----- 88 (620)
..|++.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+|+.++||||+++++++....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4679999999999999999999999999999998655422 223345789999999999999999999987643
Q ss_pred -CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 -NRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 -~~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
...+++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCCEEEccchh
Confidence 3578999999986 66666554 467999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccC------CCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCC
Q 007055 167 AIVMQQ------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIK 235 (620)
Q Consensus 167 a~~~~~------~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~---~~~ 235 (620)
+..... .......||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.. .......+.. ...
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALISQLCGSIT 249 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCC
Confidence 965432 12344678999999998754 48999999999999999999999998744 4333333322 222
Q ss_pred CCCCCCC---------------------------CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 236 PASLSKV---------------------------TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 236 p~~~~~~---------------------------~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+..++.. .++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 2222211 26789999999998 999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=382.60 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=218.0
Q ss_pred ceEEEEEEEceeCCeEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~ 89 (620)
..|++.+.||+|+||+||+|.+. .+|+.||+|+++...........+.+.+|+.+|+.+ +||||++++++|...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 131 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 131 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC--
Confidence 57899999999999999999984 589999999987543221122334567899999999 699999999988665
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKE 208 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEEE
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCcEEEeeCCCCee
Confidence 468999999999999999998889999999999999999999999999 99999999999998 789999999999965
Q ss_pred ccCC---CCccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCC---CCHHHHHHHHHcCCCCCCCC
Q 007055 170 MQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 170 ~~~~---~~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~---~~~~~i~~~i~~~~~p~~~~ 240 (620)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||... .....+...+.... ..++
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~ 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYP 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCCC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--CCCC
Confidence 4322 2345689999999998864 3789999999999999999999999643 23445555555432 2345
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCcccc
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVC 283 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~ 283 (620)
...++.+++||.+||. +|.+|| ++.|+++||||+..++..+..
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~ 335 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 335 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhh
Confidence 5678899999999998 999999 999999999999877665543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=364.49 Aligned_cols=255 Identities=26% Similarity=0.488 Sum_probs=192.4
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 87 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS--NYVY 87 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--SEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--CeEE
Confidence 4579999999999999999999999999999998754321 112246788999999999999999999998654 5789
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+||||+++|+|.+++... +.+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLT-RNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEEC-TTCCEEECCCTTCEECC-
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEEeecceeeccC
Confidence 999999999999999875 67999999999999999999999999 99999999999998 789999999999876543
Q ss_pred C--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 173 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
. ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||....... ....+.. .....+...++.+++
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~ 241 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-TLNKVVL--ADYEMPSFLSIEAKD 241 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCS--SCCCCCTTSCHHHHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-HHHHHhh--cccCCccccCHHHHH
Confidence 2 2335679999999998764 58899999999999999999999997643322 2222221 122345567899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+|.+||. +|.+||++.++|+||||....
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999998 899999999999999998643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=376.17 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=201.5
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.+..+|+.||+|+++.... ......+.+|+.+|+.++||||+++++++.+. ..+++
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 77 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTL 77 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEEEE
Confidence 47899999999999999999999999999999875431 11222355799999999999999999998655 45889
Q ss_pred EEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
||||+. |+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIP 153 (324)
T ss_dssp EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEEC-TTCCEEECSSSEEECC---
T ss_pred Eecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEEC-CCCCEEEccCcccccccCC
Confidence 999997 58888887654 5999999999999999999999999 99999999999998 7899999999998654432
Q ss_pred --CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCCC------
Q 007055 174 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPASLS------ 240 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~---~~~p~~~~------ 240 (620)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.. .......+.. ...+..++
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-VEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChHhchhhhcch
Confidence 2345578999999998754 58999999999999999999999998744 4333333322 11111111
Q ss_pred -------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 241 -------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 241 -------------------~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
...++.+++||.+||+ +|.+|||+.|+|+||||.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 2356889999999998 9999999999999999987654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=362.46 Aligned_cols=258 Identities=26% Similarity=0.452 Sum_probs=212.6
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
....|++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 85 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TD 85 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--Ce
Confidence 335678999999999999999999999999999998754321 112346788999999999999999999988654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEEC-TTSCEEECCCCGGGCCC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEEC-CCCCEEEeecccccccC
Confidence 8999999999999999998889999999999999999999999999 99999999999998 78899999999997654
Q ss_pred CC-CCccccCCCCCCCccccccc-c-CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 172 QP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 172 ~~-~~~~~~GTp~y~APEll~~~-y-~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
.. ......||+.|+|||++.+. + +.++||||||+++|+|++|+.||.. .....+...+..+..+ ++...++.++
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~ 239 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVA 239 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHH
Confidence 33 23456799999999988754 3 6899999999999999999999976 4566667777665432 3455688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 249 QFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
++|.+||. +|.+|||+.++|+||||+...+
T Consensus 240 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 99999998 9999999999999999987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=384.48 Aligned_cols=253 Identities=20% Similarity=0.309 Sum_probs=206.1
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC----C
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----T 88 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~----~ 88 (620)
...|++.++||+|+||+||+|.+..+|+.||+|++..... ...+|+++|+.|+|||||+++++|... .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 3468999999999999999999999999999999864321 133699999999999999999988642 2
Q ss_pred CCeEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 89 NRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~----~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
..++++||||+.+ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.+||+||
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCC
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccc
Confidence 3457899999986 5555443 3567999999999999999999999999 9999999999999855678999999
Q ss_pred cchhhccCC-CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------
Q 007055 165 GLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI------- 234 (620)
Q Consensus 165 Gla~~~~~~-~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~------- 234 (620)
|+++..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++.+.+....
T Consensus 202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999765432 3446789999999998753 589999999999999999999999988655555544433100
Q ss_pred -------CCCC------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 235 -------KPAS------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 235 -------~p~~------------~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.... +....++++++||.+||+ +|.+||++.|+|+||||...
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0001 223457899999999998 99999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=366.21 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=211.4
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
...+..|++.+.||+|+||+||+|.+..+|..||+|.+..... ......+++.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-- 83 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-- 83 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS--
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC--
Confidence 3445667999999999999999999999999999999875432 3456678899999999999999999999987544
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++||||+++|+|.+++...+++++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILID-SNKTLKIFDFGIAKA 160 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCSSSTT
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEEeCCCccc
Confidence 579999999999999999999999999999999999999999999999 99999999999998 789999999999976
Q ss_pred ccCC---CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCC
Q 007055 170 MQQP---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVT 243 (620)
Q Consensus 170 ~~~~---~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~ 243 (620)
.... ......||+.|+|||++.+ .++.++||||||+++|+|+||+.||.+........+.+.....+ .......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T 4eqm_A 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI 240 (294)
T ss_dssp C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCC
Confidence 5433 2334579999999998765 48899999999999999999999998754444444444333221 1244567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
++.+.++|.+||. +|.+||++.+.+.+.|..
T Consensus 241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 8999999999998 899999666666665543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=364.17 Aligned_cols=259 Identities=31% Similarity=0.498 Sum_probs=221.8
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
..+.|++.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 95 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDS--SS 95 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeCC--Ce
Confidence 345679999999999999999999999999999999755432 23456788999999999999999999988654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC--CCcEEEccccchhh
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIV 169 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~G~vKI~DFGla~~ 169 (620)
+++|+||+.+++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++.. ++.+||+|||++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 8999999999999999988888999999999999999999999999 9999999999999732 34799999999976
Q ss_pred ccCC-CCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHH
Q 007055 170 MQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQ 246 (620)
Q Consensus 170 ~~~~-~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~~~~ 246 (620)
.... ......||+.|+|||++.+.++.++||||||+++|+|++|..||.+ .+...+...+..+..+...+ ...++.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 174 FQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp BCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred ecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 5443 2344578999999999988899999999999999999999999977 45666667776665433322 456889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+++||.+||. +|.+|||+.++|+||||+...
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 9999999998 999999999999999997643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=363.39 Aligned_cols=250 Identities=32% Similarity=0.518 Sum_probs=207.5
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEecc
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 99 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~Ey~ 99 (620)
.+||+|+||+||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||++++++|... ..+++||||+
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 101 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQV 101 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEECC
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEEEeC
Confidence 49999999999999999999999999987542 23456788999999999999999999998654 4689999999
Q ss_pred CCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC--C
Q 007055 100 TSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 174 (620)
Q Consensus 100 ~gGsL~~~i~~~~---~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~--~ 174 (620)
++|+|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+||+++..+|.+||+|||++...... .
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 9999999998652 4679999999999999999999999 9999999999999855899999999999655432 2
Q ss_pred CccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 007055 175 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I 251 (620)
.....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.....................++...++.+++||
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 345679999999998864 27899999999999999999999997655554433332222233445667789999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 252 EKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 252 ~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+||. +|.+||++.++|+||||+...
T Consensus 260 ~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99998 899999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=377.19 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=211.2
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~----~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
...|++.+.||+|+||+||+|.++.+|+.||+|.++....... ....+.+.+|+.+|+.++||||++++++|.+.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~- 101 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ- 101 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS-
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC-
Confidence 3567999999999999999999999999999999986543221 11234577899999999999999999998654
Q ss_pred CCeEEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 89 NRTINMITELFTSG-SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 89 ~~~l~lV~Ey~~gG-sL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
..+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 102 -~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 -GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIA-EDFTIKLIDFGSA 177 (335)
T ss_dssp -SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTC
T ss_pred -CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEc-CCCcEEEeecccc
Confidence 5789999999777 99999999999999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCC-CCccccCCCCCCCccccccc-c-CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 168 IVMQQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 168 ~~~~~~-~~~~~~GTp~y~APEll~~~-y-~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
...... .....+||+.|+|||++.+. + +.++|||||||++|+|++|..||..... ... .....+...+
T Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~--~~~~~~~~~~ 248 (335)
T 3dls_A 178 AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVE--AAIHPPYLVS 248 (335)
T ss_dssp EECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTT--TCCCCSSCCC
T ss_pred eECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHh--hccCCCcccC
Confidence 765443 34456899999999987643 4 7899999999999999999999975211 111 1122344578
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+.+++||.+||+ +|.+|||+.++|+||||+..
T Consensus 249 ~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 999999999998 89999999999999999764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=382.57 Aligned_cols=261 Identities=30% Similarity=0.434 Sum_probs=196.7
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
..|.+.++ |++.+.||+|+||+||+|.+..+|+.||+|++.... ......+++.+|+.+|+.++||||++++++|..
T Consensus 23 ~~~~~~~~-y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 99 (367)
T 2fst_X 23 TIWEVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 99 (367)
T ss_dssp EEEEEETT-EEEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred cccCCCCc-eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 45555555 589999999999999999999999999999986432 345567789999999999999999999998865
Q ss_pred CC----CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 87 DT----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 87 ~~----~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
.. ...+++|+||+ +++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+
T Consensus 100 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kL~ 174 (367)
T 2fst_X 100 ARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKIL 174 (367)
T ss_dssp CSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEEC
T ss_pred CCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC-CCCCEEEe
Confidence 32 24578999999 7899998876 57999999999999999999999999 99999999999998 78999999
Q ss_pred cccchhhccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC----
Q 007055 163 DLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK---- 235 (620)
Q Consensus 163 DFGla~~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~---- 235 (620)
|||+++..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.. +..
T Consensus 175 DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 175 DFGLARHTADE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ecccccccccc-CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99999765432 345689999999998764 5899999999999999999999999875444333322211 100
Q ss_pred --------------------CCC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 236 --------------------PAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 236 --------------------p~~---~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+.. .....++.+++||.+||+ +|.+|||+.|+|.||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 000 112357889999999998 99999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=374.97 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=211.1
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC---C
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---N 89 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~---~ 89 (620)
+..|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+.+|+.+|+.++||||+++++++.... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 35669999999999999999999999999999998642 24556678999999999999999999999886543 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++||||+. |+|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARV 177 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred ceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEEC-CCCCEEEEeCcceEe
Confidence 46899999997 599999876 46999999999999999999999999 99999999999998 789999999999965
Q ss_pred ccCC-----CCccccCCCCCCCccccc-c-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Q 007055 170 MQQP-----TARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--------- 233 (620)
Q Consensus 170 ~~~~-----~~~~~~GTp~y~APEll~-~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~--------- 233 (620)
.... .....+||+.|+|||++. + .++.++|||||||++|+|++|+.||.+......+...+...
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 5432 134568999999999764 3 48999999999999999999999998754444333222110
Q ss_pred --------------CCCCC-----CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 234 --------------IKPAS-----LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 234 --------------~~p~~-----~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
..+.. +....++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00000 113457899999999998 99999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=365.80 Aligned_cols=258 Identities=28% Similarity=0.519 Sum_probs=210.8
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
......|++.+.||+|+||.||+|.+..+|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 96 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-- 96 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEET--
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeC--
Confidence 344567899999999999999999999999999999987542 235688999999999999999999998764
Q ss_pred CeEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 90 RTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~-~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..+++||||+.+|+|.+++. ....+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.
T Consensus 97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~ 173 (314)
T 3com_A 97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAG 173 (314)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCE
T ss_pred CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEEC-CCCCEEEeecccch
Confidence 46899999999999999987 4567999999999999999999999999 99999999999998 78999999999996
Q ss_pred hccCC--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCc
Q 007055 169 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTD 244 (620)
Q Consensus 169 ~~~~~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~~ 244 (620)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... .......+..... ....+...+
T Consensus 174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
T 3com_A 174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-PMRAIFMIPTNPPPTFRKPELWS 252 (314)
T ss_dssp ECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSSGGGSC
T ss_pred hhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCCCcccCCcccCC
Confidence 55433 2345679999999998764 58999999999999999999999998744 3333333333322 222344568
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 279 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~ 279 (620)
+.+++||.+||. +|.+|||+.++|+||||+.....
T Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV 288 (314)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence 899999999998 99999999999999999875543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=374.52 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=212.5
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.-..|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 98 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--KR 98 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--CE
Confidence 3456799999999999999999999999999999986543 3445567788999999999999999999998654 56
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCTTC----
T ss_pred EEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEc-CCCcEEEEeCCCceeec
Confidence 8999999999999999888888999999999999999999999999 99999999999998 78999999999996554
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------------
Q 007055 172 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------------- 232 (620)
Q Consensus 172 ~~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~--------------- 232 (620)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+..
T Consensus 176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 32 2345679999999998865 5899999999999999999999999875554444333221
Q ss_pred ----CCCCCCC---------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 233 ----GIKPASL---------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 233 ----~~~p~~~---------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
+...+.+ ....++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 0010000 12357899999999998 999999999999999998654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=360.05 Aligned_cols=254 Identities=31% Similarity=0.489 Sum_probs=209.1
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC----
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---- 88 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~---- 88 (620)
...|++.+.||+|+||+||+|.+..+|+.||+|.+... ....+.+.+|+.+++.++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 34579999999999999999999999999999998642 355677999999999999999999999987632
Q ss_pred -------CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEE
Q 007055 89 -------NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 160 (620)
Q Consensus 89 -------~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vK 160 (620)
...+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ ++||||||+|||++ .+|.+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~-~~~~~k 156 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVK 156 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEc-CCCCEE
Confidence 357899999999999999998654 5889999999999999999999999 99999999999998 789999
Q ss_pred EccccchhhccC----------------CCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCC
Q 007055 161 IGDLGLAIVMQQ----------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN 222 (620)
Q Consensus 161 I~DFGla~~~~~----------------~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~ 222 (620)
|+|||++..... .......||+.|+|||++.+ .++.++|||||||++|+|++ ||....+
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 999999865432 12234579999999998864 58999999999999999998 6654344
Q ss_pred HHHHHHHHHcCC--CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 223 PAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 223 ~~~i~~~i~~~~--~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.......+.... .|..+....++.++++|.+||. +|.+|||+.++|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 445555555432 2444556677889999999998 999999999999999997643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=373.17 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=203.8
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC-HHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~-~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.+.|++.+.||+|+||+||+|.+..+|+.||+|+++....... ....+.+.+|+.+++.++||||++++++|.+. ..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 86 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SN 86 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--Cc
Confidence 4567899999999999999999999999999999875432211 11234678999999999999999999998654 46
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 92 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEc-CCCCEEEEecccceec
Confidence 8899999986 888888765 46999999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCC--CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC-CCCC-----
Q 007055 171 QQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-PASL----- 239 (620)
Q Consensus 171 ~~~--~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~-p~~~----- 239 (620)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+.. +.. +..+
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 433 2345689999999998753 4899999999999999999999999875443333332221 111 1111
Q ss_pred ------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 240 ------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 240 ------------------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
....++.+++||.+||+ +|.+|||+.|+|+||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13346899999999998 99999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=378.75 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=206.2
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC----
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---- 88 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~---- 88 (620)
...|++.++||+|+||+||+|.+..++. ||+|++...... ..+|+.+|+.++||||++++++|....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 4468999999999999999999987776 888887643321 236999999999999999999986543
Q ss_pred CCeEEEEEeccCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 89 NRTINMITELFTSGSLRQYR---KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i---~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
..++++||||+.++.+.... .....+++..++.|+.||+.||.|||+++ |+||||||+|||++..+|.+||+|||
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 23588999999876544333 34578999999999999999999999999 99999999999998668999999999
Q ss_pred chhhccC-CCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------
Q 007055 166 LAIVMQQ-PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------- 235 (620)
Q Consensus 166 la~~~~~-~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------- 235 (620)
++..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.....
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9976533 33456789999999998754 5899999999999999999999999886555554443321000
Q ss_pred -----------C----C----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 236 -----------P----A----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 236 -----------p----~----~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
| . .++...++++++||.+||+ +|.+|||+.|+|+||||+....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0 0 1233467899999999998 9999999999999999987554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=387.93 Aligned_cols=252 Identities=17% Similarity=0.189 Sum_probs=200.9
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHH---HHHHhCCCCCcceEE-----
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV---HLLKSLKHENIIKFY----- 81 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei---~iL~~L~HpNIVkl~----- 81 (620)
....+.|++.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+ .+|+.++|||||+++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc-cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 3346789999999999999999999999999999999985433 2344567899999 555666899999998
Q ss_pred --eEEEcCCC----------C-----eEEEEEeccCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCC
Q 007055 82 --NSWVDDTN----------R-----TINMITELFTSGSLRQYRKKHKNVDM-------KAIKNWARQILRGLHYLHSHN 137 (620)
Q Consensus 82 --~~f~~~~~----------~-----~l~lV~Ey~~gGsL~~~i~~~~~l~e-------~~i~~i~~QIl~gL~yLHs~~ 137 (620)
+++.+.+. . ..++||||+ +|+|.+++...+.+++ ..+..|+.||+.||.|||+++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 55443311 0 378999999 6899999987665665 888899999999999999999
Q ss_pred CCEEecCCCccceEecCCCCcEEEccccchhhccCCCCccccCCCCCCCcccccc------------ccCccchhhhhHH
Q 007055 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE------------EYNELVDIYSFGM 205 (620)
Q Consensus 138 ~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~------------~y~~~~DIwSlGi 205 (620)
|+||||||+|||++ .+|.+||+|||++..... .....+| +.|+|||++.+ .|+.++|||||||
T Consensus 227 --ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 --LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp --EECSCCCGGGEEEC-TTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred --eecCCCCHHHEEEc-CCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999998 789999999999975333 3345678 99999998764 5999999999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 206 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 206 ilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
++|||++|+.||.+.. .......+.. .....++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 302 il~elltg~~Pf~~~~-~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 302 VIYWIWCADLPITKDA-ALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHSSCCC-------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHCCCCCcccc-cccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999999997532 2111122211 123567899999999998 8999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=362.72 Aligned_cols=256 Identities=23% Similarity=0.374 Sum_probs=205.5
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC-----
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----- 87 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~----- 87 (620)
+..|++.+.||+|+||.||+|.+..+|+.||+|.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 44568999999999999999999999999999998743 355677899999999999999999999987432
Q ss_pred -------CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEE
Q 007055 88 -------TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 160 (620)
Q Consensus 88 -------~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vK 160 (620)
....+++||||+. |+|.+++.. +++++..++.++.||+.||.|||+++ |+||||||+|||++..++.+|
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEE
Confidence 3357899999998 699999865 56999999999999999999999999 999999999999975678999
Q ss_pred EccccchhhccCC-----CCccccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Q 007055 161 IGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 233 (620)
Q Consensus 161 I~DFGla~~~~~~-----~~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 233 (620)
|+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+... ......+...
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~~~ 240 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-LEQMQLILES 240 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHh
Confidence 9999999755322 233457899999999775 4589999999999999999999999987543 3333333221
Q ss_pred CCC----------------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 234 IKP----------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 234 ~~p----------------------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
... .......++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 110 01123467899999999998 999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=362.43 Aligned_cols=260 Identities=24% Similarity=0.407 Sum_probs=218.4
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC--CCCcceEEeEE
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSW 84 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~--HpNIVkl~~~f 84 (620)
-...+.++.|++.+.||+|+||.||+|.+. +|+.||+|.+..... .....+.+.+|+.+++.++ ||||+++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 345677889999999999999999999985 589999999976532 4566788999999999997 59999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
... ..+++||| +.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ +|.+||+||
T Consensus 98 ~~~--~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~--~~~~kL~Df 170 (313)
T 3cek_A 98 ITD--QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDF 170 (313)
T ss_dssp ECS--SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCC
T ss_pred ecC--CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE--CCeEEEeec
Confidence 654 46899999 668899999999899999999999999999999999999 99999999999997 489999999
Q ss_pred cchhhccCCC----CccccCCCCCCCcccccc------------ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007055 165 GLAIVMQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 228 (620)
Q Consensus 165 Gla~~~~~~~----~~~~~GTp~y~APEll~~------------~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~ 228 (620)
|++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||....+......
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence 9997554322 234579999999998753 588899999999999999999999987666665556
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 229 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 229 ~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.+........++...++.++++|.+||. +|.+||++.|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 6665555555666778999999999998 89999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=380.57 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=205.6
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC------CCCCcceEEeEEEc
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL------KHENIIKFYNSWVD 86 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L------~HpNIVkl~~~f~~ 86 (620)
...|++.++||+|+||+||+|.+..+|+.||+|+++.. ......+.+|+.+++.+ +|+||++++++|..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 44579999999999999999999999999999998642 34456677888888877 57799999999876
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc--EEEc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIG 162 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~--vKI~ 162 (620)
. ..+++||||+. |+|.+++.... .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|. +||+
T Consensus 171 ~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~-~~~~~~vkL~ 244 (429)
T 3kvw_A 171 R--NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLK-QQGRSGIKVI 244 (429)
T ss_dssp T--TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEES-STTSCCEEEC
T ss_pred C--CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-cCCCcceEEe
Confidence 5 46899999996 69999988754 4999999999999999999999999 99999999999998 6666 9999
Q ss_pred cccchhhccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCC---
Q 007055 163 DLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA--- 237 (620)
Q Consensus 163 DFGla~~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~p~--- 237 (620)
|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|||+||..||.+......+...+.. +..+.
T Consensus 245 DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 245 DFGSSCYEHQ-RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp CCTTCEETTC-CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ecccceecCC-cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 9999965433 3445689999999998764 5999999999999999999999999875444433322211 00000
Q ss_pred ----------------------------------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 007055 238 ----------------------------------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPA 264 (620)
Q Consensus 238 ----------------------------------------------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa 264 (620)
.+....++.+++||.+||+ +|.+|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 0112347889999999998 99999999
Q ss_pred HHHhcCCCcCCCCC
Q 007055 265 LELLKDPFLVTDNP 278 (620)
Q Consensus 265 ~elL~hpff~~~~~ 278 (620)
.|+|+||||+...+
T Consensus 404 ~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 404 GQALRHPWLRRRLP 417 (429)
T ss_dssp HHHHTSTTTC----
T ss_pred HHHhCChhhccCCC
Confidence 99999999987543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=359.95 Aligned_cols=253 Identities=31% Similarity=0.551 Sum_probs=218.2
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
.+.|++.+.||+|+||.||+|.+..+|+.||+|.+..... ....+.+.+|+.+++.++||||++++++|.+. ..+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeE
Confidence 4567999999999999999999999999999999976542 23456789999999999999999999998765 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
++||||+.+++|.+++.. +.+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECBT
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEEC-CCCCEEEeecccceecCc
Confidence 999999999999999875 56999999999999999999999999 99999999999998 789999999999965543
Q ss_pred C--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 173 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
. ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .........+..+.. ..+....++.+++
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 249 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKNNP-PTLEGNYSKPLKE 249 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCC-CCCCSSCCHHHHH
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhcCCC-CCCccccCHHHHH
Confidence 3 2345679999999998764 589999999999999999999999976 445555555555433 3455667899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
||.+||. +|.+|||+.++|+||||...
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 9999998 89999999999999999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=366.61 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=209.7
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC---
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 88 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~--- 88 (620)
.+..|++.+.||+|+||+||+|.+..+|+.||+|.++.. ........+.+|+.+++.++||||+++++++....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 345679999999999999999999999999999998633 23556677889999999999999999999875432
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
...+++||||+. |+|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLAR 160 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-CCCcEEEEeccccc
Confidence 357899999997 689999876 56999999999999999999999999 99999999999998 78999999999986
Q ss_pred hccCC------------CCccccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Q 007055 169 VMQQP------------TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 234 (620)
Q Consensus 169 ~~~~~------------~~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~ 234 (620)
..... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 54321 122357899999999764 4589999999999999999999999987543333322211100
Q ss_pred CCC-----------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 235 KPA-----------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 235 ~p~-----------------------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.|. ......++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 000 0113467899999999998 999999999999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=373.12 Aligned_cols=253 Identities=28% Similarity=0.386 Sum_probs=200.0
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC----C
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----N 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~----~ 89 (620)
+.|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||++++++|.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 45689999999999999999999999999999987542 34556678999999999999999999999986543 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++||||+.+ +|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC---
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEEEeecccc
Confidence 378999999975 7888876 45899999999999999999999999 99999999999998 789999999999976
Q ss_pred ccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----------
Q 007055 170 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---------- 237 (620)
Q Consensus 170 ~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~---------- 237 (620)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. ....+..+......+
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 5443 2345689999999998764 58999999999999999999999998744 444444443321110
Q ss_pred ----------CC--------------CC------CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 238 ----------SL--------------SK------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 238 ----------~~--------------~~------~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
.+ +. ..++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00 00 015678999999998 9999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=352.58 Aligned_cols=252 Identities=19% Similarity=0.293 Sum_probs=212.8
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
+.+.-..|++.+.||+|+||+||+|.+. |..||+|.++... ......+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 4455667899999999999999999884 8999999987653 24556678999999999999999999999987765
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
...+++||||+++|+|.+++...+ .+++..++.|+.||+.||.|||+++++++||||||+||+++ .+|.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~ 159 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADV 159 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGS
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEeccc
Confidence 567899999999999999998766 48999999999999999999999988899999999999998 788999999888
Q ss_pred hhhccCCCCccccCCCCCCCccccccc-c---CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 007055 167 AIVMQQPTARSVIGTPEFMAPELYEEE-Y---NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 167 a~~~~~~~~~~~~GTp~y~APEll~~~-y---~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
+.... .....||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+.. .......+........++..
T Consensus 160 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3kmu_A 160 KFSFQ---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVALEGLRPTIPPG 235 (271)
T ss_dssp CCTTS---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-HHHHHHHHHHSCCCCCCCTT
T ss_pred eeeec---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-hHHHHHHHHhcCCCCCCCCC
Confidence 75422 2345789999999988643 3 347999999999999999999998754 44444444444344456667
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.++.++++|.+||. +|.+|||+.++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 88999999999998 8999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=372.89 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=218.8
Q ss_pred eeeeeeccCceEEEEEEEceeCCeEEEEEE-----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Q 007055 5 DLVIWSLFVLFLQYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENII 78 (620)
Q Consensus 5 ~~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~-----d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIV 78 (620)
+...|.+..+.|++.+.||+|+||.||+|. +..+|+.||+|.++.. ......+.+.+|+.+++++ +||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc---CCHHHHHHHHHHHHHHHhhcCCccee
Confidence 345677888899999999999999999998 6677899999998743 2345667899999999999 799999
Q ss_pred eEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCC---------------------------------------------
Q 007055 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--------------------------------------------- 113 (620)
Q Consensus 79 kl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~--------------------------------------------- 113 (620)
+++++|.+.. ..+++||||+.+|+|.+++.....
T Consensus 90 ~~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 90 NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CEEEEECSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 9999986543 457899999999999999987543
Q ss_pred ---------------------CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 114 ---------------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 114 ---------------------l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCcEEEEeccceeeecc
Confidence 899999999999999999999999 99999999999998 788999999999975432
Q ss_pred C----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 007055 173 P----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246 (620)
Q Consensus 173 ~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~ 246 (620)
. ......||+.|+|||++. ..++.++|||||||++|+|+| |..||.+......+...+..+..+ ..+...++.
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 324 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPE 324 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHH
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHH
Confidence 2 223456899999999876 458999999999999999998 999998866666666666665433 345667899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
++++|.+||. +|.+|||+.|+++|
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHH
Confidence 9999999998 99999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=354.41 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=212.8
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHH---HHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL---ERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~---~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
.+...+..|++.+.||+|+||+||+|.+..+++.||+|.+............ +.+.+|+.+++.++||||++++++|
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 4456677889999999999999999999999999999998765433322222 6789999999999999999999987
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc-----
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----- 158 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~----- 158 (620)
.+.. ++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++++|+||||||+|||++ .++.
T Consensus 93 ~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~-~~~~~~~~~ 167 (287)
T 4f0f_A 93 HNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ-SLDENAPVC 167 (287)
T ss_dssp TTTT----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES-CCCTTCSCC
T ss_pred cCCC----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe-ccCCCCcee
Confidence 4432 5899999999998887654 479999999999999999999999988899999999999997 5555
Q ss_pred EEEccccchhhccCCCCccccCCCCCCCccccc---cccCccchhhhhHHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCC
Q 007055 159 VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSGI 234 (620)
Q Consensus 159 vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~---~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~-~i~~~i~~~~ 234 (620)
+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||....... .....+....
T Consensus 168 ~kl~Dfg~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 168 AKVADFGLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp EEECCCTTCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred EEeCCCCccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 99999999864433 334567999999999873 348899999999999999999999997654433 3344444444
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 235 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 235 ~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+..++...++.++++|.+||+ +|.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4555667788999999999998 8999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=372.27 Aligned_cols=260 Identities=22% Similarity=0.377 Sum_probs=219.8
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH-------------HHHHHHHHHHHHHHhCCCCCcc
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-------------DQLERLYSEVHLLKSLKHENII 78 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~-------------~~~~~l~~Ei~iL~~L~HpNIV 78 (620)
....|++.+.||+|+||.||+|.+ +|+.||+|.+......... ...+.+.+|+.+++.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 345679999999999999999998 9999999999755332111 1126789999999999999999
Q ss_pred eEEeEEEcCCCCeEEEEEeccCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccc
Q 007055 79 KFYNSWVDDTNRTINMITELFTSGSLRQY------RKK--HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDN 149 (620)
Q Consensus 79 kl~~~f~~~~~~~l~lV~Ey~~gGsL~~~------i~~--~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~N 149 (620)
++++++.+. ..+++||||+++|+|.++ +.. ...+++..++.++.||+.||.|||+ ++ ++||||||+|
T Consensus 107 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~N 182 (348)
T 2pml_X 107 TCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSN 182 (348)
T ss_dssp CCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGG
T ss_pred eEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHh
Confidence 999998764 579999999999999998 665 5679999999999999999999999 88 9999999999
Q ss_pred eEecCCCCcEEEccccchhhccCCCCccccCCCCCCCccccccc--cCc-cchhhhhHHHHHHHHhcCCCCCCCCCHHHH
Q 007055 150 IFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNE-LVDIYSFGMCILEMVTCEYPYNECKNPAQI 226 (620)
Q Consensus 150 ILl~~~~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~~--y~~-~~DIwSlGiilyELltG~~Pf~~~~~~~~i 226 (620)
||++ .+|.+||+|||++............||+.|+|||++.+. ++. ++|||||||++|+|++|..||........+
T Consensus 183 il~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 183 ILMD-KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp EEEC-TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EEEc-CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 9998 789999999999976655555667899999999988653 666 999999999999999999999886665777
Q ss_pred HHHHHcCCCCCCC-----------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 227 YKKVTSGIKPASL-----------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 227 ~~~i~~~~~p~~~-----------------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
...+..+..+... ....++.+++||.+||. +|.+||++.|+|+||||+..+.
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 7777665432221 14578899999999998 9999999999999999987554
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=373.27 Aligned_cols=260 Identities=28% Similarity=0.403 Sum_probs=208.1
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+.+ .|++.+.||+|+||+||+|.+..+|+.||+|++.... .......++.+|+.+++.++||||++++++|...
T Consensus 37 ~~~l~~-~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 37 AWELPK-TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp EEEEET-TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred eecccc-cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 444444 4589999999999999999999999999999987542 3455667899999999999999999999998655
Q ss_pred CCC----eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 88 TNR----TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 88 ~~~----~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
... .+++||||+. |+|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~D 187 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILD 187 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECS
T ss_pred CCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEEC-CCCCEEEEe
Confidence 432 3489999997 68888764 45999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----
Q 007055 164 LGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----- 236 (620)
Q Consensus 164 FGla~~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p----- 236 (620)
||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.....|
T Consensus 188 fg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 188 FGLARHADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp TTCC---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCcccccccC-cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 9999755433 345688999999998764 58999999999999999999999998754333333322211000
Q ss_pred ----------------C-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 237 ----------------A-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 237 ----------------~-------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
. ......++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 0 0123457899999999998 999999999999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=366.42 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=206.4
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
+.+....|++.++||+|+||+||+|.+..+|+.||+|.+.. ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 79 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD- 79 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-
Confidence 44556778999999999999999999999999999998753 2456678899999999999999999999998765
Q ss_pred CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 89 NRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
..+++||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 80 -KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLA 155 (310)
T ss_dssp -TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEC-TTSCEEECCCTTC
T ss_pred -CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEEC-CCCCEEEeecccc
Confidence 468999999999999999987 567999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCCCC----------------ccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHH----H
Q 007055 168 IVMQQPTA----------------RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ----I 226 (620)
Q Consensus 168 ~~~~~~~~----------------~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~----i 226 (620)
........ ...+||+.|+|||++.+ .++.++||||||+++|+|++|..||........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 235 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence 65432211 15679999999998865 589999999999999999999999865322110 0
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 227 ~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
....... ..+...++.+.++|.+||. +|.+|||+.++++
T Consensus 236 ~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 236 VRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111111 1234566789999999998 8999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=361.49 Aligned_cols=261 Identities=27% Similarity=0.418 Sum_probs=208.8
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEc-cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCcceEEeEEEc-
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVD- 86 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~-~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpNIVkl~~~f~~- 86 (620)
..+.|++.+.||+|+||+||+|.+. .+|+.||+|+++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 4466799999999999999999995 789999999987543211 1112355677766665 89999999998862
Q ss_pred --CCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 87 --DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 87 --~~~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
.....+++||||+. |+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~-~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEc-CCCCEEEe
Confidence 23457899999998 69999998754 4999999999999999999999999 99999999999998 78999999
Q ss_pred cccchhhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC----
Q 007055 163 DLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK---- 235 (620)
Q Consensus 163 DFGla~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~---- 235 (620)
|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+...+.. +..
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 99999755432 334567999999999876 45899999999999999999999999875444333332221 000
Q ss_pred -------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 236 -------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 236 -------------------p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
...+....++.+++||.+||. +|.+||++.|+|+||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 011224467899999999998 8999999999999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.53 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=199.7
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
+....|++.+.||+|+||+||+|.+. |..||+|.++...........+.+.+|+.+++.++||||+++++++.+. .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 79 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--P 79 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--C
Confidence 34567899999999999999999874 8999999987554332233457789999999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEecCCCccceEecC-------CCCcEEEc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVNG-------NNGEVKIG 162 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~-~IiHrDLKp~NILl~~-------~~G~vKI~ 162 (620)
.+++||||+++|+|.+++. .+++++..++.++.||+.||.|||+++. +|+||||||+|||++. .++.+||+
T Consensus 80 ~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred ceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 5889999999999999986 4579999999999999999999999983 3889999999999973 26789999
Q ss_pred cccchhhccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 163 DLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 163 DFGla~~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
|||++............||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+. +.......+.....+...+.
T Consensus 159 Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 159 DFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPS 237 (271)
T ss_dssp CCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHTSCCCCCCCT
T ss_pred cCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhcCCCCCCCCc
Confidence 999997766555556789999999998764 5899999999999999999999999874 44444445555545555667
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..++.++++|.+||. +|.+|||+.|++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 788999999999998 89999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.50 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=217.5
Q ss_pred eeeeeeeccCceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcc
Q 007055 4 LDLVIWSLFVLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78 (620)
Q Consensus 4 ~~~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIV 78 (620)
++...|.+..+.|++.+.||+|+||.||+|.+. .++..||+|.++.. ......+.+.+|+.+++.++||||+
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv 89 (314)
T 2ivs_A 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRDLLSEFNVLKQVNHPHVI 89 (314)
T ss_dssp -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCcee
Confidence 445667888899999999999999999999983 56699999998643 2456678899999999999999999
Q ss_pred eEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHH
Q 007055 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN------------------------VDMKAIKNWARQILRGLHYLH 134 (620)
Q Consensus 79 kl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~------------------------l~e~~i~~i~~QIl~gL~yLH 134 (620)
+++++|.+. ..+++||||+.+|+|.+++...+. +++..++.++.||+.||.|||
T Consensus 90 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 167 (314)
T 2ivs_A 90 KLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167 (314)
T ss_dssp CEEEEECSS--SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEecC--CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence 999988654 458899999999999999987543 899999999999999999999
Q ss_pred hCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHH
Q 007055 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILE 209 (620)
Q Consensus 135 s~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyE 209 (620)
+++ |+||||||+|||++ .+|.+||+|||++...... ......+|+.|+|||++.+ .++.++|||||||++|+
T Consensus 168 ~~~--ivH~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 244 (314)
T 2ivs_A 168 EMK--LVHRDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244 (314)
T ss_dssp HTT--EECCCCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred HCC--CcccccchheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHH
Confidence 999 99999999999998 7899999999998654332 1234467889999998764 58999999999999999
Q ss_pred HHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 210 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 210 Llt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
|+| |..||.+ .....+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++++
T Consensus 245 l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 245 IVTLGGNPYPG-IPPERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCC-CCHHHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999 9999976 4556666666665433 3455678999999999998 89999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=374.02 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=202.6
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC--------CCCcceEEeE
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--------HENIIKFYNS 83 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~--------HpNIVkl~~~ 83 (620)
....|++.+.||+|+||+||+|.+..+|+.||+|+++.. ....+.+.+|+.+|+.++ ||||++++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 345679999999999999999999999999999998632 445677899999999985 7889999998
Q ss_pred EEcC--CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEecCCCC-
Q 007055 84 WVDD--TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNG- 157 (620)
Q Consensus 84 f~~~--~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~G- 157 (620)
|... ....+++||||+ +|+|.+++... +.+++..++.++.||+.||.|||++ + |+||||||+|||++ .+|
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~-~~~~ 185 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLS-VNEQ 185 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEEC-CCHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEe-ccch
Confidence 8632 345799999999 55666665543 5699999999999999999999998 8 99999999999997 444
Q ss_pred ------------------------------------------------cEEEccccchhhccCCCCccccCCCCCCCccc
Q 007055 158 ------------------------------------------------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL 189 (620)
Q Consensus 158 ------------------------------------------------~vKI~DFGla~~~~~~~~~~~~GTp~y~APEl 189 (620)
.+||+|||++...... ....+||+.|+|||+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHH
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChh
Confidence 7999999999765443 345689999999998
Q ss_pred ccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHc--CCCCC------------------------
Q 007055 190 YEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-----PAQIYKKVTS--GIKPA------------------------ 237 (620)
Q Consensus 190 l~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~-----~~~i~~~i~~--~~~p~------------------------ 237 (620)
+.+ .|+.++|||||||++|+|+||+.||..... .......+.. +..|.
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 764 599999999999999999999999975432 1111111111 11100
Q ss_pred --------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 238 --------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 238 --------------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
.++...++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0111224678999999998 9999999999999999963
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=370.86 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=213.0
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEc-------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKF 80 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-------~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl 80 (620)
|.+..+.|++.+.||+|+||+||+|.+. .++..||+|.++.. ......+.+.+|+.+|+.+ +||||+++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT---CBHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC---cCHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 3455678899999999999999999875 46778999998643 2355677899999999999 89999999
Q ss_pred EeEEEcCCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecC
Q 007055 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 144 (620)
Q Consensus 81 ~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrD 144 (620)
+++|.+. ..+|+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+|||
T Consensus 153 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrD 228 (370)
T 2psq_A 153 LGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRD 228 (370)
T ss_dssp EEEECSS--SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred EEEEccC--CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccc
Confidence 9988654 45889999999999999998753 4799999999999999999999999 99999
Q ss_pred CCccceEecCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCC
Q 007055 145 LKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYN 218 (620)
Q Consensus 145 LKp~NILl~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~ 218 (620)
|||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..|+.++|||||||++|||+| |..||.
T Consensus 229 lkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 229 LAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp CCGGGEEEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cchhhEEEC-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999998 7899999999999754432 223346789999999876 459999999999999999999 999997
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 219 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 219 ~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+ ....++...+..+..+ ..+...++.++++|.+||. +|.+||++.|++++
T Consensus 308 ~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 308 G-IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp T-CCGGGHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7 4556666777666543 3455678899999999998 89999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=362.81 Aligned_cols=265 Identities=19% Similarity=0.317 Sum_probs=196.6
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~---~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
+.+..+.|++.+.||+|+||+||+|.+..++. .||+|.++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 34556678999999999999999999888775 899999875432 2345678999999999999999999999987
Q ss_pred cCCCC----eEEEEEeccCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC
Q 007055 86 DDTNR----TINMITELFTSGSLRQYRKKHK------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 155 (620)
Q Consensus 86 ~~~~~----~l~lV~Ey~~gGsL~~~i~~~~------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 155 (620)
..... ..++||||+.+|+|.+++.... .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~-~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA-E 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-T
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc-C
Confidence 65432 2489999999999999986543 5999999999999999999999999 99999999999998 7
Q ss_pred CCcEEEccccchhhccCCC----CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHH
Q 007055 156 NGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 229 (620)
Q Consensus 156 ~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~ 229 (620)
+|.+||+|||++....... .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+. +...+...
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~ 251 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNY 251 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-ChHHHHHH
Confidence 8999999999997553321 223457889999998764 58999999999999999999 99999774 45555666
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-------HHHHhcCCCcCCCCCCc
Q 007055 230 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-------ALELLKDPFLVTDNPKD 280 (620)
Q Consensus 230 i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rps-------a~elL~hpff~~~~~~~ 280 (620)
+..+..+ ..+...++.+++||.+||. +|.+||| .++++.|||+......+
T Consensus 252 ~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p 309 (323)
T 3qup_A 252 LIGGNRL-KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309 (323)
T ss_dssp HHTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred HhcCCCC-CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 6655433 3345677899999999998 8999999 77788999998765444
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=368.01 Aligned_cols=257 Identities=25% Similarity=0.320 Sum_probs=194.5
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC-----
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----- 88 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~----- 88 (620)
..|++.+.||+|+||+||+|.+..+|+.||+|++...... ..+..++++.++.++||||++++++|....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 3578999999999999999999999999999988644321 234567888899999999999999986532
Q ss_pred CCeEEEEEeccCCCCHH---HHHHhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 89 NRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHYLH--SHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~---~~i~~~~~l~e~~i~~i~~QIl~gL~yLH--s~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
...+++||||+.++.+. .+......+++..++.++.||+.||.||| +++ |+||||||+|||++..+|.+||+|
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECC
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEee
Confidence 23588999999875333 23345677999999999999999999999 777 999999999999985489999999
Q ss_pred ccchhhccCC-CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----
Q 007055 164 LGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---- 236 (620)
Q Consensus 164 FGla~~~~~~-~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p---- 236 (620)
||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.....|
T Consensus 176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 9999765543 3345689999999998753 38999999999999999999999998754433333322210000
Q ss_pred -------------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 237 -------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 237 -------------------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.......++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 01112246789999999998 999999999999999998753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=365.17 Aligned_cols=259 Identities=28% Similarity=0.416 Sum_probs=207.3
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+.+ .|++.+.||+|+||.||+|.++.+|+.||+|++.... ......+++.+|+.+++.++||||+++++++....
T Consensus 20 ~~l~~-~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 20 WELPK-TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp EEEET-TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccCc-eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 44444 4589999999999999999999999999999986532 34556678999999999999999999999986554
Q ss_pred C----CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 89 N----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 89 ~----~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
. ..+++||||+. |+|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+||
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Df 170 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDF 170 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTCCEEECST
T ss_pred ccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeEC-CCCcEEEeec
Confidence 3 24589999997 58887764 35999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-C--------
Q 007055 165 GLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G-------- 233 (620)
Q Consensus 165 Gla~~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~-------- 233 (620)
|++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.. +
T Consensus 171 g~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 171 GLARHADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TCTTC---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred ccccCCCCC-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 999754432 345678999999998764 5899999999999999999999999874433332222110 0
Q ss_pred -------------CC---C---CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 234 -------------IK---P---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 234 -------------~~---p---~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.. . .......++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00 0 11223468899999999998 999999999999999998643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=360.91 Aligned_cols=252 Identities=22% Similarity=0.356 Sum_probs=210.9
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg---~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
...+....|++.+.||+|+||+||+|.+..+| ..||+|.++.. ......+.+.+|+.+|+.++||||++++++|
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 119 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG---YTERQRRDFLSEASIMGQFDHPNIIRLEGVV 119 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34556678899999999999999999998655 45999998743 2455667899999999999999999999998
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
.+. ..+++||||+.+|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|
T Consensus 120 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~D 194 (325)
T 3kul_A 120 TRG--RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVD-SNLVCKVSD 194 (325)
T ss_dssp CGG--GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECC
T ss_pred EeC--CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEC-CCCCEEECC
Confidence 554 4588999999999999999765 57999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCC-----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 164 LGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 164 FGla~~~~~~~-----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
||++....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .....+...+..+..+
T Consensus 195 fg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~ 273 (325)
T 3kul_A 195 FGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYRL 273 (325)
T ss_dssp CSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC
T ss_pred CCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCCC
Confidence 99997654321 22335678899999886 469999999999999999999 9999977 4566666777766443
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
. .+...++.+.++|.+||. +|.+||++.++++
T Consensus 274 ~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 P-APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3 445678999999999998 8999999999886
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=375.99 Aligned_cols=260 Identities=15% Similarity=0.150 Sum_probs=192.5
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC--CCCCcceEE-------
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL--KHENIIKFY------- 81 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L--~HpNIVkl~------- 81 (620)
...+.|++.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+++.| +||||++++
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 344568999999999999999999999999999999986542 2345566788885544444 699988865
Q ss_pred eEEEcCCC---------------CeEEEEEeccCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 007055 82 NSWVDDTN---------------RTINMITELFTSGSLRQYRKKH-KNVDMKAI------KNWARQILRGLHYLHSHNPP 139 (620)
Q Consensus 82 ~~f~~~~~---------------~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i------~~i~~QIl~gL~yLHs~~~~ 139 (620)
+++..... ..+++||||+. |+|.+++... ..+++..+ ..++.||+.||+|||+++
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 34333222 34899999999 8999999864 33455555 577799999999999999
Q ss_pred EEecCCCccceEecCCCCcEEEccccchhhccCCCCccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCC
Q 007055 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYP 216 (620)
Q Consensus 140 IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~P 216 (620)
|+||||||+|||++ .+|.+||+|||++....... ....||+.|+|||++.+ .|+.++|||||||++|+|+||+.|
T Consensus 215 ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 215 LVHGHFTPDNLFIM-PDGRLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp EEETTCSGGGEEEC-TTSCEEECCGGGEEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CccCcCCHHHEEEC-CCCCEEEEecceeeecCCCc-cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999998 78999999999997554332 24567899999998764 589999999999999999999999
Q ss_pred CCCCCCHHH-HHHH---HHcCCCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 217 YNECKNPAQ-IYKK---VTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 217 f~~~~~~~~-i~~~---i~~~~~p--~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
|.+...... .+.. ....... .......++.+++||.+||+ +|.+|||+.++|+||||+..
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 976422100 0000 0000111 11223568999999999998 99999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=348.17 Aligned_cols=250 Identities=20% Similarity=0.416 Sum_probs=212.8
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+....|++.+.||+|+||+||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46777888999999999999999999987 578899999875432 225688999999999999999999988654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++||||+++|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 78 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 78 --APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGM 152 (269)
T ss_dssp --SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECCTTG
T ss_pred --CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEc-CCCCEEeccccc
Confidence 4589999999999999999764 46899999999999999999999999 99999999999997 788999999999
Q ss_pred hhhccCC---CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 167 AIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 167 a~~~~~~---~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+...... ......||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .........+..+..+ ..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 230 (269)
T 4hcu_A 153 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPR 230 (269)
T ss_dssp GGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCT
T ss_pred cccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCC
Confidence 9755432 233456788999999886 569999999999999999999 9999976 5666777777766443 3445
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..++.++++|.+||. +|.+||++.++++|
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 678999999999998 89999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=366.79 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=202.3
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc-------CCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-------QSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~-------~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
....|++.+.||+|+||.||+|.+.. |..||+|++...... ......+.+.+|+.+|+.++||||++++++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34556899999999999999999865 999999998653221 2234457899999999999999999999998
Q ss_pred EcC---CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEE
Q 007055 85 VDD---TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 160 (620)
Q Consensus 85 ~~~---~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vK 160 (620)
... ....+++||||+. |+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~k 174 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA-DNNDIT 174 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEE
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc-CCCCEE
Confidence 653 3347899999998 5777777654 47999999999999999999999999 99999999999998 789999
Q ss_pred EccccchhhccCC-CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCC
Q 007055 161 IGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP 236 (620)
Q Consensus 161 I~DFGla~~~~~~-~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~p 236 (620)
|+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.... .....+.. ...|
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQLNKIVEVVGTP 253 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCC
Confidence 9999999654333 3345679999999998764 5899999999999999999999999875433 33333221 0000
Q ss_pred ---------------------C--------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 237 ---------------------A--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 237 ---------------------~--------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
. ......++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 0 0123357889999999998 999999999999999998753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=376.63 Aligned_cols=254 Identities=26% Similarity=0.452 Sum_probs=191.5
Q ss_pred eEEE-EEEEceeCCeEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 15 FLQY-DEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 15 ~y~i-~e~LG~G~fg~Vy~a~d~--~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.|++ +++||+|+||+||+|.++ .+++.||+|++..... ...+.+|+.+|+.|+||||++++++|.......
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 4555 568999999999999965 5789999999864322 135778999999999999999999998777788
Q ss_pred EEEEEeccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec---CCCCcE
Q 007055 92 INMITELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEV 159 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~---------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~---~~~G~v 159 (620)
+++||||+. |+|.+++... ..+++..++.|++||+.||.|||+++ |+||||||+|||+. ..+|.+
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcE
Confidence 999999997 5888877532 24999999999999999999999999 99999999999993 257899
Q ss_pred EEccccchhhccCC-----CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCC---------H
Q 007055 160 KIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN---------P 223 (620)
Q Consensus 160 KI~DFGla~~~~~~-----~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~---------~ 223 (620)
||+|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+... .
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999999765432 2345689999999998764 489999999999999999999999975432 1
Q ss_pred HHHHHHHHc-CCCC-CCCC---------------------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 007055 224 AQIYKKVTS-GIKP-ASLS---------------------------------KVTDPQVKQFIEKCIV-PASLRLPALEL 267 (620)
Q Consensus 224 ~~i~~~i~~-~~~p-~~~~---------------------------------~~~~~~lk~~I~kcL~-~p~~Rpsa~el 267 (620)
.++...+.. +..+ ..+. ...++.+++||.+||+ +|.+|||+.|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 222222211 1111 1110 1126788999999998 99999999999
Q ss_pred hcCCCcCCCC
Q 007055 268 LKDPFLVTDN 277 (620)
Q Consensus 268 L~hpff~~~~ 277 (620)
|+||||....
T Consensus 332 L~hp~f~~~~ 341 (405)
T 3rgf_A 332 MQDPYFLEDP 341 (405)
T ss_dssp HTSGGGTSSS
T ss_pred hcChhhccCC
Confidence 9999998753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=359.03 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=205.8
Q ss_pred cCceEEEEEEEceeCCeEEEEEEE-ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC------cceEEeEE
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN------IIKFYNSW 84 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d-~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN------IVkl~~~f 84 (620)
....|++.+.||+|+||+||+|.+ ..+|+.||+|+++.. ....+.+.+|+.+++.++|++ |++++++|
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 455679999999999999999999 668999999998632 345677889999999987664 99999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC-------
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------- 155 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~------- 155 (620)
... ..+++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++..
T Consensus 87 ~~~--~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 87 EHH--GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EET--TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred ccC--CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccC
Confidence 654 4799999999 899999998765 6899999999999999999999999 9999999999999732
Q ss_pred -----------CCcEEEccccchhhccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCH
Q 007055 156 -----------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP 223 (620)
Q Consensus 156 -----------~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~ 223 (620)
++.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.... .
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~ 239 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD-S 239 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC-H
T ss_pred CccccccccccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-h
Confidence 56899999999865433 3345689999999998764 58999999999999999999999998743 3
Q ss_pred HHHHHHHHc--CCCCC----------------------------------------CCCCCCcHHHHHHHHHhcC-CCCC
Q 007055 224 AQIYKKVTS--GIKPA----------------------------------------SLSKVTDPQVKQFIEKCIV-PASL 260 (620)
Q Consensus 224 ~~i~~~i~~--~~~p~----------------------------------------~~~~~~~~~lk~~I~kcL~-~p~~ 260 (620)
......+.. +..|. ......++.+++||.+||. +|.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 332222211 11110 0011225678999999998 9999
Q ss_pred CCCHHHHhcCCCcCCC
Q 007055 261 RLPALELLKDPFLVTD 276 (620)
Q Consensus 261 Rpsa~elL~hpff~~~ 276 (620)
|||+.|+|+||||+..
T Consensus 320 Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 320 RITLREALKHPFFDLL 335 (339)
T ss_dssp SCCHHHHTTSGGGGGG
T ss_pred ccCHHHHhcCHHHHHH
Confidence 9999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=356.74 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=206.7
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
..+..+.|++.+.||+|+||+||+|. +..+|+.||+|++... .....+.+.+|+.+|+.++||||++++++|
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45678899999999999999999998 6779999999998633 356667899999999999999999999998
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
.......+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~D 157 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGD 157 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEc-CCCeEEEcc
Confidence 7655556889999999999999998765 4999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCC-----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCH--------------
Q 007055 164 LGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP-------------- 223 (620)
Q Consensus 164 FGla~~~~~~~-----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~-------------- 223 (620)
||++....... .....||+.|+|||++. ..++.++||||||+++|+|+||..||......
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 99997654321 22345777899999876 45899999999999999999999998542100
Q ss_pred -HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 224 -AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 224 -~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+...+..+.. ...+...++.+.++|.+||. +|.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 238 VFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 012223333322 23455678999999999998 8999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=364.64 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=184.5
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC-
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD- 87 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~- 87 (620)
+.+.++|..+.++||+|+||+||+|.+..+|+.||+|++... ... .......++.++||||++++++|...
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKA---RQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHH---HHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 445566654467899999999999999999999999998632 122 12233446778999999999988652
Q ss_pred -CCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEc
Q 007055 88 -TNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIG 162 (620)
Q Consensus 88 -~~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~ 162 (620)
....+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEe
Confidence 2456899999999999999998764 6999999999999999999999999 999999999999973 25569999
Q ss_pred cccchhhccCCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC--CC
Q 007055 163 DLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYKKVTSGI--KP 236 (620)
Q Consensus 163 DFGla~~~~~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~---i~~~i~~~~--~p 236 (620)
|||++............||+.|+|||++. ..++.++|||||||++|+|++|..||........ ....+..+. .+
T Consensus 174 Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3fhr_A 174 DFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253 (336)
T ss_dssp CCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred ccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence 99999766655556678999999999885 4589999999999999999999999976432211 111222111 12
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.......++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 22334578999999999998 99999999999999999763
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=360.22 Aligned_cols=250 Identities=28% Similarity=0.352 Sum_probs=203.9
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
+.+....|++.++||+|+||+||+|.+. |+.||+|++.... .......+|+.+|+.++||||+++++++....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 4566778999999999999999999875 8999999986432 33445667999999999999999999987654
Q ss_pred --CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCEEecCCCccceEecCCC
Q 007055 89 --NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH----------NPPIIHRDLKCDNIFVNGNN 156 (620)
Q Consensus 89 --~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~----------~~~IiHrDLKp~NILl~~~~ 156 (620)
...+++||||+++|+|.+++... .+++..++.++.||+.||.|||++ + |+||||||+|||++ .+
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~-~~ 167 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLK-NN 167 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEEC-TT
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEEC-CC
Confidence 34689999999999999999774 599999999999999999999998 7 99999999999998 78
Q ss_pred CcEEEccccchhhccCC----CCccccCCCCCCCcccccc------ccCccchhhhhHHHHHHHHhcCCCCCCCC-----
Q 007055 157 GEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECK----- 221 (620)
Q Consensus 157 G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~~------~y~~~~DIwSlGiilyELltG~~Pf~~~~----- 221 (620)
+.+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|||+||+.||.+..
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 99999999999655432 2334679999999998764 46778999999999999999999996532
Q ss_pred ----------CHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 222 ----------NPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 222 ----------~~~~i~~~i~~~~~p~~~~~~-----~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
....+...+......+.++.. .++.+++||.+||+ +|.+|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 233344444443333333222 23469999999998 9999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=360.73 Aligned_cols=262 Identities=23% Similarity=0.415 Sum_probs=194.2
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCcceEEeEEE
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpNIVkl~~~f~ 85 (620)
..|.+....|++.+.||+|+||.||+|.++.+|+.||+|+++... .......+..|+. +++.++||||+++++++.
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 456777788999999999999999999999999999999987542 2344455666666 778889999999999987
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEecCCCCcE
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKK-----HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEV 159 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~-----~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~G~v 159 (620)
.. ..+++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++ + |+||||||+|||++ .+|.+
T Consensus 92 ~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~-~~~~~ 165 (327)
T 3aln_A 92 RE--GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNI 165 (327)
T ss_dssp CS--SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEE-TTTEE
T ss_pred eC--CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEc-CCCCE
Confidence 65 468999999985 88887763 56799999999999999999999998 8 99999999999998 78999
Q ss_pred EEccccchhhccCCC-CccccCCCCCCCccccc-----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Q 007055 160 KIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 233 (620)
Q Consensus 160 KI~DFGla~~~~~~~-~~~~~GTp~y~APEll~-----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 233 (620)
||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.+..........+..+
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (327)
T 3aln_A 166 KLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG 245 (327)
T ss_dssp EECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS
T ss_pred EEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC
Confidence 999999997654332 23447999999999873 358999999999999999999999997644333332223233
Q ss_pred CCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 234 IKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 234 ~~p~---~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
..+. ......++.+++||.+||. +|.+||++.++|+||||....
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 2221 1223568899999999998 899999999999999997543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=367.90 Aligned_cols=258 Identities=23% Similarity=0.354 Sum_probs=214.6
Q ss_pred eccCceEEEEEEEceeCCeEEEEEE-----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~-----d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
.+..+.|++.+.||+|+||+||+|. +..+++.||+|.++.. ........+.+|+.+++.++||||+++++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3445678999999999999999999 5568899999998632 2455666789999999999999999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 157 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~~-------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G 157 (620)
.+. ...++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|
T Consensus 144 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~ 218 (367)
T 3l9p_A 144 LQS--LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLT-CPG 218 (367)
T ss_dssp CSS--SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEES-CSS
T ss_pred ecC--CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEe-cCC
Confidence 654 35789999999999999998653 5899999999999999999999999 99999999999997 344
Q ss_pred ---cEEEccccchhhccC----CCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHH
Q 007055 158 ---EVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 228 (620)
Q Consensus 158 ---~vKI~DFGla~~~~~----~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~ 228 (620)
.+||+|||++..... .......||+.|+|||++. ..++.++|||||||++|||++ |..||.. .....+..
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~ 297 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLE 297 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHH
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHH
Confidence 599999999975422 2233457899999999875 569999999999999999998 9999976 56677777
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 229 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 229 ~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+..+..+. .+...++.+.+||.+||+ +|.+||++.+++++.++....
T Consensus 298 ~i~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 298 FVTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHcCCCCC-CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 777665433 345678899999999998 899999999999998775433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=359.58 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=212.8
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 81 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~ 81 (620)
.|.+..+.|++.+.||+|+||+||+|.+ ..++..||+|.++... .....+.+.+|+.+|+++ +||||++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 4566778889999999999999999997 3467899999987432 234456789999999999 999999999
Q ss_pred eEEEcCCCCeEEEEEeccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 007055 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------------------NVDMKAIKNWARQILRGLHYLHSHNP 138 (620)
Q Consensus 82 ~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~-----------------------~l~e~~i~~i~~QIl~gL~yLHs~~~ 138 (620)
+++... ..+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++
T Consensus 116 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 192 (344)
T 1rjb_A 116 GACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS- 192 (344)
T ss_dssp EEECSS--SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred EEEeeC--CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 988654 45889999999999999998653 3799999999999999999999999
Q ss_pred CEEecCCCccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-
Q 007055 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT- 212 (620)
Q Consensus 139 ~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt- 212 (620)
|+||||||+|||++ .+|.+||+|||++....... .....||+.|+|||++. +.++.++|||||||++|+|+|
T Consensus 193 -ivH~Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 193 -CVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp -EEETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred -cccCCCChhhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 99999999999998 78999999999997554332 22346788999999875 568999999999999999998
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 007055 213 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 271 (620)
Q Consensus 213 G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hp 271 (620)
|..||.+..........+..+..+ ..+...++.+.++|.+||. +|.+|||+.++++|-
T Consensus 271 g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 271 GVNPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp SCCSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcccCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999998876666666666665443 3455678999999999998 899999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.42 Aligned_cols=252 Identities=22% Similarity=0.396 Sum_probs=211.2
Q ss_pred eeeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 6 LVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 6 ~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
...|.+..+.|++.+.||+|+||+||+|.+. ++..||+|.++.... ..+.+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 3467788889999999999999999999876 788899999875432 1255889999999999999999999885
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
+. ..+++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+||
T Consensus 90 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Df 164 (283)
T 3gen_A 90 KQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDF 164 (283)
T ss_dssp SS--SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTSCEEECST
T ss_pred cC--CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEc-CCCCEEEccc
Confidence 44 468899999999999999987 567999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCC---CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 007055 165 GLAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASL 239 (620)
Q Consensus 165 Gla~~~~~~---~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~ 239 (620)
|++...... ......+|+.|+|||++. ..++.++||||||+++|+|+| |..||.. .+.......+..+..+ ..
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~ 242 (283)
T 3gen_A 165 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YR 242 (283)
T ss_dssp TGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CC
T ss_pred cccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CC
Confidence 999755432 223345788999999876 568999999999999999998 9999977 4566666777665443 33
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+...++.++++|.+||. +|.+|||+.++++|
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 45668899999999998 89999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=359.39 Aligned_cols=257 Identities=19% Similarity=0.324 Sum_probs=205.3
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC------cceEEeEE
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN------IIKFYNSW 84 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg-~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN------IVkl~~~f 84 (620)
..+.|++.+.||+|+||+||+|.+..++ ..||+|+++. .....+.+.+|+.+++.++|++ ++.+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 4566799999999999999999998877 7999999863 2345577889999999997766 89999987
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--------
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-------- 154 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-------- 154 (620)
... ..+++||||+ +|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 92 ~~~--~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 92 NFH--GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EET--TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred eeC--CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccc
Confidence 654 4789999999 66777776654 36999999999999999999999999 999999999999931
Q ss_pred ----------CCCcEEEccccchhhccCCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCH
Q 007055 155 ----------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP 223 (620)
Q Consensus 155 ----------~~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~ 223 (620)
.++.+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||......
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccccCCCcEEEeecCccccccc-cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 578999999999965433 334568999999999876 46999999999999999999999999874433
Q ss_pred HHHHHHHHc--CCCCC----------------------------------------CCCCCCcHHHHHHHHHhcC-CCCC
Q 007055 224 AQIYKKVTS--GIKPA----------------------------------------SLSKVTDPQVKQFIEKCIV-PASL 260 (620)
Q Consensus 224 ~~i~~~i~~--~~~p~----------------------------------------~~~~~~~~~lk~~I~kcL~-~p~~ 260 (620)
..+ ..+.. +..|. ......++.+++||.+||. +|.+
T Consensus 246 ~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 246 EHL-VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHH-HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHH-HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 322 22211 11110 0011124578999999998 9999
Q ss_pred CCCHHHHhcCCCcCCCCCCc
Q 007055 261 RLPALELLKDPFLVTDNPKD 280 (620)
Q Consensus 261 Rpsa~elL~hpff~~~~~~~ 280 (620)
|||+.|+|+||||+...+..
T Consensus 325 Rpt~~e~l~hp~f~~~~~~~ 344 (355)
T 2eu9_A 325 RITLAEALLHPFFAGLTPEE 344 (355)
T ss_dssp SCCHHHHTTSGGGGGCCHHH
T ss_pred CcCHHHHhcChhhcCCChhh
Confidence 99999999999999765543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.87 Aligned_cols=257 Identities=21% Similarity=0.349 Sum_probs=214.3
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCC--CCCcceEEeE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLK--HENIIKFYNS 83 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~--~~~~~l~~Ei~iL~~L~--HpNIVkl~~~ 83 (620)
........|++.+.||+|+||+||+|.+..+|+.||+|.++........ ...+++.+|+.+++.++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3445666789999999999999999999999999999999865432100 11234678999999996 5999999998
Q ss_pred EEcCCCCeEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 84 WVDDTNRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~g-GsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
+... ..+++|+|++.+ ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++..+|.+||+
T Consensus 117 ~~~~--~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 117 FERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EECS--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred EecC--CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEe
Confidence 8654 468999999986 899999998889999999999999999999999999 99999999999998667899999
Q ss_pred cccchhhccCCCCccccCCCCCCCcccccc-c-cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 163 DLGLAIVMQQPTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 163 DFGla~~~~~~~~~~~~GTp~y~APEll~~-~-y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
|||++............||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.. ... +..+ ...++
T Consensus 193 Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~---~~~----~~~~--~~~~~ 263 (320)
T 3a99_A 193 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEE----IIRG--QVFFR 263 (320)
T ss_dssp CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHH----HHHC--CCCCS
T ss_pred eCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC---hhh----hhcc--ccccc
Confidence 999998776665666789999999998764 3 46889999999999999999999964 222 2222 12244
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
...++.+++||.+||. +|.+|||+.++++||||+...
T Consensus 264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 5678999999999998 899999999999999998643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=357.64 Aligned_cols=253 Identities=22% Similarity=0.381 Sum_probs=205.8
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhC----CCCCcceEEeEE
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSL----KHENIIKFYNSW 84 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~--~~~~~l~~Ei~iL~~L----~HpNIVkl~~~f 84 (620)
.....|++.+.||+|+||.||+|.+..+|+.||+|.++........ .....+.+|+.+++++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3455679999999999999999999999999999998755432111 1233466799999998 899999999987
Q ss_pred EcCCCCeEEEEEec-cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 85 VDDTNRTINMITEL-FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey-~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
... ...++|+|| +.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++..+|.+||+|
T Consensus 108 ~~~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 108 ETQ--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp -------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred ecC--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEE
Confidence 654 457889999 789999999998888999999999999999999999999 999999999999985688999999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc-cc-CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 164 LGLAIVMQQPTARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 164 FGla~~~~~~~~~~~~GTp~y~APEll~~-~y-~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
||++............||+.|+|||++.+ .+ +.++||||||+++|+|++|+.||... .. +... ...++.
T Consensus 184 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~----~~~~--~~~~~~ 254 (312)
T 2iwi_A 184 FGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---QE----ILEA--ELHFPA 254 (312)
T ss_dssp CSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HHHT--CCCCCT
T ss_pred cchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---HH----Hhhh--ccCCcc
Confidence 99998776666667789999999998764 34 45899999999999999999999642 22 1221 223445
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
..++.+++||.+||. +|.+||++.|+|+||||+..
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 678999999999998 99999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.65 Aligned_cols=263 Identities=21% Similarity=0.361 Sum_probs=201.7
Q ss_pred eeeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 6 LVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 6 ~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
.-.+...-..|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+..+..+++.++||||+++++++.
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 33455556678999999999999999999999999999999875431 2223344455556788899999999999987
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEecCCCCcEEEcc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
+. ..+++||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ + ++||||||+|||++ .+|.+||+|
T Consensus 95 ~~--~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~d 168 (318)
T 2dyl_A 95 TN--TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGQIKLCD 168 (318)
T ss_dssp CS--SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEEC-TTSCEEECC
T ss_pred cC--CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEEC-CCCCEEEEE
Confidence 54 4789999999 5566666554 56799999999999999999999995 8 99999999999998 789999999
Q ss_pred ccchhhccCC-CCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 164 LGLAIVMQQP-TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 164 FGla~~~~~~-~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||............+..+..+
T Consensus 169 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (318)
T 2dyl_A 169 FGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP 248 (318)
T ss_dssp CTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC
T ss_pred CCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC
Confidence 9998655433 234557999999999874 348899999999999999999999998876776666666665443
Q ss_pred CC-CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 237 AS-LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 237 ~~-~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.. .....++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 249 LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 22 223468999999999998 99999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=366.60 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=203.0
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CC-----CcceEEeEEEcC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HE-----NIIKFYNSWVDD 87 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-Hp-----NIVkl~~~f~~~ 87 (620)
..|++.+.||+|+||+||+|.+..+|+.||+|+++.. ......+.+|+.+++.++ |+ +|++++++|...
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 4579999999999999999999999999999998632 344567788999998885 55 499999988765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC-CCCcEEEccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDL 164 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~G~vKI~DF 164 (620)
..+++||||+. |+|.+++... +.+++..++.++.||+.||.|||++..+|+||||||+|||++. .++.+||+||
T Consensus 129 --~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 --NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp --TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred --CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 47899999996 5999998875 4699999999999999999999964334999999999999952 4678999999
Q ss_pred cchhhccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCC----
Q 007055 165 GLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPA---- 237 (620)
Q Consensus 165 Gla~~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~--~~~p~---- 237 (620)
|++...... ....+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.+..... ....+.. +..|.
T Consensus 206 G~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 206 GSSCQLGQR-IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD-QMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp TTCEETTCC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHT
T ss_pred cCceecccc-cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence 999765433 345789999999998764 59999999999999999999999998754433 3333322 11100
Q ss_pred --------------------------------CCCC------------------------CCcHHHHHHHHHhcC-CCCC
Q 007055 238 --------------------------------SLSK------------------------VTDPQVKQFIEKCIV-PASL 260 (620)
Q Consensus 238 --------------------------------~~~~------------------------~~~~~lk~~I~kcL~-~p~~ 260 (620)
.... ...+.+++||.+||+ +|.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 0000 001478999999998 9999
Q ss_pred CCCHHHHhcCCCcCCC
Q 007055 261 RLPALELLKDPFLVTD 276 (620)
Q Consensus 261 Rpsa~elL~hpff~~~ 276 (620)
|||+.|+|+||||+..
T Consensus 364 Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 364 RIQPYYALQHSFFKKT 379 (382)
T ss_dssp SCCHHHHTTSGGGCC-
T ss_pred CCCHHHHhcCcccccC
Confidence 9999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=357.63 Aligned_cols=252 Identities=20% Similarity=0.285 Sum_probs=213.0
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
+.+....|++.+.||+|+||.||+|.+. .++..||+|.++... .....+.+.+|+.+++.++||||++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3455677899999999999999999997 456999999987432 35566789999999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPP 139 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~------------------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~ 139 (620)
+.+. ..+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++
T Consensus 119 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-- 194 (343)
T 1luf_A 119 CAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-- 194 (343)
T ss_dssp ECSS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EccC--CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 8654 4588999999999999999874 56999999999999999999999999
Q ss_pred EEecCCCccceEecCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-c
Q 007055 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-C 213 (620)
Q Consensus 140 IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G 213 (620)
|+||||||+|||++ .+|.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+| |
T Consensus 195 ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 195 FVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp CCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred eecCCCCcceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 99999999999998 7899999999999754322 223456899999999876 469999999999999999999 9
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 214 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 214 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..||.+ .+...+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++++
T Consensus 274 ~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 274 LQPYYG-MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCCC-CChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 999976 4566666777666443 3455678999999999998 89999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=352.49 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=215.4
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 81 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~ 81 (620)
.|.+....|++.+.||+|+||+||+|.+ ..+++.||+|.++... .....+.+.+|+.+++++ +||||++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 4566777889999999999999999985 5678999999987432 345667899999999999 999999999
Q ss_pred eEEEcCCCCeEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHK------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 82 ~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
+++.+. ..+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||
T Consensus 94 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~ 169 (313)
T 1t46_A 94 GACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHR 169 (313)
T ss_dssp EEECSS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred EEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecC
Confidence 988654 45789999999999999998754 4899999999999999999999999 9999
Q ss_pred CCCccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCC
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY 217 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf 217 (620)
||||+||+++ .++.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|+| |..||
T Consensus 170 dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 248 (313)
T 1t46_A 170 DLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (313)
T ss_dssp CCSGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCccceEEEc-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999998 78999999999997654432 22345788999999775 468999999999999999999 99999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 218 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 218 ~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+..........+..+..+ ..+...++.++++|.+||. +|.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 249 PGMPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp TTCCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccchhHHHHHhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 8866666666666655443 2345678899999999998 89999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.54 Aligned_cols=254 Identities=27% Similarity=0.414 Sum_probs=207.2
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
..+..++|++.+.||+|+||.||+|. +..+|+.||+|.++... .....+.+.+|+.+++.++||||++++++|
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 34567789999999999999999998 67899999999987543 223456788999999999999999999999
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
.+.....+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~D 169 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGD 169 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECC
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEc-CCCCEEECc
Confidence 87766779999999999999999954 467999999999999999999999999 99999999999998 788999999
Q ss_pred ccchhhccCCC-----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCC--------------CCH
Q 007055 164 LGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC--------------KNP 223 (620)
Q Consensus 164 FGla~~~~~~~-----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~--------------~~~ 223 (620)
||++....... .....||+.|+|||++. ..++.++||||||+++|+|+||..|+... ...
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence 99997554332 23456888999999876 45889999999999999999999876321 112
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 224 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 224 ~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+...+..+.. ...+...++.+++||.+||. +|.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 250 TRLVNTLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 233344444433 33455678999999999998 9999999999885
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=342.76 Aligned_cols=249 Identities=22% Similarity=0.385 Sum_probs=209.2
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
+.+....|++.+.||+|+||+||+|.+. ++..||+|.++.... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 75 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE- 75 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEccC-
Confidence 3456678899999999999999999776 678899999875432 225588999999999999999999988544
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 89 NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
..+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++
T Consensus 76 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 76 -YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD-RDLCVKVSDFGMT 151 (268)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEEC-TTCCEEECCTTCE
T ss_pred -CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEEC-CCCCEEEccCccc
Confidence 46899999999999999998754 5999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCCC---CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 007055 168 IVMQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 168 ~~~~~~~---~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
....... .....+|+.|+|||++.+ .++.++||||||+++|+|+| |..||.. .........+..+..+ ..+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~ 229 (268)
T 3sxs_A 152 RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-YTNSEVVLKVSQGHRL-YRPHL 229 (268)
T ss_dssp EECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTT
T ss_pred eecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc-cChHHHHHHHHcCCCC-CCCCc
Confidence 7554432 223456778999998875 58999999999999999999 9999976 4555555666655433 33455
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.++.++++|.+||+ +|.+|||+.+++++
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 230 ASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp SCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 68899999999998 89999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=364.31 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=205.4
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----------CCCcce
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----------HENIIK 79 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-----------HpNIVk 79 (620)
+....|++.+.||+|+||+||+|.+..+|+.||+|++... ....+.+.+|+.+++.++ ||||++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 4456789999999999999999999999999999998632 344567889999999886 899999
Q ss_pred EEeEEEcCC--CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCccceEec-
Q 007055 80 FYNSWVDDT--NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVN- 153 (620)
Q Consensus 80 l~~~f~~~~--~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~- 153 (620)
++++|.... ...+++||||+ +++|.+++... +.+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEI 167 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEec
Confidence 999987543 23789999999 89999999874 4599999999999999999999998 8 99999999999995
Q ss_pred ----CCCCcEEEccccchhhccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCC-----H
Q 007055 154 ----GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-----P 223 (620)
Q Consensus 154 ----~~~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~-----~ 223 (620)
...+.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||..... .
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCCCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 13458999999999765433 345579999999998765 589999999999999999999999975321 1
Q ss_pred HHHHHHHHc--CCCC--------------------------------------CCCCCCCcHHHHHHHHHhcC-CCCCCC
Q 007055 224 AQIYKKVTS--GIKP--------------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRL 262 (620)
Q Consensus 224 ~~i~~~i~~--~~~p--------------------------------------~~~~~~~~~~lk~~I~kcL~-~p~~Rp 262 (620)
......+.. +..| ..++...++.+++||.+||+ +|.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 111111111 1000 01122335788999999998 999999
Q ss_pred CHHHHhcCCCcCCCC
Q 007055 263 PALELLKDPFLVTDN 277 (620)
Q Consensus 263 sa~elL~hpff~~~~ 277 (620)
|+.|+|+||||+...
T Consensus 327 t~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 327 DAGGLVNHPWLKDTL 341 (373)
T ss_dssp CHHHHHTCGGGTTCT
T ss_pred CHHHHhhChhhhccc
Confidence 999999999998743
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=363.48 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=215.7
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcce
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIK 79 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk 79 (620)
.|.+..+.|++.+.||+|+||+||+|.+.. .+..||+|+++.. .......++.+|+.+++.+ +||||++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 456667788999999999999999999754 3468999998744 2456678899999999999 9999999
Q ss_pred EEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 80 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
++++|... ..+++||||+.+|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||
T Consensus 140 ~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~ 215 (382)
T 3tt0_A 140 LLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHR 215 (382)
T ss_dssp EEEEECSS--SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred heeeeccC--CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecC
Confidence 99988654 45889999999999999998754 4999999999999999999999999 9999
Q ss_pred CCCccceEecCCCCcEEEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCC
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPY 217 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf 217 (620)
||||+|||++ .+|.+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||
T Consensus 216 Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~ 294 (382)
T 3tt0_A 216 DLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294 (382)
T ss_dssp CCCGGGEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCcceEEEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999998 7899999999999755432 2334467889999998764 58999999999999999999 99999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 218 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 218 ~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+ .+..++...+..+..+. .+...++++++||.+||+ +|.+|||+.|++++
T Consensus 295 ~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 295 PG-VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TT-CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 76 56777777777765443 345678899999999998 89999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=369.68 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=210.9
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
.+..++.|++.++||+|+||+||+|.+..+|+.||+|+++..... ...+.+.+|+.+|+.++||||+++++++.+..
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 456678899999999999999999999999999999999754432 23456789999999999999999999998777
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEe----cCCCCcEEE
Q 007055 89 NRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKI 161 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~---~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl----~~~~G~vKI 161 (620)
...+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||+ + .++.+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL 157 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKL 157 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTT-SCEEEEE
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCC-CceeEEE
Confidence 668899999999999999997654 3999999999999999999999999 9999999999998 5 5678999
Q ss_pred ccccchhhccCC-CCccccCCCCCCCccccc---------cccCccchhhhhHHHHHHHHhcCCCCCCCC---CHHHHHH
Q 007055 162 GDLGLAIVMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYK 228 (620)
Q Consensus 162 ~DFGla~~~~~~-~~~~~~GTp~y~APEll~---------~~y~~~~DIwSlGiilyELltG~~Pf~~~~---~~~~i~~ 228 (620)
+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.... ....+..
T Consensus 158 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp CCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred ecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 999999765433 334568999999999875 358889999999999999999999996432 2234444
Q ss_pred HHHcCCCCCC-----------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 229 KVTSGIKPAS-----------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 229 ~i~~~~~p~~-----------------------~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+..+..+.. +....++.++++|.+||. +|.+||++.+++.+
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 4444433211 112235688999999998 99999999998653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=366.37 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=212.7
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+....|++.+.||+|+||.||+|.+..+|+.||+|.++.. ......+.+.+|+.+|+.++||||+++++++...
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 3556677899999999999999999999999999999998633 2345556788999999999999999999988554
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 185 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~-~~~~~kl~DfG~ 259 (377)
T 3cbl_A 185 --QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVT-EKNVLKISDFGM 259 (377)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGG
T ss_pred --CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEc-CCCcEEECcCCC
Confidence 45889999999999999998654 6999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCCC----ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 167 AIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 167 a~~~~~~~~----~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
+........ ....+++.|+|||++. +.++.++|||||||++|||+| |..||.+ ....+....+..+..+ ..+
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~ 337 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-LSNQQTREFVEKGGRL-PCP 337 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT-SCHHHHHHHHHTTCCC-CCC
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCC
Confidence 865433211 1223577899999876 569999999999999999998 9999977 4556666666665443 345
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
...++.+.++|.+||. +|.+|||+.++++
T Consensus 338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5678899999999998 8999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=353.98 Aligned_cols=257 Identities=24% Similarity=0.382 Sum_probs=217.4
Q ss_pred eeeeeccCceEEEEEEEceeCCeEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcce
Q 007055 6 LVIWSLFVLFLQYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIK 79 (620)
Q Consensus 6 ~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk 79 (620)
...|.+..+.|++.+.||+|+||+||+|.+ ..+++.||+|.++.. ......+.+.+|+.+++.+ +||||++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC---CCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345667778899999999999999999985 467899999998743 2345567799999999999 7999999
Q ss_pred EEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN----------------VDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 80 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~----------------l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
+++++... ...+++||||+.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||
T Consensus 96 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~ 172 (316)
T 2xir_A 96 LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHR 172 (316)
T ss_dssp EEEEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred EEEEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccc
Confidence 99987654 3468899999999999999987654 899999999999999999999999 9999
Q ss_pred CCCccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCC
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY 217 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf 217 (620)
||||+|||++ .+|.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||
T Consensus 173 dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 173 DLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp CCSGGGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cCccceEEEC-CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999998 78899999999997553322 22456789999999876 458999999999999999998 99999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 218 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 218 ~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+..........+..+..+ ..+...++.++++|.+||. +|.+|||+.++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 252 PGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp TTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchhHHHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8876666666666665433 3455678999999999998 89999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=349.26 Aligned_cols=248 Identities=21% Similarity=0.355 Sum_probs=205.7
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCC-------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDG-------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg-------~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~ 81 (620)
..+....|++.+.||+|+||+||+|.+..+| ..||+|.+.... ....+.+.+|+.+++.++||||++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNY 78 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 3456778899999999999999999998887 589999986432 34456789999999999999999999
Q ss_pred eEEEcCCCCeEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc--
Q 007055 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-- 158 (620)
Q Consensus 82 ~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~-l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~-- 158 (620)
+++.+.. ..++||||+.+|+|.+++...+. +++..+..++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 79 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~~ 153 (289)
T 4fvq_A 79 GVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLI-REEDRK 153 (289)
T ss_dssp EEECCTT--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-ECCBGG
T ss_pred EEEEeCC--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEe-cCCccc
Confidence 9986543 57889999999999999987765 999999999999999999999999 99999999999998 5565
Q ss_pred ------EEEccccchhhccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 007055 159 ------VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 230 (620)
Q Consensus 159 ------vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i 230 (620)
+||+|||++..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..|+....+........
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLP--KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSC--HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred ccccceeeeccCcccccccC--ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 99999999864432 233568999999998864 48999999999999999999655554545555554444
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 231 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 231 ~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
... ..++...++.++++|.+||+ +|.+|||+.++++|
T Consensus 232 ~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 EDR---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HTT---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcc---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 432 22334456789999999998 89999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.91 Aligned_cols=252 Identities=24% Similarity=0.421 Sum_probs=202.6
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
.+.+....|++.+.||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 4677788899999999999999999998654 567999987643 2455667899999999999999999999987
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
.+ ..+++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|
T Consensus 86 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~D 159 (281)
T 1mp8_A 86 TE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGD 159 (281)
T ss_dssp CS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC
T ss_pred cc---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEEC-CCCCEEECc
Confidence 32 34789999999999999998654 6999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCC
Q 007055 164 LGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 238 (620)
Q Consensus 164 FGla~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 238 (620)
||++....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+. ........+..+..+ .
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-~~~~~~~~i~~~~~~-~ 237 (281)
T 1mp8_A 160 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-P 237 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-C
T ss_pred cccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-CHHHHHHHHHcCCCC-C
Confidence 99997654332 23345788999999886 458999999999999999997 99999874 444555566655433 3
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 239 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 239 ~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+...++.++++|.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 455678999999999998 89999999998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.02 Aligned_cols=252 Identities=30% Similarity=0.502 Sum_probs=205.2
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
..+.+.+..|++.+.||+|+||+||+|.+.. .||+|.++... ......+.+.+|+.+|+.++||||++++++..
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~- 90 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-
Confidence 3566778888999999999999999997643 59999987543 34566788999999999999999999999642
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
. ..+++||||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 91 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg 165 (289)
T 3og7_A 91 A--PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLH-EDNTVKIGDFG 165 (289)
T ss_dssp S--SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEEECCCC
T ss_pred C--CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEEEccce
Confidence 2 3478999999999999999644 56999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccC----CCCccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 007055 166 LAIVMQQ----PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 237 (620)
Q Consensus 166 la~~~~~----~~~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~ 237 (620)
++..... .......||+.|+|||++. ..++.++||||||+++|+|++|+.||........+...+..+..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc
Confidence 9865432 2233457999999999874 3478899999999999999999999998888888888777765544
Q ss_pred C---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 238 S---LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 238 ~---~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
. +....++.+++||.+||. +|.+||++.++++
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3 334567999999999998 8999999999886
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.92 Aligned_cols=249 Identities=27% Similarity=0.449 Sum_probs=202.0
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEE----EEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~V----AiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
+....|++.++||+|+||+||+|.+..+|..| |+|.+.... .....+.+.+|+.++++++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 45667899999999999999999998887765 666654321 23345678999999999999999999999875
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
. ..++|+||+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 89 ~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg 162 (327)
T 3poz_A 89 S---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFG 162 (327)
T ss_dssp S---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTT
T ss_pred C---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEEC-CCCCEEEccCc
Confidence 4 377899999999999999874 57999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 007055 166 LAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASL 239 (620)
Q Consensus 166 la~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~ 239 (620)
++....... .....||+.|+|||++. ..++.++|||||||++|+|+| |+.||.+ .+...+...+..+..+ ..
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~ 240 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQ 240 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CC
T ss_pred ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHcCCCC-CC
Confidence 997654332 22345788999999876 458999999999999999999 9999976 4555566666655433 34
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+...+..+.++|.+||+ +|.+||++.+++.+
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 45578899999999998 89999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=354.57 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=213.3
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
.-+..+.|++.+.||+|+||.||+|. +..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 34556789999999999999999998 5789999999998643 355667799999999999999999999998
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
.......+++||||+++|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~-~~~~~kl~D 170 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIAD 170 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECC
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEEC-CCCCEEEcc
Confidence 877778899999999999999999874 56999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCC-----CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCC--------------H
Q 007055 164 LGLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--------------P 223 (620)
Q Consensus 164 FGla~~~~~~~-----~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~--------------~ 223 (620)
||++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... .
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 99997554322 234468889999998764 589999999999999999999999854211 1
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 224 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 224 ~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..+...+..+. ....+...++.+++||.+||. +|.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 251 SRLLELLEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhhccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22333344433 333456678999999999998 89999999999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=354.69 Aligned_cols=254 Identities=20% Similarity=0.231 Sum_probs=205.9
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC-
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD- 87 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~- 87 (620)
+.+.++.|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 345678899999999999999999999999999999998643 345677899999999999999999999998643
Q ss_pred -CCCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 88 -TNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 88 -~~~~l~lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
....+++|+||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~ 176 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLG-DEGQPVLM 176 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEEC
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEc-CCCCEEEE
Confidence 33578999999999999999876 467999999999999999999999999 99999999999997 78999999
Q ss_pred cccchhhccCCC-----------CccccCCCCCCCcccccc----ccCccchhhhhHHHHHHHHhcCCCCCCCCC-HHHH
Q 007055 163 DLGLAIVMQQPT-----------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKN-PAQI 226 (620)
Q Consensus 163 DFGla~~~~~~~-----------~~~~~GTp~y~APEll~~----~y~~~~DIwSlGiilyELltG~~Pf~~~~~-~~~i 226 (620)
|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... ...+
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 256 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence 999875432111 123467999999998753 378999999999999999999999953100 0112
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 227 ~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
...+... .........++.++++|.+||. +|.+||++.+++++
T Consensus 257 ~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 257 ALAVQNQ-LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHhhcc-CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2223322 2222334568899999999998 99999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=339.71 Aligned_cols=249 Identities=20% Similarity=0.427 Sum_probs=212.1
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+..+.|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 75 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ- 75 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEccC-
Confidence 5667788999999999999999999986 678999999875432 225688999999999999999999988654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 89 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
..+++||||+++|+|.+++... +.+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 76 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 76 -APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMT 151 (267)
T ss_dssp -SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-GGGCEEECCTTGG
T ss_pred -CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEC-CCCCEEEcccccc
Confidence 4588999999999999999875 56899999999999999999999999 99999999999997 7889999999999
Q ss_pred hhccCC---CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 007055 168 IVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 168 ~~~~~~---~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
...... ......||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+.......+..+..+ ..+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~ 229 (267)
T 3t9t_A 152 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRL 229 (267)
T ss_dssp GGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTT
T ss_pred cccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCcc
Confidence 755332 223456788999999886 458999999999999999999 8999976 4566677777766443 34456
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.++.++++|.+||. +|.+||++.+++++
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 78999999999998 89999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=353.79 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=214.7
Q ss_pred eeeeeccCceEEEEEEEceeCCeEEEEEEEc-------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCc
Q 007055 6 LVIWSLFVLFLQYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENI 77 (620)
Q Consensus 6 ~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-------~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNI 77 (620)
...|.+..+.|++.+.||+|+||+||+|.+. .++..||+|+++.. ......+.+.+|+.+++.+ +||||
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT---CCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC---CcHHHHHHHHHHHHHHHHhhcCCCE
Confidence 3456777888999999999999999999986 46789999998643 2456677899999999999 99999
Q ss_pred ceEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 007055 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPII 141 (620)
Q Consensus 78 Vkl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~Ii 141 (620)
+++++++... ..+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+
T Consensus 104 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iv 179 (334)
T 2pvf_A 104 INLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CI 179 (334)
T ss_dssp CCEEEEECSS--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred eeEEEEEccC--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 9999988654 46889999999999999998754 3899999999999999999999999 99
Q ss_pred ecCCCccceEecCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCC
Q 007055 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEY 215 (620)
Q Consensus 142 HrDLKp~NILl~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~ 215 (620)
||||||+|||++ .+|.+||+|||++...... ......+|+.|+|||++. ..++.++||||||+++|+|++ |..
T Consensus 180 H~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 258 (334)
T 2pvf_A 180 HRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258 (334)
T ss_dssp CSCCSGGGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCccceEEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 999999999998 7899999999999755432 123346788999999876 458999999999999999999 999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 216 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 216 Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
||.+ .....+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++++
T Consensus 259 p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 259 PYPG-IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp SSTT-CCHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCc-CCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9976 4666777777666443 3445678899999999998 89999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=352.30 Aligned_cols=254 Identities=23% Similarity=0.391 Sum_probs=214.0
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 81 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~ 81 (620)
-.|....+.|++.+.||+|+||.||+|.+. .++..||+|.+... ........+.+|+.+++.++||||++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 356677788999999999999999999887 46889999998643 2345567799999999999999999999
Q ss_pred eEEEcCCCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceE
Q 007055 82 NSWVDDTNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 151 (620)
Q Consensus 82 ~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~----------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NIL 151 (620)
+++.+. ..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+
T Consensus 95 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIl 170 (322)
T 1p4o_A 95 GVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCM 170 (322)
T ss_dssp EEECSS--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEE
T ss_pred EEEccC--CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEE
Confidence 988554 4578999999999999998753 45799999999999999999999999 999999999999
Q ss_pred ecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHH
Q 007055 152 VNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 225 (620)
Q Consensus 152 l~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~ 225 (620)
++ .+|.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+ .+..+
T Consensus 171 i~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~ 248 (322)
T 1p4o_A 171 VA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQ 248 (322)
T ss_dssp EC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHH
T ss_pred Ec-CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHH
Confidence 98 78999999999986543321 23346789999999876 458999999999999999999 8999976 45666
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 226 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 226 i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+...+..+..+ ..+...++.++++|.+||. +|.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 249 VLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 66666665433 2345678899999999998 89999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=345.35 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=209.8
Q ss_pred eeeeccCceEEEEE-EEceeCCeEEEEEE--EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 7 VIWSLFVLFLQYDE-ILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 7 ~~~~~~~r~y~i~e-~LG~G~fg~Vy~a~--d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
..+.+..+.|++.+ .||+|+||+||+|. +..+++.||+|.++... ......+.+.+|+.+++.++||||++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34455666778888 99999999999995 46778999999987543 233456789999999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
+. . ..+++||||+.+|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|
T Consensus 87 ~~-~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~-~~~~~kl~D 160 (291)
T 1xbb_A 87 CE-A--ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISD 160 (291)
T ss_dssp EE-S--SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECC
T ss_pred EC-C--CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEe-CCCcEEEcc
Confidence 73 2 357899999999999999999889999999999999999999999999 99999999999998 788999999
Q ss_pred ccchhhccCCC-----CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 164 LGLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 164 FGla~~~~~~~-----~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++ |+.||.+ .+...+...+..+..+
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~ 239 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM 239 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC
Confidence 99986554332 122356789999998764 58999999999999999999 9999976 4566677777766443
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+...++.++++|.+||. +|.+||++.++++
T Consensus 240 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3456678999999999998 9999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=353.75 Aligned_cols=252 Identities=26% Similarity=0.416 Sum_probs=208.8
Q ss_pred eccCceEEEEEEEceeCCeEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
.+.+|||++.+.||+|+||+||+|. +..+|+.||+|+++.. ......+.+.+|+.+|+.++||||+++++++.
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 4677889999999999999998774 4568999999998744 24566778999999999999999999999998
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
+.....+++||||+++|+|.+++...+ +++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg 179 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFG 179 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGG
T ss_pred cCCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEc-CCCCEEECCcc
Confidence 877778999999999999999997754 999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCCC-----CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCH--------------HH
Q 007055 166 LAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--------------AQ 225 (620)
Q Consensus 166 la~~~~~~~-----~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~--------------~~ 225 (620)
++....... .....||+.|+|||++.+ .++.++||||||+++|+|+||..||...... ..
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 997654322 234568889999998865 5889999999999999999999999642111 11
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 226 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 226 i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+...+..+ .....+...++.+.+||.+||. +|.+|||+.++++
T Consensus 260 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 260 LTELLERG-ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcc-cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22233333 2334456678999999999998 8999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=346.68 Aligned_cols=251 Identities=30% Similarity=0.512 Sum_probs=202.7
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||.||+|.+..+|+.||+|+++.... ......+.+.+|+.+++.++||||++++++|... ..++
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 108 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELN 108 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CcEE
Confidence 457999999999999999999999999999999975433 3456677899999999999999999999998765 4689
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 94 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++..
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~-~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEc-CCCCEEEEeccceee
Confidence 99999999999999874 456999999999999999999999999 99999999999998 789999999999875
Q ss_pred ccCC--CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcH
Q 007055 170 MQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDP 245 (620)
Q Consensus 170 ~~~~--~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~~~ 245 (620)
.... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+.. +...+...+..+..+.......++
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 5433 233557999999999876 458999999999999999999999997543 345566666666555545566789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.++++|.+||. +|.+||++.+++++
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999998 99999999999873
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=346.78 Aligned_cols=248 Identities=27% Similarity=0.484 Sum_probs=210.1
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc----
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD---- 86 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~---- 86 (620)
..+..|++.+.||+|+||.||+|.+..+|+.||+|.++... +.+.+|+.+++.++||||++++++|..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence 34567899999999999999999999999999999987542 246789999999999999999998754
Q ss_pred ----------CCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC
Q 007055 87 ----------DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 154 (620)
Q Consensus 87 ----------~~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 154 (620)
.....+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~- 156 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV- 156 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEc-
Confidence 2234689999999999999999754 57999999999999999999999999 99999999999998
Q ss_pred CCCcEEEccccchhhccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Q 007055 155 NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 232 (620)
Q Consensus 155 ~~G~vKI~DFGla~~~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~ 232 (620)
.++.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .......+..
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~ 233 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRD 233 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHT
T ss_pred CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhc
Confidence 7899999999998765433 3345679999999998764 589999999999999999999998843 3344444544
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 233 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 233 ~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+. ++...++.++++|.+||. +|.+||++.|+++|.+....
T Consensus 234 ~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 234 GI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp TC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred cc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 33 344567899999999998 89999999999999876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.64 Aligned_cols=246 Identities=20% Similarity=0.244 Sum_probs=202.9
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 89 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~ 89 (620)
..+..|++.+.||+|+||+||+|.+..+|+.||+|.+...... +.+.+|+.+++.| +||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 77 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA------PQLHLEYRFYKQLGSGDGIPQVYYFGPCG-- 77 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS------CCHHHHHHHHHHHCSCTTSCCEEEEEEET--
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch------HHHHHHHHHHHHhhCCCCCCEEEEEEecC--
Confidence 4467789999999999999999999999999999998754321 2478899999999 999999999988764
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc-----EEEcc
Q 007055 90 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIGD 163 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~-----vKI~D 163 (620)
..+++||||+ +|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|. +||+|
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~-~~~~~~~~~~kl~D 153 (330)
T 2izr_A 78 KYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIG-RPGNKTQQVIHIID 153 (330)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-CGGGTCTTSEEECC
T ss_pred CccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-cCCCCCCceEEEEE
Confidence 4789999999 99999999874 67999999999999999999999999 99999999999997 5666 99999
Q ss_pred ccchhhccCCC---------CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCC--CHHHHHHHHH
Q 007055 164 LGLAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVT 231 (620)
Q Consensus 164 FGla~~~~~~~---------~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~--~~~~i~~~i~ 231 (620)
||++....... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.. .....+..+.
T Consensus 154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 233 (330)
T 2izr_A 154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233 (330)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence 99997543322 245689999999998765 58999999999999999999999997642 3344444443
Q ss_pred cCCCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 232 SGIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 232 ~~~~p~---~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
....+. .+....+ .++++|..||. +|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 234 DTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 321111 1122234 99999999998 9999999988775
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.72 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=215.8
Q ss_pred eeeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 6 LVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 6 ~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
+-.|.+..+.|++.+.||+|+||+||+|.+..++..||+|.+... ....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 346778888999999999999999999999999999999998643 234577899999999999999999999885
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
+. ..+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|
T Consensus 80 ~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~D 154 (288)
T 3kfa_A 80 RE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVAD 154 (288)
T ss_dssp SS--SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEEC-GGGCEEECC
T ss_pred cC--CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEc-CCCCEEEcc
Confidence 54 45899999999999999998743 4999999999999999999999999 99999999999997 788999999
Q ss_pred ccchhhccCCCC---ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCC
Q 007055 164 LGLAIVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 238 (620)
Q Consensus 164 FGla~~~~~~~~---~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 238 (620)
||++........ ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+.....+ .
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~ 232 (288)
T 3kfa_A 155 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-E 232 (288)
T ss_dssp CCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-C
T ss_pred CccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-C
Confidence 999976554332 2345788999999876 458999999999999999999 9999976 4556666666665443 3
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 239 LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 239 ~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+...++.+++||.+||. +|.+||++.++++
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 445678999999999998 8999999999876
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=350.31 Aligned_cols=255 Identities=21% Similarity=0.352 Sum_probs=204.0
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~---tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
..+..+.|++.+.||+|+||+||+|.+.. ++..||+|.++... ......+.+.+|+.+++.++||||+++++++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN--SSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc--cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 44567789999999999999999998765 67799999987543 24556678999999999999999999999987
Q ss_pred cCCCC---eEEEEEeccCCCCHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCC
Q 007055 86 DDTNR---TINMITELFTSGSLRQYRK------KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 156 (620)
Q Consensus 86 ~~~~~---~l~lV~Ey~~gGsL~~~i~------~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 156 (620)
+.... ..++||||+.+|+|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR-DD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC-TT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CC
Confidence 65433 4689999999999999984 3356999999999999999999999999 99999999999998 78
Q ss_pred CcEEEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHH
Q 007055 157 GEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 230 (620)
Q Consensus 157 G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i 230 (620)
|.+||+|||++...... ......+++.|+|||++.+ .++.++||||||+++|+|++ |..||... ....+...+
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~ 262 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHEMYDYL 262 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHH
Confidence 99999999999655332 1233467889999998764 58999999999999999999 88999764 455566666
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 231 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 231 ~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..+..+ ..+...++.++++|.+||. +|.+||++.+++.+
T Consensus 263 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 263 LHGHRL-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HTTCCC-CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HcCCCC-CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 665443 3445677899999999998 89999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=350.65 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=192.0
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEc
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD 86 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~ 86 (620)
.+.+.+..|++.++||+|+||+||+|.+..+|+.||+|.+... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 3456677899999999999999999999999999999998543 3455677899999999996 9999999998853
Q ss_pred ------CCCCeEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC
Q 007055 87 ------DTNRTINMITELFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 157 (620)
Q Consensus 87 ------~~~~~l~lV~Ey~~gGsL~~~i~~---~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G 157 (620)
.....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+++++|+||||||+|||++ .+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~ 175 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQG 175 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTS
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-CCC
Confidence 33456899999996 799888765 5679999999999999999999999988899999999999998 788
Q ss_pred cEEEccccchhhccCCC--------------CccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCC
Q 007055 158 EVKIGDLGLAIVMQQPT--------------ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNE 219 (620)
Q Consensus 158 ~vKI~DFGla~~~~~~~--------------~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~ 219 (620)
.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999997554321 11456899999999873 3488999999999999999999999975
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 007055 220 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 271 (620)
Q Consensus 220 ~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hp 271 (620)
.... . +..+..........++.+++||.+||+ +|.+||++.|+++|-
T Consensus 256 ~~~~-~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 256 GAKL-R----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hhHH-H----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 3221 1 122222223344556789999999998 899999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=344.93 Aligned_cols=249 Identities=16% Similarity=0.230 Sum_probs=205.0
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 88 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~ 88 (620)
...+..|++.+.||+|+||+||+|.+..+|+.||+|++..... .+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~- 78 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG- 78 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCC-
Confidence 3456778999999999999999999999999999999864432 13477899999999 899999999987544
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc-----EEEc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIG 162 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~-----vKI~ 162 (620)
...++||||+ +|+|.+++...+ ++++..+..++.||+.||.|||+++ |+||||||+|||++ .+|. +||+
T Consensus 79 -~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~~~~~~kl~ 153 (298)
T 1csn_A 79 -LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIG-RPNSKNANMIYVV 153 (298)
T ss_dssp -TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-CSSSTTTTCEEEC
T ss_pred -ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-cCCCCCCCeEEEE
Confidence 5789999999 999999998754 5999999999999999999999999 99999999999997 4554 9999
Q ss_pred cccchhhccCCC---------CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCC--CHHHHHHHH
Q 007055 163 DLGLAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKV 230 (620)
Q Consensus 163 DFGla~~~~~~~---------~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~--~~~~i~~~i 230 (620)
|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. .....+..+
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 999997554321 245679999999998764 58999999999999999999999997643 334444444
Q ss_pred HcCCC---CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 231 TSGIK---PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 231 ~~~~~---p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..... ...+....++.++++|.+||. +|.+||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 234 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 33211 112234567899999999997 99999999998763
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=349.72 Aligned_cols=250 Identities=20% Similarity=0.239 Sum_probs=203.1
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
-..|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+.+|+.+++.++||||+++++++... ..+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 109 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID--GQL 109 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC--CeE
Confidence 3457999999999999999999999999999999875432 3345567899999999999999999999998664 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVS-ADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSCCC------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEc-CCCCEEEecCccCccccc
Confidence 999999999999999998889999999999999999999999999 99999999999998 789999999999865543
Q ss_pred CC---CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHHH
Q 007055 173 PT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQV 247 (620)
Q Consensus 173 ~~---~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~~~~l 247 (620)
.. .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||... +...+...+..... +.......++.+
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-HHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-hHHHHHHHhccCCCCccccCCCCCHHH
Confidence 32 234579999999998764 5889999999999999999999999763 34444445544333 234456678899
Q ss_pred HHHHHHhcC-CCCCCC-CHHHHhc
Q 007055 248 KQFIEKCIV-PASLRL-PALELLK 269 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rp-sa~elL~ 269 (620)
+++|.+||. +|.+|| ++.+++.
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHhccCCHHHHHHhHHHHHH
Confidence 999999998 899999 7877765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=345.47 Aligned_cols=247 Identities=30% Similarity=0.455 Sum_probs=196.5
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCcceEEeEEEcC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDD 87 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpNIVkl~~~f~~~ 87 (620)
....+.|++.+.||+|+||+||+|.+ +|+.||+|++... ....+.+|.+++.. ++||||+++++++...
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 34566779999999999999999987 6999999998643 22445667777766 7999999999987653
Q ss_pred --CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCEEecCCCccceEecCCCC
Q 007055 88 --TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNG 157 (620)
Q Consensus 88 --~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLH--------s~~~~IiHrDLKp~NILl~~~~G 157 (620)
....+++||||+++|+|.++++. ..+++..+..++.||+.||.||| +++ |+||||||+|||++ .++
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~-~~~ 150 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVK-KNG 150 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEEC-TTS
T ss_pred cCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEc-CCC
Confidence 23568999999999999999964 56999999999999999999999 777 99999999999998 789
Q ss_pred cEEEccccchhhccCCC------CccccCCCCCCCcccccc-------ccCccchhhhhHHHHHHHHhc----------C
Q 007055 158 EVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTC----------E 214 (620)
Q Consensus 158 ~vKI~DFGla~~~~~~~------~~~~~GTp~y~APEll~~-------~y~~~~DIwSlGiilyELltG----------~ 214 (620)
.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|||+|| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999999986544322 234589999999998764 355799999999999999999 8
Q ss_pred CCCCCCC----CHHHHHHHHHcCCCCCCCCC-----CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 215 YPYNECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 215 ~Pf~~~~----~~~~i~~~i~~~~~p~~~~~-----~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.||.... ....+...+........++. ..++.+.+||.+||+ +|.+|||+.++++
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 8886532 22333333333222222221 234789999999998 8999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=351.12 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=213.3
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCe-----EEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGI-----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 81 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~-----~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~ 81 (620)
.|.+....|++.+.||+|+||+||+|.+..+|. .||+|.++... .....+.+.+|+.+++.+ +||||++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 355667789999999999999999999987664 89999986432 345667899999999999 899999999
Q ss_pred eEEEcCCCCeEEEEEeccCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCc
Q 007055 82 NSWVDDTNRTINMITELFTSGSLRQYRKKH--------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 147 (620)
Q Consensus 82 ~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~--------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp 147 (620)
+++... ..+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||
T Consensus 117 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp 192 (333)
T 2i1m_A 117 GACTHG--GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAA 192 (333)
T ss_dssp EEECSS--SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred EEEecC--CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCccc
Confidence 988654 4588999999999999998753 45899999999999999999999999 99999999
Q ss_pred cceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCC
Q 007055 148 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECK 221 (620)
Q Consensus 148 ~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~ 221 (620)
+|||++ .++.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+..
T Consensus 193 ~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 193 RNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGCEEE-GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ceEEEC-CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 999998 78899999999997553322 22345788999999876 458999999999999999999 999998866
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 222 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 222 ~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
........+..+..+ ..+...++.+.++|.+||. +|.+|||+.+++++
T Consensus 272 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 272 VNSKFYKLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp SSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 666666666555433 3445568899999999998 89999999999873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=343.22 Aligned_cols=252 Identities=24% Similarity=0.414 Sum_probs=207.8
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~---tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
.+.+....|++.+.||+|+||+||+|.+.. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 456777889999999999999999998654 45679999986432 355677899999999999999999999987
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
.+. ..++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|
T Consensus 83 ~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~D 156 (281)
T 3cc6_A 83 EEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVA-SPECVKLGD 156 (281)
T ss_dssp CSS---SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-ETTEEEECC
T ss_pred cCC---CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEC-CCCcEEeCc
Confidence 432 3578999999999999997654 5999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCC
Q 007055 164 LGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 238 (620)
Q Consensus 164 FGla~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 238 (620)
||++....... .....+|+.|+|||++. ..++.++||||||+++|+|+| |+.||.... .......+..+..+ .
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-~~~~~~~~~~~~~~-~ 234 (281)
T 3cc6_A 157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-NKDVIGVLEKGDRL-P 234 (281)
T ss_dssp CCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-GGGHHHHHHHTCCC-C
T ss_pred cCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-hHHHHHHHhcCCCC-C
Confidence 99997554332 23446788999999886 458999999999999999998 999997643 33444555544333 2
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 239 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 239 ~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+...++.++++|.+||. +|.+||++.|++.+
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 445678999999999998 89999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=342.10 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=208.4
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg---~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
.-.|++.++||+|+||+||+|.+..++ ..||+|.+... ......+.+.+|+.+++.++||||+++++++.+..
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 95 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE- 95 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-
Confidence 335678899999999999999976554 48999988642 34556788999999999999999999999986554
Q ss_pred CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 90 RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
...++|+||+.+|+|.+++.. ...+++..+..|+.||+.||.|||+++ ++||||||+|||++ .+|.+||+|||++.
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLD-ESFTVKVADFGLAR 172 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECCTTSSC
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEeCcCCCcc
Confidence 345789999999999999987 456899999999999999999999999 99999999999998 78999999999996
Q ss_pred hccC------CCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 169 VMQQ------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 169 ~~~~------~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
.... .......||+.|+|||.+.+ .++.++||||||+++|+|++|..|+....+...+...+..+..+ ..+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 251 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQPE 251 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CCCT
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CCCc
Confidence 4432 22334578899999998865 58999999999999999999766665656777777777666443 3455
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..++.++++|.+||. +|.+|||+.++++.
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 678899999999998 89999999998863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.70 Aligned_cols=248 Identities=19% Similarity=0.352 Sum_probs=207.4
Q ss_pred CceEEEEEEEceeCCeEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~--~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
++|+.+.+.||+|+||+||+|.+. .++..||+|.++.. ......+.+.+|+.+++.++||||+++++++.. .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---E 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---S
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---C
Confidence 445444459999999999999864 57899999998753 245667889999999999999999999998832 3
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 91 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
.+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEc-CCCCEEECcccceee
Confidence 488999999999999999754 56999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCCC-----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 007055 170 MQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 170 ~~~~~-----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
..... .....||+.|+|||++. ..++.++||||||+++|+|+| |+.||... ....+...+..+..+ ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~ 237 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPE 237 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCC-CCCTT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHhcCCcC-CCCCC
Confidence 54321 22345789999999886 468999999999999999998 99999874 445566666665443 34566
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALELLKDP 271 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~elL~hp 271 (620)
.++.++++|.+||. +|.+||++.+++++.
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 78999999999998 899999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=350.88 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=207.8
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEE--EEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEV--AWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 87 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~V--AiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~ 87 (620)
+.-..|++.+.||+|+||.||+|.+..+|..+ |+|.++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 44456799999999999999999999999866 999886422 234556789999999999 999999999998654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceE
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 151 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NIL 151 (620)
..+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 99 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl 174 (327)
T 1fvr_A 99 --GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNIL 174 (327)
T ss_dssp --TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred --CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEE
Confidence 46899999999999999998764 6999999999999999999999999 999999999999
Q ss_pred ecCCCCcEEEccccchhhccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHH
Q 007055 152 VNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 228 (620)
Q Consensus 152 l~~~~G~vKI~DFGla~~~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~ 228 (620)
++ .+|.+||+|||++...... ......+|+.|+|||++.+ .++.++|||||||++|+|+| |..||.+ .+...+..
T Consensus 175 ~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~ 252 (327)
T 1fvr_A 175 VG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYE 252 (327)
T ss_dssp EC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHH
T ss_pred Ec-CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-CcHHHHHH
Confidence 98 7889999999998643322 2234467899999998864 58999999999999999998 9999976 56667777
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 229 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 229 ~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+..+..+. .+...++.++++|.+||. +|.+||++.+++++
T Consensus 253 ~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 253 KLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HGGGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777664433 344568899999999998 89999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=354.60 Aligned_cols=252 Identities=22% Similarity=0.381 Sum_probs=205.9
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeE----EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIE----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~----VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
...+....|++.+.||+|+||+||+|.+..+|.. ||+|.+..... ......+.+|+.+++.++||||++++++
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 83 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG---RQSFQAVTDHMLAIGSLDHAHIVRLLGL 83 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS---CSCBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc---HHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 3445667889999999999999999999888875 77776643221 1223446789999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
+.+ ..+++|+||+.+|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+
T Consensus 84 ~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~ 157 (325)
T 3kex_A 84 CPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVA 157 (325)
T ss_dssp ECB---SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEES-SSSCEEEC
T ss_pred EcC---CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEEC-CCCeEEEC
Confidence 742 3488999999999999999875 57999999999999999999999999 99999999999998 78999999
Q ss_pred cccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 007055 163 DLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 236 (620)
Q Consensus 163 DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p 236 (620)
|||++....... .....||+.|+|||++. +.++.++|||||||++|+|+| |..||.+. ....+...+..+..+
T Consensus 158 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~ 236 (325)
T 3kex_A 158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKGERL 236 (325)
T ss_dssp SCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHHHHTTCBC
T ss_pred CCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC
Confidence 999997654332 23456788999999886 569999999999999999999 99999874 445555566655333
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..+...++.+.++|.+||. +|.+||++.+++++
T Consensus 237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 237 -AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3344567789999999998 99999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=366.10 Aligned_cols=246 Identities=23% Similarity=0.426 Sum_probs=207.7
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+....|++.+.||+|+||.||+|.+. |..||+|.++... ..+.+.+|+.+|++++||||+++++++....
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 5566778999999999999999999874 8899999987432 2356889999999999999999999876543
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++||||+.+|+|.+++...+. +++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 260 -~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~ 335 (450)
T 1k9a_A 260 -GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGL 335 (450)
T ss_dssp -SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTSCEEECCCTT
T ss_pred -CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEC-CCCCEEEeeCCC
Confidence 468999999999999999987654 799999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 167 AIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 167 a~~~~~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
+...... .....+|+.|+|||++. ..++.++|||||||++|||+| |+.||.+. +..++...+..+..+ ..+...+
T Consensus 336 a~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~-~~p~~~~ 412 (450)
T 1k9a_A 336 TKEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCP 412 (450)
T ss_dssp CEECC-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-CTTTHHHHHHTTCCC-CCCTTCC
T ss_pred ccccccc-ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCC
Confidence 9754332 23346789999999876 459999999999999999998 99999874 444566667766543 3455678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+.+.++|.+||. +|.+|||+.+++.
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999998 8999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=351.54 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=211.5
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEE-----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~-----d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
+.+..+.|++.+.||+|+||.||+|. +..+|..||+|.+... ........+.+|+.+++.++||||++++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGV 101 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc---cchhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 34566778999999999999999998 6678899999998632 245566779999999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-- 154 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~-------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-- 154 (620)
+... ..+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 102 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 102 SLQS--LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPG 177 (327)
T ss_dssp ECSS--SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSS
T ss_pred EcCC--CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCC
Confidence 8654 35789999999999999998763 4899999999999999999999999 999999999999972
Q ss_pred CCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHH
Q 007055 155 NNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 228 (620)
Q Consensus 155 ~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~ 228 (620)
.++.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+| |..||.. .....+..
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~ 256 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLE 256 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHH
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHH
Confidence 3446999999999754332 223457899999999875 568999999999999999998 9999976 45666667
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 229 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 229 ~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.+..+..+ ..+...++.++++|.+||. +|.+||++.+++++.|+...
T Consensus 257 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 FVTSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 77665443 3445678899999999998 89999999999999887543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.32 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=205.6
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f 84 (620)
...+....|++.+.||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.++++++||||+++++++
T Consensus 19 ~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (298)
T 3f66_A 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 95 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred ecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence 4456677889999999999999999997543 456899987642 3456677899999999999999999999986
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 85 VDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 85 ~~~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
.... ...++||||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+||+++ .+|.+||+|
T Consensus 96 ~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~D 171 (298)
T 3f66_A 96 LRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVAD 171 (298)
T ss_dssp CCSS-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECS
T ss_pred EcCC-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEC-CCCCEEECc
Confidence 5543 4678999999999999999764 56899999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCC------CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC
Q 007055 164 LGLAIVMQQP------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 235 (620)
Q Consensus 164 FGla~~~~~~------~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~ 235 (620)
||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++ |.+||.. .+.......+..+..
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~~ 250 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRR 250 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTCC
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCCC
Confidence 9999654322 2234567889999998764 58999999999999999999 5556654 444455555555443
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 236 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 236 p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+ ..+...++.++++|.+||. +|.+||++.++++
T Consensus 251 ~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 L-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3 3345578899999999998 8999999999886
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.57 Aligned_cols=248 Identities=25% Similarity=0.418 Sum_probs=209.6
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+..+.|++.+.||+|+||+||+|.+. ++..||+|.++.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 46677788999999999999999999975 678899999864321 23568899999999999999999998743
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
..+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||
T Consensus 80 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg 154 (279)
T 1qpc_A 80 --EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFG 154 (279)
T ss_dssp --SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCT
T ss_pred --CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEc-CCCCEEECCCc
Confidence 24789999999999999987643 6999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 166 LAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 166 la~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
++....... .....+|+.|+|||++. +.++.++||||||+++|+|++ |..||.+ .+...+...+..+..+ ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~ 232 (279)
T 1qpc_A 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRP 232 (279)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCC
T ss_pred ccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCc
Confidence 997654332 23345788999999886 458999999999999999999 9999976 4556666677665443 334
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
...++.++++|.+||. +|.+|||+.++++
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 5678899999999998 8999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.41 Aligned_cols=244 Identities=28% Similarity=0.481 Sum_probs=196.9
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
.+..+.|++.+.||+|+||+||+|.+. ++.||+|.+.. ....+.+.+|+.+|++++||||+++++++.+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 72 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACLN--- 72 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT---
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---
Confidence 455677899999999999999999874 88999998853 2345678999999999999999999998642
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCEEecCCCccceEecCCCCc-EEEc
Q 007055 90 RTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHS---HNPPIIHRDLKCDNIFVNGNNGE-VKIG 162 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~---~l~e~~i~~i~~QIl~gL~yLHs---~~~~IiHrDLKp~NILl~~~~G~-vKI~ 162 (620)
.+++||||+++|+|.+++.... .+++..+..|+.||+.||.|||+ ++ |+||||||+|||++ .+|. +||+
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~~kl~ 148 (307)
T 2eva_A 73 -PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLV-AGGTVLKIC 148 (307)
T ss_dssp -TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEE-TTTTEEEEC
T ss_pred -CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEe-CCCCEEEEc
Confidence 2678999999999999998765 37899999999999999999999 66 99999999999998 5565 8999
Q ss_pred cccchhhccCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCCCCCC
Q 007055 163 DLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYKKVTSGIKPASLS 240 (620)
Q Consensus 163 DFGla~~~~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~-~~i~~~i~~~~~p~~~~ 240 (620)
|||++...... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... ..+...+..+..+ ...
T Consensus 149 Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 226 (307)
T 2eva_A 149 DFGTACDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLI 226 (307)
T ss_dssp CCCC-------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCB
T ss_pred ccccccccccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-Ccc
Confidence 99999655432 234569999999998865 5899999999999999999999999764433 3344444444333 344
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
...++.++++|.+||. +|.+|||+.+++++
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 5678899999999998 89999999999873
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=352.25 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=202.2
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEE----EEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~V----AiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
+....|++.++||+|+||+||+|.+..+|..| |+|.+.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 45567899999999999999999998888765 566554222 23345678899999999999999999999875
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
.. .++|++|+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 89 ~~---~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kL~DfG 162 (327)
T 3lzb_A 89 ST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFG 162 (327)
T ss_dssp SS---EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTT
T ss_pred CC---ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEc-CCCCEEEccCc
Confidence 43 77899999999999999874 56999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCCC----CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 007055 166 LAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASL 239 (620)
Q Consensus 166 la~~~~~~~----~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~ 239 (620)
++....... .....||+.|+|||++.+ .|+.++|||||||++|+|++ |..||.+ .....+...+..+..+ ..
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~ 240 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQ 240 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CC
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CC
Confidence 997654321 223457889999998764 58999999999999999999 9999976 4555566666655433 34
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+...++.+.++|.+||. +|.+||++.|+++.
T Consensus 241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 241 PPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55678899999999998 89999999999873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=341.16 Aligned_cols=247 Identities=23% Similarity=0.424 Sum_probs=202.3
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+..+.|++.+.||+|+||+||+|.+ +|..||+|.++.. ...+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 4567778899999999999999999977 4899999998643 2346788999999999999999999987554
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
. ..+++||||+++|+|.+++...+. +++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||
T Consensus 87 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg 162 (278)
T 1byg_A 87 K-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFG 162 (278)
T ss_dssp ---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCC
T ss_pred C-CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEe-CCCcEEEeecc
Confidence 3 468899999999999999987643 899999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 007055 166 LAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243 (620)
Q Consensus 166 la~~~~~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~ 243 (620)
++...... .....+|+.|+|||++. ..++.++||||||+++|+|+| |..||... +...+...+..+..+ ..+...
T Consensus 163 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 239 (278)
T 1byg_A 163 LTKEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGC 239 (278)
T ss_dssp C-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTTCCC-CCCTTC
T ss_pred cccccccc-ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCCC-CCcccC
Confidence 98654433 23446789999999876 458999999999999999998 99999764 455566666665433 345567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
++.++++|.+||. +|.+||++.++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 8999999999998 8999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=346.90 Aligned_cols=254 Identities=23% Similarity=0.397 Sum_probs=207.4
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEe
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 82 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg----~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~ 82 (620)
+.+.+....|++.+.||+|+||+||+|.+..++ ..||+|.++.. ........+.+|+.+++.++||||+++++
T Consensus 37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 345677788899999999999999999987653 56999998643 23456677999999999999999999999
Q ss_pred EEEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEE
Q 007055 83 SWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 161 (620)
Q Consensus 83 ~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI 161 (620)
++... ..+++||||+.+|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||
T Consensus 114 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl 188 (333)
T 1mqb_A 114 VISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKV 188 (333)
T ss_dssp EECSS--SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEE
T ss_pred EEecC--CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEEC-CCCcEEE
Confidence 87543 5689999999999999999765 57999999999999999999999999 99999999999998 7899999
Q ss_pred ccccchhhccCCC-----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCC
Q 007055 162 GDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 234 (620)
Q Consensus 162 ~DFGla~~~~~~~-----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~ 234 (620)
+|||++....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .....+...+..+.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~ 267 (333)
T 1mqb_A 189 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGF 267 (333)
T ss_dssp CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTC
T ss_pred CCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHCCC
Confidence 9999997654321 12235688999999876 458999999999999999999 9999976 45666777777664
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 235 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 235 ~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+. .+...++.++++|.+||+ +|.+||++.+++++
T Consensus 268 ~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 268 RLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 433 344678899999999998 89999999998874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=359.20 Aligned_cols=251 Identities=23% Similarity=0.394 Sum_probs=200.7
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
..+....|++.+.||+|+||.||+|.+. .++..||+|.++.. ......+.+.+|+.+|++++||||+++++++.
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG---YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc---cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3455567899999999999999999887 56788999998643 24556678999999999999999999999885
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
+. ..+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+||
T Consensus 117 ~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Df 191 (373)
T 2qol_A 117 KS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDF 191 (373)
T ss_dssp SS--SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC
T ss_pred eC--CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEc-CCCCEEECcC
Confidence 54 46889999999999999998764 6999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCCC-----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 007055 165 GLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 237 (620)
Q Consensus 165 Gla~~~~~~~-----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~ 237 (620)
|++....... .....+|+.|+|||++. ..++.++|||||||++|||++ |+.||.+ .....+...+..+..++
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~~~~~ 270 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEGYRLP 270 (373)
T ss_dssp ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTTEECC
T ss_pred ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC
Confidence 9997654321 12234578899999876 459999999999999999998 9999977 45666666776654332
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 238 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 238 ~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+...+..+.++|.+||+ +|.+||++.++++
T Consensus 271 -~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 -PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 344578899999999998 8999999999876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=341.57 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=203.2
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEcc-CC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEV-DG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~-tg--~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
....+..+.|++.+.||+|+||+||+|.+.. ++ ..||+|.++.... ......+.+.+|+.+++.++||||++++++
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 3455667789999999999999999998643 33 4799998875432 234566789999999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
+.... .++|+||+.+|+|.+++... +.+++..+..++.||+.||.|||+++ ++||||||+|||++ .+|.+||+
T Consensus 90 ~~~~~---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~ 163 (291)
T 1u46_A 90 VLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIG 163 (291)
T ss_dssp ECSSS---CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEEC
T ss_pred EccCC---ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEc-CCCCEEEc
Confidence 86543 78899999999999998764 56999999999999999999999999 99999999999998 78899999
Q ss_pred cccchhhccCCC-----CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC
Q 007055 163 DLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 235 (620)
Q Consensus 163 DFGla~~~~~~~-----~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~ 235 (620)
|||++....... .....+|+.|+|||++.+ .++.++||||||+++|+|++ |+.||.+ .+...+...+.....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~ 242 (291)
T 1u46_A 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGE 242 (291)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCC
T ss_pred cccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCC
Confidence 999986554322 223467889999998764 58999999999999999999 9999977 456666666665544
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 236 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 236 p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
....+...++.++++|.+||. +|.+||++.++++
T Consensus 243 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 445556778999999999998 8999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=357.78 Aligned_cols=258 Identities=18% Similarity=0.229 Sum_probs=199.3
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEcc---CCeEEEEEEeecccccCCHH-------HHHHHHHHHHHHHhCCCCC
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPD-------QLERLYSEVHLLKSLKHEN 76 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~---tg~~VAiK~v~~~~~~~~~~-------~~~~l~~Ei~iL~~L~HpN 76 (620)
+...+.+..|++.+.||+|+||+||+|.+.. ++..||+|.+.........+ ....+.+|+..++.++|||
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 30 VLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp EEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred eeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 3445667789999999999999999999987 88999999987542100000 1123667889999999999
Q ss_pred cceEEeEEEcC--CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC
Q 007055 77 IIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 154 (620)
Q Consensus 77 IVkl~~~f~~~--~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 154 (620)
|+++++++... ....+++||||+ +|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~- 185 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLG- 185 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEc-
Confidence 99999998763 246899999999 9999999998889999999999999999999999999 99999999999998
Q ss_pred CCC--cEEEccccchhhccCC---------CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCC-C
Q 007055 155 NNG--EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC-K 221 (620)
Q Consensus 155 ~~G--~vKI~DFGla~~~~~~---------~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~-~ 221 (620)
.++ .+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||... .
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 555 9999999999654321 1134579999999998875 4899999999999999999999999543 2
Q ss_pred CHHHHHHH---HHcCCCCCC-----CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 222 NPAQIYKK---VTSGIKPAS-----LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 222 ~~~~i~~~---i~~~~~p~~-----~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+....... ..... |.. .....++.++++|.+||. +|.+||++.++++
T Consensus 266 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 266 DPVAVQTAKTNLLDEL-PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp CHHHHHHHHHHHHHTT-THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHHHHHhhcccc-cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 33222211 11111 110 112567899999999998 9999999999886
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=338.33 Aligned_cols=248 Identities=21% Similarity=0.265 Sum_probs=200.9
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.+..|++.+.||+|+||.||+|.+..+|+.||+|++..... .+.+.+|+.+++.++|++++..+..+... ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~ 79 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDY 79 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCC-CCc
Confidence 34567999999999999999999999999999999875432 12478899999999999988877665443 457
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec--CCCCcEEEccccchh
Q 007055 92 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAI 168 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~G~vKI~DFGla~ 168 (620)
.++||||+ +|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++ ..++.+||+|||++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 89999999 9999999974 457999999999999999999999999 99999999999994 267899999999997
Q ss_pred hccCCC---------CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcC---
Q 007055 169 VMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSG--- 233 (620)
Q Consensus 169 ~~~~~~---------~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~--~~i~~~i~~~--- 233 (620)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.... .+.+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 554332 245689999999998765 5899999999999999999999999764321 1222222211
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 234 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 234 ~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.....+....++.+.++|.+||+ +|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11111234567899999999998 9999999999876
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=363.17 Aligned_cols=248 Identities=23% Similarity=0.405 Sum_probs=210.0
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+....|++.+.||+|+||+||+|.+. ++..||+|.++... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-- 253 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-- 253 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--
Confidence 45667778999999999999999999885 57889999987533 12467899999999999999999999874
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 254 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG 329 (454)
T 1qcf_A 254 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFG 329 (454)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTCCEEECSTT
T ss_pred -CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEC-CCCcEEEeeCC
Confidence 23578999999999999999754 36899999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCC---CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 166 LAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 166 la~~~~~~---~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
+++..... ......+|+.|+|||++. +.++.++|||||||++|||+| |+.||.+ .+..++...+..+..++ .+
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~ 407 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRMP-RP 407 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCCCC-CC
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CC
Confidence 99765432 122345678999999886 569999999999999999999 9999987 45666667777665433 34
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
...++.+.++|.+||. +|.+|||+.+++.
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 5678899999999998 8999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=368.73 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=212.9
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+....|++.+.||+|+||.||+|.+..++..||+|.++... ...+.+.+|+.+|++++||||+++++++...
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 35566677999999999999999999999999999999987432 1246689999999999999999999988654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 289 --~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG 363 (495)
T 1opk_A 289 --PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG-ENHLVKVADFG 363 (495)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTT
T ss_pred --CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEC-CCCcEEEeecc
Confidence 4588999999999999999864 45899999999999999999999999 99999999999997 78999999999
Q ss_pred chhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 166 LAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 166 la~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
+++...... .....+|+.|+|||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..+..+ ..+
T Consensus 364 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~ 441 (495)
T 1opk_A 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERP 441 (495)
T ss_dssp CEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCC
T ss_pred cceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCC
Confidence 997654332 22345678999999876 469999999999999999999 9999977 4555666777665443 344
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
...++.+++||.+||+ +|.+|||+.++++
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 5678999999999998 8999999999976
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=345.70 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=206.7
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 83 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~ 83 (620)
...+..+.|++.+.||+|+||.||+|. +..+|+.||+|++... .....+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 345667789999999999999999998 5678999999998643 34566789999999999999999999999
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 84 WVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
+.......+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kL~ 187 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIG 187 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEEC
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEc-CCCcEEEe
Confidence 8766656789999999999999999876 45999999999999999999999999 99999999999998 78999999
Q ss_pred cccchhhccCCC-----CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCH-------------
Q 007055 163 DLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP------------- 223 (620)
Q Consensus 163 DFGla~~~~~~~-----~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~------------- 223 (620)
|||++....... .....+|+.|+|||++.+ .++.++||||||+++|+|+||..||......
T Consensus 188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267 (326)
T ss_dssp CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred cCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence 999997654332 223457788999998764 5899999999999999999999998531100
Q ss_pred --HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 224 --AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 224 --~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+...+..+..+ ..+...++.+.++|.+||. +|.+||++.++++
T Consensus 268 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 268 IVFHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122333333222 3455678999999999998 8999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=344.19 Aligned_cols=258 Identities=27% Similarity=0.367 Sum_probs=195.3
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHH--HHHHHHHhCCCCCcceEEeEE
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLY--SEVHLLKSLKHENIIKFYNSW 84 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~--~Ei~iL~~L~HpNIVkl~~~f 84 (620)
..+.+.-..|++.+.||+|+||+||+|.+ +|+.||+|++.... ...+. .|+..+..++||||+++++.+
T Consensus 6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 76 (336)
T 3g2f_A 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGD 76 (336)
T ss_dssp ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheecc
Confidence 34566777889999999999999999966 78999999987432 12233 344445568999999999755
Q ss_pred E---cCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCEEecCCCccceEe
Q 007055 85 V---DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH---------NPPIIHRDLKCDNIFV 152 (620)
Q Consensus 85 ~---~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~---------~~~IiHrDLKp~NILl 152 (620)
. ......+++||||+++|+|.+++...+ .++..+..++.||+.||.|||++ + |+||||||+|||+
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill 153 (336)
T 3g2f_A 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLV 153 (336)
T ss_dssp EEECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEE
T ss_pred cccccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEE
Confidence 3 233457889999999999999997755 58999999999999999999999 7 9999999999999
Q ss_pred cCCCCcEEEccccchhhccCC----------CCccccCCCCCCCcccccc--------ccCccchhhhhHHHHHHHHhcC
Q 007055 153 NGNNGEVKIGDLGLAIVMQQP----------TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVTCE 214 (620)
Q Consensus 153 ~~~~G~vKI~DFGla~~~~~~----------~~~~~~GTp~y~APEll~~--------~y~~~~DIwSlGiilyELltG~ 214 (620)
+ .+|.+||+|||++...... .....+||+.|+|||++.+ .++.++|||||||++|||++|.
T Consensus 154 ~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 154 K-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp C-TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred c-CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 8 7899999999999654321 1234579999999998864 4678999999999999999998
Q ss_pred CCCCCCCC-----------------HHHHHHHHHcCCCCCCCCCC------CcHHHHHHHHHhcC-CCCCCCCHHHH---
Q 007055 215 YPYNECKN-----------------PAQIYKKVTSGIKPASLSKV------TDPQVKQFIEKCIV-PASLRLPALEL--- 267 (620)
Q Consensus 215 ~Pf~~~~~-----------------~~~i~~~i~~~~~p~~~~~~------~~~~lk~~I~kcL~-~p~~Rpsa~el--- 267 (620)
.||..... ...+...+........++.. .++.+++||.+||. +|.+|||+.|+
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 77643221 12222223322222233322 34579999999998 99999999999
Q ss_pred ---hcCCCcCCCC
Q 007055 268 ---LKDPFLVTDN 277 (620)
Q Consensus 268 ---L~hpff~~~~ 277 (620)
+.++|-+..+
T Consensus 313 L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 313 MAELMMIWERNKS 325 (336)
T ss_dssp HHHHHHCCCC---
T ss_pred HHHHHHHHHhccc
Confidence 4567776544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=337.23 Aligned_cols=247 Identities=21% Similarity=0.266 Sum_probs=197.3
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.+..|++.+.||+|+||+||+|.+..+|+.||+|.+..... .+.+.+|+.+++.++|++++..+..+... ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~ 79 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDY 79 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCC-CCc
Confidence 34567999999999999999999999999999998764432 13477899999999999988877766543 357
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEe---cCCCCcEEEccccch
Q 007055 92 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLA 167 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl---~~~~G~vKI~DFGla 167 (620)
.++||||+ +|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||+ + .++.+||+|||++
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGK-KGNLVYIIDFGLA 155 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGG-GTTCEEECCCTTC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccC-CCCeEEEecCccc
Confidence 89999999 9999999985 457999999999999999999999999 9999999999999 5 6789999999999
Q ss_pred hhccCC---------CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCC-
Q 007055 168 IVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSGI- 234 (620)
Q Consensus 168 ~~~~~~---------~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~--~~i~~~i~~~~- 234 (620)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.... ...+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 755432 1235679999999998764 5899999999999999999999999764322 11222222111
Q ss_pred --CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 235 --KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 235 --~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.........++.++++|.+||. +|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1111224467899999999998 9999999999886
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=357.16 Aligned_cols=258 Identities=18% Similarity=0.224 Sum_probs=199.4
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccC-----CeEEEEEEeecccccCCHHH--------HHHHHHHHHHHHhCCC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQ--------LERLYSEVHLLKSLKH 74 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~t-----g~~VAiK~v~~~~~~~~~~~--------~~~l~~Ei~iL~~L~H 74 (620)
+....+..|++.+.||+|+||+||+|.+..+ ++.||+|.+...... ...+ ...+..|+..++.++|
T Consensus 29 i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h 107 (364)
T 3op5_A 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLKY 107 (364)
T ss_dssp EECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCSC
T ss_pred eeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhccC
Confidence 3445667889999999999999999998765 689999998754210 0001 0124456667788899
Q ss_pred CCcceEEeEEEcCCC--CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceE
Q 007055 75 ENIIKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 151 (620)
Q Consensus 75 pNIVkl~~~f~~~~~--~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NIL 151 (620)
|||+++++++..... ..+++||||+ +|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||
T Consensus 108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nil 184 (364)
T 3op5_A 108 LGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLL 184 (364)
T ss_dssp CCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred CCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEE
Confidence 999999999876533 5689999999 99999999876 67999999999999999999999999 999999999999
Q ss_pred ecC-CCCcEEEccccchhhccCC---------CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCC
Q 007055 152 VNG-NNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC 220 (620)
Q Consensus 152 l~~-~~G~vKI~DFGla~~~~~~---------~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~ 220 (620)
++. .++.+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|||+||+.||.+.
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 972 4689999999999654322 1234569999999998875 4999999999999999999999999853
Q ss_pred CCHHHHHHHHHcCCC--------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 221 KNPAQIYKKVTSGIK--------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 221 ~~~~~i~~~i~~~~~--------p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
............... +.......++++.+||..||. +|.+||++.++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 265 LKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 332222211111000 000123467899999999998 9999999999876
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.44 Aligned_cols=249 Identities=15% Similarity=0.238 Sum_probs=201.7
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccC--------CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcc
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVD--------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~t--------g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIV 78 (620)
++....++.|++.+.||+|+||+||+|.+..+ |+.||+|.+... +.+.+|+.+++.++||||+
T Consensus 35 ~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv 105 (352)
T 2jii_A 35 VLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQV 105 (352)
T ss_dssp EEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHH
T ss_pred eeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchh
Confidence 34455678899999999999999999999884 899999998743 2478899999999999999
Q ss_pred e---------------EEeEEEcCCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 007055 79 K---------------FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPII 141 (620)
Q Consensus 79 k---------------l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~Ii 141 (620)
+ +++++... ...+++||||+ +|+|.+++... +.+++..++.++.||+.||.|||+++ |+
T Consensus 106 ~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iv 181 (352)
T 2jii_A 106 NKWKKLYSTPLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YV 181 (352)
T ss_dssp HHHHHHTTCTTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CB
T ss_pred hhhhhhccCCccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 8 55665542 46799999999 99999999986 78999999999999999999999999 99
Q ss_pred ecCCCccceEecCCCC--cEEEccccchhhccCC---------CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHH
Q 007055 142 HRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILE 209 (620)
Q Consensus 142 HrDLKp~NILl~~~~G--~vKI~DFGla~~~~~~---------~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyE 209 (620)
||||||+|||++ .++ .+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+
T Consensus 182 H~Dikp~NIl~~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 260 (352)
T 2jii_A 182 HGNVTAENIFVD-PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK 260 (352)
T ss_dssp CSCCCGGGEEEE-TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHEEEc-CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 999999999998 676 8999999999654322 1234589999999998875 58999999999999999
Q ss_pred HHhcCCCCCCCC-CHHHHHHHHH---cCCCCC----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 210 MVTCEYPYNECK-NPAQIYKKVT---SGIKPA----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 210 LltG~~Pf~~~~-~~~~i~~~i~---~~~~p~----~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
|++|+.||.... +...+..... ....+. ......++.+++||.+||. +|.+||++.++++
T Consensus 261 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 261 WLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 999999998754 4444433322 211110 0112357899999999998 9999999999876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=342.07 Aligned_cols=246 Identities=29% Similarity=0.470 Sum_probs=193.0
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC--CCCCcceEEeEEEcCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL--KHENIIKFYNSWVDDTN 89 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L--~HpNIVkl~~~f~~~~~ 89 (620)
..+.|++.+.||+|+||.||+|.+. |+.||+|++.... .....+|.+++..+ +||||+++++++.....
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 3456799999999999999999875 9999999986332 23344555555554 99999999999877643
Q ss_pred --CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCEEecCCCccceEecCCCCcE
Q 007055 90 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH--------NPPIIHRDLKCDNIFVNGNNGEV 159 (620)
Q Consensus 90 --~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~--------~~~IiHrDLKp~NILl~~~~G~v 159 (620)
..+++||||+.+|+|.++++.. .+++..++.++.||+.||.|||++ + |+||||||+|||++ .+|.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~ 181 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK-KNGTC 181 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC-TTSCE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC-CCCCE
Confidence 5789999999999999999765 699999999999999999999998 7 99999999999998 78999
Q ss_pred EEccccchhhccCCC------CccccCCCCCCCccccccc-cCc------cchhhhhHHHHHHHHhc----------CCC
Q 007055 160 KIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-YNE------LVDIYSFGMCILEMVTC----------EYP 216 (620)
Q Consensus 160 KI~DFGla~~~~~~~------~~~~~GTp~y~APEll~~~-y~~------~~DIwSlGiilyELltG----------~~P 216 (620)
||+|||++....... .....||+.|+|||++.+. +.. ++|||||||++|||+|| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999996543322 2255899999999988654 333 49999999999999999 777
Q ss_pred CCCCC----CHHHHHHHHHcCCCCCCCCC-----CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 217 YNECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 217 f~~~~----~~~~i~~~i~~~~~p~~~~~-----~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
|.... ........+........++. ..++.+.+||.+||+ +|.+|||+.++++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 75432 22233333333222222322 235679999999998 89999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=338.25 Aligned_cols=237 Identities=19% Similarity=0.320 Sum_probs=190.8
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHH-HhCCCCCcceEEeEEEc-
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVD- 86 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL-~~L~HpNIVkl~~~f~~- 86 (620)
..+.++|+.+.++||+|+||.||+|.+..+|+.||+|.++.. ..+.+|+.++ +.++||||++++++|..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 456677776669999999999999999999999999998632 2466788887 66799999999998865
Q ss_pred -CCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC--CCcEEE
Q 007055 87 -DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKI 161 (620)
Q Consensus 87 -~~~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~G~vKI 161 (620)
.....+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.. ++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEE
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEE
Confidence 33467999999999999999998764 6999999999999999999999999 9999999999999832 789999
Q ss_pred ccccchhhccCCCCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCC
Q 007055 162 GDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASL 239 (620)
Q Consensus 162 ~DFGla~~~~~~~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~ 239 (620)
+|||++.... ...|+.++|||||||++|+|+||+.||...... .....+...... ..+
T Consensus 162 ~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 162 TDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKTRIRMGQYEF 221 (299)
T ss_dssp CCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSS
T ss_pred eccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcch-hhhHHHHHHHhhccccC
Confidence 9999885322 234788999999999999999999999763221 111111111111 111
Q ss_pred C----CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 240 S----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 240 ~----~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+ ...++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 1 3468899999999998 89999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=340.98 Aligned_cols=246 Identities=23% Similarity=0.375 Sum_probs=200.0
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEEe
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~E 97 (620)
.++.||+|+||+||+|.+ ++..||+|.+............+.+.+|+.+++.++||||+++++++.+. ..+++|||
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 110 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVYV 110 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEEE
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC--CceEEEEE
Confidence 458999999999999976 68899999987543333445667899999999999999999999988654 45889999
Q ss_pred ccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 98 LFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 98 y~~gGsL~~~i~~---~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
|+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD-EAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSCS
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc-CCCcEEEeeccccccccccc
Confidence 9999999999874 356999999999999999999999999 99999999999998 78999999999986544321
Q ss_pred ----CccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCC---------CCC
Q 007055 175 ----ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIK---------PAS 238 (620)
Q Consensus 175 ----~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~---~i~~~i~~~~~---------p~~ 238 (620)
.....||+.|+|||++.+.++.++||||||+++|+|++|..||....... .+...+..... ...
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 23457999999999998889999999999999999999999997644322 22222222111 111
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 239 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 239 ~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+...+..+.++|.+||. +|.+||++.+++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 122235678999999998 89999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=358.60 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=191.7
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 89 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~ 89 (620)
..+++|.+.++||+|+||+||.+ ...+|+.||+|++.... .+.+.+|+.+|+.+ +||||+++++++.+.
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-- 81 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSETTD-- 81 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECS--
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecC--
Confidence 45667788999999999999875 46689999999986432 24578899999876 899999999987544
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--------
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVD-------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-------- 154 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~-------e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-------- 154 (620)
..+++|||||. |+|.+++...+... +..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccccc
Confidence 57999999996 69999998765432 2345689999999999999999 999999999999973
Q ss_pred ----CCCcEEEccccchhhccCCC------CccccCCCCCCCcccccc--------ccCccchhhhhHHHHHHHHh-cCC
Q 007055 155 ----NNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEY 215 (620)
Q Consensus 155 ----~~G~vKI~DFGla~~~~~~~------~~~~~GTp~y~APEll~~--------~y~~~~DIwSlGiilyELlt-G~~ 215 (620)
.++.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|||+| |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 23589999999997654321 234579999999998753 48899999999999999999 999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCC----CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 216 PYNECKNPAQIYKKVTSGIKPASLSK----VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 216 Pf~~~~~~~~i~~~i~~~~~p~~~~~----~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
||.+..... ...+........... ..++++++||.+||+ +|.+|||+.++|+||||..
T Consensus 239 Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 239 PFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 997643332 122222222222221 134789999999998 8999999999999999965
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=352.32 Aligned_cols=244 Identities=21% Similarity=0.299 Sum_probs=193.1
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEE-----EEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCcce
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIK 79 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a-----~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpNIVk 79 (620)
.+...++.|++.+.||+|+||+||+| .+..+++.||+|+++... ...+.+|+.+++.++ |+||++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 44566788999999999999999999 578899999999986431 235777888888886 999999
Q ss_pred EEeEEEcCCCCeEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC
Q 007055 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKK-----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 154 (620)
Q Consensus 80 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~-----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 154 (620)
+++++.... ..++||||+.+|+|.+++.. .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 132 ~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~- 206 (365)
T 3e7e_A 132 FYSAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILG- 206 (365)
T ss_dssp EEEEEECSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-
T ss_pred hheeeecCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEec-
Confidence 999987654 57899999999999999974 457999999999999999999999999 99999999999997
Q ss_pred C-----------CCcEEEccccchhhcc----CCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCC
Q 007055 155 N-----------NGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYN 218 (620)
Q Consensus 155 ~-----------~G~vKI~DFGla~~~~----~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~ 218 (620)
. ++.+||+|||++.... .......+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 5 7899999999996543 223345689999999998865 48999999999999999999999996
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 219 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 219 ~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
....... . ..........++.+.+++..||. +|.+|++..+.|.+
T Consensus 287 ~~~~~~~------~-~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 287 KNEGGEC------K-PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp EEETTEE------E-ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred cCCCCce------e-echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 4321100 0 00000011236789999999998 78888765554443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=361.24 Aligned_cols=254 Identities=26% Similarity=0.314 Sum_probs=195.6
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 87 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~ 87 (620)
+.+.+..|++.++||+|+||+||. ....+|+.||||++..... ..+.+|+.+|+.+ +|||||++++++.+.
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 445566789999999999999764 4467899999999864332 1256799999999 899999999988654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCC--C--CcEEEc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--N--GEVKIG 162 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~--G~vKI~ 162 (620)
..+|+|||||. |+|.+++.... .+.+..+..++.||+.||.|||+++ |+||||||+|||++.. + ..+||+
T Consensus 91 --~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 91 --QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp --TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred --CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 57899999996 59999998654 4666677899999999999999999 9999999999999521 2 357899
Q ss_pred cccchhhccCC-----CCccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHc
Q 007055 163 DLGLAIVMQQP-----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 232 (620)
Q Consensus 163 DFGla~~~~~~-----~~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~ 232 (620)
|||++...... .....+||+.|+|||++. ..++.++|||||||++|+|+| |..||.... ..+. ..+..
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-~~~~-~~~~~ 243 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-QRQA-NILLG 243 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-THHH-HHHTT
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-HHHH-HHHhc
Confidence 99999755422 234567999999999885 347789999999999999999 999996532 2222 22222
Q ss_pred CCCCC--CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 233 GIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 233 ~~~p~--~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
..... ......++.+++||.+||+ +|.+|||+.++|+||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 21211 1122345678999999998 999999999999999997643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=352.76 Aligned_cols=250 Identities=23% Similarity=0.353 Sum_probs=199.5
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
....|++.+.||+|+||+||+|.+. +|..||+|.+... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 109 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDER--NE 109 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT--TC
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--Ce
Confidence 3456688999999999999999964 7899999987643 234567789999999999999999999987544 46
Q ss_pred EEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 92 INMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~----~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLD-ENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEEC-TTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEEC-CCCCEEEeecccc
Confidence 889999999999999987543 5899999999999999999999999 99999999999998 7899999999998
Q ss_pred hhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHH-----HH-HHHHHcCCC-
Q 007055 168 IVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA-----QI-YKKVTSGIK- 235 (620)
Q Consensus 168 ~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~-----~i-~~~i~~~~~- 235 (620)
...... ......||+.|+|||++. +.++.++|||||||++|+|+||+.||....... .. ......+..
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 654322 223456899999999875 569999999999999999999999997532211 11 111111111
Q ss_pred ----CC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 007055 236 ----PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 271 (620)
Q Consensus 236 ----p~---~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hp 271 (620)
+. ......+..+.+++.+||. +|.+|||+.|++++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11 1112235678999999998 899999999999763
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.24 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=201.1
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCcceEEeEEEcCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpNIVkl~~~f~~~~~ 89 (620)
..+.|++.+.||+|+||+||+|.+ +|+.||+|.++.. ....+.+|+++++. ++||||+++++++.....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 346779999999999999999987 5999999998632 23457789998887 799999999999876543
Q ss_pred --CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCEEecCCCccceEecCCCCcE
Q 007055 90 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNGEV 159 (620)
Q Consensus 90 --~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLH--------s~~~~IiHrDLKp~NILl~~~~G~v 159 (620)
..+++||||+.+|+|.+++.+. ++++..++.++.||+.||.||| +++ |+||||||+|||++ .+|.+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~-~~~~~ 186 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTC 186 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEEC-TTSCE
T ss_pred ccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEEC-CCCCE
Confidence 2689999999999999999864 6999999999999999999999 777 99999999999998 78999
Q ss_pred EEccccchhhccCCC------CccccCCCCCCCccccccc-------cCccchhhhhHHHHHHHHhc----------CCC
Q 007055 160 KIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTC----------EYP 216 (620)
Q Consensus 160 KI~DFGla~~~~~~~------~~~~~GTp~y~APEll~~~-------y~~~~DIwSlGiilyELltG----------~~P 216 (620)
||+|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|+|| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999996554332 3455799999999988653 34789999999999999999 789
Q ss_pred CCCCC----CHHHHHHHHHcCCCCCCCCC-----CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 217 YNECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 217 f~~~~----~~~~i~~~i~~~~~p~~~~~-----~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
|.... ....+...+........++. ..++.++++|.+||. +|.+|||+.++++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 86532 33455555544433333332 224578999999998 99999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.58 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=197.4
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
.....|++.+.||+|+||+||+|.+ .+|..||+|++...... .....+.+|+.+++.++||||+++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 100 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-- 100 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS--
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEEEEecCC--
Confidence 4456678999999999999999975 46999999998754321 12235889999999999999999999886544
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCEEecCCCccceEecCCCCcEEEcc
Q 007055 91 TINMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSH---NPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~----~l~e~~i~~i~~QIl~gL~yLHs~---~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
..++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+||+|
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~-~~~~~kl~D 177 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGD 177 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEEC-TTCCEEECC
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEEC-CCCCEEecc
Confidence 5778999999999999998653 499999999999999999999999 7 99999999999998 789999999
Q ss_pred ccchhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCC----CCHHHHHHHHHcCCC
Q 007055 164 LGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIK 235 (620)
Q Consensus 164 FGla~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~----~~~~~i~~~i~~~~~ 235 (620)
||++....... .....||+.|+|||++. ..++.++|||||||++|+|+||+.||... .........+.....
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99997654322 23456999999999875 46899999999999999999999999520 111111111111111
Q ss_pred CCC------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 007055 236 PAS------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 271 (620)
Q Consensus 236 p~~------------~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hp 271 (620)
... .....++.+.+++.+||+ +|.+|||+.|+++|-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 111 111123678999999998 899999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.10 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=208.0
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+....|++.+.||+|+||.||+|.+.. +..||+|.++.... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 456677889999999999999999999875 46799999875431 23568899999999999999999998754
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 251 --~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG 325 (452)
T 1fmk_A 251 --EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFG 325 (452)
T ss_dssp --SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCC
T ss_pred --CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEC-CCCCEEECCCc
Confidence 3578999999999999999753 56999999999999999999999999 99999999999997 78899999999
Q ss_pred chhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 166 LAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 166 la~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
++....... .....+|+.|+|||++. +.++.++|||||||++|||+| |+.||.+ ....++...+..+..++ .+
T Consensus 326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~ 403 (452)
T 1fmk_A 326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CP 403 (452)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CC
T ss_pred cceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CC
Confidence 997654322 22345678999999876 569999999999999999999 9999977 45666777777665433 34
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc--CCCcCC
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLK--DPFLVT 275 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~--hpff~~ 275 (620)
...++.+.++|.+||. +|.+|||+.+++. ..++..
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 5678899999999998 9999999999886 344443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=370.80 Aligned_cols=247 Identities=21% Similarity=0.347 Sum_probs=205.9
Q ss_pred CceEEEE-EEEceeCCeEEEEEEE--ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 13 VLFLQYD-EILGKGAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 13 ~r~y~i~-e~LG~G~fg~Vy~a~d--~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
...+.+. +.||+|+||+||+|.+ +.+++.||+|+++... ......+.+.+|+.+|+.++|||||++++++..+
T Consensus 367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-- 442 (635)
T 4fl3_A 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-- 442 (635)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 3445554 4899999999999955 5678999999987543 2334567799999999999999999999987532
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
.+++||||+.+|+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 443 -~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~-~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 443 -SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKA 518 (635)
T ss_dssp -SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCTTHHHH
T ss_pred -CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEe-CCCCEEEEEcCCccc
Confidence 37899999999999999999899999999999999999999999999 99999999999998 788999999999976
Q ss_pred ccCCC-----CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 007055 170 MQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 170 ~~~~~-----~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
..... .....||+.|+|||++.+ .|+.++|||||||++|||++ |+.||.+ .+..++...+..+..+ ..+..
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~ 596 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAG 596 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTT
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCC
Confidence 54322 223356889999998864 69999999999999999998 9999977 5666777777776543 34556
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.++++.+||.+||. +|.+||++.++++
T Consensus 597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 597 CPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 78999999999998 8999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.57 Aligned_cols=251 Identities=22% Similarity=0.386 Sum_probs=198.0
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.....|++.++||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.+++.++||||+++++++...
T Consensus 86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 3445688999999999999999987643 356899987632 2345678899999999999999999999987544
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
. ...++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 163 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DFG~ 238 (373)
T 3c1x_A 163 E-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGL 238 (373)
T ss_dssp S-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC--
T ss_pred C-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEEC-CCCCEEEeeccc
Confidence 3 4678999999999999999865 45899999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCC------CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCC
Q 007055 167 AIVMQQPT------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 238 (620)
Q Consensus 167 a~~~~~~~------~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 238 (620)
+....... .....+|+.|+|||++. ..++.++|||||||++|||+| |..||... +..++...+..+..+ .
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-~~~~~~~~~~~~~~~-~ 316 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRL-L 316 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CSSCHHHHHHTTCCC-C
T ss_pred cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-CHHHHHHHHHcCCCC-C
Confidence 97543221 22346788999999876 458999999999999999999 67777654 334444555555433 3
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 239 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 239 ~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+...++.+.++|.+||. +|.+||++.+++++
T Consensus 317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 345678899999999998 89999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=343.69 Aligned_cols=252 Identities=27% Similarity=0.462 Sum_probs=208.3
Q ss_pred eeeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 6 LVIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 6 ~~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
+-.|.+....|++.+.||+|+||+||+|.+.. .||+|.++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 34566777888999999999999999998864 499999875432 2223345778999999999999999999987
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
+.. .+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ ++||||||+|||++ +|.+||+||
T Consensus 100 ~~~--~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~--~~~~~l~Df 173 (319)
T 2y4i_B 100 SPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDF 173 (319)
T ss_dssp CSS--CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCC
T ss_pred cCC--ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe--CCCEEEeec
Confidence 654 5889999999999999998765 6999999999999999999999999 99999999999997 679999999
Q ss_pred cchhhccC-------CCCccccCCCCCCCcccccc----------ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHH
Q 007055 165 GLAIVMQQ-------PTARSVIGTPEFMAPELYEE----------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 227 (620)
Q Consensus 165 Gla~~~~~-------~~~~~~~GTp~y~APEll~~----------~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~ 227 (620)
|++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .....+.
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~ 252 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAII 252 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHH
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHH
Confidence 99764421 12234468999999998753 378899999999999999999999976 4566666
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 228 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 228 ~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
..+..+..+.......++.++++|.+||. +|.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 253 WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 77777766655555678899999999998 8999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=365.42 Aligned_cols=245 Identities=19% Similarity=0.358 Sum_probs=201.5
Q ss_pred ceEEEEE-EEceeCCeEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 14 LFLQYDE-ILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 14 r~y~i~e-~LG~G~fg~Vy~a~d~--~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
..+.+.+ .||+|+||.||+|.+. .++..||+|.++... .....+.+.+|+.+|+.++|||||++++++..+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--- 408 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--- 408 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---
Confidence 3344555 8999999999999875 467789999987542 233456799999999999999999999998642
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 91 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
.+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLV-NRHYAKISDFGLSKA 485 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCSTTTT
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEc-CCCcEEEeeccCccc
Confidence 489999999999999998754 45999999999999999999999999 99999999999998 789999999999976
Q ss_pred ccCCC-----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 007055 170 MQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 170 ~~~~~-----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
..... .....+|+.|+|||++. +.|+.++|||||||++|||+| |+.||.+. +..++...+..+..+ ..+..
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~ 563 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPE 563 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CSHHHHHHHHTTCCC-CCCTT
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCc
Confidence 54321 11234578999999886 569999999999999999998 99999875 445666777776543 34556
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.++.+.++|.+||. +|.+||++.++++
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999998 9999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=360.67 Aligned_cols=248 Identities=24% Similarity=0.396 Sum_probs=209.8
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+....|++.+.||+|+||.||+|.+.. +..||+|+++.... ..+.+.+|+.+|+.|+||||+++++++.+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 466777889999999999999999999875 46799999875432 23568999999999999999999998754
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 334 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG 408 (535)
T 2h8h_A 334 --EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFG 408 (535)
T ss_dssp --SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCTT
T ss_pred --ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEc-CCCcEEEcccc
Confidence 3578999999999999999753 56999999999999999999999999 99999999999997 78899999999
Q ss_pred chhhccCC---CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 166 LAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 166 la~~~~~~---~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
++...... ......+|+.|+|||++. +.++.++|||||||++|||+| |+.||.+ ....++...+..+.... .+
T Consensus 409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~ 486 (535)
T 2h8h_A 409 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CP 486 (535)
T ss_dssp STTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCCC-CC
T ss_pred cceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CC
Confidence 99765432 122345678999999776 569999999999999999999 9999977 45666777777665433 34
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
...++.+.+||.+||. +|.+|||+.+|+.
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5678899999999998 9999999999886
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=348.01 Aligned_cols=249 Identities=19% Similarity=0.217 Sum_probs=193.5
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc----CCHHHHHHHHHHHHHHHhCC---------CCCcce
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLK---------HENIIK 79 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~----~~~~~~~~l~~Ei~iL~~L~---------HpNIVk 79 (620)
...|++.+.||+|+||+||+|.+ +|+.||+|++...... ......+.+.+|+.+|+.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35678999999999999999988 7899999999865421 12233466888999998886 777777
Q ss_pred EEeEEEcC----------------------------CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 007055 80 FYNSWVDD----------------------------TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 131 (620)
Q Consensus 80 l~~~f~~~----------------------------~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~ 131 (620)
+++.+... ....+++||||+.+|++.+.+.+ +.+++..++.+++||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 76654321 24679999999999976666644 66899999999999999999
Q ss_pred HHH-hCCCCEEecCCCccceEecCCCC--------------------cEEEccccchhhccCCCCccccCCCCCCCcccc
Q 007055 132 YLH-SHNPPIIHRDLKCDNIFVNGNNG--------------------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 190 (620)
Q Consensus 132 yLH-s~~~~IiHrDLKp~NILl~~~~G--------------------~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll 190 (620)
||| +++ |+||||||+|||++ .+| .+||+|||+|+..... ..+||+.|+|||++
T Consensus 176 ~lH~~~~--ivHrDlKp~NILl~-~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 176 VAEASLR--FEHRDLHWGNVLLK-KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHC--CBCSCCCGGGEEEE-ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGG
T ss_pred HHHHhCC--EeECCCCHHHEEEe-ccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhh
Confidence 999 899 99999999999998 555 8999999999765542 45899999999999
Q ss_pred ccccCccchhhhhHHH-HHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCC----CCCCCcHHHHHHHHHhcCCCCCCCCH
Q 007055 191 EEEYNELVDIYSFGMC-ILEMVTCEYPYNECKNPAQIYKKVTSGIK-PAS----LSKVTDPQVKQFIEKCIVPASLRLPA 264 (620)
Q Consensus 191 ~~~y~~~~DIwSlGii-lyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~~----~~~~~~~~lk~~I~kcL~~p~~Rpsa 264 (620)
.+..+.++||||||++ .+++++|..||.+......+...+..... +.. .....++++++||.+||+.+ |+
T Consensus 250 ~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----sa 325 (336)
T 2vuw_A 250 TGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----SA 325 (336)
T ss_dssp CCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----SH
T ss_pred cCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----CH
Confidence 8877899999998777 77889999999532111223333332211 111 12235788999999999843 99
Q ss_pred HHHh-cCCCcC
Q 007055 265 LELL-KDPFLV 274 (620)
Q Consensus 265 ~elL-~hpff~ 274 (620)
.|+| +||||+
T Consensus 326 ~e~l~~Hp~f~ 336 (336)
T 2vuw_A 326 TDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHCGGGC
T ss_pred HHHHhcCCCcC
Confidence 9999 999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=354.11 Aligned_cols=248 Identities=19% Similarity=0.269 Sum_probs=198.4
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.+..|++.++||+|+||.||+|.+..+|+.||||+++..... ..+.+|+.+++.|+|++++..+..|.. ....
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~ 77 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGV-EGDY 77 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEE-ETTE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEe-eCCE
Confidence 456679999999999999999999999999999988754322 237789999999988655554444333 2357
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec--CCCCcEEEccccchh
Q 007055 92 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAI 168 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~G~vKI~DFGla~ 168 (620)
.++||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..++.+||+|||++.
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 89999999 9999999985 567999999999999999999999999 99999999999993 267899999999997
Q ss_pred hccCCC---------CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC-
Q 007055 169 VMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIK- 235 (620)
Q Consensus 169 ~~~~~~---------~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~--~~~i~~~i~~~~~- 235 (620)
...... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+... ..+.+..+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 554332 225689999999998764 589999999999999999999999977433 3333333332211
Q ss_pred --CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 236 --PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 236 --p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
...+....++++.+||..||. +|.+||++.+|++
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111224467899999999998 8999999988764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=376.53 Aligned_cols=259 Identities=28% Similarity=0.376 Sum_probs=206.0
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc----
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD---- 86 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~---- 86 (620)
.....|++.+.||+|+||+||+|.+..+|..||+|+++.. ......+.+.+|+.+|+.++||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 3345679999999999999999999999999999988643 245667789999999999999999999998644
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC---cEE
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EVK 160 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~---~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G---~vK 160 (620)
......++||||+++|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++ .+| .+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~-~~g~~~~vK 164 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQ-PGPQRLIHK 164 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEE-CCSSSCEEE
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEee-cCCCceeEE
Confidence 12456789999999999999998754 6999999999999999999999999 99999999999998 444 489
Q ss_pred EccccchhhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc------
Q 007055 161 IGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------ 232 (620)
Q Consensus 161 I~DFGla~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~------ 232 (620)
|+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.....+......+..
T Consensus 165 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 165 IIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp ECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred EcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 9999999765443 344568999999999886 46999999999999999999999999764333221111100
Q ss_pred -------C--------CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 233 -------G--------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 233 -------~--------~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
+ ..|..+....++.+.+||.+||. +|.+|||+.++|.||||..
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 01112233357889999999998 9999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=350.92 Aligned_cols=252 Identities=17% Similarity=0.198 Sum_probs=191.3
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCcce----------
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIK---------- 79 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pNIVk---------- 79 (620)
...+.|++.++||+|+||+||+|.+..+|+.||||+++.... ......+.+.+|+.+++.+.| +|+..
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 445678899999999999999999999999999998874432 222335678999999999987 22211
Q ss_pred -----------EEeEEEcCC---CCeEEEEEeccCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 007055 80 -----------FYNSWVDDT---NRTINMITELFTSGSLRQYRKK-------HKNVDMKAIKNWARQILRGLHYLHSHNP 138 (620)
Q Consensus 80 -----------l~~~f~~~~---~~~l~lV~Ey~~gGsL~~~i~~-------~~~l~e~~i~~i~~QIl~gL~yLHs~~~ 138 (620)
++.++.... ...++++|+++ +|+|.++++. .+.+++..+..++.||+.||.|||+++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 231 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 111111111 12356677765 6799998852 234788899999999999999999999
Q ss_pred CEEecCCCccceEecCCCCcEEEccccchhhccCCCCccccCCCCCCCcccc----------cc-ccCccchhhhhHHHH
Q 007055 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----------EE-EYNELVDIYSFGMCI 207 (620)
Q Consensus 139 ~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll----------~~-~y~~~~DIwSlGiil 207 (620)
|+||||||+|||++ .+|.+||+|||+++..... ....+| +.|+|||++ .. .|+.++|||||||++
T Consensus 232 -iiHrDiKp~NILl~-~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp -EECSCCCGGGEEEC-TTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred -cccCCcccceEEEe-cCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999998 7889999999998654433 445678 999999987 32 388899999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 208 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 208 yELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
|+|+||+.||.... .......+... ....++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 308 ~elltg~~Pf~~~~-~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 308 YWIWCADLPNTDDA-ALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHSSCCCCTTG-GGSCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHCCCCCCCcc-hhhhHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 99999999997632 22222222211 12457899999999998 99999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=361.63 Aligned_cols=250 Identities=24% Similarity=0.426 Sum_probs=207.7
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~---tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
+.+....|++.+.||+|+||+||+|.+.. .+..||+|.++.. ......+.+.+|+.+|+.++||||+++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34556678999999999999999999865 3578999987643 24556678999999999999999999999874
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
+ ..+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+||
T Consensus 462 ~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~~~vkL~DF 535 (656)
T 2j0j_A 462 E---NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDF 535 (656)
T ss_dssp S---SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCC
T ss_pred c---CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEe-CCCCEEEEec
Confidence 3 34789999999999999998654 6999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 007055 165 GLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASL 239 (620)
Q Consensus 165 Gla~~~~~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~ 239 (620)
|++....... .....||+.|+|||++. ..++.++|||||||++|||++ |..||.+ .+...+...+..+..+ ..
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~ 613 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PM 613 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHHTCCC-CC
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCC-CC
Confidence 9997654332 22345788999999876 459999999999999999997 9999987 4556666666665443 34
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+...++.+.++|.+||. +|.+||++.+++.
T Consensus 614 ~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55678999999999998 9999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=365.06 Aligned_cols=243 Identities=19% Similarity=0.259 Sum_probs=199.3
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEcc-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC-
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 89 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~-tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~- 89 (620)
....|++.+.||+|+||+||+|.+.. +|+.||+|++... ........+.+|+.+|+.++||||++++++|.....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 34567999999999999999999976 8999999987642 245566778999999999999999999999876543
Q ss_pred --CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 90 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 90 --~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
..+|+||||++|++|.+++.. .+++..++.|+.||+.||.|||+++ |+||||||+|||++ . +.+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~-~-~~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLT-E-EQLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-S-SCEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEe-C-CcEEEEecccc
Confidence 236999999999999998765 7999999999999999999999999 99999999999997 3 48999999999
Q ss_pred hhccCCCCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 168 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 168 ~~~~~~~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
...... ...+||+.|+|||++.+.++.++|||||||++|+|++|..||.+... .+..........++.+
T Consensus 229 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l 297 (681)
T 2pzi_A 229 SRINSF--GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSY 297 (681)
T ss_dssp EETTCC--SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHH
T ss_pred hhcccC--CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHH
Confidence 765443 45679999999999988889999999999999999999988864210 0111000000124689
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
.++|.+||. +|.+||++.+.+.|+|+.
T Consensus 298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 298 GRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 999999998 899999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.24 Aligned_cols=226 Identities=14% Similarity=0.121 Sum_probs=183.9
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
.+..|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~ 105 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG-VLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AG 105 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTC-CSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccc-ccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--Cc
Confidence 3455799999999999999999999999999999987543 23456678899999999999999999999998765 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+|+||||+.|++|.++++.. .....+..|+.||+.||.|||++| |+||||||+|||++ .+|.+||+++
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~-~~g~~kl~~~------- 173 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVS-IDGDVVLAYP------- 173 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-TTSCEEECSC-------
T ss_pred EEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEc-CCCCEEEEec-------
Confidence 89999999999999999653 466678899999999999999999 99999999999998 7899999844
Q ss_pred CCCCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHH---HHHHcCCC-CCCCCCCCcHHH
Q 007055 172 QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY---KKVTSGIK-PASLSKVTDPQV 247 (620)
Q Consensus 172 ~~~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~---~~i~~~~~-p~~~~~~~~~~l 247 (620)
.|++| ++.++|||||||++|+|+||+.||.+......+. +.+..... +.......++.+
T Consensus 174 -----------~~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 174 -----------ATMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp -----------CCCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred -----------cccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 34444 7899999999999999999999997643221110 11111111 112234567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+++|.+||+ +|.+| |+.|+++.
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHH
Confidence 999999998 89999 99999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=306.54 Aligned_cols=192 Identities=13% Similarity=0.056 Sum_probs=138.4
Q ss_pred EEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccC------CHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCC
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 89 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~------~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~ 89 (620)
.....++.|+.|.+..+.....|+.||+|.+....... .+...+++.+|+++|+++ .|+||+++++++.++
T Consensus 237 ~w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-- 314 (569)
T 4azs_A 237 HWQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA-- 314 (569)
T ss_dssp EEECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--
T ss_pred hhhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--
Confidence 34455778889999998888999999999987543211 223456799999999999 799999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+||||||++||+|.+++.+.+++++. .+++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+.
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~-~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVD-ARQHARLIDFGSIVT 388 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEEC-TTSCEEECCCTTEES
T ss_pred CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEEC-CCCCEEEeecccCee
Confidence 5799999999999999999999999875 47899999999999999 99999999999998 789999999999976
Q ss_pred ccCC--CCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCC
Q 007055 170 MQQP--TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYP 216 (620)
Q Consensus 170 ~~~~--~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~P 216 (620)
.... ...+.+|||.|||||++.+.+...+|+||+|+++++|.++..|
T Consensus 389 ~~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 389 TPQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred CCCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence 5433 3456789999999999999889999999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-27 Score=262.75 Aligned_cols=185 Identities=19% Similarity=0.211 Sum_probs=144.4
Q ss_pred EEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~----~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
.-.++||+|+||+||+| ...+..+|+|.......... ....+++.+|+++|++++||||+++..++..... .
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--K 414 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT--T
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc--c
Confidence 34679999999999999 55688999998754332211 1124568999999999999999954444444443 5
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
++||||+++|+|.+++.. +..|+.||+.||.|||+++ |+||||||+|||++ . .+||+|||+++....
T Consensus 415 ~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~-~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFD-K--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEES-S--SEEECCCTTCEECCC
T ss_pred EEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEEC-C--eEEEEECccCEECCC
Confidence 899999999999999876 5689999999999999999 99999999999998 3 999999999976654
Q ss_pred CC---------CccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCC
Q 007055 173 PT---------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYN 218 (620)
Q Consensus 173 ~~---------~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~ 218 (620)
.. ..+.+||+.|||||++.. .|+..+|+|+..+-.++.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 31 235689999999999874 58899999999999999998888874
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=216.99 Aligned_cols=151 Identities=15% Similarity=0.153 Sum_probs=119.1
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc-----CCH---------HHHHHHHHHHHHHHhCCCCCcc
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-----QSP---------DQLERLYSEVHLLKSLKHENII 78 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~-----~~~---------~~~~~l~~Ei~iL~~L~HpNIV 78 (620)
+..|++.+.||+|+||.||+|.+ .+|+.||+|.++..... ... .....+.+|+.+|+.++| +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---C
Confidence 45667779999999999999999 89999999998643211 000 235678999999999994 5
Q ss_pred eEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCc
Q 007055 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 158 (620)
Q Consensus 79 kl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~ 158 (620)
++++++.. ...++||||++||+|.+ +. ......++.||+.||.|||++| |+||||||+|||++ +|.
T Consensus 165 ~v~~~~~~---~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~~ 230 (282)
T 1zar_A 165 AVPKVYAW---EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EEG 230 (282)
T ss_dssp SSCCEEEE---ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TTE
T ss_pred CcCeEEec---cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CCc
Confidence 55554322 23589999999999987 32 1335579999999999999999 99999999999998 789
Q ss_pred EEEccccchhhccCCCCccccCCCCCCCcccccc
Q 007055 159 VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE 192 (620)
Q Consensus 159 vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~~ 192 (620)
+||+|||++. .+..++|||++..
T Consensus 231 vkl~DFG~a~-----------~~~~~~a~e~l~r 253 (282)
T 1zar_A 231 IWIIDFPQSV-----------EVGEEGWREILER 253 (282)
T ss_dssp EEECCCTTCE-----------ETTSTTHHHHHHH
T ss_pred EEEEECCCCe-----------ECCCCCHHHHHHH
Confidence 9999999985 3566899998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=191.58 Aligned_cols=145 Identities=16% Similarity=0.182 Sum_probs=111.6
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeE--EEEEEeecccccCC--------------------HHHHHHHHHHHHHH
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQS--------------------PDQLERLYSEVHLL 69 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~--VAiK~v~~~~~~~~--------------------~~~~~~l~~Ei~iL 69 (620)
.+..|++.+.||+|+||.||+|.+..+|+. ||+|+++....... ......+.+|+.+|
T Consensus 45 ~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 45 KGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp TTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred CCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 455688999999999999999999889999 99998754321100 01124578999999
Q ss_pred HhCCCCCc--ceEEeEEEcCCCCeEEEEEeccCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCEE
Q 007055 70 KSLKHENI--IKFYNSWVDDTNRTINMITELFTS-G----SLRQYRKKHKNVDMKAIKNWARQILRGLHYLH-SHNPPII 141 (620)
Q Consensus 70 ~~L~HpNI--Vkl~~~f~~~~~~~l~lV~Ey~~g-G----sL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLH-s~~~~Ii 141 (620)
+.|.|++| +..+.. . ..++||||+.+ | +|.++... .++..+..++.||+.||.||| +++ |+
T Consensus 125 ~~l~~~~i~~p~~~~~--~----~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--iv 193 (258)
T 1zth_A 125 ERAKEAGVSVPQPYTY--M----KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LV 193 (258)
T ss_dssp HHHHHTTCCCCCEEEE--E----TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EE
T ss_pred HHHHhCCCCCCeEEEc--C----CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EE
Confidence 99988864 444432 1 35789999942 3 77776433 235678899999999999999 998 99
Q ss_pred ecCCCccceEecCCCCcEEEccccchhhc
Q 007055 142 HRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 142 HrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
||||||+|||++ . .++|+|||+|...
T Consensus 194 HrDlkp~NILl~-~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYI-D--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEES-S--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEc-C--cEEEEECcccccC
Confidence 999999999997 3 8999999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=7.8e-16 Score=165.25 Aligned_cols=139 Identities=14% Similarity=0.159 Sum_probs=99.9
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc-----------C---CHHHH----HHHHHHHHHHHhCCCCC
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-----------Q---SPDQL----ERLYSEVHLLKSLKHEN 76 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~-----------~---~~~~~----~~l~~Ei~iL~~L~HpN 76 (620)
-|++...||+|+||.||+|.+. +|+.||+|+++..... . ..... -...+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4789999999999999999985 6999999987643110 0 00111 11245777777775554
Q ss_pred cc--eEEeEEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC
Q 007055 77 II--KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 154 (620)
Q Consensus 77 IV--kl~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 154 (620)
+. ..++ ... .++||||+.|++|.++.. ......++.||+.+|.|||++| ||||||||.|||++
T Consensus 175 v~vp~p~~--~~~----~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~- 239 (397)
T 4gyi_A 175 FPVPEPIA--QSR----HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIR- 239 (397)
T ss_dssp CSCCCEEE--EET----TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-
T ss_pred CCCCeeee--ccC----ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe-
Confidence 42 2232 111 258999999998865422 2345678899999999999999 99999999999997
Q ss_pred CCC----------cEEEccccchhh
Q 007055 155 NNG----------EVKIGDLGLAIV 169 (620)
Q Consensus 155 ~~G----------~vKI~DFGla~~ 169 (620)
.+| .+.|+||+-+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 555 389999997643
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=9.6e-15 Score=121.71 Aligned_cols=60 Identities=23% Similarity=0.409 Sum_probs=58.4
Q ss_pred CceEEEEEecCCCCCceeeeeecccCCCCHHHHHHHHHhccCCCCcCHHHHHHHHHHHHH
Q 007055 353 DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIM 412 (620)
Q Consensus 353 ~~i~l~lri~d~~~~~~~i~f~f~~~~Dta~~va~EmV~~~~i~~~d~~~ia~~i~~~i~ 412 (620)
.+|+|+||++|+.+++++|+|+|.+++|||++||+|||.+|+|++.|+.+||++|+++|.
T Consensus 1 ~pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 1 GPISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CCeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 368999999999999999999999999999999999999999999999999999999997
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.04 E-value=7.6e-14 Score=117.79 Aligned_cols=63 Identities=30% Similarity=0.393 Sum_probs=58.7
Q ss_pred CCceEEEEEecCCC---CCce---eeeeecccCCCCHHHHHHHHHhccCCCCcCHHHHHHHHHHHHHHh
Q 007055 352 DDTVSLTLRIGDKS---GHVS---NIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 414 (620)
Q Consensus 352 ~~~i~l~lri~d~~---~~~~---~i~f~f~~~~Dta~~va~EmV~~~~i~~~d~~~ia~~i~~~i~~~ 414 (620)
..+|.|+|||.|++ |+.| +|+|+|++++|||++||+|||++|+++++|...||++|++-|..+
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~ 91 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLI 91 (98)
Confidence 46899999999994 7888 999999999999999999999999999999999999999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=4.9e-10 Score=112.43 Aligned_cols=138 Identities=16% Similarity=0.066 Sum_probs=104.6
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeEEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l~l 94 (620)
|++...+|.|+.+.||++... |..+++|....... .. ...+.+|+.+|+.|. +.++.++++++.+. ...|+
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~-~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~l 87 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK-GT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNL 87 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT-TS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEE
T ss_pred ceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC-CC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEE
Confidence 578888998999999999643 67899998764211 11 134788999999984 67788888876543 57889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN------------------------------------- 137 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~------------------------------------- 137 (620)
||||++|.+|.+... +......++.++..+|..||+..
T Consensus 88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999999987521 22234578899999999999811
Q ss_pred --------------------CCEEecCCCccceEecCCCCcEEEccccch
Q 007055 138 --------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 138 --------------------~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
+.++|+|++|.||+++ .++.+.|+||+.+
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~lIDwe~a 211 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRS 211 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEECCCTTC
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-CCcEEEEEEchhc
Confidence 2389999999999997 4445679999876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.93 E-value=5e-09 Score=103.90 Aligned_cols=134 Identities=13% Similarity=0.016 Sum_probs=93.4
Q ss_pred EEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--cceEEeEEEcCCCCeEE
Q 007055 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 16 y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN--IVkl~~~f~~~~~~~l~ 93 (620)
+.+..+.+.|..+.||++. ..+|..+++|...... ...+.+|+.+++.+.+.+ +.+++.++... ...+
T Consensus 22 ~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~ 91 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDW 91 (264)
T ss_dssp CEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEE
T ss_pred CceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCE
Confidence 3444443456669999995 4567889999865321 134778999999885544 45587765443 4578
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN------------------------------------ 137 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~------------------------------------ 137 (620)
+||||++|.+|. . ...+ ...++.++...|..||+..
T Consensus 92 ~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999998884 1 1122 2356777778888888753
Q ss_pred --------------------CCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 138 --------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 138 --------------------~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
+.++|+|++|.||+++ .++.+.|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE-NGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE-CCcEEEEEcchhcc
Confidence 1299999999999997 45556799999863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=6.7e-09 Score=109.37 Aligned_cols=144 Identities=15% Similarity=0.159 Sum_probs=102.3
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEee--cccccCCHHHHHHHHHHHHHHHhCC--CCCcceEEeEEEcCCC-CeE
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDTN-RTI 92 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~--~~~~~~~~~~~~~l~~Ei~iL~~L~--HpNIVkl~~~f~~~~~-~~l 92 (620)
-.+.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+++.|. +.++++++.++.+... +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~---~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL---LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC---CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 3577899999999998653 4578888654 2211 112345788999999997 4567888886544321 357
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH------------------------------------ 136 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~------------------------------------ 136 (620)
++||||++|..+.+. ....++......++.++...|..||+.
T Consensus 117 ~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 789999999887541 223478888899999999999999973
Q ss_pred --------------------CCCEEecCCCccceEecCCCC-cEEEccccchh
Q 007055 137 --------------------NPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAI 168 (620)
Q Consensus 137 --------------------~~~IiHrDLKp~NILl~~~~G-~vKI~DFGla~ 168 (620)
.+.++|+|++|+||+++...+ .+.|+||+.+.
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 134999999999999984332 36899999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=7.8e-09 Score=106.44 Aligned_cols=183 Identities=21% Similarity=0.197 Sum_probs=120.6
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCC--cceEEeEEEcCC-CCeEEEE
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN--IIKFYNSWVDDT-NRTINMI 95 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpN--IVkl~~~f~~~~-~~~l~lV 95 (620)
+.++.|.+..||++. ..+++|+-. .......+.+|+.+|+.+ .+.. +.+.+....... ....|+|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPK------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEES------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecC------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 458999999999873 357888643 123456788999999888 3333 334444321111 1244789
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-------------------------------------- 137 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~-------------------------------------- 137 (620)
|++++|.+|..... ..++..+...++.|+...|..||+..
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988875432 34777888888889988888888621
Q ss_pred ------------------CCEEecCCCccceEecCC-CCcEEEccccchhhccCCCCccccCCCCC---CCccccc---c
Q 007055 138 ------------------PPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTARSVIGTPEF---MAPELYE---E 192 (620)
Q Consensus 138 ------------------~~IiHrDLKp~NILl~~~-~G~vKI~DFGla~~~~~~~~~~~~GTp~y---~APEll~---~ 192 (620)
+.++|+|++|.||+++.. .+.+.|+||+.+...... ........+ ..|+... .
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--NDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HHHHHHHhhccccCHHHHHHHHH
Confidence 238999999999999833 456789999987542211 000011111 2333221 1
Q ss_pred ccC------------ccchhhhhHHHHHHHHhcCCCC
Q 007055 193 EYN------------ELVDIYSFGMCILEMVTCEYPY 217 (620)
Q Consensus 193 ~y~------------~~~DIwSlGiilyELltG~~Pf 217 (620)
.|. ...+.|++|.+++.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222 2268999999999999998777
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=7.6e-06 Score=84.46 Aligned_cols=136 Identities=21% Similarity=0.127 Sum_probs=91.4
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC---CcceEEeEEEcCCCCeEEEE
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---NIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp---NIVkl~~~f~~~~~~~l~lV 95 (620)
.+.++.|....||+. |..+++|+-. .......+.+|..+|+.|.+. .+.+.+.+.. ......++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v 91 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVG 91 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEE
Confidence 345788888999998 5667888632 234557789999999999753 3455655543 233456799
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-------------------------------------- 137 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~-------------------------------------- 137 (620)
||+++|..|....- ..++......++.|+...|..||+..
T Consensus 92 ~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 92 YRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp EECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred EeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 99999988876321 22344555555555555555555432
Q ss_pred --------------------CCEEecCCCccceEecC--CCCc-EEEccccchh
Q 007055 138 --------------------PPIIHRDLKCDNIFVNG--NNGE-VKIGDLGLAI 168 (620)
Q Consensus 138 --------------------~~IiHrDLKp~NILl~~--~~G~-vKI~DFGla~ 168 (620)
+.++|+|++|.||+++. .++. +.|+||+.+.
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 23699999999999983 1345 5899999774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=1.2e-05 Score=80.35 Aligned_cols=133 Identities=15% Similarity=0.086 Sum_probs=93.1
Q ss_pred EceeCCe-EEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeEEEEEecc
Q 007055 22 LGKGAFK-TVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELF 99 (620)
Q Consensus 22 LG~G~fg-~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l~lV~Ey~ 99 (620)
+..|..+ .||+......+..+++|.-.. .....+.+|...|+.|. +-.+.+++.++.+. ...++|||++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l 102 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAI 102 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEee
Confidence 4445444 699988877788899987542 23456888999998884 33466777766554 4678999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----------------------------------------
Q 007055 100 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP----------------------------------------- 138 (620)
Q Consensus 100 ~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~----------------------------------------- 138 (620)
+|.++.+..... ......+..++...|..||...+
T Consensus 103 ~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 103 PGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp CSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred CCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 998887765432 12334556666666666665321
Q ss_pred ---------------CEEecCCCccceEecCCCCcEEEccccchh
Q 007055 139 ---------------PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 139 ---------------~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
-++|+|+.+.||+++ .++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECcccc
Confidence 179999999999998 55566799998763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=6.9e-05 Score=79.72 Aligned_cols=80 Identities=15% Similarity=0.148 Sum_probs=49.0
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccc-cC--CHHHHHHHHHHHHHHHhCCC--CC-cceEEeEEEcCCCCeE
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV-MQ--SPDQLERLYSEVHLLKSLKH--EN-IIKFYNSWVDDTNRTI 92 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~-~~--~~~~~~~l~~Ei~iL~~L~H--pN-IVkl~~~f~~~~~~~l 92 (620)
.+.||.|.++.||++.+..++..|++|....... .. .....+++..|.++|+.+.. |. +.+++.+ +... .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~--~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM--A 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc--c
Confidence 5689999999999998766778999998642211 00 00123456779898887742 33 4456543 3332 4
Q ss_pred EEEEeccCCC
Q 007055 93 NMITELFTSG 102 (620)
Q Consensus 93 ~lV~Ey~~gG 102 (620)
++|||++++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 6899999864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.0003 Score=73.41 Aligned_cols=86 Identities=5% Similarity=-0.102 Sum_probs=53.5
Q ss_pred EEEEEEE-ceeCCeEEEEEEEc--c----CCeEEEEEEeecccc--cCCHHHHHHHHHHHHHHHhCC-C--CCcceEEeE
Q 007055 16 LQYDEIL-GKGAFKTVYKGFDE--V----DGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKSLK-H--ENIIKFYNS 83 (620)
Q Consensus 16 y~i~e~L-G~G~fg~Vy~a~d~--~----tg~~VAiK~v~~~~~--~~~~~~~~~l~~Ei~iL~~L~-H--pNIVkl~~~ 83 (620)
....+.| +.|....+|+.... . +|..+++|....... ... ...+.+|+.+|+.|. + ..+.+++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 3445778 88999999987543 1 267888887543220 000 123677888888874 2 356777775
Q ss_pred EEcCC-CCeEEEEEeccCCCCH
Q 007055 84 WVDDT-NRTINMITELFTSGSL 104 (620)
Q Consensus 84 f~~~~-~~~l~lV~Ey~~gGsL 104 (620)
..+.. ....++|||+++|..+
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCC
T ss_pred ccCCCccCCceEEEEecCCCCh
Confidence 43321 1345789999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0006 Score=69.99 Aligned_cols=29 Identities=24% Similarity=0.437 Sum_probs=25.2
Q ss_pred CCEEecCCCccceEecCCCCcEEEccccch
Q 007055 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 138 ~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
+.++|+|+++.||+++ .++.+.|+||+.+
T Consensus 222 ~~l~HgD~~~~Nil~~-~~~~~~lIDfe~a 250 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLG-ENEQIWVIDLDTV 250 (346)
T ss_dssp CCEECSSCSTTSEEEC-GGGCEEECCCTTC
T ss_pred CceecCCCCcccEEEe-CCCcEEEEehhhc
Confidence 4499999999999996 4678999999876
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0036 Score=67.04 Aligned_cols=29 Identities=21% Similarity=0.454 Sum_probs=24.5
Q ss_pred CCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 138 ~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
+.++|+|++|.||+++ .++ ++|+||+.+.
T Consensus 232 ~~liHGDl~~~Nil~~-~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVT-QDS-TQVIDPEFSF 260 (420)
T ss_dssp CEEECSCCSGGGEEEC-SSC-EEECCCTTCE
T ss_pred CeEEecCCCCCcEEEe-CCC-CEEEeCcccc
Confidence 3499999999999997 444 9999998763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0081 Score=62.21 Aligned_cols=76 Identities=14% Similarity=0.034 Sum_probs=55.6
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCcceEEeEEEcCCCCeEEE
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpNIVkl~~~f~~~~~~~l~l 94 (620)
-.+.|+.|.+..+|+... ++..+++|..... ....+..|...|+.|. ...+++.+.+... ....++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~l 108 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFL 108 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEE
Confidence 356789999999999864 4677888876422 2456788998888883 3567778775443 356889
Q ss_pred EEeccCCCCH
Q 007055 95 ITELFTSGSL 104 (620)
Q Consensus 95 V~Ey~~gGsL 104 (620)
||||++|..+
T Consensus 109 vme~l~G~~~ 118 (312)
T 3jr1_A 109 LLEALNKSKN 118 (312)
T ss_dssp EEECCCCCCC
T ss_pred EEEeccCCCC
Confidence 9999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0097 Score=60.08 Aligned_cols=84 Identities=13% Similarity=-0.033 Sum_probs=57.2
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-C--CCcceEEeEEEc
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-H--ENIIKFYNSWVD 86 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-H--pNIVkl~~~f~~ 86 (620)
...|+.+.-.+.+|.|..+.||+.. ..+|+.|.+|+-..... .....+..|...|+.|. . -.+.+.+.. +
T Consensus 11 ~l~G~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~ 83 (288)
T 3f7w_A 11 ELTGREVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAP----ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D 83 (288)
T ss_dssp HHHCCCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCC----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E
T ss_pred HhcCCCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCc----chhhHHHHHHHHHHHHHhhCCCCcceEEec--c
Confidence 3567777788999999999999986 45789999997542221 11234678999998884 2 234555552 2
Q ss_pred CCCCeEEEEEeccCCCCH
Q 007055 87 DTNRTINMITELFTSGSL 104 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL 104 (620)
. -++||||+.++..
T Consensus 84 ~----~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 D----RTLAMEWVDERPP 97 (288)
T ss_dssp T----TEEEEECCCCCCC
T ss_pred C----ceEEEEeecccCC
Confidence 2 2568899987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.61 E-value=0.014 Score=57.40 Aligned_cols=121 Identities=19% Similarity=0.176 Sum_probs=80.5
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCCCcccc
Q 007055 102 GSLRQYRKK-HKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 179 (620)
Q Consensus 102 GsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~~~~~~ 179 (620)
-+|.++++. ..+++|+++|.++.|.+.+|.-+ +...+ ..+=+.|..|++. .+|.|-..+ +.+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVW-RDGAVTLAP-AADD----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEE-TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEe-cCCceeccc-cccc----------c
Confidence 378998875 46899999999999999998775 32221 2344456889998 788888764 1110 1
Q ss_pred CCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 007055 180 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256 (620)
Q Consensus 180 GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~ 256 (620)
....|.|||......+.+.=|||||+++|..+--..|- ..+...++.+.+||..|..
T Consensus 99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e--------------------~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKE--------------------NEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCT--------------------TEEECCCHHHHHHHHHHTT
T ss_pred cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCc--------------------ccchhhCHHHHHHHHHHHh
Confidence 23356788877656678889999999999987544332 2233467888899988875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.21 E-value=0.016 Score=59.59 Aligned_cols=30 Identities=23% Similarity=0.277 Sum_probs=24.9
Q ss_pred CEEecCCCccceEecCC---CCcEEEccccchh
Q 007055 139 PIIHRDLKCDNIFVNGN---NGEVKIGDLGLAI 168 (620)
Q Consensus 139 ~IiHrDLKp~NILl~~~---~G~vKI~DFGla~ 168 (620)
.++|||+.+.||+++.. .+.+.|+||+.+.
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 49999999999999732 2679999998774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.016 Score=58.95 Aligned_cols=71 Identities=8% Similarity=0.063 Sum_probs=41.2
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceEEeEEEcCCCCeEEEEEe
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vkl~~~f~~~~~~~l~lV~E 97 (620)
.+.|+.|....+|+. ..+++|+..... .......+|+.+++.+...++ .+++.. +.... ++|+|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~-----~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~--~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT-----EEYINRANEAVAAREAAKAGVSPEVLHV--DPATG--VMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTC--CEEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc-----cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCC--EEEEe
Confidence 567888999999998 357777654221 001112457777777642223 455543 33322 46889
Q ss_pred cc-CCCCH
Q 007055 98 LF-TSGSL 104 (620)
Q Consensus 98 y~-~gGsL 104 (620)
|+ +|.+|
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 65444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.95 E-value=0.025 Score=61.06 Aligned_cols=73 Identities=12% Similarity=0.100 Sum_probs=47.2
Q ss_pred EEEEceeCCeEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceEEeEEEcCCCC
Q 007055 19 DEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNR 90 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vkl~~~f~~~~~~ 90 (620)
.+.|+.|-...||++.... ++..+++|+.... .. .+.+.+|..+++.|...++ .++++.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~-- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHLVAESVIFTLLSERHLGPKLYGIF--SG-- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT--
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC--
Confidence 4577888899999997642 3578888876321 11 1335579888888843333 5677654 22
Q ss_pred eEEEEEeccCCCC
Q 007055 91 TINMITELFTSGS 103 (620)
Q Consensus 91 ~l~lV~Ey~~gGs 103 (620)
.+|+||++|.+
T Consensus 148 --g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 --GRLEEYIPSRP 158 (429)
T ss_dssp --EEEECCCCEEE
T ss_pred --CEEEEEeCCcc
Confidence 26889998633
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.80 E-value=0.019 Score=61.11 Aligned_cols=138 Identities=14% Similarity=0.189 Sum_probs=79.5
Q ss_pred EEEceeCCeEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCe
Q 007055 20 EILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~ 91 (620)
+.|..|-...+|++.... ++..+++++-.. .. .....+.+|..+++.|. +.-..++++.+ ++
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~--- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--IL---QGVDSLVLESVMFAILAERSLGPQLYGVF--PE--- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--cc---chHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC---
Confidence 466668888899987642 357888887421 11 12344568999888874 32235666654 32
Q ss_pred EEEEEeccCCCCHHH-----------H---HHh-C-------CCC--CHHHHHHHHHHHHH-------------------
Q 007055 92 INMITELFTSGSLRQ-----------Y---RKK-H-------KNV--DMKAIKNWARQILR------------------- 128 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~-----------~---i~~-~-------~~l--~e~~i~~i~~QIl~------------------- 128 (620)
.+|+||++|.+|.. + +.+ | +.. -..++.+|..++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 17899999855421 1 111 1 112 24677777766532
Q ss_pred HHHHH----HhCC--CCEEecCCCccceEecCC---CCcEEEccccchh
Q 007055 129 GLHYL----HSHN--PPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAI 168 (620)
Q Consensus 129 gL~yL----Hs~~--~~IiHrDLKp~NILl~~~---~G~vKI~DFGla~ 168 (620)
.+..| ...+ ..++|+|+.++||+++.. .+.+.|+||..+.
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 12333 2222 238999999999999843 2689999998763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.76 E-value=0.036 Score=56.42 Aligned_cols=142 Identities=14% Similarity=0.113 Sum_probs=73.6
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--cceEEeE----EEcCCCCe
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNS----WVDDTNRT 91 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN--IVkl~~~----f~~~~~~~ 91 (620)
-.+.|+.|....+|+.... +| .+++|...... ..+.+..|+.+++.|...+ +.+++.. .+....+.
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 3466788888999998643 34 67888775321 1123556777777663212 2333321 00001235
Q ss_pred EEEEEeccCCCCHH-----HH------H----HhCCC--------CCHHHHHHHH---------------HHHHHHHHHH
Q 007055 92 INMITELFTSGSLR-----QY------R----KKHKN--------VDMKAIKNWA---------------RQILRGLHYL 133 (620)
Q Consensus 92 l~lV~Ey~~gGsL~-----~~------i----~~~~~--------l~e~~i~~i~---------------~QIl~gL~yL 133 (620)
.+++++|++|..+. .+ + ..... .........+ ..+...+.++
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 68899999885431 11 0 11001 1111111100 1133344555
Q ss_pred HhC-----CCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 134 HSH-----NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 134 Hs~-----~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
+.. .+.++|+|+.++||+++ .++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~-~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFL-GDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEe-CCceEEEecchhcc
Confidence 432 12389999999999998 44455799998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.63 E-value=0.057 Score=55.07 Aligned_cols=77 Identities=10% Similarity=-0.025 Sum_probs=45.1
Q ss_pred EEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CcceEEeE---EEcCCCCeEEE
Q 007055 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNS---WVDDTNRTINM 94 (620)
Q Consensus 20 e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--NIVkl~~~---f~~~~~~~l~l 94 (620)
..|+ |....||+... .+|..+++|....... + ...+..|..+++.|... .+++++.. ......+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~--~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC--C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 3566 88889998753 3566789998752211 2 23466688887777321 23444432 00001235678
Q ss_pred EEeccCCCC
Q 007055 95 ITELFTSGS 103 (620)
Q Consensus 95 V~Ey~~gGs 103 (620)
|+++++|..
T Consensus 105 l~~~i~G~~ 113 (328)
T 1zyl_A 105 VFPSVGGRQ 113 (328)
T ss_dssp EEECCCCEE
T ss_pred EEEecCCCC
Confidence 999998744
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.63 E-value=0.098 Score=56.96 Aligned_cols=75 Identities=17% Similarity=0.108 Sum_probs=46.5
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceEEeEEEcCCCCeEEEEEe
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vkl~~~f~~~~~~~l~lV~E 97 (620)
.+.|+.|-...+|++.....+..+++|+.... .... .. -.+|..+++.|...++ .++++.+ .+ . +|+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~-~~~~---id-R~~E~~vl~~L~~~gl~P~ll~~~--~~--G--~v~e 181 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPK-TDEI---IN-REREKKISCILYNKNIAKKIYVFF--TN--G--RIEE 181 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC--CCSC---SC-HHHHHHHHHHHTTSSSBCCEEEEE--TT--E--EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCC-hhhh---cC-HHHHHHHHHHHHhcCCCCCEEEEe--CC--e--EEEE
Confidence 45778898999999977554688888875321 1000 00 1478888988865555 5677655 22 2 4899
Q ss_pred ccCCCCH
Q 007055 98 LFTSGSL 104 (620)
Q Consensus 98 y~~gGsL 104 (620)
|++|.+|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.09 E-value=0.037 Score=57.89 Aligned_cols=74 Identities=14% Similarity=0.114 Sum_probs=41.8
Q ss_pred EEEEceeCCeEEEEEEEcc--------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-cceEEeEEEcCCC
Q 007055 19 DEILGKGAFKTVYKGFDEV--------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDTN 89 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~--------tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN-IVkl~~~f~~~~~ 89 (620)
.+.|+.|....+|+..... .+..+++|+..... ........|..+++.|...+ +.+++..+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DELYNTISEFEVYKTMSKYKIAPQLLNTF--N-- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cceecHHHHHHHHHHHHhcCCCCceEEec--C--
Confidence 4567788889999987543 13678888654211 11111356888887774333 44666543 2
Q ss_pred CeEEEEEeccCCCC
Q 007055 90 RTINMITELFTSGS 103 (620)
Q Consensus 90 ~~l~lV~Ey~~gGs 103 (620)
. ++|+||++|..
T Consensus 109 ~--~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 G--GRIEEWLYGDP 120 (369)
T ss_dssp T--EEEEECCCSEE
T ss_pred C--cEEEEEecCCc
Confidence 2 46899998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.61 E-value=0.14 Score=53.20 Aligned_cols=29 Identities=24% Similarity=0.413 Sum_probs=25.2
Q ss_pred CEEecCCCccceEecCCCCcEEEccccchh
Q 007055 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 139 ~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
.++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~-~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVG-NEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEEC-GGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEe-CCCeEEEEECCCCe
Confidence 499999999999997 56789999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=87.91 E-value=3.1 Score=44.62 Aligned_cols=137 Identities=12% Similarity=0.141 Sum_probs=79.1
Q ss_pred EEEEceeCCeEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCC
Q 007055 19 DEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR 90 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~ 90 (620)
.+.|..|-...+|+..... ++..+++++-... . . ..-...+|..+++.|. +.-..++++.+ .+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t---~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-V---G-KFYDSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-c---c-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 4556668888999987652 1577888874321 1 0 0111246888887774 22245566533 21
Q ss_pred eEEEEEeccCCCCHHH-----------H---HH------h-C-------CC--CCHHHHHHHHHHHHH------------
Q 007055 91 TINMITELFTSGSLRQ-----------Y---RK------K-H-------KN--VDMKAIKNWARQILR------------ 128 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~-----------~---i~------~-~-------~~--l~e~~i~~i~~QIl~------------ 128 (620)
++|+||++|.+|.. . +. . . .+ .-..++..|..++-.
T Consensus 146 --~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~ 223 (424)
T 3mes_A 146 --GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKE 223 (424)
T ss_dssp --EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHH
T ss_pred --CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccc
Confidence 46899999865311 0 10 1 0 11 124556666654322
Q ss_pred -------HHHHHHh----------------------CCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 129 -------GLHYLHS----------------------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 129 -------gL~yLHs----------------------~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
.+.+|.. ....++|+|+.++||+ + .++.+.++||..+.
T Consensus 224 ~~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~-~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 224 LYSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-Q-TQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-E-CSSCEEECCCTTCE
T ss_pred cHHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-c-CCCcEEEEecccCC
Confidence 2223221 1123899999999999 5 67899999998763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.01 E-value=2 Score=45.35 Aligned_cols=29 Identities=17% Similarity=0.264 Sum_probs=23.7
Q ss_pred EEecCCCccceEec-----CCCCcEEEccccchh
Q 007055 140 IIHRDLKCDNIFVN-----GNNGEVKIGDLGLAI 168 (620)
Q Consensus 140 IiHrDLKp~NILl~-----~~~G~vKI~DFGla~ 168 (620)
++|+|+.+.||++. ..++.+.++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 57999999999993 245689999998763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 620 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-82 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-56 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-52 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-49 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-49 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-41 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-18 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (659), Expect = 2e-82
Identities = 135/262 (51%), Positives = 185/262 (70%), Gaps = 5/262 (1%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
FL++D +G+G+FKTVYKG D +EVAW ++ + + + +R E +LK L+H
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQH 67
Query: 75 ENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 132
NI++FY+SW + I ++TEL TSG+L+ Y K+ K + +K +++W RQIL+GL +
Sbjct: 68 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE 192
LH+ PPIIHRDLKCDNIF+ G G VKIGDLGLA + + A++VIGTPEFMAPE+YEE
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE 187
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252
+Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY++VTSG+KPAS KV P+VK+ IE
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247
Query: 253 KCIVP-ASLRLPALELLKDPFL 273
CI R +LL F
Sbjct: 248 GCIRQNKDERYSIKDLLNHAFF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 6e-63
Identities = 70/265 (26%), Positives = 130/265 (49%), Gaps = 16/265 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G G++ K + DG + W +++ + + + + L SEV+LL+ LKH NI++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLHS 135
+Y+ +D TN T+ ++ E G L K+ + +D + + Q+ L H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 136 HN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY 190
+ ++HRDLK N+F++G VK+GD GLA ++ T A++ +GTP +M+PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 191 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249
YNE DI+S G + E+ P+ + ++ K+ G K + ++ +
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNE 244
Query: 250 FIEKCIVP-ASLRLPALELLKDPFL 273
I + + R E+L++P +
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (524), Expect = 5e-62
Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 15/289 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G G+F VY D + VA +++ QS ++ + + EV L+ L+H N I+
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ ++ + ++ E + K + I L+GL YLHSHN
Sbjct: 80 YRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 135
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EEEYN 195
+IHRD+K NI ++ G VK+GD G A +M A S +GTP +MAPE+ E +Y+
Sbjct: 136 MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYD 192
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
VD++S G+ +E+ + P N + PA S + F++ C+
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 256 VP-ASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLAHSE 302
R + LLK F++ + P ++ D + R + V E+ NL + +
Sbjct: 252 QKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRK 300
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-60
Identities = 59/260 (22%), Positives = 118/260 (45%), Gaps = 11/260 (4%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
LGKG F VY ++ +A + ++ +L EV + L+H NI++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
Y + D T + +I E G++ + +K D + + ++ L Y HS
Sbjct: 71 LYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-- 126
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 198
+IHRD+K +N+ + + GE+KI D G ++ ++ GT +++ PE + ++E V
Sbjct: 127 VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185
Query: 199 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP- 257
D++S G+ E + + P+ E + YK+++ + + I + +
Sbjct: 186 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKHN 242
Query: 258 ASLRLPALELLKDPFLVTDN 277
S R E+L+ P++ ++
Sbjct: 243 PSQRPMLREVLEHPWITANS 262
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 7e-59
Identities = 81/281 (28%), Positives = 133/281 (47%), Gaps = 23/281 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +G+GA TVY D G EVA Q+N++ + E + +E+ +++ K+ NI+
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVN 81
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ +S++ + ++ E GSL + D I R+ L+ L +LHS+
Sbjct: 82 YLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNE 196
+IHRD+K DNI + +G VK+ D G I +Q +++GTP +MAPE + + Y
Sbjct: 137 VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256
VDI+S G+ +EM+ E PY +Y T+G + + F+ +C+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 257 P-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVM 296
R A ELL+ FL P L +L P +
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKP---------LSSLTPLIA 287
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-58
Identities = 75/277 (27%), Positives = 131/277 (47%), Gaps = 19/277 (6%)
Query: 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 74
F + LG GAF VYK ++ + A ++ +S ++LE E+ +L S H
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID----TKSEEELEDYMVEIDILASCDH 68
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYL 133
NI+K +++ + N + ++ E G++ + + + I+ +Q L L+YL
Sbjct: 69 PNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY- 190
H + IIHRDLK NI +G++K+ D G++ + R S IGTP +MAPE+
Sbjct: 127 HDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 191 -----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 245
+ Y+ D++S G+ ++EM E P++E + K S +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243
Query: 246 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 281
K F++KC+ R +LL+ PF+ D+ K +
Sbjct: 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-57
Identities = 65/267 (24%), Positives = 120/267 (44%), Gaps = 15/267 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ LG+GA+ V + V VA V+++ + P+ +++ E+ + K L HEN++K
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVK 67
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
FY + + E + G L + + + + Q++ G+ YLH
Sbjct: 68 FYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEEE-- 193
I HRD+K +N+ ++ +KI D GLA V ++ + GT ++APEL +
Sbjct: 124 ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 194 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253
+ E VD++S G+ + M+ E P+++ + Q Y + K D + K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 254 CIVP-ASLRLPALELLKDPFLVTDNPK 279
+V S R+ ++ KD + K
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-56
Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 50/304 (16%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
LG G V+K + G+ +A +++E P ++ E+ +L I+
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
FY ++ D I++ E GSL Q KK + + + + +++GL YL +
Sbjct: 69 FYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-K 125
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 198
I+HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y+
Sbjct: 126 IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 199 DIYSFGMCILEMVTCEYPY----------------------------------------- 217
DI+S G+ ++EM YP
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 218 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 276
++ + + P S V + + F+ KC++ + R +L+ F+
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304
Query: 277 NPKD 280
+ ++
Sbjct: 305 DAEE 308
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-54
Identities = 78/267 (29%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
+ + +G G+F TVYKG +VA +N+ +P QL+ +EV +L+ +H
Sbjct: 10 ITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHV 64
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
NI+ F + ++T+ SL + +M + + ARQ +G+ YLH
Sbjct: 65 NILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY 190
+ + IIHRDLK +NIF++ + VKIGD GLA V + + + G+ +MAPE+
Sbjct: 122 AKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 191 EEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD-- 244
+ Y+ D+Y+FG+ + E++T + PY+ N QI V G LSKV
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 245 -PQVKQFIEKCIVP-ASLRLPALELLK 269
+K+ + +C+ R ++L
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 5e-53
Identities = 67/263 (25%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
++ +ILG+G+F TV + E A + + +++ + E ++ L H
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRH-IIKENKVPYVTRERDVMSRLDHPF 69
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
+K Y ++ DD + +G L +Y +K + D + + +I+ L YLH
Sbjct: 70 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 191
IIHRDLK +NI +N + ++I D G A V+ +Q A S +GT ++++PE L E
Sbjct: 128 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 192 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 251
+ + D+++ G I ++V P+ N I++K+ + P+ + +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKL--EYDFPEKFFPKARDLV 241
Query: 252 EKCIVP-ASLRLPALELLKDPFL 273
EK +V A+ RL E+ L
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 182 bits (463), Expect = 1e-52
Identities = 68/296 (22%), Positives = 125/296 (42%), Gaps = 18/296 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E LG GAF V++ + G A V E + E+ + L+H ++
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVN 87
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
++++ DD + MI E + G L + +H + + RQ+ +GL ++H +N
Sbjct: 88 LHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 139 PIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELYE-EEYN 195
+H DLK +NI + E+K+ D GL + + + + GT EF APE+ E +
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEK 253
D++S G+ +++ P+ +N + + V S S K FI K
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262
Query: 254 CIVP-ASLRLPALELLKDPFLVTDNP--KDLVCDPLRLPNLVPEVMNLAHSEPHPM 306
++ + R+ + L+ P+L N +D R + + + P P+
Sbjct: 263 LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPL 318
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 5e-52
Identities = 58/279 (20%), Positives = 116/279 (41%), Gaps = 15/279 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
++LG GAF V D+ VA + + + +E E+ +L +KH NI+
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMEN---EIAVLHKIKHPNIVA 71
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ + + + +I +L + G L + + Q+L + YLH
Sbjct: 72 LDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG-- 127
Query: 140 IIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAP-ELYEEEYN 195
I+HRDLK +N+ + ++ I D GL+ + + + GTP ++AP L ++ Y+
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEK 253
+ VD +S G+ ++ P+ + +N A++++++ + K FI
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 254 CIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 291
+ R + L+ P++ D D +
Sbjct: 247 LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 180 bits (457), Expect = 7e-52
Identities = 59/266 (22%), Positives = 109/266 (40%), Gaps = 14/266 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E LG GAF V++ ++ G +N P + +E+ ++ L H +I
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
++++ D + +I E + G L + + + N+ RQ GL ++H H+
Sbjct: 91 LHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS- 147
Query: 139 PIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYN 195
I+H D+K +NI VKI D GLA + + T EF APE+ + E
Sbjct: 148 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKC 254
D+++ G+ +++ P+ + + + P+ K FI+
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266
Query: 255 IVP-ASLRLPALELLKDPFLVTDNPK 279
+ RL + L+ P+L D+
Sbjct: 267 LQKEPRKRLTVHDALEHPWLKGDHSN 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 172 bits (436), Expect = 1e-49
Identities = 65/271 (23%), Positives = 118/271 (43%), Gaps = 23/271 (8%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-----QSPDQLERLYSEVHLLKSLK- 73
EILG+G V + + E A +++ + + E EV +L+ +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
H NII+ +++ +T ++ +L G L Y + + K + R +L + L
Sbjct: 69 HPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 126
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEE 192
H N I+HRDLK +NI ++ ++ +K+ D G + + R V GTP ++APE+ E
Sbjct: 127 HKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 183
Query: 193 E-------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD- 244
Y + VD++S G+ + ++ P+ + + + + SG + D
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDY 242
Query: 245 -PQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
VK + + +V R A E L PF
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-49
Identities = 55/261 (21%), Positives = 113/261 (43%), Gaps = 17/261 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E LG+G F V++ + V ++ Q + E+ +L +H NI+
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-----VLVKKEISILNIARHRNILH 65
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
+ S+ + MI E + + + ++ + I ++ Q+ L +LHSHN
Sbjct: 66 LHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 139 PIIHRDLKCDNIFV-NGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE-YN 195
I H D++ +NI + +KI + G A ++ R + PE+ APE+++ + +
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEK 253
D++S G + +++ P+ + QI + + + K + F+++
Sbjct: 182 TATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 254 CIVP-ASLRLPALELLKDPFL 273
+V R+ A E L+ P+L
Sbjct: 241 LLVKERKSRMTASEALQHPWL 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 172 bits (438), Expect = 1e-49
Identities = 71/285 (24%), Positives = 129/285 (45%), Gaps = 18/285 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
LG G+F V+ +G A + ++++ Q+E E +L + H II+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
+ ++ D I MI + G L +K + K +A ++ L YLHS +
Sbjct: 69 MWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-- 124
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 198
II+RDLK +NI ++ NG +KI D G A + T ++ GTP+++APE + + YN+ +
Sbjct: 125 IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSI 182
Query: 199 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-- 256
D +SFG+ I EM+ P+ + N + Y+K+ + + VK + + I
Sbjct: 183 DWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRD 239
Query: 257 ----PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 297
+L+ ++ P+ + L+ + P P +
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP-YEPPIQQ 283
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 3e-49
Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 15/282 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLYSEVHLLKSLKHENI 77
E LG G F V K ++ G++ A + S E + EV +LK ++H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
I + + + T+ + +I EL G L + + +++ + + +QIL G++YLHS
Sbjct: 76 ITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 138 PPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELYE-E 192
I H DLK +NI + N +KI D GLA + + GTPEF+APE+ E
Sbjct: 134 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQF 250
D++S G+ +++ P+ + V++ T K F
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250
Query: 251 IEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 291
I + +V R+ + L+ P++ + + + P
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 8e-49
Identities = 60/285 (21%), Positives = 131/285 (45%), Gaps = 19/285 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
++LGKG F V ++ G A + ++V+ + D++ +E +L++ +H +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
++ + + E G L + + + + + + +I+ L YLHS +
Sbjct: 70 LKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 125
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE-EEYNE 196
+++RD+K +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E +Y
Sbjct: 126 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 197 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 256
VD + G+ + EM+ P+ ++ ++++ + + P+ K + +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILME--EIRFPRTLSPEAKSLLAGLLK 241
Query: 257 ------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 295
A E+++ F ++ N +D+V L P P+V
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP-FKPQV 285
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-48
Identities = 55/258 (21%), Positives = 112/258 (43%), Gaps = 18/258 (6%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ + +GKG F V G + G +VA +++ + +E ++ L+H
Sbjct: 9 LKLLQTIGKGEFGDVMLG--DYRGNKVAVK------CIKNDATAQAFLAEASVMTQLRHS 60
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYL 133
N+++ V++ + ++TE GSL Y + + + ++ + + YL
Sbjct: 61 NLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEE 192
+N +HRDL N+ V+ + K+ D GL T + ++ APE L E+
Sbjct: 120 EGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEALREK 175
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252
+++ D++SFG+ + E+ + + +V G K + P V + ++
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMK 234
Query: 253 KCIVP-ASLRLPALELLK 269
C A++R L+L +
Sbjct: 235 NCWHLDAAMRPSFLQLRE 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 169 bits (428), Expect = 1e-48
Identities = 58/264 (21%), Positives = 103/264 (39%), Gaps = 14/264 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
EILG G V+ D +VA + D+ + P R E +L H I+
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 80 FYNSWVDDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
Y++ +T ++ E +LR + K + L++ H +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG 131
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE- 191
IIHRD+K NI ++ N VK+ D G+A + +VIGT ++++PE
Sbjct: 132 --IIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 192 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTDPQVKQF 250
+ + D+YS G + E++T E P+ + Y+ V P S + +
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 248
Query: 251 IEKCIVP-ASLRLPALELLKDPFL 273
+ K + R ++ +
Sbjct: 249 VLKALAKNPENRYQTAAEMRADLV 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (424), Expect = 7e-48
Identities = 50/264 (18%), Positives = 100/264 (37%), Gaps = 16/264 (6%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
++ ++++G G F V G ++ G + + + Q SE ++ H
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 87
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
N+I T + +ITE +GSL + R+ + + R I G+ YL
Sbjct: 88 NVIHLEGVVTKSTP--VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-------IGTPEFMAP 187
N +HRDL NI VN +N K+ D GL+ ++ T+ + AP
Sbjct: 146 DMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 188 ELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 246
E + ++ D++S+G+ + E+++ + + +
Sbjct: 203 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-PSA 261
Query: 247 VKQFIEKCIVP-ASLRLPALELLK 269
+ Q + C + R +++
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 9e-48
Identities = 61/271 (22%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ E LG G F V+ G+ +VA ++ + Q + +E +L+K L+H+
Sbjct: 15 LKLVERLGAGQFGEVWMGYYN-GHTKVA-----VKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLHYL 133
+++ Y + I +ITE +GSL + K + + + + A QI G+ ++
Sbjct: 69 RLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTPEFMAP-EL 189
N IHRDL+ NI V+ + KI D GLA ++ + ++ AP +
Sbjct: 126 EERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 190 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249
+ D++SFG+ + E+VT ++ + + G + ++ Q
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQ 241
Query: 250 FIEKCIVP-ASLRLPA---LELLKDPFLVTD 276
+ C R +L+D F T+
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-47
Identities = 49/261 (18%), Positives = 103/261 (39%), Gaps = 19/261 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKSLK--HE 75
+LG G F +VY G D + VA V + + R+ EV LLK +
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
+I+ + + + + + L + + + + +++ Q+L + + H+
Sbjct: 70 GVIRLLDWFERPDSFVLIL-ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-- 193
++HRD+K +NI ++ N GE+K+ D G +++ GT + PE
Sbjct: 129 CG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRY 186
Query: 194 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253
+ ++S G+ + +MV + P+ + + + + + I
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSECQHLIRW 237
Query: 254 CIVP-ASLRLPALELLKDPFL 273
C+ S R E+ P++
Sbjct: 238 CLALRPSDRPTFEEIQNHPWM 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-47
Identities = 49/260 (18%), Positives = 101/260 (38%), Gaps = 18/260 (6%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L + + +G G F V+ G+ + +VA + + E E ++ L H
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHP 60
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
+++ Y ++ I ++ E G L Y R + + + + G+ YL
Sbjct: 61 KLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPE-LY 190
+IHRDL N V N +K+ D G+ + ++ +PE
Sbjct: 119 EAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 191 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250
Y+ D++SFG+ + E+ + E ++ +++ + +++G + ++ V Q
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQI 234
Query: 251 IEKCIVP-ASLRLPALELLK 269
+ C R LL+
Sbjct: 235 MNHCWKERPEDRPAFSRLLR 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-47
Identities = 69/282 (24%), Positives = 129/282 (45%), Gaps = 16/282 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENII 78
++LGKG+F V+ + A + +DV+ D +E E +L + +H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
+ ++ N M E G L + + D+ +A +I+ GL +LHS
Sbjct: 67 HMFCTFQTKENLFFVM--EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-LYEEEYN 195
I++RDLK DNI ++ +G +KI D G+ A+ + GTP+++APE L ++YN
Sbjct: 124 -IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
VD +SFG+ + EM+ + P+ ++ +++ + + + + K + K
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLF 238
Query: 256 VP-ASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 295
V RL ++ + P N ++L + P P+V
Sbjct: 239 VREPEKRLGVRGDIRQHPLFREINWEELERKEID-PPFRPKV 279
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-47
Identities = 69/301 (22%), Positives = 120/301 (39%), Gaps = 39/301 (12%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL-ERLYSEVHLLKSLKHENII 78
+ LG+G F TVYK D+ VA ++ + ++ D + E+ LL+ L H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
+++ +N I+++ + + + + IK + L+GL YLH H
Sbjct: 64 GLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY--EEEY 194
I+HRDLK +N+ ++ NG +K+ D GLA P + T + APEL Y
Sbjct: 121 -ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 195 NELVDIYSFGMCILEMVTCEYPY-------------------------NECKNPAQIYKK 229
VD+++ G + E++ + C P + K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 230 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRL 288
GI + + I+ + R+ A + LK + ++ P +L
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRPGP--TPGCQL 295
Query: 289 P 289
P
Sbjct: 296 P 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-46
Identities = 51/266 (19%), Positives = 107/266 (40%), Gaps = 21/266 (7%)
Query: 19 DEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 76
D+ LG G F TV KG+ ++ VA + E P + L +E ++++ L +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPY 69
Query: 77 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 136
I++ ++ ++ E+ G L +Y +++++V K I Q+ G+ YL
Sbjct: 70 IVRMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 137 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LY 190
N +HRDL N+ + KI D GL+ ++ ++ APE +
Sbjct: 127 N--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 191 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250
+++ D++SFG+ + E + +++ + G + + ++
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDL 242
Query: 251 IEKCIVP-ASLRLPA---LELLKDPF 272
+ C R L++ +
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 6e-46
Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 16/281 (5%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQ-VNIEDVMQSPDQLERLYSEVHLLKSLKHENII 78
++LG GAF TVYKG +G +V + SP + + E +++ S+ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 137
+ + T + +IT+L G L Y ++HK N+ + + NW QI +G++YL
Sbjct: 75 RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYEE 192
++HRDL N+ V VKI D GLA ++ ++ A ++MA E +
Sbjct: 132 --LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 193 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252
Y D++S+G+ + E++T + ++I + G + + V +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQPPICTIDVYMIMV 247
Query: 253 KCIVP-ASLRLPALELLKDP-FLVTDNPKDLVCDPLRLPNL 291
KC + A R EL+ + + D + LV +L
Sbjct: 248 KCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (411), Expect = 3e-45
Identities = 58/284 (20%), Positives = 116/284 (40%), Gaps = 20/284 (7%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENI 77
I+G+G F VY G A ++ + + Q + L+ + I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 78 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
+ ++ ++ I +L G L + +H ++ +A +I+ GL ++H+
Sbjct: 70 VCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YN 195
+++RDLK NI ++ +G V+I DLGLA + + +GT +MAPE+ ++ Y+
Sbjct: 128 --VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 255
D +S G + +++ P+ + K + + L P+++ +E +
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 256 V------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 293
L A E+ + PF + L + L P
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFF-----RSLDWQMVFLQKYPP 283
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-45
Identities = 48/278 (17%), Positives = 106/278 (38%), Gaps = 29/278 (10%)
Query: 14 LFLQYDEI------LGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSE 65
LFL+ D + LG G F +V +G + I+VA + + E + E
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMRE 59
Query: 66 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWAR 124
++ L + I++ + ++ E+ G L ++ K + + + +
Sbjct: 60 AQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 116
Query: 125 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 179
Q+ G+ YL N +HRDL N+ + N KI D GL+ + +
Sbjct: 117 QVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 180 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 238
++ APE + +++ D++S+G+ + E ++ + ++ + G +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-E 232
Query: 239 LSKVTDPQVKQFIEKCIVPASLRLP----ALELLKDPF 272
P++ + C + P + ++ +
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (404), Expect = 4e-45
Identities = 58/261 (22%), Positives = 104/261 (39%), Gaps = 18/261 (6%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
+ LG G + VY+G + + VA + + ++E E ++K +KH
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHP 73
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYL 133
N+++ + I E T G+L Y + V + A QI + YL
Sbjct: 74 NLVQLLGVCTREPPFYIIT--EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT---PEFMAP-EL 189
N IHRDL N V N VK+ D GL+ +M T + G ++ AP L
Sbjct: 132 EKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 190 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249
+++ D+++FG+ + E+ T + +Q+Y+ + + +V +
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP-EKVYE 247
Query: 250 FIEKCIVP-ASLRLPALELLK 269
+ C S R E+ +
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQ 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 7e-45
Identities = 57/272 (20%), Positives = 112/272 (41%), Gaps = 14/272 (5%)
Query: 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 66
V+ L + ++E++G+G F VY G + + V + + ++ + +E
Sbjct: 20 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 79
Query: 67 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQ 125
++K H N++ + + ++ G LR + + + N +K + + Q
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 126 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS------VI 179
+ +G+ + +HRDL N ++ VK+ D GLA M S
Sbjct: 139 VAKGMK--FLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 180 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 238
++MA E L +++ D++SFG+ + E++T P N I + G +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255
Query: 239 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 269
DP + + + KC P A +R EL+
Sbjct: 256 PEYCPDP-LYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 7e-45
Identities = 56/261 (21%), Positives = 108/261 (41%), Gaps = 13/261 (4%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
++ +G+G F V++G + S E+ E ++ H
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
+I+K ++ + +I EL T G LR + + + ++D+ ++ +A Q+ L YL
Sbjct: 69 HIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPE-LY 190
S +HRD+ N+ V+ N VK+GD GL+ M+ T ++MAPE +
Sbjct: 126 SKR--FVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 191 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250
+ D++ FG+C+ E++ + + ++ +G + + P +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-PMPPNCPPTLYSL 241
Query: 251 IEKCIVP-ASLRLPALELLKD 270
+ KC S R EL
Sbjct: 242 MTKCWAYDPSRRPRFTELKAQ 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-44
Identities = 54/261 (20%), Positives = 101/261 (38%), Gaps = 18/261 (6%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L + + LG G F V G +VA + + + + E ++ +L HE
Sbjct: 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHE 59
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 134
+++ Y I +ITE +G L Y R+ + + + + + YL
Sbjct: 60 KLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 135 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGTPEFMAPELYE 191
S +HRDL N VN + G VK+ D GL+ + S + PE+
Sbjct: 118 SKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 192 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250
+++ DI++FG+ + E+ + E ++ + + G++ + +V
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTI 233
Query: 251 IEKCIVP-ASLRLPALELLKD 270
+ C A R LL +
Sbjct: 234 MYSCWHEKADERPTFKILLSN 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-44
Identities = 67/265 (25%), Positives = 108/265 (40%), Gaps = 18/265 (6%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 72
L+ E LG G+F V +G + + VA + DV+ P+ ++ EV+ + SL
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDDFIREVNAMHSL 68
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLH 131
H N+I+ Y + + M+TEL GSL +KH+ + + +A Q+ G+
Sbjct: 69 DHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 132 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMA 186
YL S IHRDL N+ + VKIGD GL + Q + A
Sbjct: 126 YLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 187 PE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 245
PE L ++ D + FG+ + EM T N +QI K+ + +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242
Query: 246 QVKQFIEKCIVP-ASLRLPALELLK 269
+ + +C R + L
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-44
Identities = 57/273 (20%), Positives = 108/273 (39%), Gaps = 22/273 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 75
L+ + LG+G F V+ G VA + + E E ++K L+HE
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-----EAFLQEAQVMKKLRHE 72
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYL 133
+++ Y + I ++TE + GSL + + K + + + + A QI G+ Y+
Sbjct: 73 KLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPE-L 189
N +HRDL+ NI V N K+ D GLA +++ + ++ APE
Sbjct: 130 ERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 190 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249
+ D++SFG+ + E+ T ++ +V G + + +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHD 245
Query: 250 FIEKCIVP-ASLRLPALELLK--DPFLVTDNPK 279
+ +C R L + + + P+
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (404), Expect = 2e-44
Identities = 64/285 (22%), Positives = 126/285 (44%), Gaps = 18/285 (6%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ LG G+F V + G A ++ + + Q+E +E +L+++ ++K
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-VVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
S+ D N + M+ E G + + ++ + +A QI+ YLHS +
Sbjct: 106 LEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD-- 161
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 198
+I+RDLK +N+ ++ G +++ D G A ++ T ++ GTPE +APE + + YN+ V
Sbjct: 162 LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKGYNKAV 219
Query: 199 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-- 256
D ++ G+ I EM P+ P QIY+K+ SG +K + +
Sbjct: 220 DWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVD 276
Query: 257 ----PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 297
+L+ ++ + T + + + P +P+
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP-FIPKFKG 320
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 5e-43
Identities = 64/307 (20%), Positives = 112/307 (36%), Gaps = 50/307 (16%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G+G F V+K G +VA +V +E+ + E+ +L+ LKHEN++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVN 73
Query: 80 FYNSWVDDT------NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 133
+I ++ + + IK + +L GL+Y+
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 133
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPEFMAP 187
H + I+HRD+K N+ + +G +K+ D GLA + + T + P
Sbjct: 134 HRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 188 E--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY------------------ 227
E L E +Y +D++ G + EM T Q+
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 228 -----------KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVT 275
K +K + V DP I+K +V + R+ + + L F +
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310
Query: 276 D-NPKDL 281
D P DL
Sbjct: 311 DPMPSDL 317
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 7e-43
Identities = 58/274 (21%), Positives = 107/274 (39%), Gaps = 27/274 (9%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KH 74
+++ +++G+G F V K + DG+ + + S D E+ +L L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 75 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKA 118
NII + + + E G+L + +K + +
Sbjct: 71 PNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 119 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 178
+ ++A + RG+ YL IHRDL NI V N KI D GL+ + +++
Sbjct: 129 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTM 185
Query: 179 I-GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 236
+MA E L Y D++S+G+ + E+V+ A++Y+K+ G +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245
Query: 237 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 269
D +V + +C R ++L
Sbjct: 246 EKPLNC-DDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-43
Identities = 67/322 (20%), Positives = 125/322 (38%), Gaps = 54/322 (16%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+++G G+F VY+ G VA +V + E+ +++ L H NI++
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--------RFKNRELQIMRKLDHCNIVR 77
Query: 80 ----FYNSWVDDTNRTINMITELFTSG---SLRQYRKKHKNVDMKAIKNWARQILRGLHY 132
FY+S +N++ + R Y + + + + +K + Q+ R L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 133 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELY- 190
+HS I HRD+K N+ ++ + +K+ D G A + + S I + + APEL
Sbjct: 138 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 191 -EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT------------------ 231
+Y +D++S G + E++ + + Q+ + +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 232 ----SGIKPASLSKV----TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 282
IK +KV T P+ + + + RL LE F +L
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-----DELR 310
Query: 283 CDPLRLPNL--VPEVMNLAHSE 302
++LPN P + N E
Sbjct: 311 DPNVKLPNGRDTPALFNFTTQE 332
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 9e-43
Identities = 49/276 (17%), Positives = 107/276 (38%), Gaps = 28/276 (10%)
Query: 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENI 77
++LG G V + F++ + A + + EV ++ + +I
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHI 67
Query: 78 IKFYNSWVD--DTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYL 133
++ + + + + + ++ E G L + + + + I + YL
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 134 HSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY 190
HS N I HRD+K +N+ N +K+ D G A + + TP ++APE+
Sbjct: 128 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185
Query: 191 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------PASLSKVT 243
E+Y++ D++S G+ + ++ P+ + I + + I+ P
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 244 DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 278
+VK I + + R+ E + P+++
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 1e-42
Identities = 58/266 (21%), Positives = 107/266 (40%), Gaps = 21/266 (7%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 71
+ +++G G F VYKG + + VA + + Q E ++
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQ 65
Query: 72 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGL 130
H NII+ I ITE +G+L ++ R+K + + R I G+
Sbjct: 66 FSHHNIIRLEGVISKYKPMMI--ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFM 185
YL + N +HRDL NI VN +N K+ D GL+ V++ T +
Sbjct: 124 KYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 186 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244
APE + ++ D++SFG+ + E++T + ++ K + G + +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC-P 239
Query: 245 PQVKQFIEKCIVP-ASLRLPALELLK 269
+ Q + +C + R +++
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 39/287 (13%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLYSEVHLLKSL- 72
L++ ++LG GAF V QV ++ + + D E L SE+ ++ L
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 73 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN------------------- 113
HENI+ + I +I E G L Y + +
Sbjct: 99 SHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 114 ----VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169
+ + + +A Q+ +G+ +L + +HRDL N+ V + VKI D GLA
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT-HGKVVKICDFGLARD 213
Query: 170 MQQP----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNP 223
+ + ++MAPE L+E Y D++S+G+ + E+ + PY
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 224 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 269
A YK + +G K T ++ ++ C + R L
Sbjct: 274 ANFYKLIQNGFKMDQPFYAT-EEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 39/286 (13%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +G+G + VYK +++ G VA ++ ++ ++ E+ LLK L H NI+K
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNP 138
+ + + ++ E + + + IK++ Q+L+GL + HSH
Sbjct: 66 LLDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY--EEEY 194
++HRDLK N+ +N G +K+ D GLA P + T + APE+ + Y
Sbjct: 123 -VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 195 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------------ 236
+ VDI+S G EMVT + Q+++ + P
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 237 --------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
+ + D + + + + + R+ A L PF
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (378), Expect = 2e-41
Identities = 63/285 (22%), Positives = 108/285 (37%), Gaps = 39/285 (13%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +G+G + VYK + G A ++ +E + E+ +LK LKH NI+K
Sbjct: 8 EKIGEGTYGVVYKAQNN-YGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVK 64
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
Y+ + ++ E + ++ K++ Q+L G+ Y H
Sbjct: 65 LYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR-- 120
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE--YN 195
++HRDLK N+ +N GE+KI D GLA P + I T + AP++ Y+
Sbjct: 121 VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--------------------------K 229
+DI+S G EMV + Q+ +
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 230 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
V + S K D + K + + R+ A + L+ +
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-41
Identities = 60/286 (20%), Positives = 118/286 (41%), Gaps = 39/286 (13%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +G+G + TV+K + VA +V ++D E+ LLK LKH+NI++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVR 65
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
++ D T+ E + + + ++D + +K++ Q+L+GL + HS N
Sbjct: 66 LHDVLHSDKKLTLVF--EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPELY--EEEYN 195
++HRDLK N+ +N NGE+K+ + GLA P + T + P++ + Y+
Sbjct: 122 VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--------------------- 234
+D++S G E+ P + K++ +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 235 ------KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
++ + + ++ + R+ A E L+ P+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-41
Identities = 59/295 (20%), Positives = 125/295 (42%), Gaps = 27/295 (9%)
Query: 20 EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE- 75
++LG GA+ V+ G A + ++Q E +E +L+ ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 76 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
++ + ++ +T + + + G L + + + ++ + +I+ L +LH
Sbjct: 90 FLVTLHYAFQTETKLHLIL--DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV---MQQPTARSVIGTPEFMAPELY-- 190
II+RD+K +NI ++ +NG V + D GL+ + A GT E+MAP++
Sbjct: 148 LG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 191 -EEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQ 246
+ +++ VD +S G+ + E++T P+ E + A+I +++ P +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSAL 262
Query: 247 VKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 295
K I++ ++ A E+ + F N DL + P P +
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP-FKPVI 316
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (374), Expect = 8e-41
Identities = 52/274 (18%), Positives = 97/274 (35%), Gaps = 30/274 (10%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G G+F +Y G D G EVA ++ + +L+ E + K ++ I
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIP 66
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
W M+ EL + + +K + A Q++ + Y+HS N
Sbjct: 67 TIR-WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 140 IIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPE 188
IHRD+K DN + V I D GLA + +++ GT + +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 189 LYE-EEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSG---IKPASLSKV 242
+ E + D+ S G ++ + + Q Y++++ L K
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 243 TDPQVKQFIEKCIVPASLRLP----ALELLKDPF 272
+ ++ C P +L ++ F
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 9e-41
Identities = 64/292 (21%), Positives = 110/292 (37%), Gaps = 45/292 (15%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G+GA+ V +D V+ + VA +++ + +R E+ +L +HENII
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIG 70
Query: 80 FYNSWVDDTNRTIN--MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
+ T + + L + K + I + QILRGL Y+HS N
Sbjct: 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSAN 129
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVIGTPEFMAPELYEE 192
++HRDLK N+ +N ++KI D GLA V + T + APE+
Sbjct: 130 --VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 193 E--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------- 236
Y + +DI+S G + EM++ + Q+ + P
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 237 --------------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
L D + ++K + R+ + L P+L
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 148 bits (373), Expect = 2e-40
Identities = 54/301 (17%), Positives = 117/301 (38%), Gaps = 53/301 (17%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 78
LG+G + V++ + + +V + P + +++ E+ +L++L+ NII
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNII 93
Query: 79 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 138
+ D +RT ++ E + +Q ++ + I+ + +IL+ L Y HS
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG- 149
Query: 139 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEE--YN 195
I+HRD+K N+ ++ + ++++ D GLA + + F PEL + Y+
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT------------------------ 231
+D++S G + M+ + P+ + ++
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 232 -----------SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 279
+ + P+ F++K + RL A E ++ P+ K
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF-YTVVK 327
Query: 280 D 280
D
Sbjct: 328 D 328
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-40
Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 36/287 (12%)
Query: 20 EILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENI 77
+G+GA+ V+K D + G VA +V ++ + P R + + L++ +H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 78 IKFYNSWVD---DTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYL 133
++ ++ D + ++ E + V + IK+ Q+LRGL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 134 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPE-LYE 191
HSH ++HRDLK NI V ++G++K+ D GLA I Q SV+ T + APE L +
Sbjct: 133 HSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 192 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS------------- 238
Y VD++S G EM + + + Q+ K + P
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 239 -----------LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
D K + KC+ + R+ A L P+
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (365), Expect = 1e-39
Identities = 49/289 (16%), Positives = 93/289 (32%), Gaps = 44/289 (15%)
Query: 16 LQYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
++Y +G+GAF V++ VA + E S D E L+
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMA 71
Query: 71 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN----------------- 113
+ NI+K + ++ E G L ++ +
Sbjct: 72 EFDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 114 -------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166
+ ARQ+ G+ YL +HRDL N V N VKI D GL
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG-ENMVVKIADFGL 186
Query: 167 AIVMQQPTAR----SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 221
+ + + +M PE ++ Y D++++G+ + E+ +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 222 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 269
++ V G + + ++ + C + R + +
Sbjct: 247 AHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-39
Identities = 69/291 (23%), Positives = 111/291 (38%), Gaps = 50/291 (17%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
E +GKG F V++G G EVA + + ++ +E++ L+HENI+
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILG 61
Query: 80 FYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-- 135
F + D + +++ GSL Y ++ V ++ + A GL +LH
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEI 120
Query: 136 ----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFM 185
P I HRDLK NI V NG I DLGLA+ T +GT +M
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 186 APELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG----- 233
APE+ ++ E + DIY+ G+ E+ ++ Y +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 234 --------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 269
I S + + + +C + RL AL + K
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 74/287 (25%), Positives = 116/287 (40%), Gaps = 39/287 (13%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ +G GA+ V D G +VA ++ QS +R Y E+ LLK ++HEN+I
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIG 81
Query: 80 FYNSWVDDTNRTINMITELFTS--GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
+ + D L G+ KH+ + I+ Q+L+GL Y+H+
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 141
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY--EEEYN 195
HRDLK N+ VN + E+KI D GLA + T + APE+ Y
Sbjct: 142 II--HRDLKPGNLAVN-EDCELKILDFGLARQADSEM-TGYVVTRWYRAPEVILNWMRYT 197
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------------- 236
+ VDI+S G + EM+T + + + Q+ + + P
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 237 ---------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
AS+ P +EK +V A R+ A E L P+
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 6e-39
Identities = 55/284 (19%), Positives = 109/284 (38%), Gaps = 38/284 (13%)
Query: 16 LQYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 70
L + + LG GAF V + + VA + + E L SE+ +L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLS 81
Query: 71 SLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN---------------- 113
L H NI+ + +ITE G L + ++ ++
Sbjct: 82 YLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 114 --VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171
+D++ + +++ Q+ +G+ +L S N IHRDL NI + + KI D GLA ++
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIK 196
Query: 172 QPTARSV----IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 226
+ V ++MAPE ++ Y D++S+G+ + E+ +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 269
+ K+ + ++ ++ C R ++++
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 7e-39
Identities = 68/285 (23%), Positives = 117/285 (41%), Gaps = 39/285 (13%)
Query: 16 LQYDEILGKGAFKTVYKGFD-------EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 68
L + LG+GAF V +VA + + + L L SE+ +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEM 71
Query: 69 LKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--------------- 112
+K + KH+NII + D + +I E + G+LR+Y + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 113 -NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171
+ K + + A Q+ RG+ YL S IHRDL N+ V + +KI D GLA +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIH 186
Query: 172 QP----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 226
+ ++MAPE L++ Y D++SFG+ + E+ T ++
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 270
+K + G + S T ++ + C S R +L++D
Sbjct: 247 FKLLKEGHRMDKPSNCT-NELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 53/272 (19%), Positives = 106/272 (38%), Gaps = 24/272 (8%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLK 73
+ LG+G+F VY+G + + +V I+ + S + +E ++K
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV----------DMKAIKNWA 123
++++ +I EL T G L+ Y + + + + A
Sbjct: 82 CHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 124 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVI 179
+I G+ YL+++ +HRDL N V + VKIGD G+ + + +
Sbjct: 140 GEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 180 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 238
+M+PE L + + D++SFG+ + E+ T + + Q+ + V G
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 239 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 269
+ + + C +R LE++
Sbjct: 257 PDNC-PDMLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (354), Expect = 3e-38
Identities = 36/254 (14%), Positives = 93/254 (36%), Gaps = 28/254 (11%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G+G+F +++G + ++ +VA + E QL Y LL +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 139
++ ++ +L + +K + A+Q+L + +H +
Sbjct: 68 YF----GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 140 IIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMA 186
+++RD+K DN + N + + D G+ + P +++ GT +M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 187 PELYE-EEYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243
+ E + D+ + G + + + + Q Y+++ + L ++
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 244 D---PQVKQFIEKC 254
+ +++
Sbjct: 242 AGFPEEFYKYMHYA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-37
Identities = 57/279 (20%), Positives = 109/279 (39%), Gaps = 29/279 (10%)
Query: 16 LQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLK 73
L+ + LG+GAF V + V ++ + + L SE+ +L +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 74 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN----------------VDMK 117
H + + +I E G+L Y + +N + ++
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 118 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---- 173
+ ++ Q+ +G+ +L S IHRDL NI ++ VKI D GLA + +
Sbjct: 135 HLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYV 191
Query: 174 TARSVIGTPEFMA-PELYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 231
++MA +++ Y D++SFG+ + E+ + PY K + +++
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 232 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 269
G + T P++ Q + C S R EL++
Sbjct: 252 EGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 78/302 (25%), Positives = 126/302 (41%), Gaps = 41/302 (13%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+G GA+ +V FD G+ VA +++ QS +R Y E+ LLK +KHEN+I
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 80 FYNSWVDDTNRTI--NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 137
+ + + ++ G+ K + + ++ QILRGL Y+HS +
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 138 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY--EEEYN 195
IIHRDLK N+ VN + E+KI D GLA + T + APE+ YN
Sbjct: 142 --IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEM-TGYVATRWYRAPEIMLNWMHYN 197
Query: 196 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------------- 236
+ VDI+S G + E++T + + Q+ + P
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257
Query: 237 ---------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVT-DNPKDL-VCD 284
A++ +P +EK +V + R+ A + L + +P D V D
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD 317
Query: 285 PL 286
P
Sbjct: 318 PY 319
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 70/324 (21%), Positives = 126/324 (38%), Gaps = 60/324 (18%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
+ +G GA V +D V VA +++ Q+ +R Y E+ L+K + H+NII
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 80 FYNSWVDD----TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 135
N + + + ++ EL + + + + D + + Q+L G+ +LHS
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHS 137
Query: 136 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPE-LYEEE 193
IHRDLK NI V ++ +KI D GLA + + T + APE +
Sbjct: 138 AGI--IHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 194 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------------- 236
Y E VDI+S G + EMV + + Q K + P
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 237 ----------------------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 273
+ +K+ Q + + K +V + R+ + L+ P++
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 274 VTDNPKDLVCDPLRLPNLVPEVMN 297
++ DP + P++ +
Sbjct: 315 ------NVWYDPAEVEAPPPQIYD 332
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (270), Expect = 2e-26
Identities = 62/337 (18%), Positives = 118/337 (35%), Gaps = 77/337 (22%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 79
LG G F TV+ D V+ VA V + V E E+ LL+ + + K
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-----EAAEDEIKLLQRVNDADNTK 73
Query: 80 --------------FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 125
+N + + + L + + +H+ + + +K ++Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 126 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGT 181
+L GL Y+H IIH D+K +N+ + + + + +A + + I T
Sbjct: 134 LLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 182 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY------NECKNPAQIYKKVTSGI 234
E+ +PE L + DI+S I E++T ++ + + K+ I + +
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 235 KPAS---------------------------------------LSKVTDPQVKQFIEKCI 255
+ S SK ++ F+ +
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 256 VP-ASLRLPALELLKDPFLVTDNPKD-LVCDPLRLPN 290
R A L+ P+L KD L + +R+P+
Sbjct: 313 QLDPRKRADAGGLVNHPWL-----KDTLGMEEIRVPD 344
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 1e-18
Identities = 30/199 (15%), Positives = 61/199 (30%), Gaps = 22/199 (11%)
Query: 20 EILGKGAFKTVYKGFDEVDGIEVA-----WNQVNIEDVMQSPDQLE-RLYSEVHLLKSLK 73
+++G+G V+ + E E + + V + D + +
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 74 HENIIKFYNSWVD---DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 130
+ K V ++ EL K+ V ++ IL +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNA-VLMELI-------DAKELYRVRVENPDEVLDMILEEV 116
Query: 131 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 190
+ I+H DL N+ V+ + I D ++ + + R ++ +
Sbjct: 117 AKFYHRG--IVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 191 EEEYNELVDIYSFGMCILE 209
Y DI S IL+
Sbjct: 173 SRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 620 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.6 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.26 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.02 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.33 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-61 Score=490.74 Aligned_cols=266 Identities=52% Similarity=0.941 Sum_probs=245.1
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
+..+..||||++.++||+|+||+||+|.++.+|+.||+|.+..... .....+++.+|+++|++++|||||++|++|.+
T Consensus 2 ~g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 79 (270)
T d1t4ha_ 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79 (270)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Confidence 4567899999999999999999999999999999999999876543 45667789999999999999999999999865
Q ss_pred C--CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 87 D--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 87 ~--~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
. ....+|+|||||++|+|.+++.+.+.+++..++.|++||+.||.|||+++++|+||||||+|||+++.+|.+||+||
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 3 34678999999999999999999999999999999999999999999998889999999999999766899999999
Q ss_pred cchhhccCCCCccccCCCCCCCccccccccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 165 GLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 165 Gla~~~~~~~~~~~~GTp~y~APEll~~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
|+|+........+.+|||.|||||++.+.|+.++|||||||++|||++|+.||.+..+..++++.+..+..|..++...+
T Consensus 160 Gla~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 160 GLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred CcceeccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 99987766667788999999999999999999999999999999999999999988888999999999888888888889
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLV 274 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~ 274 (620)
+++++||.+||+ +|.+|||+.|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999998 899999999999999996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-57 Score=461.27 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=220.5
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
+-..|++.+.||+|+||+||+|.++.+|+.||+|+++.... .+..+++.+|+.+|++++|||||+++++|.++ ..
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~ 77 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NI 77 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ce
Confidence 44568999999999999999999999999999999976532 23345689999999999999999999998765 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+|+|||||++|+|.+++.+.+.+++..++.+++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+...
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECE
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEEC-CCCCEEEccchhheeec
Confidence 9999999999999999998889999999999999999999999999 99999999999998 78999999999997653
Q ss_pred CC----CCccccCCCCCCCcccccc-cc-CccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 007055 172 QP----TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 245 (620)
Q Consensus 172 ~~----~~~~~~GTp~y~APEll~~-~y-~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~ 245 (620)
.. .....+||+.|||||++.+ .| +.++|||||||++|||+||+.||....+....+..+.............++
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCH
Confidence 22 2456789999999998865 44 678999999999999999999998766666666666655444444455689
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 246 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 246 ~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
++++||.+||+ +|.+|||+.|+|+||||++..
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 235 APLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 99999999998 899999999999999998643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=456.61 Aligned_cols=253 Identities=23% Similarity=0.423 Sum_probs=225.3
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.+|+.++|||||+++++|.++ ..+|+
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~i 83 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVYL 83 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEEE
Confidence 4799999999999999999999999999999987543211 22346688999999999999999999998754 46999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCCC
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 174 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~ 174 (620)
|||||++|+|.+++.+.+.+++..++.|++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|.......
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCCC
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceec-CCCCEeecccceeeecCCCc
Confidence 9999999999999999999999999999999999999999999 99999999999998 78999999999998776666
Q ss_pred CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 007055 175 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 253 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~k 253 (620)
....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. .++...++++++||.+
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISR 237 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHH
Confidence 677889999999999875 489999999999999999999999976 677778888776533 3556788999999999
Q ss_pred hcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 254 CIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 254 cL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
||+ +|.+|||+.|+|+||||+..
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCCc
Confidence 998 89999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=451.96 Aligned_cols=255 Identities=26% Similarity=0.465 Sum_probs=212.2
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.++.+|+.||+|.++.... .+...+.+.+|+++|++++|||||+++++|.+.....+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 457999999999999999999999999999999976543 456677899999999999999999999999887777899
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCEEecCCCccceEecCCCCcEEEccccc
Q 007055 94 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~---~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
+|||||++|+|.+++.+ .+.+++..++.|+.||+.||.|||+++ .+|+||||||+|||++ .+|.+||+|||+
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~ 160 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGL 160 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeeccc
Confidence 99999999999999864 467999999999999999999999865 2499999999999998 789999999999
Q ss_pred hhhccCC--CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 007055 167 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 243 (620)
Q Consensus 167 a~~~~~~--~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~ 243 (620)
++..... .....+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..++...+..+..+ .++...
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~ 238 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRY 238 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTS
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCccc
Confidence 9876543 3456789999999998864 599999999999999999999999976 5677788888776544 355667
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
++++++||.+||+ +|.+|||+.|+|+|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 8999999999998 89999999999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=455.85 Aligned_cols=254 Identities=30% Similarity=0.493 Sum_probs=221.6
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
++|++.+.||+|+||+||+|.++.+|+.||+|+++..... ..+.+.+|+.+|+.++|||||+++++|.+. ..+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ 93 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVG--DELW 93 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh----HHHHHHHHHHHHHhCCCCCEeeEeEEEEEC--CEEE
Confidence 4578999999999999999999999999999999865432 245689999999999999999999998765 4699
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+|||||+||+|.+++.+ +++++..++.|++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.....
T Consensus 94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEEC-CCCcEeeccchhheeeccc
Confidence 99999999999998876 46999999999999999999999999 99999999999998 7899999999999765433
Q ss_pred --CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 174 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
.....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+......+...+..+..+...+...++.+++|
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence 3456689999999998875 5999999999999999999999999876555556666666555555566678999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 251 IEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
|.+||+ +|.+|||+.|+|+||||+...
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 999998 899999999999999997543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-56 Score=463.37 Aligned_cols=259 Identities=26% Similarity=0.436 Sum_probs=218.2
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCe
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~ 91 (620)
....|++.+.||+|+||+||+|.++.+|+.||+|+++... .....+++.+|+.+|++++|||||+++++|.++ ..
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 3566899999999999999999999999999999997542 334557799999999999999999999999765 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCCcEEEccccchhhc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 170 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~ 170 (620)
+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||+|...
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeEC-CCCCEEEeeCCCcccc
Confidence 99999999999999999999999999999999999999999997 58 99999999999998 7899999999999877
Q ss_pred cCCCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHH------------------------
Q 007055 171 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ------------------------ 225 (620)
Q Consensus 171 ~~~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~------------------------ 225 (620)
......+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+......
T Consensus 156 ~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 156 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp HHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred CCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 6666677899999999998875 599999999999999999999999976432211
Q ss_pred -----------------HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 226 -----------------IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 226 -----------------i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
....+.....|.......++++++||.+||+ +|.+||||.|+|+||||+...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 1111122222222233467899999999998 9999999999999999986443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=452.05 Aligned_cols=254 Identities=28% Similarity=0.510 Sum_probs=217.6
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
++|++.+.||+|+||+||+|.++.+|+.||+|+++... ....+.+.+|+++|++|+|||||+++++|.++ ..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CeEE
Confidence 46799999999999999999999999999999987542 34456788999999999999999999998765 4699
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+|||||++|+|.+++.+ .+++++..++.|++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|.....
T Consensus 86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECHH
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeEC-CCCCEEEEechhhhccCC
Confidence 99999999999999765 567999999999999999999999999 99999999999998 789999999999865433
Q ss_pred C--CCccccCCCCCCCccccc------cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCC
Q 007055 173 P--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVT 243 (620)
Q Consensus 173 ~--~~~~~~GTp~y~APEll~------~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~ 243 (620)
. ...+.+||+.|||||++. ..|+.++|||||||++|||+||+.||.+. +..+++..+..+.. ....+...
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 241 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRW 241 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHHSCCCCCSSGGGS
T ss_pred CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCCCCCccccC
Confidence 2 234678999999999873 34899999999999999999999999875 44445555555433 33344567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 244 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 244 ~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 242 s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 8999999999998 899999999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-55 Score=453.55 Aligned_cols=255 Identities=28% Similarity=0.460 Sum_probs=223.8
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.|+..+.||+|+||+||+|.++.+|+.||+|+++.... ......+.+.+|+.+|++|+|||||+++++|.+. ..+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEEE
Confidence 457999999999999999999999999999999986543 2345567799999999999999999999998765 4699
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+|||||.+|+|..++...+++++..++.|++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS-
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEC-CCCCEEEeecccccccCC-
Confidence 99999999999988888889999999999999999999999999 99999999999998 789999999999975443
Q ss_pred CCccccCCCCCCCccccc----cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 007055 174 TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 249 (620)
Q Consensus 174 ~~~~~~GTp~y~APEll~----~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~ 249 (620)
....+||+.|||||++. +.|+.++|||||||++|||++|..||.+. +..+....+..+..|...+...++++++
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 34578999999999874 34899999999999999999999999874 4555555666665665556678899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 250 FIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 250 ~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
||.+||+ +|.+|||+.|+|+||||....
T Consensus 246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 9999998 899999999999999997643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-55 Score=450.30 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=225.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+++|++++|||||+++++|.++ ..+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 84 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLY 84 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC-HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEE
Confidence 35899999999999999999999999999999997543211 23346789999999999999999999998654 5799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+|||||+||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC--
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccC-CCceEEecccccceecccC
Confidence 99999999999999999999999999999999999999999999 99999999999998 7899999999999765432
Q ss_pred ----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 174 ----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 174 ----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
...+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++..+..+. ..++...+++++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~ 238 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLE--YDFPEKFFPKAR 238 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTC--CCCCTTCCHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCC--CCCCccCCHHHH
Confidence 2345689999999998875 599999999999999999999999986 57777888887653 235567789999
Q ss_pred HHHHHhcC-CCCCCCCHHH------HhcCCCcCCCCCCccc
Q 007055 249 QFIEKCIV-PASLRLPALE------LLKDPFLVTDNPKDLV 282 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa~e------lL~hpff~~~~~~~~~ 282 (620)
+||.+||+ +|.+|||++| +++||||+..++..+.
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence 99999998 8999999987 5889999998877654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=446.51 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=224.1
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC--HHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~--~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
...+|++.+.||+|+||+||+|.++.+|+.||+|+++....... ....+.+.+|+.+|++|+|||||+++++|.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-- 85 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-- 85 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence 45678999999999999999999999999999999986543222 22357789999999999999999999998655
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCC----cEEEcccc
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLG 165 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G----~vKI~DFG 165 (620)
..+|+|||||++|+|.+++...+.+++..++.+++||+.||+|||+++ |+||||||+|||++ .+| .+||+|||
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~-~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL-DRNVPKPRIKIIDFG 162 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CSSSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEe-cCCCcccceEecchh
Confidence 579999999999999999999899999999999999999999999999 99999999999997 444 59999999
Q ss_pred chhhccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCC
Q 007055 166 LAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSK 241 (620)
Q Consensus 166 la~~~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~ 241 (620)
++...... ......||+.|+|||++.+ .|+.++|||||||++|||+||+.||.+ .+..+.+..+..+..+ .....
T Consensus 163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhcC
Confidence 99766443 3456789999999998875 599999999999999999999999986 5667777777765432 22335
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCCCCccc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~~~~~ 282 (620)
..++.+++||.+||. +|.+|||+.|+|+||||+..++...+
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-------
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHhh
Confidence 678899999999998 89999999999999999976665543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=455.28 Aligned_cols=264 Identities=23% Similarity=0.430 Sum_probs=231.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+++.+|+.+|+.++|||||+++++|.+. ..+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~ 81 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--cccc
Confidence 35799999999999999999999999999999998653221 23456788999999999999999999998765 5799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC-
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~- 172 (620)
+|||||+||+|.+++.+.+.+++..++.+++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEec-CCCCEEEeecccccccccC
Confidence 99999999999999999999999999999999999999999999 99999999999998 789999999999976543
Q ss_pred -CCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 173 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 173 -~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
......+|||.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+..++++.+..+. ..++...++++++|
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dl 235 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSL 235 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCC--CCCCccCCHHHHHH
Confidence 34456789999999998864 599999999999999999999999987 67777888887764 34566789999999
Q ss_pred HHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCccccCCC
Q 007055 251 IEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPL 286 (620)
Q Consensus 251 I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~ 286 (620)
|.+||+ +|.+|++ +.|+++||||+..++..+....+
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~ 277 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 277 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred HHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCC
Confidence 999998 8999994 89999999999887766544433
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-54 Score=448.99 Aligned_cols=256 Identities=22% Similarity=0.385 Sum_probs=206.9
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
...|++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+|+.+|+.++|||||+++++|.++ ..+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESG--GHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 35589999999999999999999999999999999765432 2335688999999999999999999998654 579
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEccccchhhc
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVM 170 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~DFGla~~~ 170 (620)
|+|||||+||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+.. .+|.+||+|||++...
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999999999999999999999999999999999999999 999999999999952 4789999999999765
Q ss_pred cCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHH
Q 007055 171 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQ 246 (620)
Q Consensus 171 ~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~~~~ 246 (620)
... ...+.+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .+...+...+..+..+ .......+++
T Consensus 161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 239 (307)
T d1a06a_ 161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDS 239 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCCCHH
Confidence 443 3456789999999998875 599999999999999999999999987 5566777777765443 3344567899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 247 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 247 lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 240 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999998 89999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.4e-54 Score=447.64 Aligned_cols=266 Identities=28% Similarity=0.433 Sum_probs=230.5
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.|++.+.||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|+.+|+.++|||||+++++|.+. ..+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ 80 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIF 80 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeC--Ceee
Confidence 3479999999999999999999999999999999754321 123356789999999999999999999998754 5799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+|||||.||+|..++.....+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|......
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEc-CCCCEEEecCccceEeccc
Confidence 99999999999999999999999999999999999999999999 99999999999998 7899999999999765443
Q ss_pred CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 007055 174 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252 (620)
Q Consensus 174 ~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~ 252 (620)
..+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. .++...+++++++|.
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLS 233 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence 356789999999999875 499999999999999999999999987 567777777776533 345567899999999
Q ss_pred HhcC-CCCCCC-----CHHHHhcCCCcCCCCCCccccCCCCCC
Q 007055 253 KCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 289 (620)
Q Consensus 253 kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~~~p 289 (620)
+||+ +|.+|+ |++++|+||||+..++..+....+..|
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p 276 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 276 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcC
Confidence 9998 899886 899999999999988776554444333
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-53 Score=452.86 Aligned_cols=265 Identities=22% Similarity=0.358 Sum_probs=223.1
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc--CCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~--~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
.|++.++||+|+||+||+|.++.+|+.||+|++...... .......+...|+.+++.++|||||+++++|.+. ..+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~~~ 82 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKL 82 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--CEE
Confidence 479999999999999999999999999999998754321 1222233344567788888999999999998665 469
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 93 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
|+|||||+||+|.+++.+++.+++..++.|++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEc-CCCcEEEeeeceeeecCC
Confidence 999999999999999999999999999999999999999999999 99999999999998 789999999999987776
Q ss_pred CCCccccCCCCCCCccccc-c-ccCccchhhhhHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHHH
Q 007055 173 PTARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVK 248 (620)
Q Consensus 173 ~~~~~~~GTp~y~APEll~-~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~~~~lk 248 (620)
......+||+.|+|||++. + .|+.++|||||||++|||+||+.||.+... ...+...+. ..+..++...+++++
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPELR 237 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS--SCCCCCCSSSCHHHH
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCCCCHHHH
Confidence 6677789999999999875 3 489999999999999999999999976432 223333322 234455667889999
Q ss_pred HHHHHhcC-CCCCCCC-----HHHHhcCCCcCCCCCCccccCCC
Q 007055 249 QFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPL 286 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~ 286 (620)
+||.+||+ +|.+||| |+|+|+||||+..++..+.....
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~ 281 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY 281 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCC
Confidence 99999998 9999999 79999999999988766544333
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-53 Score=450.91 Aligned_cols=266 Identities=23% Similarity=0.388 Sum_probs=230.5
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
..|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+++|+.++|||||+++++|.+. ..++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~ 117 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLY 117 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHHcCCCcEeecccccccc--cccc
Confidence 45799999999999999999999999999999997543211 23456789999999999999999999998654 4689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
+||||+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+.....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccC-CCCCEEeeeceeeeecccc
Confidence 99999999999999999999999999999999999999999999 99999999999998 7899999999999766543
Q ss_pred CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 007055 174 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 252 (620)
Q Consensus 174 ~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~ 252 (620)
..+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+...++..+..+.. .++...++++++||.
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLR 270 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHH
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHHH
Confidence 346789999999998875 599999999999999999999999976 567777777776643 345567899999999
Q ss_pred HhcC-CCCCCC-----CHHHHhcCCCcCCCCCCccccCCCCCC
Q 007055 253 KCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 289 (620)
Q Consensus 253 kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~~~p 289 (620)
+||+ +|.+|+ |+.++|+||||+..++..+....+..|
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p 313 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcC
Confidence 9998 898884 899999999999988766654444444
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.7e-53 Score=448.02 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=221.0
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.++.+|+.||+|++... .....+.+.+|+.+|++|+|||||+++++|.++ ..+|+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~i 100 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVM 100 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 479999999999999999999999999999998643 345567899999999999999999999998765 46999
Q ss_pred EEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC-CCCcEEEccccchhhccC
Q 007055 95 ITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~-~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~G~vKI~DFGla~~~~~ 172 (620)
|||||+||+|.+++. ..+++++..++.|++||+.||.|||++| |+||||||+|||++. .+|.+||+|||+++....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999999985 4567999999999999999999999999 999999999999963 368999999999976654
Q ss_pred C-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHH
Q 007055 173 P-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVK 248 (620)
Q Consensus 173 ~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~~~~lk 248 (620)
. ......||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. +.......++.++
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 4 3446789999999998875 599999999999999999999999976 566666776665533 2223345688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCcCCCCC
Q 007055 249 QFIEKCIV-PASLRLPALELLKDPFLVTDNP 278 (620)
Q Consensus 249 ~~I~kcL~-~p~~Rpsa~elL~hpff~~~~~ 278 (620)
+||.+||+ +|.+|||+.|+|+||||+..+.
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 99999998 8999999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-52 Score=445.36 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=220.5
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
.+|++.+.||+|+||+||+|.++.+|+.||+|+++... ....+.+.+|+.+|++|+|||||+++++|.++ ..+|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ 102 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMV 102 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 45799999999999999999999999999999987542 34556788999999999999999999998754 5799
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC-CCCcEEEccccchhhcc
Q 007055 94 MITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~G~vKI~DFGla~~~~ 171 (620)
+|||||+||+|.+++.+.+ ++++..++.|++||+.||.|||++| |+||||||+|||++. .+|.+||+|||+|....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecC
Confidence 9999999999999876554 6999999999999999999999999 999999999999973 46899999999997765
Q ss_pred CC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHH
Q 007055 172 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQV 247 (620)
Q Consensus 172 ~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~~~~l 247 (620)
.. ......||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++..+..+.. +.......++++
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 44 3445689999999998875 599999999999999999999999987 455666666665433 334445678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999998 89999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.1e-52 Score=426.29 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=221.8
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCC-----HHHHHHHHHHHHHHHhCC-CCCcceEEeEEEc
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-----PDQLERLYSEVHLLKSLK-HENIIKFYNSWVD 86 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~-----~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~ 86 (620)
...|++.+.||+|+||+||+|.++.+|+.||+|+++....... +...+.+.+|+.+|++|+ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 3567999999999999999999999999999999987643321 223456889999999997 9999999999865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
+ ..+|+|||||++|+|.+++...+++++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 82 ~--~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 N--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGF 156 (277)
T ss_dssp S--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTT
T ss_pred C--cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-CCCCeEEccchh
Confidence 4 579999999999999999999999999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC-CCccccCCCCCCCcccccc-------ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--C
Q 007055 167 AIVMQQP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 236 (620)
Q Consensus 167 a~~~~~~-~~~~~~GTp~y~APEll~~-------~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p 236 (620)
++..... .....+||+.|+|||++.+ .|+.++||||+||++|+|+||+.||.+ .+.......+..+.. +
T Consensus 157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCC
T ss_pred eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCC
Confidence 9765433 3455789999999998753 378899999999999999999999987 556666666666543 2
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 237 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 237 ~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
.......++++++||.+||+ +|.+|||+.|+|+||||++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 22334578999999999998 8999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=439.58 Aligned_cols=259 Identities=24% Similarity=0.428 Sum_probs=223.2
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHH-hCCCCCcceEEeEEEcCCCCeEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~-~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
.|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|+.++. .++|||||+++++|.+. ..+|
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y 79 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF 79 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence 4789999999999999999999999999999997543211 223455667777654 78999999999998765 4699
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC-
Q 007055 94 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~- 172 (620)
+|||||++|+|.+++...+++++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeec-CCCceeccccchhhhcccc
Confidence 99999999999999999999999999999999999999999999 99999999999998 789999999999975443
Q ss_pred -CCCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 007055 173 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 250 (620)
Q Consensus 173 -~~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~ 250 (620)
.......||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .++.+++..+..+. ..++...++.+++|
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dl 233 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN--PFYPRWLEKEAKDL 233 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCccCCHHHHHH
Confidence 23445689999999998875 699999999999999999999999976 57778888877653 34566789999999
Q ss_pred HHHhcC-CCCCCCCHH-HHhcCCCcCCCCCCccc
Q 007055 251 IEKCIV-PASLRLPAL-ELLKDPFLVTDNPKDLV 282 (620)
Q Consensus 251 I~kcL~-~p~~Rpsa~-elL~hpff~~~~~~~~~ 282 (620)
|.+||+ +|.+||++. ++++||||+..++..+.
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~ 267 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREINWEELE 267 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHH
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccCCHHHHH
Confidence 999998 899999996 89999999987665543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=431.77 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=205.5
Q ss_pred EEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH-HHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEEEE
Q 007055 18 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 96 (620)
Q Consensus 18 i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~-~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~lV~ 96 (620)
..++||+|+||+||+|.++.+|+.||+|+++........ ...+++.+|+.+|++++|||||+++++|.++ ..+|+||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC--Cceeehh
Confidence 357999999999999999999999999999765432221 2235688999999999999999999998655 4589999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC--C
Q 007055 97 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 174 (620)
Q Consensus 97 Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~--~ 174 (620)
||+.+|++..++...+.+++..++.|++||+.||+|||++| |+||||||+|||++ .+|.+||+|||++...... .
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEec-CCCccccccCccccccCCCccc
Confidence 99999988888777788999999999999999999999999 99999999999998 7899999999999765443 3
Q ss_pred CccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC-CCC------------
Q 007055 175 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-PAS------------ 238 (620)
Q Consensus 175 ~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~-p~~------------ 238 (620)
....+||+.|+|||++.+ .|+.++|||||||++|||+||..||.+..+.+++...... +.. ...
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 445689999999998753 4899999999999999999999999875444443332221 000 000
Q ss_pred -----------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 239 -----------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 239 -----------~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.....++++++||.+||+ +|.+||||.|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 012357899999999998 99999999999999999853
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=426.51 Aligned_cols=252 Identities=21% Similarity=0.370 Sum_probs=213.6
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCC--CCCcceEEeEEEcC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLK--HENIIKFYNSWVDD 87 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~--~~~~~l~~Ei~iL~~L~--HpNIVkl~~~f~~~ 87 (620)
....|++.++||+|+||+||+|.++.+|+.||+|+++........ ....++.+|+.+|++++ |||||+++++|.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 344579999999999999999999999999999999865432111 11234678999999996 89999999998654
Q ss_pred CCCeEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~g-GsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++||||+.+ +++.+++.+.+.+++..++.|++||+.||.|||+++ |+||||||+|||++.+++.+||+|||+
T Consensus 82 --~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 82 --DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp --SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred --CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccc
Confidence 468999999976 688999998899999999999999999999999999 999999999999986668999999999
Q ss_pred hhhccCCCCccccCCCCCCCcccccc-c-cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 167 AIVMQQPTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 167 a~~~~~~~~~~~~GTp~y~APEll~~-~-y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
|.........+..||+.|+|||++.+ . ++.++|||||||++|+|+||+.||.. .. .+..+ ...++...+
T Consensus 158 a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~----~i~~~--~~~~~~~~s 228 (273)
T d1xwsa_ 158 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DE----EIIRG--QVFFRQRVS 228 (273)
T ss_dssp CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HH----HHHHC--CCCCSSCCC
T ss_pred ceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC---ch----HHhhc--ccCCCCCCC
Confidence 98776666677899999999998864 3 46789999999999999999999965 22 22332 223455678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999998 99999999999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=433.23 Aligned_cols=255 Identities=22% Similarity=0.354 Sum_probs=219.0
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 90 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~ 90 (620)
+++| |++.+.||+|+||+||+|.++.+|+.||+|.++... .....+.+|+++|+.++|||||+++++|.++ .
T Consensus 3 ~~~r-Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~ 74 (321)
T d1tkia_ 3 LYEK-YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESM--E 74 (321)
T ss_dssp CTTT-EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--T
T ss_pred Cccc-eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--C
Confidence 4555 489999999999999999999999999999997542 3345688999999999999999999998765 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC-CCCcEEEccccchh
Q 007055 91 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAI 168 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~G~vKI~DFGla~ 168 (620)
.+|+|||||+||+|.+++...+ .+++..++.|++||+.||.|||++| |+||||||+|||++. ..+.+||+|||++.
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhh
Confidence 6999999999999999998765 7999999999999999999999999 999999999999973 23589999999997
Q ss_pred hccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCc
Q 007055 169 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTD 244 (620)
Q Consensus 169 ~~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~~ 244 (620)
..... ......||+.|+|||.+.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+... .......+
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCC
Confidence 65443 3455689999999998764 599999999999999999999999976 5667777777765432 22223568
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 232 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 899999999998 89999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=429.40 Aligned_cols=256 Identities=19% Similarity=0.322 Sum_probs=206.9
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHH-hCCCCCcceEEeEEEc--
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWVD-- 86 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~-~L~HpNIVkl~~~f~~-- 86 (620)
.+.++|.-+.++||+|+||+||+|.++.+|+.||+|+++.. ..+.+|+.++. .++|||||+++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 34556644457899999999999999999999999998632 34678998865 4589999999999865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIG 162 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~ 162 (620)
.....+|+|||||+||+|.+++.+. .++++..++.|++||+.||+|||++| |+||||||+|||++. .++.+||+
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccc
Confidence 3346799999999999999999875 46999999999999999999999999 999999999999973 35689999
Q ss_pred cccchhhccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCC--
Q 007055 163 DLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYKKVTSGIK-- 235 (620)
Q Consensus 163 DFGla~~~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~---i~~~i~~~~~-- 235 (620)
|||+|+..... .....+|||.|||||++.+ .|+.++|||||||++|+|+||+.||.+...... +...+..+..
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 99999765433 4456789999999999875 599999999999999999999999976433222 2222222211
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 236 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 236 p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
|.......++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 111112367899999999998 89999999999999999754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-50 Score=414.34 Aligned_cols=259 Identities=21% Similarity=0.307 Sum_probs=210.5
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC-
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 89 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~- 89 (620)
....+|++.+.||+|+||+||+|.++.+|+.||+|+++.... ......+++.+|+++|+.++|||||++++++.....
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 344557999999999999999999999999999999975433 345667789999999999999999999999876543
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 90 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 90 -~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..+|+|||||+||+|.+++...+++++..++.|++||+.||.|||++| |+||||||+|||++ .++.++|+|||.+.
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIAR 159 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCE
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccC-ccccceeehhhhhh
Confidence 468999999999999999999999999999999999999999999999 99999999999998 78999999999885
Q ss_pred hccCC-----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCC
Q 007055 169 VMQQP-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSK 241 (620)
Q Consensus 169 ~~~~~-----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~ 241 (620)
..... .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+........+.+.....+ .....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 43222 3345689999999998875 59999999999999999999999998754444444555554433 23455
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 273 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff 273 (620)
..++.+++||.+||+ +|.+||++.+.|.|+|.
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 678999999999998 89999954444455554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=416.98 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=207.4
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
.|++.+.||+|+||+||+|.++.+|+.||+|+++.... .....+++.+|+++|++++|||||+++++|.+. ..+|+
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~i 78 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYL 78 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--cceeE
Confidence 57899999999999999999999999999999975432 223346788999999999999999999999765 46999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC
Q 007055 95 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~ 173 (620)
||||+.++.+...... .+++++..++.++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+|......
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCCC
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeec-ccCcceeccCCcceeccCC
Confidence 9999976555444333 456999999999999999999999999 99999999999998 7889999999999766543
Q ss_pred --CCccccCCCCCCCcccccc-c-cCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Q 007055 174 --TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS----------- 238 (620)
Q Consensus 174 --~~~~~~GTp~y~APEll~~-~-y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~----------- 238 (620)
.....+||+.|+|||++.. . ++.++|||||||++|+|++|+.||.+......+++.......+..
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 3445689999999997653 3 688999999999999999999999876555555544332111100
Q ss_pred ----C-----------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 239 ----L-----------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 239 ----~-----------~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+ ....++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0 11346789999999998 89999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-51 Score=416.72 Aligned_cols=251 Identities=30% Similarity=0.476 Sum_probs=212.0
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+....|++.+.||+|+||+||+|... ..||||+++.... .....+.+.+|+.+|++++|||||++++++..
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-- 75 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-- 75 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--
Confidence 5666677899999999999999999753 3599999875432 34567889999999999999999999997532
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 89 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
..+++|||||++|+|.+++... .++++..+..++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|
T Consensus 76 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla 151 (276)
T d1uwha_ 76 -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLA 151 (276)
T ss_dssp -SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCS
T ss_pred -cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEc-CCCCEEEccccce
Confidence 3478999999999999999765 56999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCC----CCccccCCCCCCCcccccc----ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-
Q 007055 168 IVMQQP----TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS- 238 (620)
Q Consensus 168 ~~~~~~----~~~~~~GTp~y~APEll~~----~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~- 238 (620)
+..... ......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+......+...+..+..++.
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231 (276)
T ss_dssp CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG
T ss_pred eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc
Confidence 655432 2345689999999998752 4899999999999999999999999988778888888877765443
Q ss_pred --CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 239 --LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 239 --~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+...++.+++||.+||. +|.+|||+.|++++
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 445578999999999998 89999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=411.58 Aligned_cols=252 Identities=21% Similarity=0.358 Sum_probs=210.4
Q ss_pred CceEEEE-EEEceeCCeEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 13 VLFLQYD-EILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 13 ~r~y~i~-e~LG~G~fg~Vy~a~d~--~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
.+++.+. ++||+|+||+||+|.+. .+++.||+|+++... ..+...+++.+|+.+|++++|||||+++++|..+
T Consensus 5 ~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-- 80 (277)
T d1xbba_ 5 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-- 80 (277)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS--
T ss_pred hhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC--
Confidence 3455565 47999999999999864 467899999986443 2345567899999999999999999999987533
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..++|||||++|+|.+++.+.+.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++.
T Consensus 81 -~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~ 156 (277)
T d1xbba_ 81 -SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKA 156 (277)
T ss_dssp -SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEE
T ss_pred -CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccc-ccCcccccchhhhhh
Confidence 36899999999999999999999999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCC-----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 007055 170 MQQP-----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 170 ~~~~-----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
.... ......||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+ ..+..
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~ 234 (277)
T d1xbba_ 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAG 234 (277)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTT
T ss_pred ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcc
Confidence 5432 123457899999999876 559999999999999999998 8999987 5677788888877554 34566
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHH---hcCCCcC
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALEL---LKDPFLV 274 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~el---L~hpff~ 274 (620)
.++++++||.+||+ +|.+|||+.++ |+|+|+.
T Consensus 235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 78999999999998 89999999987 5676653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-50 Score=416.24 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=218.0
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+....|++.+.||+|+||+||+|.++.+|+.||+|+++... ...+++.+|+.+|++|+|||||+++++|.+.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~- 85 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE- 85 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEeeC-
Confidence 6666778999999999999999999999999999999986432 2345689999999999999999999998654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 86 -~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFG~ 161 (287)
T d1opja_ 86 -PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGL 161 (287)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCC
T ss_pred -CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEEC-CCCcEEEccccc
Confidence 4588999999999999998764 56899999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCCC---ccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 007055 167 AIVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 167 a~~~~~~~~---~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
|+....... ....||+.|+|||++. +.|+.++|||||||++|||++|..||....+..++++.+..+..+. .+..
T Consensus 162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~ 240 (287)
T d1opja_ 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-RPEG 240 (287)
T ss_dssp TTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC-CCTT
T ss_pred eeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC-CCcc
Confidence 987654432 2345889999999876 5699999999999999999998888777788888888888775543 4556
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.++.+++||.+||+ +|.+|||+.|+++
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 78999999999998 8999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.6e-50 Score=412.48 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=208.3
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
+|++.++||+|+||+||+|.++ +|+.||+|+++.... .....+++.+|+.+|++++|||||+++++|.+++ .+++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~i 77 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVL 77 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEE
T ss_pred CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--ceeE
Confidence 5689999999999999999986 889999999976542 2233567899999999999999999999997664 5889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
++||+.++.+..+....+.+++..++.+++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV 154 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC--
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEc-CCCCEEecccccceecccCc
Confidence 9999999888888888889999999999999999999999999 99999999999998 7899999999999766543
Q ss_pred -CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC--------------
Q 007055 174 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-------------- 235 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~-------------- 235 (620)
......|++.|+|||.+.+ .++.++|||||||++|||++|+.||.+.....++.+.... +..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 2345579999999998753 4799999999999999999999999875444443332211 000
Q ss_pred -----------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 236 -----------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 236 -----------p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
........++.+++||.+||+ +|.+|||+.|+|+||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 011223457899999999998 9999999999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=409.96 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=217.0
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+....|++.+.||+|+||+||+|.++ ++..||||+++.... ..+.+.+|+.+|++++|||||++++++.++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-----CHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 35666778999999999999999999975 678999999874321 235689999999999999999999976432
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
.+++|||||++|+|.+++... .++++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 81 ---~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG 154 (272)
T d1qpca_ 81 ---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFG 154 (272)
T ss_dssp ---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCT
T ss_pred ---CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeee-cccceeecccc
Confidence 468999999999999977543 35999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCC---CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 166 LAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 166 la~~~~~~---~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+|+..... ......||+.|||||++. +.|+.++|||||||++|||+||..|+....+..++...+..+..+. .+.
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~ 233 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPD 233 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCT
T ss_pred ceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-Ccc
Confidence 99766443 233467899999999886 5699999999999999999997766666677888888888775554 455
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc--CCCcCC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK--DPFLVT 275 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~--hpff~~ 275 (620)
..++++++||.+||+ +|.+|||+.++++ |+||..
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 678899999999998 8999999999998 788753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=412.69 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=207.0
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccC-CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCcceEEeEEEcC-
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDD- 87 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~t-g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpNIVkl~~~f~~~- 87 (620)
...|++.+.||+|+||+||+|.+..+ ++.||+|+++...... .....+.+|+.+|+.| +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 35679999999999999999999765 6789999997653221 1122355677776655 899999999998642
Q ss_pred --CCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 88 --TNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 88 --~~~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
....+++++||+.+|.+...... ...+++..++.+++||+.||+|||+++ |+||||||+|||++ .+|.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc-CCCCeeecch
Confidence 34578999999998887655443 456999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CC------
Q 007055 165 GLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK------ 235 (620)
Q Consensus 165 Gla~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~-~~------ 235 (620)
|++...... .....+||+.|+|||++. ..|+.++|||||||++|||+||+.||.+.. ..+....+... ..
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhhCCCchhcc
Confidence 998655433 345678999999999875 569999999999999999999999998754 44333333210 00
Q ss_pred ------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 236 ------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 236 ------------------p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
...+....++.+++||.+||+ +|.+||||.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 011234467899999999998 999999999999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=417.36 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=211.3
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEe
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 82 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg-----~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~ 82 (620)
|.+....|++.++||+|+||+||+|.+..++ ..||+|.+.... .......+.+|+.+|.++ +|||||++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4455567899999999999999999987654 479999886432 234456788999999998 8999999999
Q ss_pred EEEcCCCCeEEEEEeccCCCCHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 007055 83 SWVDDTNRTINMITELFTSGSLRQYRKKH-----------------------KNVDMKAIKNWARQILRGLHYLHSHNPP 139 (620)
Q Consensus 83 ~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~-----------------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~ 139 (620)
+|.+.. .+++|||||++|+|.+++... ..+++..++.++.||+.||.|||+++
T Consensus 109 ~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-- 184 (325)
T d1rjba_ 109 ACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 184 (325)
T ss_dssp EECSSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEeeCC--eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 986554 588999999999999999754 24899999999999999999999999
Q ss_pred EEecCCCccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-c
Q 007055 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-C 213 (620)
Q Consensus 140 IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G 213 (620)
||||||||+|||++ .+|.+||+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+| |
T Consensus 185 IiHRDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 185 CVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp EEETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred eeeccCchhccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 99999999999998 78999999999997654432 23456899999999775 569999999999999999998 8
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 214 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 214 ~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+.||.+......+.+.+..+..+ ..+...++++++||.+||+ +|.+|||+.||++|
T Consensus 264 ~~Pf~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 264 VNPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99998876667777777766544 4556778999999999998 89999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-49 Score=411.49 Aligned_cols=252 Identities=21% Similarity=0.371 Sum_probs=203.9
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~---~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
..+....|++.++||+|+||+||+|.++.+|. .||+|.+... ......+.+.+|+.+|++|+|||||++++++.
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~ 97 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT 97 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 34556788999999999999999999987765 5888877533 34566778999999999999999999999986
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
+. ..+++|||||++|+|.+++... +.+++.++..|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+||
T Consensus 98 ~~--~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DF 172 (299)
T d1jpaa_ 98 KS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDF 172 (299)
T ss_dssp SS--SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC
T ss_pred eC--CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEEC-CCCcEEECCc
Confidence 55 4588999999999999988874 56999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCCC-------CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC
Q 007055 165 GLAIVMQQPT-------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 235 (620)
Q Consensus 165 Gla~~~~~~~-------~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~ 235 (620)
|+++...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ ....++...+..+..
T Consensus 173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYR 251 (299)
T ss_dssp -----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCC
T ss_pred ccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCC
Confidence 9997654321 11245799999999876 569999999999999999998 8999987 456777788877755
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 236 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 236 p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
++ .+...++.+++||.+||+ +|.+|||+.|++++
T Consensus 252 ~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 252 LP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CC-CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 44 345678999999999998 89999999998864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=403.24 Aligned_cols=246 Identities=20% Similarity=0.374 Sum_probs=202.0
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
.+.|++.+.||+|+||+||+|.+. ++..||||+++.... ..+.+.+|+.++++++|||||++++++..+. .+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~ 75 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PI 75 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-----cHHHHHHHHHHHHhcCCCCcccccceeccCC--ce
Confidence 456899999999999999999976 678899999874321 2356899999999999999999999986554 58
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 93 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
++|||||++|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC------
T ss_pred EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeec-CCCCeEecccchheecc
Confidence 8999999999999998755 56899999999999999999999999 99999999999998 78999999999997654
Q ss_pred CCC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 172 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 172 ~~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
... .....||+.|+|||++. +.|+.++|||||||++|||+|+..|+....+..++...+..+..+. .+...++++
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l 231 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHV 231 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-CCTTSCHHH
T ss_pred CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC-CccccCHHH
Confidence 332 23457899999999887 4699999999999999999996555555577888888888775543 456678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.+||.+||+ +|.+|||+.|+|+|
T Consensus 232 ~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 232 YQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999998 89999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=406.34 Aligned_cols=252 Identities=19% Similarity=0.368 Sum_probs=213.4
Q ss_pred cCceEEEEEE-EceeCCeEEEEEEEcc--CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 12 FVLFLQYDEI-LGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 12 ~~r~y~i~e~-LG~G~fg~Vy~a~d~~--tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
....+.+.+. ||+|+||+||+|.++. ++..||||.++.. ......+++.+|+++|++++|||||++++++..+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 81 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 81 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence 3456778885 9999999999998754 5668999998643 3456678899999999999999999999987543
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 89 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
.+|+|||||++|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 82 --~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla 156 (285)
T d1u59a_ 82 --ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLS 156 (285)
T ss_dssp --SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTC
T ss_pred --eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeec-cCCceeeccchhh
Confidence 478999999999999997654 57999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCC-----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 007055 168 IVMQQP-----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 168 ~~~~~~-----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 240 (620)
+..... ......||+.|+|||++. +.|+.++|||||||++|||+| |+.||.+. +..++...+..+..++ .+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-~~~~~~~~i~~~~~~~-~p 234 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRME-CP 234 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCCC-CC
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CC
Confidence 765432 223457899999999876 569999999999999999998 99999875 4566777888776554 45
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHH---hcCCCcC
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRLPALEL---LKDPFLV 274 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rpsa~el---L~hpff~ 274 (620)
...++++.+||.+||+ +|.+|||+.++ |+|+|+.
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 6688999999999998 89999999877 6788764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.8e-49 Score=410.64 Aligned_cols=253 Identities=21% Similarity=0.361 Sum_probs=211.1
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCe
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT 91 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~ 91 (620)
.+.|++.++||+|+||+||+|.++.+|+.||+|+++... .+++.+|+.+|+.+. ||||++++++|.......
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 345899999999999999999999999999999986432 356889999999995 999999999998777778
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhcc
Q 007055 92 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 171 (620)
Q Consensus 92 l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~ 171 (620)
+++|||||.+|+|..+ .+.+++..++.+++||+.||.|||++| |+||||||+|||++..++.+||+|||+|....
T Consensus 107 ~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 107 PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999999999765 356999999999999999999999999 99999999999998556679999999997655
Q ss_pred CC-CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------------CC
Q 007055 172 QP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------------GI 234 (620)
Q Consensus 172 ~~-~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~--------------~~ 234 (620)
.. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||....+.......+.. ..
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 43 4556789999999998654 4899999999999999999999999876554432222210 00
Q ss_pred ---------------------CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 235 ---------------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 235 ---------------------~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
.+.......++++++||.+||+ +|.+|||++|+|+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 0011112357899999999998 999999999999999998754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=412.86 Aligned_cols=252 Identities=21% Similarity=0.341 Sum_probs=205.9
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC----CCC
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----TNR 90 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~----~~~ 90 (620)
.|+..++||+|+||+||+|.++.+|+.||+|+++..... ..+|+++|++|+||||++++++|... +..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 578899999999999999999999999999999755322 23699999999999999999998653 345
Q ss_pred eEEEEEeccCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 91 TINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~---i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
++++|||||++|.+..+ ......+++..++.|++||+.||+|||++| |+||||||+|||++.++..+||+|||++
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccch
Confidence 78999999987754433 345667999999999999999999999999 9999999999999854458999999999
Q ss_pred hhccC-CCCccccCCCCCCCccccc--cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-C----------
Q 007055 168 IVMQQ-PTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G---------- 233 (620)
Q Consensus 168 ~~~~~-~~~~~~~GTp~y~APEll~--~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~---------- 233 (620)
..... ....+.+||+.|+|||++. ..|+.++|||||||++|||++|+.||.......++...+.. +
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 76543 3455678999999999764 35899999999999999999999999875544444433221 0
Q ss_pred -------CCCC--------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 234 -------IKPA--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 234 -------~~p~--------~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
..+. ......++++++||.+||+ +|.+||||.|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0000 1123467899999999998 99999999999999999764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=399.57 Aligned_cols=254 Identities=23% Similarity=0.396 Sum_probs=217.7
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEEE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 94 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~l 94 (620)
+|++.+.||+|+||+||+|.++.+|+.||||+++.... ......++.+|+.+|+.++||||++++++|.+. ..+++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~i 78 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTL 78 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeeccccccc--cceeE
Confidence 57999999999999999999999999999999976542 345667899999999999999999999998765 46889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccCC-
Q 007055 95 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 173 (620)
Q Consensus 95 V~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~~- 173 (620)
|++++.+++|..++..++.+++..++.+++|++.||+|||+++ |+||||||+|||++ .++.+||+|||.+......
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSCC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccc-cCCceeeeecchhhcccCCC
Confidence 9999999999999999999999999999999999999999999 99999999999998 6889999999999765443
Q ss_pred -CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------
Q 007055 174 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--------------- 235 (620)
Q Consensus 174 -~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--------------- 235 (620)
......+++.|+|||++.+ .++.++|||||||++|||++|..||....+..+....+.....
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 2334567889999998764 3789999999999999999999998777777766665532100
Q ss_pred ------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 236 ------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 236 ------------p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
........++.+++||.+||+ +|.+||||+|+|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 111223457899999999998 9999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-49 Score=413.65 Aligned_cols=260 Identities=29% Similarity=0.444 Sum_probs=208.1
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+.. .|++.+.||+|+||+||+|.++.+|+.||||+++... .+....+++.+|+++|+.++|||||+++++|....
T Consensus 14 ~~~~~-~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 14 WEVRA-VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp ECCBS-SEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred eecCC-cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 45544 4589999999999999999999999999999987542 34566788999999999999999999999987653
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 89 ----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 89 ----~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
...+|+||||+ +++|..+.+ .+++++..++.+++||+.||.|||++| |+||||||+|||++ .+|.+||+||
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Df 165 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDF 165 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCC
T ss_pred cccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcc-cccccccccc
Confidence 23679999999 567777665 467999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-C--------
Q 007055 165 GLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G-------- 233 (620)
Q Consensus 165 Gla~~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~-~-------- 233 (620)
|++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...... +
T Consensus 166 g~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 166 GLARQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp TTCEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cceeccCCc-cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 999765443 356789999999998754 4789999999999999999999999875433333222111 0
Q ss_pred ----------------CCC---CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCCC
Q 007055 234 ----------------IKP---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 277 (620)
Q Consensus 234 ----------------~~p---~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~~ 277 (620)
... .......++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000 11223467899999999998 999999999999999998754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=407.15 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=206.2
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC-----
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----- 88 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~----- 88 (620)
..|++.+.||+|+||+||+|.++.+|+.||||++..... ......++.+|+.+|+.++||||+++++++....
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 356999999999999999999999999999999876543 2234466889999999999999999999986532
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccch
Q 007055 89 -NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 167 (620)
Q Consensus 89 -~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla 167 (620)
...+++||||+.++.+..+......+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeec-CCCcEEeeeccee
Confidence 3468999999998888777777788999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccC------CCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCC
Q 007055 168 IVMQQ------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKP 236 (620)
Q Consensus 168 ~~~~~------~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~---~~~p 236 (620)
..... ....+.+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+. +.......+.. ...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-CHHHHHHHHHHhcCCCCh
Confidence 64432 12334689999999998753 5899999999999999999999999764 44433333322 1111
Q ss_pred CCCCC---------------------------CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 237 ASLSK---------------------------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 237 ~~~~~---------------------------~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
..... ..++.+++||.+||+ +|.+||||.|+|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 11110 125678899999998 9999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=396.42 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=207.6
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg----~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
+....|++.++||+|+||+||+|.+..++ ..||||+++.. ........+.+|+.+|++++|||||++++++.+
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc---cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 44456889999999999999999987665 57999998643 245566779999999999999999999998865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
. ..+++|||||.+|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 81 ~--~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFG 155 (283)
T d1mqba_ 81 Y--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFG 155 (283)
T ss_dssp S--SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCC
T ss_pred C--CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEEC-CCCeEEEcccc
Confidence 4 4588999999999999987655 67999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCC-----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 007055 166 LAIVMQQP-----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 239 (620)
Q Consensus 166 la~~~~~~-----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~ 239 (620)
+++..... ......||+.|||||++. +.|+.++|||||||++|||++|..||....+..+++..+..+..++ .
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~ 234 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-T 234 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-C
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-C
Confidence 99765432 122346899999999876 4599999999999999999997777766678888888888886654 4
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+...++.++++|.+||. +|.+|||+.|+++
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 235 PMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 55678999999999998 8999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=415.44 Aligned_cols=267 Identities=21% Similarity=0.354 Sum_probs=219.8
Q ss_pred ceEEEEEEEceeCCeEEEEEEE---ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCcceEEeEEEcCCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFD---EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTN 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d---~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pNIVkl~~~f~~~~~ 89 (620)
+.|++.+.||+|+||+||+|.+ +.+|+.||+|+++...........+.+.+|+.+|++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 4589999999999999999987 457999999998755432222334568899999999977 8999999988665
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhh
Q 007055 90 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 169 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~ 169 (620)
..+++|+||+.+|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKE 178 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEEE
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeec-CCCCEEEeeccchhh
Confidence 468999999999999999999999999999999999999999999999 99999999999998 789999999999965
Q ss_pred ccCC---CCccccCCCCCCCcccccc---ccCccchhhhhHHHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCCCCC
Q 007055 170 MQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLS 240 (620)
Q Consensus 170 ~~~~---~~~~~~GTp~y~APEll~~---~y~~~~DIwSlGiilyELltG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~ 240 (620)
.... ...+..||+.|+|||.+.+ .++.++|||||||++|+|+||+.||.+.. ....+.+..... +..++
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~--~~~~~ 256 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYP 256 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CCCCC
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC--CCCCc
Confidence 4322 2345689999999998753 37889999999999999999999996643 233444444433 23355
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCcCCCCCCccccCCCC
Q 007055 241 KVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLR 287 (620)
Q Consensus 241 ~~~~~~lk~~I~kcL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~~ 287 (620)
...++++++||.+||+ +|.+|| +++|+|+||||+..++..+....++
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~ 309 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 309 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCC
Confidence 6789999999999998 899999 5899999999998776665544443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=408.55 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=205.8
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
.+..| |++.+.||+|+||+||+|.++.+|+.||||+++... .....+++.+|+.+|++|+||||+++++++.....
T Consensus 5 ~i~~r-Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 5 DVGPR-YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp CCCTT-EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CcCCC-eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 34445 699999999999999999999999999999987432 35566789999999999999999999999865432
Q ss_pred ---CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 90 ---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 90 ---~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++ ++|+.+|+|.+++... ++++..++.+++||+.||+|||++| ||||||||+|||++ .+|.+||+|||+
T Consensus 81 ~~~~~~~l-~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~ 155 (345)
T d1pmea_ 81 EQMKDVYL-VTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGL 155 (345)
T ss_dssp TTCCCEEE-EEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTT
T ss_pred cccceEEE-EEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEEC-CCCCEEEcccCc
Confidence 23444 5667799999999764 6999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC-----CCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----
Q 007055 167 AIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---- 235 (620)
Q Consensus 167 a~~~~~~-----~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~---- 235 (620)
+...... .....+||+.|+|||++.. .|+.++||||+||++|+|++|+.||............+.....
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 8654322 2345689999999998753 4789999999999999999999999765433333222211000
Q ss_pred ---------------------CC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 236 ---------------------PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 236 ---------------------p~---~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
+. ......++++++||.+||+ +|.+||||.|+|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00 0122456789999999998 99999999999999999854
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=394.71 Aligned_cols=244 Identities=22% Similarity=0.402 Sum_probs=210.9
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeEE
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 93 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l~ 93 (620)
+.|++.++||+|+||+||+|.++ ++..||||.++.... ..+.+.+|+.++++++||||++++++|.++ ..++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~ 75 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIF 75 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-----CHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceE
Confidence 45678999999999999999984 889999999885432 234689999999999999999999988654 4589
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchhhccC
Q 007055 94 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 172 (620)
Q Consensus 94 lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~~~~~ 172 (620)
+||||+.+|+|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+++....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSS
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEc-CCCcEEECcchhheeccC
Confidence 99999999999999654 457999999999999999999999999 99999999999998 789999999999975543
Q ss_pred CC---CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 007055 173 PT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 247 (620)
Q Consensus 173 ~~---~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~~~l 247 (620)
.. .....||+.|+|||++. ..|+.++|||||||++|||+| |+.||.+. +..++...+..+..+ ..+...++++
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l 230 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRL-YRPHLASEKV 230 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-CHHHHHHHHHhCCCC-CCcccccHHH
Confidence 32 23457899999999876 569999999999999999998 89999774 567788888877554 3566788999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 248 KQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 248 k~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
++||.+||+ +|.+|||+.++|+|
T Consensus 231 ~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 231 YTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999998 89999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=398.45 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=213.7
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.|.+..+.|++.+.||+|+||+||+|.+..+ .+||+|+++.... ..+.+.+|+.+|++++|||||++|+++.++
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC-----CHHHHHHHHHHHHhcccCCEeEEEEEEecC
Confidence 3667778899999999999999999998755 6799999874432 235689999999999999999999987432
Q ss_pred CCCeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
.+++|||||++|+|..++.. .+.+++.++..++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 85 ---~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~DfG 158 (285)
T d1fmka3 85 ---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFG 158 (285)
T ss_dssp ---SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCC
T ss_pred ---CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEEC-CCCcEEEcccc
Confidence 36899999999999988754 457999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCC---CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 007055 166 LAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 241 (620)
Q Consensus 166 la~~~~~~---~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 241 (620)
+++..... ......||+.|+|||++. +.++.++|||||||++|||+||..||.......++...+..+..++ .+.
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~ 237 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPP 237 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCT
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCc
Confidence 99765432 223457899999999876 5699999999999999999998777766678888888888776544 556
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc--CCCcCCC
Q 007055 242 VTDPQVKQFIEKCIV-PASLRLPALELLK--DPFLVTD 276 (620)
Q Consensus 242 ~~~~~lk~~I~kcL~-~p~~Rpsa~elL~--hpff~~~ 276 (620)
..++++++||.+||+ +|.+||++.+++. ++||...
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 678999999999998 9999999999987 8888754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=395.32 Aligned_cols=251 Identities=24% Similarity=0.416 Sum_probs=205.0
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 85 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~ 85 (620)
|.+....|++.+.||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.+|++++|||||++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 566677899999999999999999998654 467888887532 34566778999999999999999999999874
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccc
Q 007055 86 DDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 86 ~~~~~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
+ ..+++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+||
T Consensus 79 ~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~-~~~~~Kl~Df 152 (273)
T d1mp8a_ 79 E---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDF 152 (273)
T ss_dssp S---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC-
T ss_pred c---CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeec-CCCcEEEccc
Confidence 3 358899999999999998765 457999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCC---CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 007055 165 GLAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASL 239 (620)
Q Consensus 165 Gla~~~~~~---~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~ 239 (620)
|+++..... ......||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+ .+..+++..+..+..+ ..
T Consensus 153 G~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~-~~ 230 (273)
T d1mp8a_ 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PM 230 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CC
T ss_pred hhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CC
Confidence 999765432 233457899999999886 569999999999999999998 8889976 5667777788877654 35
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+...++.+++||.+||. +|.+|||+.|+++|
T Consensus 231 ~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 56778999999999998 89999999999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=397.87 Aligned_cols=256 Identities=24% Similarity=0.364 Sum_probs=207.2
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceE
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKF 80 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl 80 (620)
..|.+....|++.+.||+|+||.||+|.+.. +++.||+|+++... .....+.+.+|+..+.++ +||||+.+
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 3466666789999999999999999999754 55799999986432 345566788888888776 68999999
Q ss_pred EeEEEcCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecC
Q 007055 81 YNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 144 (620)
Q Consensus 81 ~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrD 144 (620)
++++.... ..+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+|||
T Consensus 83 ~~~~~~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrD 159 (299)
T d1ywna1 83 LGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD 159 (299)
T ss_dssp EEEECSTT-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred eeeeccCC-CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCc
Confidence 99876543 5688999999999999999753 24899999999999999999999999 99999
Q ss_pred CCccceEecCCCCcEEEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhc-CCCCC
Q 007055 145 LKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTC-EYPYN 218 (620)
Q Consensus 145 LKp~NILl~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG-~~Pf~ 218 (620)
|||+|||++ .+|.+||+|||+|+..... ......||+.|||||++.+ .|+.++|||||||++|||+|| ..||.
T Consensus 160 lKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 160 LAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCGGGEEEC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCccceeEC-CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999998 7899999999999755432 2335679999999998764 599999999999999999987 56787
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 219 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 219 ~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+......+...+..+..+. .+...+++++++|.+||. +|.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 239 GVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp TCCCSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7666777777777776553 556678999999999998 89999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=399.62 Aligned_cols=247 Identities=27% Similarity=0.447 Sum_probs=204.3
Q ss_pred ceEEEEEEEceeCCeEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC
Q 007055 14 LFLQYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 89 (620)
Q Consensus 14 r~y~i~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~ 89 (620)
..|++.++||+|+||+||+|.+..+|+ +||+|.++... +....+.+.+|+.+|++++|||||+++++|.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 358999999999999999999988876 57888775332 233456799999999999999999999998754
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 90 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
..++++||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~-~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAK 159 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCCSHHH
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeC-CCCCeEeeccccce
Confidence 367889999999999887654 57999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 007055 169 VMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 242 (620)
Q Consensus 169 ~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 242 (620)
...... .....||+.|+|||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..+..++ .+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~ 237 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPI 237 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCTT
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcc
Confidence 654322 23446899999999776 569999999999999999998 7888876 55667778887776553 4556
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 007055 243 TDPQVKQFIEKCIV-PASLRLPALELLKDP 271 (620)
Q Consensus 243 ~~~~lk~~I~kcL~-~p~~Rpsa~elL~hp 271 (620)
.++.++++|.+||. +|.+|||+.|++.|.
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 78999999999998 899999999999883
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=405.75 Aligned_cols=261 Identities=29% Similarity=0.410 Sum_probs=208.6
Q ss_pred eeeeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 7 VIWSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 7 ~~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
.+|.+..| |++.+.||+|+||+||+|.++.+|+.||||+++... .+....+++.+|+++|++|+|||||+++++|..
T Consensus 12 ~~~~~~~r-Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~ 88 (348)
T d2gfsa1 12 TIWEVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88 (348)
T ss_dssp SEEEEETT-EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred ccccCCCC-eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 34655444 699999999999999999999999999999987543 345566789999999999999999999999864
Q ss_pred CC---CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcc
Q 007055 87 DT---NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 163 (620)
Q Consensus 87 ~~---~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~D 163 (620)
.. ....++|++|+.+|+|.+++.. +++++..++.+++||+.||.|||++| |+||||||+|||++ .+|.+|++|
T Consensus 89 ~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~d 164 (348)
T d2gfsa1 89 ARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILD 164 (348)
T ss_dssp CSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECC
T ss_pred ccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccc-ccccccccc
Confidence 32 2234556778889999999865 57999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc--ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCC----
Q 007055 164 LGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKP---- 236 (620)
Q Consensus 164 FGla~~~~~~~~~~~~GTp~y~APEll~~--~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~-~~p---- 236 (620)
||++..... ...+..||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+. +.......+... ..+
T Consensus 165 fg~a~~~~~-~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 165 FGLARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-DHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp C----CCTG-GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCHHH
T ss_pred cchhcccCc-ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChHH
Confidence 999965443 2345678999999997653 3689999999999999999999999874 333333333211 000
Q ss_pred ----------------CC--------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCCC
Q 007055 237 ----------------AS--------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 276 (620)
Q Consensus 237 ----------------~~--------~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~~ 276 (620)
.. .....++++++||.+||. +|.+||||.|+|+||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00 012357899999999998 99999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=405.44 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=199.0
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC--
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD-- 87 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~-- 87 (620)
++..| |++.++||+|+||+||+|.|+.+|+.||||+++... .+.....++.+|+.+|++++|||||+++++|...
T Consensus 14 ~i~~~-Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 14 TVLKR-YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp EEETT-EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred eecCC-eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh--cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 33445 799999999999999999999999999999997543 2456677899999999999999999999998654
Q ss_pred --CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 88 --TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 88 --~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
....+|+|||||.++.+.. + ...+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+|++|||
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~~~-~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~ 164 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLCQV-I--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFG 164 (355)
T ss_dssp TTTCCEEEEEEECCSEEHHHH-H--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCC
T ss_pred cccCceeEEEEeccchHHHHh-h--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccc-cccceeeechh
Confidence 3368999999997765543 3 457999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCC-CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----------
Q 007055 166 LAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------- 232 (620)
Q Consensus 166 la~~~~~~-~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~----------- 232 (620)
++...... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+.. ......++..
T Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp C---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHT
T ss_pred hhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC-HHHHHHHHHHhccCCCHHHHH
Confidence 98655443 3456689999999998764 58999999999999999999999998743 3332222211
Q ss_pred -----------CCCCCC------------CC------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcCC
Q 007055 233 -----------GIKPAS------------LS------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 275 (620)
Q Consensus 233 -----------~~~p~~------------~~------~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~hpff~~ 275 (620)
...+.. .. ...++.+++||.+||+ +|.+||||+|+|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 100000 00 0125678999999998 9999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=387.36 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=199.5
Q ss_pred eccCceEEEEEEEceeCCeEEEEEEEcc-C--CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEc
Q 007055 10 SLFVLFLQYDEILGKGAFKTVYKGFDEV-D--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 86 (620)
Q Consensus 10 ~~~~r~y~i~e~LG~G~fg~Vy~a~d~~-t--g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~ 86 (620)
-+..+.|++.+.||+|+||+||+|.+.. + +..||||+++.... ......+.+.+|+.+|++++|||||++|+++.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3445679999999999999999998643 3 35799999875443 334566789999999999999999999998854
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEcccc
Q 007055 87 DTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 165 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL~~~i~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFG 165 (620)
. .+++|||||++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 83 ~---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~-~~~~vkl~DfG 156 (273)
T d1u46a_ 83 P---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFG 156 (273)
T ss_dssp S---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCT
T ss_pred c---chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccc-cccceeeccch
Confidence 2 46899999999999987665 456999999999999999999999999 99999999999998 68899999999
Q ss_pred chhhccCCC-----CccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCC
Q 007055 166 LAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 238 (620)
Q Consensus 166 la~~~~~~~-----~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 238 (620)
+++...... .....||+.|+|||++.+ .|+.++|||||||++|||+| |+.||.+ .+..++...+........
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLP 235 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCC
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCC
Confidence 997654332 234467889999998875 58999999999999999998 8999987 566666666665544445
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 239 LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 239 ~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+...++.++++|.+||. +|.+|||+.|++.
T Consensus 236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 566778999999999998 8999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=387.11 Aligned_cols=247 Identities=23% Similarity=0.426 Sum_probs=205.4
Q ss_pred eeccCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCC
Q 007055 9 WSLFVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 88 (620)
Q Consensus 9 ~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~ 88 (620)
|.+.-+.|++.+.||+|+||+||+|.+ +|.+||+|+++.. ...+.+.+|+++|++++||||+++++++.+..
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 677778899999999999999999987 4889999998643 23456899999999999999999999886543
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 89 NRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 89 ~~~l~lV~Ey~~gGsL~~~i~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
..+++||||+++|+|.+++.+.+ .+++..+..|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 74 -~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~ 149 (262)
T d1byga_ 74 -GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGL 149 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC
T ss_pred -CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheec-CCCCEeeccccc
Confidence 35789999999999999986543 5899999999999999999999998 99999999999998 789999999999
Q ss_pred hhhccCCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 007055 167 AIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 244 (620)
Q Consensus 167 a~~~~~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~~ 244 (620)
++..... .....+|+.|+|||++. +.|+.++|||||||++|||+| |+.||.. .+..++...+..+..|+ ++...+
T Consensus 150 s~~~~~~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~ 226 (262)
T d1byga_ 150 TKEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCP 226 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCC
T ss_pred ceecCCC-CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCC
Confidence 9765433 34557899999999875 569999999999999999998 6777765 57778888888776664 455678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 245 PQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 245 ~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+++++||.+||. +|.+|||+.+++++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999998 89999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-46 Score=389.41 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=209.3
Q ss_pred CceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
...|++.+.||+|+||+||+|.++ .++..||||+++.. ......+++.+|+.+|++++||||++++++|...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh---cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 445799999999999999999875 46789999998643 2455667899999999999999999999998654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~------------------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
..+++||||+.+|+|.+++... ..+++..+..+++||+.||+|||+++ ||||
T Consensus 89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHr 164 (301)
T d1lufa_ 89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR 164 (301)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEee
Confidence 4588899999999999998643 24889999999999999999999999 9999
Q ss_pred CCCccceEecCCCCcEEEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCC-CC
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEY-PY 217 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~-Pf 217 (620)
||||+|||++ .++.+||+|||+++..... ...+..||+.|+|||++.+ .|+.++|||||||++|||++|.. ||
T Consensus 165 DlKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 165 DLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EEcccceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999998 7899999999999765332 2234678999999998764 69999999999999999999964 56
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 218 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 218 ~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+ .+..++...+..+..+. .+...++++.+||.+||. +|.+|||+.|+++
T Consensus 244 ~~-~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YG-MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55 67788888888876543 456678999999999998 8999999999865
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=387.76 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=211.0
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEccCC-------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcce
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDEVDG-------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIK 79 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~~tg-------~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk 79 (620)
.|.+..+.|++.+.||+|+||.||+|.+..++ ..||+|+++.. ........+.+|+..+.++ +|||||+
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT---CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc---cChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 47777888999999999999999999876654 57999998643 2455667789999999888 8999999
Q ss_pred EEeEEEcCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 80 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 80 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
++++|.++ ..+++|||||++|+|.+++... ..+++.+++.|++||+.||.|||+++ ||||
T Consensus 84 ~~~~~~~~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHr 159 (299)
T d1fgka_ 84 LLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHR 159 (299)
T ss_dssp EEEEECSS--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred cccccccC--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEee
Confidence 99998654 4689999999999999999754 35899999999999999999999999 9999
Q ss_pred CCCccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCC
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY 217 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf 217 (620)
||||+|||++ .+|.+||+|||+++...... .....||+.|+|||.+. +.|+.++|||||||++|||++ |..||
T Consensus 160 DiKp~NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~ 238 (299)
T d1fgka_ 160 DLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238 (299)
T ss_dssp CCSGGGEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eecccceeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence 9999999998 78999999999997654432 33467899999999876 569999999999999999998 68888
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 218 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 218 ~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
.+ .+..+++..+..+..+. .+...++.+++||.+||+ +|.+|||+.|+|+
T Consensus 239 ~~-~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 239 PG-VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TT-CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 65 67778888888876554 456678999999999998 8999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=390.81 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=207.4
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeE--EEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEeEEEcCCC
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 89 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~--VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~~~f~~~~~ 89 (620)
-+.|++.++||+|+||+||+|.++.+|.. ||||.++.. ......+.+.+|+++|.++ +|||||+++++|.+.
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-- 83 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-- 83 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc---cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--
Confidence 35678999999999999999999999875 667766532 2234556799999999999 799999999998765
Q ss_pred CeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEec
Q 007055 90 RTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 153 (620)
Q Consensus 90 ~~l~lV~Ey~~gGsL~~~i~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 153 (620)
..+++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG 161 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc
Confidence 4699999999999999998654 57999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEccccchhhccCC-CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCC-CCCCCCCHHHHHHHH
Q 007055 154 GNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKV 230 (620)
Q Consensus 154 ~~~G~vKI~DFGla~~~~~~-~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~-Pf~~~~~~~~i~~~i 230 (620)
.++.+||+|||+++..... ......||+.|+|||.+. +.|+.++|||||||++|||++|.. ||. ..+..+++..+
T Consensus 162 -~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~-~~~~~~~~~~i 239 (309)
T d1fvra_ 162 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKL 239 (309)
T ss_dssp -GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHG
T ss_pred -CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC-CCCHHHHHHHH
Confidence 7889999999999654433 233557899999999876 569999999999999999999765 564 47888888888
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 231 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 231 ~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
..+..+. .+...++++++||.+||. +|.+|||+.|+|++
T Consensus 240 ~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 240 PQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8876654 455678999999999998 89999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=387.03 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=209.3
Q ss_pred ccCceEEEEEEEceeCCeEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcC
Q 007055 11 LFVLFLQYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 87 (620)
Q Consensus 11 ~~~r~y~i~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~ 87 (620)
.....+.+.++||+|+||+||+|.+..+ ...||||+++.. .+....+++.+|+++|++|+|||||++++++...
T Consensus 24 ~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 100 (311)
T d1r0pa_ 24 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100 (311)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET
T ss_pred hHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec
Confidence 3344556789999999999999998654 347999998632 3566778899999999999999999999998754
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEccccc
Q 007055 88 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 166 (620)
Q Consensus 88 ~~~~l~lV~Ey~~gGsL~~~i~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~DFGl 166 (620)
. ..+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 101 ~-~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~kL~DFG~ 176 (311)
T d1r0pa_ 101 E-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGL 176 (311)
T ss_dssp T-TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSSGG
T ss_pred C-CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeEC-CCCCEEEecccc
Confidence 3 4688999999999999988754 45788899999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC------CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 007055 167 AIVMQQP------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 239 (620)
Q Consensus 167 a~~~~~~------~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~~ 239 (620)
++..... ......||+.|+|||.+. +.++.++|||||||++|||+||..||....+..++...+..+..+. .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~ 255 (311)
T d1r0pa_ 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-Q 255 (311)
T ss_dssp GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-C
T ss_pred hhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-C
Confidence 9755332 122357899999999876 5699999999999999999998888877667777778888876554 4
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 240 SKVTDPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 240 ~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
+...++.+.+||.+||+ +|.+||++.|+++|
T Consensus 256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 56678899999999998 89999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=385.57 Aligned_cols=252 Identities=23% Similarity=0.387 Sum_probs=214.0
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEe
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 82 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~ 82 (620)
.|.+....|++.+.||+|+||+||+|.+. .++..||||+++.. ........+.+|+.++++++|||||++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc---cChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 36677788899999999999999999885 34689999998643 24556677999999999999999999999
Q ss_pred EEEcCCCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEe
Q 007055 83 SWVDDTNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 152 (620)
Q Consensus 83 ~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~----------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 152 (620)
+|..+. .+++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 91 ~~~~~~--~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 91 VVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV 166 (308)
T ss_dssp EECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE
T ss_pred EEecCC--ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceee
Confidence 886544 588999999999999998643 34789999999999999999999998 9999999999999
Q ss_pred cCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcC-CCCCCCCCHHHH
Q 007055 153 NGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE-YPYNECKNPAQI 226 (620)
Q Consensus 153 ~~~~G~vKI~DFGla~~~~~~----~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~-~Pf~~~~~~~~i 226 (620)
+ .++.+||+|||+++..... ......||+.|+|||.+. +.|+.++|||||||++|||+||. .||.+ .+..++
T Consensus 167 d-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~ 244 (308)
T d1p4oa_ 167 A-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQV 244 (308)
T ss_dssp C-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHH
T ss_pred c-CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHH
Confidence 8 7899999999999755432 233457899999999876 45899999999999999999985 66654 677888
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 227 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 227 ~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
+..+..+..+. .+...++.++++|.+||+ +|.+|||+.++++
T Consensus 245 ~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 245 LRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88888776543 445678899999999998 8999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=384.20 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=213.5
Q ss_pred eeeccCceEEEEEEEceeCCeEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceEE
Q 007055 8 IWSLFVLFLQYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 81 (620)
Q Consensus 8 ~~~~~~r~y~i~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVkl~ 81 (620)
.|.+....|+++++||+|+||.||+|.+ ..+++.||+|+++... .......+.+|+.+++.+ +|||||+++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 4666667889999999999999999986 3578899999987542 456667899999999999 799999999
Q ss_pred eEEEcCCCCeEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 007055 82 NSWVDDTNRTINMITELFTSGSLRQYRKKHK------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR 143 (620)
Q Consensus 82 ~~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 143 (620)
+++.+. ..+++|||||++|+|.+++.+.. .+++..+..|+.||+.||+|||+++ ++||
T Consensus 94 g~~~~~--~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHr 169 (311)
T d1t46a_ 94 GACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHR 169 (311)
T ss_dssp EEECSS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred EEEeeC--CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 998654 45889999999999999987543 5899999999999999999999999 9999
Q ss_pred CCCccceEecCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHh-cCCCC
Q 007055 144 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY 217 (620)
Q Consensus 144 DLKp~NILl~~~~G~vKI~DFGla~~~~~~~----~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELlt-G~~Pf 217 (620)
||||+||+++ .++.+||+|||+++...... .....||+.|+|||++. +.++.++|||||||++|||+| |.+||
T Consensus 170 DLKp~NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 170 DLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp CCSGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccccccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 9999999998 78999999999997654322 23467899999999876 568999999999999999999 56666
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 007055 218 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 269 (620)
Q Consensus 218 ~~~~~~~~i~~~i~~~~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL~ 269 (620)
........+.+.+..+..+. .+...++.+++||.+||. +|.+|||+.++|+
T Consensus 249 ~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 249 PGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TTCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66555566666666665543 455678999999999998 8999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=372.12 Aligned_cols=249 Identities=27% Similarity=0.380 Sum_probs=193.5
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCC--C
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--R 90 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~--~ 90 (620)
.|.|.+.+.||+|+||+||+|.+ +|+.||||+++... ........|+..+.+++|||||++++++.++.. .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 47788999999999999999975 69999999986432 122223346666678899999999999986543 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCEEecCCCccceEecCCCCcEEEccc
Q 007055 91 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDL 164 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~------~~~IiHrDLKp~NILl~~~~G~vKI~DF 164 (620)
.+++|||||++|+|.+++++. ++++..+..++.|++.||.|||+. .++|+||||||+|||++ .+|.+||+||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DF 152 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADL 152 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCC
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEec
Confidence 689999999999999999875 599999999999999999999974 22499999999999998 7899999999
Q ss_pred cchhhccCC------CCccccCCCCCCCcccccc-------ccCccchhhhhHHHHHHHHhcCCCCCCC-----------
Q 007055 165 GLAIVMQQP------TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNEC----------- 220 (620)
Q Consensus 165 Gla~~~~~~------~~~~~~GTp~y~APEll~~-------~y~~~~DIwSlGiilyELltG~~Pf~~~----------- 220 (620)
|++...... .....+||+.|+|||++.+ .++.++|||||||++|||+||..||...
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 999755332 2335689999999998764 2678999999999999999998876321
Q ss_pred ---CCHHHHHHHHHcCCCCCCCCCCC-----cHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 007055 221 ---KNPAQIYKKVTSGIKPASLSKVT-----DPQVKQFIEKCIV-PASLRLPALELLKD 270 (620)
Q Consensus 221 ---~~~~~i~~~i~~~~~p~~~~~~~-----~~~lk~~I~kcL~-~p~~Rpsa~elL~h 270 (620)
.....+...+......+.++... ...+.+++.+||+ +|.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12334444444333322222221 2358899999998 89999999999763
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-44 Score=370.02 Aligned_cols=252 Identities=21% Similarity=0.256 Sum_probs=195.6
Q ss_pred CceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceEEeEEEcCCCCeE
Q 007055 13 VLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 13 ~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVkl~~~f~~~~~~~l 92 (620)
|..|++.+.||+|+||+||+|.+..+|+.||+|++...... +++..|+++++.++|+|++..+..+... ....
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~ 78 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYN 78 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEec-CCEE
Confidence 34579999999999999999999999999999988754321 2478899999999988777665554443 3578
Q ss_pred EEEEeccCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC--CCCcEEEccccchhh
Q 007055 93 NMITELFTSGSLRQYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIV 169 (620)
Q Consensus 93 ~lV~Ey~~gGsL~~~i-~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~G~vKI~DFGla~~ 169 (620)
++||||+. |+|.+.+ ...+.+++..+..++.||+.||+|||+++ |+||||||+|||++. .++.+||+|||+|+.
T Consensus 79 ~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 79 VMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCccee
Confidence 89999995 4555554 45668999999999999999999999999 999999999999752 345799999999976
Q ss_pred ccCC---------CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCCCHHHHH--HHHHc---CC
Q 007055 170 MQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY--KKVTS---GI 234 (620)
Q Consensus 170 ~~~~---------~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~~~~~i~--~~i~~---~~ 234 (620)
.... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.......... ..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 5432 2345689999999998775 59999999999999999999999997644332211 11111 11
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH---HHhcCCCcC
Q 007055 235 KPASLSKVTDPQVKQFIEKCIV-PASLRLPAL---ELLKDPFLV 274 (620)
Q Consensus 235 ~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~---elL~hpff~ 274 (620)
.+.......++++.+||.+||. +|.+||++. ++|+|+|.+
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 1222345578899999999997 999999986 557777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.6e-42 Score=355.86 Aligned_cols=246 Identities=17% Similarity=0.237 Sum_probs=199.1
Q ss_pred cCceEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCcceEEeEEEcCCCC
Q 007055 12 FVLFLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTNR 90 (620)
Q Consensus 12 ~~r~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pNIVkl~~~f~~~~~~ 90 (620)
.|..|++.+.||+|+||+||+|.+..+|+.||+|++..... ...+.+|++.++.|.| +||+.+++++... .
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~ 74 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--L 74 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--T
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecC--C
Confidence 35667999999999999999999999999999998864321 1236789999999975 8999999987654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecC----CCCcEEEcccc
Q 007055 91 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDLG 165 (620)
Q Consensus 91 ~l~lV~Ey~~gGsL~~~i~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~----~~G~vKI~DFG 165 (620)
..++||||+ +|+|.+++...+ .+++..+..++.|++.||.|||++| |+||||||+|||++. .++.+||+|||
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccc
Confidence 688999999 789999887654 6999999999999999999999999 999999999999963 35789999999
Q ss_pred chhhccCC---------CCccccCCCCCCCcccccc-ccCccchhhhhHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcC
Q 007055 166 LAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSG 233 (620)
Q Consensus 166 la~~~~~~---------~~~~~~GTp~y~APEll~~-~y~~~~DIwSlGiilyELltG~~Pf~~~~--~~~~i~~~i~~~ 233 (620)
+|+..... .....+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+.. +....+..+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 99754322 2335689999999998765 59999999999999999999999997533 333444433322
Q ss_pred ---CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 007055 234 ---IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 268 (620)
Q Consensus 234 ---~~p~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~elL 268 (620)
..+..+.+..++++.+++..|+. +|.+||+...+.
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 12222344567899999999997 899999877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-42 Score=362.44 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=194.6
Q ss_pred eEEEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----------CCCcceEEeE
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----------HENIIKFYNS 83 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-----------HpNIVkl~~~ 83 (620)
+|++.++||+|+||+||+|.++.+|+.||||+++.. ....+.+.+|+.+++.++ ||||++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 379999999999999999999999999999998743 233456788999888875 5789999999
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCccceEecCCCC--
Q 007055 84 WVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNG-- 157 (620)
Q Consensus 84 f~~~~~~~l~lV~Ey~~gGsL~~~---i~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~G-- 157 (620)
|........+++++++..+..... ......+++..++.+++||+.||.|||+ +| |+||||||+|||++ .+|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~-~~~~~ 165 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLME-IVDSP 165 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEE-EEETT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeee-ccCcc
Confidence 876665667777777765543222 2334679999999999999999999998 77 99999999999997 333
Q ss_pred ----cEEEccccchhhccCCCCccccCCCCCCCccccc-cccCccchhhhhHHHHHHHHhcCCCCCCCCCH------HHH
Q 007055 158 ----EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP------AQI 226 (620)
Q Consensus 158 ----~vKI~DFGla~~~~~~~~~~~~GTp~y~APEll~-~~y~~~~DIwSlGiilyELltG~~Pf~~~~~~------~~i 226 (620)
.+|++|||.+..... .....+||+.|+|||++. ..|+.++||||+||++++|++|+.||...... ..+
T Consensus 166 ~~~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp TTEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cccceeeEeeccccccccc-ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 499999999875443 345678999999999776 56999999999999999999999999653211 111
Q ss_pred HHHHHc-CC--------------------CC------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHH
Q 007055 227 YKKVTS-GI--------------------KP------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALE 266 (620)
Q Consensus 227 ~~~i~~-~~--------------------~p------------------~~~~~~~~~~lk~~I~kcL~-~p~~Rpsa~e 266 (620)
...+.. +. .+ .......++++++||.+||. +|.+||||.|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111100 00 00 00112235789999999998 9999999999
Q ss_pred HhcCCCcCCCC
Q 007055 267 LLKDPFLVTDN 277 (620)
Q Consensus 267 lL~hpff~~~~ 277 (620)
+|+||||+...
T Consensus 325 ~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 325 LVNHPWLKDTL 335 (362)
T ss_dssp HHTCGGGTTCT
T ss_pred HhcCcccCCCC
Confidence 99999998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=4.2e-24 Score=204.99 Aligned_cols=170 Identities=17% Similarity=0.188 Sum_probs=123.3
Q ss_pred EEEEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc-----C-------C--HHHHHHHHHHHHHHHhCCCCCcceEEe
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-----Q-------S--PDQLERLYSEVHLLKSLKHENIIKFYN 82 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~-----~-------~--~~~~~~l~~Ei~iL~~L~HpNIVkl~~ 82 (620)
-++++||+|+||+||+|.+. +|++||+|+++..... . . ........+|+..+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 47899999999999999985 7999999987532110 0 0 111234567899999999999999887
Q ss_pred EEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCccceEecCCCCcEEEc
Q 007055 83 SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 162 (620)
Q Consensus 83 ~f~~~~~~~l~lV~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~G~vKI~ 162 (620)
+. . -+++|||+.++.+.+ +++..+..++.|++.+|.|||++| |+||||||+|||++ + +.++|+
T Consensus 82 ~~--~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~li 144 (191)
T d1zara2 82 WE--G----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWII 144 (191)
T ss_dssp EE--T----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEEC
T ss_pred ec--C----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeee-C-CCEEEE
Confidence 52 2 257999999866542 556667889999999999999999 99999999999998 4 458999
Q ss_pred cccchhhccCCCCccccC-CCCCCCccccccccCccchhhhhHH
Q 007055 163 DLGLAIVMQQPTARSVIG-TPEFMAPELYEEEYNELVDIYSFGM 205 (620)
Q Consensus 163 DFGla~~~~~~~~~~~~G-Tp~y~APEll~~~y~~~~DIwSlGi 205 (620)
|||+|.....+....... +.. --.+.+...|+..+|+||..-
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~-~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR-NIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH-HHHHHHHHHHCCCCCHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHH-HHHHHHcCCCCCcccHHHHHH
Confidence 999986554433221110 000 001234567899999999643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.84 E-value=3.5e-05 Score=74.22 Aligned_cols=138 Identities=14% Similarity=0.019 Sum_probs=84.7
Q ss_pred EEEEEEceeCCeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEcCCCCeEEEE
Q 007055 17 QYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI 95 (620)
Q Consensus 17 ~i~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~~~~~~l~lV 95 (620)
+..+..+.++.+.||+.. .++..+++|+....... ....+.+|...++.|. +-.+.+++.+..+ ....++|
T Consensus 17 ~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv 88 (263)
T d1j7la_ 17 RCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLL 88 (263)
T ss_dssp EEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEE
T ss_pred EEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc----chhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEEE
Confidence 445544445557899874 45666778876533211 1223667888887773 3345666665433 3567899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 007055 96 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-------------------------------------- 137 (620)
Q Consensus 96 ~Ey~~gGsL~~~i~~~~~l~e~~i~~i~~QIl~gL~yLHs~~-------------------------------------- 137 (620)
|++++|.++...... ......++.++...|..||+..
T Consensus 89 ~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 999999887654221 1112233444444455555321
Q ss_pred -------------------CCEEecCCCccceEecCCCCcEEEccccchh
Q 007055 138 -------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 138 -------------------~~IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
+.++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec-CCceEEEeechhcc
Confidence 1179999999999998 45555799998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.60 E-value=9.9e-05 Score=76.40 Aligned_cols=81 Identities=15% Similarity=0.148 Sum_probs=49.3
Q ss_pred EEEEceeCCeEEEEEEEccCCeEEEEEEeeccccc---CCHHHHHHHHHHHHHHHhCC-C--CCcceEEeEEEcCCCCeE
Q 007055 19 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM---QSPDQLERLYSEVHLLKSLK-H--ENIIKFYNSWVDDTNRTI 92 (620)
Q Consensus 19 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~v~~~~~~---~~~~~~~~l~~Ei~iL~~L~-H--pNIVkl~~~f~~~~~~~l 92 (620)
.+.||.|....||+..+..+|+.|++|+-...-.. ..+...++...|.+.|+.+. + ..++++|. .++.. -
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~--~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM--A 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT--T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCC--C
Confidence 45689999999999998888889999975321110 11122345667888887662 2 34556665 34443 3
Q ss_pred EEEEeccCCCC
Q 007055 93 NMITELFTSGS 103 (620)
Q Consensus 93 ~lV~Ey~~gGs 103 (620)
++|||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 47899998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.26 E-value=0.00051 Score=65.38 Aligned_cols=74 Identities=11% Similarity=-0.049 Sum_probs=47.0
Q ss_pred EEceeCC-eEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCcceEEeEEEcCCCCeEEEEEe
Q 007055 21 ILGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITE 97 (620)
Q Consensus 21 ~LG~G~f-g~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pNIVkl~~~f~~~~~~~l~lV~E 97 (620)
.+..|.. +.||+... ..|..+++|...... ...+..|...|+.|.. -.+.+++.+..+. ...++||+
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~ 86 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLG 86 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEE
Confidence 4455553 67898864 456668888754322 1236678888877743 3356677654433 46788999
Q ss_pred ccCCCCH
Q 007055 98 LFTSGSL 104 (620)
Q Consensus 98 y~~gGsL 104 (620)
+++|.++
T Consensus 87 ~i~G~~~ 93 (255)
T d1nd4a_ 87 EVPGQDL 93 (255)
T ss_dssp CCSSEET
T ss_pred eeecccc
Confidence 9988655
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.02 E-value=0.024 Score=57.59 Aligned_cols=77 Identities=14% Similarity=0.119 Sum_probs=47.9
Q ss_pred eEEEEEEEceeCCeEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceEEeEEEc
Q 007055 15 FLQYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD 86 (620)
Q Consensus 15 ~y~i~e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVkl~~~f~~ 86 (620)
.+++ +.|+.|-.-.+|++.... ....|.+++.-.. .. . ....+|..+++.+. +.-..+++.++
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~--~-idr~~E~~i~~~ls~~gl~Pkll~~~-- 114 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET--E-SHLVAESVIFTLLSERHLGPKLYGIF-- 114 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC--H-HHHHHHHHHHHHHHHTTSSSCEEEEE--
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---ch--h-hHHHHHHHHHHHHHhCCCCCeEEEEc--
Confidence 3444 577879999999987653 3456766654311 11 1 23457888888884 43345677765
Q ss_pred CCCCeEEEEEeccCCCCH
Q 007055 87 DTNRTINMITELFTSGSL 104 (620)
Q Consensus 87 ~~~~~l~lV~Ey~~gGsL 104 (620)
++ .+|+||++|..|
T Consensus 115 ~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 115 SG----GRLEEYIPSRPL 128 (395)
T ss_dssp TT----EEEECCCCEEEC
T ss_pred CC----ceEEEEeccccC
Confidence 22 368899987443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.72 E-value=0.036 Score=54.68 Aligned_cols=69 Identities=10% Similarity=0.033 Sum_probs=40.3
Q ss_pred CeEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc--ceEEe----EEEcCCCCeEEEEEeccC
Q 007055 27 FKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI--IKFYN----SWVDDTNRTINMITELFT 100 (620)
Q Consensus 27 fg~Vy~a~d~~tg~~VAiK~v~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI--Vkl~~----~f~~~~~~~l~lV~Ey~~ 100 (620)
--.||++.. .+|..|++|+..... .+ .+.+..|+..+..|...+| +.... ... ......+.+++++.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~--~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~-~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER--WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL-NHQGFYFAVFPSVG 107 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT--SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE-EETTEEEEEEECCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC--CC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeee-eeeeEEEEEEeecC
Confidence 457999864 578889999865321 12 2446778888877742222 11111 111 12346778899987
Q ss_pred CC
Q 007055 101 SG 102 (620)
Q Consensus 101 gG 102 (620)
|.
T Consensus 108 G~ 109 (325)
T d1zyla1 108 GR 109 (325)
T ss_dssp CE
T ss_pred Cc
Confidence 63
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.33 E-value=0.13 Score=49.70 Aligned_cols=28 Identities=32% Similarity=0.387 Sum_probs=24.0
Q ss_pred EEecCCCccceEecCCCCcEEEccccchh
Q 007055 140 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 168 (620)
Q Consensus 140 IiHrDLKp~NILl~~~~G~vKI~DFGla~ 168 (620)
+||+|+.++||+++ .++..-|.||+.+.
T Consensus 185 iIHgDl~~dNvl~~-~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 185 VIHADLFQDNVFFL-GDELSGLIDFYFAC 212 (316)
T ss_dssp EECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred cccCCcchhhhhcc-cccceeEecccccc
Confidence 99999999999998 45556799999873
|